PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Berger, J; Swenson, JE; Persson, IL				Berger, J; Swenson, JE; Persson, IL			Recolonizing carnivores and naive prey: Conservation lessons from Pleistocene extinctions	SCIENCE			English	Article							BEHAVIOR; BEARS	The current extinction of many of Earth's Large terrestrial carnivores has Left some extant prey species Lacking knowledge about contemporary predators, a situation roughly parallel to that 10,000 to 50,000 years ago, when naive animals first encountered colonizing human hunters. Along present-day carnivore recolonization fronts, brown (also called grizzly) bears killed predator-naive adult moose at disproportionately high rates in Scandinavia, and moose mothers who Lost juveniles to recolonizing wolves in North America's Yellowstone region developed hypersensitivity to wolf howls. Although prey that had been unfamiliar with dangerous predators for as few as 50 to 130 years were highly vulnerable to initial encounters, behavioral adjustments to reduce predation transpired within a single generation. The fact that at Least one prey species quickly Learns to be wary of restored carnivores should negate fears about Localized prey extinction.	Univ Nevada, Program Ecol Evolut & Conservat Biol, Reno, NV 89512 USA; Wildlife Conservat Soc, Moose, WY 83012 USA; Agr Univ Norway, Dept Biol & Nat Conservat, N-1432 As, Norway; Norwegian Inst Nat Res, N-7485 Trondheim, Norway; Univ Oslo, Dept Zool, N-1040 Oslo, Norway	Nevada System of Higher Education (NSHE); University of Nevada Reno; Wildlife Conservation Society; Norwegian University of Life Sciences; Norwegian Institute Nature Research; University of Oslo	Berger, J (corresponding author), Univ Nevada, Program Ecol Evolut & Conservat Biol, Reno, NV 89512 USA.	berger@unr.edu	Swenson, Jon/AAE-2890-2019; Swenson, Jon/E-2883-2013					Berger J, 1999, P ROY SOC B-BIOL SCI, V266, P2261, DOI 10.1098/rspb.1999.0917; BERGER J, 1999, CONSERV BIOL, V13, P380; Boyd R, 1985, CULTURE EVOLUTIONARY; Byers JA, 1998, AM PRONGHORN SOCIAL; Cheney DL, 1991, MONKEYS SEE WORLD; Coulson Graeme, 1996, P158; Craighead J.J., 1995, GRIZZLY BEARS YELLOW; Guthrie R. D., 1990, CURR RES PLEISTOCENE, V7, P111; Haglund B., 1968, VILTREVY, V5, P213; Heinrich B., 1999, MIND RAVEN; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Laland Kevin N., 1996, P129, DOI 10.1016/B978-012273965-1/50008-X; Martin P.S., 1984, P354; MARTIN PS, 1984, Q EXTINCTIONS; MECH LD, 1966, US NAT PARK SERV FAU, V7, P1; MOSIMANN JE, 1975, AM SCI, V63, P304; MURIE A, 1981, NATL PARK SERV MONOG, V14, P1; Reading Richard P., 1996, P296; SCHWARTZ C. C., 1992, ALCES S, V1, P177; Swenson JE, 1999, J WILDLIFE MANAGE, V63, P354, DOI 10.2307/3802519; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Testa J. Ward, 2000, Alces, V36, P155	23	298	304	4	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2001	291	5506					1036	1039		10.1126/science.1056466	http://dx.doi.org/10.1126/science.1056466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11161215				2022-12-24	WOS:000166860100043
J	Niklason, LE; Langer, R				Niklason, LE; Langer, R			Prospects for organ and tissue replacement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STEM-CELLS; IN-VITRO; TRANSPLANTATION; FAILURE; THERAPY	Damage or loss of a tissue or organ is common, costly, and tragic. Advances in mechanical artificial organs and organ transplantation have improved the treatment of organ failure, and advances in molecular immunology, tissue engineering, and stem cell biology offer the promise of even better therapeutic modalities for treating organ failure in the future. Enhancement of immune tolerance of transplanted tissues, improved understanding of cellular differentiation and tissue development, and advances in biomaterials may enable the de novo creation of implantable tissue and organs for transplantation, Innovative techniques for prevention and treatment of tissue loss and organ failure should improve the quality and length of life.	Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA; Duke Univ, Dept Anesthesia, Durham, NC 27710 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; MIT, Dept Chem Engn, Div Bioengn & Environm Hlth, Cambridge, MA 02139 USA	Duke University; Duke University; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Niklason, LE (corresponding author), Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003492, R01HL060435] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL03492-04, HL-60435] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baquerizo A, 1999, TRANSPLANTATION, V67, P5, DOI 10.1097/00007890-199901150-00003; BARNARD C N, 1967, South African Medical Journal, V41, P1271; Barrington K, 1997, BRIT MED J, V315, P1215, DOI 10.1136/bmj.315.7117.1215; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; DEVRIES WC, 1984, NEW ENGL J MED, V310, P273, DOI 10.1056/NEJM198402023100501; El-Banayosy A, 2000, J THORAC CARDIOV SUR, V119, P581, DOI 10.1016/S0022-5223(00)70140-1; Giannoukakis N, 1999, GENE THER, V6, P1499, DOI 10.1038/sj.gt.3300981; Goddard MJ, 2000, J CLIN PATHOL, V53, P44, DOI 10.1136/jcp.53.1.44; Gudmundsdottir H, 2000, SEMIN NEPHROL, V20, P209; Guinan EC, 1999, NEW ENGL J MED, V340, P1704, DOI 10.1056/NEJM199906033402202; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hancock WW, 2000, SEMIN NEPHROL, V20, P217; Hattler BG, 1999, PERFUSION-UK, V14, P311, DOI 10.1177/026765919901400411; Helderman JH, 2000, SEMIN NEPHROL, V20, P83; Humes HD, 1999, KIDNEY INT, V55, P2502, DOI 10.1046/j.1523-1755.1999.00486.x; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kolff WJ, 1944, ACTA MED SCAND, V117, P121; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lanza RP, 1999, NAT BIOTECHNOL, V17, P1171, DOI 10.1038/70709; MURRAY JE, 1976, ANN SURG, V184, P565, DOI 10.1097/00000658-197611000-00006; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramiya VK, 2000, NAT MED, V6, P278; Schwartz RS, 1999, NEW ENGL J MED, V340, P1754, DOI 10.1056/NEJM199906033402209; Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; *UN NETW ORG SHAR, 2001, CRIT DAT 2000 US FAC; Vacanti JP, 1999, LANCET S1, V354, pSI32	31	74	78	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					573	576		10.1001/jama.285.5.573	http://dx.doi.org/10.1001/jama.285.5.573			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176861	Bronze			2022-12-24	WOS:000166714200014
J	Richards, M; Hardy, R; Kuh, D; Wadsworth, MEJ				Richards, M; Hardy, R; Kuh, D; Wadsworth, MEJ			Birth weight and cognitive function in the British 1946 birth cohort: longitudinal population based study	BRITISH MEDICAL JOURNAL			English	Article							GROWTH-FACTORS; FOLLOW-UP; INSULIN; BRAIN; REGRESSION	Objective To examine the association between birth weight and cognitive function in the normal population. Design A longitudinal, population based, birth cohort study. Participants 3900 males and females born in 1946. Main outcome measures Cognitive function from childhood to middle life (measured at ages 8, 11, 15, 26, and 43 years). Results Birth weight was significantly and positively associated with cognitive ability at age 8 (with an estimated standard deviation score of 0.44 (95%, confidence interval 0.28 to 0.59)) between the lowest and highest birthweight categories after sex, father's social class, mother's education, and birth order were controlled for. This association was evident across the normal birthweight range (> 2.5 kg) and so was not accounted for exclusively by low birth weight The association was also observed at ages 11, 15, and 26, and weakly at age 43, although these associations were dependent on the association at age 8. Birth weight was also associated with education, with those of higher. birth weight more likely to have achieved higher qualifications, and this effect was accounted for partly by cognitive function at age 8. Conclusions Birth weight was associated with cognitive ability at age 8 in the general population, and in the normal birthweight range. The effect at this age largely explains associations between birth weight and cognitive function at subsequent ages. Similarly, the association between birth weight and education was accounted for partly by earlier cognitive scores.	UCL, Dept Epidemiol & Publ Hlth, Natl Survey Hlth & Dev, London WC1E 6BT, England	University of London; University College London	Richards, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Natl Survey Hlth & Dev, Mortimer St, London WC1E 6BT, England.	m.richards@ucl.ac.uk	Hardy, Rebecca/AFR-1989-2022; Kuh, Diana/L-6019-2014	Kuh, Diana/0000-0001-7386-2857; Hardy, Rebecca/0000-0001-9949-0799; Richards, Marcus/0000-0001-9191-2192				Barker DJP, 1998, MOTHERS BABIES HLTH; BLAND JM, 1994, BRIT MED J, V309, P780, DOI 10.1136/bmj.309.6957.780; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; BRESLAU N, 1995, EPIDEMIOL REV, V17, P96, DOI 10.1093/oxfordjournals.epirev.a036191; COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9; DEPABLO F, 1995, TRENDS NEUROSCI, V18, P143, DOI 10.1016/0166-2236(95)93892-2; Eckstein LW, 1997, DEV BRAIN RES, V103, P59, DOI 10.1016/S0165-3806(97)00117-X; Fall C. H. D., 1995, Archives of Disease in Childhood, V73, P287; Fawer CL, 1995, EARLY HUM DEV, V43, P151, DOI 10.1016/0378-3782(95)01673-2; Illsley R, 1984, LOW BIRTH WEIGHT MED; Kline J.S., 1989, CONCEPTION BIRTH EPI; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Martyn CN, 1996, BRIT MED J, V312, P1393; NELSON KB, 1970, DEV MED CHILD NEUROL, V12, P487; PAZ I, 1995, OBSTET GYNECOL, V85, P452; Pigeon DA, 1968, ALL OUR FUTURE; Pigeon DA, 1964, HOME SCH; Plewis I, 1996, BRIT J MATH STAT PSY, V49, P25, DOI 10.1111/j.2044-8317.1996.tb01073.x; RECORD RG, 1969, ANN HUM GENET, V33, P71, DOI 10.1111/j.1469-1809.1969.tb01631.x; Richards M, 1999, NEUROLOGY, V53, P308, DOI 10.1212/WNL.53.2.308; Singh SP, 1996, P SOC EXP BIOL MED, V212, P349; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; Stein Z., 1975, FAMINE HUM DEV DUTCH; Wadsworth M. E. J., 1991, IMPRINT TIME CHILDHO; WADSWORTH MEJ, 1992, J EPIDEMIOL COMMUN H, V46, P300, DOI 10.1136/jech.46.3.300; Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517	26	266	271	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 27	2001	322	7280					199	203		10.1136/bmj.322.7280.199	http://dx.doi.org/10.1136/bmj.322.7280.199			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	398BF	11159613	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000166733700024
J	Hatcher, MB; Fallowfield, L; A'Hern, R				Hatcher, MB; Fallowfield, L; A'Hern, R			The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews	BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; FAMILY-HISTORY; RISK PERCEPTION; WOMEN	Objectives To investigate the psychosocial impact of bilateral prophylactic mastectomy for women with increased risk of breast cancer and to identify, preoperatively, risk factors for postoperative distress. Design Prospective study using interviews and questionnaire assessments. Setting Participants' homes throughout the United Kingdom. Participants 143 women with increased risk of developing breast cancer who were offered bilateral prophylactic mastectomy and who accepted or declined the surgery; a further 11 were offered surgery but deferred making a decision. Main outcome measures Psychological and sexual morbidity. Results Psychological morbidity decreased significantly over time for the 79 women who chose to have surgery (accepters): 58% (41/71) preoperatively v 41% (29/71) 6 months postoperatively (difference in percentages 17%, 95% confidence interval 2% to 32%; P = 0.04) and 60% (39/65) preoperatively v 29% (19/65) 18 months postoperatively (31%, 15% to 47%; P < 0.001). Psychological morbidity in the 64 women who declined surgery (decliners) did not decrease significantly: 57% (31/54) at baseline v 43% (23/54) at 6 months (14%, 0% to 29%; P = 0.08) and 57% (29/52) at baseline v 41% (21/52) at 18 months (16%; - 2% to 33%; P = 0.11). Greater than normal proneness to anxiety was more common in the decliners than in the accepters: 78% (45/58) v 56% (41/73) (22%, 6% to 35%; P = 0.006). Accepters were more likely than decliners to believe it inevitable that they would develop breast cancer (32% (24/74) v 10% (6/58) (difference in percentages 22%, 9% to 35%;P = 0.003)), and decliners were more likely to believe that screening could help (92% (55/60) v 74% (55/74) (18%, 5% to 31%; P = 0.007)). Level of sexual discomfort and degree of sexual pleasure did not change significantly over time in either of the two groups. Conclusions Bilateral prophylactic mastectomy may provide psychological benefits in women with a high risk of developing breast cancer.	UCL Royal Free & Univ Coll Med Sch, Bland Sutton Inst, Canc Res Campaign, Psychosocial Oncol Grp, London W1P 7PL, England; Royal Marsden NHS Trust, London SW3 6JJ, England	University of London; University College London; UCL Medical School; Royal Marsden NHS Foundation Trust	Fallowfield, L (corresponding author), UCL Royal Free & Univ Coll Med Sch, Bland Sutton Inst, Canc Res Campaign, Psychosocial Oncol Grp, London W1P 7PL, England.	l.fallowfield@ucl.ac.uk		Fallowfield, Lesley/0000-0003-0577-4518				Al-Ghazal SK, 2000, EUR J SURG ONCOL, V26, P17, DOI 10.1053/ejso.1999.0733; Borgen PI, 1998, ANN SURG ONCOL, V5, P603, DOI 10.1007/BF02303829; EELES JWR, 1996, CLIN ONCOL, V8, P222; EVANS DGR, 1994, BRIT J CANCER, V70, P934, DOI 10.1038/bjc.1994.423; Fallowfield L, 1996, INT CONGR SER, V1120, P219; FALLOWFIELD LJ, 1994, BREAST, V3, P202; FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150; Frost MH, 2000, JAMA-J AM MED ASSOC, V284, P319, DOI 10.1001/jama.284.3.319; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Hopwood P, 1998, PSYCHO-ONCOL, V7, P402, DOI 10.1002/(SICI)1099-1611(1998090)7:5<402::AID-PON317>3.3.CO;2-O; HOPWOOD P, IN PRESS EUR J CANC; LERMAN C, 1994, ARCH INTERN MED, V154, P609, DOI 10.1001/archinte.154.6.609; LYNCH HT, 1994, CANCER, V74, P1184, DOI 10.1002/1097-0142(19940801)74:3+<1184::AID-CNCR2820741530>3.0.CO;2-4; MACKE E, 1996, TROUBLED HELIX SOCIA, P31; SPIELBERGER CD, 1983, MANUAL STATE TRAIT A; Stead ML, 1999, BRIT J OBSTET GYNAEC, V106, P50, DOI 10.1111/j.1471-0528.1999.tb08084.x; Stefanek M E, 1995, J Natl Cancer Inst Monogr, P37; THIRLAWAY K, 1995, BREAST, V4, P203, DOI 10.1016/0960-9776(95)90078-0; Thirlaway K, 1996, BRIT J CANCER, V73, P1422, DOI 10.1038/bjc.1996.269; Thirlaway K, 1996, QUAL LIFE RES, V5, P81, DOI 10.1007/BF00435972; Watson M, 1999, BRIT J CANCER, V79, P868, DOI 10.1038/sj.bjc.6690139; ZATZ J, 1996, TROUBLED HELIX SOCIA, P27	23	121	122	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 13	2001	322	7278					76	79		10.1136/bmj.322.7278.76	http://dx.doi.org/10.1136/bmj.322.7278.76			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393XZ	11154619	Bronze, Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000166496100023
J	Smith, KC				Smith, KC			Genetic disease, genetic testing, and the clinician	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Clemson Univ, Clemson, SC 29634 USA	Clemson University	Smith, KC (corresponding author), Clemson Univ, Clemson, SC 29634 USA.							HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Smith KC, 1998, MT SINAI J MED, V65, P178; SMITH KC, IN PRESS EUR J MED P	3	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2001	285	1					91	91		10.1001/jama.285.1.91	http://dx.doi.org/10.1001/jama.285.1.91			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387GH	11150119	hybrid, Green Submitted			2022-12-24	WOS:000166114500033
J	Sandock, LF				Sandock, LF			From rites of passage to last rights	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2000	284	24					3100	3102		10.1001/jama.284.24.3100	http://dx.doi.org/10.1001/jama.284.24.3100			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	385FZ	11135750				2022-12-24	WOS:000165994100001
J	Odelberg, SJ; Kollhoff, A; Keating, MT				Odelberg, SJ; Kollhoff, A; Keating, MT			Dedifferentiation of mammalian myotubes induced by msx1	CELL			English	Article							MESENCHYMAL STEM-CELLS; TERMINAL DIFFERENTIATION; MYOGENIC DIFFERENTIATION; LIMB REGENERATION; GENE-EXPRESSION; C2C12 MYOBLASTS; MUSCLE-CELLS; FATTY-ACIDS; REVERSAL; CYCLE	The process of cellular differentiation culminating in terminally differentiated mammalian cells is thought to be irreversible. Here, we present evidence that terminally differentiated murine myotubes can be induced to dedifferentiate. Ectopic expression of msx1 in C2C12 myotubes reduced the nuclear muscle proteins MyoD, myogenin, MRF4, and p21 to undetectable levels in 20%-50% of the myotubes. Approximately 9% of the myotubes cleave to produce either smaller multinucleated myotubes or proliferating, mononucleated cells. Finally, clonal populations of the myotube-derived mononucleated cells can be induced to redifferentiate into cells expressing chondrogenic, adipogenic, myogenic, and osteogenic markers. These results suggest that terminally differentiated mammal lan myotubes can dedifferentiate when stimulated with the appropriate signals and that msx1 can contribute to the dedifferentiation process.	Univ Utah, Dept Internal Med, Div Cardiol, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Odelberg, SJ (corresponding author), Univ Utah, Dept Internal Med, Div Cardiol, Salt Lake City, UT 84112 USA.	odelberg@howard.genetics.utah.edu; mkeating@genetics.med.harvard.edu	Wilson, Matthew H/K-3193-2013					AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; BECKER RO, 1974, NATURE, V248, P145, DOI 10.1038/248145a0; BODEMER CW, 1959, DEV BIOL, V1, P327, DOI 10.1016/0012-1606(59)90032-6; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; CATRON KM, 1995, MOL CELL BIOL, V15, P861; CHALKLEY DT, 1954, J MORPHOL, V94, P21, DOI 10.1002/jmor.1050940103; COMELISON DDW, 1997, DEV BIOL, V191, P270; DAVIS BM, 1990, EXP NEUROL, V108, P198, DOI 10.1016/0014-4886(90)90124-B; Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700; Endo T, 1998, J CELL SCI, V111, P1081; Endo T., 1989, CELLULAR MOL BIOL MU, P95; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; Grimaldi PA, 1997, PROSTAG LEUKOTR ESS, V57, P71, DOI 10.1016/S0952-3278(97)90495-6; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; HILL RE, 1989, GENE DEV, V3, P26, DOI 10.1101/gad.3.1.26; Hoshimaru M, 1996, P NATL ACAD SCI USA, V93, P1518, DOI 10.1073/pnas.93.4.1518; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kumar A, 2000, DEV BIOL, V218, P125, DOI 10.1006/dbio.1999.9569; Lee TC, 1998, NUCLEIC ACIDS RES, V26, P3215, DOI 10.1093/nar/26.13.3215; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; LUJVIDIN S, 1990, DIFFERENTIATION, V43, P192; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Namiki M, 1997, J BIOL CHEM, V272, P22046, DOI 10.1074/jbc.272.35.22046; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; ROBERT B, 1989, EMBO J, V8, P91, DOI 10.1002/j.1460-2075.1989.tb03352.x; Rosania GR, 2000, NAT BIOTECHNOL, V18, P304, DOI 10.1038/73753; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; SIMON HG, 1995, DEV DYNAM, V202, P1, DOI 10.1002/aja.1002020102; SONG KN, 1992, NATURE, V360, P477, DOI 10.1038/360477a0; STEEN TP, 1968, J EXP ZOOL, V167, P49, DOI 10.1002/jez.1401670105; TEBOUL L, 1995, J BIOL CHEM, V270, P28183, DOI 10.1074/jbc.270.47.28183; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; WOLOSHIN P, 1995, CELL, V82, P611, DOI 10.1016/0092-8674(95)90033-0; Yoshida N, 1998, J CELL SCI, V111, P769	42	350	379	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2000	103	7					1099	1109		10.1016/S0092-8674(00)00212-9	http://dx.doi.org/10.1016/S0092-8674(00)00212-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163185	Bronze			2022-12-24	WOS:000166040600012
J	Veenstra, GJC; Weeks, DL; Wolffe, AP				Veenstra, GJC; Weeks, DL; Wolffe, AP			Distinct roles for TBP and TBP-like factor in early embryonic gene transcription in Xenopus	SCIENCE			English	Article							MAJOR DEVELOPMENTAL TRANSITION; BOX-BINDING PROTEIN; MIDBLASTULA TRANSITION; EXPRESSION; EMBRYOGENESIS; LAEVIS	The TATA-binding protein (TBP) is believed to function as a key component of the general transcription machinery. We tested the role of TBP during the onset of embryonic transcription by antisense oligonucleotide-mediated turnover of maternal TBP messenger RNA. Embryos without detectable TBP initiated gastrulation but died before completing gastrulation. The expression of many genes transcribed by RNA polymerase II and III was reduced: however, some genes were transcribed with an efficiency identical to that of TBP-containing embryos. Using a similar antisense strategy, we found that the TBP-Like factor TLF/TRF2 is essential for development past the mid-blastula stage. Because TBP and a TLF factor play complementary roles in embryonic development, our results indicate that although similar mechanistic roles exist in common. TBP and TLF function differentially to control transcription of specific genes.	NICHHD, Mol Embryol Lab, Bethesda, MD 20892 USA; NICHHD, Mol Genet Lab, Bethesda, MD 20892 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; Sangamo Biosci, Richmond, CA 94804 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Iowa; Sangamo Therapeutics, Inc.	Veenstra, GJC (corresponding author), NICHHD, Mol Embryol Lab, Bethesda, MD 20892 USA.		Veenstra, Gert Jan C./D-4963-2012; Weeks, Daniel/F-6216-2010	Veenstra, Gert Jan C./0000-0002-7787-4940; Weeks, Daniel/0000-0002-4977-2410				ALMOUZNI G, 1995, EMBO J, V14, P1752, DOI 10.1002/j.1460-2075.1995.tb07164.x; Bell P, 1999, EXP CELL RES, V248, P122, DOI 10.1006/excr.1999.4411; Dagle JM, 2000, NUCLEIC ACIDS RES, V28, P2153, DOI 10.1093/nar/28.10.2153; Dagle JM, 2000, METHOD ENZYMOL, V313, P420; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; Dantonel JC, 1999, TRENDS BIOCHEM SCI, V24, P335, DOI 10.1016/S0968-0004(99)01436-X; Gawantka V, 1998, MECH DEVELOP, V77, P95, DOI 10.1016/S0925-4773(98)00115-4; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Holmes MC, 2000, SCIENCE, V288, P867, DOI 10.1126/science.288.5467.867; JAMRICH M, 1987, GENE DEV, V1, P124, DOI 10.1101/gad.1.2.124; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; KRIECHBAUM M, 1988, SUPERLATTICE MICROST, V5, P93, DOI 10.1016/0749-6036(89)90074-8; KRIEG PA, 1985, EMBO J, V4, P3463, DOI 10.1002/j.1460-2075.1985.tb04105.x; Moore PA, 1999, MOL CELL BIOL, V19, P7610; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; PRIOLEAU MN, 1994, CELL, V77, P439, DOI 10.1016/0092-8674(94)90158-9; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; RUPP RAW, 1991, CELL, V65, P927, DOI 10.1016/0092-8674(91)90545-A; Sible JC, 1997, DEV BIOL, V189, P335, DOI 10.1006/dbio.1997.8683; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; Teichmann M, 1999, P NATL ACAD SCI USA, V96, P13720, DOI 10.1073/pnas.96.24.13720; Veenstra GJC, 1999, MOL CELL BIOL, V19, P7972, DOI 10.1128/mcb.19.12.7972; VEENSTRA GJC, UNPUB	25	109	113	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2000	290	5500					2312	+		10.1126/science.290.5500.2312	http://dx.doi.org/10.1126/science.290.5500.2312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125147				2022-12-24	WOS:000165995800047
J	Liu, ZH; Sun, CH; Olejniczak, ET; Meadows, RP; Betz, SF; Oost, T; Herrmann, J; Wu, JC; Fesik, SW				Liu, ZH; Sun, CH; Olejniczak, ET; Meadows, RP; Betz, SF; Oost, T; Herrmann, J; Wu, JC; Fesik, SW			Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain	NATURE			English	Article							APOPTOSIS PROTEIN XIAP; DISTANCE RESTRAINTS; NMR STRUCTURE; INHIBITOR; DROSOPHILA; HOMOLOGY; CASPASES; CANCER; GENE; IAP	The inhibitor-of-apoptosis proteins (IAPs)(1) regulate programmed cell death by inhibiting members of the caspase family of enzymes(2-5). Recently, a mammalian protein called Smac(6) (also named DIABLO(7)) was identified that binds to the IAPs and promotes caspase activation. Although undefined in the X-ray structure, the amino-terminal residues of Smac are critical for its function(8,9). To understand the structural basis for molecular recognition between Smac and the IAPs, we determined the solution structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac. The peptide binds across the third beta -strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein. The complex is stabilized by four intermolecular hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions. This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small molecules that may be used for the treatment of cancers that overexpress IAPs(10-12).	Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA; Idun Pharmaceut Inc, Dept Biochem, La Jolla, CA 92037 USA	Abbott Laboratories	Fesik, SW (corresponding author), Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA.							Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Cutforth T, 1999, MECH DEVELOP, V82, P23, DOI 10.1016/S0925-4773(99)00006-4; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Hawkins CJ, 1996, P NATL ACAD SCI USA, V93, P13786, DOI 10.1073/pnas.93.24.13786; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300	27	519	580	0	39	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					1004	1008		10.1038/35050006	http://dx.doi.org/10.1038/35050006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140637				2022-12-24	WOS:000165951100058
J	Kristensen, I; Aaby, P; Jensen, H				Kristensen, I; Aaby, P; Jensen, H			Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa	BRITISH MEDICAL JOURNAL			English	Article							CALMETTE-GUERIN THERAPY; MEASLES VACCINATION; EDMONSTON-ZAGREB; RANDOMIZED TRIAL; MORTALITY; BCG; IMMUNIZATION; PROTECTION; PERTUSSIS; VACCINES	Objective To examine the association between routine childhood vaccinations and survival among infants in Guinea-Bissau. Design Follow up study. Participants 15 351 women and their children born during 1990 and 1996. Setting Rural Guinea-Bissau. Main outcome measures Infant mortality over sh months (between age 0-6 months and 7-13 months for BCG; diphtheria, tetanus, and pertussis; and polio vaccines and between 7-13 months and 14-20 months for measles vaccine). Results Mortality was lower in the group vaccinated with any vaccine compared with those not vaccinated, the mortality ratio being 0.74 (95% confidence interval 0.53 to 1.03). After cluster, age, and other vaccines were adjusted for, BCG was associated with significantly lower mortality ratio (0.55 (0.36 to 0.85)). However, recipients of one dose of diphtheria, tetanus, and pertussis or polio vaccines had higher mortality than children who had received none of these vaccines (1.84 (1.10 to 3.10) for diphtheria, tetanus, and pertussis). Recipients of measles vaccine had a mortality ratio of 0.18 (0.27 to 0.87). When deaths from measles were excluded from the analysis the mortality ratio was 0.51 (0.28 to 0.95). Estimates were unchanged by controls for background factors. Conclusions These trends are unlikely to be explained exclusively by selection biases since different vaccines were associated with opposite tendencies. Measles and BCG vaccines may have beneficial effects in addition to protection against measles and tuberculosis.	Statens Serum Inst, Danish Epidemiol Sci Ctr, DK-2300 Copenhagen, Denmark; Bandim Hlth Project, Bissau, Guinea Bissau	Aarhus University; Statens Serum Institut	Aaby, P (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen, Denmark.			Aaby, Peter/0000-0001-8331-1389				AABY P, 1993, BRIT MED J, V307, P1308, DOI 10.1136/bmj.307.6915.1308; Aaby P, 1996, T ROY SOC TROP MED H, V90, P326, DOI 10.1016/S0035-9203(96)90275-8; AABY P, 1989, PEDIATR INFECT DIS J, V8, P197; Aaby P, 2000, CLIN EXP ALLERGY, V30, P644, DOI 10.1046/j.1365-2222.2000.00803.x; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; AABY P, 1993, J PEDIATR-US, V122, P904, DOI 10.1016/S0022-3476(09)90015-4; Cox D. R., 1984, ANAL SURVIVAL DATA; Diggle PJ, 2002, ANAL LONGITUDINAL DA; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Garly ML, 1999, INT J EPIDEMIOL, V28, P347, DOI 10.1093/ije/28.2.347; HERR HW, 1995, J CLIN ONCOL, V13, P1404, DOI 10.1200/JCO.1995.13.6.1404; Hoj L, 1999, INT J EPIDEMIOL, V28, P70, DOI 10.1093/ije/28.1.70; Ivanoff B, 1997, DEV BIOL STAND, V89, P3; JAMISON DT, 1993, DIS CONTROL PRIORITI, P117; KOENIG MA, 1990, B WORLD HEALTH ORGAN, V68, P441; Lindblad EB, 1997, INFECT IMMUN, V65, P623, DOI 10.1128/IAI.65.2.623-629.1997; LUGOSI L, 1992, TUBERCLE LUNG DIS, V73, P252, DOI 10.1016/0962-8479(92)90129-8; Marchant A, 1999, J IMMUNOL, V163, P2249; MCCULLAGH P., 1991, GEN LINEAR MODELS; NIOBEY FML, 1992, REV SAUDE PUBL, V26, P229, DOI 10.1590/S0034-89101992000400004; RAMSAY MEB, 1993, LANCET, V342, P203, DOI 10.1016/0140-6736(93)92298-8; RAVAUD A, 1990, J CLIN ONCOL, V8, P608, DOI 10.1200/JCO.1990.8.4.608; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; ROSENTHAL SR, 1988, AM J SURG, V156, P1, DOI 10.1016/S0002-9610(88)80158-2; United Nations Children's Fund, 1998, STAT WORLDS CHILDR 1; VELEMA JP, 1991, INT J EPIDEMIOL, V20, P474, DOI 10.1093/ije/20.2.474; *WHO, 1996, STAT WORLDS VACC IMM; Zochetti C, 1995, INT J EPIDEMIOL, V24, P1064	28	298	299	0	19	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 9	2000	321	7274					1435	+		10.1136/bmj.321.7274.1435	http://dx.doi.org/10.1136/bmj.321.7274.1435			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	382XH	11110734	Green Published, Bronze			2022-12-24	WOS:000165852300023
J	Shang, YF; Hu, X; DiRenzo, J; Lazar, MA; Brown, M				Shang, YF; Hu, X; DiRenzo, J; Lazar, MA; Brown, M			Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription	CELL			English	Article							RNA-POLYMERASE-II; NUCLEAR-RECEPTOR; ALPHA-AMANITIN; VITAMIN-D-3 RECEPTOR; COACTIVATOR COMPLEX; CHROMATIN STRUCTURE; N-COR; ACTIVATION; INHIBITOR; BINDING	Many cofactors bind the hormone-activated estrogen receptor (ER), yet the specific regulators of endogenous ER-mediated gene transcription are unknown. Using chromatin immunoprecipitation (ChIP), we find that ER and a number of coactivators rapidly associate with estrogen responsive promoters following estrogen treatment in a cyclic fashion that is not predicted by current models of hormone activation. Cycles of ER complex assembly are followed by transcription. In contrast, the anti-estrogen tamoxifen (TAM) recruits corepressors but not coactivators. Using a genetic approach, we show that recruitment of the p160 class of coactivators is sufficient for gene activation and for the growth stimulatory actions of estrogen in breast cancer supporting a model in which ER cofactors play unique roles in estrogen signaling.	Brigham & Womens Hosp, Dept Adult Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Penn Diabet Ctr, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Brown, M (corresponding author), Brigham & Womens Hosp, Dept Adult Oncol, 75 Francis St, Boston, MA 02115 USA.		Lazar, Mitchell A/AAF-3738-2019; Brown, Myles/B-6906-2008; Brown, Myles/AAX-5332-2021	Brown, Myles/0000-0002-8213-1658	NATIONAL CANCER INSTITUTE [R01CA057374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043806, R37DK043806] Funding Source: NIH RePORTER; NCI NIH HHS [CA57374] Funding Source: Medline; NIDDK NIH HHS [DK43806] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Atkins GB, 1999, MOL ENDOCRINOL, V13, P1550, DOI 10.1210/me.13.9.1550; AUGEREAU P, 1994, MOL ENDOCRINOL, V8, P693, DOI 10.1210/me.8.6.693; Bentley D, 1998, NATURE, V395, P21, DOI 10.1038/25616; Berk AJ, 1999, CURR OPIN CELL BIOL, V11, P330, DOI 10.1016/S0955-0674(99)80045-3; Blanco JCG, 1998, GENE DEV, V12, P1638, DOI 10.1101/gad.12.11.1638; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Burakov D, 2000, J BIOL CHEM, V275, P20928, DOI 10.1074/jbc.M002013200; Castro-Rivera E, 1999, MOL CELL ENDOCRINOL, V150, P11, DOI 10.1016/S0303-7207(99)00041-6; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Corden JL, 1997, TRENDS BIOCHEM SCI, V22, P413, DOI 10.1016/S0968-0004(97)01125-0; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; DEMERCOYROL L, 1989, BIOCHEM J, V258, P165, DOI 10.1042/bj2580165; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; DUBIK D, 1992, ONCOGENE, V7, P1587; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; Glass CK, 2000, GENE DEV, V14, P121; Guenther MG, 2000, GENE DEV, V14, P1048; Hahn S, 1998, CELL, V95, P579, DOI 10.1016/S0092-8674(00)81625-6; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Huang EY, 2000, GENE DEV, V14, P45; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; ONATE SA, 1995, SCIENCE, V270, P1354; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Polly P, 1996, J CELL BIOCHEM, V60, P322, DOI 10.1002/(SICI)1097-4644(19960301)60:3<322::AID-JCB4>3.0.CO;2-Y; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rachez C, 2000, MOL CELL BIOL, V20, P2718, DOI 10.1128/MCB.20.8.2718-2726.2000; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Smith WL, 1997, ACAD RADIOL, V4, P657, DOI 10.1016/S1076-6332(05)80273-9; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Verlinden L, 1998, MOL CELL ENDOCRINOL, V142, P57, DOI 10.1016/S0303-7207(98)00117-8; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922	50	1402	1439	2	66	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 8	2000	103	6					843	852		10.1016/S0092-8674(00)00188-4	http://dx.doi.org/10.1016/S0092-8674(00)00188-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136970	Bronze			2022-12-24	WOS:000165801300004
J	Bennett, M; Ryall, N				Bennett, M; Ryall, N			Using the modified Barthel index to estimate survival in cancer patients in hospice: observational study	BRITISH MEDICAL JOURNAL			English	Article							KARNOFSKY		Rheumatol & Res Unit, Leeds LS2 9NZ, W Yorkshire, England; St Gemmas Hospice, Leeds LS17 6QD, W Yorkshire, England		Bennett, M (corresponding author), St Gemmas Hospice, Leeds LS17 6QD, W Yorkshire, England.		Bennett, Michael I/A-1620-2009	Bennett, Michael I/0000-0002-8369-8349				EVANS C, 1985, LANCET, V1, P1204; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Tennant A, 1996, CLIN REHABIL, V10, P301, DOI DOI 10.1177/026921559601000407; YATES JW, 1980, CANCER, V45, P2220, DOI 10.1002/1097-0142(19800415)45:8<2220::AID-CNCR2820450835>3.0.CO;2-Q	4	42	44	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 2	2000	321	7273					1381	1382		10.1136/bmj.321.7273.1381	http://dx.doi.org/10.1136/bmj.321.7273.1381			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380TT	11099282	Green Published			2022-12-24	WOS:000165720100025
J	Eggan, K; Akutsu, H; Hochedlinger, K; Rideout, W; Yanagimachi, R; Jaenisch, R				Eggan, K; Akutsu, H; Hochedlinger, K; Rideout, W; Yanagimachi, R; Jaenisch, R			X-chromosomes inactivation in cloned mouse embryos	SCIENCE			English	Article							XIST EXPRESSION; GENE; MICE	To study whether cloning resets the epigenetic differences between the two X chromosomes of a somatic female nucleus, we monitored X inactivation in cloned mouse embryos. Both X chromosomes were active during cleavage of cloned embryos, followed by random X inactivation in the embryo proper. In the trophectoderm (TE), X inactivation was nonrandom with the inactivated X of the somatic donor being chosen for inactivation. When female embryonic stem cells with two active X chromosomes were used as donors, random X inactivation was seen in the TE and embryo. These results demonstrate that epigenetic marks can be removed and reestablished on either X chromosome during cloning. Our results also suggest that the epigenetic marks imposed on the X chromosomes during gametogenesis, responsible for normal imprinted X inactivation in the TE, are functionally equivalent to the marks imposed on the chromosomes during somatic X inactivation.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Hawaii, John A Burns Sch Med, Dept Anat & Reprod Biol, Honolulu, HI 96822 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Hawaii System	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Eggan, Kevin/P-7119-2018		NCI NIH HHS [R01-CA84198, 5-R35-CA44339] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084198, R35CA044339] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEARD C, 1995, GENE DEV, V19, P235; Blake JA, 2000, NUCLEIC ACIDS RES, V28, P108, DOI 10.1093/nar/28.1.108; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; Cattanach BM, 1994, MOUSE GENOME, V92, P114; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; CONSTANZI C, 1998, NATURE, V393, P599; CSANKOVSKI G, 1999, NAT GENET, V4, P323; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; Gurdon JB, 1999, NATURE, V402, P743, DOI 10.1038/45429; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Kikyo N, 2000, J CELL SCI, V113, P11; KRATZER PG, 1978, NATURE, V274, P503, DOI 10.1038/274503a0; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1998, CELL, V92, P657, DOI 10.1016/S0092-8674(00)81133-2; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; McDonald LE, 1998, GENOMICS, V54, P379, DOI 10.1006/geno.1998.5570; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; NORRIS DP, 1991, MAMM GENOME, V1, P78, DOI 10.1007/BF02443782; Panning B, 1996, GENE DEV, V10, P1991, DOI 10.1101/gad.10.16.1991; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; PRIEST JH, 1967, J CELL BIOL, V35, P483, DOI 10.1083/jcb.35.2.483; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	35	210	230	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2000	290	5496					1578	1581		10.1126/science.290.5496.1578	http://dx.doi.org/10.1126/science.290.5496.1578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376EX	11090356				2022-12-24	WOS:000165446200051
J	Lundgren, M; Chow, CM; Sabbattini, P; Georgiou, A; Minaee, S; Dillon, N				Lundgren, M; Chow, CM; Sabbattini, P; Georgiou, A; Minaee, S; Dillon, N			Transcription factor dosage affects changes in higher order chromatin structure associated with activation of a heterochromatic gene	CELL			English	Article							POSITION-EFFECT VARIEGATION; SURROGATE LIGHT-CHAIN; LOCUS-CONTROL REGION; B-CELL FACTOR; CENTROMERIC HETEROCHROMATIN; DROSOPHILA; EXPRESSION; EBF; ORGANIZATION; CHROMOSOMES	The mechanisms of transcriptional activation in heterochromatin were investigated by using FISH to directly visualize changes in chromatin organization during activation of a heterochromatic lambda5 transgene. A DNase I hypersensitive site was shown to relocate the transgene to the outside of the pericentromeric heterochromatin complex in the absence of transcription. Activation of transcription, which is dependent on the transcription factor EBF, occurs in a stochastic manner that resembles telomeric silencing in yeast, with the transcribed gene remaining closely associated with the heterochromatin complex. Reducing the dosage of EBF results in a reduced frequency of localization of the transgene to the outside of the heterochromatin complex and lower levels of transcription. These data provide evidence that transcription factors can initiate changes in higher order chromatin structure during the earliest stages of gene activation.	Univ London Imperial Coll Sci Technol & Med, Sch Med, Hammersmith Hosp, Clin Sci Ctr,Gene Regulat & Chromatin Grp,MRC, London W12 0NN, England	Imperial College London	Dillon, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Hammersmith Hosp, Clin Sci Ctr,Gene Regulat & Chromatin Grp,MRC, London W12 0NN, England.	niall.dillon@csc.mrc.ac.uk						BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Belmont AS, 1999, CURR OPIN CELL BIOL, V11, P307, DOI 10.1016/S0955-0674(99)80041-6; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; Brockdorff N, 1998, CURR OPIN GENET DEV, V8, P328, DOI 10.1016/S0959-437X(98)80090-7; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Dillon N, 2000, BIOESSAYS, V22, P657, DOI 10.1002/1521-1878(200007)22:7<657::AID-BIES8>3.3.CO;2-U; DILLON N, 1993, GENE TRANSCRIPTION P, P1523; EISSENBERG JC, 1995, CHROMATIN STRUCTURE, P147; FAUVARQUE MO, 1993, GENE DEV, V7, P1508, DOI 10.1101/gad.7.8.1508; Felsenfeld G, 1996, CELL, V86, P13, DOI 10.1016/S0092-8674(00)80073-2; Festenstein R, 1999, NAT GENET, V23, P457, DOI 10.1038/70579; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Heitz E, 1928, JAHRB WISS BOT, V69, P762; HENIKOFF S, 1990, TRENDS GENET, V6, P422, DOI 10.1016/0168-9525(90)90304-O; Henikoff S, 1996, BIOESSAYS, V18, P401, DOI 10.1002/bies.950180510; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Li G, 1998, J CELL BIOL, V140, P975, DOI 10.1083/jcb.140.5.975; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; LOCKE J, 1988, GENETICS, V120, P181; MANUELIDIS L, 1990, SCIENCE, V250, P1533, DOI 10.1126/science.2274784; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Sabbattini P, 1999, MOL CELL BIOL, V19, P671; Schubeler D, 2000, GENE DEV, V14, P940; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Spector D. L., 1998, CELLS LAB MANUAL; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Talbert PB, 2000, GENETICS, V154, P259; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; WEINTRAUB H, 1984, CELL, V38, P17, DOI 10.1016/0092-8674(84)90522-1; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239; Zucker-Franklin D, 1988, ATLAS BLOOD CELLS FU	48	109	111	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 22	2000	103	5					733	743		10.1016/S0092-8674(00)00177-X	http://dx.doi.org/10.1016/S0092-8674(00)00177-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	375ZJ	11114330	Bronze			2022-12-24	WOS:000165433100006
J	Engstrom, DR; Fritz, SC; Almendinger, JE; Juggins, S				Engstrom, DR; Fritz, SC; Almendinger, JE; Juggins, S			Chemical and biological trends during lake evolution in recently deglaciated terrain	NATURE			English	Article							SOUTHEASTERN ALASKA; GLACIER BAY; ACIDIFICATION; HISTORY; WATER; PARK	As newly formed landscapes evolve, physical and biological changes occur that are collectively known as primary succession. Although succession is a fundamental concept in ecology, it is poorly understood in the context of aquatic environments. The prevailing view is that lakes become more enriched in nutrients as they age, leading to increased biological production. Here we report the opposite pattern of lake development, observed from the water chemistry of lakes that formed at various times within the past 10,000 years during glacial retreat at Glacier Bay, Alaska. The lakes have grown more dilute and acidic with time, accumulated dissolved organic carbon and undergone a transient rise in nitrogen concentration, all as a result of successional changes in surrounding vegetation and soils. Similar trends are evident from fossil diatom stratigraphy of lake sediment cores. These results demonstrate a tight hydrologic coupling between terrestrial and aquatic environments during the colonization of newly deglaciated landscapes, and provide a conceptual basis for mechanisms of primary succession in boreal lake ecosystems.	Sci Museum Minnesota, St Croix Watershed Res Stn, Marine On St Croix, MN 55047 USA; Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Newcastle Upon Tyne, Dept Geog, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Newcastle University - UK	Engstrom, DR (corresponding author), Sci Museum Minnesota, St Croix Watershed Res Stn, Marine On St Croix, MN 55047 USA.		Juggins, Stephen/D-1653-2010	Juggins, Stephen/0000-0003-4466-424X; Engstrom, Daniel/0000-0002-8066-029X				ALMENDINGER JE, 1990, P 2 GLAC BAY SCI S, P133; Battarbee Richard W., 1999, P85; Birks HH, 2000, J PALEOLIMNOL, V23, P91, DOI 10.1023/A:1008079725596; BIRKS HJB, 1990, PHILOS T R SOC B, V327, P263, DOI 10.1098/rstb.1990.0062; BORMANN BT, 1990, J ECOL, V78, P561, DOI 10.2307/2260884; BREW DA, 1978, 78494 US GEOL SURV, P1; BROWER WA, 1977, CLIMATIC ATLAS OUTER, V1; Carpenter S. R., 1998, NONPOINT POLLUTION S; CHAPIN FS, 1994, J ECOL, V64, P149; CHAPIN FS, 1995, P 3 GLAC BAY SCI S 1, P96; Cooper WS, 1931, ECOLOGY, V12, P61, DOI 10.2307/1932934; Cooper WS, 1923, ECOLOGY, V4, P223, DOI 10.2307/1929047; CROCKER RL, 1955, J ECOL, V43, P427, DOI 10.2307/2257005; CRONAN CS, 1985, GEOCHIM COSMOCHIM AC, V49, P1697, DOI 10.1016/0016-7037(85)90140-1; ENGSTROM DR, 1990, SCIENCE, V250, P1383, DOI 10.1126/science.250.4986.1383; ENGSTROM DR, 1987, CAN J FISH AQUAT SCI, V44, P1306, DOI 10.1139/f87-154; ENGSTROM DR, 1990, P 2 GLAC BAY SCI S, P127; FASTIE CL, 1995, ECOLOGY, V76, P1899, DOI 10.2307/1940722; FORD MSJ, 1990, ECOL MONOGR, V60, P57, DOI 10.2307/1943026; GOLDMAN CR, 1961, ECOLOGY, V42, P282, DOI 10.2307/1932080; Hunter L. E., 1995, P 3 GLAC BAY SCI S 1, P46; Juggins S, 1996, FRESHWATER BIOL, V36, P203, DOI 10.1046/j.1365-2427.1996.00079.x; KORHOLA AA, 1991, BOREAS, V20, P333, DOI 10.1111/j.1502-3885.1991.tb00284.x; Lawrence D. B., 1951, Yearbook, American Philosophical Society, Philadelphia 1950, P175; LAWRENCE DB, 1958, AM SCI, V46, P89; MANN DH, 1985, CAN J EARTH SCI, V22, P913, DOI 10.1139/e85-095; Matthews JA., 1992, ECOLOGY RECENTLY DEG; MCBRIDE MS, 1975, J RES US GEOL SURV, V3, P505; NAUMANN E, 1932, BINNENGEWASSER, V11, P1; NOBLE MG, 1984, BRYOLOGIST, V87, P119, DOI 10.2307/3243117; Olson O. G., 1995, P 3 GLAC BAY SCI S N, P154; OLSON OG, 1998, THESIS LEHIGH U; Pearsall WH, 1921, P R SOC LOND B-CONTA, V92, P259, DOI 10.1098/rspb.1921.0024; RASMUSSEN JB, 1989, LIMNOL OCEANOGR, V34, P1336, DOI 10.4319/lo.1989.34.7.1336; REINERS W A, 1971, Ecology (Washington D C), V52, P55, DOI 10.2307/1934737; RENBERG I, 1993, AMBIO, V22, P264; RODHE W, 1969, EUTROPHICATION CAUSE, P50; Taylor J. K, 1966, AUSTR ENV, P29; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Thienemann A., 1931, Archiv fuer Hydrobiologie Stuttgart Suppl, V9, P205; UGOLINI FC, 1979, NATURE, V281, P366, DOI 10.1038/281366a0; WHITEHEAD D R, 1989, Journal of Paleolimnology, V2, P185; WILLIAMSON CE, IN PRESS ECOLOGY; WINTER TC, 1988, LIMNOL OCEANOGR, V33, P1209, DOI 10.4319/lo.1988.33.5.1209	44	247	252	3	88	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					161	166		10.1038/35041500	http://dx.doi.org/10.1038/35041500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089963	Green Published			2022-12-24	WOS:000165180400035
J	van Dijk, MR; Janse, CJ; Thompson, J; Waters, AP; Braks, JAM; Dodemont, HJ; Stunnenberg, HG; van Gemert, GJ; Sauerwein, RW; Eling, W				van Dijk, MR; Janse, CJ; Thompson, J; Waters, AP; Braks, JAM; Dodemont, HJ; Stunnenberg, HG; van Gemert, GJ; Sauerwein, RW; Eling, W			A central role for P48/45 in malaria parasite male gamete fertility	CELL			English	Article							TRANSMISSION-BLOCKING ACTIVITY; SEXUAL STAGE ANTIGENS; PLASMODIUM-FALCIPARUM; SURFACE-ANTIGENS; TARGET ANTIGEN; SIALIC-ACID; PFS 48/45; EXPRESSION; ANTIBODIES; BERGHEI	Fertilization and zygote development are obligate features of the malaria parasite life cycle and occur during parasite transmission to mosquitoes. The surface protein PFS48/45 is expressed by male and female gametes of Plasmodium falciparum and PFS48/45 antibodies prevent zygote development and transmission. Here, gene disruption was used to show that Pfs48/45 and the ortholog Pbs48/45 from a rodent malaria parasite P. berghei play a conserved and important role in fertilization. p48/45(-) parasites had a reduced capacity to produce oocysts in mosquitoes due to greatly reduced zygote formation. Unexpectedly, only male gamete fertility of p48/45(-) parasites was affected, failing to penetrate otherwise fertile female gametes. P48/45 is shown to be a surface protein of malaria parasites with a demonstrable role in fertilization.	Leiden Univ, Med Ctr, Parasitol Lab, NL-2300 RC Leiden, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; Univ Nijmegen, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Radboud University Nijmegen	Waters, AP (corresponding author), Leiden Univ, Med Ctr, Parasitol Lab, POB 9600, NL-2300 RC Leiden, Netherlands.	waters@lumc.nl	Stunnenberg, Hendrik G./D-6875-2012; Sauerwein, Robert/C-8519-2013; Waters, Andy P/C-9377-2009	Stunnenberg, Hendrik G./0000-0002-0066-1576; Waters, Andy P/0000-0001-8900-2982; Janse, Chris J/0000-0002-6410-6205				Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Birago C, 1996, MOL BIOCHEM PARASIT, V80, P193, DOI 10.1016/0166-6851(96)02680-1; BOUDIN C, 1993, AM J TROP MED HYG, V48, P700, DOI 10.4269/ajtmh.1993.48.700; Brooks SR, 2000, MOL BIOCHEM PARASIT, V106, P77, DOI 10.1016/S0166-6851(99)00201-7; CARTER R, 1990, PARASITE IMMUNOL, V12, P587, DOI 10.1111/j.1365-3024.1990.tb00990.x; CARTER R, 1995, MOL BIOCHEM PARASIT, V71, P203, DOI 10.1016/0166-6851(94)00054-Q; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; Duffy PE, 1997, INFECT IMMUN, V65, P1109, DOI 10.1128/IAI.65.3.1109-1113.1997; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; GRAVES PM, 1992, AM J TROP MED HYG, V46, P711, DOI 10.4269/ajtmh.1992.46.711; Guinet F, 1996, J CELL BIOL, V135, P269, DOI 10.1083/jcb.135.1.269; GUPTA SK, 1985, J PROTOZOOL, V32, P91, DOI 10.1111/j.1550-7408.1985.tb03020.x; JANSE CJ, 1985, PARASITOLOGY, V91, P219, DOI 10.1017/S0031182000057322; JANSE CJ, 1985, PARASITOLOGY, V91, P19, DOI 10.1017/S0031182000056481; JANSE CJ, 1989, EXP PARASITOL, V68, P274, DOI 10.1016/0014-4894(89)90109-4; JANSE CJ, 1986, MOL BIOCHEM PARASIT, V20, P173, DOI 10.1016/0166-6851(86)90029-0; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; Kaslow David C., 1996, P181; KASLOW DC, 1988, NATURE, V333, P74, DOI 10.1038/333074a0; KAUSHAL DC, 1984, MOL BIOCHEM PARASIT, V11, P145, DOI 10.1016/0166-6851(84)90061-6; KOCKEN CHM, 1993, MOL BIOCHEM PARASIT, V61, P59, DOI 10.1016/0166-6851(93)90158-T; KUMAR N, 1987, PARASITE IMMUNOL, V9, P321, DOI 10.1111/j.1365-3024.1987.tb00511.x; Lobo CA, 1999, MOL CELL, V3, P793, DOI 10.1016/S1097-2765(01)80011-3; MAESSEN S, 1993, MOL BIOCHEM PARASIT, V60, P27, DOI 10.1016/0166-6851(93)90025-S; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; Menard R, 2000, MICROBES INFECT, V2, P633, DOI 10.1016/S1286-4579(00)00362-2; Milek RLB, 1998, PARASITE IMMUNOL, V20, P377, DOI 10.1046/j.1365-3024.1998.00171.x; MOELANS IIMD, 1995, MOL BIOCHEM PARASIT, V72, P179, DOI 10.1016/0166-6851(95)00072-9; Mulder B, 1999, EXP PARASITOL, V92, P81, DOI 10.1006/expr.1999.4398; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; ROEFFEN W, 1995, AM J TROP MED HYG, V52, P60, DOI 10.4269/ajtmh.1995.52.60; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; TARGETT GAT, 1990, IMMUNOL LETT, V25, P77, DOI 10.1016/0165-2478(90)90095-8; Temple RC, 1999, DIABETES, V48, pA52; Templeton TJ, 1998, J EXP MED, V187, P1599, DOI 10.1084/jem.187.10.1599; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; VAIDYA AB, 1995, MOL BIOCHEM PARASIT, V69, P65, DOI 10.1016/0166-6851(94)00199-W; VERMEULEN AN, 1986, MOL BIOCHEM PARASIT, V20, P155, DOI 10.1016/0166-6851(86)90027-7; VERMEULEN AN, 1985, J EXP MED, V162, P1460, DOI 10.1084/jem.162.5.1460; Wahlgren M, 1999, CELL, V96, P603, DOI 10.1016/S0092-8674(00)80569-3; Wengelnik K, 1999, EMBO J, V18, P5195, DOI 10.1093/emboj/18.19.5195; WILLIAMSON KC, 1993, MOL BIOCHEM PARASIT, V58, P355, DOI 10.1016/0166-6851(93)90058-6; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130	49	281	291	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2001	104	1					153	164		10.1016/S0092-8674(01)00199-4	http://dx.doi.org/10.1016/S0092-8674(01)00199-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163248	Bronze			2022-12-24	WOS:000166882300015
J	Dietz, WH				Dietz, WH			"Adiposity rebound": reality or epiphenomenon?	LANCET			English	Editorial Material							CHILDREN; AGE; ADULTHOOD; PATTERNS; OBESITY; GROWTH; BMI		Ctr Dis Control & Prevent, Div Nutr & Phys Act, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Dietz, WH (corresponding author), Ctr Dis Control & Prevent, Div Nutr & Phys Act, Atlanta, GA 30341 USA.							BIRCH LL, 1984, CHILD DEV, V55, P431, DOI 10.2307/1129954; DIETZ WH, 1985, PEDIATRICS, V75, P807; DIETZ WH, 1994, AM J CLIN NUTR, V59, P995; Dorosty AR, 2000, PEDIATRICS, V105, P1115, DOI 10.1542/peds.105.5.1115; Fisher JO, 1999, AM J CLIN NUTR, V69, P1264; JOHNSON SL, 1994, PEDIATRICS, V94, P653; PROKOPEC M, 1993, ANN HUM BIOL, V20, P517, DOI 10.1080/03014469300002922; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; ROLLANDCACHERA MF, 1995, INT J OBESITY, V19, P573; ROLLANDCACHERA MF, 1987, ANN HUM BIOL, V14, P219, DOI 10.1080/03014468700008991; ROLLANDCACHWERA MF, 1988, OBESITY EUROPE 88; Scaglioni S, 2000, INT J OBESITY, V24, P777, DOI 10.1038/sj.ijo.0801225; SIERVOGEL RM, 1991, INT J OBESITY, V15, P479; Whitaker RC, 1998, PEDIATRICS, P101; Williams S, 1999, INT J OBESITY, V23, P348, DOI 10.1038/sj.ijo.0800824	15	54	56	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 16	2000	356	9247					2027	2028		10.1016/S0140-6736(00)03396-1	http://dx.doi.org/10.1016/S0140-6736(00)03396-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385GB	11145485				2022-12-24	WOS:000165994300005
J	Misteli, T; Gunjan, A; Hock, R; Bustin, M; Brown, DT				Misteli, T; Gunjan, A; Hock, R; Bustin, M; Brown, DT			Dynamic binding of histone H1 to chromatin in living cells	NATURE			English	Article							VARIANT OVEREXPRESSION; IN-VIVO; ACETYLATION; PHOSPHORYLATION; PROTEINS; EXCHANGE; CYCLE; BASAL	The linker histone H1 is believed to be involved in chromatin organization by stabilizing higher-order chromatin structure(1-3). Histone H1 is generally viewed as a repressor of transcription as it prevents the access of transcription factors and chromatin remodelling complexes to DNA(4-6). Determining the binding properties of histone H1 to chromatin in vivo is central to understanding how it exerts these functions. We have used photobleaching techniques to measure the dynamic binding of histone H1-GFP to unperturbed chromatin in living cells. Here we show that almost the entire population of H1-GFP is bound to chromatin at any one time; however, H1-GFP is exchanged continuously between chromatin regions. The residence time of H1-GFP on chromatin between exchange events is several minutes in both euchromatin and heterochromatin. In addition to the mobile fraction, we detected a kinetically distinct, less mobile fraction. After hyperacetylation of core histones, the residence time of H1-GFP is reduced, suggesting a higher rate of exchange upon chromatin remodelling. These results support a model in which linker histones bind dynamically to chromatin in a stop-and-go mode.	NCI, NIH, Bethesda, MD 20892 USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Univ Wurzburg, Bioctr, D-97070 Wurzburg, Germany; NCI, NIH, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Mississippi; University of Mississippi Medical Center; University of Wurzburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Bustin, Michael/G-6155-2015	Gunjan, Akash/0000-0001-8478-3978; Bustin, Michael/0000-0002-5147-7242				BATES DL, 1981, EUR J BIOCHEM, V119, P469, DOI 10.1111/j.1432-1033.1981.tb05631.x; Berger SL, 1999, CURR OPIN CELL BIOL, V11, P336, DOI 10.1016/S0955-0674(99)80046-5; BRESNICK EH, 1992, NUCLEIC ACIDS RES, V20, P273, DOI 10.1093/nar/20.2.273; Brown DT, 1996, NUCLEIC ACIDS RES, V24, P486, DOI 10.1093/nar/24.3.486; CARON F, 1981, J MOL BIOL, V146, P513, DOI 10.1016/0022-2836(81)90045-0; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gunjan A, 1999, NUCLEIC ACIDS RES, V27, P3355, DOI 10.1093/nar/27.16.3355; Gunjan A, 1999, J BIOL CHEM, V274, P37950, DOI 10.1074/jbc.274.53.37950; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; JUAN LJ, 1994, EMBO J, V13, P6031, DOI 10.1002/j.1460-2075.1994.tb06949.x; Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540; LOUTERS L, 1985, BIOCHEMISTRY-US, V24, P3080, DOI 10.1021/bi00334a002; LU MJ, 1995, MOL BIOL CELL, V6, P1077, DOI 10.1091/mbc.6.8.1077; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Ramakrishnan V, 1997, CRIT REV EUKAR GENE, V7, P215, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.20; RIDSDALE JA, 1990, J BIOL CHEM, V265, P5150; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; THOMA F, 1977, CELL, V12, P101, DOI 10.1016/0092-8674(77)90188-X; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; URA K, 1994, J BIOL CHEM, V269, P27171; WU LH, 1986, J CELL BIOL, V103, P465, DOI 10.1083/jcb.103.2.465; Zlatanova J, 1998, BIOESSAYS, V20, P584, DOI 10.1002/(SICI)1521-1878(199807)20:7<584::AID-BIES10>3.0.CO;2-W	29	492	500	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2000	408	6814					877	881		10.1038/35048610	http://dx.doi.org/10.1038/35048610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130729				2022-12-24	WOS:000165831300055
J	Pacold, ME; Suire, S; Perisic, O; Lara-Gonzalez, S; Davis, CT; Walker, EH; Hawkins, PT; Stephens, L; Eccleston, JF; Williams, RL				Pacold, ME; Suire, S; Perisic, O; Lara-Gonzalez, S; Davis, CT; Walker, EH; Hawkins, PT; Stephens, L; Eccleston, JF; Williams, RL			Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma	CELL			English	Article							H-RAS; 3-OH KINASE; PROTEIN; ACTIVATION; MECHANISM; SUBUNITS; SWITCH; BETA; TRANSFORMATION; HYDROLYSIS	Ras activation of phosphoinositide 3-kinase (PI3K) is important for survival of transformed cells. We find that PI3K gamma is strongly and directly activated by H-Ras G12V in vivo or by GTP gammaS-loaded H-Ras in vitro. We have determined a crystal structure of a PI3Ky/Ras.GMPPNP complex. A critical loop in the Ras binding domain positions Ras so that it uses its switch I and switch II regions to bind PI3K gamma. Mutagenesis shows that interactions with both regions are essential for binding PI3K gamma. Ras also forms a direct contact with the PI3K gamma catalytic domain. These unique Ras/PI3K gamma interactions are likely to be shared by PI3K alpha. The complex with Ras shows a change in the PI3K conformation that may represent an allosteric component of Ras activation.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Babraham Inst, Cambridge CB2 4AT, England; Natl Inst Med Res, London NW7 1AA, England	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; MRC National Institute for Medical Research	Williams, RL (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	rlw@mrc-lmb.cam.ac.uk		Hawkins, Phillip/0000-0002-6979-0464; Lara-Gonzalez, Samuel/0000-0002-3313-0165; suire, sabine/0000-0002-2773-2215; stephens, len/0000-0002-2771-3487; Williams, Roger/0000-0001-7754-4207; Perisic, Olga/0000-0002-3842-2896	MRC [MC_U105184308] Funding Source: UKRI; Medical Research Council [MC_U105184308] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARNETT SF, 1995, BIOCHEMISTRY-US, V34, P14254, DOI 10.1021/bi00043a033; BENNETT JP, 1982, BIOCHEM J, V208, P801, DOI 10.1042/bj2080801; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Condliffe AM, 1998, FEBS LETT, V439, P147, DOI 10.1016/S0014-5793(98)01358-1; Deora AA, 1998, J BIOL CHEM, V273, P29923, DOI 10.1074/jbc.273.45.29923; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Feig LA, 1996, TRENDS BIOCHEM SCI, V21, P438, DOI 10.1016/S0968-0004(96)10058-X; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gire V, 2000, ONCOGENE, V19, P2269, DOI 10.1038/sj.onc.1203544; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kinashi T, 2000, J BIOL CHEM, V275, P22590, DOI 10.1074/jbc.M000633200; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krugmann S, 1999, J BIOL CHEM, V274, P17152, DOI 10.1074/jbc.274.24.17152; LESLIE AGW, 1992, JOINT CCP4 ESFEACMB, V6; LOWRY DR, 1993, ANNU REV BIOCHEM, V62, P851; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MOODIE SA, 1995, ONCOGENE, V11, P447; MOORE KJM, 1993, BIOCHEMISTRY-US, V32, P7451, DOI 10.1021/bi00080a016; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RodriguezViciana P, 1996, PHILOS T ROY SOC B, V351, P225, DOI 10.1098/rstb.1996.0020; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Rubio I, 1997, BIOCHEM J, V326, P891, DOI 10.1042/bj3260891; Rubiol I, 1999, EUR J BIOCHEM, V266, P70, DOI 10.1046/j.1432-1327.1999.00815.x; Runnels LW, 1998, BIOCHEMISTRY-US, V37, P15563, DOI 10.1021/bi9811258; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; Tanaka Y, 1999, J IMMUNOL, V163, P6209; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wymann MP, 2000, IMMUNOL TODAY, V21, P260, DOI 10.1016/S0167-5699(00)01649-2; Xue LZ, 2000, J BIOL CHEM, V275, P8817, DOI 10.1074/jbc.275.12.8817; Zhou J, 1997, BIOCHEMISTRY-US, V36, P15733, DOI 10.1021/bi971438n	63	459	496	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 8	2000	103	6					931	943		10.1016/S0092-8674(00)00196-3	http://dx.doi.org/10.1016/S0092-8674(00)00196-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136978	Bronze			2022-12-24	WOS:000165801300012
J	Watanabe, Y; Martini, JEJ; Ohmoto, H				Watanabe, Y; Martini, JEJ; Ohmoto, H			Geochemical evidence for terrestrial ecosystems 2.6 billion years ago	NATURE			English	Article							SOUTH-AFRICA; PALEOSOLS; SEDIMENTS; GREENLAND; EVOLUTION; GRAPHITE; ROCKS; BIOTA; LAND; LIFE	Microorganisms have flourished in the oceans since at least 3.8 billion years (3.8 Gyr) ago(1,2), but it is not at present clear when they first colonized the land. Organic matter in some Au/U-rich conglomerates and ancient soils of 2.3-2.7 Gyr age has been suggested as remnants of terrestrial organisms(3-5). Some 2.7-Gyr-old stromatolites have also been suggested as structures created by terrestrial organisms(6-7). However, it has been disputed whether this organic matter is indigenous or exogenic, and whether these stromatolites formed in marine or fresh water. Consequently, the oldest undisputed remnants of terrestrial organisms are currently the 1.2-Gyr-old microfossils from Arizona, USA(8). Unusually carbonaceous ancient soils-palaeosols-have been found in the Mpumalanga Province (Eastern Transvaal) of South Africa(9). Here we report the occurrences, elemental ratios (C, H, N, P) and isotopic compositions of this organic matter and its host rocks. These data show that the organic matter very probably represents remnants of microbial mats that developed on the soil surface between 2.6 and 2.7 Gyr ago. This places the development of terrestrial biomass more than 1.4 billion years earlier than previously reported.	Penn State Univ, Astrobiol Res Ctr, University Pk, PA 16802 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Tohoku Univ, Fac Sci, Sendai, Miyagi 9808578, Japan; Geol Survey S Africa, Pretoria, South Africa	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Tohoku University	Watanabe, Y (corresponding author), Penn State Univ, Astrobiol Res Ctr, University Pk, PA 16802 USA.	yumiko@essc.psu.edu						Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; BUCK SG, 1980, PRECAMBRIAN RES, V12, P311, DOI 10.1016/0301-9268(80)90033-9; BUICK R, 1992, SCIENCE, V255, P74, DOI 10.1126/science.11536492; CAMPBELL SE, 1979, ORIGINS LIFE EVOL B, V9, P335, DOI 10.1007/BF00926826; Des Marais D.J., 1992, PROTEROZOIC BIOSPHER, P299; Des Marais DJ, 1997, ORG GEOCHEM, V27, P185, DOI 10.1016/S0146-6380(97)00061-2; GAY AL, 1980, PRECAMBRIAN RES, V12, P349, DOI 10.1016/0301-9268(80)90035-2; HALLBAUER D K, 1974, Precambrian Research, V1, P199, DOI 10.1016/0301-9268(74)90010-2; HORODYSKI RJ, 1994, SCIENCE, V263, P494, DOI 10.1126/science.263.5146.494; Luque FJ, 1998, AM J SCI, V298, P471, DOI 10.2475/ajs.298.6.471; MARTINI JEJ, 1994, PRECAMBRIAN RES, V67, P159, DOI 10.1016/0301-9268(94)90009-4; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Mossman DJ, 1992, EARLY ORGANIC EVOLUT, P67; Naraoka H, 1996, CHEM GEOL, V133, P251, DOI 10.1016/S0009-2541(96)00076-9; NISBET EG, 1995, SPECIAL PUBLICATION, P27; Ohmoto H, 1996, GEOLOGY, V24, P1135, DOI 10.1130/0091-7613(1996)024<1135:EIPGPF>2.3.CO;2; Ohmoto H., 1997, GEOCHEMISTRY HYDROTH, P517; RETTALLACK GJ, 1990, SOILS PAST INTRO PAL; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Ruttenberg KC, 1997, MAR GEOL, V139, P123, DOI 10.1016/S0025-3227(96)00107-7; Strauss H., 1992, PROTEROZOIC BIOSPHER, P709; Wright VP, 1994, NATO ADV SCI INST SE, V453, P95; [No title captured]	23	156	161	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2000	408	6812					574	578		10.1038/35046052	http://dx.doi.org/10.1038/35046052			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117742				2022-12-24	WOS:000165548600115
J	Fischer, MB; Roeckl, C; Parizek, P; Schwarz, HP; Aguzzi, A				Fischer, MB; Roeckl, C; Parizek, P; Schwarz, HP; Aguzzi, A			Binding of disease-associated prion protein to plasminogen	NATURE			English	Article							MICE; PRP; ACTIVATOR; EPITOPE; DEATH	Transmissible spongiform encephalopathies are associated with accumulation of PrPSc, a conformer of a cellular protein called PrPC. PrPSc is thought to replicate by imparting its conformation onto PrPC (ref. 1), yet conformational discrimination between PrPC and PrPSc has remained elusive. Because deposition of PrPSc alone is not enough to cause neuropathology(2), PrPSc probably damages the brain by interacting with other cellular constituents. Here we rnd activities in human and mouse blood which bind PrPSc and prion infectivity, but not PrPC. We identify plasminogen, a pro-protease implicated in neuronal excitotoxicity(3,4), as a PrPSc-binding protein. Binding is abolished if the conformation of PrPSc is disrupted by 6M urea or guanidine. The isolated lysine binding site 1 of plasminogen (kringles I-III) retains this binding activity, and binding can be competed for with lysine. Therefore, plasminogen represents the first endogenous factor discriminating between normal and pathological prion protein. This unexpected property may be exploited for diagnostic purposes.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Baxter Hyland Immuno, A-1221 Vienna, Austria	University of Zurich; University Zurich Hospital	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano@pathol.unizh.ch	Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708				Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; LEDESMA MD, IN PRESS EMBO REP; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Prusiner SB, 1997, ANNU REV GENET, V31, P139, DOI 10.1146/annurev.genet.31.1.139; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Shibuya S, 1998, LANCET, V351, P419, DOI 10.1016/S0140-6736(05)78358-6; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Tsirka SE, 1996, NATURE, V384, P123, DOI 10.1038/384123b0; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	20	183	210	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2000	408	6811					479	483		10.1038/35044100	http://dx.doi.org/10.1038/35044100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100730				2022-12-24	WOS:000165429800050
J	Waddell, S; Armstrong, JD; Kitamoto, T; Kaiser, K; Quinn, WG				Waddell, S; Armstrong, JD; Kitamoto, T; Kaiser, K; Quinn, WG			The amnesiac gene product is expressed in two neurons in the Drosophila brain that are critical for memory	CELL			English	Article							SHORT-TERM-MEMORY; DEPENDENT PROTEIN-KINASE; MUSHROOM BODIES; PRESYNAPTIC FACILITATION; PREFERENTIAL EXPRESSION; CAMP; DOPAMINE; LOCALIZATION; HIPPOCAMPAL; SEROTONIN	Mutations in the amnesiac gene in Drosophila affect both memory retention and ethanol sensitivity. The predicted amnesiac gene product, AMN, is an apparent preproneuropeptide, and previous studies suggest that ii stimulates cAMP synthesis. Here we show that, unlike other learning-related Drosophila proteins, AMN is not preferentially expressed in mushroom bodies. Instead, it is strongly expressed in two large neurons that project over all the robes of the mushroom bodies, a finding that suggests a modulatory role for AMN in memory formation. Genetically engineered blockade of vesicle recycling in these cells abbreviates memory as in the amnesiac mutant. Moreover, restoration of amn gene expression to these cells reestablishes normal olfactory memory in an amn deletion background. These results indicate that AMN neuropeptide release onto the mushroom bodies is critical for normal olfactory memory.	MIT, Dept Brain & Cognit Sci, Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Glasgow, Div Mol Genet, Glasgow G11 6NU, Lanark, Scotland; City Hope Natl Med Ctr, Beckman Res Inst, Div Neurosci, Duarte, CA 91010 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Glasgow; City of Hope; Beckman Research Institute of City of Hope	Waddell, S (corresponding author), MIT, Dept Brain & Cognit Sci, Ctr Learning & Memory, E25-618, Cambridge, MA 02139 USA.	waddell@mit.edu		Kitamoto, Toshihiro/0000-0003-0863-8466; Armstrong, Douglas/0000-0002-5397-3864; Waddell, Scott/0000-0003-4503-6229				ABRAMS TW, 1984, P NATL ACAD SCI-BIOL, V81, P7956, DOI 10.1073/pnas.81.24.7956; Armstrong JD, 1998, LEARN MEMORY, V5, P102; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DeZazzo J, 1999, J NEUROSCI, V19, P8740, DOI 10.1523/JNEUROSCI.19-20-08740.1999; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Fox LE, 2000, J NEUROPHYSIOL, V83, P1567, DOI 10.1152/jn.2000.83.3.1567; Fox LE, 1997, J NEUROSCI, V17, P6064; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Harlow E, 1988, ANTIBODIES LAB MANUA; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hitier R, 1998, NEUROREPORT, V9, P2717, DOI 10.1097/00001756-199808240-00006; HOOPER SL, 1994, NEUROSCI LETT, V179, P167, DOI 10.1016/0304-3940(94)90960-1; HUANG YH, 1995, SEPAR TECHNOL, V5, P1, DOI 10.1016/0956-9618(94)00102-X; Ito K, 1998, LEARN MEMORY, V5, P52; Iversen L, 2000, MOL PSYCHIATR, V5, P357, DOI 10.1038/sj.mp.4000728; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; MACKEY SL, 1989, J NEUROSCI, V9, P4227; Matthies H, 1997, NEUROREPORT, V8, P3533, DOI 10.1097/00001756-199711100-00023; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McCall K, 1997, TRENDS GENET, V13, P222, DOI 10.1016/S0168-9525(97)01126-8; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Otto C, 1999, MOL BRAIN RES, V66, P163, DOI 10.1016/S0169-328X(99)00010-8; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Shioda S, 1997, NEUROSCI RES, V28, P345, DOI 10.1016/S0168-0102(97)00065-5; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SKOULAKIS EMC, 1993, NEURON, V11, P197, DOI 10.1016/0896-6273(93)90178-T; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; TAGHERT PH, 1990, J NEUROSCI, V10, P1929; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Vilim FS, 2000, J NEUROSCI, V20, P2036; Wolf R, 1998, LEARN MEMORY, V5, P166; YANG MY, 1995, NEURON, V15, P45; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	52	247	253	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 22	2000	103	5					805	813		10.1016/S0092-8674(00)00183-5	http://dx.doi.org/10.1016/S0092-8674(00)00183-5			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	375ZJ	11114336	Bronze			2022-12-24	WOS:000165433100012
J	Hayflick, L				Hayflick, L			The future of ageing	NATURE			English	Editorial Material							TELOMERASE	Advances in our knowledge of age-associated diseases have far outpaced advances in our understanding of the fundamental ageing processes that underlie the vulnerability to these pathologies. If we are to increase human life expectancy beyond the fifteen-year limit that would result if today's leading causes of death were resolved, more attention must be paid to basic research on ageing. Determination of longevity must be distinguished from ageing to take us from the common question of why we age to a more revealing question that is rarely posed: why do we live as long as we do? But if the ability to intervene in ageing ever becomes a reality, it will be rife with unintended and undesirable consequences.	Univ Calif San Francisco, Sch Med, Dept Anat, Sea Ranch, CA 95497 USA	University of California System; University of California San Francisco	Hayflick, L (corresponding author), Univ Calif San Francisco, Sch Med, Dept Anat, POB 89, Sea Ranch, CA 95497 USA.		Hayflick, Leonard/AAW-2460-2020					Anderson MA, 1999, CLAY CLAY MINER, V47, P28, DOI 10.1346/CCMN.1999.0470103; Anderson RN, 1999, US DECENNIAL LIFE TA, V1, P7; ANDESON RN, 1999, NATL VITAL STAT REPO, V47, P32; ANERSON RN, 1999, US DECENNIAL LIFE TA, V1; CRIMMINS EM, 1994, DEMOGRAPHY, V31, P159, DOI 10.2307/2061913; Hayflick L, 2000, BRIT J CANCER, V83, P841, DOI 10.1054/bjoc.2000.1296; Hayflick L, 1998, EXP GERONTOL, V33, P639, DOI 10.1016/S0531-5565(98)00023-0; Hayflick L, 2000, NATURE, V403, P365, DOI 10.1038/35000303; HAYFLICK L, 1996, WHY WE AGE; HOBBS FB, 1996, US BUREAU CEN P23190, P3; Klapper W, 1998, FEBS LETT, V439, P143, DOI 10.1016/S0014-5793(98)01357-X; Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; *US BUR CENS, 1996, CURR POP REP P251130; WADE A, 1991, SOCIAL SECURITY MORT	16	199	207	1	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					267	269		10.1038/35041709	http://dx.doi.org/10.1038/35041709			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	371LL	11089985				2022-12-24	WOS:000165180400058
J	Courseaux, A; Nahon, JL				Courseaux, A; Nahon, JL			Birth of two chimeric genes in the Hominidae lineage	SCIENCE			English	Article							MELANIN-CONCENTRATING HORMONE; ANTARCTIC NOTOTHENIOID FISH; DROSOPHILA; EVOLUTION; ORIGIN; JINGWEI; FUSION; RNAS	How genes with newly characterized functions originate remains a fundamental question. PMCHL1 and PMCHL2, two chimeric genes derived from the melanin-concentrating hormone (MCH) gene, offer an opportunity to examine such an issue in the human Lineage. Detailed structural, expression, and phylogenetic analysis showed that the PMCHL1 gene was created near 25 million years ago (Ma) by a complex mechanism of exon shuffling through retrotransposition of an antisense MCH messenger RNA coupled to de novo creation of splice sites. PMCHL2 arose 5 to 10 Ma by an event of duplication involving a large chromosomal region encompassing the PMCHL1 Locus. The RNA expression patterns of those chimeric genes suggest that they have been submitted to strong regulatory constraints during primate evolution.	Inst Pharmacol Mol & Cellulaire, CNRS, UMR 6097, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Nahon, JL (corresponding author), Inst Pharmacol Mol & Cellulaire, CNRS, UMR 6097, 660 Route Lucioles Sophia Antipolis, F-06560 Valbonne, France.		NAHON, Jean-Louis/O-7977-2016	NAHON, Jean-Louis/0000-0001-9572-7779				Borsu L, 2000, J BIOL CHEM, V275, P40576, DOI 10.1074/jbc.M006524200; BRETON C, 1993, MOL BRAIN RES, V18, P297, DOI 10.1016/0169-328X(93)90093-5; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3811, DOI 10.1073/pnas.94.8.3811; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; COURSEAUX A, 1995, LEUKEMIA, V9, P1313; Gilbert W, 1997, P NATL ACAD SCI USA, V94, P7698, DOI 10.1073/pnas.94.15.7698; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEVINSON B, 1990, GENOMICS, V7, P1, DOI 10.1016/0888-7543(90)90512-S; Long M, 1999, GENE, V238, P135, DOI 10.1016/S0378-1119(99)00229-2; Long MY, 2000, GENOME RES, V10, P1655, DOI 10.1101/gr.165700; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; MANLEY JL, 1988, BIOCHIM BIOPHYS ACTA, V950, P1, DOI 10.1016/0167-4781(88)90067-X; Miller CL, 1998, GENOME RES, V8, P737, DOI 10.1101/gr.8.7.737; NAHON JL, 1994, CRIT REV NEUROBIOL, V8, P221; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Thomson TM, 2000, GENOME RES, V10, P1743, DOI 10.1101/gr.GR-1405R; Viale A, 1998, MOL BIOL EVOL, V15, P196, DOI 10.1093/oxfordjournals.molbev.a025915; Viale A, 2000, MOL BIOL EVOL, V17, P1626, DOI 10.1093/oxfordjournals.molbev.a026262; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413	22	107	114	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1293	+		10.1126/science.1057284	http://dx.doi.org/10.1126/science.1057284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11181993				2022-12-24	WOS:000166993400039
J	Bodeker, G				Bodeker, G			Lessons on integration from the developing world's experience	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRADITIONAL MEDICINE; CHINESE MEDICINE; HEALTH		Univ Oxford Green Coll, Commonwealth Working Grp Tradit & Complementary H, Oxford OX2 6HG, England	University of Oxford	Bodeker, G (corresponding author), Univ Oxford Green Coll, Commonwealth Working Grp Tradit & Complementary H, Oxford OX2 6HG, England.	gerry.bodeker@green.ox.ac.uk						Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Bannerman R.H., 1983, TRADITIONAL MED HEAL; Bodeker G, 1999, J ALTERN COMPLEM MED, V5, P97; CHI CH, 1994, SOC SCI MED, V39, P307, DOI 10.1016/0277-9536(94)90127-9; Cho HJ, 2000, SOC SCI MED, V50, P123, DOI 10.1016/S0277-9536(99)00284-1; *DEP IND SYST MED, 2000, ANN REP 1999 2000; Easthope G, 1998, MED J AUSTRALIA, V169, P197, DOI 10.5694/j.1326-5377.1998.tb140221.x; Hesketh T, 1997, BRIT MED J, V315, P115, DOI 10.1136/bmj.315.7100.115; HESKETH T, 1994, BRIT MED J, V309, P1441, DOI 10.1136/bmj.309.6966.1441; Kumar S, 2000, LANCET, V355, P1252, DOI 10.1016/S0140-6736(05)74695-X; OSUIDE GE, 1999, INT C ETHN DRUG DISC; 2000, STRAITS TIMES   1114	12	69	70	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2001	322	7279					164	167		10.1136/bmj.322.7279.164	http://dx.doi.org/10.1136/bmj.322.7279.164			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	396AZ	11159579	Green Published			2022-12-24	WOS:000166615300034
J	Nahin, RL; Straus, SE				Nahin, RL; Straus, SE			Research into complementary and alternative medicine: problems and potential	BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; UNITED-STATES; ACUPUNCTURE; THERAPIES		NIH, Div Extramural Res Training & Review, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Nahin, RL (corresponding author), NIH, Div Extramural Res Training & Review, Natl Ctr Complementary & Alternat Med, 9000 Rockville Pike, Bethesda, MD 20892 USA.			Nahin, Richard/0000-0002-3682-4816				Astin JA, 2000, J GERONTOL A-BIOL, V55, pM4; Birch S, 1998, CLIN J PAIN, V14, P248, DOI 10.1097/00002508-199809000-00012; Brody H, 2000, J FAM PRACTICE, V49, P649; Druss BG, 1999, JAMA-J AM MED ASSOC, V282, P651, DOI 10.1001/jama.282.7.651; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ellis PM, 2000, ANN ONCOL, V11, P939, DOI 10.1023/A:1008342222205; Eskinazi D, 2000, ALTERN THER HEALTH M, V6, P49; Hammerschlag R, 1998, J ALTERN COMPLEM MED, V4, P159, DOI 10.1089/acm.1998.4.159; Jenkins V, 2000, BRIT J CANCER, V82, P1783, DOI 10.1054/bjoc.2000.1142; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; Linde K, 1996, BRIT MED J, V313, P253, DOI 10.1136/bmj.313.7052.253; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; *NAT CTR COMPL ALT, 2000, 5 YEAR STRAT PLAN; *NAT CTR COMPL ALT, 2000, LIST THES RES IN; Oken BS, 1998, ARCH NEUROL-CHICAGO, V55, P1409, DOI 10.1001/archneur.55.11.1409; Paramore LC, 1997, J PAIN SYMPTOM MANAG, V13, P83, DOI 10.1016/S0885-3924(96)00299-0; Pelletier KR, 1997, AM J HEALTH PROMOT, V12, P112, DOI 10.4278/0890-1171-12.2.112; Richardson MA, 1998, ANN BEHAV MED, V20, P190, DOI 10.1007/BF02884960; ROBERTS AH, 1993, CLIN PSYCHOL REV, V13, P375, DOI 10.1016/0272-7358(93)90010-J; VINCENT C, 1995, J ROY SOC MED, V88, P199; Wilt TJ, 1998, JAMA-J AM MED ASSOC, V280, P1604, DOI 10.1001/jama.280.18.1604	22	119	123	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	2001	322	7279					161	164		10.1136/bmj.322.7279.161	http://dx.doi.org/10.1136/bmj.322.7279.161			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	396AZ	11159578	Green Published			2022-12-24	WOS:000166615300033
J	Muramoto, O				Muramoto, O			Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's Witnesses	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Reg Eth Council, Kaiser Permanente Interstate Med Off E, Portland, OR 97227 USA		Muramoto, O (corresponding author), Reg Eth Council, Kaiser Permanente Interstate Med Off E, Portland, OR 97227 USA.	muramoto@aracnet.com						Bailey R, 1998, ARTIF CELL BLOOD SUB, V26, P571, DOI 10.3109/10731199809117476; Elder L, 2000, J MED ETHICS, V26, P375, DOI 10.1136/jme.26.5.375; GLEDHILL R, 2000, TIMES           0615; LITTLE J, 2000, BBC NEWS        0614; Mullon J, 2000, NEW ENGL J MED, V342, P1638, DOI 10.1056/NEJM200006013422204; Muramoto O, 2000, J MED ETHICS, V26, P381, DOI 10.1136/jme.26.5.381; Muramoto O, 1999, WESTERN J MED, V170, P297; Muramoto O, 1998, J MED ETHICS, V24, P223, DOI 10.1136/jme.24.4.223; Muramoto O, 1998, LANCET, V352, P824, DOI 10.1016/S0140-6736(05)60725-8; Muramoto O, 1999, J MED ETHICS, V25, P463, DOI 10.1136/jme.25.6.463; Ridley DT, 1999, J MED ETHICS, V25, P469, DOI 10.1136/jme.25.6.469; Sharp D, 2000, LANCET, V356, P8, DOI 10.1016/S0140-6736(00)02424-7; *WATCH TOW BIBL TR, 1981, WATCHTOWER      0915, P20; *WATCH TOW BIBL TR, 1987, WATCHTOWER      0901, P12; Watch Tower Bible & Tract Society, 2000, THE WATCHTOWER, P29; Wilcox P, 1999, LANCET, V353, P757, DOI 10.1016/S0140-6736(05)76132-8	16	59	61	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2001	322	7277					37	39		10.1136/bmj.322.7277.37	http://dx.doi.org/10.1136/bmj.322.7277.37			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EP	11141155	Green Published			2022-12-24	WOS:000166341400025
J	Hausser, M; Major, G; Stuart, GJ				Hausser, M; Major, G; Stuart, GJ			Differential shunting of EPSPs by action potentials	SCIENCE			English	Article							NEURONS	Neurons encode information and communicate via action potentials, which are generated following the summation of synaptic events. It is commonly assumed that action potentials reset the membrane potential completely, allowing another round of synaptic integration to begin. We show here that the conductances underlying the action potential act instead as a variable reset of synaptic integration. The strength of this reset is cell type-specific and depends on the kinetics, Location, and timing of the synaptic input. As a consequence, distal synapses. as well as inputs mediated by N-methyl-D-aspartate receptor activation, can contribute disproportionately to synaptic integration during action potential firing.	UCL, Dept Physiol, London WC1E 6BT, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia	University of London; University College London; University of Oxford; Australian National University; John Curtin School of Medical Research	Stuart, GJ (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	m.hausser@ucl.ac.uk	Major, Guy/A-4335-2010; stuart, greg j/F-7328-2011; Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957; stuart, greg/0000-0001-9395-2219				[Anonymous], [No title captured]; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Cole KS, 1939, J GEN PHYSIOL, V22, P649, DOI 10.1085/jgp.22.5.649; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P374, DOI 10.1113/jphysiol.1955.sp005413; CURTIS DR, 1959, J PHYSIOL-LONDON, V145, P529, DOI 10.1113/jphysiol.1959.sp006159; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MAYER ML, 1984, NATURE, V309, P262; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; STORM JF, 1987, BRAIN RES, V435, P387, DOI 10.1016/0006-8993(87)91631-3; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177	15	81	82	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2001	291	5501					138	141		10.1126/science.291.5501.138	http://dx.doi.org/10.1126/science.291.5501.138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389VJ	11141567				2022-12-24	WOS:000166259100053
J	Xiao, SY; Ellwood, S; Calis, O; Patrick, E; Li, TX; Coleman, M; Turner, JG				Xiao, SY; Ellwood, S; Calis, O; Patrick, E; Li, TX; Coleman, M; Turner, JG			Broad-spectrum mildew resistance in Arabidopsis thaliana mediated by RPW8	SCIENCE			English	Article							PLANT-DISEASE-RESISTANCE; POWDERY MILDEW; GENES; TOMATO; SEQUENCES	Plant disease resistance (R) genes control the recognition of specific pathogens and activate subsequent defense responses. We show that the Arabidopsis thaliana Locus RESISTANCE TO POWDERY MILDEW8 (RPW8) contains two naturally polymorphic, dominant R genes, RPW8.1 and RPW8.2, which individually control resistance to a broad range of powdery mildew pathogens. Although the predicted RPW8.1 and RPW8.2 proteins are different from the previously characterized R proteins, they induce Localized, salicylic acid-dependent defenses similar to those induced by R genes that control specific resistance. Apparently, broad-spectrum resistance mediated by RPW8 uses the same mechanisms as specific resistance.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Turner, JG (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.		CALIS, Ozer/C-5608-2016; Bruening, Stefan/B-8505-2011; Ellwood, Simon/K-2023-2013; Xiao, Shunyuan/K-2598-2013	CALIS, Ozer/0000-0002-7219-1219; Ellwood, Simon/0000-0002-2673-0816; 				Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Adam L, 1999, MOL PLANT MICROBE IN, V12, P1031, DOI 10.1094/MPMI.1999.12.12.1031; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Botella MA, 1997, PLANT J, V12, P1197, DOI 10.1046/j.1365-313X.1997.12051197.x; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DANGL JL, 1995, CELL, V80, P363, DOI 10.1016/0092-8674(95)90485-9; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Hwang CF, 2000, PLANT CELL, V12, P1319, DOI 10.1105/tpc.12.8.1319; KEEN NT, 1990, ANNU REV GENET, V24, P447, DOI 10.1146/annurev.ge.24.120190.002311; Leister D, 1999, THEOR APPL GENET, V98, P509, DOI 10.1007/s001220051099; Luck JE, 2000, PLANT CELL, V12, P1367, DOI 10.1105/tpc.12.8.1367; Mylne J, 1998, PLANT MOL BIOL REP, V16, P257, DOI 10.1023/A:1007520410190; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Rommens CM, 2000, CURR OPIN BIOTECH, V11, P120, DOI 10.1016/S0958-1669(00)00083-5; Saenz GS, 1999, CAN J BOT, V77, P150, DOI 10.1139/cjb-77-1-150; SOMERVILLE SJ, COMMUNICATION; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; Thomas CM, 1998, PHILOS T ROY SOC B, V353, P1413, DOI 10.1098/rstb.1998.0296; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Whipps JM, 1998, PLANT PATHOL, V47, P36, DOI 10.1046/j.1365-3059.1998.00207.x; XIAO SQ, UNPUB; Xiao SY, 1997, PLANT J, V12, P757, DOI 10.1046/j.1365-313X.1997.12040757.x	24	334	385	5	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2001	291	5501					118	120		10.1126/science.291.5501.118	http://dx.doi.org/10.1126/science.291.5501.118			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389VJ	11141561				2022-12-24	WOS:000166259100047
J	Smalley, W; Shatin, D; Wysowski, DK; Gurwitz, J; Andrade, SE; Goodman, M; Chan, KA; Platt, R; Schech, SD; Ray, WA				Smalley, W; Shatin, D; Wysowski, DK; Gurwitz, J; Andrade, SE; Goodman, M; Chan, KA; Platt, R; Schech, SD; Ray, WA			Contraindicated use of cisapride - Impact of food and drug administration regulatory action	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TORSADES-DE-POINTES; CLARITHROMYCIN	Context Cisapride, a gastrointestinal tract promotility agent, can cause life-threatening cardiac arrhythmias in patients susceptible either because of concurrent use of medications that interfere with cisapride metabolism or prolong the QT interval or because of the presence of other diseases that predispose to such arrhythmias. In June 1998, the US Food and Drug Administration (FDA) determined that use of cisapride was contraindicated in such patients and informed practitioners through additions to the boxed warning in the label and a "Dear Health Care Professional" letter sent by the drug's manufacturer. Objective To evaluate the impact of the FDA's 1998 regulatory action regarding contraindicated use of cisapride. Design and Setting Analysis of data for the 1-year periods before (July 1997-June 1998) and after (July 1998-June 1999) the regulatory action from the population-based, pharmacoepidemiology research databases of 2 managed care organizations (sites A and B) and a state Medicaid program (site C). Participants Patients with at least 180 days of prior enrollment in 1 of the 3 sites who were prescribed cisapride at least once in the period before (n = 24840) or after (n = 22459) regulatory action. Patients could be included in both cohorts. Main Outcome Measures Proportion of cisapride users in each period for whom cisapride use was contraindicated by the product label, based on computerized patient medical encounter records. Results In the year prior to regulatory action, cisapride use was contraindicated for 26%, 30%, and 60% of users in study sites A, B, and C, respectively. In the year after regulatory action, use was contraindicated for 24%, 28%, and 58% of users, a reduction in contraindicated use of approximately 2 per 100 cisapride users at each site. When the analysis was restricted to new users of cisapride after regulatory action, only minor reductions in contraindicated use were found. Conclusion The FDA's 1998 regulatory action regarding cisapride use had no material effect on contraindicated cisapride use. More effective ways to communicate new information about drug safety are needed.	Vanderbilt Univ, Med Ctr, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; VA Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN USA; Unitedhlth Grp, Ctr Hlth Care Policy & Evaluat, Minnetonka, MN USA; US FDA, Off Postmkt Drug Risk Assessment, Rockville, MD 20857 USA; Univ Massachusetts, Sch Med, Fallon Healthcare Syst, Worcester, MA USA; Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Worcester, MA USA; Univ Rhode Isl, Coll Pharm, Kingston, RI 02881 USA; Healthpartners Res Fdn, Bloomington, MN USA; Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; US Food & Drug Administration (FDA); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Rhode Island; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ray, WA (corresponding author), Vanderbilt Univ, Med Ctr, Sch Med, Dept Prevent Med, Med Ctr N,A-1124, Nashville, TN 37232 USA.			Chan, Kinwei/0000-0001-8161-1986				*IMS HLTH, 1995, NAT PRESCR AUD PLUS; KLAUSNER MA, 1998, DEAR HLTH CARE PROF; Piquette RK, 1999, ANN PHARMACOTHER, V33, P22, DOI 10.1345/aph.18107; RAY WA, 1993, NEW ENGL J MED, V329, P2029, DOI 10.1056/NEJM199312303292710; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Sekkarie MA, 1997, AM J KIDNEY DIS, V30, P437, DOI 10.1016/S0272-6386(97)90291-2; SHATIN D, 2000, PHARMACOEPIDEMIOLOGY; US Dept of Health and Human Services . International Classification of Diseases, 1988, INT CLASS DIS; van Haarst AD, 1998, CLIN PHARMACOL THER, V64, P542, DOI 10.1016/S0009-9236(98)90137-0; Vitola J, 1998, J CARDIOVASC ELECTR, V9, P1109, DOI 10.1111/j.1540-8167.1998.tb00888.x; WOOSLEY RL, 1994, CLIN PHARMACOL THER, V55, P249, DOI 10.1038/clpt.1994.24; Wysowski DK, 1996, NEW ENGL J MED, V335, P290, DOI 10.1056/NEJM199607253350416	12	200	206	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2000	284	23					3036	3039		10.1001/jama.284.23.3036	http://dx.doi.org/10.1001/jama.284.23.3036			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	382VC	11122591	Bronze			2022-12-24	WOS:000165847200029
J	Hart, AW; Baeza, N; Apelqvist, A; Edlund, H				Hart, AW; Baeza, N; Apelqvist, A; Edlund, H			Attenuation of FGF signalling in mouse beta-cells leads to diabetes	NATURE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; FIBROBLAST GROWTH-FACTORS; INSULIN; GENE; PROINSULIN; ONSET; MUTATIONS; NIDDM; DIFFERENTIATION; CONVERSION	Fibroblast growth factor (FGF) signalling has been implicated in patterning, proliferation and cell differentiation in many organs, including the developing pancreas(1,2). Here we show that the FGF receptors (FGFRs) 1 and 2, together with the ligands FGF1, FGF2, FGF4, FGF5, FGF7 and FGF10, are expressed in adult mouse beta -cells, indicating that FGF signalling may have a role in differentiated beta -cells. When we perturbed signalling by expressing dominant-negative forms of the receptors, FGFR1c and FGFR2b, in the pancreas, we found that that mice with attenuated FGFR1c signalling, but not those with reduced FGFR2b signalling, develop diabetes with age and exhibit a decreased number of beta -cells, impaired expression of glucose transporter 2 and increased proinsulin content in beta -cells owing to impaired expression of prohormone convertases 1/3 and 2. These defects are all characteristic of patients with type-2 diabetes. Mutations in the homeobox gene Ipf1/Pdx1 are linked to diabetes in both mouse and human. We also show that Ipf1/Pdx1 is required for the expression of FGFR1 signalling components in beta -cells, indicating that Ipf1/Pdx1 acts upstream of FGFR1 signalling in beta -cells to maintain proper glucose sensing, insulin processing and glucose homeostasis.	Umea Univ, Dept Microbiol, S-90187 Umea, Sweden; Umea Univ, ULMM, S-90187 Umea, Sweden	Umea University; Umea University	Edlund, H (corresponding author), Umea Univ, Dept Microbiol, S-90187 Umea, Sweden.			Hart, Alan/0000-0001-7463-2535; Edlund, Helena/0000-0002-3553-7348				Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; BLUME N, 1992, MOL ENDOCRINOL, V6, P299, DOI 10.1210/me.6.2.299; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; CHEON HG, 1994, P NATL ACAD SCI USA, V91, P989, DOI 10.1073/pnas.91.3.989; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; Furuta M, 1998, J BIOL CHEM, V273, P3431, DOI 10.1074/jbc.273.6.3431; GITHENS S, 1988, J PEDIATR GASTR NUTR, V7, P486, DOI 10.1097/00005176-198807000-00004; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Haffner SM, 1997, DIABETOLOGIA, V40, P830, DOI 10.1007/s001250050756; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Hellerstrom C, 1988, PATHOLOGY ENDOCRINE, P141; Itoh N, 1996, DEVELOPMENT, V122, P291; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; KAHN SE, 1995, DIABETES, V44, P173, DOI 10.2337/diabetes.44.2.173; Kato S, 1999, CELL MOL BIOL, V45, P631; Larsson H, 1999, J CLIN ENDOCR METAB, V84, P2068, DOI 10.1210/jc.84.6.2068; Macfarlane WM, 1999, J CLIN INVEST, V104, pR33, DOI 10.1172/JCI7449; Nijpels G, 1996, DIABETOLOGIA, V39, P113; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Takumi I, 1998, MODERN PATHOL, V11, P232; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; Thorens B, 2000, J BIOL CHEM, V275, P23751, DOI 10.1074/jbc.M002908200; van Assche F A, 1979, Contrib Gynecol Obstet, V5, P44; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	30	184	201	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2000	408	6814					864	868		10.1038/35048589	http://dx.doi.org/10.1038/35048589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130726				2022-12-24	WOS:000165831300052
J	Bohn, LM; Gainetdinov, RR; Lin, FT; Lefkowitz, RJ; Caron, MG				Bohn, LM; Gainetdinov, RR; Lin, FT; Lefkowitz, RJ; Caron, MG			mu-Opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence	NATURE			English	Article							KNOCKOUT MICE; OPIATE DEPENDENCE; INDUCED ANALGESIA; ADENYLYL CYCLASE; CELL-MEMBRANES; BINDING; PROTEIN; ACTIVATION; WITHDRAWAL; ADDICTION	Morphine is a powerful pain reliever, but also a potent inducer of tolerance and dependence. The development of opiate tolerance occurs on continued use of the drug such that the amount of drug required to elicit pain relief must be increased to compensate for diminished responsiveness(1-3). In many systems, decreased responsiveness to agonists has been correlated with the desensitization of G-protein-coupled receptors. In vitro evidence indicates that this process involves phosphorylation of G-protein-coupled receptors and subsequent binding of regulatory proteins called beta -arrestins(4,5). Using a knockout mouse lacking beta -arrestin-2 (beta arr2(-/-)), we have assessed the contribution of desensitization of the mu -opioid receptor to the development of morphine antinociceptive tolerance and the subsequent onset of physical dependence. Here we show that in mice lacking beta -arrestin-2, desensitization of the mu -opioid receptor does not occur after chronic morphine treatment, and that these animals fail to develop antinociceptive tolerance. However, the deletion of beta -arrestin-2 does not prevent the chronic morphine-induced upregulation of adenylyl cyclase activity, a cellular marker of dependence, and the mutant mice still become physically dependent on the drug.	Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA.		Gainetdinov, Raul R/G-5875-2011; Bohn, Laura/A-4412-2008; Lefkowitz, Robert/AAW-2649-2021; Bohn, Laura M/A-7483-2014	Gainetdinov, Raul R/0000-0003-2951-6038; Bohn, Laura M/0000-0002-6474-8179	NIDA NIH HHS [F32 DA006023] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA006023] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AVIDORREISS T, 1995, J BIOL CHEM, V270, P29732; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; BRASE DA, 1977, J PHARMACOL EXP THER, V201, P368; Breivogel CS, 1997, J NEUROCHEM, V68, P1462; COLLIER HOJ, 1980, NATURE, V283, P625, DOI 10.1038/283625a0; Cox B. M., 1999, OPIOIDS PAIN CONTROL, P109; Elliott J, 1997, BRIT J PHARMACOL, V121, P1422, DOI 10.1038/sj.bjp.0701253; Fairbanks CA, 1999, J PHARMACOL EXP THER, V288, P1107; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; HAUSDORFF WP, 1990, J BIOL CHEM, V265, P1388; Jolas T, 2000, NEUROSCIENCE, V95, P433; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Kovoor A, 1997, J BIOL CHEM, V272, P27605, DOI 10.1074/jbc.272.44.27605; LaneLadd SB, 1997, J NEUROSCI, V17, P7890; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Nestler EJ, 1996, NEURON, V16, P897, DOI 10.1016/S0896-6273(00)80110-5; Noble F, 1996, BRIT J PHARMACOL, V117, P161, DOI 10.1111/j.1476-5381.1996.tb15169.x; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; PUTTFARCKEN PS, 1988, MOL PHARMACOL, V33, P520; SCHULTEIS G, 1994, J PHARMACOL EXP THER, V271, P1391; Sim LJ, 1996, J NEUROSCI, V16, P8057; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; WAY EL, 1969, J PHARMACOL EXP THER, V167, P1; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3	30	682	711	0	66	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2000	408	6813					720	723		10.1038/35047086	http://dx.doi.org/10.1038/35047086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130073				2022-12-24	WOS:000165815200049
J	Schiff, ML; Siderovski, DP; Jordan, JD; Brothers, G; Snow, B; De Vries, L; Ortiz, DF; Diverse-Pierluissi, M				Schiff, ML; Siderovski, DP; Jordan, JD; Brothers, G; Snow, B; De Vries, L; Ortiz, DF; Diverse-Pierluissi, M			Tyrosine-kinase-dependent recruitment of RGS12 to the N-type calcium channel	NATURE			English	Article							HETEROTRIMERIC G-PROTEINS; DESENSITIZATION; RECEPTOR; SUBUNIT	gamma -Aminobutyric acid (GABA)(B) receptors couple to G(o) to inhibit N-type calcium channels in embryonic chick dorsal root ganglion neurons(1). The voltage-independent inhibition, mediated by means of a tyrosine-kinase pathway(2), is transient and lasts up to 100 seconds. Inhibition of endogenous RGS12, a member of the family of regulators of G-protein signalling, selectively alters the time course of voltage-independent inhibition. The RGS12 protein, in addition to the RGS domain, contains PDZ and PTB domains(3). Fusion proteins containing the PTB domain of RGS12 alter the rate of termination of the GABAB signal, whereas the PDZ or RGS domains of RGS12 have no observable effects. Using primary dorsal root ganglion neurons in culture, here we show an endogenous agonist-induced tyrosine-kinase-dependent complex of RGS12 and the calcium channel. These results indicate that RGS12 is a multifunctional protein capable of direct interactions through its PTB domain with the tyrosine-phosphorylated calcium channel. Recruitment of RGS proteins to G-protein effecters may represent an additional mechanism for signal termination in G-protein-coupled pathways.	CUNY Mt Sinai Sch Med, Dept Pharmacol, New York, NY 10029 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27559 USA; Amgen Res Inst, Toronto, ON M5G 2C1, Canada; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; Tufts University	Diverse-Pierluissi, M (corresponding author), CUNY Mt Sinai Sch Med, Dept Pharmacol, Box 1215, New York, NY 10029 USA.		Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Jordan, Dedrick/0000-0002-0706-9583				AHLIJANIAN MK, 1991, J BIOL CHEM, V266, P20192; De Vries L, 1998, MOL BIOL CELL, V9, P1123, DOI 10.1091/mbc.9.5.1123; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Diverse-Pierluissi MA, 1999, J BIOL CHEM, V274, P14490, DOI 10.1074/jbc.274.20.14490; DiversePierluissi M, 1996, NEURON, V16, P579, DOI 10.1016/S0896-6273(00)80077-X; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; DiversePierluissi M, 1997, P NATL ACAD SCI USA, V94, P5417, DOI 10.1073/pnas.94.10.5417; DUBEL SJ, 1992, P NATL ACAD SCI USA, V89, P5058, DOI 10.1073/pnas.89.11.5058; LUEBKE JI, 1994, PFLUG ARCH EUR J PHY, V428, P499, DOI 10.1007/BF00374571; MCENERY MW, 1991, P NATL ACAD SCI USA, V88, P11095, DOI 10.1073/pnas.88.24.11095; Snow BE, 1998, J BIOL CHEM, V273, P17749, DOI 10.1074/jbc.273.28.17749; Srinivasa SP, 1998, P NATL ACAD SCI USA, V95, P5584, DOI 10.1073/pnas.95.10.5584; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687	13	111	114	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2000	408	6813					723	727		10.1038/35047093	http://dx.doi.org/10.1038/35047093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130074				2022-12-24	WOS:000165815200050
J	Elser, JJ; Fagan, WF; Denno, RF; Dobberfuhl, DR; Folarin, A; Huberty, A; Interlandi, S; Kilham, SS; McCauley, E; Schulz, KL; Siemann, EH; Sterner, RW				Elser, JJ; Fagan, WF; Denno, RF; Dobberfuhl, DR; Folarin, A; Huberty, A; Interlandi, S; Kilham, SS; McCauley, E; Schulz, KL; Siemann, EH; Sterner, RW			Nutritional constraints in terrestrial and freshwater food webs	NATURE			English	Article							N-P STOICHIOMETRY; ECOSYSTEMS; PHOSPHORUS; GROWTH; PHYTOPLANKTON; ZOOPLANKTON; LIMITATION; PATTERNS; DAPHNIA; PLANTS	Biological and environmental contrasts between aquatic and terrestrial systems have hindered analyses of community and ecosystem structure across Earth's diverse habitats. Ecological stoichiometry(1,2) provides an integrative approach for such analyses, as all organisms are composed of the same major elements (C, N, P) whose balance affects production, nutrient cycling, and food-web dynamics(3,4). Here we show both similarities and differences in the C:N:P ratios of primary producers (autotrophs) and invertebrate primary consumers (herbivores) across habitats. Terrestrial food webs are built on an extremely nutrient-poor autotroph base with C:P and C:N ratios higher than in lake particulate matter, although the N:P ratios are nearly identical. Terrestrial herbivores (insects) and their freshwater counterparts (zooplankton) are nutrient-rich and indistinguishable in C:N:P stoichiometry. In both lakes and terrestrial systems, herbivores should have low growth efficiencies (10-30%) when consuming autotrophs with typical carbon-to-nutrient ratios. These stoichiometric constraints on herbivore growth appear to be qualitatively similar and widespread in both environments.	Arizona State Univ, Dept Biol, Tempe, AZ 85287 USA; Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; Drexel Univ, Sch Environm Sci Engn & Policy, Philadelphia, PA 19104 USA; Univ Calgary, Dept Biol Sci, Div Ecol, Calgary, AB T2N 1N4, Canada; SUNY Syracuse, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Arizona State University; Arizona State University-Tempe; University System of Maryland; University of Maryland College Park; Drexel University; University of Calgary; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Rice University; University of Minnesota System; University of Minnesota Twin Cities	Elser, JJ (corresponding author), Arizona State Univ, Dept Biol, Tempe, AZ 85287 USA.		Elser, James/A-7082-2008	Elser, James/0000-0002-1460-2155; Sterner, Robert/0000-0003-2292-6122; Schulz, Kimberly/0000-0003-1506-5694				Andersen T., 1997, PELAGIC NUTR CYCLES; BUTLER NM, 1989, OECOLOGIA, V78, P368, DOI 10.1007/BF00379111; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; CYR H, 1993, NATURE, V361, P148, DOI 10.1038/361148a0; DeMott WR, 1998, LIMNOL OCEANOGR, V43, P1147, DOI 10.4319/lo.1998.43.6.1147; ELSER JJ, 1995, MICROBIAL ECOL, V29, P145, DOI 10.1007/BF00167161; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; Elton C., 1927, ANIMAL ECOLOGY; FUTUYMA DJ, 1979, ECOL MONOGR, V49, P33, DOI 10.2307/1942571; LEIBOLD MA, 1989, AM NAT, V134, P922, DOI 10.1086/285022; Main TM, 1997, LIMNOL OCEANOGR, V42, P1474, DOI 10.4319/lo.1997.42.6.1474; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; REINERS WA, 1986, AM NAT, V127, P59, DOI 10.1086/284467; Schlesinger W.H., 1997, BIOGEOCHEMISTRY ANAL, V2nd Edition; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; Sterner RW, 1997, FRESHWATER BIOL, V38, P473, DOI 10.1046/j.1365-2427.1997.00234.x; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Strong DR, 1984, INSECTS PLANTS COMMU; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Verhoeven JTA, 1996, TRENDS ECOL EVOL, V11, P494, DOI 10.1016/S0169-5347(96)10055-0; White T. C. R., 1993, INADEQUATE ENV NITRO	25	1056	1438	60	1250	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2000	408	6812					578	580		10.1038/35046058	http://dx.doi.org/10.1038/35046058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117743				2022-12-24	WOS:000165548600116
J	Mrazek, MF; Mossialos, E				Mrazek, MF; Mossialos, E			Increasing demand while decreasing costs of generic medicines	LANCET			English	Editorial Material							PRESCRIPTION		Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England	University of London; London School Economics & Political Science	Mossialos, E (corresponding author), Univ London London Sch Econ & Polit Sci, LSE Hlth, Houghton St, London WC2A 2AE, England.		Mossialos, Elias/ABE-1301-2021					Bussow R., 1996, Formal Methods for Industrial Applications. Specifying and Programming the Steam Boiler Control, P109, DOI 10.1007/BFb0027233; *DEP HLTH UK, 1998, STAT B DEP HLTH UK, V24; *DEP HLTH UK, 2000, GOV RESP HLTH SEL CO; *EUR OBS HLTH CAR, 1999, HLTH CAR SYST TRANS; Giuliani G, 1998, HEALTH POLICY, V44, P73, DOI 10.1016/S0168-8510(98)00012-8; Gosden T, 1997, HEALTH POLICY, V40, P103, DOI 10.1016/S0168-8510(96)00888-3; Hellerstein JK, 1998, RAND J ECON, V29, P108, DOI 10.2307/2555818; Hillman AL, 1999, HEALTH AFFAIR, V18, P189, DOI 10.1377/hlthaff.18.2.189; *HOECHST MAR ROUS, 1998, MAN CAR DIG SER; Hong SH, 1996, CLIN THER, V18, P528, DOI 10.1016/S0149-2918(96)80035-X; *PHARM PRIC REV, 1998, PHARMA PRICING REV, V3, P200; *US DEP HHS, 2000, PRESCR DRUG COV SPEN	12	9	10	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2000	356	9244					1784	1785		10.1016/S0140-6736(00)03225-6	http://dx.doi.org/10.1016/S0140-6736(00)03225-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377UY	11117905				2022-12-24	WOS:000165545700004
J	Vogelauer, M; Wu, JS; Suka, N; Grunstein, M				Vogelauer, M; Wu, JS; Suka, N; Grunstein, M			Global histone acetylation and deacetylation in yeast	NATURE			English	Article							POLYMERASE-II HOLOENZYME; CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; PHO5 PROMOTER; ACETYLTRANSFERASE; CHROMATIN; TRANSCRIPTION; NUCLEOSOMES; ACTIVATION	Histone acetyltransferases and deacetylases can be targeted to promoters to activate or repress genes. For example, the histone acetyltransferase GCN5 is part of a yeast multiprotein complex that is recruited by the DNA-binding activator protein GCN4 (refs 1-3). The histone deacetylase RPD3 complex is recruited to DNA by the repressor UME6 (refs 4, 5); similar mechanisms exist in other eukaryotes(6). However, deletion of RPD3 also increases expression of the PHO5 gene(7) that is repressed by nucleosomes(8,9), and regulated by GCN5 (ref. 10) but not by UME6. We have determined whether acetylation and deacetylation are promoter specific at PHO5, by using antibodies against acetylated lysine residues and chromatin immunoprecipitation to examine the acetylation state of a 4.25-kilobase region surrounding the PHO5 gene. Here we show that this region is acetylated extensively by ESA1 and GCN5 and deacetylated by HDA1 and RPD3, and that widespread histone modification affects three separate chromosomal regions examined, which total 22 kb. Our data indicate that targeted modification occurs in a background of global acetylation and deacetylation that not only reduces basal transcription, but also allows a rapid return to the initial state of acetylation when targeting is removed.	Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Grunstein, M (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Boyer Hall, Los Angeles, CA 90095 USA.							ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; Drysdale CM, 1998, MOL CELL BIOL, V18, P1711, DOI 10.1128/MCB.18.3.1711; EhrenhoferMurray AE, 1997, GENETICS, V145, P923; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; HAN M, 1988, EMBO J, V7, P2221, DOI 10.1002/j.1460-2075.1988.tb03061.x; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; LAMAN H, 1995, MOL CELL BIOL, V15, P3608; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Reifnyder C, 1997, NAT GENET, V16, P109, DOI 10.1038/ng0597-109b; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; VIDAL M, 1991, MOL CELL BIOL, V11, P6317, DOI 10.1128/MCB.11.12.6317; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X	29	342	362	1	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2000	408	6811					495	498		10.1038/35044127	http://dx.doi.org/10.1038/35044127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100734				2022-12-24	WOS:000165429800054
J	Bowman, AB; Kamal, A; Ritchings, BW; Philp, AV; McGrail, M; Gindhart, JG; Goldstein, LSB				Bowman, AB; Kamal, A; Ritchings, BW; Philp, AV; McGrail, M; Gindhart, JG; Goldstein, LSB			Kinesin-dependent axonal transport is mediated by the Sunday driver (SYD) protein	CELL			English	Article							FORMIMINOTRANSFERASE CYCLODEAMINASE; HEAVY-CHAIN; CYTOPLASMIC DYNEIN; TAIL DOMAIN; MOTOR; BINDING; MOTILITY; IDENTIFICATION; DROSOPHILA; KINECTIN	A broadly conserved membrane-associated protein required for the functional interaction of kinesin-1 with axonal cargo was identified. Mutations in sunday driver (syd) and the axonal transport motor kinesin-1 cause similar phenotypes in Drosophila, including aberrant accumulations of axonal cargoes. GFP-tagged mammalian SYD localizes to tubulovesicular structures that costain for kinesin-1 and a marker of the secretory pathway. Coimmunoprecipitation analysis indicates that mouse SYD forms a complex with kinesin-1 in vivo. Yeast two-hybrid analysis and in vitro interaction studies reveal that SYD directly binds kinesin-1 via the tetratricopeptide repeat (TPR) domain of kinesin light chain (KLC) with K-d approximate to 200 nM. We propose that SYD mediates the axonal transport of at least one class of vesicles by interacting directly with KLC.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Massachusetts, Dept Biol, Boston, MA 02125 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Massachusetts System; University of Massachusetts Boston	Goldstein, LSB (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.		McGrail, Maura/AAA-5610-2021	McGrail, Maura/0000-0001-9308-6189; Bowman, Aaron/0000-0001-8728-3346	NIGMS NIH HHS [GM35252] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035252] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Bashour AM, 1998, J BIOL CHEM, V273, P19612, DOI 10.1074/jbc.273.31.19612; Bowman AB, 1999, J CELL BIOL, V146, P165; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Friedman DS, 1999, NAT CELL BIOL, V1, P293, DOI 10.1038/13008; Gao YS, 1998, J BIOL CHEM, V273, P33825, DOI 10.1074/jbc.273.50.33825; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; GRASSO G, 1996, DIS, V77, P94; Hennig D, 1998, J BIOL CHEM, V273, P19602, DOI 10.1074/jbc.273.31.19602; Hurd DD, 1996, GENETICS, V144, P1075; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; KUMAR J, 1995, SCIENCE, V267, P1834, DOI 10.1126/science.7892610; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; ORCI L, 1993, NATURE, V362, P648, DOI 10.1038/362648a0; PARCHALIUK DL, 1999, YEAST 2 HYBRID SYS C; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sheetz MP, 1999, EUR J BIOCHEM, V262, P19, DOI 10.1046/j.1432-1327.1999.00340.x; SKOUFIAS DA, 1994, J BIOL CHEM, V269, P1477; STEINBERG G, 1995, MOL BIOL CELL, V6, P1605, DOI 10.1091/mbc.6.11.1605; Stenoien DL, 1997, MOL BIOL CELL, V8, P675, DOI 10.1091/mbc.8.4.675; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Toyoshima I, 1996, NEUROSCI LETT, V211, P171, DOI 10.1016/0304-3940(96)12752-X; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A	38	261	269	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 10	2000	103	4					583	594		10.1016/S0092-8674(00)00162-8	http://dx.doi.org/10.1016/S0092-8674(00)00162-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	374MB	11106729	Bronze			2022-12-24	WOS:000165348000004
J	Wood, RD; Mitchell, M; Sgouros, J; Lindahl, T				Wood, RD; Mitchell, M; Sgouros, J; Lindahl, T			Human DNA repair genes	SCIENCE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; SEQUENCE; DAMAGE; CELLS; PROTEINS; DATABASE; SYSTEMS; AGENTS; MGMT	Cellular DNA is subjected to continual attack, both by reactive species inside cells and by environmental agents. Toxic and mutagenic consequences are minimized by distinct pathways of repair, and 130 known human DNA repair genes are described here. Notable features presently include four enzymes that can remove uracil from DNA, seven recombination genes related to RAD51, and many recently discovered DNA polymerases that bypass damage, but only one system to remove the main DNA lesions induced by ultraviolet Light. More human DNA repair genes will be found by comparison with model organisms and as common folds in three-dimensional protein structures are determined. Modulation of DNA repair should Lead to clinical applications including improvement of radiotherapy and treatment with anticancer drugs and an advanced understanding of the cellular aging process.	Imperial Canc Res Fund, Clare Hall Labs, Potters Bar EN6 3LD, Herts, England; Imperial Canc Res Fund, London WC2A 3PX, England	Cancer Research UK	Wood, RD (corresponding author), Univ Pittsburgh, Inst Canc, 5867 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.		Wood, Richard D/M-6319-2018	Wood, Richard D/0000-0002-9495-6892; Sgouros, John G./0000-0002-9141-5257				Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1; Bearzatto A, 2000, CANCER RES, V60, P3262; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Claij N, 1999, EXP CELL RES, V246, P1, DOI 10.1006/excr.1998.4299; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Duell EJ, 2000, CARCINOGENESIS, V21, P965, DOI 10.1093/carcin/21.5.965; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Friedberg EC, 2000, MUTAT RES-DNA REPAIR, V459, P243, DOI 10.1016/S0921-8777(00)00006-9; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Koberle B, 1999, CURR BIOL, V9, P273, DOI 10.1016/S0960-9822(99)80118-3; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Sekelsky JJ, 2000, J CELL BIOL, V150, pF31, DOI 10.1083/jcb.150.2.F31; Tainer JA, 2000, MUTAT RES-DNA REPAIR, V460, P139, DOI 10.1016/S0921-8777(00)00037-9; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	23	1016	1124	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1284	+		10.1126/science.1056154	http://dx.doi.org/10.1126/science.1056154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11181991				2022-12-24	WOS:000166993400037
J	Olefsky, JM				Olefsky, JM			Prospects for research in diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-2	Diabetes mellitus is the sixth leading cause of death in the United States, and morbidities resulting from diabetes-related complications such as retinopathy, kidney disease, and limb amputation cause a huge burden to the national health care system. Identification of the genetic components of type 1 and type 2 diabetes is the most important area of research because elucidation of the diabetes genes will influence all efforts toward a mechanistic understanding of the disease, its complications, and its treatment, cure, and prevention. Also, the link between obesity and type 2 diabetes mandates a redoubled effort to understand the genetic and behavioral contributions to obesity.	Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Dept Vet Affairs, San Diego, CA USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.							*C EST DIAB RES WO, 1999, NIH PUBL; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; EISENBARTH GS, 1994, JOSLINS DIABETES MEL, P216; Ferris FL, 1999, NEW ENGL J MED, V341, P667, DOI 10.1056/NEJM199908263410907; Harris MI, 1998, DIABETES CARE, V21, pC11, DOI 10.2337/diacare.21.3.C11; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; HARRIS MI, 1996, DIABETES SPECTRUM, V9, P26; LeRoith D., 2000, DIABETES MELLITUS FU; OLEFSKY JM, IN PRESS DEGROOT TXB; Reiber GE, 1995, DIABETES AM, P409; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UNGER RH, 1998, DIABETES MELLITUS WI, P973; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909	15	35	35	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					628	632		10.1001/jama.285.5.628	http://dx.doi.org/10.1001/jama.285.5.628			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176871	Bronze			2022-12-24	WOS:000166714200024
J	Abdulla, S; Armstrong, J; Schellenberg, A; Nathan, R; Mukasa, O; Marchant, T; Smith, T; Tanner, M; Lengeler, C				Abdulla, S; Armstrong, J; Schellenberg, A; Nathan, R; Mukasa, O; Marchant, T; Smith, T; Tanner, M; Lengeler, C			Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERENNIAL TRANSMISSION; FALCIPARUM-MALARIA; INTENSE; ANEMIA; AREA; CHLOROQUINE; EFFICACY; INFANTS	Objective To assess the impact of a social marketing programme for distributing nets treated with insecticide on malarial parasitaemia and anaemia in very young children in an area of high malaria transmission. Design Community cross sectional study. Annual, cross sectional data were collected at the beginning of the social marketing campaign (1997) and the subsequent two years. Net ownership and other risk and confounding factors were assessed with a questionnaire. Blood samples were taken from the children to assess prevalence of parasitaemia and haemoglobin levels. Setting 18 villages in the Kilombero and Ulanga districts of southwestern Tanzania. participants A random sample of children aged under 2 years. Main outcome measures The presence of any parasitaemia in the peripheral blood sample and the presence of anaemia (classified as a haemoglobin level of <80 g/l). Results Ownership of nets increased rapidly (treated or not treated nets: from 58% to 83%; treated nets: from 10% to 61%). The mean haemoglobin level rose from 80 g/l to 89 g/l in the stud children in the successive surveys. Overall, the prevalence of anaemia in the stud population decreased from 49% to 26% in the two years studied. Treated nets had a protective efficacy of 62% (95% confidence interval 38% to 77%) on the prevalence of parasitaemia and of 63% (27% to 82%) on anaemia. Conclusions These results show that nets treated with insecticide have a substantial impact on morbidity when distributed in a public health setting.	Swiss Trop Inst, Basel, Switzerland; Ifakara Hlth Res & Dev Ctr, Ifakara, Tanzania	University of Basel; Swiss Tropical & Public Health Institute; Ifakara Health Institute	Lengeler, C (corresponding author), Swiss Trop Inst, POB 4002, Basel, Switzerland.	Christian.Lengeler@unibas.ch	Smith, Thomas/B-5569-2015	Smith, Thomas/0000-0002-3650-9381; Marchant, Tanya/0000-0002-4228-4334; Schellenberg, Joanna/0000-0002-0708-3676				BLOLAND PB, 1993, J INFECT DIS, V167, P932, DOI 10.1093/infdis/167.4.932; Hatz C, 1998, TROP MED INT HEALTH, V3, P498, DOI 10.1046/j.1365-3156.1998.00250.x; Kitua AY, 1997, TROP MED INT HEALTH, V2, P325; Kitua AY, 1996, TROP MED INT HEALTH, V1, P475, DOI 10.1046/j.1365-3156.1996.d01-89.x; Langeler C, 1996, B WORLD HEALTH ORGAN, V74, P325; Lengeler C, 2000, COCHRANE DATABASE SY; *MAL CONS LOND SCH, 1999, 2 INT C INS TREAT NE; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Schellenberg JRMA, 1999, T ROY SOC TROP MED H, V93, P225, DOI 10.1016/S0035-9203(99)90001-9; Smith T, 1999, T ROY SOC TROP MED H, V93, pS15, DOI 10.1016/S0035-9203(99)90322-X; *STAT CORP, 1999, STATA STAT SOFTW REL; Stoltzfus RJ, 1997, LANCET, V349, P1764, DOI 10.1016/S0140-6736(96)12355-2; Tanner M., 1991, DIS MORTALITY SUBSAH	15	110	113	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2001	322	7281					270	273		10.1136/bmj.322.7281.270	http://dx.doi.org/10.1136/bmj.322.7281.270			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401FM	11157527	Bronze, Green Published, Green Submitted, Green Accepted			2022-12-24	WOS:000166917600027
J	Ascherio, A; Zhang, SM; Hernan, MA; Olek, MJ; Coplan, PM; Brodovicz, K; Walker, AM				Ascherio, A; Zhang, SM; Hernan, MA; Olek, MJ; Coplan, PM; Brodovicz, K; Walker, AM			Hepatitis B vaccination and the risk of multiple sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NERVOUS-SYSTEM DEMYELINATION; MS	Background: Reports of multiple sclerosis developing after hepatitis B vaccination have led to the concern that this vaccine might be a cause of multiple sclerosis in previously healthy subjects. Methods: We conducted a nested case-control study in two large cohorts of nurses in the United States, those in the Nurses' Health Study (which has followed 121,700 women since 1976) and those in the Nurses' Health Study II (which has followed 116,671 women since 1989). For each woman with multiple sclerosis, we selected as controls five healthy women and one woman with breast cancer. Information about hepatitis B vaccination was obtained by means of a mailed questionnaire and was confirmed by means of vaccination certificates. The analyses included 192 women with multiple sclerosis and 645 matched controls (534 healthy controls and 111 with breast cancer) and were conducted with the use of conditional logistic regression. Results: The multivariate relative risk of multiple sclerosis associated with exposure to the hepatitis B vaccine at any time before the onset of the disease was 0.9 (95 percent confidence interval, 0.5 to 1.6). The relative risk associated with hepatitis B vaccination within two years before the onset of the disease was 0.7 (95 percent confidence interval, 0.3 to 1.8). The results were similar in analyses restricted to women with multiple sclerosis that began after the introduction of the recombinant hepatitis B vaccine. There was also no association between the number of doses of vaccine received and the risk of multiple sclerosis. Conclusions: These results indicate no association between hepatitis B vaccination and the development of multiple sclerosis. (N Engl J Med 2001;344:327-32.) Copyright (C) 2001 Massachusetts Medical Society.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Multiple Sclerosis Unit, Boston, MA 02115 USA; Merck Res Labs, W Point, PA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Merck & Company	Ascherio, A (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.			Coplan, Paul/0000-0002-7078-7780; Olek, Michael/0000-0002-3840-2772	NATIONAL CANCER INSTITUTE [R01CA050385, R01CA040356, R37CA040356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035624] Funding Source: NIH RePORTER; NCI NIH HHS [CA40356, CA50385] Funding Source: Medline; NINDS NIH HHS [NS35624] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brex PA, 1999, NEUROLOGY, V53, P1184, DOI 10.1212/WNL.53.6.1184; Fourrier A., 1999, PHARMACOEPIDEMIOL DR, V8, pS140; Hall M, 1999, UNIX REV-PERFORM COM, V17, P5; Hernan MA, 1999, NEUROLOGY, V53, P1711, DOI 10.1212/WNL.53.8.1711; Hernan MA, 1999, AM J EPIDEMIOL, V149, pS37; HERROELEN L, 1991, LANCET, V338, P1174, DOI 10.1016/0140-6736(91)92034-Y; KANE M, 1995, VACCINE, V13, pS47; KAPLANSKI G, 1995, J NEUROL NEUROSUR PS, V58, P758, DOI 10.1136/jnnp.58.6.758-a; Marshall E, 1998, SCIENCE, V281, P630, DOI 10.1126/science.281.5377.630; MCMAHON BJ, 1992, AM J MED, V92, P254, DOI 10.1016/0002-9343(92)90073-K; NADLER JP, 1993, CLIN INFECT DIS, V17, P928, DOI 10.1093/clinids/17.5.928-b; Niu MT, 1996, PEDIATR INFECT DIS J, V15, P771, DOI 10.1097/00006454-199609000-00007; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Sadovnick AD, 2000, LANCET, V355, P549, DOI 10.1016/S0140-6736(99)02991-8; SHAW FE, 1988, AM J EPIDEMIOL, V127, P337, DOI 10.1093/oxfordjournals.aje.a114808; Sturkenboom MC, 1999, PHARMACOEPIDEM DR S, V8, pS170; Tourbah A, 1999, NEUROLOGY, V53, P396, DOI 10.1212/WNL.53.2.396; Touze E, 2000, REV NEUROL, V156, P242; Zipp F, 1999, NAT MED, V5, P964, DOI 10.1038/12376	19	295	303	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2001	344	5					327	332		10.1056/NEJM200102013440502	http://dx.doi.org/10.1056/NEJM200102013440502			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397CM	11172163				2022-12-24	WOS:000166675800002
J	Harris, NS; Crawford, PB; Yangzom, Y; Pinzo, L; Gyaltsen, P; Hudes, M				Harris, NS; Crawford, PB; Yangzom, Y; Pinzo, L; Gyaltsen, P; Hudes, M			Nutritional and health status of Tibetan children living at high altitudes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNATIONAL GROWTH REFERENCE; KASHIN-BECK-DISEASE; MALNUTRITION; CHINA; URBAN; POPULATIONS; MORTALITY; PNEUMONIA; REFORMS; ORIGIN	Background: Children living at high altitudes often have delayed growth, but whether growth retardation is related to altitude or to other factors is not known. Methods: A multicultural health care team assessed 2078 Tibetan children 0 to 84 months of age for anthropometric and clinical signs of malnutrition. The children lived in 11 counties, which contained more than 50 diverse urban and nonurban (nomadic, agricultural, or periurban) communities in the Tibet Autonomous Region of China. The height and weight of the children were compared with those of U.S. children. Height and weight were expressed as z scores (the number of standard deviations from the median of the age- and sex-specific reference group). Results: The mean z score for height fell from -0.5 to -1.6 in the first 12 months of life and generally ranged from -2.0 to -2.4 in older children. Overall, of 2078 children, 1067 (51 percent) had moderately or severely stunted growth, as defined by a z score of -2.0 or lower. Of the 1556 children 24 months of age or older, 871 (56 percent) had stunted growth, which was severe (z score, -3.0 or lower) in 380 (24 percent). Among the children in this age group, 787 of the 1313 nonurban children (60 percent) had stunting, as compared with 84 of the 243 urban children (35 percent). Stunting was associated with clinical conditions such as rickets, abdominal distention, hair depigmentation, and skin lesions and with a maternal history of hepatitis or goiter. Stunting was not associated with altitude, after adjustment for the type of community. Conclusions: In Tibetan children, severe stunting due to malnutrition occurs early in life, and morbidity is high. (N Engl J Med 2001;344:341-7.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Calif Berkeley, Dept Nutr Sci, Berkeley, CA 94720 USA; Inst Publ Hlth, Tibet child Nutr & Collaborat Hlth Project, Santa Cruz, CA 95064 USA; First Peoples Hosp, Tibet Med Res Inst, Lhasa, Peoples R China; First Peoples Hosp, Dept Pediat & Med Res, Lhasa, Tibet, Peoples R China	University of California System; University of California Berkeley; Public Health Institute	Crawford, PB (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.							ALLEN LH, 1993, NUTR REV, V51, P255, DOI 10.1111/j.1753-4887.1993.tb03117.x; BEALL CM, 1981, ANN HUM BIOL, V8, P31, DOI 10.1080/03014468100004761; BEATON GH, 1989, EUR J CLIN NUTR, V43, P863; Burger Susan E., 1993, American Journal of Clinical Nutrition, V57, p295S, DOI 10.1093/ajcn/57.2.295S; Chang Y, 1996, Biomed Environ Sci, V9, P164; Chasseur C, 1997, LANCET, V350, P1074, DOI 10.1016/S0140-6736(05)70453-0; CHEN LC, 1980, AM J CLIN NUTR, V33, P1836, DOI 10.1093/ajcn/33.8.1836; *COMM EUR COMM, 1994, CHIN FEAS STUD INT R; Delange F, 1986, ERADICATION ENDEMIC, P373; Delong G. Robeert, 1993, American Journal of Clinical Nutrition, V57, p286S, DOI 10.1093/ajcn/57.2.286S; DELONG GR, 1993, AM J CLIN NUTR, V57, P286; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P749, DOI 10.1093/ajcn/46.5.749; DORJE G, 1999, TIET HDB; Frisancho A R, 1983, Prog Clin Biol Res, V136, P383; GARN SM, 1973, ECOL FOOD NUTR, V2, P79; GOPLAN CC, 1983, SMALL HLTH POOR NOT, P1; Grantham-Mcgregor Sally M., 1993, American Journal of Clinical Nutrition, V57, p303S, DOI 10.1093/ajcn/57.2.303S; HAAS JD, 1982, AM J PHYS ANTHROPOL, V59, P251, DOI 10.1002/ajpa.1330590304; Haas JD, 1980, HUM BIOL, V52, P459; HABICHT JP, 1974, LANCET, V1, P611; HUO L, 1991, J RES CHILD HLTH, P1; Jelliffe D.B., 1966, ASSESSMENT NUTR STAT; KARIM MR, 1998, GEE SAS MACRO LONGIT; Kirk R.E., 1968, EXPT DESIGN PROCEDUR; KOLSTEREN P, 1990, NUTR HLTH WATER SANI; LEONARD WR, 1989, AM J PHYS ANTHROPOL, V80, P341, DOI 10.1002/ajpa.1330800308; MAJUMDER PP, 1986, AM J PHYS ANTHROPOL, V70, P377, DOI 10.1002/ajpa.1330700312; MARTORELL R, 1978, PROGR HUMAN NUTRITIO, V2, P142; Mathieu F, 1997, INT ORTHOP, V21, P151, DOI 10.1007/s002640050139; Moreno-Reyes R, 1998, NEW ENGL J MED, V339, P1112, DOI 10.1056/NEJM199810153391604; Muhe L, 1997, LANCET, V349, P1801, DOI 10.1016/S0140-6736(96)12098-5; *NAT CTR HLTH INF, MCH BAS STUD; National Family Health Survey, 1992, NAT FAM HLTH SURV; PAWSON IG, 1977, AM J PHYS ANTHROPOL, V47, P473, DOI 10.1002/ajpa.1330470320; PELLETIER DL, 1994, NUTR REV, V52, P409, DOI 10.1111/j.1753-4887.1994.tb01376.x; Seckler D., 1982, NEWER CONCEPTS NUTR, P127; Shen TF, 1996, NEW ENGL J MED, V335, P400, DOI 10.1056/NEJM199608083350606; SHI LY, 1993, B WORLD HEALTH ORGAN, V71, P723; SINGH S P, 1980, Zeitschrift fuer Morphologie und Anthropologie, V71, P187; TROWBRIDGE FL, 1987, AM J CLIN NUTR, V46, P411, DOI 10.1093/ajcn/46.3.411; TROWBRIDGE FL, 1981, AM J CLIN NUTR, V34, P2591, DOI 10.1093/ajcn/34.11.2591; VICTORA CG, 1990, AM J CLIN NUTR, V52, P391, DOI 10.1093/ajcn/52.2.391; VICTORA CG, 1992, J NUTR, V122, P1105, DOI 10.1093/jn/122.5.1105; ZHOUT AH, 1986, SURVEY STUDY NUTR GR	45	83	91	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2001	344	5					341	347		10.1056/NEJM200102013440504	http://dx.doi.org/10.1056/NEJM200102013440504			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397CM	11172165				2022-12-24	WOS:000166675800004
J	Mills, SY				Mills, SY			Regulation in complementary and alternative medicine	BRITISH MEDICAL JOURNAL			English	Article									Sch Educ, Dept Lifelong Learning, Complementary Hlth Studies Programme, Exeter EX1 2LU, Devon, England		Mills, SY (corresponding author), Sch Educ, Dept Lifelong Learning, Complementary Hlth Studies Programme, Exeter EX1 2LU, Devon, England.			Mills, Simon/0000-0001-7729-5300				DICKINSON D, 1995, COMPLEMENT THER MED, V3, P9; Ernst E., 1995, COMPLEMENT THER MED, V3, P6; *F INT MED, 1998, INT HEALTHC WAY NEXT; *HOUS LORDS SEL CO, 2000, COMPL ALT MED SESS 1; Mills S., 1997, PROFESSIONAL ORG COM; MILLS S, 2000, PROFESSIONAL ORG COM; Mills S. Y., 1996, COMPLEMENT THER MED, V4, P48; SHIFFIN K, 1993, COMPLEMENTARY THERAP, V1, P91; STONE J, 1996, COMPLEMENTARY MED LA; THOMAS KJ, 1991, BRIT MED J, V302, P207, DOI 10.1136/bmj.302.6770.207	10	31	31	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	2001	322	7279					158	160		10.1136/bmj.322.7279.158	http://dx.doi.org/10.1136/bmj.322.7279.158			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	396AZ	11159577	Green Published			2022-12-24	WOS:000166615300032
J	Hanaoka, K; Qian, F; Boletta, A; Bhumia, AK; Piontek, K; Tsiokas, L; Sukhatme, VP; Guggino, WB; Germino, GG				Hanaoka, K; Qian, F; Boletta, A; Bhumia, AK; Piontek, K; Tsiokas, L; Sukhatme, VP; Guggino, WB; Germino, GG			Co-assembly of polycystin-1 and-2 produces unique cation-permeable currents	NATURE			English	Article							KIDNEY-DISEASE; GENE-PRODUCT; PKD1; CHANNEL; RECEPTOR; IDENTIFICATION; HETEROGENEITY; ENCODES	The human kidney is composed of roughly 1.2-million renal tubules that must maintain their tubular structure to function properly. In autosomal dominant polycystic kidney disease (ADPKD) cysts develop from renal tubules and enlarge independently, in a process that ultimately causes renal failure in 50% of affected individuals(1,2). Mutations in either PKD1 or PKD2 are associated with ADPKD but the function of these genes is unknown. PKD1 is thought to encode a membrane protein, polycystin-1, involved in cell-cell or cell-matrix interactions(3-5), whereas the PKD2 gene product, polycystin-2, is thought to be a channel protein(6). Here we show that polycystin-1 and -2 interact to produce new calcium-permeable non-selective cation currents. Neither polycystin-1 nor -2 alone is capable of producing currents. Moreover, disease-associated mutant forms of either polycystin protein that are incapable of heterodimerization do not result in new channel activity. We also show that polycystin-2 is localized in the cell in the absence of polycystin-1, but is translocated to the plasma membrane in its presence. Thus, polycystin-1 and -2 co-assemble at the plasma membrane to produce a new channel and to regulate renal tubular morphology and function.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Warren Med Res Inst, Oklahoma City, OK 73104 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Renal, Boston, MA 02215 USA	Johns Hopkins University; Johns Hopkins University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 725 N Wolfe St, Baltimore, MD 21205 USA.	wguggino@jhmi.edu; ggermino@mail.jhmi.edu	Sukhatme, Vikas/W-2776-2019	Tsiokas, Leonidas/0000-0002-3659-1813; Germino, Gregory/0000-0002-3609-5588				BENHAM CD, 1987, NATURE, V328, P275, DOI 10.1038/328275a0; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chen XZ, 1999, NATURE, V401, P383, DOI 10.1038/43907; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; *EUR POL KIDN DIS, 1994, CELL, V78, P881; Fan JS, 1998, PFLUG ARCH EUR J PHY, V436, P1021, DOI 10.1007/PL00008086; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; GRANTHAM JJ, 1993, J AM SOC NEPHROL, V3, P1843; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hanaoka K, 1996, AM J PHYSIOL-CELL PH, V270, pC389, DOI 10.1152/ajpcell.1996.270.1.C389; Hanaoka K, 1999, J MEMBRANE BIOL, V172, P193, DOI 10.1007/s002329900596; Harris PC, 1999, HUM MOL GENET, V8, P1861, DOI 10.1093/hmg/8.10.1861; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; KIMBERLING WJ, 1988, NEW ENGL J MED, V319, P913, DOI 10.1056/NEJM198810063191405; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Peral B, 1996, AM J HUM GENET, V58, P86; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; Popp R, 1993, EXS, V66, P213; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Van Driessche W, 1993, EXS, V66, P225; Watnick T, 1999, SEMIN NEPHROL, V19, P327; Wu GQ, 2000, MOL GENET METAB, V69, P1, DOI 10.1006/mgme.1999.2943	30	627	651	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2000	408	6815					990	994		10.1038/35050128	http://dx.doi.org/10.1038/35050128			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140688				2022-12-24	WOS:000165951100054
J	Ross, RS; Viazov, S; Gross, T; Hofmann, F; Seipp, H; Roggendorf, M				Ross, RS; Viazov, S; Gross, T; Hofmann, F; Seipp, H; Roggendorf, M			Transmission of hepatitis C virus from a patient to an anesthesiology assistant to five patients.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIV-TRANSMISSION; B-VIRUS; EPIDEMIOLOGY; INFECTION		Univ Essen Gesamthsch, Natl Reference Ctr Hepatitis C, Inst Virol, D-45122 Essen, Germany; Univ Gesamthsch Wuppertal, Dept Occupat Hlth, D-5600 Wuppertal, Germany; Dr Horst Schmidt Kliniken, Wiesbaden, Germany	University of Duisburg Essen; University of Wuppertal	Ross, RS (corresponding author), Univ Essen Gesamthsch, Natl Reference Ctr Hepatitis C, Inst Virol, Hufelandstr 55, D-45122 Essen, Germany.	ross@uni-essen.de						ALLANDER T, 1995, LANCET, V345, P603, DOI 10.1016/S0140-6736(95)90518-9; Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711; ALTER MJ, 1983, ANN INTERN MED, V99, P330, DOI 10.7326/0003-4819-99-3-330; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Brown P, 1999, BRIT MED J, V319, P1219, DOI 10.1136/bmj.319.7219.1219; Centers for Disease Control and Prevention, 1988, MMWR MORB MORTAL WKL, V37, P387; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; Chouela E, 1996, INT J DERMATOL, V35, P797, DOI 10.1111/j.1365-4362.1996.tb02977.x; Cohen J, 1999, SCIENCE, V285, P26, DOI 10.1126/science.285.5424.26; COUTINHO RA, 1982, LANCET, V1, P345; Duckworth G J, 1999, Commun Dis Public Health, V2, P188; Esteban JI, 1998, CURR STUD HEMATOL BL, P102; Esteban JI, 1996, NEW ENGL J MED, V334, P555, DOI 10.1056/NEJM199602293340902; FARCI P, 1991, NEW ENGL J MED, V325, P98, DOI 10.1056/NEJM199107113250205; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Katzenstein TL, 1999, AIDS, V13, P1737, DOI 10.1097/00002030-199909100-00018; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Major ME, 1997, HEPATOLOGY, V25, P1527, DOI 10.1002/hep.510250637; MIZOKAMI M, 1998, METH MOLEC MED, V19, P147; OHTO H, 1994, NEW ENGL J MED, V330, P744, DOI 10.1056/NEJM199403173301103; OREN I, 1989, ANN INTERN MED, V110, P691, DOI 10.7326/0003-4819-110-9-691; OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165; POLAKOFF S, 1986, BRIT MED J, V293, P33, DOI 10.1136/bmj.293.6538.33; PRENTICE MB, 1992, BRIT MED J, V304, P761, DOI 10.1136/bmj.304.6829.761; Ross RS, 2000, J MED VIROL, V60, P122, DOI 10.1002/(SICI)1096-9071(200002)60:2&lt;122::AID-JMV3&gt;3.0.CO;2-#; SNYDMAN DR, 1976, ANN INTERN MED, V85, P573, DOI 10.7326/0003-4819-85-5-573; SUZUKI K, 1994, J INFECT DIS, V170, P1575, DOI 10.1093/infdis/170.6.1575; VIAZOV S, 1994, J VIROL METHODS, V48, P81, DOI 10.1016/0166-0934(94)90091-4; WEINER AJ, 1993, J VIROL, V67, P4365, DOI 10.1128/JVI.67.7.4365-4368.1993; Widell A, 1999, ANN INTERN MED, V130, P130, DOI 10.7326/0003-4819-130-2-199901190-00007; 1988, MMWR MORB MORTAL WKL, V37, P377	31	102	106	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2000	343	25					1851	1854		10.1056/NEJM200012213432505	http://dx.doi.org/10.1056/NEJM200012213432505			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384KB	11117977				2022-12-24	WOS:000165940400005
J	Donnelly, CA				Donnelly, CA			Likely size of the French BSE epidemic - Epidemiological analysis helps in evaluating the potential risks of eating French beef.	NATURE			English	Article							TRANSMISSION DYNAMICS; CATTLE		Imperial Coll Sch Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Donnelly, CA (corresponding author), Imperial Coll Sch Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.			Donnelly, Christl/0000-0002-0195-2463				Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Butler D, 1996, NATURE, V382, P5, DOI 10.1038/382005c0; Doherr MG, 1999, VET REC, V145, P155, DOI 10.1136/vr.145.6.155; Donnelly C A, 1999, J Epidemiol Biostat, V4, P277; Donnelly CA, 1997, NATURE, V389, P903, DOI 10.1038/39982; DONNELLY CA, 1999, STAT ASPECTS BSE VCJ; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Schreuder BEC, 1997, VET REC, V141, P187, DOI 10.1136/vr.141.8.187; *SPONG ENC ADV COM, 1999, SPONG ENC ADV COMM M	9	33	35	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2000	408	6814					787	788		10.1038/35048666	http://dx.doi.org/10.1038/35048666			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130705				2022-12-24	WOS:000165831300030
J	Tromans, A				Tromans, A			Plant biology - Volatile defence	NATURE			English	Editorial Material																			0	1	1	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2000	408	6814					785	785		10.1038/35048660	http://dx.doi.org/10.1038/35048660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11147529	Bronze			2022-12-24	WOS:000165831300028
J	Berge, KE; Tian, H; Graf, GA; Yu, LQ; Grishin, NV; Schultz, J; Kwiterovich, P; Shan, B; Barnes, R; Hobbs, HH				Berge, KE; Tian, H; Graf, GA; Yu, LQ; Grishin, NV; Schultz, J; Kwiterovich, P; Shan, B; Barnes, R; Hobbs, HH			Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; STEROL ABSORPTION; RECEPTOR; GENE; METABOLISM; PHYTOSTEROLEMIA; XANTHOMATOSIS; SEQUENCES; ELEMENTS; PATHWAY	In healthy individuals, acute changes in cholesterol intake produce modest changes in plasma cholesterol levels. A striking exception occurs in sitosterolemia, an autosomal recessive disorder characterized by increased intestinal absorption and decreased biliary excretion of dietary sterols, hypercholesterolemia, and premature coronary atherosclerosis. We identified seven different mutations in two adjacent, oppositely oriented genes that encode new members of the adenosine triphosphate (ATP)-binding cassette (ABC) transporter family (six mutations in ABCG8 and one in ABCG5) in nine patients with sitosterolemia. The two genes are expressed at highest levels in Liver and intestine and, in mice, cholesterol feeding up-regulates expressions of both genes. These data suggest that ABCG5 and ABCG8 normally cooperate to Limit intestinal absorption and to promote biliary excretion of sterols, and that mutated forms of these transporters predispose to sterol accumulation and atherosclerosis.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Tularik Inc, San Francisco, CA 94080 USA; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21205 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	Hobbs, HH (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Helen.Hobbs@UTSouthwestern.edu	Eckhardt, Erik/G-1567-2010	Graf, Gregory/0000-0002-0130-9929	NHLBI NIH HHS [HL07360, HL20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360, P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEATY TH, 1986, AM J HUM GENET, V38, P492; BERGE KE, UNPUB; BHATTACHARYYA AK, 1974, J CLIN INVEST, V53, P1033, DOI 10.1172/JCI107640; BINGHAM PM, 1981, CELL, V25, P693, DOI 10.1016/0092-8674(81)90176-8; Bjorkhem I., 1995, METABOLIC MOL BASES, P2073; EWART GD, 1994, J BIOL CHEM, V269, P10370; GREGG RE, 1986, J CLIN INVEST, V77, P1864, DOI 10.1172/JCI112513; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cellbio.8.1.67; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Ikeda S, 2000, BIOCHEM BIOPH RES CO, V273, P1063, DOI 10.1006/bbrc.2000.3071; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; JOKINEN EV, 1994, J BIOL CHEM, V269, P26411; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; KWITEROVICH PO, 1981, LANCET, V1, P466; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; LUTJOHANN D, 1995, J LIPID RES, V36, P1763; MIETTINEN TA, 1980, EUR J CLIN INVEST, V10, P27, DOI 10.1111/j.1365-2362.1980.tb00006.x; MORGANRO.J, 1974, J PEDIATR-US, V85, P639, DOI 10.1016/S0022-3476(74)80506-8; NYE ER, 1988, NEW ZEAL MED J, V101, P418; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Patel SB, 1998, J CLIN INVEST, V102, P1041, DOI 10.1172/JCI3963; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Pollner R, 1997, FEBS LETT, V405, P31, DOI 10.1016/S0014-5793(97)00152-X; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; SALEN G, 1970, J CLIN INVEST, V49, P952, DOI 10.1172/JCI106315; SALEN G, 1992, J LIPID RES, V33, P945; SALEN G, 1985, J LIPID RES, V26, P1126; SALEN G, 1985, J LIPID RES, V26, P203; STELL PS, 1990, TOP CLIN NUTR, V5, P63; SULLIVAN DT, 1974, J EXP ZOOL, V188, P225, DOI 10.1002/jez.1401880210; VENKATESWARAN, 2000, J BIOL CHEM, V275; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	36	1212	1272	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2000	290	5497					1771	1775		10.1126/science.290.5497.1771	http://dx.doi.org/10.1126/science.290.5497.1771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379FY	11099417				2022-12-24	WOS:000165632400045
J	Noad, MJ; Cato, DH; Bryden, MM; Jenner, MN; Jenner, KCS				Noad, MJ; Cato, DH; Bryden, MM; Jenner, MN; Jenner, KCS			Cultural revolution in whale songs	NATURE			English	Article							HUMPBACK WHALES; EVOLUTION		Univ Sydney, Dept Vet Anat & Pathol, Sydney, NSW 2006, Australia; Def Sci & Technol Org, Pyrmont, NSW 2009, Australia; Ctr Whale Res, Fremantle, WA 6959, Australia	University of Sydney; Defence Science & Technology	Noad, MJ (corresponding author), Univ Sydney, Dept Vet Anat & Pathol, Sydney, NSW 2006, Australia.		Noad, Michael/D-7975-2013	Noad, Michael/0000-0002-2799-8320				Baker CS, 1998, MAR MAMMAL SCI, V14, P721, DOI 10.1111/j.1748-7692.1998.tb00758.x; CATO D H, 1991, Memoirs of the Queensland Museum, V30, P277; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; MUNDINGER PC, 1980, ETHOL SOCIOBIOL, V1, P183, DOI 10.1016/0162-3095(80)90008-4; Payne K., 1983, COMMUNICATION BEHAV, P9; PAYNE RB, 1985, Z TIERPSYCHOL, V70, P1; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; TRAINER JM, 1989, ETHOLOGY, V80, P190; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; WINN HE, 1981, BEHAV ECOL SOCIOBIOL, V8, P41, DOI 10.1007/BF00302842; WINN HE, 1978, MAR BIOL, V47, P97, DOI 10.1007/BF00395631	11	251	259	4	97	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2000	408	6812					537	537		10.1038/35046199	http://dx.doi.org/10.1038/35046199			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	377WE	11117730	Bronze			2022-12-24	WOS:000165548600102
J	Takayanagi, H; Ogasawara, K; Hida, S; Chiba, T; Murata, S; Sato, K; Takaoka, A; Yokochi, T; Oda, H; Tanaka, K; Nakamura, K; Taniguchi, T				Takayanagi, H; Ogasawara, K; Hida, S; Chiba, T; Murata, S; Sato, K; Takaoka, A; Yokochi, T; Oda, H; Tanaka, K; Nakamura, K; Taniguchi, T			T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma	NATURE			English	Article							COLLAGEN-INDUCED ARTHRITIS; INTERFERON-GAMMA; DEFECTIVE INTERLEUKIN-1; DIFFERENTIATION FACTOR; RHEUMATOID-ARTHRITIS; TARGETED DISRUPTION; MICE; RECEPTOR; LIGAND; GENE	Bone resorption is regulated by the immune system(1,2), where T-cell expression of RANKL (receptor activator of nuclear factor (NF)-kappaB ligand), a member of the tumour-necrosis factor family that is essential for osteoclastogenesis, may contribute to pathological conditions, such as autoimmune arthritis(3,4). However, whether activated T cells maintain bone homeostasis by counterbalancing the action of RANKL remains unknown. Here we show that T-cell production of interferon (IFN)-gamma strongly suppresses osteoclastogenesis by interfering with the RANKL-RANK signalling pathway. IFN-gamma induces rapid degradation of the RANK adapter protein, TRAF6 (tumour necrosis factor receptor-associated factor 6), which results in strong inhibition of the RANKL-induced activation of the transcription factor NF-kappaB and JNK. This inhibition of osteoclastogenesis is rescued by overexpressing TRAF6 in precursor cells, which indicates that TRAF6 is the target critical for the IFN-gamma action. Furthermore, we provide evidence that the accelerated degradation of TRAF6 requires both its ubiquitination, which is initiated by RANKL, and IFN-gamma -induced activation of the ubiquitin-proteasome system. Our study shows that there is cross-talk between the tumour necrosis factor and IFN families of cytokines, through which IFN-gamma provides a negative link between T-cell activation and bone resorption. Our results may offer a therapeutic approach to treat the inflammation-induced tissue breakdown.	Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138613, Japan; Japan Technol Corp, CREST, Bunkyo Ku, Tokyo 1138613, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST)	Taniguchi, T (corresponding author), Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Murata, Shigeo/A-1426-2010; Ogasawara, Kouetsu/G-9892-2011	Murata, Shigeo/0000-0002-3177-3503; 				Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9; Chiang CY, 1999, INFECT IMMUN, V67, P4231, DOI 10.1128/IAI.67.8.4231-4236.1999; FIRESTEIN GS, 1990, ARTHRITIS RHEUM, V33, P768, DOI 10.1002/art.1780330602; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Horwood NJ, 1999, BIOCHEM BIOPH RES CO, V265, P144, DOI 10.1006/bbrc.1999.1623; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Kinne RW, 1997, BBA-MOL BASIS DIS, V1360, P109, DOI 10.1016/S0925-4439(96)00079-8; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Preckel T, 1999, SCIENCE, V286, P2162, DOI 10.1126/science.286.5447.2162; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAKAHASHI N, 1986, J IMMUNOL, V137, P3544; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Takayanagi H, 1999, J CLIN INVEST, V104, P137, DOI 10.1172/JCI6093; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tanaka K, 1998, IMMUNOL REV, V163, P161; Taniguchi T, 1997, BBA-REV CANCER, V1333, pM9, DOI 10.1016/S0304-419X(97)00014-0; Udagawa N, 1997, J EXP MED, V185, P1005, DOI 10.1084/jem.185.6.1005; Ukai T, 1996, J PERIODONTAL RES, V31, P414, DOI 10.1111/j.1600-0765.1996.tb00510.x; Vermeire K, 1997, J IMMUNOL, V158, P5507; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	30	992	1055	5	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2000	408	6812					600	605		10.1038/35046102	http://dx.doi.org/10.1038/35046102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117749				2022-12-24	WOS:000165548600122
J	Wang, JX; Davies, M; Norman, RJ				Wang, JX; Davies, M; Norman, RJ			Body mass and probability of pregnancy during assisted reproduction treatment: retrospective study	BRITISH MEDICAL JOURNAL			English	Article									Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Woodville, SA 5011, Australia	University of Adelaide	Wang, JX (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Woodville, SA 5011, Australia.		Norman, Robert J/A-1155-2007; Davies, Michael/GWV-2527-2022; Davies, Michael John/Y-3542-2018	Norman, Robert J/0000-0002-3118-3896; Davies, Michael John/0000-0003-1526-0801				CORREA H, 1978, AM J CLIN NUTR, V31, P1431, DOI 10.1093/ajcn/31.8.1431; FRISCH RE, 1989, SCIENCE, V246, P432, DOI 10.1126/science.2814472; Lake JK, 1997, INT J OBESITY, V21, P432, DOI 10.1038/sj.ijo.0800424; NORMAN RJ, 1995, FERTIL STERIL, V63, P329; NORMAN RJ, 1991, HUM REPROD, V6, P206, DOI 10.1093/oxfordjournals.humrep.a137307	5	222	232	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	NOV 25	2000	321	7272					1320	1321		10.1136/bmj.321.7272.1320	http://dx.doi.org/10.1136/bmj.321.7272.1320			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378BK	11090515	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000165561600026
J	Verveer, PJ; Wouters, FS; Reynolds, AR; Bastiaens, PIH				Verveer, PJ; Wouters, FS; Reynolds, AR; Bastiaens, PIH			Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane	SCIENCE			English	Article							EPIDERMAL GROWTH-FACTOR; TYROSINE KINASE-ACTIVITY; SPATIAL-RESOLUTION; DIMERIZATION; ACTIVATION; PHOSPHORYLATION; CELLS; TRANSDUCTION; AGGREGATION; MICROSCOPY	Evidence for a new signaling mechanism consisting of ligand-independent lateral propagation of receptor activation in the plasma membrane is presented. We visualized the phosphorylation of green fluorescent protein (GFP)-tagged ErbB1 (ErbB1-GFP) receptors in cells focally stimulated with epidermal growth factor (EGF) covalently attached to beads. This was achieved by quantitative imaging of protein reaction states in cells by fluorescence resonance energy transfer (FRET) with global analysis of fluorescence lifetime imaging microscopy (FLIM) data. The rapid and extensive propagation of receptor phosphorylation over the entire cell after focal stimulation demonstrates a signaling wave at the plasma membrane resulting in full activation of all receptors.	European Mol Biol Lab, Cell Biol & Cell Biophys Program, D-69117 Heidelberg, Germany; Imperial Canc Res Fund, Cell Biophys Lab, London WC2A 3PX, England	European Molecular Biology Laboratory (EMBL); Cancer Research UK	Verveer, PJ (corresponding author), European Mol Biol Lab, Cell Biol & Cell Biophys Program, Meyerhofstr 1, D-69117 Heidelberg, Germany.							Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; BEECHEM JM, 1992, METHOD ENZYMOL, V210, P37; BUDAY L, 1993, MOL CELL BIOL, V13, P1903, DOI 10.1128/MCB.13.3.1903; COCHET C, 1988, J BIOL CHEM, V263, P3290; GADELLA TWJ, 1993, BIOPHYS CHEM, V48, P221, DOI 10.1016/0301-4622(93)85012-7; Gamett DC, 1997, J BIOL CHEM, V272, P12052, DOI 10.1074/jbc.272.18.12052; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; HONEGGER AM, 1989, P NATL ACAD SCI USA, V86, P925, DOI 10.1073/pnas.86.3.925; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; LAKOWICZ JR, 1991, REV SCI INSTRUM, V62, P1727, DOI 10.1063/1.1142413; Marques MM, 1999, EXP CELL RES, V252, P432, DOI 10.1006/excr.1999.4634; MOHAMMADI M, 1993, BIOCHEMISTRY-US, V32, P8742, DOI 10.1021/bi00085a004; Nagai Y, 2000, NAT BIOTECHNOL, V18, P313, DOI 10.1038/73767; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; PAWSON T, 1988, ONCOGENE, V3, P491; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; SOROKIN A, 1994, J BIOL CHEM, V269, P9752; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Squire A, 1999, J MICROSC-OXFORD, V193, P36, DOI 10.1046/j.1365-2818.1999.00427.x; Verveer PJ, 2000, BIOPHYS J, V78, P2127, DOI 10.1016/S0006-3495(00)76759-2; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Weiss FU, 1997, CURR OPIN GENET DEV, V7, P80, DOI 10.1016/S0959-437X(97)80113-X; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Wouters FS, 1999, CURR BIOL, V9, P1127, DOI 10.1016/S0960-9822(99)80484-9; WOUTERS FS, 2000, CURRENT PROTOCOLS CE, V17; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; ZHOU M, 1993, BIOCHEMISTRY-US, V32, P8193, DOI 10.1021/bi00083a020	30	284	298	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2000	290	5496					1567	1570		10.1126/science.290.5496.1567	http://dx.doi.org/10.1126/science.290.5496.1567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376EX	11090353				2022-12-24	WOS:000165446200048
J	Agalioti, T; Lomvardas, S; Parekh, B; Yie, JM; Maniatis, T; Thanos, D				Agalioti, T; Lomvardas, S; Parekh, B; Yie, JM; Maniatis, T; Thanos, D			Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter	CELL			English	Article							RNA-POLYMERASE-II; NUCLEOSOME DISRUPTION; HUMAN SWI/SNF; HMG I(Y); IN-VITRO; ENHANCEOSOME; HISTONE; HOLOENZYME; COMPLEX; BINDING	Here, we show that the IFN-beta enhanceosome activates transcription by directing the ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. The enhanceosome is assembled in the nucleosome-free enhancer region of the IFN-beta gene, leading to the modification and remodeling of a strategically positioned nucleosome that masks the TATA box and the start site of transcription. Initially, the GCN5 complex is recruited, which acetylates the nucleosome, and this is followed by recruitment of the CBP-PoIII holoenzyme complex. Nucleosome acetylation in turn facilitates SWI/SNF recruitment by CBP, resulting in chromatin remodeling. This program of recruitment culminates in the binding of TFIID to the promoter and the activation of transcription.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA	Columbia University; Harvard University	Thanos, D (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.		Thanos, Dimitris/AAE-5720-2019	Lomvardas, Stavros/0000-0002-7668-3026; Agalioti, Theodora/0000-0002-5898-2751	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054605] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-54605] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; Berger SL, 1999, CURR OPIN CELL BIOL, V11, P336, DOI 10.1016/S0955-0674(99)80046-5; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; FRAGOSO G, 1995, GENE DEV, V9, P1933, DOI 10.1101/gad.9.15.1933; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Imbalzano AN, 1996, J BIOL CHEM, V271, P20726, DOI 10.1074/jbc.271.34.20726; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kim DS, 1997, POLYM ADVAN TECHNOL, V8, P1, DOI 10.1002/(SICI)1099-1581(199701)8:1<1::AID-PAT601>3.0.CO;2-G; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; KINGSTONR E, 1999, GENE DEV, V15, P2339; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Utley RT, 1996, METHOD ENZYMOL, V274, P276; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108; ZINN K, 1986, CELL, V45, P611, DOI 10.1016/0092-8674(86)90293-X	34	591	606	0	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 10	2000	103	4					667	678		10.1016/S0092-8674(00)00169-0	http://dx.doi.org/10.1016/S0092-8674(00)00169-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	374MB	11106736	Bronze			2022-12-24	WOS:000165348000011
J	West, SA; Herre, EA; Sheldon, BC				West, SA; Herre, EA; Sheldon, BC			The benefits of allocating sex	SCIENCE			English	Editorial Material							SELECTION THEORY; KIN SELECTION; FIG WASPS; RATIOS; ANT; STRATEGIES		Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Smithsonian Trop Res Inst, Balboa, Panama; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Edinburgh; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Oxford	West, SA (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	stu.west@ed.ac.uk	West, Stuart A/M-3608-2014; Sheldon, Ben C/A-8056-2010	West, Stuart A/0000-0003-2152-3153; Sheldon, Ben C/0000-0002-5240-7828				BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; BOOMSMA JJ, 1990, EVOLUTION, V44, P1026, DOI [10.2307/2409564, 10.1111/j.1558-5646.1990.tb03823.x]; Campbell DR, 2000, TRENDS ECOL EVOL, V15, P227, DOI 10.1016/S0169-5347(00)01872-3; Chapuisat M, 1999, HEREDITY, V82, P473, DOI 10.1038/sj.hdy.6885340; CHARNOV E L, 1982; EVANS JD, 1995, P NATL ACAD SCI USA, V92, P6514, DOI 10.1073/pnas.92.14.6514; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; FRANK SA, 1985, EVOLUTION, V39, P949, DOI 10.1111/j.1558-5646.1985.tb00440.x; Godfray HCJ, 1996, TRENDS ECOL EVOL, V11, pA59; Greeff JM, 1996, J EVOLUTION BIOL, V9, P855, DOI 10.1046/j.1420-9101.1996.9060855.x; Hamilton W.D., 1979, P167; Hamilton W.D., 1996, NARROW ROADS GENE LA, V1; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HERRE EA, 1987, NATURE, V329, P627, DOI 10.1038/329627a0; HERRE EA, 1985, SCIENCE, V228, P896, DOI 10.1126/science.228.4701.896; KING BH, 1989, OECOLOGIA, V78, P420, DOI 10.1007/BF00379119; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; MUELLER UG, 1991, SCIENCE, V254, P442, DOI 10.1126/science.254.5030.442; Paul REL, 2000, SCIENCE, V287, P128, DOI 10.1126/science.287.5450.128; Pickering J, 2000, EVOL ECOL RES, V2, P171; READ AF, 1995, P ROY SOC B-BIOL SCI, V260, P359, DOI 10.1098/rspb.1995.0105; REESE S, 2000, TRENDS ENCOL EVOL, V15, P169; Seger Jon, 1996, P93; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Shutler D, 1998, OIKOS, V82, P417, DOI 10.2307/3546363; Sundstrom L, 2000, P ROY SOC B-BIOL SCI, V267, P1439, DOI 10.1098/rspb.2000.1161; Sundstrom L, 1996, SCIENCE, V274, P993, DOI 10.1126/science.274.5289.993; SUNDSTROM L, 1994, NATURE, V367, P266, DOI 10.1038/367266a0; TAYLOR PD, 1981, NATURE, V291, P64, DOI 10.1038/291064a0; Tibayrenc M., 1995, Advances in Parasitology, V36, P47, DOI 10.1016/S0065-308X(08)60490-X; WERREN JH, 1984, AM NAT, V124, P143, DOI 10.1086/284259; West SA, 1997, J THEOR BIOL, V186, P213, DOI 10.1006/jtbi.1996.0369; West SA, 1998, EVOLUTION, V52, P475, DOI [10.2307/2411083, 10.1111/j.1558-5646.1998.tb01647.x]; West SA, 2000, P ROY SOC B-BIOL SCI, V267, P257, DOI 10.1098/rspb.2000.0995	36	113	117	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 13	2000	290	5490					288	290		10.1126/science.290.5490.288	http://dx.doi.org/10.1126/science.290.5490.288			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11183376				2022-12-24	WOS:000089818100033
J	Venter, JC; Adams, MD; Myers, EW; Li, PW; Mural, RJ; Sutton, GG; Smith, HO; Yandell, M; Evans, CA; Holt, RA; Gocayne, JD; Amanatides, P; Ballew, RM; Huson, DH; Wortman, JR; Zhang, Q; Kodira, CD; Zheng, XQH; Chen, L; Skupski, M; Subramanian, G; Thomas, PD; Zhang, JH; Miklos, GLG; Nelson, C; Broder, S; Clark, AG; Nadeau, C; McKusick, VA; Zinder, N; Levine, AJ; Roberts, RJ; Simon, M; Slayman, C; Hunkapiller, M; Bolanos, R; Delcher, A; Dew, I; Fasulo, D; Flanigan, M; Florea, L; Halpern, A; Hannenhalli, S; Kravitz, S; Levy, S; Mobarry, C; Reinert, K; Remington, K; Abu-Threideh, J; Beasley, E; Biddick, K; Bonazzi, V; Brandon, R; Cargill, M; Chandramouliswaran, I; Charlab, R; Chaturvedi, K; Deng, ZM; Di Francesco, V; Dunn, P; Eilbeck, K; Evangelista, C; Gabrielian, AE; Gan, W; Ge, WM; Gong, FC; Gu, ZP; Guan, P; Heiman, TJ; Higgins, ME; Ji, RR; Ke, ZX; Ketchum, KA; Lai, ZW; Lei, YD; Li, ZY; Li, JY; Liang, Y; Lin, XY; Lu, F; Merkulov, GV; Milshina, N; Moore, HM; Naik, AK; Narayan, VA; Neelam, B; Nusskern, D; Rusch, DB; Salzberg, S; Shao, W; Shue, BX; Sun, JT; Wang, ZY; Wang, AH; Wang, X; Wang, J; Wei, MH; Wides, R; Xiao, CL; Yan, CH; Yao, A; Ye, J; Zhan, M; Zhang, WQ; Zhang, HY; Zhao, Q; Zheng, LS; Zhong, F; Zhong, WY; Zhu, SPC; Zhao, SY; Gilbert, D; Baumhueter, S; Spier, G; Carter, C; Cravchik, A; Woodage, T; Ali, F; An, HJ; Awe, A; Baldwin, D; Baden, H; Barnstead, M; Barrow, I; Beeson, K; Busam, D; Carver, A; Center, A; Cheng, ML; Curry, L; Danaher, S; Davenport, L; Desilets, R; Dietz, S; Dodson, K; Doup, L; Ferriera, S; Garg, N; Gluecksmann, A; Hart, B; Haynes, J; Haynes, C; Heiner, C; Hladun, S; Hostin, D; Houck, J; Howland, T; Ibegwam, C; Johnson, J; Kalush, F; Kline, L; Koduru, S; Love, A; Mann, F; May, D; McCawley, S; McIntosh, T; McMullen, I; Moy, M; Moy, L; Murphy, B; Nelson, K; Pfannkoch, C; Pratts, E; Puri, V; Qureshi, H; Reardon, M; Rodriguez, R; Rogers, YH; Romblad, D; Ruhfel, B; Scott, R; Sitter, C; Smallwood, M; Stewart, E; Strong, R; Suh, E; Thomas, R; Tint, NN; Tse, S; Vech, C; Wang, G; Wetter, J; Williams, S; Williams, M; Windsor, S; Winn-Deen, E; Wolfe, K; Zaveri, J; Zaveri, K; Abril, JF; Guigo, R; Campbell, MJ; Sjolander, KV; Karlak, B; Kejariwal, A; Mi, HY; Lazareva, B; Hatton, T; Narechania, A; Diemer, K; Muruganujan, A; Guo, N; Sato, S; Bafna, V; Istrail, S; Lippert, R; Schwartz, R; Walenz, B; Yooseph, S; Allen, D; Basu, A; Baxendale, J; Blick, L; Caminha, M; Carnes-Stine, J; Caulk, P; Chiang, YH; Coyne, M; Dahlke, C; Mays, AD; Dombroski, M; Donnelly, M; Ely, D; Esparham, S; Fosler, C; Gire, H; Glanowski, S; Glasser, K; Glodek, A; Gorokhov, M; Graham, K; Gropman, B; Harris, M; Heil, J; Henderson, S; Hoover, J; Jennings, D; Jordan, C; Jordan, J; Kasha, J; Kagan, L; Kraft, C; Levitsky, A; Lewis, M; Liu, XJ; Lopez, J; Ma, D; Majoros, W; McDaniel, J; Murphy, S; Newman, M; Nguyen, T; Nguyen, N; Nodell, M; Pan, S; Peck, J; Peterson, M; Rowe, W; Sanders, R; Scott, J; Simpson, M; Smith, T; Sprague, A; Stockwell, T; Turner, R; Venter, E; Wang, M; Wen, MY; Wu, D; Wu, M; Xia, A; Zandieh, A; Zhu, XH				Venter, JC; Adams, MD; Myers, EW; Li, PW; Mural, RJ; Sutton, GG; Smith, HO; Yandell, M; Evans, CA; Holt, RA; Gocayne, JD; Amanatides, P; Ballew, RM; Huson, DH; Wortman, JR; Zhang, Q; Kodira, CD; Zheng, XQH; Chen, L; Skupski, M; Subramanian, G; Thomas, PD; Zhang, JH; Miklos, GLG; Nelson, C; Broder, S; Clark, AG; Nadeau, C; McKusick, VA; Zinder, N; Levine, AJ; Roberts, RJ; Simon, M; Slayman, C; Hunkapiller, M; Bolanos, R; Delcher, A; Dew, I; Fasulo, D; Flanigan, M; Florea, L; Halpern, A; Hannenhalli, S; Kravitz, S; Levy, S; Mobarry, C; Reinert, K; Remington, K; Abu-Threideh, J; Beasley, E; Biddick, K; Bonazzi, V; Brandon, R; Cargill, M; Chandramouliswaran, I; Charlab, R; Chaturvedi, K; Deng, ZM; Di Francesco, V; Dunn, P; Eilbeck, K; Evangelista, C; Gabrielian, AE; Gan, W; Ge, WM; Gong, FC; Gu, ZP; Guan, P; Heiman, TJ; Higgins, ME; Ji, RR; Ke, ZX; Ketchum, KA; Lai, ZW; Lei, YD; Li, ZY; Li, JY; Liang, Y; Lin, XY; Lu, F; Merkulov, GV; Milshina, N; Moore, HM; Naik, AK; Narayan, VA; Neelam, B; Nusskern, D; Rusch, DB; Salzberg, S; Shao, W; Shue, BX; Sun, JT; Wang, ZY; Wang, AH; Wang, X; Wang, J; Wei, MH; Wides, R; Xiao, CL; Yan, CH; Yao, A; Ye, J; Zhan, M; Zhang, WQ; Zhang, HY; Zhao, Q; Zheng, LS; Zhong, F; Zhong, WY; Zhu, SPC; Zhao, SY; Gilbert, D; Baumhueter, S; Spier, G; Carter, C; Cravchik, A; Woodage, T; Ali, F; An, HJ; Awe, A; Baldwin, D; Baden, H; Barnstead, M; Barrow, I; Beeson, K; Busam, D; Carver, A; Center, A; Cheng, ML; Curry, L; Danaher, S; Davenport, L; Desilets, R; Dietz, S; Dodson, K; Doup, L; Ferriera, S; Garg, N; Gluecksmann, A; Hart, B; Haynes, J; Haynes, C; Heiner, C; Hladun, S; Hostin, D; Houck, J; Howland, T; Ibegwam, C; Johnson, J; Kalush, F; Kline, L; Koduru, S; Love, A; Mann, F; May, D; McCawley, S; McIntosh, T; McMullen, I; Moy, M; Moy, L; Murphy, B; Nelson, K; Pfannkoch, C; Pratts, E; Puri, V; Qureshi, H; Reardon, M; Rodriguez, R; Rogers, YH; Romblad, D; Ruhfel, B; Scott, R; Sitter, C; Smallwood, M; Stewart, E; Strong, R; Suh, E; Thomas, R; Tint, NN; Tse, S; Vech, C; Wang, G; Wetter, J; Williams, S; Williams, M; Windsor, S; Winn-Deen, E; Wolfe, K; Zaveri, J; Zaveri, K; Abril, JF; Guigo, R; Campbell, MJ; Sjolander, KV; Karlak, B; Kejariwal, A; Mi, HY; Lazareva, B; Hatton, T; Narechania, A; Diemer, K; Muruganujan, A; Guo, N; Sato, S; Bafna, V; Istrail, S; Lippert, R; Schwartz, R; Walenz, B; Yooseph, S; Allen, D; Basu, A; Baxendale, J; Blick, L; Caminha, M; Carnes-Stine, J; Caulk, P; Chiang, YH; Coyne, M; Dahlke, C; Mays, AD; Dombroski, M; Donnelly, M; Ely, D; Esparham, S; Fosler, C; Gire, H; Glanowski, S; Glasser, K; Glodek, A; Gorokhov, M; Graham, K; Gropman, B; Harris, M; Heil, J; Henderson, S; Hoover, J; Jennings, D; Jordan, C; Jordan, J; Kasha, J; Kagan, L; Kraft, C; Levitsky, A; Lewis, M; Liu, XJ; Lopez, J; Ma, D; Majoros, W; McDaniel, J; Murphy, S; Newman, M; Nguyen, T; Nguyen, N; Nodell, M; Pan, S; Peck, J; Peterson, M; Rowe, W; Sanders, R; Scott, J; Simpson, M; Smith, T; Sprague, A; Stockwell, T; Turner, R; Venter, E; Wang, M; Wen, MY; Wu, D; Wu, M; Xia, A; Zandieh, A; Zhu, XH			The sequence of the human genome	SCIENCE			English	Review							SINGLE-NUCLEOTIDE POLYMORPHISMS; DNA-SEQUENCE; CPG ISLANDS; FUNCTIONAL GENOMICS; MESSENGER-RNA; GENE MARKERS; PHYSICAL MAP; CHROMOSOME; EXPRESSION; IDENTIFICATION	A 2.91-billion base pair (bp) consensus sequence of the euchromatic portion of the human genome was generated by the whole-genome shotgun sequencing method. The 14.8-billion bp DNA sequence was generated over 9 months from 27,271,853 high-quality sequence reads (5.11-fold coverage of the genome) from both ends of plasmid clones made from the DNA of five individuals. Two assembly strategies-a whole-genome assembly and a regional chromosome assembly-were used, each combining sequence data from Celera and the publicly funded genome effort. The public data were shredded into 550-bp segments to create a 2.9-fold coverage of those genome regions that had been sequenced, without including biases inherent in the cloning and assembly procedure used by the publicly funded group. This brought the effective coverage in the assemblies to eightfold, reducing the number and size of gaps in the final assembly over what would be obtained with 5.11-fold coverage. The two assembly strategies yielded very similar results that Largely agree with independent mapping data. The assemblies effectively cover the euchromatic regions of the human chromosomes. More than 90% of the genome is in scaffold assemblies of 100,000 bp or more, and 25% of the genome is in scaffolds of 10 million bp or larger. Analysis of the genome sequence revealed 26,588 protein-encoding transcripts for which there was strong corroborating evidence and an additional similar to 12,000 computationally derived genes with mouse matches or other weak supporting evidence. Although gene-dense clusters are obvious, almost half the genes are dispersed in Low G+C sequence separated by large tracts of apparently noncoding sequence. Only 1.1% of the genome is spanned by exons, whereas 24% is in introns, with 75% of the genome being intergenic DNA. Duplications of segmental blocks, ranging in size up to chromosomal Lengths, are abundant throughout the genome and reveal a complex evolutionary history. Comparative genomic analysis indicates vertebrate expansions of genes associated with neuronal function, with tissue-specific developmental regulation, and with the hemostasis and immune systems. DNA sequence comparisons between the consensus sequence and publicly funded genome data provided locations of 2.1 million single-nucleotide polymorphisms (SNPs). A random pair of human haploid genomes differed at a rate of 1 bp per 1250 on average, but there was marked heterogeneity in the Level of polymorphism across the genome. Less than 1% of all SNPs resulted in variation in proteins, but the task of determining which SNPs have functional consequences remains an open challenge.	Celera Genom, Rockville, MD 20850 USA; GenetixXpress, Sydney, NSW 2108, Australia; Univ Calif Berkeley, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA; Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Johns Hopkins Univ, Johns Hopkins Hosp, Sch Med, Baltimore, MD 21287 USA; Rockefeller Univ, New York, NY 10021 USA; New England Biolabs Inc, Beverly, MA 01915 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Yale Univ, Sch Med, New Haven, CT 06520 USA; Appl Biosyst Inc, Foster City, CA 94404 USA; Inst Genom Res, Rockville, MD 20850 USA; Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; Univ Pompeu Fabra, Inst Municipal Invest Med, Grp Recerca Informat Med, Barcelona, Catalonia, Spain	University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Case Western Reserve University; Johns Hopkins University; Johns Hopkins Medicine; Rockefeller University; California Institute of Technology; Yale University; Thermo Fisher Scientific; Applied Biosystems; J. Craig Venter Institute; Bar Ilan University; Pompeu Fabra University	Venter, JC (corresponding author), Celera Genom, 45 W Gude Dr, Rockville, MD 20850 USA.	humangenome@celera.com	Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019; Tuluc, Petronel/C-2527-2011; Guigo, Roderic/D-1303-2010; Hart, Brit/G-6205-2015; Bafna, Vineet/AAY-8111-2020; Ferrando, Josep F Abril/B-3877-2014; Gasull, Martina/J-4076-2019; Schwartz, Russell/A-1998-2016; Holt, Robert A/C-3303-2009; Huson, Daniel H./AAC-5494-2019; Reinert, Knut/V-3327-2019; Scott, Rodney/B-2827-2013	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432; Guigo, Roderic/0000-0002-5738-4477; Hart, Brit/0000-0002-9389-2786; Bafna, Vineet/0000-0002-5810-6241; Ferrando, Josep F Abril/0000-0001-7793-589X; Schwartz, Russell/0000-0002-4970-2252; Holt, Robert A/0000-0002-7259-1247; Reinert, Knut/0000-0003-3078-8129; Harris, Michael/0000-0001-8789-0912; Yooseph, Shibu/0000-0001-5581-5002; Wortman, Jennifer/0000-0002-8713-1227; Nguyen, Dac-Trung/0000-0003-2591-9948; Zheng Bradley, Xiangqun/0000-0002-9324-2708; Ballew, Richard M/0000-0003-4866-284X; Bonazzi, Vivien/0000-0002-7359-9072; Stockwell, Timothy/0000-0002-3595-4539; Eilbeck, Karen/0000-0002-0831-6427; Roberts, Richard/0000-0002-4348-0169; Thomas, Russell/0000-0002-2340-0301; Clark, Andrew/0000-0001-7159-8511; Scott, Rodney/0000-0001-7724-3404; Thomas, Paul/0000-0002-9074-3507				ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1995, NATURE, V377, P3; ADAMS MD, 1994, NATURE, V368, P474, DOI 10.1038/368474a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Aeschlimann D, 2000, CONNECT TISSUE RES, V41, P1, DOI 10.3109/03008200009005638; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Bailey JE, 1999, NAT BIOTECHNOL, V17, P616, DOI 10.1038/10794; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bernardi G, 2000, GENE, V241, P3, DOI 10.1016/S0378-1119(99)00485-0; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BICKMORE WA, 1989, TRENDS GENET, V5, P144, DOI 10.1016/0168-9525(89)90055-3; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CAPANNA E, 1971, CARYOLOGIA, V24, P471, DOI 10.1080/00087114.1971.10796455; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carvalho AB, 2000, P NATL ACAD SCI USA, V97, P13239, DOI 10.1073/pnas.230438397; Casaccia-Bonnefil P, 1999, ADV EXP MED BIOL, V468, P275; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; CHARLESWORTH D, 1995, GENETICS, V141, P1619; CHAUDHARI N, 1983, SCIENCE, V220, P924, DOI 10.1126/science.6189184; Chen F W, 1999, Int Rev Immunol, V18, P429, DOI 10.3109/08830189909088492; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; Collins FS, 1998, SCIENCE, V282, P682, DOI 10.1126/science.282.5389.682; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Cook-Deegan Robert, 1996, GENE WARS SCI POLITI; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; Cross SH, 2000, MAMM GENOME, V11, P373, DOI 10.1007/s003350010071; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dickson D, 1999, NATURE, V401, P311, DOI 10.1038/43722; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eddy SR, 1999, CURR OPIN GENET DEV, V9, P695, DOI 10.1016/S0959-437X(99)00022-2; Elliott DJ, 2000, HUM MOL GENET, V9, P2117, DOI 10.1093/hmg/9.14.2117; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; FEINBERG AP, 2000, CURR TOP MICROBIOL I, V249, P7; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; GARCIAMEUNIER P, 1993, MAMM GENOME, V4, P695, DOI 10.1007/BF00357792; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gell-Mann M., 1996, Complexity, V2, P44, DOI 10.1002/(SICI)1099-0526(199609/10)2:1<44::AID-CPLX10>3.0.CO;2-X; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; GOCAYNE J, 1987, P NATL ACAD SCI USA, V84, P8296, DOI 10.1073/pnas.84.23.8296; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Goncalves I, 2000, GENOME RES, V10, P672, DOI 10.1101/gr.10.5.672; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Green P, 1997, GENOME RES, V7, P410, DOI 10.1101/gr.7.5.410; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Jensen M A, 1991, DNA Seq, V1, P233, DOI 10.3109/10425179109020778; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Kandel ER, 2000, PRINCIPLES NEURAL SC; Kehoe JW, 2000, CHEM BIOL, V7, pR57, DOI 10.1016/S1074-5521(00)00093-4; Kenmochi N, 1998, GENOME RES, V8, P509, DOI 10.1101/gr.8.5.509; Khalyfa A, 1999, DEV DYNAM, V216, P267, DOI 10.1002/(SICI)1097-0177(199911)216:3<267::AID-DVDY5>3.0.CO;2-V; Kimura M, 1985, NEUTRAL THEORY MOL E; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; LANDER E S, 1988, Genomics, V2, P231; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LEMKE G, 1993, GLIA, V7, P263, DOI 10.1002/glia.440070402; Li W-H, 1997, MOL EVOLUTION; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LITTLETON JT, 1995, TRENDS NEUROSCI, V18, P177; MADSEN HO, 1990, NUCLEIC ACIDS RES, V18, P1513, DOI 10.1093/nar/18.6.1513; MAHY BWJ, 1991, ASM NEWS, V57, P577; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; Maleszka R, 1998, P NATL ACAD SCI USA, V95, P3731, DOI 10.1073/pnas.95.7.3731; MANSUR NR, 1993, NUCLEIC ACIDS RES, V21, P993, DOI 10.1093/nar/21.4.993; Marra M, 1999, NAT GENET, V21, P191, DOI 10.1038/5976; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Marshall E, 1998, SCIENCE, V280, P994, DOI 10.1126/science.280.5366.994; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Martin-Gallardo A, 1992, DNA Seq, V3, P237, DOI 10.3109/10425179209034023; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McLysaght A, 2000, YEAST, V17, P22, DOI 10.1002/(SICI)1097-0061(200004)17:1<22::AID-YEA5>3.0.CO;2-S; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; MIKLOS GLG, 1979, AM J HUM GENET, V31, P264; MIKLOS GLG, 1993, J NEUROBIOL, V24, P842, DOI 10.1002/neu.480240610; MILNER RJ, 1983, NUCLEIC ACIDS RES, V11, P5497, DOI 10.1093/nar/11.16.5497; Muller H. J., 1967, Heritage from Mendel., P419; MULLER HP, 1967, Z NATURFORSCH PT B, VB 22, P1330, DOI 10.1515/znb-1967-1218; Munroe PB, 1999, NAT GENET, V21, P142, DOI 10.1038/5102; Mural RJ, 1999, METHOD ENZYMOL, V303, P77; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; MYERS EW, 1996, COMPUTATIONAL METHOD, P73; Myers G, 1996, J COMPUT BIOL, V3, P563, DOI 10.1089/cmb.1996.3.563; Nachman MW, 1998, GENETICS, V150, P1133; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Nei M, 1987, MOL EVOLUTIONARY GEN; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; NOUVEL P, 1994, GENETICA, V93, P191, DOI 10.1007/BF01435251; OHNO S, 1985, TRENDS GENET, V1, P160, DOI 10.1016/0168-9525(85)90070-8; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; Pan YZ, 1999, GENOMICS, V59, P282, DOI 10.1006/geno.1999.5874; Pawson T, 2000, GENE DEV, V14, P1027; Pennisi E, 1998, SCIENCE, V280, P1185, DOI 10.1126/science.280.5367.1185; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Peters J, 2000, GENOME BIOL, V1; POLYMEROPOULOS MH, 1993, NAT GENET, V4, P381, DOI 10.1038/ng0893-381; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sambrook JFE, 1989, MOL CLONING LAB MANU; Sampo B, 2000, P NATL ACAD SCI USA, V97, P3666, DOI 10.1073/pnas.97.7.3666; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmitt H, 1996, GENOMICS, V33, P9, DOI 10.1006/geno.1996.0154; Schuler GD, 1998, TRENDS BIOTECHNOL, V16, P456, DOI 10.1016/S0167-7799(98)01232-3; Seeburg P H, 1977, Trans Assoc Am Physicians, V90, P109; Sharon D, 1999, GENOMICS, V61, P24, DOI 10.1006/geno.1999.5900; SINSHEIMER RL, 1989, GENOMICS, V5, P954, DOI 10.1016/0888-7543(89)90142-0; Sjolander K, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P165; Skrabanek L, 1998, CURR OPIN GENET DEV, V8, P694, DOI 10.1016/S0959-437X(98)80039-7; Slavov D, 2000, GENE, V247, P215, DOI 10.1016/S0378-1119(00)00089-5; SMIT AFA, 1995, NUCLEIC ACIDS RES, V23, P98, DOI 10.1093/nar/23.1.98; SMITH JM, 1987, J THEOR BIOL, V128, P247, DOI 10.1016/S0022-5193(87)80172-8; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; STRAUSS EC, 1986, ANAL BIOCHEM, V154, P353, DOI 10.1016/0003-2697(86)90536-1; Taillon-Miller P, 1999, GENOME RES, V9, P499; Taillon-Miller P, 1998, GENOME RES, V8, P748, DOI 10.1101/gr.8.7.748; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; Uberbacher EC, 1996, METHOD ENZYMOL, V266, P259; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; *US DOE, 1986, SANT FE WORKSH SANT; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang SL, 2000, NEURON, V27, P197, DOI 10.1016/S0896-6273(00)00028-3; Warburton PE, 1996, HUMAN GENOME EVOLUTI, P121; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; WHITE O, 1993, NUCLEIC ACIDS RES, V21, P3829, DOI 10.1093/nar/21.16.3829; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; WU SM, 1991, SCIENCE, V254, P1634, DOI 10.1126/science.1749935; YANDELL M, UNPUB; Zhang JH, 1997, GENOME RES, V7, P649, DOI 10.1101/gr.7.6.649; Zhao S, 2000, GENOMICS, V63, P321, DOI 10.1006/geno.1999.6082; Zoubak S, 1996, GENE, V174, P95, DOI 10.1016/0378-1119(96)00393-9	191	9079	9670	38	1770	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2001	291	5507					1304	+		10.1126/science.1058040	http://dx.doi.org/10.1126/science.1058040			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11181995				2022-12-24	WOS:000166993400041
J	Newman, MF; Kirchner, JL; Phillips-Bute, B; Gaver, V; Grocott, H; Jones, RH; Mark, DB; Reves, JG; Blumenthal, JA				Newman, MF; Kirchner, JL; Phillips-Bute, B; Gaver, V; Grocott, H; Jones, RH; Mark, DB; Reves, JG; Blumenthal, JA		Neurological Outcome Res Grp Cardi	Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; COGNITIVE DECLINE; RISK-FACTORS; APOE EPSILON-4; OUTCOMES; DYSFUNCTION; STATEMENT	Background: Cognitive decline complicates early recovery after coronary-artery bypass grafting (CABG) and may be evident in as many as three quarters of patients at the time of discharge from the hospital and a third of patients after six months. We sought to determine the course of cognitive change during the five years after CABG and the effect of perioperative decline on long-term cognitive function. Methods: In 261 patients who underwent CABG, neurocognitive tests were performed preoperatively (at base line), before discharge, and six weeks, six months, and five years after CABG surgery. Decline in postoperative function was defined as a drop of 1 SD or more in the scores on tests of any one of four domains of cognitive function. (A reduction of 1 SD represents a decline in function of approximately 20 percent.) Overall neurocognitive status was assessed with a composite cognitive index score representing the sum of the scores for the individual domains. Factors predicting long-term cognitive decline were determined by multivariable logistic and linear regression. Results: Among the patients studied, the incidence of cognitive decline was 53 percent at discharge, 36 percent at six weeks, 24 percent at six months, and 42 percent at five years. We investigated predictors of cognitive decline at five years and found that cognitive function at discharge was a significant predictor of long-term function (P<0.001). Conclusions: These results confirm the relatively high prevalence and persistence of cognitive decline after CABG and suggest a pattern of early improvement followed by a later decline that is predicted by the presence of early postoperative cognitive decline. Interventions to prevent or reduce short- and long-term cognitive decline after cardiac surgery are warranted. (N Engl J Med 2001;344:395-402.) Copyright (C) 2001 Massachusetts Medical Society.	Duke Univ, Med Ctr, Div Cardiothorac Anesthesia, Dept Anesthesiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Newman, MF (corresponding author), Duke Univ, Med Ctr, Div Cardiothorac Anesthesia, Dept Anesthesiol, Box 3094, Durham, NC 27710 USA.	newma005@mc.duke.edu		Mark, Daniel/0000-0001-6340-8087	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009663] Funding Source: NIH RePORTER; NHLBI NIH HHS [1R01HL54316] Funding Source: Medline; NIA NIH HHS [R01-AG09663] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Benton A, 1978, PSYCHOL ASSESSMENT R; BLUMENTHAL JA, 1995, ANN THORAC SURG, V59, P1345, DOI 10.1016/0003-4975(95)00055-P; Carmelli D, 1998, NEUROLOGY, V50, P1580, DOI 10.1212/WNL.50.6.1580; Cohen RA, 1999, AM J CARDIOL, V83, P1374, DOI 10.1016/S0002-9149(99)00103-4; Emery CF, 1998, HEALTH PSYCHOL, V17, P232, DOI 10.1037/0278-6133.17.3.232; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; Hammon JW, 1997, ANN THORAC SURG, V63, P1613, DOI 10.1016/S0003-4975(97)00261-0; JONES EL, 1991, J THORAC CARDIOV SUR, V101, P108; Lloyd AJ, 2000, BRIT J SURG, V87, P443, DOI 10.1046/j.1365-2168.2000.01428.x; Murkin JM, 1997, ANN THORAC SURG, V64, P904, DOI 10.1016/S0003-4975(97)00743-1; MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U; MURKIN JM, 1996, ANESTH ANALG, V82, pS328; Newman MF, 2000, ANESTH ANALG, V90, pSCA4; NEWMAN MF, 1995, ANN THORAC SURG, V59, P1326, DOI 10.1016/0003-4975(95)00076-W; NEWMAN MF, 1994, CIRCULATION, V90, P243; O'Hara R, 1998, J AM GERIATR SOC, V46, P1493, DOI 10.1111/j.1532-5415.1998.tb01532.x; RANDT CT, 1983, ADM MANUAL RANDT MEM; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Selnes OA, 1999, LANCET, V353, P1601, DOI 10.1016/S0140-6736(98)07576-X; Slooter AJC, 1998, J NEURAL TRANSM-SUPP, P17; SOTANIEMI KA, 1986, STROKE, V17, P410, DOI 10.1161/01.STR.17.3.410; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Troster AI, 1999, NEUROLOGY, V53, P1774, DOI 10.1212/WNL.53.8.1774; TUMAN KJ, 1992, J THORAC CARDIOV SUR, V104, P1510, DOI 10.1016/S0022-5223(19)33877-2; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; WEINTRAUB WS, 1989, CIRCULATION, V80, P276, DOI 10.1161/01.CIR.80.2.276	27	1366	1442	0	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2001	344	6					395	402		10.1056/NEJM200102083440601	http://dx.doi.org/10.1056/NEJM200102083440601			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399FH	11172175				2022-12-24	WOS:000166800600001
J	Silberstein, LE; Toy, P				Silberstein, LE; Toy, P			Research opportunities in transfusion medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MODIFIED DENDRITIC CELLS; BLOOD; HYPORESPONSIVENESS; REQUIREMENTS; INACTIVATION	In recent years, the translation of basic research in transfusion medicine has led to development of novel cellular therapies using well-characterized cell populations isolated from either bone marrow or blood (eg, hematopoietic stem and progenitor cells, T lymphocytes, dendritic cells). Refinements in cell therapies will make possible optimal stem cell engraftment, gene therapy, immunotherapy of cancer and infectious disease, and even solid organ regeneration. Moreover, the immune consequences of transfusion therapy are better appreciated and opportunities are at hand to prevent or blunt unwanted immune responses, such as platelet refractoriness and graft-vs-host disease. Transfusion medicine has become a broad, multidisciplinary field that has evolved beyond issues related to blood procurement and storage. The next series of advances in transfusion medicine will complement the current approaches of donor blood screening and viral/bacterial inactivation steps to ensure a safe and adequate blood supply.	Harvard Univ, Sch Med, Boston, MA USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Silberstein, LE (corresponding author), Childrens Hosp, Dana Farber Canc Inst, Joint Program Transfus Med, Bader 4,300 Longwood Ave, Boston, MA 02115 USA.							Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Armstrong B, 2000, CYTOMETRY, V40, P102, DOI 10.1002/(SICI)1097-0320(20000601)40:2<102::AID-CYTO3>3.3.CO;2-W; Blajchman MA, 1999, TRANSFUSION, V39, P665, DOI 10.1046/j.1537-2995.1999.39070665.x; BLAKESLEE S, 2000, NY TIMES        0725; Daniels G, 1999, BLOOD REV, V13, P14, DOI 10.1016/S0268-960X(99)90020-6; GULNAN EC, 1999, NEW ENGL J MED, V340, P1704; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HOROWITZ MM, 1990, BLOOD, V75, P555; Kirk CJ, 2000, HUM GENE THER, V11, P797, DOI 10.1089/10430340050015419; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; Klein HG, 2000, NEW ENGL J MED, V342, P1666, DOI 10.1056/NEJM200006013422211; KLEINMAN S, 2000, NEW ASPECTS BLOOD TR; Landsteiner K, 1936, SPECIFICITY SEROLOGI; Lin L, 1997, TRANSFUSION, V37, P423, DOI 10.1046/j.1537-2995.1997.37497265344.x; MCCULLOUGH J, 1995, TRANSFUSION, V35, P374, DOI 10.1046/j.1537-2995.1995.35595259145.x; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Murphy WJ, 1999, CURR OPIN IMMUNOL, V11, P509, DOI 10.1016/S0952-7915(99)00002-3; Niimi M, 1998, J IMMUNOL, V161, P5331; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; REED WF, 1999, CURR OPIN HEMATOL, P6432; Reid ME, 2000, TRANSFUSION, V40, P48, DOI 10.1046/j.1537-2995.2000.40010048.x; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; SIENA S, 1989, BLOOD, V74, P1905; SKYES M, 1988, BONE MARROW TRANSPL, V3, P379; Taylor PA, 2000, J IMMUNOL, V164, P612, DOI 10.4049/jimmunol.164.2.612; Thurer RL, 2000, TRANSFUSION, V40, P751, DOI 10.1046/j.1537-2995.2000.40060751.x; Wallace EL, 1998, TRANSFUSION, V38, P625, DOI 10.1046/j.1537-2995.1998.38798346630.x; YANKEE RA, 1969, NEW ENGL J MED, V281, P1208, DOI 10.1056/NEJM196911272812202; Yee C, 1997, CURR OPIN IMMUNOL, V9, P702, DOI 10.1016/S0952-7915(97)80052-0	29	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					577	580		10.1001/jama.285.5.577	http://dx.doi.org/10.1001/jama.285.5.577			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176862				2022-12-24	WOS:000166714200015
J	Pattani, S; Constantinovici, N; Williams, S				Pattani, S; Constantinovici, N; Williams, S			Who retires early from the NHS because of ill health and what does it cost? A national cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									UCL Royal Free Hampstead NHS Trust, Occupat Hlth & Safety Unit, London NW3 2QG, England; Univ London, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England	University of London; University College London; University of London; University College London	Williams, S (corresponding author), UCL Royal Free Hampstead NHS Trust, Occupat Hlth & Safety Unit, London NW3 2QG, England.	Sian.Williams@rfh.nthames.nhs.uk						*GOV STAT SERV, 1998, HLTH PERS SOC SERV S; *NHS PENS AG, 1999, NHS PENS AG ANN REP; Poole CJM, 1997, BRIT MED J, V314, P929, DOI 10.1136/bmj.314.7085.929	3	48	49	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 27	2001	322	7280					208	209		10.1136/bmj.322.7280.208	http://dx.doi.org/10.1136/bmj.322.7280.208			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	398BF	11159617	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000166733700027
J	Clutton-Brock, TH; Brotherton, PNM; Russell, AF; O'Riain, MJ; Gaynor, D; Kansky, R; Griffin, A; Manser, M; Sharpe, L; McIlrath, GM; Small, T; Moss, A; Monfort, S				Clutton-Brock, TH; Brotherton, PNM; Russell, AF; O'Riain, MJ; Gaynor, D; Kansky, R; Griffin, A; Manser, M; Sharpe, L; McIlrath, GM; Small, T; Moss, A; Monfort, S			Cooperation, control, and concession in meerkat groups	SCIENCE			English	Article							SURICATA-SURICATTA; ANIMAL SOCIETIES	"Limited control" models of reproductive skew in cooperative societies suggest that the frequency of breeding by subordinates is determined by the outcome of power struggles with dominants. In contrast, "optimal skew" models suggest that dominants have full control of subordinate reproduction and allow subordinates to breed only when this serves to retain subordinates' assistance with rearing dominants' own Litters. The results of our 7-year field study of cooperative meerkats, Suricata suricatta, support the predictions of Limited control models and provide no indication that dominant females grant reproductive concessions to subordinates to retain their assistance with future breeding attempts.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Smithsonian Inst, Conservat & Res Ctr, Front Royal, VA 22630 USA	University of Cambridge; University of Pretoria; University of Edinburgh; Smithsonian Institution	Clutton-Brock, TH (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.		Griffin, Ashleigh/C-6244-2014	Griffin, Ashleigh/0000-0001-7674-9825; O'Riain, M. Justin/0000-0001-5233-8327				BROTHERTON PNM, IN PRESS BEHAV ECOL; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P185, DOI 10.1098/rspb.1998.0281; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P2291, DOI 10.1098/rspb.1998.0573; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; CLUTTONBROCK TH, UNPUB; Doolan SP, 1999, ETHOLOGY, V105, P851, DOI 10.1046/j.1439-0310.1999.00461.x; GRIFFIN AS, 1999, THESIS EDINBURGH U; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Koenig WD, 1998, AM NAT, V151, P243, DOI 10.1086/286115; MONFORT SL, 1991, J REPROD FERTIL, V91, P155, DOI 10.1530/jrf.0.0910155; MOSS A, 2000, THESIS G MASON U FAI; ORIAIN MJ, IN PRESS BEHAV ECOL; Reeve HK, 1998, BEHAV ECOL, V9, P267, DOI 10.1093/beheco/9.3.267; [No title captured]	15	253	256	5	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2001	291	5503					478	481		10.1126/science.291.5503.478	http://dx.doi.org/10.1126/science.291.5503.478			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11161200				2022-12-24	WOS:000166487500039
J	Petrovic, M; Roberts, R; Ramsay, M				Petrovic, M; Roberts, R; Ramsay, M			Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals	BRITISH MEDICAL JOURNAL			English	Article							ADVERSE EVENTS; SURVEILLANCE; CAUSAL	Objective To determine the knowledge, attitudes, and practices among health professionals regarding the measles, mumps, and rubella (MMR) vaccine, particularly the second dose. Design Self administered postal questionnaire survey. Setting North Wales Health Authority, 1998. Participants 148 health visitors, 239 practice nurses, and 206 general practitioners. Main outcome measures Respondents' views on MMR vaccination, including their views on the likelihood of an association with autism and Crohn's disease and on who is the best person to give advice to parents, whether they agree with the policy of a second dose of the vaccine, and how confident they are in explaining the rationale behind the second dose. Results Concerning the second dose of the vaccine, 48% of the professionals (220/460) had reservations and 3% (15) disagreed with the policy of giving it Over half the professionals nominated health visitors as the best initial source of advice on the second vaccine. 61% of health visitors (86/140), compared with 46% of general practitioners (73/158), reported feeling very confident about explaining the rationale of a two dose schedule to a well informed parent, but only 20% (28/138) would unequivocally recommend the second dose to a wavering parent 33% of the practice nurses (54/163) stated that the MMR vaccine was very likely or possibly associated with Crohn's disease and 27% (44/164) that it was associated with autism. Nearly a fifth of general practitioners (27/158) reported that they had not read the MMR section in the "green book," and 29% (44/152) reported that they had not received the Health Education Authority's factsheet on MMR immunisation. Conclusions Knowledge and practice among health professionals regarding the second dose of the MMR vaccine vary widely. Many professionals are not aware of or do not use the good written resources that exist, though local educational initiatives could remedy this.	N Wales Hlth Author, Dept Publ Hlth, Mold, Flint, Wales; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England	Public Health England	Petrovic, M (corresponding author), N Wales Hlth Author, Dept Publ Hlth, Mold, Flint, Wales.		Ramsay, Mary Elizabeth/S-8281-2016	Ramsay, Mary Elizabeth/0000-0002-7156-7640				*CDCP, 1998, MMWR-MORBID MORTAL W, V47, P2; *CDSC, 1998, COMMUN DIS REP CDR W, V8, P345; Chen RT, 1998, LANCET, V351, P611, DOI 10.1016/S0140-6736(05)78423-3; CUTTS FT, 1994, J INFECT DIS, V170, pS32, DOI 10.1093/infdis/170.Supplement_1.S32; DEAN AG, 1995, EPI INFO VERS 6 WORD; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; GAY NJ, 1995, EPIDEMIOL INFECT, V115, P139, DOI 10.1017/S0950268800058209; *HLTH ED AUTH, 1997, MMR IMM FACTSH; HMSO, 1996, IMM INF DIS; PETOLA H, 1994, NEW ENGL J MED, V331, P1397; ROBERTS N, 1998, GP, P63; STRATTON KR, 1994, ADVERSE EVENTS ASS C, P118; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; *WELSH OFF, 1998, CMO987 WELSH OFF; WHO, 1999, EUR HLTH ALL SER; 1996, COMMUN DIS REP CDR W, V6, P259	17	58	58	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	2001	322	7278					82	85		10.1136/bmj.322.7278.82	http://dx.doi.org/10.1136/bmj.322.7278.82			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	393XZ	11154622	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000166496100027
J	Seo, SB; McNamara, P; Heo, S; Turner, A; Lane, WS; Chakravarti, D				Seo, SB; McNamara, P; Heo, S; Turner, A; Lane, WS; Chakravarti, D			Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein	CELL			English	Article							ACTIVATING FACTOR-I; PROTEIN PHOSPHATASE 2A; ACETYLTRANSFERASE ACTIVITY; STIMULATES TRANSCRIPTION; NUCLEAR PHOSPHOPROTEIN; MYELOID LEUKEMOGENESIS; CHROMATIN STRUCTURE; PUTATIVE ONCOGENE; COACTIVATORS P300; DNA-BINDING	Acetylation of histones by p300/CBP and PCAF is considered to be a critical step in transcriptional regulation. In order to understand the role of cellular activities that modulate histone acetylation and transcription, we have purified and characterized a multiprotein cellular complex that potently inhibits the histone acetyltransferase activity of p300/CBP and PCAF. We have mapped a novel acetyltransferase-inhibitory domain of this INHAT (inhibitor of acetyltransferases) complex that binds to histones and masks them from being acetyltransferase substrates. Endogenous INHAT subunits, which include the Set/TAF-I beta oncoprotein, associate with chromatin in vivo and can block coactivator-mediated transcription when transfected in cells. We propose that histone masking by INHAT plays a regulatory role in chromatin modification and serves as a novel mechanism of transcriptional regulation.	Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Harvard Univ, Harvard Microchem & Prot Facil, Cambridge, MA 02138 USA	University of Pennsylvania; Harvard University	Chakravarti, D (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA.	debu@pharm.med.upenn.edu		Chakravarti, Debabrata/0000-0001-8446-8599	NIDDK NIH HHS [R01-DK57079-01A1, P30-DK19925, R01 DK057079] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019925, R01DK057079] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; Creaven M, 1999, BIOCHEMISTRY-US, V38, P8826, DOI 10.1021/bi9907274; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Glass CK, 2000, GENE DEV, V14, P121; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7; Kadkol SS, 1999, NAT MED, V5, P275, DOI 10.1038/6488; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okuwaki M, 1998, J BIOL CHEM, V273, P34511, DOI 10.1074/jbc.273.51.34511; Perlmann T, 1997, CELL, V90, P391, DOI 10.1016/S0092-8674(00)80498-5; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Saito S, 1999, BIOCHEM BIOPH RES CO, V259, P471, DOI 10.1006/bbrc.1999.0790; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Tyler JK, 1999, CELL, V99, P443, DOI 10.1016/S0092-8674(00)81530-5; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; WALENSKY LD, 1993, CANCER RES, V53, P4720; Weissman JD, 1998, P NATL ACAD SCI USA, V95, P11601, DOI 10.1073/pnas.95.20.11601; Wolffe AP, 1996, SCIENCE, V272, P371, DOI 10.1126/science.272.5260.371; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang QH, 2000, MOL CELL BIOL, V20, P4970, DOI 10.1128/MCB.20.14.4970-4978.2000	45	386	397	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2001	104	1					119	130		10.1016/S0092-8674(01)00196-9	http://dx.doi.org/10.1016/S0092-8674(01)00196-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163245	Bronze			2022-12-24	WOS:000166882300012
J	Chinn, S; Rona, RJ				Chinn, S; Rona, RJ			Prevalence and trends in overweight and obesity in three cross sectional studies of British children, 1974-94	BRITISH MEDICAL JOURNAL			English	Article							GROWTH; HEALTH	Objectives To report trends in overweight and obesity, defined by new internationally agreed cut-off points, in children in the United Kingdom. Design Three independent cross sectional surveys. Setting Primary schools in England and Scotland. Participants 10 414 boys and 9737 girls in England and 5385 boys and 5219 girls in Scotland aged 4 to 11 years. Main outcome measures Prevalence and change in prevalence of overweight and obesity as defined by the international obesity; task force, in 1974, 1984, and 1994, for each ses and country. Results Little change was found in the prevalence of overweight or obesity from 1974 to 1984. From 1984 lo 1994 overweight increased from 5.4% to 9.0% in English boys (increase 3.6%, 95% confidence interval 2.3% to 5.0%) and from 6.4% to 10.0% in Scottish boys (3.6%, 1.9% to 5.4%). Values for girls were 9.3% to 13.5% (4.1%, 2.4% to 5.9%) and 10.4% to 15.8% (5.4%, 3.2% to 7.6%) respectively. The prevalence of obesity increased correspondingly, reaching 1.7% (English boys), 2.1% (Scottish boys) 2.6% (English girls), and 3.2% (Scottish girls). Conclusion These results form a base from which trends can be monitored. The rising trends are likely; to be reflected in increases in adult obesity and associated morbidity.	Kings Coll London, Dept Publ Hlth Sci, London SE1 3QD, England	University of London; King's College London	Chinn, S (corresponding author), Kings Coll London, Dept Publ Hlth Sci, London SE1 3QD, England.	sue.chinn@kcl.ac.uk	Rona, Roberto J/C-2348-2011	Rona, Roberto/0000-0003-3739-5571				Chinn S, 1998, ARCH DIS CHILD, V78, P513, DOI 10.1136/adc.78.6.513; CHINN S, 1994, PAEDIATR PERINAT EP, V8, P90, DOI 10.1111/j.1365-3016.1994.tb00438.x; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Hughes JM, 1997, ARCH DIS CHILD, V76, P182, DOI 10.1136/adc.76.3.182; PECKHAM CS, 1983, BMJ-BRIT MED J, V286, P1237, DOI 10.1136/bmj.286.6373.1237; Power C, 1997, INT J OBESITY, V21, P507, DOI 10.1038/sj.ijo.0800454; Prentice AM, 1998, BRIT MED J, V317, P1401, DOI 10.1136/bmj.317.7170.1401; Reilly JJ, 1999, BRIT MED J, V319, P1039, DOI 10.1136/bmj.319.7216.1039; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005	10	363	380	0	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	2001	322	7277					24	26		10.1136/bmj.322.7277.24	http://dx.doi.org/10.1136/bmj.322.7277.24			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EP	11141148	Bronze, Green Published			2022-12-24	WOS:000166341400020
J	Havas, K; Flaus, A; Phelan, M; Kingston, R; Wade, PA; Lilley, DMJ; Owen-Hughes, T				Havas, K; Flaus, A; Phelan, M; Kingston, R; Wade, PA; Lilley, DMJ; Owen-Hughes, T			Generation of superhelical torsion by ATP-dependent chromatin remodeling activities	CELL			English	Article							T4 ENDONUCLEASE-VII; NUCLEOSOME DISRUPTION; DNA TRANSLOCATION; CELL-CYCLE; SWI-SNF; CRUCIFORM STRUCTURES; SUPERCOILED DNA; HUMAN SWI/SNF; YEAST; COMPLEX	ATP-dependent chromatin remodeling activities participate in the alteration of chromatin structure during gene regulation. Ail have DNA- or chromatin-stimulated ATPase activity and many can alter the structure of chromatin; however, the means by which they do this have remained unclear. Here we describe a novel activity for ATP-dependent chromatin remodeling activities, the ability to generate unconstrained negative superhelical torsion in DNA and chromatin. We find that the ability to distort DNA is shared by the yeast SWI/SNF complex, Xenopus Mi-2 complex, recombinant ISWI, and recombinant BRG1, suggesting that the generation of superhelical torsion represents a primary biomechanical activity shared by all Snf2-prelated ATPase motors. The generation of superhelical torque provides a potent means by which ATP-dependent chromatin remodeling activities can manipulate chromatin structure.	Univ Dundee, Wellcome Trust Bioctr, Div Gene Regulat, Dundee DD1 5EH, Scotland; Harvard Univ, Massachusetts Gen Hosp, Boston, MA 02114 USA; Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	University of Dundee; Harvard University; Massachusetts General Hospital; Emory University	Owen-Hughes, T (corresponding author), Univ Dundee, Wellcome Trust Bioctr, Div Gene Regulat, Dundee DD1 5EH, Scotland.	t.a.owenhughes@dundee.ac.uk	Wade, Paul A/D-2374-2019; Flaus, Andrew/D-5076-2011	Wade, Paul A/0000-0002-6042-357X; Flaus, Andrew/0000-0002-5720-7139; Owen-Hughes, Tom/0000-0002-0618-8185; Havas-Cavalletti, Kristina/0000-0002-6324-629X	Cancer Research UK [11722] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Auble DT, 1999, MOL CELL BIOL, V19, P412; Bazett-Jones DP, 1999, MOL CELL BIOL, V19, P1470; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Cote J, 1998, P NATL ACAD SCI USA, V95, P4947, DOI 10.1073/pnas.95.9.4947; COUREY AJ, 1983, CELL, V33, P817, DOI 10.1016/0092-8674(83)90024-7; Davies GP, 1999, J MOL BIOL, V292, P787, DOI 10.1006/jmbi.1999.3081; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Ellis DJ, 1999, NAT STRUCT BIOL, V6, P15; Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094; GiraudPanis MJE, 1996, J BIOL CHEM, V271, P33148, DOI 10.1074/jbc.271.51.33148; GODING CR, 1983, NUCLEIC ACIDS RES, V11, P21, DOI 10.1093/nar/11.1.21; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; GREAVES DR, 1985, J MOL BIOL, V185, P461, DOI 10.1016/0022-2836(85)90064-6; Guschin D, 2000, BIOCHEMISTRY-US, V39, P5238, DOI 10.1021/bi000421t; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; Imbalzano AN, 1996, J BIOL CHEM, V271, P20726, DOI 10.1074/jbc.271.34.20726; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Janscak P, 2000, J MOL BIOL, V295, P1089, DOI 10.1006/jmbi.1999.3414; Jaskelioff M, 2000, MOL CELL BIOL, V20, P3058, DOI 10.1128/MCB.20.9.3058-3068.2000; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; LILLEY DMJ, 1984, CELL, V36, P413, DOI 10.1016/0092-8674(84)90234-4; LILLEY DMJ, 1984, J MOL BIOL, V180, P179, DOI 10.1016/0022-2836(84)90436-4; LILLEY DMJ, 1980, P NATL ACAD SCI-BIOL, V77, P6468, DOI 10.1073/pnas.77.11.6468; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MCCLELLAN JA, 1990, P NATL ACAD SCI USA, V87, P8373, DOI 10.1073/pnas.87.21.8373; MIZUUCHI K, 1982, CELL, V29, P357, DOI 10.1016/0092-8674(82)90152-0; MIZUUCHI K, 1982, J MOL BIOL, V156, P229, DOI 10.1016/0022-2836(82)90325-4; Owen-Hughes T, 1999, METH MOL B, V119, P319; OwenHughes T, 1996, SCIENCE, V273, P513, DOI 10.1126/science.273.5274.513; PANAYOTATOS N, 1981, NATURE, V289, P466, DOI 10.1038/289466a0; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; PECK LJ, 1982, P NATL ACAD SCI-BIOL, V79, P4560, DOI 10.1073/pnas.79.15.4560; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Petukhova G, 1999, J BIOL CHEM, V274, P29453, DOI 10.1074/jbc.274.41.29453; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Shimizu M, 2000, EMBO J, V19, P3358, DOI 10.1093/emboj/19.13.3358; SINGLETON CK, 1982, NATURE, V299, P312, DOI 10.1038/299312a0; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Szczelkun MD, 1996, EMBO J, V15, P6335, DOI 10.1002/j.1460-2075.1996.tb01023.x; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; Tran HG, 2000, EMBO J, V19, P2323, DOI 10.1093/emboj/19.10.2323; TRAVERS AA, 1992, CELL, V69, P573, DOI 10.1016/0092-8674(92)90218-2; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Tyler JK, 1999, CELL, V99, P443, DOI 10.1016/S0092-8674(00)81530-5; UMEK RM, 1988, CELL, V52, P559, DOI 10.1016/0092-8674(88)90469-2; van Holde KE, 1985, STRUCTURE FUNCTION G, P35, DOI DOI 10.1007/978-1-4684-5024-8_4; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; WEINTRAUB H, 1983, CELL, V32, P1191, DOI 10.1016/0092-8674(83)90302-1; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90167-3; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472	78	212	215	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2000	103	7					1133	1142		10.1016/S0092-8674(00)00215-4	http://dx.doi.org/10.1016/S0092-8674(00)00215-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163188	Bronze			2022-12-24	WOS:000166040600015
J	Naureckiene, S; Sleat, DE; Lackland, H; Fensom, A; Vanier, MT; Wattiaux, R; Jadot, M; Lobel, P				Naureckiene, S; Sleat, DE; Lackland, H; Fensom, A; Vanier, MT; Wattiaux, R; Jadot, M; Lobel, P			Identification of HE1 as the second gene of Niemann-Pick C disease	SCIENCE			English	Article							MAJOR SECRETORY PROTEIN; MOLECULAR-CLONING; HUMAN EPIDIDYMIS; EXPRESSION; COMPLEMENTATION; GLYCOPROTEINS; HYBRIDIZATION; LYSOSOMES; CELLS; FLUID	Niemann-Pick type C2 disease (NP-C2) is a fatal hereditary disorder of unknown etiology characterized by defective egress of cholesterol from lysosomes. Here we show that the disease is caused by a deficiency in HE1, a ubiquitously expressed lysosomal protein identified previously as a cholesterol-binding protein. HE1 was undetectable in fibroblasts from NP-C2 patients but present in fibroblasts from unaffected controls and NP-C1 patients. Mutations in the HE1 gene, which maps to chromosome 14q24.3, were found in NP-C2 patients but not in controls. Treatment of NP-C2 fibroblasts with exogenous recombinant HE1 protein ameliorated lysosomal accumulation of low density lipoprotein-derived cholesterol.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; Guys Hosp, Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London SE1 9RT, England; Lyon Sud Med Sch, INSERM 189, Oullins, France; Lyon Sud Hosp, Fdn Gillet Merieux, Pierre Benite, France; Fac Univ Notre Dame Paix, Physiol Chem Lab, B-5000 Namur, Belgium	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; University of Namur	Lobel, P (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	lobel@cabm.rutgers.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054317, R01DK045992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037918] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54317, DK45992] Funding Source: Medline; NINDS NIH HHS [NS37918] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRADY RO, 1989, NEUROL CLIN, V7, P75, DOI 10.1016/S0733-8619(18)30829-6; Brown D, 2000, J EXP BIOL, V203, P137; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; ELLERBROCK K, 1994, INT J ANDROL, V17, P314, DOI 10.1111/j.1365-2605.1994.tb01262.x; Fouchecourt S, 2000, BIOL REPROD, V62, P1790, DOI 10.1095/biolreprod62.6.1790; Frohlich O, 1996, BIOL REPROD, V54, P857, DOI 10.1095/biolreprod54.4.857; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; JADOT M, 1985, EUR J BIOCHEM, V151, P485, DOI 10.1111/j.1432-1033.1985.tb09127.x; Kirchhoff C, 1998, ANDROLOGIA, V30, P225; Kirchhoff C, 1996, BIOL REPROD, V54, P847, DOI 10.1095/biolreprod54.4.847; KORNFELD S, 2001, METABOLIC MOL BASES, V2, P3469; KRULL N, 1993, MOL REPROD DEV, V34, P16, DOI 10.1002/mrd.1080340104; Larsen LB, 1997, EUR J BIOCHEM, V243, P437, DOI 10.1111/j.1432-1033.1997.0437a.x; Nakamura Y, 2000, GENE, V251, P55, DOI 10.1016/S0378-1119(00)00189-X; NAURECKIENE S, UNPUB; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; NISHIYAMA C, 1993, INT ARCH ALLERGY IMM, V101, P159, DOI 10.1159/000236514; Okamura N, 1999, BBA-MOL CELL BIOL L, V1438, P377, DOI 10.1016/S1388-1981(99)00070-0; Patterson M., 2001, METABOLIC MOL BASES, VII, P3611; RACZEK S, 1995, CELL TISSUE RES, V280, P415, DOI 10.1007/s004410050370; Sleat DE, 1996, J BIOL CHEM, V271, P19191, DOI 10.1074/jbc.271.32.19191; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Sohar I, 2000, CLIN CHEM, V46, P1005; Steinberg SJ, 1996, J INHERIT METAB DIS, V19, P769, DOI 10.1007/BF01799171; STEINBERG SJ, 1994, J MED GENET, V31, P317, DOI 10.1136/jmg.31.4.317; TOMOMASA H, 1994, J HISTOCHEM CYTOCHEM, V42, P417, DOI 10.1177/42.3.8308258; VALENZANO KJ, 1993, ANAL BIOCHEM, V209, P156, DOI 10.1006/abio.1993.1096; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; Vanier MT, 1996, AM J HUM GENET, V58, P118; Vanier MT, 1998, BRAIN PATHOL, V8, P163; WATTIAUX R, 1963, CIBA F S LYSOSOMES, P176; Xiang X, 2000, CURR BIOL, V10, P603, DOI 10.1016/S0960-9822(00)00488-7	33	637	656	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2000	290	5500					2298	+		10.1126/science.290.5500.2298	http://dx.doi.org/10.1126/science.290.5500.2298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125141				2022-12-24	WOS:000165995800041
J	Amico, G; Aizen, MA				Amico, G; Aizen, MA			Ecology - Mistletoe seed dispersal by a marsupial	NATURE			English	Article							TEMPERATE		Univ Nacl Comahue, CRUB, Lab Ecotono, RA-8400 Bariloche, Rio Negro, Argentina	Universidad Nacional del Comahue	Amico, G (corresponding author), Univ Nacl Comahue, CRUB, Lab Ecotono, Unidad Postal Univ, RA-8400 Bariloche, Rio Negro, Argentina.		Amico, Guillermo C c/HGD-9402-2022	Aizen, Marcelo/0000-0001-9079-9749; Amico, Guillermo/0000-0002-3709-3111				Armesto JJ, 1998, SCIENCE, V282, P1271, DOI 10.1126/science.282.5392.1271; AXELROD DI, 1991, REV CHIL HIST NAT, V64, P413; Goin F. J., 1997, VERTEBRATE PALEONTOL, P185; Kalin Arroyo M. T., 1996, High-latitude rainforests and associated ecosystems of the West Coast of the Americas: climate, hydrology, ecology and conservation., P134; MARSHALL L.G., 1978, MAMMALIAN SPECIES, V99, P1; REID N, 1991, AUST J ECOL, V16, P457, DOI 10.1111/j.1442-9993.1991.tb01075.x; Reid Nick, 1995, P285; Salle G.L., 1983, BIOL MISTLETOES; SARGENT S, 1995, FUNCT ECOL, V9, P197, DOI 10.2307/2390565; Springer MS, 1998, P ROY SOC B-BIOL SCI, V265, P2381, DOI 10.1098/rspb.1998.0587; Tambussi Claudia, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P245; Van der Pijl L, 1982, PRINCIPLES DISPERSAL, V214	12	118	126	2	41	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					929	930		10.1038/35050170	http://dx.doi.org/10.1038/35050170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140671				2022-12-24	WOS:000165951100037
J	Buckling, A; Kassen, R; Bell, G; Rainey, PB				Buckling, A; Kassen, R; Bell, G; Rainey, PB			Disturbance and diversity in experimental microcosms	NATURE			English	Article							EXPERIMENTAL EVOLUTION; MAINTENANCE; COMPETITION; SELECTION; PEAKS	External agents of mortality (disturbances) occur over a wide range of scales of space and time, and are believed to have large effects on species diversity. The "intermediate disturbance hypothesis''(1-3), which proposes maximum diversity at intermediate frequencies of disturbance, has received support from both field(4,5) and laboratory(6,7) studies. Coexistence of species at intermediate frequencies of disturbance is thought to require trade-offs between competitive ability and disturbance tolerance(8), and a metapopulation structure, with disturbance affecting only a few patches at any given time(9-11). However, a unimodal relationship can also be generated by global disturbances that affect all patches simultaneously, provided that the environment contains spatial niches to which different species are adapted(12). Here we report the results of tests of this model using both isogenic and diverse populations of the bacterium Pseudomonas fluorescens. In both cases, a unimodal relationship between diversity and disturbance frequency was generated in heterogeneous, but not in homogeneous, environments. The cause of this relationship is competition among niche-specialist genotypes, which maintains diversity at intermediate disturbance, but not at high or low disturbance. Our results show that disturbance can modulate the effect of spatial heterogeneity on biological diversity in natural environments.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	University of Oxford; McGill University; McGill University	Buckling, A (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	angus.buckling@plant-sciences.ox.ac.uk	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795; Buckling, Angus/0000-0003-1170-4604				ATWOOD KC, 1951, COLD SPRING HARB SYM, V16, P345, DOI 10.1101/SQB.1951.016.01.026; Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; Bell GAC, 1997, HEREDITY, V78, P490, DOI 10.1038/sj.hdy.6881220; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; COLLINS SL, 1987, ECOLOGY, V68, P1243, DOI 10.2307/1939208; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Crawley M.J., 1993, GLIM ECOLOGISTS; Elena SF, 1996, SCIENCE, V272, P1802, DOI 10.1126/science.272.5269.1802; Floder S, 1999, LIMNOL OCEANOGR, V44, P1114; GAEDEKE A, 1986, OECOLOGIA, V71, P25, DOI 10.1007/BF00377315; Gause GF, 1934, STRUGGLE EXISTENCE; GRIME JP, 1973, J ENVIRON MANAGE, V1, P151; Haldane J. B. S., 1932, CAUSES EVOLUTION; Huston M.A., 1994, BIOL DIVERSITY; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; MILTON WEJ, 1947, J ECOL, V35, P65, DOI 10.2307/2256500; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SLATKIN M, 1974, ECOLOGY, V55, P128, DOI 10.2307/1934625; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; WEIDER LJ, 1992, J EVOLUTION BIOL, V5, P505, DOI 10.1046/j.1420-9101.1992.5030505.x	30	192	199	1	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2000	408	6815					961	964		10.1038/35050080	http://dx.doi.org/10.1038/35050080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140680				2022-12-24	WOS:000165951100046
J	Cnattingius, S; Signorello, LB; Anneren, G; Clausson, B; Ekbom, A; Ljunger, E; Blot, WJ; McLaughlin, JK; Petersson, G; Rane, A; Granath, F				Cnattingius, S; Signorello, LB; Anneren, G; Clausson, B; Ekbom, A; Ljunger, E; Blot, WJ; McLaughlin, JK; Petersson, G; Rane, A; Granath, F			Caffeine intake and the risk of first-trimester spontaneous abortion.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FETAL GROWTH; COFFEE CONSUMPTION; BIRTH-WEIGHT; PREGNANCY; CIGARETTE; KARYOTYPE; MODERATE	Background: Some epidemiologic studies have suggested that the ingestion of caffeine increases the risk of spontaneous abortion, but the results have been inconsistent. Methods: We performed a population-based, case-control study of early spontaneous abortion in Uppsala County, Sweden. The subjects were 562 women who had spontaneous abortion at 6 to 12 completed weeks of gestation (the case patients) and 953 women who did not have spontaneous abortion and were matched to the case patients according to the week of gestation (controls). Information on the ingestion of caffeine was obtained from in-person interviews. Plasma cotinine was measured as an indicator of cigarette smoking, and fetal karyotypes were determined from tissue samples. Multivariate analysis was used to estimate the relative risks associated with caffeine ingestion after adjustment for smoking and symptoms of pregnancy such as nausea, vomiting, and tiredness. Results: Among nonsmokers, more spontaneous abortions occurred in women who ingested at least 100 mg of caffeine per day than in women who ingested less than 100 mg per day, with the increase in risk related to the amount ingested (100 to 299 mg per day: odds ratio, 1.3; 95 percent confidence interval, 0.9 to 1.8; 300 to 499 mg per day: odds ratio, 1.4; 95 percent confidence interval, 0.9 to 2.0; and 500 mg or more per day: odds ratio, 2.2; 95 percent confidence interval, 1.3 to 3.8). Among smokers, caffeine ingestion was not associated with an excess risk of spontaneous abortion. When the analyses were stratified according to the results of karyotyping, the ingestion of moderate or high levels of caffeine was found to be associated with an excess risk of spontaneous abortion when the fetus had a normal or unknown karyotype but not when the fetal karyotype was abnormal. Conclusions: The ingestion of caffeine may increase the risk of an early spontaneous abortion among nonsmoking women carrying fetuses with normal karyotypes. (N Engl J Med 2000;343:1839-45.) (C) 2000, Massachusetts Medical Society.	Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Lab Sci & Tech, Stockholm, Sweden; Int Epidemiol Inst, Rockville, MD USA; Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University; Uppsala University	Cnattingius, S (corresponding author), Karolinska Inst, Dept Med Epidemiol, POB 281, SE-17177 Stockholm, Sweden.		Rane, Anders/L-2675-2013					ARMSTRONG BG, 1992, AM J PUBLIC HEALTH, V82, P85, DOI 10.2105/AJPH.82.1.85; ARMSTRONG EG, 1984, J CLIN ENDOCR METAB, V59, P867, DOI 10.1210/jcem-59-5-867; Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3; BEAULACBAILLARGEON L, 1987, AM J OBSTET GYNECOL, V157, P1236, DOI 10.1016/S0002-9378(87)80301-0; BROWN CR, 1988, CLIN PHARMACOL THER, V43, P488, DOI 10.1038/clpt.1988.63; Cook DG, 1996, BRIT MED J, V313, P1358, DOI 10.1136/bmj.313.7069.1358; Dlugosz L, 1996, EPIDEMIOLOGY, V7, P250, DOI 10.1097/00001648-199605000-00006; DLUGOSZ L, 1992, EPIDEMIOL REV, V14, P83, DOI 10.1093/oxfordjournals.epirev.a036093; Eskenazi B, 1999, NEW ENGL J MED, V341, P1688, DOI 10.1056/NEJM199911253412210; Fenster L, 1991, Epidemiology, V2, P168, DOI 10.1097/00001648-199105000-00002; Fenster L, 1997, EPIDEMIOLOGY, V8, P515, DOI 10.1097/00001648-199709000-00008; Fernandes O, 1998, REPROD TOXICOL, V12, P435, DOI 10.1016/S0890-6238(98)00024-0; GIBAS LM, 1987, PRENATAL DIAG, V7, P323, DOI 10.1002/pd.1970070505; INFANTERIVARD C, 1993, JAMA-J AM MED ASSOC, V270, P2940, DOI 10.1001/jama.270.24.2940; *INT AG RES CANC, 1991, IARC MON EV CARC RIS, V51, P41; Klebanoff MA, 1999, NEW ENGL J MED, V341, P1639, DOI 10.1056/NEJM199911253412202; KLINE J, 1995, AM J EPIDEMIOL, V141, P417, DOI 10.1093/oxfordjournals.aje.a117444; KLINE J, 1991, EPIDEMIOLOGY, V2, P409, DOI 10.1097/00001648-199111000-00004; Knutti R, 1982, Arch Toxicol Suppl, V5, P187; MILLS JL, 1993, JAMA-J AM MED ASSOC, V269, P593, DOI 10.1001/jama.269.5.593; Ness RB, 1999, NEW ENGL J MED, V340, P333, DOI 10.1056/NEJM199902043400501; OLSSON P, 1991, ADV PHAR SC, P57; Parazzini F, 1998, HUM REPROD, V13, P2286, DOI 10.1093/humrep/13.8.2286; Peacock JL, 1998, INT J EPIDEMIOL, V27, P647, DOI 10.1093/ije/27.4.647; SRISUPHAN W, 1986, AM J OBSTET GYNECOL, V154, P14, DOI 10.1016/0002-9378(86)90385-6; Stanton CK, 1995, AM J EPIDEMIOL, V142, P1322, DOI 10.1093/oxfordjournals.aje.a117600; STEIN H, 1991, ANN ONCOL, V2, P163, DOI 10.1093/annonc/2.suppl_2.163; Vlajinac HD, 1997, AM J EPIDEMIOL, V145, P335, DOI 10.1093/oxfordjournals.aje.a009110; WEATHERSBEE PS, 1977, J REPROD MED, V19, P55	29	164	170	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2000	343	25					1839	1845		10.1056/NEJM200012213432503	http://dx.doi.org/10.1056/NEJM200012213432503			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384KB	11117975				2022-12-24	WOS:000165940400003
J	Griffin, TM; Kram, R				Griffin, TM; Kram, R			Biomechanics - Penguin waddling is not wasteful	NATURE			English	Article							LOCOMOTION; ENERGETICS; FORCE; SPEED; COST		Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Colorado, Dept Kinesiol & Appl Physiol, Boulder, CO 80309 USA	University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder	Griffin, TM (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	tmgriff@uclink4.berkeley.edu	Griffin, Timothy M./V-8838-2019	Griffin, Timothy M./0000-0001-8840-9940				CAVAGNA GA, 1975, J APPL PHYSIOL, V39, P174, DOI 10.1152/jappl.1975.39.1.174; CAVAGNA GA, 1963, J APPL PHYSIOL, V18, P1, DOI 10.1152/jappl.1963.18.1.1; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; DEWASMES G, 1980, J APPL PHYSIOL, V49, P888, DOI 10.1152/jappl.1980.49.5.888; Farley CT, 1997, J EXP BIOL, V200, P2177; Gatesy SM, 1999, J MORPHOL, V240, P115, DOI 10.1002/(SICI)1097-4687(199905)240:2<115::AID-JMOR3>3.0.CO;2-Y; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; PINSHOW B, 1977, SCIENCE, V195, P592, DOI 10.1126/science.835018; Rall J A, 1985, Exerc Sport Sci Rev, V13, P33; Roberts TJ, 1998, J EXP BIOL, V201, P2745	11	92	92	29	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2000	408	6815					929	929		10.1038/35050167	http://dx.doi.org/10.1038/35050167			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140670	Bronze			2022-12-24	WOS:000165951100036
J	Morgan, D; Diamond, DM; Gottschall, PE; Ugen, KE; Dickey, C; Hardy, J; Duff, K; Jantzen, P; DiCarlo, G; Wilcock, D; Connor, K; Hatcher, J; Hope, C; Gordon, M; Arendash, GW				Morgan, D; Diamond, DM; Gottschall, PE; Ugen, KE; Dickey, C; Hardy, J; Duff, K; Jantzen, P; DiCarlo, G; Wilcock, D; Connor, K; Hatcher, J; Hope, C; Gordon, M; Arendash, GW			A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; PRESENILIN-1 TRANSGENES; MUTANT PRESENILIN-1; PHENOTYPE; PATHOLOGY; PLAQUES	Vaccinations with amyloid-beta peptide (AB) can dramatically reduce amyloid deposition in a transgenic mouse model of Alzheimer's disease(1). To determine if the vaccinations had deleterious or beneficial functional consequences, we tested eight months of A beta vaccination in a different transgenic model for Alzheimer's disease in which mice develop learning deficits as amyloid accumulates(2,3). Here we show that vaccination with A beta protects transgenic mice from the learning and age-related memory deficits that normally occur in this mouse model for Alzheimer's disease. During testing for potential deleterious effects of the vaccine, all mice performed superbly on the radial-arm water-maze test of working memory. Later, at an age when untreated transgenic mice show memory deficits, the A beta -vaccinated transgenic mice showed cognitive performance superior to that of the control transgenic mice and, ultimately, performed as well as nontransgenic mice. The A beta -vaccinated mice also had a partial reduction in amyloid burden at the end of the study. This therapeutic approach may thus prevent and, possibly, treat Alzheimer's dementia.	Univ S Florida, Dept Pharmacol, Alzheimer Res Lab, Tampa, FL 33612 USA; Univ S Florida, Dept Psychol, Tampa, FL 33612 USA; Univ S Florida, Dept Med Microbiol & Immunol, Tampa, FL 33612 USA; Univ S Florida, Dept Biol, Alzheimer Res Lab, Tampa, FL 33612 USA; James A Haley Vet Adm Med Ctr, Tampa, FL 33612 USA; Mayo Clin Jacksonville, Dept Pharmacol, Jacksonville, FL 32224 USA; Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; Mayo Clinic; Nathan Kline Institute for Psychiatric Research	Morgan, D (corresponding author), Univ S Florida, Dept Pharmacol, Alzheimer Res Lab, Tampa, FL 33612 USA.		Gordon, Marcia N. N/K-2420-2012; Morgan, David G/J-5989-2012; Dickey, Chad A/H-4441-2011; Hardy, John/C-2451-2009; Duff, Karen EK/C-2510-2009; Wilcock, Donna M/J-7517-2016; Ugen, Kenneth E/H-6544-2011	Gordon, Marcia N. N/0000-0002-4051-9283; Hardy, John/0000-0002-3122-0423; Duff, Karen/0000-0002-6177-868X	NATIONAL INSTITUTE ON AGING [ZIAAG000950, Z01AG000950] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ARENDASH GW, IN PRESS BRAIN RES; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Frautschy SA, 1998, AM J PATHOL, V152, P307; Frenkel D, 2000, J NEUROIMMUNOL, V106, P23, DOI 10.1016/S0165-5728(99)00232-5; Gordon MN, 1997, J COMP NEUROL, V388, P106; GORDON MN, IN PRESS NEUROBIOL A; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Masliah E, 1996, J NEUROSCI, V16, P5795; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; McGowan E, 1999, NEUROBIOL DIS, V6, P231, DOI 10.1006/nbdi.1999.0243; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N	19	1290	1450	1	142	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					982	985		10.1038/35050116	http://dx.doi.org/10.1038/35050116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140686				2022-12-24	WOS:000165951100052
J	Sorensen, HT; Mellemkjaer, L; Olsen, JH; Baron, JA				Sorensen, HT; Mellemkjaer, L; Olsen, JH; Baron, JA			Prognosis of cancers associated with venous thromboembolism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; CLINICAL COURSE; MALIGNANCY; DIAGNOSIS; WARFARIN; RISK; LUNG	Background: Little is known about the prognosis of cancer discovered during or after an episode of venous thromboembolism. Methods: We linked the Danish National Registry of Patients, the Danish Cancer Registry, and the Danish Mortality Files to obtain data on the survival of patients who received a diagnosis of cancer at the same time as or after an episode of venous thromboembolism. Their survival was compared with that of patients with cancer who did not have venous thromboembolism (control patients), who were matched in terms of type of cancer, age, sex, and year of diagnosis. Results: Of 668 patients who had cancer at the time of an episode of deep venous thromboembolism, 44.0 percent of those with data on the spread of disease (563 patients) had distant metastasis, as compared with 35.1 percent of 5371 control patients with data on spread (prevalence ratio, 1.26; 95 percent confidence interval, 1.13 to 1.40). In the group with cancer at the time of venous thromboembolism, the one-year survival rate was 12 percent, as compared with 36 percent in the control group (P<0.001), and the mortality ratio for the entire follow-up period was 2.20 (95 percent confidence interval, 2.05 to 2.40). Patients in whom cancer was diagnosed within one year after an episode of venous thromboembolism had a slightly increased risk of distant metastasis at the time of the diagnosis (prevalence ratio, 1.23 [95 percent confidence interval, 1.08 to 1.40]) and a relatively low rate of survival at one year (38 percent, vs. 47 percent in the control group; P<0.001). Conclusions: Cancer diagnosed at the same time as or within one year after an episode of venous thromboembolism is associated with an advanced stage of cancer and a poor prognosis. (N Engl J Med 2000;343:1846-50.) (C) 2000, Massachusetts Medical Society.	Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; Aarhus Univ Hosp, Dept Med 5, DK-8000 Aarhus, Denmark; Aalborg Hosp, Aarhus, Denmark; Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; Dartmouth Med Sch, Dept Med, Hanover, NH USA; Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA	Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Danish Cancer Society; Dartmouth College; Dartmouth College	Sorensen, HT (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Vennelyst Bldg 6,Bldg 260, DK-8000 Aarhus, Denmark.		Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Olsen, Jorgen Helge/0000-0001-9633-5662				Andersen TF, 1999, DAN MED BULL, V46, P263; Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016/S0140-6736(97)10018-6; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Cornuz J, 1996, ANN INTERN MED, V125, P785, DOI 10.7326/0003-4819-125-10-199611150-00001; Francis JL, 1998, SEMIN THROMB HEMOST, V24, P93, DOI 10.1055/s-2007-995829; GOLDBERG RJ, 1987, ARCH INTERN MED, V147, P251, DOI 10.1001/archinte.147.2.251; GREEN D, 1992, LANCET, V339, P1476, DOI 10.1016/0140-6736(92)92064-M; Hettiarachchi RJK, 1998, CANCER, V83, P180, DOI 10.1002/(SICI)1097-0142(19980701)83:1<180::AID-CNCR24>3.0.CO;2-S; Maurer LH, 1997, J CLIN ONCOL, V15, P3378, DOI 10.1200/JCO.1997.15.11.3378; MONREAL M, 1991, CANCER, V67, P541, DOI 10.1002/1097-0142(19910115)67:2<541::AID-CNCR2820670237>3.0.CO;2-J; *NAT BOARD HLTH, 1999, CANC INC DENM 1996; NORDSTROM M, 1994, BRIT MED J, V308, P891, DOI 10.1136/bmj.308.6933.891; Piccioli A, 1996, AM HEART J, V132, P850, DOI 10.1016/S0002-8703(96)90321-X; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Schulman S, 2000, NEW ENGL J MED, V342, P1953, DOI 10.1056/NEJM200006293422604; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; Storm HH, 1997, DAN MED BULL, V44, P535; *SUNDH, 1976, KLASS SYGD; TROUSSEAU A, 1977, LECT CLIN MED, P281; ZACHARSKI LR, 1981, JAMA-J AM MED ASSOC, V245, P831, DOI 10.1001/jama.245.8.831; ZACHARSKI LR, 1992, SEMIN THROMB HEMOST, V18, P104, DOI 10.1055/s-2007-1002415	22	1147	1198	2	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 21	2000	343	25					1846	1850		10.1056/NEJM200012213432504	http://dx.doi.org/10.1056/NEJM200012213432504			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384KB	11117976				2022-12-24	WOS:000165940400004
J	Zhang, MS; Barash, S				Zhang, MS; Barash, S			Neuronal switching of sensorimotor transformations for antisaccades	NATURE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; SACCADE-RELATED ACTIVITY; SUPERIOR COLLICULUS; TASK; RESPONSES; MACAQUE; MONKEY	The influence of cognitive context on orienting behaviour can be explored using the mixed memory-prosaccade, memory-antisaccade task. A symbolic cue, such as the colour of a visual stimulus, instructs the subject to make a brief, rapid eye movement (a saccade) either towards the stimulus (prosaccade) or in the opposite direction (antisaccade)(1-3). Thus, the appropriate sensorimotor transformation must be switched on to execute the instructed task. Despite advances in our understanding of the neuronal processing of antisaccades(4-8), it remains unclear how the brain selects and computes the sensorimotor transformation leading to an antisaccade. Here we show that area LIP of the posterior parietal cortex is involved in these processes. LIP's population activity turns from the visual direction to the motor direction during memory-antisaccade trials. About one-third of the visual neurons in LIP produce a brisk, transient discharge in certain memory-antisaccade trials. We call this discharge 'paradoxical' because its timing is visual-like but its direction is motor. The paradoxical discharge shows, first, that switching occurs already at the level of visual cells, as previously proposed by Schlag-Rey and colleagues(5); and second, that this switching is accomplished very rapidly, within 50 ms from the arrival of the visual signals in LIP.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Barash, S (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.							Amador N, 1998, J NEUROPHYSIOL, V80, P1775, DOI 10.1152/jn.1998.80.4.1775; Andersen RA, 1987, HDB PHYSL 1, VV, P483; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Barash S, 1998, J NEUROPHYSIOL, V79, P2766, DOI 10.1152/jn.1998.79.5.2766; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLBY CL, 1988, J COMP NEUROL, V269, P392, DOI 10.1002/cne.902690307; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 1998, EXP BRAIN RES, V118, P27, DOI 10.1007/s002210050252; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Grunewald A, 1999, J NEUROPHYSIOL, V82, P330, DOI 10.1152/jn.1999.82.1.330; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713	24	198	200	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					971	975		10.1038/35050097	http://dx.doi.org/10.1038/35050097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140683				2022-12-24	WOS:000165951100049
J	von Gunten, CF; Ferris, FD; Emanuel, LL				von Gunten, CF; Ferris, FD; Emanuel, LL			Ensuring competency in end-of-life care - Communication and relational skills	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN-ASSISTED SUICIDE; ADVANCE DIRECTIVES; EUTHANASIA; DEATH; ATTITUDES; FUTILITY; REQUESTS	Physician competence in end-of-life care requires skill in communication, decision making, and building relationships, yet these skills were not taught to the majority of physicians during their training. This article presents a 7-step approach for physicians for structuring communication regarding care at the end of life. Physicians should prepare for discussions by confirming medical facts and establishing an appropriate environment; establish what the patient (and family) knows by using open-ended questions; determine how information is to be handled at the beginning of the patient-physician relationship; deliver the information in a sensitive but straightforward manner; respond to emotions of the patients, parents, and families; establish goals for care and treatment priorities when possible; and establish an overall plan. These 7 steps can be used in situations such as breaking bad news, setting treatment goals, advance care planning, withholding or withdrawing therapy, making decisions in sudden life-threatening illness, resolving conflict around medical futility, responding to a request for physician-assisted suicide, and guiding patients and families through the last hours of living and early stages after death. Effective application as part of core end-of-life care competencies is likely to improve patients' and families' experiences of care. It may also enhance physicians' professional fulfillment from satisfactory relationships with their patients and patients' families.	Northwestern Univ, Sch Med, Interdisciplinary Program Professionalism & Human, EPEC Project, Chicago, IL 60611 USA; San Diego Hospice, Ctr Palliat Studies, San Diego, CA USA	Northwestern University	Emanuel, LL (corresponding author), Northwestern Univ, Sch Med, Interdisciplinary Program Professionalism & Human, EPEC Project, 750 N Lake Shore Dr,Suite 601, Chicago, IL 60611 USA.	lemanuel@epec.net						[Anonymous], 1989, Ann Intern Med, V110, P734; [Anonymous], 1991, JAMA, V265, P1868; *ASP REF GROUP, 1999, PALL CAR PAT FAM COU; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BREITBART W, 1998, TXB PSYCHOONCOLOGY, P437; Buckman R, 1992, BREAK BAD NEWS GUIDE, P65, DOI 10.3138/9781487596989; CASSEM NH, 1976, ACUTE GRIEF FUNERAL; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; CHOCHINOV HM, 1998, PSYCHO-ONCOLOGY, P1016; *COUN ETH JUD AFF, 1998, COUNC ETH JUD AFF RE, P41; *COUNC ETH JUD AFF, 1998, COUNC ETH JUD AFF RE, P46; *COUNC ETH JUD AFF, 1998, COUNC ETH JUD AFF RE, P30; *COUNC ETH JUD AFF, 1998, REP END LIF CAR, P52; COUSINS N, 1985, NEW ENGL J MED, V313, P1422, DOI 10.1056/NEJM198511283132227; Doyle D., 1998, OXFORD TXB PALLIATIV, P957; ELLERSHAW JE, 1995, J PAIN SYMPTOM MANAG, V10, P192, DOI 10.1016/0885-3924(94)00123-3; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; EMANUEL L, 1993, J CLIN ETHIC, V4, P8; Emanuel L. L., 1998, REGULATING WE DIE ET; Emanuel LL, 1998, JAMA-J AM MED ASSOC, V280, P643, DOI 10.1001/jama.280.7.643; EMANUEL LL, 1995, J AM GERIATR SOC, V43, P440, DOI 10.1111/j.1532-5415.1995.tb05821.x; EMANUEL LL, 2000, EPEC CURRICULUM ED P; Emanuel LL, 1998, PRINCIPLES PRACTICE, P791; Evans Alison, 1994, Palliative Medicine, V8, P159, DOI 10.1177/026921639400800211; Field MJ, 1997, APPROACHING DEATH IM; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; GUTHEIL TG, 1984, NEW ENGL J MED, V311, P49, DOI 10.1056/NEJM198407053110110; Halevy A, 1996, JAMA-J AM MED ASSOC, V276, P571, DOI 10.1001/jama.276.7.571; HINOHARA S, 1993, ANN INTERN MED, V118, P638, DOI 10.7326/0003-4819-118-8-199304150-00012; *HOSP I FLOR SUNC, 1996, CAR TIM DEATH HOSP R; *HOSP I FLOR SUNC, 1996, GRIEF BER HOSP TRAIN; HUDSON T, 1994, HOSP HEALTH NETWORK, V68, P26; HUDSON T, 1994, HOSP HEALTH NETWORK, V68, P32; IRVINE P, 1985, NEW ENGL J MED, V312, P1704, DOI 10.1056/NEJM198506273122608; Janson L J, 1991, J Palliat Care, V7, P51; Laine C, 1996, ANN INTERN MED, V125, P640, DOI 10.7326/0003-4819-125-8-199610150-00003; MARTINEZ J, 1997, CANC NURSING PRINCIP; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; MORRISON RS, 1995, JAMA-J AM MED ASSOC, V274, P478, DOI 10.1001/jama.274.6.478; O'Gorman SM, 1998, J ADV NURS, V27, P1127, DOI 10.1046/j.1365-2648.1998.00659.x; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2229; PEARLMAN R, 1992, YOUR LIFE YOUR CHOIC; Ptacek JT, 1996, JAMA-J AM MED ASSOC, V276, P496; Quill TE, 1998, ANN INTERN MED, V128, P552, DOI 10.7326/0003-4819-128-7-199804010-00006; ROY DJ, 1998, OXFORD TXB PALLIATIV, P112; SHELDON F, 1993, MANAGEMENT TERMINAL, P29; TENO JM, 1994, J AM GERIATR SOC, V42, P1202, DOI 10.1111/j.1532-5415.1994.tb06990.x; Teno JM, 1996, J CLIN ETHIC, V7, P205; The Council for Environmental Education, 1998, COUNCIL ENV ED AGEND, P1; TODRES ID, 1994, PEDIATR CLIN N AM, V41, P1395; TOMLINSON T, 1988, NEW ENGL J MED, V318, P43, DOI 10.1056/NEJM198801073180109; TRUOG RD, 1992, NEW ENGL J MED, V326, P1560, DOI 10.1056/NEJM199206043262310; TULSKY JA, 1995, J GEN INTERN MED, V10, P436, DOI 10.1007/BF02599915; *U TOR JOINT CTR B, 1999, JOINT CTR BIOETH CAN; VACHON MLS, 1982, AM J PSYCHIAT, V139, P998; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; vanderWal G, 1996, NEW ENGL J MED, V335, P1706; Vincent JL, 1998, INTENS CARE MED, V24, P1251, DOI 10.1007/s001340050758; von Gunten C F, 2000, J Palliat Med, V3, P157, DOI 10.1089/10966210050085223; Weber M, 1998, J PALLIATIVE CARE, V14, P34, DOI 10.1177/082585979801400406; Yancey D, 1990, J Palliat Care, V6, P24; YOUNGNER SJ, 1994, J AM GERIATR SOC, V42, P887, DOI 10.1111/j.1532-5415.1994.tb06565.x	62	166	167	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2000	284	23					3051	3057		10.1001/jama.284.23.3051	http://dx.doi.org/10.1001/jama.284.23.3051			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	382VC	11122596	Bronze			2022-12-24	WOS:000165847200034
J	Grodstein, F; Manson, JE; Colditz, GA; Willett, WC; Speizer, FE; Stampfer, MJ				Grodstein, F; Manson, JE; Colditz, GA; Willett, WC; Speizer, FE; Stampfer, MJ			A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; ESTROGEN REPLACEMENT THERAPY; MYOCARDIAL-INFARCTION; FOLLOW-UP; RISK; STROKE; USERS; PROGESTIN; WOMEN	Background: Most primary prevention studies have found that long-term users of postmenopausal hormone therapy are at lower risk for coronary events, but numerous questions remain. An adverse influence of hormone therapy on cardiovascular risk has been suggested during the initial year of use; however, few data are available on short-term hormone therapy. In addition, the cardiovascular effects of daily doses of oral conjugated estrogen lower than 0.625 mg are unknown, and few studies have examined estrogen plus progestin in this regard. Objective: To investigate duration, dose, and type of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Design: Prospective, observational cohort study. Setting: Nurses' Health Study, with follow-up from 1976 to 1996. Patients: 70 533 postmenopausal women, in whom 1258 major coronary events (nonfatal myocardial infarction or fatal coronary disease) and 767 strokes were identified. Measurements: Details of postmenopausal hormone use were ascertained by using biennial questionnaires. Cardiovascular disease was established by using a questionnaire and was confirmed by medical record review. Logistic regression models were used to calculate relative risks and 95% Cls, adjusted for confounders. Results: When all cardiovascular risk factors were considered, the risk for major coronary events was lower among current users of hormone therapy, including short-term users, compared with never-users (relative risk, 0.61 [95% CI, 0.52 to 0.71]). Among women taking oral conjugated estrogen, the risk for coronary events was similarly reduced in those currently taking 0.625 mg daily (relative risk, 0.54 [CI, 0.44 to 0.67]) and those taking 0.3 mg daily (relative risk, 0.58 [CI, 0.37 to 0.92]) compared with never-users. However, the risk for stroke was statistically significantly increased among women taking 0.625 mg or more of oral conjugated estrogen daily (relative risk, 1.35 [CI, 1.08 to 1.68] for 0.625 mg/d and 1.63 [CI, 1.18 to 2.26] for greater than or equal to1.25 mg/d) and those taking estrogen plus progestin (relative risk, 1.45 [CI, 1.10 to 1.92]). Overall, little relation was observed between combination hormone therapy and risk for cardiovascular disease (major coronary heart disease plus stroke) (relative risk, 0.91 [CI, 0.75 to 1.11]). Conclusions: Postmenopausal hormone use appears to decrease risk for major coronary events in women without previous heart disease. Furthermore, 0.3 mg of oral conjugated estrogen daily is associated with a reduction similar to that seen with the standard dose of 0.625 mg. However, estrogen at daily doses of 0.625 mg or greater and in combination with progestin may increase risk for stroke.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Grodstein, F (corresponding author), Channing Labs, 181 Longwood Ave, Boston, MA 02115 USA.		Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NCI NIH HHS [CA40356] Funding Source: Medline; NHLBI NIH HHS [HL34594] Funding Source: Medline; NIA NIH HHS [AG13482] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040356, R37CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG013482] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; BOURNE T, 1990, LANCET, V335, P1470, DOI 10.1016/0140-6736(90)91505-5; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; FALKEBORN M, 1993, ARCH INTERN MED, V153, P1201, DOI 10.1001/archinte.153.10.1201; GANGAR KF, 1996, EUR MENOPAUSE J, V3, P147; Genant HK, 1997, ARCH INTERN MED, V157, P2609, DOI 10.1001/archinte.157.22.2609; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P199, DOI 10.1016/S0033-0620(95)80012-3; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; GRODSTEIN F, 2000, CIRCULATION S, V100, P18; Heckbert SR, 1997, ARCH INTERN MED, V157, P1330, DOI 10.1001/archinte.157.12.1330; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; HERNANDEZ AM, 1990, EPIDEMIOLOGY, V1, P128; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jick H, 1996, LANCET, V348, P981, DOI 10.1016/S0140-6736(96)07114-0; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; PAGANINIHILL A, 1988, BMJ-BRIT MED J, V297, P519, DOI 10.1136/bmj.297.6647.519; Pedersen AT, 1997, LANCET, V350, P1277, DOI 10.1016/S0140-6736(97)06005-4; Petitti DB, 1998, STROKE, V29, P23, DOI 10.1161/01.STR.29.1.23; PFEFFER RI, 1978, J CHRON DIS, V31, P389, DOI 10.1016/0021-9681(78)90003-6; ROSENBERG L, 1980, JAMA-J AM MED ASSOC, V244, P339, DOI 10.1001/jama.244.4.339; Rothman K, 1979, NIH PUBL; Rothman K, 1986, MODERN EPIDEMIOLOGY; SACK MN, 1994, LANCET, V343, P269, DOI 10.1016/S0140-6736(94)91117-7; SARREL PM, 1992, AM J OBSTET GYNECOL, V167, P467, DOI 10.1016/S0002-9378(11)91431-8; Sidney S, 1997, ANN INTERN MED, V127, P501, DOI 10.7326/0003-4819-127-7-199710010-00001; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Walker AE, 1981, STROKE S1, V12, P13; *WHO, 1971, IHD REGISTER REPORT; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598	37	760	789	2	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2000	133	12					933	941		10.7326/0003-4819-133-12-200012190-00008	http://dx.doi.org/10.7326/0003-4819-133-12-200012190-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384NT	11119394				2022-12-24	WOS:000165952300001
J	Kronzon, I				Kronzon, I			The department of card tricks and close magic	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NYU Med Ctr, New York, NY 10016 USA	New York University	Kronzon, I (corresponding author), NYU Med Ctr, 560 1st Ave, New York, NY 10016 USA.	Itzhak.Kronzon@med.nyu.edu							0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2000	133	12					1005	1007		10.7326/0003-4819-133-12-200012190-00018	http://dx.doi.org/10.7326/0003-4819-133-12-200012190-00018			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384NT	11119404				2022-12-24	WOS:000165952300011
J	Rollins, G				Rollins, G			Developments in cervical and ovarian cancer screening: Implications for current practice	ANNALS OF INTERNAL MEDICINE			English	Article																			0	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2000	133	12					1021	1024		10.7326/0003-4819-133-12-200012190-00101	http://dx.doi.org/10.7326/0003-4819-133-12-200012190-00101			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384NT	11119415				2022-12-24	WOS:000165952300019
J	Kaul, S; Koo, HL; Jenkins, J; Rizzo, M; Rooney, T; Tallon, LJ; Feldblyum, T; Nierman, W; Benito, MI; Lin, XY; Town, CD; Venter, JC; Fraser, CM; Tabata, S; Nakamura, Y; Kaneko, T; Sato, S; Asamizu, E; Kato, T; Kotani, H; Sasamoto, S; Ecker, JR; Theologis, A; Federspiel, NA; Palm, CJ; Osborne, BI; Shinn, P; Conway, AB; Vysotskaia, VS; Dewar, K; Conn, L; Lenz, CA; Kim, CJ; Hansen, NF; Liu, SX; Buehler, E; Altafi, H; Sakano, H; Dunn, P; Lam, B; Pham, PK; Chao, Q; Nguyen, M; Yu, GX; Chen, HM; Southwick, A; Lee, JM; Miranda, M; Toriumi, MJ; Davis, RW; Wambutt, R; Murphy, G; Dusterhoft, A; Stiekema, W; Pohl, T; Entian, KD; Terryn, N; Volckaert, G; Salanoubat, M; Choisne, N; Rieger, M; Ansorge, W; Unseld, M; Fartmann, B; Valle, G; Artiguenave, F; Weissenbach, J; Quetier, F; Wilson, RK; de la Bastide, M; Sekhon, M; Huang, E; Spiegel, L; Gnoj, L; Pepin, K; Murray, J; Johnson, D; Habermann, K; Dedhia, N; Parnell, L; Preston, R; Hillier, L; Chen, E; Marra, M; Martienssen, R; McCombie, WR; Mayer, K; White, O; Bevan, M; Lemcke, K; Creasy, TH; Bielke, C; Haas, B; Haase, D; Maiti, R; Rudd, S; Peterson, J; Schoof, H; Frishman, D; Morgenstern, B; Zaccaria, P; Ermolaeva, M; Pertea, M; Quackenbush, J; Volfovsky, N; Wu, DY; Lowe, TM; Salzberg, SL; Mewes, HW; Rounsley, S; Bush, D; Subramaniam, S; Levin, I; Norris, S; Schmidt, R; Acarkan, A; Bancroft, I; Quetier, F; Brennicke, A; Eisen, JA; Bureau, T; Legault, BA; Le, QH; Agrawal, N; Yu, Z; Martienssen, R; Copenhaver, GP; Luo, S; Pikaard, CS; Preuss, D; Paulsen, IT; Sussman, M; Britt, AB; Selinger, DA; Pandey, R; Mount, DW; Chandler, VL; Jorgensen, RA; Pikaard, C; Juergens, G; Meyerowitz, EM; Theologis, A; Dangl, J; Jones, JDG; Chen, M; Chory, J; Somerville, MC				Kaul, S; Koo, HL; Jenkins, J; Rizzo, M; Rooney, T; Tallon, LJ; Feldblyum, T; Nierman, W; Benito, MI; Lin, XY; Town, CD; Venter, JC; Fraser, CM; Tabata, S; Nakamura, Y; Kaneko, T; Sato, S; Asamizu, E; Kato, T; Kotani, H; Sasamoto, S; Ecker, JR; Theologis, A; Federspiel, NA; Palm, CJ; Osborne, BI; Shinn, P; Conway, AB; Vysotskaia, VS; Dewar, K; Conn, L; Lenz, CA; Kim, CJ; Hansen, NF; Liu, SX; Buehler, E; Altafi, H; Sakano, H; Dunn, P; Lam, B; Pham, PK; Chao, Q; Nguyen, M; Yu, GX; Chen, HM; Southwick, A; Lee, JM; Miranda, M; Toriumi, MJ; Davis, RW; Wambutt, R; Murphy, G; Dusterhoft, A; Stiekema, W; Pohl, T; Entian, KD; Terryn, N; Volckaert, G; Salanoubat, M; Choisne, N; Rieger, M; Ansorge, W; Unseld, M; Fartmann, B; Valle, G; Artiguenave, F; Weissenbach, J; Quetier, F; Wilson, RK; de la Bastide, M; Sekhon, M; Huang, E; Spiegel, L; Gnoj, L; Pepin, K; Murray, J; Johnson, D; Habermann, K; Dedhia, N; Parnell, L; Preston, R; Hillier, L; Chen, E; Marra, M; Martienssen, R; McCombie, WR; Mayer, K; White, O; Bevan, M; Lemcke, K; Creasy, TH; Bielke, C; Haas, B; Haase, D; Maiti, R; Rudd, S; Peterson, J; Schoof, H; Frishman, D; Morgenstern, B; Zaccaria, P; Ermolaeva, M; Pertea, M; Quackenbush, J; Volfovsky, N; Wu, DY; Lowe, TM; Salzberg, SL; Mewes, HW; Rounsley, S; Bush, D; Subramaniam, S; Levin, I; Norris, S; Schmidt, R; Acarkan, A; Bancroft, I; Quetier, F; Brennicke, A; Eisen, JA; Bureau, T; Legault, BA; Le, QH; Agrawal, N; Yu, Z; Martienssen, R; Copenhaver, GP; Luo, S; Pikaard, CS; Preuss, D; Paulsen, IT; Sussman, M; Britt, AB; Selinger, DA; Pandey, R; Mount, DW; Chandler, VL; Jorgensen, RA; Pikaard, C; Juergens, G; Meyerowitz, EM; Theologis, A; Dangl, J; Jones, JDG; Chen, M; Chory, J; Somerville, MC		Ar Gen In	Analysis of the genome sequence of the flowering plant Arabidopsis thaliana	NATURE			English	Review							PRE-MESSENGER-RNA; SIGNAL-TRANSDUCTION; DNA; REGIONS; GENES; PROTEINS; LIGHT; MAIZE; PREDICTION; DIVERGENCE	The flowering plant Arabidopsis thaliana is an important model system for identifying genes and determining their functions. Here we report the analysis of the genomic sequence of Arabidopsis. The sequenced regions cover 115.4 megabases of the 125-megabase genome and extend into centromeric regions. The evolution of Arabidopsis involved a whole-genome duplication, followed by subsequent gene loss and extensive local gene duplications, giving rise to a dynamic genome enriched by lateral gene transfer from a cyanobacterial-like ancestor of the plastid. The genome contains 25,498 genes encoding proteins from 11,000 families, similar to the functional diversity of Drosophila and Caenorhabditis elegans - the other sequenced multicellular eukaryotes. Arabidopsis has many families of new proteins but also lacks several common protein families, indicating that the sets of common proteins have undergone differential expansion and contraction in the three multicellular eukaryotes. This is the first complete genome sequence of a plant and provides the foundations for more comprehensive comparison of conserved processes in all eukaryotes, identifying a wide range of plant-specific gene functions and establishing rapid systematic ways to identify genes for crop improvement.	Inst Genom Res, Rockville, MD 20850 USA; Kazusa DNA Res Inst, Kisarazu, Chiba 292, Japan; Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA; Univ Calif Berkeley, USDA, Ctr Plant Gene Express, Albany, CA 94710 USA; Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Exelixis Inc, San Francisco, CA 94083 USA; AGOWA Gmbh, D-12489 Berlin, Germany; John Innes Ctr, Norwich NR4 7UH, Norfolk, England; QIAGEN Gmbh, D-40724 Hilden, Germany; Plant Res Int, Greenomics, NL-6700 AA Wageningen, Netherlands; GATC Gmbh, D-78467 Constance, Germany; SRD Gmbh, D-61440 Oberursel, Germany; Univ Ghent VIB, Dept Plant Genet, B-9000 Ghent, Belgium; Katholieke Univ Leuven, Lab Gene Technol, B-3001 Leuven, Belgium; Genoscope & CNRS FRE2231, F-91057 Evry, France; Genotype Gmbh, D-69259 Wilhemlsfeld, Germany; European Mol Biol Lab, Biochem Instrumentat Program, D-69117 Heidelberg, Germany; LION Biosci AG, D-69120 Heidelberg, Germany; MWG Biotech AG, D-69117 Ebersberg, Germany; Univ Padua, CRIBI, I-35131 Padua, Italy; Washington Univ, St Louis Sch Med, Washington Univ Genome Sequencing Ctr, St Louis, MO 63108 USA; Cold Spring Harbor Lab, Lita Annenberg Hazen Genome Ctr, Cold Spring Harbor, NY 11724 USA; Celera Genomics, Foster City, CA 94494 USA; Cold Spring Harbor Lab, Plant Biol Grp, Cold Spring Harbor, NY 11724 USA; Max Planck Inst Biochem, GSF Forschungszentrum Umwelt & Gesundheit, Munich Informat Ctr Protein Sequences, D-82152 Munich, Germany; Inst Genomic Res, Rockville, MD 20850 USA; John Innes Ctr, Molec Genet Dept, Norwich NR4 7UH, Norfolk, England; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Cereon Genomics LLC, Cambridge, MA 02139 USA; Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany; John Innes Ctr, Brassicas & Oilseeds Res Dept, Norwich NR4 7UJ, England; Ctr Natl Sequencage, Genoscope, F-91057 Evry, France; Univ Ulm, Molek Bot, D-89069 Ulm, Germany; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; Univ Chicago, Howard Hughes Med Inst, Chicago, IL USA; Washington Univ, Biol Dept, St Louis, MO 63130 USA; Univ Wisconsin, Biotechnol Ctr, Madison, WI 53706 USA; Univ Calif Davis, Sect Plant Biol, Davis, CA 95616 USA; Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; Univ Arizona, Dept Molec & Cell Biol, Tucson, AZ 85721 USA; ZMBP, Ctr Plant Molec Biol, Entwicklungsgenet, D-72076 Tubingen, Germany; Calif Inst Biol, Div Biol, Pasadena, CA 91125 USA; Univ N Carolina, Dept Biol, Coker Hall, Chapel Hill, NC 27599 USA; John Innes Ctr, Sainsbury Lab, Norwich NR4 7UI, Norfolk, England; Salk Inst Biol Studies, Howard Hughes Med Inst, Plant Biol Lab, La Jolla, CA 92037 USA; Carnegie Inst, Stanford, CA 94305 USA	J. Craig Venter Institute; Kazusa DNA Research Institute; University of Pennsylvania; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; Stanford University; Salk Institute; Exelixis, Inc.; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; QIAGEN GmbH; Flanders Institute for Biotechnology (VIB); Ghent University; KU Leuven; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); University of Padua; Saint Louis University; Washington University (WUSTL); Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; J. Craig Venter Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Stanford University; Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Ulm University; McGill University; Howard Hughes Medical Institute; University of Chicago; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of Arizona; University of Arizona; Eberhard Karls University of Tubingen; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; Salk Institute; Carnegie Institution for Science		genomeanalysis@tigr.org	Copenhaver, Gregory/AFL-9831-2022; Eisen, Jonathan A./H-2706-2019; Salzberg, Steven/Q-6514-2019; Rudd, Stephen A/A-6434-2013; Salzberg, Steven L/F-6162-2011; Copenhaver, Gregory/AAH-2031-2022; Paulsen, Ian T/K-3832-2012; Frishman, Dmitrij/AAT-7815-2020; Jones, Jonathan DG/J-5129-2012; Sato, Shusei/A-3616-2015; Somerville, Christopher R/A-4048-2009; Copenhaver, Gregory P/A-7549-2014; Entian, Karl-Dieter/D-3080-2011; Nakamura, Yasukazu/T-9038-2019; Wilson, Richard K./AAF-4139-2019; Pikaard, Craig S/K-8772-2012; Ecker, Joseph R/B-9144-2008; Meyerowitz, Elliot M/A-7118-2009; Chen, Meng/C-7109-2014; Pertea, Mihaela/AAT-2705-2021; Marra, Marco A/B-5987-2008; Lowe, Todd Michael/ABJ-5261-2022; Bancroft, Ian/AAH-3831-2020; Ansorge, Wilhelm/AAN-8780-2020; Schoof, Heiko/Y-7073-2018; Morgenstern, Burkhard/A-7486-2008; Mayer, Klaus FX/M-7941-2015	Copenhaver, Gregory/0000-0002-7962-3862; Eisen, Jonathan A./0000-0002-0159-2197; Salzberg, Steven/0000-0002-8859-7432; Rudd, Stephen A/0000-0002-0344-7487; Salzberg, Steven L/0000-0002-8859-7432; Copenhaver, Gregory/0000-0002-7962-3862; Paulsen, Ian T/0000-0001-9015-9418; Jones, Jonathan DG/0000-0002-4953-261X; Sato, Shusei/0000-0002-0293-5366; Somerville, Christopher R/0000-0003-4647-0094; Copenhaver, Gregory P/0000-0002-7962-3862; Wilson, Richard K./0000-0002-1992-1358; Pikaard, Craig S/0000-0001-8204-7459; Ecker, Joseph R/0000-0001-5799-5895; Chen, Meng/0000-0003-0351-5897; Pertea, Mihaela/0000-0003-0762-8637; Marra, Marco A/0000-0001-7146-7175; Schoof, Heiko/0000-0002-1527-3752; Morgenstern, Burkhard/0000-0002-7431-2862; Mayer, Klaus FX/0000-0001-6484-1077; Chen, Huaming/0000-0001-5289-7882				Acarkan A, 2000, PLANT J, V23, P55, DOI 10.1046/j.1365-313x.2000.00790.x; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALONSOBLANCO C, 1999, TRENDS PLANT SCI, V5, P1360; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; APWEILER R, 2000, 11 COLL COMP PROJ; Bassham DC, 2000, CURR OPIN CELL BIOL, V12, P491, DOI 10.1016/S0955-0674(00)00121-6; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; BENT AF, 1994, SCIENCE, V265, P1856, DOI 10.1126/science.8091210; Bent E, 1998, PLANT J, V13, P849, DOI 10.1046/j.1365-313X.1998.00082.x; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOWLER C, 1994, CELL, V77, P73, DOI 10.1016/0092-8674(94)90236-4; Brendel V, 1998, NUCLEIC ACIDS RES, V26, P4748, DOI 10.1093/nar/26.20.4748; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Britt AB, 1999, TRENDS PLANT SCI, V4, P20, DOI 10.1016/S1360-1385(98)01355-7; Buchanan BB., 2000, BIOCH MOL BIOL PLANT, P1367; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Canaday J, 2000, MICROSC RES TECHNIQ, V49, P487, DOI 10.1002/(SICI)1097-0029(20000601)49:5<487::AID-JEMT11>3.0.CO;2-I; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Carpita N, 1998, SCIENCE, V279, P672, DOI 10.1126/science.279.5351.672; Cavell AC, 1998, GENOME, V41, P62, DOI 10.1139/gen-41-1-62; CHOI S, 1995, WEEDS WORLD, V2, P17; Chory J, 2000, PLANT PHYSIOL, V123, P423, DOI 10.1104/pp.123.2.423; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Copenhaver GP, 1996, PLANT J, V9, P273, DOI 10.1046/j.1365-313X.1996.09020273.x; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; D'Agostino IB, 1999, TRENDS BIOCHEM SCI, V24, P452, DOI 10.1016/S0968-0004(99)01465-6; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; DANGL M, 1998, SCIENCE, V280, P1167; de Vries H, 1900, CR HEBD ACAD SCI, V130, P845; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; den Boer BGW, 2000, TRENDS CELL BIOL, V10, P245, DOI 10.1016/S0962-8924(00)01765-7; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; ELLIS J, 2000, TRENDS PLANT SCI, V3, P278; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; Feschotte C, 2000, MOL BIOL EVOL, V17, P730, DOI 10.1093/oxfordjournals.molbev.a026351; Fransz P, 1998, PLANT J, V13, P867, DOI 10.1046/j.1365-313X.1998.00086.x; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; FRISHMAN D, IN PRESS BIOINFORMAT; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; GOLBECK JH, 1992, ANNU REV PLANT PHYS, V43, P293, DOI 10.1146/annurev.pp.43.060192.001453; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Heese M, 1998, CURR OPIN PLANT BIOL, V1, P486, DOI 10.1016/S1369-5266(98)80040-X; Henikoff S, 1998, GENETICS, V149, P307; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Hung MS, 1999, P NATL ACAD SCI USA, V96, P11940, DOI 10.1073/pnas.96.21.11940; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kotani H, 1998, ANNU REV PLANT PHYS, V49, P151, DOI 10.1146/annurev.arplant.49.1.151; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LIU YG, 1995, PLANT J, V7, P351, DOI 10.1046/j.1365-313X.1995.7020351.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LUI YG, 1999, P NATL ACAD SCI USA, V96, P6535; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Makino S, 2000, PLANT CELL PHYSIOL, V41, P791, DOI 10.1093/pcp/41.6.791; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; Martienssen R, 1998, TRENDS GENET, V14, P263, DOI 10.1016/S0168-9525(98)01518-2; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; MAYER K, UNPUB GENOME RES; McCarty DR, 2000, CELL, V103, P201, DOI 10.1016/S0092-8674(00)00113-6; McCombie WR, 2000, CELL, V100, P377, DOI 10.1016/S0092-8674(00)80673-X; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Mekhedov S, 2000, PLANT PHYSIOL, V122, P389, DOI 10.1104/pp.122.2.389; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; MEYEROWITZ EM, 1999, TRENDS GENET, V15, pM65; MEYEROWITZ EM, 1994, ARABIDOPSIS; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Mozo T, 1998, MOL GEN GENET, V258, P562, DOI 10.1007/s004380050769; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Noel L, 1999, PLANT CELL, V11, P2099, DOI 10.1105/tpc.11.11.2099; O'Neill CM, 2000, PLANT J, V23, P233, DOI 10.1046/j.1365-313x.2000.00781.x; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; Pavy N, 1999, BIOINFORMATICS, V15, P887, DOI 10.1093/bioinformatics/15.11.887; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Quackenbush J, 2000, NUCLEIC ACIDS RES, V28, P141, DOI 10.1093/nar/28.1.141; RICHARDS EJ, 1988, CELL, V53, P127, DOI 10.1016/0092-8674(88)90494-1; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ryan CA, 1998, ANNU REV CELL DEV BI, V14, P1, DOI 10.1146/annurev.cellbio.14.1.1; Salanoubat M, 2000, NATURE, V408, P820, DOI 10.1038/35048706; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Sato S, 1997, DNA Res, V4, P215, DOI 10.1093/dnares/4.3.215; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; SINGER T, IN PRESS GENES DEV; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SLAYMAN CL, 1974, P NATL ACAD SCI USA, V71, P1935, DOI 10.1073/pnas.71.5.1935; SOMERVILLE CR, 1981, PLANT PHYSIOL, V67, P666, DOI 10.1104/pp.67.4.666; Stahl EA, 2000, CURR OPIN PLANT BIOL, V3, P299, DOI 10.1016/S1369-5266(00)00083-2; Stepanova AN, 2000, CURR OPIN PLANT BIOL, V3, P353, DOI 10.1016/S1369-5266(00)00096-0; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; TANKSLEY SD, 1992, GENETICS, V132, P1141; Theologis A, 2000, NATURE, V408, P816, DOI 10.1038/35048500; Torii KU, 2000, CURR OPIN PLANT BIOL, V3, P361, DOI 10.1016/S1369-5266(00)00097-2; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Urao T, 2000, TRENDS PLANT SCI, V5, P67, DOI 10.1016/S1360-1385(99)01542-3; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; van Dodeweerd AM, 1999, GENOME, V42, P887, DOI 10.1139/gen-42-5-887; WANG DYC, 1999, P ROY SOC LOND B BIO, V266, P63; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; YU Z, IN PRESS GENETICS; Zheng ZL, 2000, TRENDS PLANT SCI, V5, P298, DOI 10.1016/S1360-1385(00)01654-X	121	4699	4950	25	1076	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 14	2000	408	6814					796	815		10.1038/35048692	http://dx.doi.org/10.1038/35048692			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130711	Bronze			2022-12-24	WOS:000165831300037
J	Manzanares, M; Wada, H; Itasaki, N; Trainor, PA; Krumlauf, R; Holland, PWH				Manzanares, M; Wada, H; Itasaki, N; Trainor, PA; Krumlauf, R; Holland, PWH			Conservation and elaboration of Hox gene regulation during evolution of the vertebrate head	NATURE			English	Article							HOMEOBOX-CONTAINING GENES; RETINOIC ACID; HINDBRAIN SEGMENTATION; NEURAL CREST; EXPRESSION; KREISLER; INSIGHTS; KROX-20; CLUSTER; EMBRYOS	The comparison of Hox genes between vertebrates and their closest invertebrate relatives (amphioxus and ascidia) highlights two derived features of Hox genes in vertebrates: duplication of the Hox gene cluster(1,2), and an elaboration of Hox expression patterns and roles compared with non-vertebrate chordates(3-8). We have investigated how new expression domains and their associated developmental functions evolved, by testing the cis-regulatory activity of genomic DNA fragments from the cephalochordate amphioxus Hox cluster in transgenic mouse and chick embryos. Here we present evidence for the conservation of cis-regulatory mechanisms controlling gene expression in the neural tube for half a billion years of evolution, including a dependence on retinoic acid signalling. We also identify amphioxus Hox gene regulatory elements that drive spatially localized expression in vertebrate neural crest cells, in derivatives of neurogenic placodes and in branchial arches, despite the fact that cephalochordates lack both neural crest and neurogenic placodes. This implies an elaboration of cis-regulatory elements in the Hox gene cluster of vertebrate ancestors during the evolution of craniofacial patterning.	Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; Natl Inst Med Res, MRC, Div Dev Neurobiol, London NW7 1AA, England; Kyoto Univ, Seto Marine Biol Lab, Shirahama, Wakayama 6492211, Japan	University of Reading; MRC National Institute for Medical Research; Kyoto University	Krumlauf, R (corresponding author), Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England.	rek@stowers-institute.org; p.w.h.holland@reading.ac.uk	Manzanares, Miguel/AAZ-8305-2021; Manzanares, Miguel/E-1702-2015; Krumlauf, Robb/AAH-5012-2019	Manzanares, Miguel/0000-0003-4849-2836; Manzanares, Miguel/0000-0003-4849-2836; Krumlauf, Robb/0000-0001-9102-7927; Holland, Peter/0000-0003-1533-9376; Trainor, Paul/0000-0003-2774-3624; Itasaki, Nobue/0000-0003-0587-9141				Blumberg B, 1997, DEVELOPMENT, V124, P373; Finnerty JR, 1998, CURR OPIN GENET DEV, V8, P681, DOI 10.1016/S0959-437X(98)80037-3; GANS C, SCIENCE, V220, P268; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Gionti M, 1998, DEV GENES EVOL, V207, P515, DOI 10.1007/s004270050142; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Holland LZ, 1996, DEVELOPMENT, V122, P1829; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; HUNT P, 1991, NATURE, V353, P861, DOI 10.1038/353861a0; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; KATSUYAMA Y, 1995, DEVELOPMENT, V121, P3197; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; KURATANI SC, 1992, DEV DYNAM, V195, P15, DOI 10.1002/aja.1001950103; LEDOUARIN NM, 1986, TRENDS NEUROSCI, V9, P175, DOI 10.1016/0166-2236(86)90055-X; Locascio A, 1999, DEVELOPMENT, V126, P4737; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Maconochie M, 1996, ANNU REV GENET, V30, P529, DOI 10.1146/annurev.genet.30.1.529; Manzanares M, 1999, DEVELOPMENT, V126, P759; Manzanares M, 1997, NATURE, V387, P191, DOI 10.1038/387191a0; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Marshall H, 1996, FASEB J, V10, P969, DOI 10.1096/fasebj.10.9.8801179; MURPHY P, 1991, DEVELOPMENT, V111, P61; Nonchev S, 1996, P NATL ACAD SCI USA, V93, P9339, DOI 10.1073/pnas.93.18.9339; Nonchev S, 1996, DEVELOPMENT, V122, P543; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; SUNDIN OH, 1990, DEVELOPMENT, V108, P47; Wada H, 1999, DEV BIOL, V213, P131, DOI 10.1006/dbio.1999.9369	28	144	148	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2000	408	6814					854	857		10.1038/35048570	http://dx.doi.org/10.1038/35048570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130723				2022-12-24	WOS:000165831300049
J	Chen, HT; Bhandoola, A; Difilippantonio, MJ; Zhu, J; Brown, MJ; Tai, XG; Rogakou, EP; Brotz, TM; Bonner, WM; Ried, T; Nussenzweig, A				Chen, HT; Bhandoola, A; Difilippantonio, MJ; Zhu, J; Brown, MJ; Tai, XG; Rogakou, EP; Brotz, TM; Bonner, WM; Ried, T; Nussenzweig, A			Response to RAG-mediated V(D)J cleavage by NBS1 and gamma-H2AX	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; T-CELL; MICE DEFICIENT; RECOMBINATION; DNA; THYMOCYTES; COMPLEX; REPAIR; REARRANGEMENT; EXPRESSION	Genetic disorders affecting cellular responses to DNA damage are characterized by high rates of translocations involving antigen receptor loci and increased susceptibility to lymphoid malignancies. We report that the Nijmegen breakage syndrome protein (NBS1) and histone gamma -H2AX, which associate with irradiation-induced DNA double-strand breaks (DSBs), are also found at sites of V(D)J (variable, diversity, joining) recombination-induced DSBs. In developing thymocytes, NBS1 and gamma -H2AX form nuclear foci that colocalize with the T cell receptor alpha locus in response to recombination activating gene (RAG) protein-mediated V(D)J cleavage. Our results suggest that surveillance of T cell receptor recombination intermediates by NBS1 and gamma -H2AX may be important for preventing oncogenic translocations.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Dept Genet, NIH, Bethesda, MD 20892 USA; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.		Difilippantonio, Michael/AAF-2839-2021; Brotz, Tilmann M/R-6599-2016	Difilippantonio, Michael/0000-0002-4676-7034; Brotz, Tilmann M/0000-0001-8212-459X	DIVISION OF CLINICAL SCIENCES - NCI [Z01SC010299, Z01SC010298] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Danska J S, 1997, Semin Immunol, V9, P199, DOI 10.1006/smim.1997.0072; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; HSIEH CL, 1993, J BIOL CHEM, V268, P20105; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; Livak F, 1996, MOL CELL BIOL, V16, P609; Livak F, 1997, J MOL BIOL, V267, P1, DOI 10.1006/jmbi.1996.0834; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; RAMSDEN DA, 1995, GENE DEV, V9, P2409, DOI 10.1101/gad.9.19.2409; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schlissel MS, 1998, MOL CELL BIOL, V18, P2029, DOI 10.1128/MCB.18.4.2029; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; ZHU CM, 1995, IMMUNITY, V2, P101, DOI 10.1016/1074-7613(95)90082-9	25	260	268	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2000	290	5498					1962	1964		10.1126/science.290.5498.1962	http://dx.doi.org/10.1126/science.290.5498.1962			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382EL	11110662	Green Accepted			2022-12-24	WOS:000165810000045
J	Chen, T; Hiroko, T; Chaudhuri, A; Inose, F; Lord, M; Tanaka, S; Chant, J; Fujita, A				Chen, T; Hiroko, T; Chaudhuri, A; Inose, F; Lord, M; Tanaka, S; Chant, J; Fujita, A			Multigenerational cortical inheritance of the Rax2 protein in orienting polarity and division in yeast	SCIENCE			English	Article							BUD-SITE SELECTION; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; PATTERN; GENE	Diploid yeast cells repeatedly polarize and bud from their poles, probably because of highly stable marks of unknown composition. Here, Rax2, a membrane protein, was shown to behave as such a mark. The Rax2 protein itself was inherited immutably at the cell cortex for multiple generations, and Rax2 was shown to have a half-life exceeding several generations. The persistent inheritance of cortical protein markers would provide a means to couple a cell's history to the future development of a precise morphogenetic form.	Natl Inst Biosci & Human Technol, Tsukuba, Ibaraki 3058566, Japan; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	National Institute of Advanced Industrial Science & Technology (AIST); Harvard University	Chant, J (corresponding author), Natl Inst Biosci & Human Technol, AIST 1-1 Higahsi, Tsukuba, Ibaraki 3058566, Japan.	chant@fas.harvard.edu; atsushi@nibh.go.jp			NIGMS NIH HHS [GM49782] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049782] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEISSON J, 1965, P NATL ACAD SCI USA, V53, P275, DOI 10.1073/pnas.53.2.275; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; CHANT J, 1995, J CELL BIOL, V129, P767, DOI 10.1083/jcb.129.3.767; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chen T., UNPUB; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; FREIFELDER D, 1960, J BACTERIOL, V80, P567, DOI 10.1128/JB.80.4.567-568.1960; FUJITA A, 1994, NATURE, V372, P567, DOI 10.1038/372567a0; Halme A, 1996, CURR BIOL, V6, P570, DOI 10.1016/S0960-9822(02)00543-2; HICKS JB, 1977, GENETICS, V85, P373; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Zahner JE, 1996, MOL CELL BIOL, V16, P1857	17	62	65	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2000	290	5498					1975	1978		10.1126/science.290.5498.1975	http://dx.doi.org/10.1126/science.290.5498.1975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382EL	11110666				2022-12-24	WOS:000165810000049
J	Gershon, D				Gershon, D			Vaccine centres unite specialists in the battle against infectious diseases	NATURE			English	Article																			0	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2000	408	6813					753	754		10.1038/35047215	http://dx.doi.org/10.1038/35047215			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130080				2022-12-24	WOS:000165815200059
J	Kopp, A; Duncan, I; Carroll, SB				Kopp, A; Duncan, I; Carroll, SB			Genetic control and evolution of sexually dimorphic characters in Drosophila	NATURE			English	Article							MELANOGASTER SPECIES-GROUP; MOLECULAR PHYLOGENY; SEX DETERMINATION; HOX GENES; DIFFERENTIATION; PROTEIN; DIVERGENCE; SELECTION; MUTATIONS; COURTSHIP	Sexually dimorphic abdominal pigmentation and segment morphology evolved recently in the melanogaster species group of the fruitfly Drosophila. Here we show that these traits are controlled by the bric-a-brac (bab) gene, which integrates regulatory inputs from the homeotic and sex-determination pathways. bab expression is modulated segment- and sex-specifically in sexually dimorphic species, but is uniform in sexually monomorphic species. We suggest that bab has an ancestral homeotic function, and that regulatory changes at the bab locus played a key role in the evolution of sexual dimorphism. Pigmentation patterns specified by bab affect mating preferences, suggesting that sexual selection has contributed to the evolution of bab regulation.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL)	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@facstaff.wisc.edu						Anderson M., 1994, SEXUAL SELECTION, DOI 10.1515/9780691207278; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; BAKER BS, 1980, GENETICS, V94, P383; Bender W, 2000, DEVELOPMENT, V127, P3981; Bock I.R., 1972, U TEXAS PUBL, V7213, P1, DOI DOI 10.1590/S0085-56262014000400004; BOCK IR, 1980, SYST ENTOMOL, V5, P341, DOI 10.1111/j.1365-3113.1980.tb00420.x; Bock IR, 1971, U TEXAS PUBL, V7103, P273; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; BURKE AC, 1995, DEVELOPMENT, V121, P333; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; Burtis KC, 1993, CURR OPIN CELL BIOL, V5, P1006, DOI 10.1016/0955-0674(93)90085-5; Carson H.L., 1978, ECOLOGICAL GENETICS, P93; CARSON HI, 1999, EVOL GENET, P495; CELNIKER SE, 1990, EMBO J, V9, P4277, DOI 10.1002/j.1460-2075.1990.tb07876.x; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Cordts R, 1996, ANIM BEHAV, V52, P269, DOI 10.1006/anbe.1996.0172; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; CROSBY MA, 1993, GENETICS, V134, P809; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; EBERHARD WG, 1991, BIOL REV, V66, P1, DOI 10.1111/j.1469-185X.1991.tb01133.x; Fisher R., 2005, TEACHING CHILDREN TH; GODT D, 1993, DEVELOPMENT, V119, P799; Gurganus MC, 1999, GENETICS, V152, P1585; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; HOPMANN R, 1995, GENETICS, V139, P815; JURSNICH VA, 1993, DEV BIOL, V155, P235, DOI 10.1006/dbio.1993.1021; KELLERMAN KA, 1990, GENE DEV, V4, P1936, DOI 10.1101/gad.4.11.1936; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI [10.2307/2407961, 10.1111/j.1558-5646.1982.tb05003.x]; Kopp A, 1997, DEVELOPMENT, V124, P3703; KOPP A, IN PRESS DROS INFO S; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lyman RF, 1999, GENET RES, V74, P303, DOI 10.1017/S001667239900419X; McKeown M, 1992, CURR OPIN GENET DEV, V2, P299, DOI 10.1016/S0959-437X(05)80288-6; NAGOSHI RN, 1990, GENE DEV, V4, P89, DOI 10.1101/gad.4.1.89; OHNISHI S, 1985, JPN J GENET, V60, P355, DOI 10.1266/jjg.60.355; PELANDAKIS M, 1993, J MOL EVOL, V37, P525, DOI 10.1007/BF00160433; POINTUD JC, 1998, COMMUNICATION; ROBERTSON A, 1977, GENETICA, V47, P73, DOI 10.1007/BF00122443; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; TODA MJ, 1991, ORIENT INSECTS, V25, P69, DOI 10.1080/00305316.1991.10432216; True JR, 1997, EVOLUTION, V51, P816, DOI [10.2307/2411157, 10.1111/j.1558-5646.1997.tb03664.x]; WARREN RW, 1994, NATURE, V372, P458, DOI 10.1038/372458a0; Waterbury JA, 1999, GENETICS, V152, P1653	47	274	280	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2000	408	6812					553	559		10.1038/35046017	http://dx.doi.org/10.1038/35046017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117736				2022-12-24	WOS:000165548600109
J	Lunde, C; Jensen, PE; Haldrup, A; Knoetzel, J; Scheller, HV				Lunde, C; Jensen, PE; Haldrup, A; Knoetzel, J; Scheller, HV			The PSI-H subunit of photosystem I is essential for state transitions in plant photosynthesis	NATURE			English	Article							PROTEIN-PHOSPHORYLATION; CHLAMYDOMONAS-REINHARDTII; CHLOROPHYLL-PROTEINS; ARABIDOPSIS-THALIANA; EXCITATION-ENERGY; THYLAKOIDS; EXPRESSION; MUTANTS; MAIZE	Photosynthesis in plants involves two photosystems responsible for converting light energy into redox processes. The photosystems, PSI and PSII, operate largely in series, and therefore their excitation must be balanced in order to optimize photosynthetic performance(1). When plants are exposed to illumination favouring either PSII or PSI they can redistribute excitation towards the light-limited photosystem. Long-term changes in illumination lead to changes in photosystem stoichiometry(2,3). In contrast, state transition is a dynamic mechanism that enables plants to respond rapidly to changes in illumination. When PSII is favoured (state 2), the redox conditions in the thylakoids change and result in activation of a protein kinase(4-6). The kinase phosphorylates the main light-harvesting complex (LHCII) and the mobile antenna complex is detached from PSII. It has not been clear if attachment of LHCII to PSI in state 2 is important in state transitions. Here we show that in the absence of a specific PSI subunit, PSI-H, LHCII cannot transfer energy to PSI, and state transitions are impaired.	Royal Vet & Agr Univ, Dept Plant Biol, Plant Biochem Lab, DK-1871 Copenhagen C, Denmark	University of Copenhagen	Scheller, HV (corresponding author), Royal Vet & Agr Univ, Dept Plant Biol, Plant Biochem Lab, 40 Thorvaldsensvej, DK-1871 Copenhagen C, Denmark.		Scheller, Henrik/AAH-4770-2020; Jensen, Poul Erik/A-4862-2014; Scheller, Henrik V/A-8106-2008	Scheller, Henrik/0000-0002-6702-3560; Jensen, Poul Erik/0000-0001-6524-7723; Scheller, Henrik V/0000-0002-6702-3560; Haldrup, Anna/0000-0002-2348-7072				ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Allen JF, 1997, PHYSIOL PLANTARUM, V100, P863, DOI 10.1034/j.1399-3054.1997.1000412.x; BASSI R, 1985, CARLSBERG RES COMMUN, V50, P145, DOI 10.1007/BF02907142; BASSI R, 1985, CARLSBERG RES COMMUN, V50, P127, DOI 10.1007/BF02907141; BOEKEMA EJ, IN PRESS BIOCHEMISTR; Fleischmann MM, 1999, J BIOL CHEM, V274, P30987, DOI 10.1074/jbc.274.43.30987; Fromme P, 1996, CURR OPIN STRUC BIOL, V6, P473, DOI 10.1016/S0959-440X(96)80112-6; Gal A, 1997, PHYSIOL PLANTARUM, V100, P869, DOI 10.1034/j.1399-3054.1997.1000413.x; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; Horton P, 1999, AUST J PLANT PHYSIOL, V26, P659, DOI 10.1071/PP99095; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jensen PE, 2000, J BIOL CHEM, V275, P24701, DOI 10.1074/jbc.M000550200; Kjaer B, 1996, PHOTOSYNTH RES, V47, P33, DOI 10.1007/BF00017751; KNOETZEL J, 1991, PLANTA, V185, P111, DOI 10.1007/BF00194522; Kruse O, 1999, PHOTOSYNTH RES, V61, P43, DOI 10.1023/A:1006229308606; Naver H, 1999, J BIOL CHEM, V274, P10784, DOI 10.1074/jbc.274.16.10784; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; SAMSON G, 1995, BBA-BIOENERGETICS, V1232, P21, DOI 10.1016/0005-2728(95)00104-6; Scheller HV, 1997, PHYSIOL PLANTARUM, V100, P842, DOI 10.1034/j.1399-3054.1997.1000410.x; STEINBACK KE, 1982, ARCH BIOCHEM BIOPHYS, V216, P356, DOI 10.1016/0003-9861(82)90221-1; WALTERS RG, 1994, PLANTA, V195, P248, DOI 10.1007/BF00199685; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	24	282	306	0	52	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2000	408	6812					613	615		10.1038/35046121	http://dx.doi.org/10.1038/35046121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117752				2022-12-24	WOS:000165548600125
J	Hellstrom, AL				Hellstrom, AL			Influence of potty training habits on dysfunctional bladder in children	LANCET			English	Editorial Material							INFANTS		Queen Silvia Childrens Hosp, Urotherapeut Unit, S-41685 Gothenburg, Sweden; Gothenburg Univ, Inst Nursing, Div Hlth & Caring Sci, S-41685 Gothenburg, Sweden	Queen Silvia Children's Hospital; University of Gothenburg	Hellstrom, AL (corresponding author), Queen Silvia Childrens Hosp, Urotherapeut Unit, S-41685 Gothenburg, Sweden.							Bachelard M, 1999, J UROLOGY, V162, P1733, DOI 10.1016/S0022-5347(05)68226-2; Bakker E, 2000, BJU INT, V86, P248, DOI 10.1046/j.1464-410x.2000.00737.x; GOELLNER MH, 1981, NEPHRON, V28, P174, DOI 10.1159/000182168; Holmdahl G, 1996, J UROLOGY, V156, P1809, DOI 10.1016/S0022-5347(01)65543-5; JANSSON UB, IN PRESS J UROL; MUELLNER SR, 1960, JAMA-J AM MED ASSOC, V172, P1256, DOI 10.1001/jama.1960.03020120034007; Sillen U, 2000, J UROLOGY, V163, P278, DOI 10.1016/S0022-5347(05)68036-6; SILLEN U, 2000, BJU INT S, V85, P13; YEUNG CK, 1995, BRIT J UROL, V75, P531, DOI 10.1111/j.1464-410X.1995.tb07278.x; YEUNG CK, 1995, BRIT J UROL, V76, P235, DOI 10.1111/j.1464-410X.1995.tb07682.x	10	30	36	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2000	356	9244					1787	1787		10.1016/S0140-6736(00)03228-1	http://dx.doi.org/10.1016/S0140-6736(00)03228-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377UY	11117908				2022-12-24	WOS:000165545700007
J	Nishida, M; Maruyama, Y; Tanaka, R; Kontani, K; Nagao, T; Kurose, H				Nishida, M; Maruyama, Y; Tanaka, R; Kontani, K; Nagao, T; Kurose, H			G alpha(i) and G alpha(o) are target proteins of reactive oxygen species	NATURE			English	Article							BETA-GAMMA-SUBUNITS; RECOMBINANT ADENOVIRUSES; REOXYGENATION INJURY; OXIDATIVE STRESS; CARDIAC MYOCYTES; RECEPTOR KINASE; FREE-RADICALS; ACTIVATION; PATHWAY; BINDING	Reactive oxygen species (ROS) have been identified as central mediators in certain signalling events(1-4). In the heart, ROS have important functions in ischaemia/reperfusion-induced cardiac injury(5,6) and in cytokine-stimulated hypertrophy(7). Extracellular signal-regulated kinase (ERK) is one of the ROS-responsive serine/threonine kinases. Previous studies showed that tyrosine kinases and small G proteins are involved in the activation of ERK by ROS4,8; however, the initial target protein of ROS that leads to ERK activation remains unknown. Here we show that inhibition of the beta gamma -subunit of G protein (G beta gamma) attenuates hydrogen peroxide (H2O2)-induced ERK activation in rat neonatal cardiomyocytes. The G beta gamma -responsive ERK activation induced by H2O2 is independent of ligands binding to G(i)-coupled receptors, but requires phosphatidylinositol-3-kinase and Src activation. In in vitro studies, however, treatment with H2O2 increases [S-35]GTP-gammaS binding to cardiac membranes and directly activates purified heterotrimeric G(i) and G(o) but not G(s). Analysis using heterotrimeric G(o) and its individual subunits indicates that H2O2 modifies G alpha (o) but not G beta gamma, which leads to subunit dissociation. We conclude that G alpha (i) and G alpha (o) are critical targets of oxidative stress for activation of ERK.	Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Physiol Chem Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Kurose, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kurose@mol.f.u-tokyo.ac.jp						Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; ALBAS J, 1993, J BIOL CHEM, V268, P19196; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Coffer PJ, 1998, BIOCHEM J, V335, P1; Delmas P, 1999, J PHYSIOL-LONDON, V518, P23, DOI 10.1111/j.1469-7793.1999.0023r.x; DOWNEY JM, 1990, ANNU REV PHYSIOL, V52, P487, DOI 10.1146/annurev.ph.52.030190.002415; GRANGER DN, 1995, ANNU REV PHYSIOL, V57, P311, DOI 10.1146/annurev.ph.57.030195.001523; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HOWE LR, 1993, J BIOL CHEM, V268, P20717; Isogaya M, 1998, MOL PHARMACOL, V54, P616; KATADA T, 1986, J BIOL CHEM, V261, P8182; Kim KS, 1998, J CLIN INVEST, V101, P1821, DOI 10.1172/JCI1830; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KUROSE H, 2000, CRC METH SIG TRANS, P185; LANDER HM, 1995, J BIOL CHEM, V270, P21195, DOI 10.1074/jbc.270.36.21195; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Sonoda Y, 1999, J BIOL CHEM, V274, P10566, DOI 10.1074/jbc.274.15.10566; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Wilkins JF, 1996, J BIOL CHEM, V271, P19232, DOI 10.1074/jbc.271.32.19232; Yamashita N, 1997, J MOL CELL CARDIOL, V29, P1805, DOI 10.1006/jmcc.1997.0415; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648	28	215	222	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2000	408	6811					492	495		10.1038/35044120	http://dx.doi.org/10.1038/35044120			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100733				2022-12-24	WOS:000165429800053
J	Katzen, F; Beckwith, J				Katzen, F; Beckwith, J			Transmembrane electron transfer by the membrane protein DsbD occurs via a disulfide bond cascade	CELL			English	Article							CYTOCHROME-C MATURATION; ISOMERASE-LIKE PROTEIN; ESCHERICHIA-COLI; IN-VIVO; RESPIRATORY-CHAIN; FORMATION INVIVO; PATHWAY; THIOREDOXIN; IDENTIFICATION; BIOGENESIS	The cytoplasmic membrane protein DsbD transfers electrons from the cytoplasm to the periplasm of E. coli, where its reducing power is used to maintain cysteines in certain proteins in the reduced state. We split DsbD into three structural domains, each containing two essential cysteines. Remarkably, when coexpressed, these truncated proteins restore DsbD function. Utilizing this three piece system, we were able to determine a pathway of the electrons through DsbD. Our findings strongly suggest that the pathway is based on a series of multistep redox reactions that include direct interactions between thioredoxin end DsbD, and between DsbD and its periplasmic substrates. A thioredoxin-fold domain in DsbD appears to have the novel role of intramolecular electron shuttle.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Beckwith, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	jbeckwith@hms.harvard.edu			NIGMS NIH HHS [GM-55090] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055090] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Chung J, 2000, MOL MICROBIOL, V35, P1099, DOI 10.1046/j.1365-2958.2000.01778.x; CROOKE H, 1995, MOL MICROBIOL, V15, P1139, DOI 10.1111/j.1365-2958.1995.tb02287.x; Darby NJ, 1998, BIOCHEMISTRY-US, V37, P783, DOI 10.1021/bi971888f; Debarbieux L, 1998, P NATL ACAD SCI USA, V95, P10751, DOI 10.1073/pnas.95.18.10751; Debarbieux L, 2000, J BACTERIOL, V182, P723, DOI 10.1128/JB.182.3.723-727.2000; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; Fabianek RA, 1998, J BACTERIOL, V180, P1947, DOI 10.1128/JB.180.7.1947-1950.1998; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Frishman D, 1996, BIOCHEM BIOPH RES CO, V219, P686, DOI 10.1006/bbrc.1996.0295; Gordon EHJ, 2000, MOL MICROBIOL, V35, P1360, DOI 10.1046/j.1365-2958.2000.01796.x; GUILHOT C, 1995, P NATL ACAD SCI USA, V92, P9895, DOI 10.1073/pnas.92.21.9895; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Guzman LM, 1997, J BACTERIOL, V179, P5094, DOI 10.1128/jb.179.16.5094-5103.1997; Joly JC, 1997, BIOCHEMISTRY-US, V36, P10067, DOI 10.1021/bi9707739; Kishigami S, 1996, GENES CELLS, V1, P201, DOI 10.1046/j.1365-2443.1996.d01-233.x; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; MISSIAKAS D, 1995, EMBO J, V14, P3415, DOI 10.1002/j.1460-2075.1995.tb07347.x; Page MD, 1997, MICROBIOL-SGM, V143, P3111, DOI 10.1099/00221287-143-10-3111; POOIE LB, 2000, BIOCHEMISTRY-US, V39, P6602; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; SAMBONGI Y, 1994, FEBS LETT, V353, P235, DOI 10.1016/0014-5793(94)01053-6; Schiott T, 1997, J BACTERIOL, V179, P1962, DOI 10.1128/jb.179.6.1962-1973.1997; SINGER M, 1989, MICROBIOL REV, V53, P1; Sone M, 1997, J BIOL CHEM, V272, P10349; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Walker KW, 1997, J BIOL CHEM, V272, P8845; Wang QQ, 1999, EMBO J, V18, P5972, DOI 10.1093/emboj/18.21.5972; WIELES B, 1995, J BIOL CHEM, V270, P25604, DOI 10.1074/jbc.270.43.25604; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019	43	166	172	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 22	2000	103	5					769	779		10.1016/S0092-8674(00)00180-X	http://dx.doi.org/10.1016/S0092-8674(00)00180-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	375ZJ	11114333	Bronze			2022-12-24	WOS:000165433100009
J	Adams, KL; Daley, DO; Qiu, YL; Whelan, J; Palmer, JD				Adams, KL; Daley, DO; Qiu, YL; Whelan, J; Palmer, JD			Repeated, recent and diverse transfers of a mitochondrial gene to the nucleus in flowering plants	NATURE			English	Article							MOLECULAR-CLONING; SWEET-POTATO; EVOLUTION; GENOMES; SUBUNIT; IMPORT; PRESEQUENCE; PROTEIN; SIGNALS; OXIDASE	A central component of the endosymbiotic theory for the bacterial origin of the mitochondrion is that many of its genes were transferred to the nucleus. Most of this transfer occurred early in mitochondrial evolution(1); functional transfer of mitochondrial genes has ceased in animals(2). Although mitochondrial gene transfer continues to occur in plants(3), no comprehensive study of the frequency and timing of transfers during plant evolution has been conducted. Here we report frequent loss (26 times) and transfer to the nucleus of the mitochondrial gene rps10 among 277 diverse angiosperms. Characterization of nuclear rps10 genes from 16 out of 26 loss lineages implies that many independent, RNA-mediated rps10 transfers occurred during recent angiosperm evolution; each of the genes may represent a separate functional gene transfer. Thus, rps10 has been transferred to the nucleus at a surprisingly high rate during angiosperm evolution. The structures of several nuclear rps10 genes reveal diverse mechanisms by which transferred genes become activated, including parasitism of pre-existing nuclear genes for mitochondrial or cytoplasmic proteins, and activation without gain of a mitochondrial targeting sequence.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Western Australia, Dept Biochem, Nedlands, WA 6907, Australia	Indiana University System; Indiana University Bloomington; University of Western Australia	Palmer, JD (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.		Palmer, Jeffrey/P-6747-2014; Whelan, James/F-6402-2011	Palmer, Jeffrey/0000-0002-4626-2220; Whelan, James/0000-0001-5754-025X; Daley, Daniel/0000-0002-6425-5059				Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; BENASSON D, 2000, MOL BIOL EVOL, V17, P406; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; BRAUN HP, 1994, FEBS LETT, V347, P90, DOI 10.1016/0014-5793(94)00515-X; DAY DA, 1985, AUST J PLANT PHYSIOL, V12, P219, DOI 10.1071/PP9850219; Figueroa P, 1999, MOL GEN GENET, V262, P139, DOI 10.1007/s004380051068; Figueroa P, 1999, PLANT J, V18, P601, DOI 10.1046/j.1365-313x.1999.00485.x; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; Herrmann RG, 1997, EUKARYOTISM SYMBIOSI, P73, DOI [10.1007/978-3-642-60885-8_7, DOI 10.1007/978-3-642-60885-8_7]; Kadowaki KI, 1996, EMBO J, V15, P6652, DOI 10.1002/j.1460-2075.1996.tb01055.x; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Kubo N, 1999, P NATL ACAD SCI USA, V96, P9207, DOI 10.1073/pnas.96.16.9207; Kubo N, 2000, MOL GEN GENET, V263, P733, DOI 10.1007/s004380051222; Laroche J, 1997, P NATL ACAD SCI USA, V94, P5722, DOI 10.1073/pnas.94.11.5722; Long MY, 1996, P NATL ACAD SCI USA, V93, P7727, DOI 10.1073/pnas.93.15.7727; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; MORIKAMI A, 1993, J BIOL CHEM, V268, P17205; NAKAGAWA T, 1990, EUR J BIOCHEM, V191, P557, DOI 10.1111/j.1432-1033.1990.tb19157.x; NEUBURGER M, 1982, ARCH BIOCHEM BIOPHYS, V217, P312, DOI 10.1016/0003-9861(82)90507-0; Palmer JD, 1997, SCIENCE, V275, P790, DOI 10.1126/science.275.5301.790; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; SWOFFORD DL, 2000, PAUP PHYLOGENETIC AN; Tanudji M, 1999, J BIOL CHEM, V274, P1286, DOI 10.1074/jbc.274.3.1286; WISCHMANN C, 1995, FEBS LETT, V374, P152, DOI 10.1016/0014-5793(95)01100-S; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054	27	159	165	2	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2000	408	6810					354	357		10.1038/35042567	http://dx.doi.org/10.1038/35042567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099041				2022-12-24	WOS:000165296000044
J	Piwon, N; Gunther, W; Schwake, M; Bosl, MR; Jentsch, TJ				Piwon, N; Gunther, W; Schwake, M; Bosl, MR; Jentsch, TJ			CIC-5Cl(-)-channel disruption impairs endocytosis in a mouse model for Dent's disease	NATURE			English	Article							MOLECULAR-WEIGHT PROTEINURIA; CHLORIDE CHANNEL GENE; P-I; KIDNEY; CLC-5; RECEPTOR; MEGALIN; MICE; HYPERCALCIURIA; EXPRESSION	Dent's disease is an X-linked disorder associated with the urinary loss of low-molecular-weight proteins, phosphate and calcium, which often leads to kidney stones(1,2). It is caused by mutations(3) in ClC-5, a renal chloride channel(4,5) that is expressed in endosomes of the proximal tubule(6,7). Here we show that disruption of the mouse clcn5 gene causes proteinuria by strongly reducing apical proximal tubular endocytosis. Both receptor-mediated and fluid-phase endocytosis are affected, and the internalization of the apical transporters NaPi-2 and NHE3 is slowed. At steady state, however, both proteins are redistributed from the plasma membrane to intracellular vesicles. This may be caused by an increased stimulation of luminal parathyroid hormone (PTH) receptors owing to the observed decreased tubular endocytosis of PTH. The rise in luminal PTH concentration should also stimulate the hydroxylation of 25(OH) vitamin D-3 to the active hormone. However, this is counteracted by a urinary loss of the precursor 25(OH) vitamin D-3. The balance between these opposing effects, both of which are secondary to the defect in proximal tubular endocytosis, probably determines whether there will be hypercalciuria and kidney stones.	Univ Hamburg, ZMNH, D-20246 Hamburg, Germany	University of Hamburg	Jentsch, TJ (corresponding author), Univ Hamburg, ZMNH, Martinistr 85, D-20246 Hamburg, Germany.		Schwake, Michael/F-5381-2010	Jentsch, Thomas/0000-0002-3509-2553; Piwon, Nils/0000-0002-1225-5794; Schwake, Michael/0000-0002-4173-2166				Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Biemesderfer D, 1997, AM J PHYSIOL-RENAL, V273, pF289, DOI 10.1152/ajprenal.1997.273.2.F289; Bosio M, 1999, PEDIATR NEPHROL, V13, P278, DOI 10.1007/s004670050608; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; CUSTER M, 1994, AM J PHYSIOL, V266, pF767, DOI 10.1152/ajprenal.1994.266.5.F767; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; Devuyst O, 1999, HUM MOL GENET, V8, P247, DOI 10.1093/hmg/8.2.247; FISHER SE, 1994, HUM MOL GENET, V3, P2053; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gekle M, 1999, J PHYSIOL-LONDON, V520, P709, DOI 10.1111/j.1469-7793.1999.00709.x; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hilpert J, 1999, J BIOL CHEM, V274, P5620, DOI 10.1074/jbc.274.9.5620; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; KAUFMANN M, 1994, ENDOCRINOLOGY, V134, P1173, DOI 10.1210/en.134.3.1173; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Luyckx VA, 1999, P NATL ACAD SCI USA, V96, P12174, DOI 10.1073/pnas.96.21.12174; Morimoto T, 1998, J AM SOC NEPHROL, V9, P811; Murer H, 1999, AM J PHYSIOL-RENAL, V277, pF676, DOI 10.1152/ajprenal.1999.277.5.F676; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Orlando RA, 1998, J AM SOC NEPHROL, V9, P1759; Sakamoto H, 1999, AM J PHYSIOL-RENAL, V277, pF957, DOI 10.1152/ajprenal.1999.277.6.F957; Scheinman SJ, 1998, KIDNEY INT, V53, P3, DOI 10.1046/j.1523-1755.1998.00718.x; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Traebert M, 2000, AM J PHYSIOL-RENAL, V278, pF792, DOI 10.1152/ajprenal.2000.278.5.F792; Traebert M, 2000, AM J PHYSIOL-RENAL, V278, pF148, DOI 10.1152/ajprenal.2000.278.1.F148; WRONG OM, 1994, Q J MED, V87, P473; Zhang YB, 1999, AM J PHYSIOL-RENAL, V276, pF711, DOI 10.1152/ajprenal.1999.276.5.F711; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321	30	432	439	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2000	408	6810					369	373		10.1038/35042597	http://dx.doi.org/10.1038/35042597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099045				2022-12-24	WOS:000165296000048
J	Kleemann, R; Hausser, A; Geiger, G; Mischke, R; Burger-Kentischer, A; Flieger, O; Johannes, FJ; Roger, T; Calandra, T; Kapurniotu, A; Grell, M; Finkelmeier, D; Brunner, H; Bernhagen, J				Kleemann, R; Hausser, A; Geiger, G; Mischke, R; Burger-Kentischer, A; Flieger, O; Johannes, FJ; Roger, T; Calandra, T; Kapurniotu, A; Grell, M; Finkelmeier, D; Brunner, H; Bernhagen, J			Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1	NATURE			English	Article							MIGRATION-INHIBITORY FACTOR; PROTEIN; GENES; EXPRESSION; SUBUNITS; BINDING; REVEALS	Cytokines are multifunctional mediators that classically modulate immune activity by receptor-mediated pathways. Macrophage migration inhibitory factor (MIF) is a cytokine that has a critical role in several inflammatory conditions(1-3) but that also has endocrine(4,5) and enzymatic functions(6,7). The molecular targets of MIF action have so far remained unclear. Here we show that MIF specifically interacts with an intracellular protein, Jab1, which is a coactivator of AP-1 transcription(8,9) that also promotes degradation of the cyclin-dependent kinase inhibitor p27(Kip1) (ref. 10). MIF colocalizes with Jab1 in the cytosol, and both endogenous and exogenously added MIF following endocytosis bind Jab1. MIF inhibits Jab1- and stimulus-enhanced AP-1 activity, but does not interfere with the induction of the transcription factor NF kappaB. Jab1 activates c-Jun amino-terminal kinase (JNK) activity and enhances endogenous phospho-c-Jun levels, and MIF inhibits these effects. MIF also antagonizes Jab1-dependent cell-cycle regulation by increasing p27(Kip1) expression through stabilization of p27(Kip1) protein. Consequently, Jab1-mediated rescue of fibroblasts from growth arrest is blocked by MIF. Amino acids 50-65 and Cys 60 of MIF are important for Jab1 binding and modulation. We conclude that MIF may act broadly to negatively regulate Jab1-controlled pathways and that the MIF-Jab1 interaction may provide a molecular basis for key activities of MIF.	Univ Stuttgart, Biochem Lab, Inst Interfacial Engn, D-70569 Stuttgart, Germany; Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany; Fraunhofer IGB, D-70569 Stuttgart, Germany; CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland; Univ Tubingen, Inst Physiol Chem, D-72076 Tubingen, Germany	University of Stuttgart; University of Stuttgart; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Eberhard Karls University of Tubingen	Bernhagen, J (corresponding author), Univ Stuttgart, Biochem Lab, Inst Interfacial Engn, Nobelstr 12, D-70569 Stuttgart, Germany.		Hausser, Angelika/AAC-4531-2021; Roger, Thierry/G-2007-2012; Calandra, Thierry/D-9017-2015	Roger, Thierry/0000-0002-9358-0109; Calandra, Thierry/0000-0003-3051-1285				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; Bacher M, 1998, MOL MED, V4, P217, DOI 10.1007/BF03401919; Berberich I, 1996, EMBO J, V15, P92, DOI 10.1002/j.1460-2075.1996.tb00337.x; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chauchereau A, 2000, J BIOL CHEM, V275, P8540, DOI 10.1074/jbc.275.12.8540; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Dedio J, 1998, J IMMUNOL, V160, P3534; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Johannes FJ, 1998, EUR J BIOCHEM, V257, P47, DOI 10.1046/j.1432-1327.1998.2570047.x; KARIN M, 1995, J BIOL CHEM, V270; Kleemann R, 1999, EUR J BIOCHEM, V261, P753, DOI 10.1046/j.1432-1327.1999.00327.x; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; Roger T, 1998, BIOCHEM J, V330, P429, DOI 10.1042/bj3300429; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782; WISTOW GJ, 1993, P NATL ACAD SCI USA, V90, P1271	30	486	519	0	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					211	216		10.1038/35041591	http://dx.doi.org/10.1038/35041591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089976				2022-12-24	WOS:000165180400048
J	Catania, JA; Morin, SF; Canchola, J; Pollack, L; Chang, J; Coates, TJ				Catania, JA; Morin, SF; Canchola, J; Pollack, L; Chang, J; Coates, TJ			Health care policy - US priorities - HIV prevention	SCIENCE			English	Editorial Material							SAN-FRANCISCO; UNITED-STATES; PREVALENCE; AMEN; AIDS		Univ Calif San Francisco, AIDS Res Inst, Ctr AIDS Prevent Studies, San Francisco, CA 94105 USA	University of California System; University of California San Francisco	Catania, JA (corresponding author), Univ Calif San Francisco, AIDS Res Inst, Ctr AIDS Prevent Studies, San Francisco, CA 94105 USA.				NIMH NIH HHS [MH42459, MH43892, MH51523] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051523, P50MH042459, R01MH043892] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], 1993, METHODOLOGICAL ISSUE; Blair J, 1999, J SEX RES, V36, P39, DOI 10.1080/00224499909551965; CATANIA J, IN PRESS AM J PUBL H; CATANIA JA, 1993, J SEX RES, V30, P121, DOI 10.1080/00224499309551691; Cates W, 1999, SEX TRANSM DIS, V26, pS2, DOI 10.1097/00007435-199904001-00002; *CDCP, 1999, HIV AIDS SURVEILL RE, V11, P33; Chesson HW, 1999, AIDS, V13, P1387, DOI 10.1097/00002030-199907300-00017; Des Jarlais DC, 2000, AM J PUBLIC HEALTH, V90, P352, DOI 10.2105/AJPH.90.3.352; FULLILOVE MT, 1992, WESTERN J MED, V157, P32; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; Kaplan EH, 1998, HDB EC EVALUATION HI, P177; McFarland W, 1999, J ACQ IMMUN DEF SYND, V22, P484; OSMOND D, 1998, 12 WORLD AIDS C GEN; Osmond DH, 2000, J ACQ IMMUN DEF SYND, V24, P363; WINKELSTEIN W, 1988, AM J PUBLIC HEALTH, V78, P1472, DOI 10.2105/AJPH.78.11.1472; Wortley PM, 1997, JAMA-J AM MED ASSOC, V278, P911, DOI 10.1001/jama.278.11.911; 1999, MORB MORTAL WKLY REP, V48, P873; 1996, MORB MORTAL WKLY REP, V46, P861	18	16	16	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					717	717		10.1126/science.290.5492.717	http://dx.doi.org/10.1126/science.290.5492.717			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367ND	11184201				2022-12-24	WOS:000090067600024
J	Glickman, D				Glickman, D			Regulations for the use of laboratory animals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									USDA, Off Commun, Washington, DC 20250 USA	United States Department of Agriculture (USDA)	Glickman, D (corresponding author), USDA, Off Commun, Washington, DC 20250 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2001	285	7					941	941		10.1001/jama.285.7.941	http://dx.doi.org/10.1001/jama.285.7.941			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402BE	11180740				2022-12-24	WOS:000166965500034
J	Kimberly, RP				Kimberly, RP			Research advances in systemic lupus erythematosus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY	Systemic lupus erythematosus is an autoimmune disease with a significant genetic component to susceptibility. Some environmental risks are known, and identification of specific genetic factors promises to define new molecular targets for therapy. Broad immunosuppression will be replaced by early, selective, and individualized intervention. Mortality rates will decline, and insights into therapy may apply to other autoimmune conditions.	Univ Alabama, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Kimberly, RP (corresponding author), Univ Alabama, Dept Med, Div Clin Immunol & Rheumatol, Tinsley Harrison Tower,Room 429, Birmingham, AL 35294 USA.			Kimberly, Robert/0000-0002-5330-3086				Alarcon GS, 1999, LUPUS, V8, P197, DOI 10.1191/096120399678847704; Gaffney PM, 2000, AM J HUM GENET, V66, P547, DOI 10.1086/302767; Gray-McGuire C, 2000, AM J HUM GENET, V67, P1460, DOI 10.1086/316891; KIMBERLY RP, 1999, GENES GENETICS AUTOI, P99; Uramoto KM, 1999, ARTHRITIS RHEUM, V42, P46, DOI 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2; Urowitz MB, 1997, J RHEUMATOL, V24, P1061	6	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					650	651		10.1001/jama.285.5.650	http://dx.doi.org/10.1001/jama.285.5.650			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176876	Bronze			2022-12-24	WOS:000166714200029
J	Koopman, WJ				Koopman, WJ			Prospects for autoimmune disease - Research advances in rheumatoid arthritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METHOTREXATE	Rheumatoid arthritis (RA) is a common chronic inflammatory disease associated with progressive destruction of diarthrodial joints, substantial morbidity and economic burden, and a shortened lifespan. Significant progress has been made in understanding the pathogenesis of RA, and increasingly effective therapies have been introduced, including anti-tumor necrosis factor alpha agents. Advances made in the past quarter century will pale in comparison to those anticipated for the next 25 years, including delineation of the genetic basis of disease susceptibility and severity, genetic definition of disease subtypes that differ in severity and response to therapy, and prompt initiation of effective individualized treatment based on genetic and environmental assessment. Reconstructive surgery will become increasingly unnecessary and the morbidity, economic burden, and mortality due to RA will be reduced substantially.	Univ Alabama, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Koopman, WJ (corresponding author), Univ Alabama, Dept Med, Boshell Diabet Bldg,Room 420, Birmingham, AL 35294 USA.							DELEURAN BW, 1996, SCAND J RHEUMAT S104, V25, P1; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; FELSON DT, 2001, ARTHRITIS ALLIED CON, P3; FIRESTEIN GS, 1990, ARTHRITIS RHEUM, V33, P768, DOI 10.1002/art.1780330602; Fox D., 2001, ARTHRITIS ALLIED CON, P1085; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; JANOSSY G, 1981, LANCET, V2, P839; MORELAND LW, 2001, ARTHRITIS ALLIED CON, P877; MullerLadner U, 1996, AM J PATHOL, V149, P1607; ODell JR, 1996, NEW ENGL J MED, V334, P1287, DOI 10.1056/NEJM199605163342002; VANBOXEL JA, 1975, NEW ENGL J MED, V293, P517, DOI 10.1056/NEJM197509112931101; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401	12	20	21	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					648	650		10.1001/jama.285.5.648	http://dx.doi.org/10.1001/jama.285.5.648			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176875				2022-12-24	WOS:000166714200028
J	Livingston, DM; Shivdasani, R				Livingston, DM; Shivdasani, R			Toward mechanism-based cancer care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENE; HOMOLOG; PROTEIN; BCL-2; MICE	in the past 25 years, research has elucidated molecular mechanisms directing key aspects of tumor cell behavior. Detailed understanding of these mechanisms has already changed methods for diagnosis, prognosis, and treatment. with continuing advances in cancer science and the emergence of-new technologies for applying basic science to clinical practice, new methods based on molecular mechanisms will dominate cancer care and prevention.	Dana Farber Canc Inst, Div Neoplast Dis Mech, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Livingston, DM (corresponding author), Dana Farber Canc Inst, Div Neoplast Dis Mech, 44 Binney St, Boston, MA 02115 USA.	david_livingston@dfci.harvard.edu						Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bartek J, 1997, EXP CELL RES, V237, P1, DOI 10.1006/excr.1997.3776; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Folkman J, 1996, SCI AM, V275, P150, DOI 10.1038/scientificamerican0996-150; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Hellman S., 1989, CANCER PRINCIPLES PR, P3; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Horvitz HR, 1999, CANCER RES, V59, p1701S; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kaelin WG, 1999, BIOESSAYS, V21, P950, DOI 10.1002/(SICI)1521-1878(199911)21:11<950::AID-BIES7>3.0.CO;2-D; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Mahmood U, 1999, RADIOLOGY, V213, P866, DOI 10.1148/radiology.213.3.r99dc14866; McLean TW, 1996, BLOOD, V88, P4252; NOWELL PC, 1975, HUMANGENETIK, V30, P13, DOI 10.1007/BF00273627; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Rosenberg SA, 2000, CANCER J, V6, pS142; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schulman Ira G., 1997, Leukemia (Basingstoke), V11, P376; Semenza GL, 2000, GENE DEV, V14, P1983; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Weiner LM, 1999, SEMIN ONCOL, V26, P43	31	17	19	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					588	593		10.1001/jama.285.5.588	http://dx.doi.org/10.1001/jama.285.5.588			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176864	Bronze			2022-12-24	WOS:000166714200017
J	Tsomides, T				Tsomides, T			Reflections on a death	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Maine Med Ctr, Dept Med, Portland, ME 04102 USA	Maine Medical Center	Tsomides, T (corresponding author), Maine Med Ctr, Dept Med, 22 Bramhall St, Portland, ME 04102 USA.								0	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2001	134	3					246	248		10.7326/0003-4819-134-3-200102060-00017	http://dx.doi.org/10.7326/0003-4819-134-3-200102060-00017			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397KR	11177339				2022-12-24	WOS:000166695300010
J	Harris, DR; Gonin, R; Alter, HJ; Wright, EC; Buskell, ZJ; Hollinger, FB; Seeff, LB				Harris, DR; Gonin, R; Alter, HJ; Wright, EC; Buskell, ZJ; Hollinger, FB; Seeff, LB		Natl Heart Lung Blood Inst Study G	The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse	ANNALS OF INTERNAL MEDICINE			English	Article							C VIRUS-INFECTION; LIVER-DISEASE; PROGRESSION; PREVALENCE; DONORS; RISK	Background: Although concomitant alcoholism is widely believed to enhance liver disease progression in persons with hepatitis C virus (HCV) infection, this relationship has not been well quantified. Objective: To quantify the relationship of transfusion-associated HCV infection and history of heavy alcohol abuse to development of cirrhosis. Design: Retrospective cohort study. Setting: river clinics in university and government hospitals. Patients: Extended follow-up of 1030 patients in prospective investigations of transfusion-associated viral hepatitis conducted in the United States between 1968 and 1980. Measurements: Development of cirrhosis and history of heavy alcohol abuse were determined from review of interviews with patients or their proxies, medical records, death certificates, and autopsy and biopsy reports. Logistic regression was used to estimate the risk for cirrhosis associated with transfusion-associated HCV infection and history of heavy alcohol abuse. Results: The absolute risk for cirrhosis was 17% among patients with transfusion-associated HCV; 3.2% among patients with transfusion-associated non-A, non-B, non-C hepatitis; and 2.8% among controls. Patients with transfusion-associated HCV were more likely than controls to develop cirrhosis (odds ratio, 7.8 [95% CI, 4.0 to 15.1]). A history of heavy alcohol abuse was associated with a fourfold increased risk for cirrhosis. Hepatitis C virus infection plus a history of heavy alcohol abuse led to a substantial increase in risk for cirrhosis (odds ratio, 31.1 [CI, 11.4 to 84.5]) compared with controls without such a history. Conclusions: Heavy alcohol abuse greatly exacerbates the risk for cirrhosis among patients with HCV infection. This finding emphasizes the need to counsel such patients about their drinking habits.	NIDDKD, NIH, Bethesda, MD 20892 USA; WESTAT Corp, Rockville, MD 20850 USA; New England Res Inst, Watertown, MA 02172 USA; Vet Affairs Med Ctr, Washington, DC 20422 USA; Georgetown Univ, Sch Med, Washington, DC USA; Baylor Coll Med, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Westat; HealthCore, Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); Georgetown University; Baylor College of Medicine	Seeff, LB (corresponding author), NIDDKD, NIH, 31 Ctr Dr,Room 9A18,Mail Drop MSC2560, Bethesda, MD 20892 USA.	seeffl@extra.niddk.nih.gov	Hollinger, F Blaine/AAY-3323-2021		NHLBI NIH HHS [N01-HB-87047, N01-HB-37093] Funding Source: Medline; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB037093, N01HB087047] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AACH RD, 1981, NEW ENGL J MED, V304, P989, DOI 10.1056/NEJM198104233041701; Alter HJ, 1997, HEPATOLOGY, V26, pS29, DOI 10.1002/hep.510260705; Alter HJ, 1978, VIRAL HEPATITIS, P359; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bellentani S, 1999, GUT, V44, P874, DOI 10.1136/gut.44.6.874; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.2307/2332323; HOSMER DW, 1989, APPL LOGISTIC REGRES, P25; MENDENHALL CL, 1991, HEPATOLOGY, V14, P581; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Noda K, 1996, ALCOHOL CLIN EXP RES, V20, pA95, DOI 10.1111/j.1530-0277.1996.tb01739.x; Ostapowicz G, 1998, HEPATOLOGY, V27, P1730, DOI 10.1002/hep.510270637; Pessione F, 1998, HEPATOLOGY, V27, P1717, DOI 10.1002/hep.510270635; Schiff ER, 1997, HEPATOLOGY, V26, pS39, DOI 10.1002/hep.510260707; Seeff L B, 1997, Clin Liver Dis, V1, P587, DOI 10.1016/S1089-3261(05)70323-8; SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703; SEEFF LB, 1978, VIRAL HEPATITIS, P371; SUZUKI T, 1993, ANAT REC S, V1, P109; Wiley TE, 2000, GASTROENTEROLOGY, V118, pA1012, DOI 10.1016/S0016-5085(00)86198-3; Wiley TE, 1998, HEPATOLOGY, V28, P805, DOI 10.1002/hep.510280330	19	137	144	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2001	134	2					120	124		10.7326/0003-4819-134-2-200101160-00012	http://dx.doi.org/10.7326/0003-4819-134-2-200101160-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391KW	11177315				2022-12-24	WOS:000166356000005
J	Passegue, E; Jochum, W; Schorpp-Kistner, M; Mohle-Steinlein, U; Wagner, EF				Passegue, E; Jochum, W; Schorpp-Kistner, M; Mohle-Steinlein, U; Wagner, EF			Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking JunB expression in the myeloid lineage	CELL			English	Article							COLONY-STIMULATING FACTOR; C-JUN; TRANSCRIPTION FACTORS; TRANSGENIC MICE; NEUTROPHILS; APOPTOSIS; PROMOTER; BETA; DIFFERENTIATION; IDENTIFICATION	The functions of JunB during myelopoiesis were studied in vivo. Transgenic mice specifically lacking JunB expression in the myeloid lineage (junB(-/-)Ubi-junB mice) develop a transplantable myeloproliferative disease eventually progressing to blast crisis, which resembles human chronic myeloid leukemia. Similarly, mice reconstituted with ES cell-derived junB(-/-) fetal liver cells also develop a myeloproliferative disease. In both cases, the absence of JunB expression results in increased numbers of granulocyte progenitors, which display enhanced GM-CSF-mediated proliferation and extended survival, associated with changes in the expression levels of the GM-CSF alpha receptor, the anti-apoptotic proteins Bcl2 and Bclx, and the cell cycle regulators p16(INK4a) and c-Jun. Importantly, ectopic expression of JunB fully reverts the immature and hyperproliferative phenotype of JunB-deficient myeloid cells. These results identify JunB as a key transcriptional regulator of myelopoiesis and a potential tumor suppressor gene.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Deutsch Krebsforschungszentrum, Div Signal Transduct & Growth Control, D-69120 Heidelberg, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Helmholtz Association; German Cancer Research Center (DKFZ)	Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.			Wagner, Erwin F/0000-0001-7872-0196; Passegue, Emmanuelle/0000-0002-3516-297X				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bagley CJ, 1997, BLOOD, V89, P1471, DOI 10.1182/blood.V89.5.1471.1471_1471_1482; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; D'Andrea RJ, 1998, J CLIN INVEST, V102, P1951, DOI 10.1172/JCI3729; DRANOFF G, 1994, STEM CELLS, V12, P173; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; HSU JC, 1993, CANCER RES, V53, P3789; JOHNSON GR, 1989, EMBO J, V8, P441, DOI 10.1002/j.1460-2075.1989.tb03396.x; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kieslinger M, 2000, GENE DEV, V14, P232; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Liebermann DA, 1998, ONCOGENE, V17, P3319, DOI 10.1038/sj.onc.1202574; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; LORD KA, 1993, MOL CELL BIOL, V13, P841, DOI 10.1128/MCB.13.2.841; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; MOLLINEDO F, 1991, BIOCHEM J, V273, P477, DOI 10.1042/bj2730477; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Sjin RMTT, 1999, J BIOL CHEM, V274, P28697, DOI 10.1074/jbc.274.40.28697; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; Wang ZQ, 1997, MECH DEVELOP, V62, P137, DOI 10.1016/S0925-4773(97)00655-2	34	188	194	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2001	104	1					21	32		10.1016/S0092-8674(01)00188-X	http://dx.doi.org/10.1016/S0092-8674(01)00188-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163237	Bronze			2022-12-24	WOS:000166882300004
J	Whitehouse, CJ; Taylor, RM; Thistlethwaite, A; Zhang, H; Karimi-Busheri, F; Lasko, DD; Weinfeld, M; Caldecott, KW				Whitehouse, CJ; Taylor, RM; Thistlethwaite, A; Zhang, H; Karimi-Busheri, F; Lasko, DD; Weinfeld, M; Caldecott, KW			XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair	CELL			English	Article							BASE EXCISION-REPAIR; LIGASE-III; POLY(ADP-RIBOSE) POLYMERASE; MOLECULAR-CLONING; IONIZING-RADIATION; PROTEIN XRCC1; END-GROUPS; BETA; GENE; ALPHA	XRCC1 protein is required for DNA single-strand break repair and genetic stability but its biochemical role is unknown. Here, we report that XRCC1 interacts with human polynucleotide kinase in addition to its established interactions with DNA polymerase-beta and DNA ligase III. Moreover, these four proteins are coassociated in multiprotein complexes in human cell extract and together they repair single-strand breaks typical of those induced by reactive oxygen species and ionizing radiation. Strikingly, XRCC1 stimulates the DNA kinase and DNA phosphatase activities of polynucleotide kinase at damaged DNA termini and thereby accelerates the overall repair reaction. These data identify a novel pathway for mammalian single-strand break repair and demonstrate a concerted role for XRCC1 and PNK in the initial step of processing damaged DNA ends.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada	University of Manchester; University of Alberta; Lady Davis Institute; McGill University	Caldecott, KW (corresponding author), Univ Manchester, Sch Biol Sci, G 38 Stopford Bldg, Manchester M13 9PT, Lancs, England.	caldecott@man.ac.uk	Caldecott, Keith/S-4245-2019; Karimi-Busheri, Feridoun/AAX-7541-2020	Caldecott, Keith/0000-0003-4255-9016; Karimi-Busheri, Feridoun/0000-0002-1936-0503				BAILLY V, 1989, BIOCHEM J, V261, P707, DOI 10.1042/bj2610707; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; CALDECOTT KW, 1992, NUCLEIC ACIDS RES, V20, P4575, DOI 10.1093/nar/20.17.4575; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; COQUERELLE T, 1973, INT J RADIAT BIOL, V24, P397, DOI 10.1080/09553007314551251; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Divine KK, 2001, MUTAT RES-DNA REPAIR, V461, P273, DOI 10.1016/S0921-8777(00)00059-8; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; LENNARTZ M, 1975, INT J RADIAT BIOL, V27, P577, DOI 10.1080/09553007514550611; Lunn RM, 1999, CANCER RES, V59, P2557; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MILLER MR, 1982, J BIOL CHEM, V257, P46; MILLER MR, 1982, J BIOL CHEM, V257, P204; Miura M, 2000, RADIAT RES, V153, P773, DOI 10.1667/0033-7587(2000)153[0773:BRTIRI]2.0.CO;2; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; Nitiss JL, 1998, CONT CANC RES, P517; Rice PA, 1999, NAT STRUCT BIOL, V6, P805, DOI 10.1038/12257; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Shen MR, 1998, CANCER RES, V58, P604; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Sturgis EM, 1999, CARCINOGENESIS, V20, P2125, DOI 10.1093/carcin/20.11.2125; SUGIYAMA H, 1994, CHEM RES TOXICOL, V7, P673, DOI 10.1021/tx00041a013; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Ward JF, 1998, CONT CANC RES, P65; WEI YF, 1995, MOL CELL BIOL, V15, P3206; Wilson DM, 1998, CONT CANC RES, P29; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; WINTERS TA, 1992, NUCLEIC ACIDS RES, V20, P2573, DOI 10.1093/nar/20.10.2573; Winters TA, 1999, NUCLEIC ACIDS RES, V27, P2423, DOI 10.1093/nar/27.11.2423	45	498	517	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2001	104	1					107	117		10.1016/S0092-8674(01)00195-7	http://dx.doi.org/10.1016/S0092-8674(01)00195-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163244	Bronze			2022-12-24	WOS:000166882300011
J	Henney, JE				Henney, JE			Devices for in-stent restenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Henney, JE (corresponding author), US FDA, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2001	285	1					34	34		10.1001/jama.285.1.34	http://dx.doi.org/10.1001/jama.285.1.34			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387GH	11150092				2022-12-24	WOS:000166114500004
J	Rajagopalan, S; Vivancos, V; Nicolas, E; Dickson, BJ				Rajagopalan, S; Vivancos, V; Nicolas, E; Dickson, BJ			Selecting a longitudinal pathway: Robo receptors specify the lateral position of axons in the Drosophila CNS	CELL			English	Article							NEURONAL GROWTH CONES; GRASSHOPPER EMBRYOS; NERVOUS-SYSTEM; GUIDANCE RECEPTORS; FASCICLIN-II; MIDLINE; SLIT; EXPRESSION; DOMAINS; FASCICULATION	On each side of the midline of the Drosophila CNS, axons are organized into a series of parallel pathways. Here we show that the midline repellent Slit, previously identified as a short-range signal that regulates midline crossing, also functions at long range to pattern these longitudinal pathways. In this long-range function, Slit signals through the receptors Robo2 and Robo3. Axons expressing neither, one, or both of these receptors project in one of three discrete lateral zones, each successively further from the midline. Loss of robo2 or robo3 function repositions axons closer to the midline, while gain of robo2 or robo3 function shifts axons further from the midline. Local cues further refine the lateral position. Together, these long- and short-range guidance cues allow growth cones to select with precision a specific longitudinal pathway.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@nt.imp.univie.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BASTIANI MJ, 1984, J NEUROSCI, V4, P2311; Battye R, 1999, DEVELOPMENT, V126, P2475; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; FRASER SE, 1980, ANNU REV NEUROSCI, V3, P319, DOI 10.1146/annurev.ne.03.030180.001535; Fritz JL, 2000, DEVELOPMENT, V127, P1991; GIERER A, 1981, BIOL CYBERN, V42, P69, DOI 10.1007/BF00335161; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Newsome TP, 2000, DEVELOPMENT, V127, P851; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PRESTIGE MC, 1975, PROC R SOC SER B-BIO, V190, P77, DOI 10.1098/rspb.1975.0080; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; RAPER JA, 1983, J NEUROSCI, V3, P20; RAPER JA, 1984, J NEUROSCI, V4, P2329; RAPER JA, 1983, J NEUROSCI, V3, P31; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sun Q, 2000, DEVELOPMENT, V127, P801; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; XU T, 1993, DEVELOPMENT, V117, P1223; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	42	230	233	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2000	103	7					1033	1045		10.1016/S0092-8674(00)00207-5	http://dx.doi.org/10.1016/S0092-8674(00)00207-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163180	Bronze			2022-12-24	WOS:000166040600007
J	Pende, M; Kozma, SC; Jaquet, M; Oorschot, V; Burcelin, R; Le Marchand-Brustel, Y; Klumperman, J; Thorens, B; Thomas, G				Pende, M; Kozma, SC; Jaquet, M; Oorschot, V; Burcelin, R; Le Marchand-Brustel, Y; Klumperman, J; Thorens, B; Thomas, G			Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice	NATURE			English	Article							P70 S6 KINASE; INSULIN-RECEPTOR; YOUNG-RAT; DISRUPTION; RESISTANCE; SECRETION; GROWTH; GENE; MALNUTRITION; MECHANISM	Insulin controls glucose homeostasis by regulating glucose use in peripheral tissues, and its own production and secretion in pancreatic beta cells(1-3). These responses are largely mediated downstream of the insulin receptor substrates, IRS-1 and IRS-2 (refs 4-8), through distinct signalling pathways. Although a number of effectors of these pathways have been identified, their roles in mediating glucose homeostasis are poorly defined(9). Here we show that mice deficient for S6 kinase 1, an effector of the phosphatidylinositide-3-OH kinase signalling pathway(9), are hypoinsulinaemic and glucose intolerant. Whereas insulin resistance is not observed in isolated muscle, such mice exhibit a sharp reduction in glucose-induced insulin secretion and in pancreatic insulin content. This is not due to a lesion in glucose sensing or insulin production, but to a reduction in pancreatic endocrine mass, which is accounted for by a selective decrease in beta -cell size. The observed phenotype closely parallels those of preclinical type 2 diabetes mellitus, in which malnutrition-induced hypoinsulinaemia predisposes individuals to glucose intolerance(10-12).	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; Univ Utrecht, Med Ctr, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Res Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; Fac Med, INSERM, E 99 11, F-06107 Nice, France	Friedrich Miescher Institute for Biomedical Research; University of Lausanne; Utrecht University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Thomas, G (corresponding author), Friedrich Miescher Inst, CH-4058 Basel, Switzerland.	gthomas@fmi.ch	Thomas, George/K-9235-2014; Pende, Mario/AFR-1348-2022	Thomas, George/0000-0003-3518-8149; Pende, Mario/0000-0002-7864-8937				ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; CASTELLINO P, 1987, J CLIN INVEST, V80, P1784, DOI 10.1172/JCI113272; CRACE CJ, 1990, DIABETES METAB, V16, P484; DeFronzo RA, 1997, DIABETES REV, V5, P177; Dumonteil E, 1998, ENDOCRINOLOGY, V139, P4540, DOI 10.1210/en.139.11.4540; FABIAN MC, 1993, TRANSPLANTATION, V56, P1137, DOI 10.1097/00007890-199311000-00017; GIORDANO E, 1993, AM J PHYSIOL, V265, pC358, DOI 10.1152/ajpcell.1993.265.2.C358; Guillam MT, 1997, NAT GENET, V17, P503, DOI 10.1038/ng1297-503b; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HOPCROFT DW, 1985, HORM METAB RES, V17, P559, DOI 10.1055/s-2007-1013606; Hugl SR, 1998, J BIOL CHEM, V273, P17771, DOI 10.1074/jbc.273.28.17771; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kuliawat R, 1997, J CELL BIOL, V137, P595, DOI 10.1083/jcb.137.3.595; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Phillips DIW, 1996, DIABETOLOGIA, V39, P1119; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Shepherd PR, 1998, BIOCHEM J, V335, P711; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Stenbit AE, 1996, J CLIN INVEST, V98, P629, DOI 10.1172/JCI118833; SWENNE I, 1992, DIABETOLOGIA, V35, P939, DOI 10.1007/BF00401422; SWENNE I, 1992, DIABETOLOGIA, V35, P193, DOI 10.1007/BF00400917; SWENNE I, 1988, J ENDOCRINOL, V118, P295, DOI 10.1677/joe.0.1180295; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; WEIBEL ER, 1979, B EUR PHYSIOPATH RES, V15, P999; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	32	360	377	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2000	408	6815					994	997		10.1038/35050135	http://dx.doi.org/10.1038/35050135			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140689				2022-12-24	WOS:000165951100055
J	de Urquiza, AM; Liu, SY; Sjoberg, M; Zetterstrom, RH; Griffiths, W; Sjovall, J; Perlmann, T				de Urquiza, AM; Liu, SY; Sjoberg, M; Zetterstrom, RH; Griffiths, W; Sjovall, J; Perlmann, T			Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain	SCIENCE			English	Article							POLYUNSATURATED FATTY-ACIDS; NUCLEAR RECEPTOR; RXR-ALPHA; RAR; ESSENTIALITY; ACTIVATION; PATHWAYS; GENE; RATS	The retinoid X receptor (RXR) is a nuclear receptor that functions as a ligand-activated transcription factor. Little is known about the Ligands that activate RXR in vivo. Here, we identified a factor in brain tissue from adult mice that activates RXR in cell-based assays. Purification and analysis of the factor by mass spectrometry revealed that it is docosahexaenoic acid (DHA), a long-chain polyunsaturated fatty acid that is highly enriched in the adult mammalian brain. Previous work has shown that DHA is essential for brain maturation, and deficiency of DHA in both rodents and humans Leads to impaired spatial Learning and other abnormalities. These data suggest that DHA may influence neural function through activation of an RXR signaling pathway.	Ludwig Inst Canc Res, Stockholm Branch, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Ludwig Institute for Cancer Research; Karolinska Institutet	Perlmann, T (corresponding author), Ludwig Inst Canc Res, Stockholm Branch, Box 240, S-17177 Stockholm, Sweden.	thomas.perlmann@licr.ki.se	Griffiths, William/N-4641-2016	Griffiths, William/0000-0002-4129-6616; Zetterstrom, Rolf/0000-0002-3016-0019				Bischoff ED, 1998, CANCER RES, V58, P479; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Botling J, 1997, J BIOL CHEM, V272, P9443; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; CAVAILLES V, 1994, P NATL ACAD SCI USA, V91, P10009, DOI 10.1073/pnas.91.21.10009; Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Fernstrom JD, 1999, LIPIDS, V34, P161, DOI 10.1007/s11745-999-0350-3; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Gamoh S, 1999, NEUROSCIENCE, V93, P237, DOI 10.1016/S0306-4522(99)00107-4; Garcia MC, 1997, BRAIN RES, V768, P43, DOI 10.1016/S0006-8993(97)00583-0; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Greiner RS, 1999, LIPIDS, V34, pS239, DOI 10.1007/BF02562305; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; HORTON C, 1995, DEV DYNAM, V202, P312, DOI 10.1002/aja.1002020310; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Kitareewan S, 1996, MOL BIOL CELL, V7, P1153, DOI 10.1091/mbc.7.8.1153; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Lu HC, 1997, DEVELOPMENT, V124, P195; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MAKRIDES M, 1995, LANCET, V345, P1463, DOI 10.1016/S0140-6736(95)91035-2; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mascrez B, 1998, DEVELOPMENT, V125, P4691; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505; ONATE SA, 1995, SCIENCE, V270, P1354; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Peet DJ, 1998, CHEM BIOL, V5, P13, DOI 10.1016/S1074-5521(98)90083-7; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; ROY DY, 1995, MOL CELL BIOL, V15, P6481; Salem N. Jr., 1986, Health effects of polyunsaturated fatty acids in seafoods, P263; Solomin L, 1998, NATURE, V395, P398, DOI 10.1038/26515; Spector AA, 1999, LIPIDS, V34, pS1, DOI 10.1007/BF02562220; Storlien L H, 1998, Curr Opin Clin Nutr Metab Care, V1, P559, DOI 10.1097/00075197-199811000-00014; Wang S, 1999, NEURAL COMPUT APPL, V8, P3, DOI 10.1007/s005210050002; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g	41	588	615	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2000	290	5499					2140	2144						5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	383ER	11118147				2022-12-24	WOS:000165870600055
J	Samet, JM; Dominici, F; Curriero, FC; Coursac, I; Zeger, SL				Samet, JM; Dominici, F; Curriero, FC; Coursac, I; Zeger, SL			Fine particulate air pollution and mortality in 20 US Cities, 1987-1994.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXPOSURE; HEALTH	Background: Air pollution in cities has been linked to increased rates of mortality and morbidity in developed and developing countries. Although these findings have helped lead to a tightening of air-quality standards, their validity with respect to public health has been questioned. Methods: We assessed the effects of five major outdoor-air pollutants on daily mortality rates in 20 of the largest cities and metropolitan areas in the United States from 1987 to 1994. The pollutants were particulate matter that is less than 10 mum in aerodynamic diameter (PM10), ozone, carbon monoxide, sulfur dioxide, and nitrogen dioxide. We used a two-stage analytic approach that pooled data from multiple locations. Results: After taking into account potential confounding by other pollutants, we found consistent evidence that the level of PM(sub 10) is associated with the rate of death from all causes and from cardiovascular and respiratory illnesses. The estimated increase in the relative rate of death from all causes was 0.51 percent (95 percent posterior interval, 0.07 to 0.93 percent) for each increase in the PM10 level of 10 mug per cubic meter. The estimated increase in the relative rate of death from cardiovascular and respiratory causes was 0.68 percent (95 percent posterior interval, 0.20 to 1.16 percent) for each increase in the PM10 level of 10 mug per cubic meter. There was weaker evidence that increases in ozone levels increased the relative rates of death during the summer, when ozone levels are highest, but not during the winter. Levels of the other pollutants were not significantly related to the mortality rate. Conclusions: There is consistent evidence that the levels of fine particulate matter in the air are associated with the risk of death from all causes and from cardiovascular and respiratory illnesses. These findings strengthen the rationale for controlling the levels of respirable particles in outdoor air. (N Engl J Med 2000;343:1742-9.) (C) 2000, Massachusetts Medical Society.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Samet, JM (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, 615 N Wolfe St,Suite 6041, Baltimore, MD 21205 USA.	jsamet@jhsph.edu		Zeger, Scott/0000-0001-8907-1603	NIEHS NIH HHS [P30 ES0 3819-12] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES003819] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bascom R, 1996, AM J RESP CRIT CARE, V153, P477, DOI 10.1164/ajrccm.153.2.8564086; *BUR CENS, 1990, STAT ABSTR US; Dockery D., 1996, PARTICLES OUR AIR CO, P123; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; DOMINICI F, 2000, J R STAT SOC A, V152, P397; *ENV PROT AG, 1996, REV NAT AMB AIR QUAL; Gamble JF, 1996, ENVIRON HEALTH PERSP, V104, P838, DOI 10.2307/3432938; Gamble JF, 1998, ENVIRON HEALTH PERSP, V106, P535, DOI 10.1289/ehp.98106535; Gelman A, 2013, BAYESIAN DATA ANAL, P16; HASTIC TJ, 1990, GEN ADDITIVE MODELS; Kaiser J, 1997, SCIENCE, V277, P466, DOI 10.1126/science.277.5325.466; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658; Kelsall JE, 1997, AM J EPIDEMIOL, V146, P750; LINDLEY DV, 1972, J ROY STAT SOC B, V34, P1; Lipfert FW, 1997, J AIR WASTE MANAGE, V47, P517, DOI 10.1080/10473289.1997.10464417; *MATHS, 1998, S PLUS VERS 3 4; Mc Clellan R. O., 1997, CIIT ACTIVITIES CHEM, P1; Moolgavkar SH, 1996, EPIDEMIOLOGY, V7, P420, DOI 10.1097/00001648-199607000-00014; Morris CN, 1992, BAYESIAN STATISTICS, P321; *NAT CLIM DAT CTR, 1994, TD3280 NAT CLIM DAT; *OFF AIR QUAL PLAN, 1999, ACR INF RETR SYST; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Samet J, 1997, PARTICULATE AIR POLL; SAMET JM, 2000, NATL MORBIDITY MORTA, V1; Samet JM, 1995, PARTICULATE AIR POLL; SAMET JM, 2000, NATL MORBIDITY MORTA, V2; Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528; Schwartz J, 2000, AM J EPIDEMIOL, V151, P440, DOI 10.1093/oxfordjournals.aje.a010228; SCHWARTZ J, 1994, ENVIRON RES, V64, P36, DOI 10.1006/enrs.1994.1005; Thurston G.D., 1999, AIR POLLUT HLTH, P485, DOI DOI 10.1016/B978-012352335-8/50097-1; Touloumi G, 1997, AM J EPIDEMIOL, V146, P177, DOI 10.1093/oxfordjournals.aje.a009249; U.S. Environmental Protection Agency, 1997, FED REGISTER, V62, P138; Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015	34	1816	1930	10	440	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2000	343	24					1742	1749		10.1056/NEJM200012143432401	http://dx.doi.org/10.1056/NEJM200012143432401			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	382FH	11114312				2022-12-24	WOS:000165812000001
J	Kerlikowske, K; Carney, PA; Geller, B; Mandelson, MT; Taplin, SH; Malvin, K; Ernster, V; Urban, N; Cutter, G; Rosenberg, R; Ballard-Barbash, R				Kerlikowske, K; Carney, PA; Geller, B; Mandelson, MT; Taplin, SH; Malvin, K; Ernster, V; Urban, N; Cutter, G; Rosenberg, R; Ballard-Barbash, R			Performance of screening mammography among women with and without a first-degree relative with breast cancer	ANNALS OF INTERNAL MEDICINE			English	Article							POSITIVE PREDICTIVE VALUE; CARCINOMA IN-SITU; FAMILY-HISTORY; FOLLOW-UP; GROWTH-RATES; AGE; RISK; INTERVAL; SENSITIVITY; DENSITY	Background: Although it is recommended that women with a family history of breast cancer begin screening mammography at a younger age than average-risk women, few studies have evaluated the performance of mammography in this group. Objective: To compare the performance of screening mammography in women with a first-degree family history of breast cancer and women of similar age without such history. Design: Cross-sectional. Setting: Mammography registries in California (n = 1) New Hampshire (n = 1), New Mexico (n = 1), Vermont (n = 1) Washington State (n = 2), and Colorado (n = 1). Measurements: Risk factors for breast cancer; results of first screening examination captured for a woman by a registry; and any invasive cancer or ductal carcinoma in situ identified by linkage to a pathology database, the Surveillance, Epidemiology, and End Results program, or a state tumor registry. Results: The number of cancer cases per 1000 examinations increased with age and was higher in women with a family history of breast cancer than in those without (3.2 vs. 1.6 for ages 30 to 39 years, 4.7 vs. 2.7 for ages 40 to 49 years, 6.6 vs. 4.6 for ages 50 to 59 years, and 9.3 vs. 6.9 for ages 60 to 69 years). The sensitivity of mammography increased significantly with age (P = 0.001 [chi-square test for trend]) in women with a family history and in those without (63.2% [95% CI, 41.5% to 84.8%] vs. 69.5% [Ct, 57.7% to 81.2%] for ages 30 to 39 years, 70.2% [CI, 61.0% to 79.5%] vs. 77.5% [CI, 73.3% to 81.8%] for ages 40 to 49 years, 81.3% [CI, 73.3% to 89.3%] vs. 80.2% [CI, 76.5% to 83.9%] for ages 50 to 59 years, and 83.8% [CI, 76.8% to 90.9%] vs. 87.7% [Cf, 84.8% to 90.7%] for ages 60 to 69 years). Sensitivity was similar for each decade of age regardless of family history. The positive predictive value of mammography was higher in women with a family history than in those without (3.7% vs. 2.9%; P = 0.001). Conclusions: Cancer detection rates in women who had a first-degree relative with a history of breast cancer were similar to those in women a decade older without such a history. The sensitivity of screening mammography was influenced primarily by age.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Dartmouth Med Sch, Lebanon, NH USA; Univ Vermont, Coll Med, Burlington, VT USA; Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Ctr Canc Res, AMC, Denver, CO USA; Univ New Mexico, Med Ctr, New Mexico Tumor Registry, Albuquerque, NM 87131 USA; Natl Canc Inst, Bethesda, MD USA	University of California System; University of California San Francisco; Dartmouth College; University of Vermont; Group Health Cooperative; Fred Hutchinson Cancer Center; AMC Cancer Research Center; University of New Mexico; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kerlikowske, K (corresponding author), Vet Affairs Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA.		Cutter, Gary/AAY-5392-2021	Cutter, Gary/0000-0002-8455-980X	NCI NIH HHS [1 U01 CA 63740, K07CA71869, CA63146] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063146, K07CA071869, U01CA063740] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1993, BREAST IMAGING REPOR; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; BREKELMANS CTM, 1992, EUR J CANCER, V28A, P893, DOI 10.1016/0959-8049(92)90144-Q; BROWN ML, 1995, AM J ROENTGENOL, V165, P1373, DOI 10.2214/ajr.165.6.7484568; Burman ML, 1999, ANN INTERN MED, V131, P1, DOI 10.7326/0003-4819-131-1-199907060-00002; CALLE EE, 1993, AM J EPIDEMIOL, V138, P675, DOI 10.1093/oxfordjournals.aje.a116904; COLDITZ GA, 1993, JAMA-J AM MED ASSOC, V270, P338, DOI 10.1001/jama.270.3.338; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Elmore JG, 1997, JAMA-J AM MED ASSOC, V277, P49, DOI 10.1001/jama.277.1.49; Gilbert FJ, 1998, EUR J CANCER, V34, P2010, DOI 10.1016/S0959-8049(98)00294-9; Gilliland FD, 2000, J NATL CANCER I, V92, P743, DOI 10.1093/jnci/92.9.743; Gordis L, 1997, J NATL CANCER I, V89, P1015, DOI 10.1093/jnci/89.14.1015; HARRIS JR, 1992, NEW ENGL J MED, V327, P319, DOI 10.1056/NEJM199207303270505; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P39, DOI 10.1001/jama.276.1.39; KERLIKOWSKE K, 1993, JAMA-J AM MED ASSOC, V270, P2444, DOI 10.1001/jama.270.20.2444; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Kerlikowske K, 1997, JNCI-J NATL CANCER I, V89, P76, DOI 10.1093/jnci/89.1.76; Kerlikowske K, 1997, J Natl Cancer Inst Monogr, P105; Kollias J, 1998, EUR J CANCER, V34, P878, DOI 10.1016/S0959-8049(97)00365-1; Lalloo F, 1998, EUR J CANCER, V34, P937, DOI 10.1016/S0959-8049(98)00005-7; LEE JRJ, 1995, CANCER EPIDEM BIOMAR, V4, P901; Lippert MT, 1999, CANCER DETECT PREV, V23, P265, DOI 10.1046/j.1525-1500.1999.99023.x; May DS, 1998, AM J ROENTGENOL, V170, P97, DOI 10.2214/ajr.170.1.9423608; MONTICCIOLO DL, 1990, AM J ROENTGENOL, V155, P751, DOI 10.2214/ajr.155.4.2119104; MOSKOWITZ M, 1986, RADIOLOGY, V161, P37, DOI 10.1148/radiology.161.1.3532183; *NAT CANC ADV BOAR, 1997, CANC LETT, V23, P4; PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; RENNERT G, 1999, PROGR BREAST CANC SC; Rosenberg RD, 1998, RADIOLOGY, V209, P511, DOI 10.1148/radiology.209.2.9807581; SICKLES EA, 1990, RADIOLOGY, V175, P323, DOI 10.1148/radiology.175.2.2326455; SLATTERY ML, 1993, JAMA-J AM MED ASSOC, V270, P1563, DOI 10.1001/jama.270.13.1563; SLATTERY ML, 1993, EPIDEMIOLOGY, V4, P543, DOI 10.1097/00001648-199311000-00011; SPRATT JS, 1986, CANCER RES, V46, P970; Tabar L, 1997, J Natl Cancer Inst Monogr, P43; TABAR L, 1987, BRIT J CANCER, V55, P547, DOI 10.1038/bjc.1987.112; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Yang QH, 1998, AM J EPIDEMIOL, V147, P652	39	170	177	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2000	133	11					855	863		10.7326/0003-4819-133-11-200012050-00009	http://dx.doi.org/10.7326/0003-4819-133-11-200012050-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378LL	11103055				2022-12-24	WOS:000165585800004
J	Fagerhol, MK				Fagerhol, MK			Calprotectin, a faecal marker of organic gastrointestinal abnormality	LANCET			English	Editorial Material							FECAL CALPROTECTIN; PROTEIN CALPROTECTIN; COLORECTAL-CANCER; DISEASE		Ullevaal Univ Hosp, Dept Immunol & Transfus Med, N-0407 Oslo, Norway	University of Oslo	Fagerhol, MK (corresponding author), Ullevaal Univ Hosp, Dept Immunol & Transfus Med, N-0407 Oslo, Norway.			Fagerhol, Magne Kristoffer/0000-0002-5103-6981				Campbell SS, 2000, GASTROENTEROLOGY, V118, pA103, DOI 10.1016/S0016-5085(00)82490-7; Fagerhol M. K., 1990, STIMULUS RESPONSE CO, P187; Fagerhol MK, 1996, J CLIN PATHOL-CL MOL, V49, pM74; FAGERHOL MK, 1980, SCAND J HAEMATOL, V24, P393; Gilbert JA, 1996, SCAND J GASTROENTERO, V31, P1001, DOI 10.3109/00365529609003120; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Kristinsson J, 1998, DIS COLON RECTUM, V41, P316, DOI 10.1007/BF02237485; Kronborg O, 2000, GUT, V46, P795, DOI 10.1136/gut.46.6.795; Meling TR, 1996, SCAND J GASTROENTERO, V31, P339, DOI 10.3109/00365529609006407; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; Roseth AG, 1997, DIGESTION, V58, P176, DOI 10.1159/000201441; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; ROSETH AG, 1993, SCAND J GASTROENTERO, V28, P1073, DOI 10.3109/00365529309098312; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506; Tibble JA, 2000, GASTROENTEROLOGY, V119, P15, DOI 10.1053/gast.2000.8523; Tibble JA, 1999, GUT, V45, P362, DOI 10.1136/gut.45.3.362; Ton H, 2000, CLIN CHIM ACTA, V292, P41, DOI 10.1016/S0009-8981(99)00206-5; Yui S, 1995, J LEUKOCYTE BIOL, V58, P650, DOI 10.1002/jlb.58.6.650	18	113	118	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2000	356	9244					1783	1784		10.1016/S0140-6736(00)03224-4	http://dx.doi.org/10.1016/S0140-6736(00)03224-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377UY	11117904				2022-12-24	WOS:000165545700003
J	Yang, HQ; Wu, YJ; Tang, RH; Liu, DM; Liu, Y; Cashmore, AR				Yang, HQ; Wu, YJ; Tang, RH; Liu, DM; Liu, Y; Cashmore, AR			The C termini of Arabidopsis cryptochromes mediate a constitutive light response	CELL			English	Article							PHYTOCHROME-B; RECEPTOR CRYPTOCHROME-2; HYPOCOTYL ELONGATION; NUCLEAR-LOCALIZATION; SEEDLING DEVELOPMENT; GENE-EXPRESSION; CIRCADIAN CLOCK; FLOWERING TIME; DNA PHOTOLYASE; COP9 COMPLEX	Cryptochrome blue light photoreceptors share sequence similarity to photolyases, flavoproteins that mediate light-dependent DNA repair. However, cryptochromes lack photolyase activity and are characterized by distinguishing C-terminal domains. Here we show that the signaling mechanism of Arabidopsis cryptochrome is mediated through the C terminus. On fusion with beta -glucuronidase (GUS), both the Arabidopsis CRY1 C-terminal domain (CCT1) and the CRY2 C-terminal domain (CCT2) mediate a constitutive light response. This constitutive photomorphogenic (COP) phenotype was not observed for mutants of cct1 corresponding to previously described cry1 alleles. We propose that the C-terminal domain of Arabidopsis cryptochrome is maintained in an inactive state in the dark. Irradiation with blue light relieves this repression, presumably through an intra- or intermolecular redox reaction mediated through the flavin bound to the N-terminal photolyase-like domain.	Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA	University of Pennsylvania	Cashmore, AR (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.	cashmore@sas.upenn.edu		wu, yingjie/0000-0002-2694-1971; Tang, Ruhang/0000-0003-4918-3525; Yang, Hong-Quan/0000-0001-6215-2665	NIGMS NIH HHS [GM38409, GM51956] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051956] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD M, 1995, PLANT J, V8, P653, DOI 10.1046/j.1365-313X.1995.08050653.x; Ahmad M, 1998, PLANT CELL, V10, P197, DOI 10.1105/tpc.10.2.197; Ahmad M, 1997, PLANT J, V11, P421, DOI 10.1046/j.1365-313X.1997.11030421.x; Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Bagnall DJ, 1996, PLANTA, V200, P278, DOI 10.1007/BF00208319; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BOYLAN M, 1994, PLANT CELL, V6, P449, DOI 10.1105/tpc.6.3.449; Bruggemann EP, 1998, GENETICS, V149, P1575; Casal JJ, 1998, PLANT PHYSIOL, V118, P19, DOI 10.1104/pp.118.1.19; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Cashmore AR, 1997, PLANT CELL ENVIRON, V20, P764, DOI 10.1046/j.1365-3040.1997.d01-125.x; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; CHORY J, 1992, DEVELOPMENT, V115, P337; CHORY J, 1989, PLANT CELL, V1, P867, DOI 10.1105/tpc.1.9.867; CHORY J, 1990, P NATL ACAD SCI USA, V87, P8776, DOI 10.1073/pnas.87.22.8776; CHORY J, 1989, CELL, V58, P991, DOI 10.1016/0092-8674(89)90950-1; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; Devlin PF, 1999, PLANT PHYSIOL, V119, P909, DOI 10.1104/pp.119.3.909; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Fankhauser C, 2000, PLANT PHYSIOL, V124, P39, DOI 10.1104/pp.124.1.39; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kleiner O, 1999, PLANT J, V19, P289, DOI 10.1046/j.1365-313X.1999.00535.x; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Lin CT, 1996, PLANT J, V10, P893, DOI 10.1046/j.1365-313X.1996.10050893.x; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Poppe C, 1998, PLANT J, V16, P465, DOI 10.1046/j.1365-313x.1998.00322.x; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Sakamoto K, 1996, PLANT J, V10, P859, DOI 10.1046/j.1365-313X.1996.10050859.x; SANCAR A, 1994, BIOCHEMISTRY-US, V33, P2, DOI 10.1021/bi00167a001; SCHARDL CL, 1987, GENE, V61, P1, DOI 10.1016/0378-1119(87)90359-3; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Staub B, 1996, CD-ROM PROF, V9, P8; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.biochem.59.1.971; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Torii KU, 1998, EMBO J, V17, P5577, DOI 10.1093/emboj/17.19.5577; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Wagner D, 1996, P NATL ACAD SCI USA, V93, P4011, DOI 10.1073/pnas.93.9.4011; WEI N, 1992, PLANT CELL, V4, P1507, DOI 10.1105/tpc.4.12.1507; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Whitelam GC, 1998, PLANT PHYSIOL BIOCH, V36, P125, DOI 10.1016/S0981-9428(98)80097-1	62	313	341	6	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 22	2000	103	5					815	827		10.1016/S0092-8674(00)00184-7	http://dx.doi.org/10.1016/S0092-8674(00)00184-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	375ZJ	11114337	Bronze			2022-12-24	WOS:000165433100013
J	Fraser, AG; Kamath, RS; Zipperlen, P; Martinez-Campos, M; Sohrmann, M; Ahringer, J				Fraser, AG; Kamath, RS; Zipperlen, P; Martinez-Campos, M; Sohrmann, M; Ahringer, J			Functional genomic analysis of C-elegans chromosome I by systematic RNA interference	NATURE			English	Article							CAENORHABDITIS-ELEGANS; ZINC-FINGER; PROTEIN; KAKAPO; GENE; IDENTIFICATION; EXPRESSION; DROSOPHILA; ADHESION; SEQUENCE	Complete genomic sequence is known for two multicellular eukaryotes, the nematode Caenorhabditis elegans and the fruit fly Drosophila melanogaster, and it will soon be known for humans. However, biological function has been assigned to only a small proportion of the predicted genes in any animal. Here we have used RNA-mediated interference (RNAi) to target nearly 90% of predicted genes on C. elegans chromosome I by feeding worms with bacteria that express double-stranded RNA. We have assigned function to 13.9% of the genes analysed, increasing the number of sequenced genes with known phenotypes on chromosome I from 70 to 378. Although most genes with sterile or embryonic lethal RNAi phenotypes are involved in basal cell metabolism, many genes giving post-embryonic phenotypes have conserved sequences but unknown function. In addition, conserved genes are significantly more likely to have an RNAi phenotype than are genes with no conservation. We have constructed a reusable library of bacterial clones that will permit unlimited RNAi screens in the future; this should help develop a more complete view of the relationships between the genome, gene function and the environment.	Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Sanger Ctr, Cambridge CB10 1SA, England	University of Cambridge; Wellcome Trust Sanger Institute	Ahringer, J (corresponding author), Univ Cambridge, Wellcome CRC Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	jaa@mole.bio.cam.ac.uk	Martínez Campos, Maruxa/F-5254-2015	Martínez Campos, Maruxa/0000-0001-7322-5268; Fraser, Andrew/0000-0001-9939-6014	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ahringer J, 1997, CURR OPIN GENET DEV, V7, P410, DOI 10.1016/S0959-437X(97)80157-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARMSTRONG RC, 1995, GLIA, V14, P303, DOI 10.1002/glia.440140407; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BARNES TM, 1995, GENETICS, V141, P159; Bowerman B, 1999, CURR OPIN GENET DEV, V9, P390, DOI 10.1016/S0959-437X(99)80059-8; BURRIDGE K, 1983, CELL MOTIL CYTOSKEL, V3, P405, DOI 10.1002/cm.970030509; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen JJW, 1998, GENOMICS, V51, P313, DOI 10.1006/geno.1998.5354; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gregory SL, 1998, J CELL BIOL, V143, P1271, DOI 10.1083/jcb.143.5.1271; Hodgkin J, 1998, TRENDS GENET, V14, P352, DOI 10.1016/S0168-9525(98)01543-1; Hodgkin J, 1999, CELL, V98, P277, DOI 10.1016/S0092-8674(00)81956-X; KAMATH RS, IN PRESS GENOME BIOL; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; KIM JG, 1992, MOL CELL BIOL, V12, P5632, DOI 10.1128/MCB.12.12.5632; Lee S, 2000, J NEUROSCI, V20, P1096, DOI 10.1523/JNEUROSCI.20-03-01096.2000; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Prokop A, 1998, J CELL BIOL, V143, P1283, DOI 10.1083/jcb.143.5.1283; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Srayko M, 2000, GENE DEV, V14, P1072; Strumpf D, 1998, J CELL BIOL, V143, P1259, DOI 10.1083/jcb.143.5.1259; Svetlov VV, 1995, YEAST, V11, P1439, DOI 10.1002/yea.320111502; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116	32	1290	1432	3	110	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 16	2000	408	6810					325	330		10.1038/35042517	http://dx.doi.org/10.1038/35042517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099033				2022-12-24	WOS:000165296000036
J	Zwieniecki, MA; Melcher, PJ; Holbrook, NM				Zwieniecki, MA; Melcher, PJ; Holbrook, NM			Hydrogel control of xylem hydraulic resistance in plants	SCIENCE			English	Article							WATER TRANSPORT; CONDUCTIVITY; PRESSURE; PECTIN; CONDUCTANCE; L.	Increasing concentrations of ions flowing through the xylem of plants produce rapid, substantial, and reversible decreases in hydraulic resistance. Changes in hydraulic resistance in response to solution ion concentration, pH, and nonpolar solvents are consistent with this process being mediated by hydrogels, The effect is Localized to intervessel bordered pits, suggesting that microchannels in the pit membranes are altered by the swelling and deswelling of pectins, which are known hydrogels, The existence of an ion-mediated response breaks the Long-held paradigm of the xylem as a system of inert pipes and suggests a mechanism by which plants may regulate their internal flow regime.	Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Zwieniecki, MA (corresponding author), Harvard Univ, 16 Divin Ave, Cambridge, MA 02138 USA.	mzwienie@oeb.harvard.edu	Melcher, Peter J/S-4579-2017; Zwieniecki, Maciej A/D-3078-2011	Melcher, Peter J/0000-0002-6778-5792; Zwieniecki, Maciej/0000-0002-3774-4455				Barker Martin, 1995, Selbyana, V16, P201; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; BRETT K, 1996, PHYSL BIOCH PLANT CE; Brodribb TJ, 2000, PLANT CELL ENVIRON, V23, P1381, DOI 10.1046/j.1365-3040.2000.00647.x; deBoer AH, 1997, J EXP BOT, V48, P441, DOI 10.1093/jxb/48.Special_Issue.441; Gartner B.L., 1995, PLANT STEMS PHYSL FU; HOLBROOK NM, 1995, SCIENCE, V270, P1193, DOI 10.1126/science.270.5239.1193; Hubbard RM, 1999, TREE PHYSIOL, V19, P165; LIDE DR, 1995, CRC HDB CHEM PHYSICS; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; MEINZER FC, 1990, PLANT CELL ENVIRON, V13, P383, DOI 10.1111/j.1365-3040.1990.tb02142.x; Melcher PJ, 1998, J EXP BOT, V49, P1757, DOI 10.1093/jexbot/49.327.1757; Mencuccini M, 1999, AUST J PLANT PHYSIOL, V26, P115, DOI 10.1071/PP98137; Musabayane CT, 2000, J ENDOCRINOL, V164, P1, DOI 10.1677/joe.0.1640001; Pate John S., 1995, P177, DOI 10.1016/B978-012276460-8/50010-2; POCKMAN WT, 1995, NATURE, V378, P715, DOI 10.1038/378715a0; SCHMID R, 1964, CELLULAR ULTRASTRUCT, P291; SCHURR U, 1995, PLANT CELL ENVIRON, V18, P409, DOI 10.1111/j.1365-3040.1995.tb00375.x; Sperry John S., 1995, P105, DOI 10.1016/B978-012276460-8/50007-2; SPERRY JS, 1988, PLANT CELL ENVIRON, V11, P35, DOI 10.1111/j.1365-3040.1988.tb01774.x; TANAKA T, 1981, SCI AM, V244, P124, DOI 10.1038/scientificamerican0181-124; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Tibbits CW, 1998, CARBOHYD RES, V310, P101, DOI 10.1016/S0008-6215(98)00172-4; TYREE MT, 1989, ANNU REV PLANT PHYS, V40, P19, DOI 10.1146/annurev.pp.40.060189.000315; van Ieperen W, 2000, J EXP BOT, V51, P769, DOI 10.1093/jexbot/51.345.769; Zimmermann M. H., 1982, Encyclopedia of plant physiology. New series. Volume 12B. Physiological plant ecology. II. Water relations and carbon assimilation. [Lange, O.L.; Nobel, P.S.; Osmond, C.B.; Ziegler, H. (Editors)], P135; Zimmermann M.H., 1984, XYLEM STRUCTURE ASCE, V26, P165; ZIMMERMANN MH, 1978, CAN J BOT, V56, P2286, DOI 10.1139/b78-274; Zimmermann U, 2000, BIOTECHNIQUES, V29, P564, DOI 10.2144/00293rv01; Zwieniecki MA, 2000, PLANT CELL ENVIRON, V23, P407, DOI 10.1046/j.1365-3040.2000.00554.x; Zwieniecki MA, 1998, PLANT CELL ENVIRON, V21, P1173, DOI 10.1046/j.1365-3040.1998.00342.x; ZWIENIECKI MA, IN PRESS J EXP BOT	32	425	455	5	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2001	291	5506					1059	1062		10.1126/science.1057175	http://dx.doi.org/10.1126/science.1057175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11161220				2022-12-24	WOS:000166860100049
J	Reynolds, TB; Fink, GR				Reynolds, TB; Fink, GR			Bakers' yeast, a model for fungal biofilm formation	SCIENCE			English	Article							SLIDING MOTILITY; INVASIVE GROWTH; SACCHAROMYCES; FLO11	Biofilms are formed by the aggregation of microorganisms into multicellular structures that adhere to surfaces. Here we show that bakers' yeast Saccharomyces cerevisiae can initiate biofilm formation. When grown in Low-glucose medium, the yeast cells adhered avidly to a number of plastic surfaces. On semi-solid (0.3% agar) medium they formed "mats": complex multicellular structures composed of yeast-form cells. Both attachment to plastic and mat formation require Flo11p, a member of a Large family of fungal cell surface glycoproteins involved in adherence. The ability to study biofilm formation in a tractable genetic system may facilitate the identification of new targets for antifungal therapy.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Fink, GR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	gfink@wi.mit.edu		Reynolds, Todd/0000-0002-2867-7182	NIGMS NIH HHS [GM20565, 5 RO1 GM40266] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040266, F32GM020565] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baillie GS, 1999, METHOD ENZYMOL, V310, P644; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Gagiano M, 1999, MOL MICROBIOL, V31, P103, DOI 10.1046/j.1365-2958.1999.01151.x; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P12; HAZEN KC, 1987, J MICROBIOL METH, V6, P289, DOI 10.1016/0167-7012(87)90066-2; Hoyer LL, 1998, CURR GENET, V33, P451, DOI 10.1007/s002940050359; Liu HP, 1996, GENETICS, V144, P967; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Martinez A, 1999, J BACTERIOL, V181, P7331; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Sundstrom P, 1999, CURR OPIN MICROBIOL, V2, P353, DOI 10.1016/S1369-5274(99)80062-9	19	428	445	5	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2001	291	5505					878	881		10.1126/science.291.5505.878	http://dx.doi.org/10.1126/science.291.5505.878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11157168				2022-12-24	WOS:000166771700046
J	Owen, DK; Lewith, G; Stephens, CR				Owen, DK; Lewith, G; Stephens, CR			Can doctors respond to patients' increasing interest in complementary and alternative medicine?	BRITISH MEDICAL JOURNAL			English	Article									Winchester Homeopath Practice, Winchester SO22 6RL, Hants, England; Southampton Gen Hosp, Sch Med, Southampton SO16 6YD, Hants, England	University of Southampton	Owen, DK (corresponding author), Homeopath Phys Teaching Grp Oxford, Oxford OX1 2NP, England.			Lewith, George/0000-0002-2364-3960				BARBERIS L, IN PRESS J ALTERNATI; Barker S, 2000, MED EDUC, V34, P159, DOI 10.1046/j.1365-2923.2000.00617.x; Berman B M, 1995, J Am Board Fam Pract, V8, P361; *BMA HOUS, 1999, REP M DIFF MED SCH P; British Medical Association, 1993, COMPL MED NEW APPR G; CARSTON M, 1997, FAM MED, V29, P559; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; ERNST E, 1995, ARCH INTERN MED, V155, P2405, DOI 10.1001/archinte.155.22.2405; FISHER P, 1994, BRIT MED J, V309, P107, DOI 10.1136/bmj.309.6947.107; FREEMAN R, 1998, MENTORING GEN PRACTI, P103; FURNHAM A, 1993, COMPLEMENTARY THERAP, V1, P120; *GEN MED COUNC, 1993, TOM DOCT REC UND MED; GRIFFITHS M, 1992, J EDUC TEACHING, V18, P69, DOI 10.1080/0260747920180107; Hawkins P., 2000, SUPERVISION HELPING; LEWITH G, IN PRESS J R COLL PH; Lewith GT, 2000, COMPLEMENT THER MED, V8, P202, DOI 10.1054/ctim.2000.0377; Morgan D., 1998, COMPLEMENT THER MED, V6, P64; OWEN D, IN PRESS J MED ED; Rampes H, 1997, J ROY SOC MED, V90, P19, DOI 10.1177/014107689709000107; REILLY D, 1987, DEV INTEGRATED MED R; THOMAS K, 1995, NATL SURVEY ACCESS C; WHARTON R, 1986, BRIT MED J, V292, P1498, DOI 10.1136/bmj.292.6534.1498; Zollman C, 2000, ABC COMPLEMENTARY ME	23	63	65	1	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 20	2001	322	7279					154	157		10.1136/bmj.322.7279.154	http://dx.doi.org/10.1136/bmj.322.7279.154			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	396AZ	11159576	Green Published			2022-12-24	WOS:000166615300030
J	Madden, JC; Ruiz, N; Caparon, M				Madden, JC; Ruiz, N; Caparon, M			Cytolysin-mediated translocation (CMT): A functional equivalent of type III secretion in Gram-positive bacteria	CELL			English	Article							GROUP-A STREPTOCOCCI; CYCLIC ADP-RIBOSE; PROINFLAMMATORY RESPONSES; YERSINIA-ENTEROCOLITICA; CHOLESTEROL-BINDING; CYSTEINE PROTEASE; STREPTOLYSIN-O; VIRULENCE; PORE; MEMBRANE	Type III secretion for injection of effector proteins into host cells has not been described for Gram-positive bacteria despite their importance in disease. Here, we describe an injection pathway for the Gram-positive pathogen Streptococcus pyogenes that utilizes streptolysin O (SLO), a cholesterol-dependent cytolysin. The data support a model in which an effector is translocated through the SLO pore by a polarized process. The effector, SPN (S. pyogenes NAD-glycohydrolase), is capable of producing the potent second messenger cyclic ADP-ribose, and SLO and SPN act synergistically to trigger cytotoxicity. These data provide a novel paradigm for the function of the cholesterol-dependent cytolysin family and its wide distribution suggests that cytolysin-mediated translocation (CMT) may be the equivalent of type III secretion for Gram-positive pathogens.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Caparon, M (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	caparon@borcim.wustl.edu		Ruiz, Natividad/0000-0002-6369-2206	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR045254] Funding Source: NIH RePORTER; NIAID NIH HHS [AI38273] Funding Source: Medline; NIAMS NIH HHS [AR45254] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALOUF JE, 1980, PHARMACOL THERAPEUT, V11, P616; Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; BHAKDI S, 1993, MED MICROBIOL IMMUN, V182, P167; Billington SJ, 2000, FEMS MICROBIOL LETT, V182, P197, DOI 10.1016/S0378-1097(99)00536-4; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; BOMFORD R, 1980, INT ARCH ALLER A IMM, V63, P170, DOI 10.1159/000232623; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; CAPARON MG, 1992, J BACTERIOL, V174, P5693, DOI 10.1128/JB.174.17.5693-5701.1992; CARLSON AS, 1957, J EXP MED, V106, P15, DOI 10.1084/jem.106.1.15; Cheng LW, 2000, TRENDS MICROBIOL, V8, P214, DOI 10.1016/S0966-842X(99)01665-0; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Ellemor DM, 1999, INFECT IMMUN, V67, P4902, DOI 10.1128/IAI.67.9.4902-4907.1999; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gerlach D, 1996, FEMS MICROBIOL LETT, V136, P71; GRECO R, 1995, RES MICROBIOL, V146, P551, DOI 10.1016/0923-2508(96)80561-4; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Harshey RM, 1996, TRENDS MICROBIOL, V4, P226, DOI 10.1016/0966-842X(96)10037-8; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Jost BH, 1999, INFECT IMMUN, V67, P1723; KARASAWA T, 1995, FEMS MICROBIOL LETT, V130, P201; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Lee VT, 1999, MOL MICROBIOL, V31, P1619, DOI 10.1046/j.1365-2958.1999.01270.x; Lukomski S, 1999, INFECT IMMUN, V67, P1779; LUTTICKEN R, 1976, J CLIN MICROBIOL, V3, P533; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Nagarajan Vasantha, 1993, P713; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; OKADA N, 1993, MOL MICROBIOL, V7, P893, DOI 10.1111/j.1365-2958.1993.tb01180.x; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; SCOTT JR, 1986, J EXP MED, V164, P1641, DOI 10.1084/jem.164.5.1641; SEKIYA K, 1993, J BACTERIOL, V175, P5953, DOI 10.1128/JB.175.18.5953-5961.1993; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shresta S, 1998, CURR OPIN IMMUNOL, V10, P581, DOI 10.1016/S0952-7915(98)80227-6; Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793; Tsai PJ, 1998, INFECT IMMUN, V66, P1460, DOI 10.1128/IAI.66.4.1460-1466.1998; TWETEN RK, 1995, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 2ND EDITION, P207; Wang B, 1997, INFECT IMMUN, V65, P2119, DOI 10.1128/IAI.65.6.2119-2126.1997	44	228	239	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2001	104	1					143	152		10.1016/S0092-8674(01)00198-2	http://dx.doi.org/10.1016/S0092-8674(01)00198-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163247	Bronze			2022-12-24	WOS:000166882300014
J	Juengst, E; Fossel, M				Juengst, E; Fossel, M			The ethics of embryonic stem cells - Now and forever, cells without end	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLONING; TRANSPLANTATION; DIFFERENTIATE; REPLACEMENT; DERIVATION; THERAPY; BIOLOGY		Case Western Reserve Univ, Sch Med, Ctr Biomed Eth, Cleveland, OH 44106 USA; Michigan State Univ, Coll Human Med, Dept Med, E Lansing, MI 48824 USA	Case Western Reserve University; Michigan State University; Michigan State University College of Human Medicine	Fossel, M (corresponding author), Box 630, Ada, MI 49301 USA.	Mfossel@aol.com		Juengst, Eric/0000-0002-8374-5774				Ad Hoc Group of Consultants to the Advisory Committee to the Director,NIH, 1994, REP HUM EMBR RES PAN; *AM ASS ADV SCI, 1999, STEM CELL RES APPL M; ANDREWS LB, 2000, ETHICAL ISSUES HUMAN, V2, pA1; Armstrong RJE, 2000, CELL TRANSPLANT, V9, P139, DOI 10.1177/096368970000900202; Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Barnett SC, 2000, BRAIN, V123, P1581, DOI 10.1093/brain/123.8.1581; Basser RL, 1998, RECENT RES CANCER, V152, P355; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Boogaerts MA, 1996, ANN ONCOL, V7, P1; Branick V, 1999, Health Prog, V80, P37; Brooks PM, 1997, J RHEUMATOL, V24, P19; Burt RK, 2000, J CLIN IMMUNOL, V20, P1, DOI 10.1023/A:1006673408343; CALLAHAN D, 1995, HASTINGS CENT REP, V25, P39, DOI 10.2307/3562493; Chapman AR., 1999, STEM CELL RES APPL M; Colman A, 2000, TRENDS BIOTECHNOL, V18, P192, DOI 10.1016/S0167-7799(00)01434-7; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; Edwards BE, 2000, FERTIL STERIL, V74, P1, DOI 10.1016/S0015-0282(00)00583-5; Exner BG, 1997, STEM CELLS, V15, P171, DOI 10.1002/stem.5530150822; FLANNERY EJ, 2000, ETHICAL ISSUES HUMAN, V2, pD1; Furton Edward J, 1999, Ethics Medics, V24, P3; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; Gearhart J, 1998, SCIENCE, V282, P1061, DOI 10.1126/science.282.5391.1061; Harris LH, 2000, WOMEN HEALTH ISS, V10, P146, DOI 10.1016/S1049-3867(00)00035-9; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kikyo N, 2000, J CELL SCI, V113, P11; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kruse F E, 1997, Curr Opin Ophthalmol, V8, P46, DOI 10.1097/00055735-199708000-00007; Lake JA, 2000, J CELL SCI, V113, P555; Lavoir MC, 1998, REPROD FERT DEVELOP, V10, P557, DOI 10.1071/RD98083; Lazarus HM, 1998, CANCER INVEST, V16, P102, DOI 10.3109/07357909809039764; Lebacqz K, 1999, HASTINGS CENT REP, V29, P31; Lin HF, 1997, ANNU REV GENET, V31, P455, DOI 10.1146/annurev.genet.31.1.455; McGee G, 1999, KENNEDY INST ETHIC J, V9, P151, DOI 10.1353/ken.1999.0012; McGuire WP, 1998, CURR PROB CANCER, V22, P138, DOI 10.1016/S0147-0272(98)90005-8; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; MURPHY TF, 1985, J MED ETHICS, V11, P79, DOI 10.1136/jme.11.2.79; *NAT BIOETH ADV CO, 2000, ETH ISS HUM STEM CEL, V2; *NAT BIOETH ADV CO, 1999, ETH ISS HUM STEM CEL, V1; Ourednik V, 1999, CLIN GENET, V56, P267, DOI 10.1034/j.1399-0004.1999.560403.x; Pedersen RA, 1999, SCI AM, V280, P68, DOI 10.1038/scientificamerican0499-68; Revel M, 2000, ISR MED ASSOC J, V2, P8; ROBERTSON JA, 1995, HASTINGS CENT REP, V25, P37, DOI 10.2307/3562492; Robertson JA, 1999, KENNEDY INST ETHIC J, V9, P109, DOI 10.1353/ken.1999.0013; Roche PA, 2000, WOMEN HEALTH ISS, V10, P136, DOI 10.1016/S1049-3867(00)00037-2; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; SAULESCU J, 2000, AUST NZ J MED, V30, P492; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Snowden John A., 1999, Current Opinion in Rheumatology, V11, P167, DOI 10.1097/00002281-199905000-00003; Solter D, 1999, CROAT MED J, V40, P309; Steinbock B, 1992, LIFE BIRTH MORAL LEG; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P1773, DOI 10.1001/jama.284.14.1773; Territo M, 1997, J RHEUMATOL, V24, P36; Thomas E. Donnall, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P1; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tooley Michael, 1983, ABORTION INFANTICIDE; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Trounson A, 1998, REPROD FERT DEVELOP, V10, P121, DOI 10.1071/R98042; Tyndall A, 1997, J RHEUMATOL, V24, P94; Warren MA., 1997, MORAL STATUS OBLIGAT; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Young FE, 2000, SCIENCE, V287, P1424, DOI 10.1126/science.287.5457.1424; 1968, HUMANAE VITAE REGULA	63	33	33	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2000	284	24					3180	3184		10.1001/jama.284.24.3180	http://dx.doi.org/10.1001/jama.284.24.3180			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	385FZ	11135785				2022-12-24	WOS:000165994100039
J	Tenenbaum, JB; de Silva, V; Langford, JC				Tenenbaum, JB; de Silva, V; Langford, JC			A global geometric framework for nonlinear dimensionality reduction	SCIENCE			English	Article							COMPONENT ANALYSIS	Scientists working with Large volumes of high-dimensional data, such as global climate patterns, stellar spectra, or human gene distributions, regularly confront the problem of dimensionality reduction: finding meaningful Low-dimensional structures hidden in their high-dimensional observations. The human brain confronts the same problem in everyday perception, extracting from its high-dimensional sensory inputs-30,000 auditory nerve fibers or 10(6) optic nerve fibers-a manageably small number of perceptually relevant features. Here we describe an approach to solving dimensionality reduction problems that uses easily measured local metric information to Learn the underlying global geometry of a data set. Unlike classical techniques such as principal component analysis (PCA) and multidimensional scaling (MDS), our approach is capable of discovering the nonlinear degrees of freedom that underlie complex natural observations, such as human handwriting or images of a face under different viewing conditions. In contrast to previous algorithms for nonlinear dimensionality reduction, ours efficiently computes a globally optimal solution, and, for an important class of data manifolds, is guaranteed to converge asymptotically to the true structure.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Dept Math, Stanford, CA 94305 USA; Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15217 USA	Stanford University; Stanford University; Carnegie Mellon University	Tenenbaum, JB (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	jbt@psych.stanford.edu	cai, chao/C-4840-2009					Bailer-Jones CAL, 1998, MON NOT R ASTRON SOC, V298, P361, DOI 10.1046/j.1365-8711.1998.01596.x; Basri R, 1998, PROC CVPR IEEE, P414, DOI 10.1109/CVPR.1998.698639; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Beymer D, 1996, SCIENCE, V272, P1905, DOI 10.1126/science.272.5270.1905; Bishop CM, 1998, NEURAL COMPUT, V10, P215, DOI 10.1162/089976698300017953; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Bregler C., 1995, Advances in Neural Information Processing Systems 7, P973; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; DeMers D., 1993, ADV NEURAL INFORM PR, P580; DURBIN R, 1987, NATURE, V326, P689, DOI 10.1038/326689a0; ELMAN JL, 1988, J ACOUST SOC AM, V83, P1615, DOI 10.1121/1.395916; HASTIE T, 1989, J AM STAT ASSOC, V84, P502, DOI 10.2307/2289936; HECHTNIELSEN R, 1995, SCIENCE, V269, P1860, DOI 10.1126/science.269.5232.1860; Hinton G. E., 1995, ADV NEURAL INFORMATI, V7, P1015; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; KLEIN W, 1970, J ACOUST SOC AM, V48, P999, DOI 10.1121/1.1912239; KOHONEN T, 1988, SELF ORG ASS MEMORY, P119; KRAMER MA, 1991, AICHE J, V37, P233, DOI 10.1002/aic.690370209; KUMAR V, 1994, INTRO PARALLEL COMPU, P257; Mardia K. V., 1979, MULTIVARIATE ANAL; MARTINETZ T, 1994, NEURAL NETWORKS, V7, P507, DOI 10.1016/0893-6080(94)90109-0; MCCLURKIN JW, 1991, SCIENCE, V253, P675, DOI 10.1126/science.1908118; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; MONAHAN AH, IN PRESS J CLIM; MURASE H, 1995, INT J COMPUT VISION, V14, P5, DOI 10.1007/BF01421486; SANGER TD, 1995, ADV NEURAL INFO P SY, V7, P1023; SHEPARD RN, 1994, PSYCHON B REV, V1, P2, DOI 10.3758/BF03200759; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; SHEPARD RN, 1976, SCIENCE, V191, P952, DOI 10.1126/science.1251207; SHIFFRAR M, 1990, PSYCHOL SCI, V1, P257, DOI 10.1111/j.1467-9280.1990.tb00210.x; Simard P., 1993, ADV NEURAL INFORMATI, P50; Tenenbaum JB, 1998, ADV NEUR IN, V10, P682; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	34	8087	8991	45	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2000	290	5500					2319	+		10.1126/science.290.5500.2319	http://dx.doi.org/10.1126/science.290.5500.2319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125149				2022-12-24	WOS:000165995800049
J	Gauthier-Clerc, M; Le Maho, Y; Clerquin, Y; Drault, S; Handrich, Y				Gauthier-Clerc, M; Le Maho, Y; Clerquin, Y; Drault, S; Handrich, Y			Ecophysiology - Penguin fathers preserve food for their chicks	NATURE			English	Article							KING PENGUIN; APTENODYTES-PATAGONICA		CNRS, Ctr Ecol & Physiol Energet, F-67087 Strasbourg 2, France; Inst Francais Rech Tecnol Polaire, F-29280 Plouzane, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gauthier-Clerc, M (corresponding author), CNRS, Ctr Ecol & Physiol Energet, 23 Rue Becquerel, F-67087 Strasbourg 2, France.		Handrich, Yves/AAD-6472-2022					Barrat A, 1976, COM NAT FR RECH ANTA, V40, P9, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2014.12.010; BARRE H, 1978, J PHYSIOL-PARIS, V74, P555; CHEREL Y, 1992, IBIS, V134, P118, DOI 10.1111/j.1474-919X.1992.tb08388.x; Foxton P., 1956, Discovery Reports, V28, P191; Hart T. J., 1942, Discovery Reports Cambridge, V21, P261; JOUVENTIN P, 1994, MAR ECOL PROG SER, V106, P11, DOI 10.3354/meps106011; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; WILSON RP, 1984, J FIELD ORNITHOL, V55, P109	8	38	40	1	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					928	929		10.1038/35050163	http://dx.doi.org/10.1038/35050163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140669				2022-12-24	WOS:000165951100035
J	Lay, AJ; Jiang, XM; Kisker, O; Flynn, E; Underwood, A; Condron, R; Hogg, PJ				Lay, AJ; Jiang, XM; Kisker, O; Flynn, E; Underwood, A; Condron, R; Hogg, PJ			Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase	NATURE			English	Article							PROTEIN DISULFIDE-ISOMERASE; LEWIS-LUNG-CARCINOMA; 3-PHOSPHOGLYCERATE KINASE; GLYCOLYTIC ENZYME; ANGIOSTATIN; INHIBITOR; SUPPRESSION; PROTEOLYSIS; PLASMIN; MATRIX	Disulphide bonds in secreted proteins are considered to be inert because of the oxidizing nature of the extracellular milieu. An exception to this rule is a reductase secreted by tumour cells that reduces disulphide bonds in the serine proteinase plasmin(1,2). Reduction of plasmin initiates proteolytic cleavage in the kringle 5 domain and release of the tumour blood vessel inhibitor angiostatin(3). New blood vessel formation or angiogenesis is critical for tumour expansion and metastasis(4,5). Here we show that the plasmin reductase isolated from conditioned medium of fibrosarcoma cells is the glycolytic enzyme phosphoglycerate kinase(6). Recombinant phosphoglycerate kinase had the same specific activity as the fibrosarcoma-derived protein. Plasma of mice bearing fibrosarcoma tumours contained several-fold more phosphoglycerate kinase, as compared with mice without tumours. Administration of phosphoglycerate kinase to tumour-bearing mice caused an increase in plasma levels of angiostatin, and a decrease in tumour vascularity and rate of tumour growth. Our findings indicate that phosphoglycerate kinase not only functions in glycolysis but is secreted by tumour cells and participates in the angiogenic process as a disulphide reductase.	Univ New S Wales, Sch Pathol, Ctr Thrombosis & Vasc Res, Sydney, NSW 2052, Australia; Univ New S Wales, Prince Wales Hosp, Dept Haematol, Sydney, NSW 2052, Australia; Childrens Hosp, Dept Surg Res, Boston, MA 02115 USA; CSIRO Mol Sci, N Ryde, NSW 2113, Australia; La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Harvard University; Boston Children's Hospital; Commonwealth Scientific & Industrial Research Organisation (CSIRO); La Trobe University	Hogg, PJ (corresponding author), Univ New S Wales, Sch Pathol, Ctr Thrombosis & Vasc Res, Sydney, NSW 2052, Australia.			Hogg, Philip/0000-0001-6486-2863				Alloush HM, 1997, MICROBIOL-SGM, V143, P321, DOI 10.1099/00221287-143-2-321; Cao RH, 1999, P NATL ACAD SCI USA, V96, P5728, DOI 10.1073/pnas.96.10.5728; Cornelius LA, 1998, J IMMUNOL, V161, P6845; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1; Gately S, 1996, CANCER RES, V56, P4887; Gately S, 1997, P NATL ACAD SCI USA, V94, P10868, DOI 10.1073/pnas.94.20.10868; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; KUNTZ GWK, 1982, METHOD ENZYMOL, V90, P103; MICHELSON AM, 1983, P NATL ACAD SCI-BIOL, V80, P472, DOI 10.1073/pnas.80.2.472; O'Reilly MS, 1999, J BIOL CHEM, V274, P29568, DOI 10.1074/jbc.274.41.29568; Ogino T, 1999, J BIOL CHEM, V274, P35999, DOI 10.1074/jbc.274.50.35999; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Popanda O, 1998, BBA-GENE STRUCT EXPR, V1397, P102, DOI 10.1016/S0167-4781(97)00229-7; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Stathakis P, 1997, J BIOL CHEM, V272, P20641, DOI 10.1074/jbc.272.33.20641; Stathakis P, 1999, J BIOL CHEM, V274, P8910, DOI 10.1074/jbc.274.13.8910; UNDERWOOD PA, 1988, J IMMUNOL METHODS, V107, P119; VISHWANATHA JK, 1992, J CELL SCI, V101, P25; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407	23	214	229	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2000	408	6814					869	873		10.1038/35048596	http://dx.doi.org/10.1038/35048596			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130727				2022-12-24	WOS:000165831300053
J	Sveinbjornsdottir, S; Hicks, AA; Jonsson, T; Petursson, H; Guomundsson, G; Frigge, ML; Kong, A; Gulcher, JR; Stefansson, K				Sveinbjornsdottir, S; Hicks, AA; Jonsson, T; Petursson, H; Guomundsson, G; Frigge, ML; Kong, A; Gulcher, JR; Stefansson, K			Familial aggregation of Parkinson's disease in Iceland.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECESSIVE JUVENILE PARKINSONISM; ALPHA-SYNUCLEIN; GENE; MUTATIONS; TWINS; LINKAGE; PAIRS	Background: The role of genetics in early-onset Parkinson's disease has been established, but whether there is a genetic contribution to the more common, late-onset form remains uncertain. Methods: We reviewed the medical records and confirmed the diagnosis of Parkinson's disease in 772 living and deceased patients in whom the disease had been diagnosed during the previous 50 years in Iceland. With the use of an extensive computerized data base containing genealogic information on 610,920 people in Iceland during the past 11 centuries, several analyses were conducted to determine whether the patients were more related to each other than random members of the population (control subjects). Results: Patients with Parkinson's disease, including a subgroup of 560 patients with late-onset disease (onset at >50 years of age), were significantly more related to each other than were subjects in matched groups of controls, and this relatedness extended beyond the nuclear family. The risk ratio for Parkinson's disease was 6.7 (95 percent confidence interval, 4.3 to 9.6) for siblings, 3.2 (95 percent confidence interval, 1.2 to 7.8) for offspring, and 2.7 (95 percent confidence interval, 1.6 to 3.9) for nephews and nieces of patients with late-onset Parkinson's disease. Conclusions: Late-onset Parkinson's disease has a genetic component as well as an environmental component. (N Engl J Med 2000;343:1765-70.) (C) 2000, Massachusetts Medical Society.	Natl Univ Hosp, Reykjavik, Iceland; deCODE Genet, Reykjavik, Iceland; Univ Chicago, Dept Human Genet, Chicago, IL USA	Landspitali National University Hospital; University of Chicago	Stefansson, K (corresponding author), Natl Univ Hosp, Reykjavik, Iceland.		Hicks, Andrew Anthony/E-9518-2017; Stefansson, Kari/AAE-7187-2019	Hicks, Andrew Anthony/0000-0001-6320-0411; Kong, Augustine/0000-0001-8193-5438				Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; BHARUCHA NE, 1986, NEUROLOGY, V36, P284, DOI 10.1212/WNL.36.2.284; Duvoisin R C, 1987, Adv Neurol, V45, P307; DUVOISIN RC, 1981, NEUROLOGY, V31, P77, DOI 10.1212/WNL.31.1.77; Gasser T, 1998, ANN NEUROL, V44, pS53, DOI 10.1002/ana.410440708; Gudmundsson K. R., 1967, ACTA NEUROL SCAND  S, V43, P1; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Guo SW, 1998, AM J HUM GENET, V63, P252, DOI 10.1086/301928; GUOMUNDSSON H, 2000, EUR J HUM GENET, V8, P743; Hattori N, 1998, BIOCHEM BIOPH RES CO, V251, P666, DOI 10.1006/bbrc.1998.9504; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LANGE K, 1997, MATH STAT METHODS AN, P70; Matsumine H, 1998, GENOMICS, V49, P143, DOI 10.1006/geno.1997.5196; Moceri VM, 2000, NEUROLOGY, V54, P415, DOI 10.1212/WNL.54.2.415; Piccini P, 1999, ANN NEUROL, V45, P577, DOI 10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RISCH N, 1990, AM J HUM GENET, V46, P222; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Tassin J, 1998, AM J HUM GENET, V63, P88, DOI 10.1086/301934; WARD CD, 1983, NEUROLOGY, V33, P815, DOI 10.1212/WNL.33.7.815; Wood NW, 1998, ANN NEUROL, V44, pS58, DOI 10.1002/ana.410440709	26	212	216	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2000	343	24					1765	1770		10.1056/NEJM200012143432404	http://dx.doi.org/10.1056/NEJM200012143432404			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	382FH	11114315				2022-12-24	WOS:000165812000004
J	Graham, TA; Weaver, C; Mao, F; Kimelman, D; Xu, WQ				Graham, TA; Weaver, C; Mao, F; Kimelman, D; Xu, WQ			Crystal structure of a beta-catenin/Tcf complex	CELL			English	Article							E-CADHERIN; ALPHA-CATENIN; TUMOR-SUPPRESSOR; XENOPUS-EMBRYOS; PROTEIN; ARMADILLO; BINDING; PROGRAM; AXIN; ASSOCIATION	The Wnt signaling pathway plays critical roles in embryonic development and tumorigenesis. Stimulation of the Wnt pathway results in the accumulation of a nuclear beta -catenin/Tcf complex, activating Wnt target genes. A crystal structure of beta -catenin bound to the beta -catenin binding domain of Tcf3 (Tcf3-CBD) has been determined. The Tcf3-CBD forms an elongated structure with three binding modules that runs antiparallel to beta -catenin along the positively charged groove formed by the armadillo repeats. Structure-based mutagenesis defines three sites in beta -catenin that are critical for binding the Tcf3-CBD and are differentially involved in binding APC, cadherin, and Axin. The structural and mutagenesis data reveal a potential target for molecular drug design studies.	Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Xu, WQ (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.		Mao, Feng/B-8280-2019	Xu, Wenqing/0000-0002-2884-3101	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027262] Funding Source: NIH RePORTER; NICHD NIH HHS [HD27262, HD07183] Funding Source: Medline; NIGMS NIH HHS [GM07270] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Barker N, 2000, ADV CANCER RES, V77, P1; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Hedgepeth CM, 1999, MECH DEVELOP, V80, P147, DOI 10.1016/S0925-4773(98)00203-2; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Kato Y, 1999, J NEUROSCI, V19, P9364; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVINE E, 1994, DEVELOPMENT, V120, P901; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Omer CA, 1999, BIOCHEM BIOPH RES CO, V256, P584, DOI 10.1006/bbrc.1999.0379; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Otwinowski Z, 1997, PROCESSING XRAY DIFF, V276; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Polakis P, 2000, GENE DEV, V14, P1837; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; RUBINFELD B, 1995, J BIOL CHEM, V270, P5549, DOI 10.1074/jbc.270.10.5549; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vleminckx K, 1997, J CELL BIOL, V136, P411, DOI 10.1083/jcb.136.2.411; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zhurinsky J, 2000, J CELL SCI, V113, P3127	46	331	343	1	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 8	2000	103	6					885	896		10.1016/S0092-8674(00)00192-6	http://dx.doi.org/10.1016/S0092-8674(00)00192-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136974	Bronze			2022-12-24	WOS:000165801300008
J	Henney, JE				Henney, JE			Preventive use for ramipril	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	22	25	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2000	284	21					2711	2711		10.1001/jama.284.21.2711-c	http://dx.doi.org/10.1001/jama.284.21.2711-c			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377JB	11105160				2022-12-24	WOS:000165509500006
J	Sabatini, BL; Svoboda, K				Sabatini, BL; Svoboda, K			Analysis of calcium channels in single spines using optical fluctuation analysis	NATURE			English	Article							G-PROTEIN MODULATION; DENDRITIC SPINES; CA2+ CHANNELS; PYRAMIDAL NEURONS; VOLTAGE DEPENDENCE; NMDA RECEPTORS; TRANSIENTS; CURRENTS; RELEASE; INFLUX	Most synapses form on small, specialized postsynaptic structures known as dendritic spines(1). The influx of Ca2+ ions into such spines-through synaptic receptors and voltage-sensitive Ca2+ channels (VSCCs)-triggers diverse processes that underlie synaptic plasticity(2). Using two-photon laser scanning microscopy(3), we imaged action-potential-induced transient changes in Ca2+ concentration in spines and dendrites of CA1 pyramidal neurons in rat hippocampal slices(4). Through analysis of the large trial-to-trial fluctuations in these transients, we have determined the number and properties of VSCCs in single spines. Here we report that each spine contains 1-20 VSCCs, and that this number increases with spine volume. We are able to detect the opening of a single VSCC on a spine. In spines located on the proximal dendritic tree, VSCCs normally open with high probability (similar to0.5) following dendritic action potentials. Activation of GABA(B) receptors reduced this probability in apical spines to similar to0.3 but had no effect on VSCCs in dendrites or basal spines. Our studies show that the spatial distribution of VSCC subtypes and their modulatory potential is regulated with submicrometre precision.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.							BARAK SL, 1982, J CELL BIOL, V95, P846; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; BOLAND LM, 1993, J NEUROSCI, V13, P516; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; JONES R, 1970, APPL OPTICS, V10, P1673; KATZ B, 1970, NATURE, V226, P962, DOI 10.1038/226962a0; Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0; KOCH C, 1993, J NEUROSCI, V13, P413; KUO CC, 1993, NATURE, V365, P258, DOI 10.1038/365258a0; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; Page KM, 1998, J NEUROSCI, V18, P4815; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Rice S. O., 1954, NOISE STOCHASTIC PRO, P133; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tottene A, 1996, J NEUROSCI, V16, P6353; TRIGGLE DJ, 1989, TRENDS PHARMACOL SCI, V10, P507, DOI 10.1016/0165-6147(89)90051-5; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	30	206	209	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2000	408	6812					589	593		10.1038/35046076	http://dx.doi.org/10.1038/35046076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117746				2022-12-24	WOS:000165548600119
J	Yudkovsky, N; Ranish, JA; Hahn, S				Yudkovsky, N; Ranish, JA; Hahn, S			A transcription reinitiation intermediate that is stabilized by activator	NATURE			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; FACTOR TFIIA; IN-VITRO; RECRUITMENT; HOLOENZYME; INITIATION; YEAST; PROMOTER	High levels of gene transcription by RNA polymerase II depend on high rates of transcription initiation and reinitiation. Initiation requires recruitment of the complete transcription machinery to a promoter, a process facilitated by activators and chromatin remodelling factors. Reinitiation probably occurs through a different pathway(1). After initiation, a subset of the transcription machinery remains at the promoter, forming a platform for assembly of a second transcription complex(2-4). Here we describe the isolation of a reinitiation intermediate that includes transcription factors TFIID, TFIIA, TFIIH, TFIIE and Mediator. This intermediate can act as a scaffold for formation of a functional reinitiation complex. Formation of this scaffold is dependent on ATP and TFIIH. The scaffold is stabilized in the presence of the activator Gal4-VP16, but not Gal4-AH, suggesting a new role for some activators and Mediator in promoting high levels of transcription.	Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98109 USA; Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Hahn, S (corresponding author), Univ Washington, Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.			Hahn, Steven/0000-0001-7240-2533				CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; Farrell S, 1996, GENE DEV, V10, P2359, DOI 10.1101/gad.10.18.2359; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; Hahn S, 1998, COLD SPRING HARB SYM, V63, P181, DOI 10.1101/sqb.1998.63.181; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; JIANG Y, 1993, MOL CELL BIOL, V13, P4572, DOI 10.1128/MCB.13.8.4572; KANG JJ, 1995, MOL CELL BIOL, V15, P1234; Keaveney M, 1998, MOL CELL, V1, P917, DOI 10.1016/S1097-2765(00)80091-X; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KLEIN C, 1994, SCIENCE, V266, P280, DOI 10.1126/science.7939664; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Lee YC, 1999, MOL CELL BIOL, V19, P2967; OZER J, 1994, GENE DEV, V8, P2324, DOI 10.1101/gad.8.19.2324; RANISH JA, 1991, J BIOL CHEM, V266, P19320; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; ROBERTS SGE, 1995, CURR BIOL, V5, P508, DOI 10.1016/S0960-9822(95)00103-5; Sandaltzopoulos R, 1998, MOL CELL BIOL, V18, P361, DOI 10.1128/MCB.18.1.361; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; XIAO H, 1995, MOL CELL BIOL, V15, P5757; Yean D, 1997, MOL CELL BIOL, V17, P3809, DOI 10.1128/MCB.17.7.3809; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	27	286	290	2	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					225	229		10.1038/35041603	http://dx.doi.org/10.1038/35041603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089979				2022-12-24	WOS:000165180400051
J	Zhang, ZG; Shibahara, K; Stillman, B				Zhang, ZG; Shibahara, K; Stillman, B			PCNA connects DNA replication to epigenetic inheritance in yeast	NATURE			English	Article							ASSEMBLY FACTOR-I; ORIGIN RECOGNITION COMPLEX; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL STATES; POLYMERASE-EPSILON; CELL-CYCLE; CHROMATIN; REPRESSION; MUTATIONS; PROTEINS	Formation of a heterochromatin-like structure results in transcriptional silencing at the HM mating-type loci and telomeres in Saccharomyces cerevisiae(1-3). Once formed, such epigenetically determined structures are inherited for many mitotic divisions(4). Here we show that mutations in the proliferating cell nuclear antigen (PCNA), an essential component at the DNA replication fork(5), reduced repression of genes near a telomere and at the silent mating-type locus, HMR. The pol30-8 mutant displayed coexistence of both repressed (pink) and de-repressed (white) cells within a single colony when assayed with the ADE2 gene inserted at HMR. Unlike pol30-8, the pol30-6 and pol30-79 mutants partially reduced gene silencing at telomeres and the HMR and synergistically decreased silencing in cells lacking chromatin assembly factor 1 (CAF-1). All silencing defective mutants showed reduced binding to CAF-1 in vitro and altered chromatin association of the CAF-1 large subunit in vivo. Thus, PCNA participates in inheritance of both DNA and epigenetic chromatin structures during the S phase of the cell cycle, the latter by at least two mechanisms.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.			Stillman, Bruce/0000-0002-9453-4091				AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; Ehrenhofer-Murray AE, 1999, GENETICS, V153, P1171; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; Fox CA, 1997, SCIENCE, V276, P1547, DOI 10.1126/science.276.5318.1547; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; HENDERSON DS, 1994, EMBO J, V13, P1450, DOI 10.1002/j.1460-2075.1994.tb06399.x; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; LAMAN H, 1995, MOL CELL BIOL, V15, P3608; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; MAHONEY DJ, 1991, GENE DEV, V5, P605, DOI 10.1101/gad.5.4.605; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Scott MP, 2000, CELL, V100, P27, DOI 10.1016/S0092-8674(00)81681-5; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SUSSEL L, 1993, MOL CELL BIOL, V13, P3919, DOI 10.1128/MCB.13.7.3919; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Verreault A, 2000, GENE DEV, V14, P1430; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721	30	239	243	5	34	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					221	225		10.1038/35041601	http://dx.doi.org/10.1038/35041601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089978				2022-12-24	WOS:000165180400050
J	Noselli, S; Perrimon, N				Noselli, S; Perrimon, N			Signal transduction - Are there close encounters between signaling pathways?	SCIENCE			English	Editorial Material							MAP KINASES; ACTIVATION; DROSOPHILA; RECEPTOR		Inst Rech, CNRS, UMR 65643, F-06108 Nice 2, France; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA	Centre National de la Recherche Scientifique (CNRS); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Noselli, S (corresponding author), Inst Rech, CNRS, UMR 65643, Parc Valrose, F-06108 Nice 2, France.	noselli@unice.fr; perrimon@rascal.med.harvard.edu	Perrimon, Norbert/F-9766-2011	Perrimon, Norbert/0000-0001-7542-472X; Noselli, stephane/0000-0002-7296-324X				Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Engstrom L, 1997, CURR TOP DEV BIOL, V35, P229, DOI 10.1016/S0070-2153(08)60261-6; Gabay L, 1997, DEVELOPMENT, V124, P3535; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Scheid MP, 2000, CURR BIOL, V10, pR191, DOI 10.1016/S0960-9822(00)00349-3; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; Therond PP, 1999, DEVELOPMENT, V126, P4039; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	13	27	29	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					68	69		10.1126/science.290.5489.68	http://dx.doi.org/10.1126/science.290.5489.68			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11183153				2022-12-24	WOS:000089724800033
J	Psaty, BM; Smith, NL; Lemaitre, RN; Vos, HL; Heckbert, SR; LaCroix, AZ; Rosendaal, FR				Psaty, BM; Smith, NL; Lemaitre, RN; Vos, HL; Heckbert, SR; LaCroix, AZ; Rosendaal, FR			Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FACTOR-V-LEIDEN; CORONARY HEART-DISEASE; ACTIVATED PROTEIN-C; GENE-ENVIRONMENT INTERACTION; COAGULATION-FACTOR-V; VENOUS THROMBOSIS; 3'-UNTRANSLATED REGION; VASCULAR-DISEASE; YOUNG-WOMEN; FACTOR-II	Context Estrogens are known to be prothrombotic, and findings from the Heart and Estrogen/progestin Replacement Study suggest that in women with clinically recognized heart disease, hormone replacement therapy (HRT) may be associated with early harm and late benefit in terms of coronary events. Objective To assess whether, as hypothesized, prothrombotic mutations modify the association between HRT use and incidence of first myocardial infarction (MI). Design and Setting Population-based, case-control study conducted in a Seattle-based health maintenance organization. Participants Cases were 232 postmenopausal women aged 30 to 79 years who had their first nonfatal MI between 1995 and 1998. Controls were a stratified random sample of 723 postmenopausal women without MI who were frequency-matched to cases by age. calendar year, and hypertension status. Main Outcome Measure Risk of first nonfatal MI based on current use of HRT and the presence or absence of coagulation factor V Leiden and prothrombin 20210 G-->A variants among cases and controls, stratified by hypertension. Results One hundred eight MI cases and 387 controls had hypertension and 124 MI cases and 336 controls did not. Among hypertensive women, the prothrombin variant was a risk factor for MI (odds ratio [OR], 4.32; 95% confidence interval [CI], 1.52-12.1) and, in this stratum, there was also a significant interaction between use of HRT and presence of the prothrombin variant on risk of Mi. Compared with nonusers of HRT with wild-type genotype, women who were current users and who had the prothrombin variant (n=8) had a nearly Ii-fold increase in risk of a nonfatal MI (OR, 10.9; 95% CI, 2.15-55.2). The interaction with the prothrombin variant was more pronounced in analyses assuming 100% compliance than in those assuming 80% compliance with HRT, The interaction was absent among nonhypertensive women and was less pronounced if hypertensive and nonhypertensive women were combined into 1 group. No interaction was found for factor V Leiden in either hypertensive or nonhypertensive women. Among hypertensive women, the estimates were affected only in trivial ways by adjustment, and the interaction with the prothrombin variant was specific to HRT. Conclusions Our results suggest that among postmenopausal hypertensive women, the association between HRT use and MI risk differed between those with and without. the prothrombin 20210 G-->A variant. If these findings are confirmed in other studies. screening for the prothrombin variant may permit a better assessment of the risks and benefits associated with HRT in postmenopausal women.	Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA; Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Group Health Cooperative; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.		Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060739, R01HL043201] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL43201, HL60739] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1970, JAMA, V214, P1303; Arruda VR, 1998, CARDIOVASC RES, V37, P42, DOI 10.1016/S0008-6363(97)00211-3; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; BARRETTCONNOR E, 1998, ANNU REV PUBL HEALTH, V19, P35; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Breslow N. E., 1980, IARC SCI PUBLICATION, V32; Cushman M, 1998, THROMB HAEMOSTASIS, V79, P912; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; Doggen CJM, 1998, CIRCULATION, V97, P1037, DOI 10.1161/01.CIR.97.11.1037; Franco RF, 1999, BRIT J HAEMATOL, V104, P50, DOI 10.1046/j.1365-2141.1999.01149.x; Gardemann A, 1999, THROMB HAEMOSTASIS, V81, P208; Glueck CJ, 1999, AM J CARDIOL, V84, P549, DOI 10.1016/S0002-9149(99)00375-6; GRADY D, 1992, ANN INTERN MED, V117, P1038; Grodstein F, 1996, LANCET, V348, P983, DOI 10.1016/S0140-6736(96)07308-4; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; INMAN WHW, 1970, BMJ-BRIT MED J, V2, P203, DOI 10.1136/bmj.2.5703.203; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; Lip GYH, 2000, HYPERTENSION, V36, P975, DOI 10.1161/01.HYP.36.6.975; Lowe G, 2000, THROMB HAEMOSTASIS, V83, P530; Matthews KA, 1996, AM J EPIDEMIOL, V143, P971; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; PSATY BM, 1993, ARCH INTERN MED, V153, P1421, DOI 10.1001/archinte.153.12.1421; PSATY BM, 1994, ARCH INTERN MED, V154, P1333, DOI 10.1001/archinte.154.12.1333; PSATY BM, 1991, STAT MED, V10, P653, DOI 10.1002/sim.4780100416; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; PSATY BM, 1989, JAMA-J AM MED ASSOC, V261, P2087, DOI 10.1001/jama.261.14.2087; Redondo M, 1999, ARTERIOSCL THROM VAS, V19, P1020, DOI 10.1161/01.ATV.19.4.1020; Ridker PM, 1999, CIRCULATION, V99, P999, DOI 10.1161/01.CIR.99.8.999; Rosendaal FR, 1997, BLOOD, V89, P2817, DOI 10.1182/blood.V89.8.2817; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Rosendaal FR, 1997, BLOOD, V90, P1747, DOI 10.1182/blood.V90.5.1747; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Sechi LA, 2000, HYPERTENSION, V36, P978, DOI 10.1161/01.HYP.36.6.978; SMITH PG, 1984, INT J EPIDEMIOL, V13, P356, DOI 10.1093/ije/13.3.356; SOTANIEMI EA, 1975, SCAND J UROL NEPHROL, V9, P89, DOI 10.3109/00365597509180912; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; Yang QH, 1997, AM J EPIDEMIOL, V146, P713	43	123	127	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2001	285	7					906	913		10.1001/jama.285.7.906	http://dx.doi.org/10.1001/jama.285.7.906			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402BE	11180734	Bronze			2022-12-24	WOS:000166965500028
J	Edwards, S; Tenant-Flowers, M; Buggy, J; Horne, P; Hulme, N; Easterbrook, P; Taylor, C				Edwards, S; Tenant-Flowers, M; Buggy, J; Horne, P; Hulme, N; Easterbrook, P; Taylor, C			Issues in the management of prisoners infected with HIV-1: the King's College Hospital HIV prison service retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article									Kings Coll London Hosp, Caldecot Ctr, Dept Genitourinary HIV Med, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Edwards, S (corresponding author), Kings Coll London Hosp, Caldecot Ctr, Dept Genitourinary HIV Med, London SE5 9RS, England.	S.Edwards@cichs-tr.nthames.nhs.uk	Easterbrook, Philippa J/A-3937-2009	Easterbrook, Philippa/0000-0002-2603-5418				DIXON PS, 1993, AM J MED, V95, P629, DOI 10.1016/0002-9343(93)90359-W; Gazzard BG, 1997, LANCET, V349, P1086, DOI 10.1016/S0140-6736(96)12073-0; Her Majesty's Chief Inspector for Health Care in Prisons, 1996, PAT PRIS NEW STRAT H; *JOINT PRIS SERV N, 1999, FUT ORG DEL PRIS HL; WALSH JC, 1998, 38 INT C ANT AG CHEM	5	11	12	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 17	2001	322	7283					398	399		10.1136/bmj.322.7283.398	http://dx.doi.org/10.1136/bmj.322.7283.398			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404JH	11179158	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000167093600026
J	Schwetz, BA				Schwetz, BA			New treatment for eczema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									Off Commissioner Food & Drugs, Rockville, MD 20857 USA		Schwetz, BA (corresponding author), Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2001	285	6					724	724		10.1001/jama.285.6.724-a	http://dx.doi.org/10.1001/jama.285.6.724-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399MP	11176890				2022-12-24	WOS:000166817200005
J	Wilson, JD				Wilson, JD			Prospects for research for disorders of the endocrine system	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LUTEINIZING-HORMONE RECEPTOR; THYROTROPIN RECEPTOR; PRECOCIOUS PUBERTY; THYROID-HORMONE; MUTATIONS; AUTOANTIBODIES; RESISTANCE; GENE	Endocrine disorders, primarily diseases of the thyroid, parathyroids, pituitary, gonad, and adrenal glands, constitute a major health problem in all societies. As a result of improved insight into the diagnosis, pathophysiology, and molecular bases, it is now possible to diagnose the disorders earlier in their development, and the treatment of the deficiency states for most hormones is successful. Furthermore, with recognition that many of these disorders are either the consequence of single-gene mutations or have a major genetic component, it is now possible to diagnose affected fetuses and family members at risk. Therapies for the syndromes of hormone overproduction are less successful and frequently result in destruction of the endocrine organ involved, and the treatment of hormone resistance states is similarly unsatisfactory. These disorders are candidates for the development of superagonists/antagonists and gene therapies.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wilson, JD (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.							AHONEN P, 1990, NEW ENGL J MED, V322, P1830; Albright F, 1942, ENDOCRINOLOGY, V30, P922; BESSER GM, 1972, BRIT MED J, V3, P669, DOI 10.1136/bmj.3.5828.669; Blizzard R M, 1966, Clin Exp Immunol, V1, P119; Delange F, 1991, WERNER INGBARS THYRO, P368; DJERASSI C, 1990, STEROIDS MADE IT POS, P205; DUPREZ L, 1994, NAT GENET, V7, P396, DOI 10.1038/ng0794-396; GRIFFIN JE, IN PRESS METABOLIC M; GROLLMAN A, 1962, CLIN ENDOCRINOLOGY I, P20; KARP DR, 1998, WILLIAMS TXB ENDOCRI, P153; KREMER H, 1993, HUM MOL GENET, V2, P1779, DOI 10.1093/hmg/2.11.1779; Ma T., 1993, American Journal of Clinical Nutrition, V57, p264S, DOI 10.1093/ajcn/57.2.264S; Olefsky JM, 2001, JAMA-J AM MED ASSOC, V285, P628, DOI 10.1001/jama.285.5.628; Parma J, 1997, J CLIN ENDOCR METAB, V82, P2695, DOI 10.1210/jc.82.8.2695; Paschke R, 1997, NEW ENGL J MED, V337, P1675, DOI 10.1056/NEJM199712043372307; POSINI B, 1996, TRENDS GENET, V1, P138; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; SALVI M, 1988, ENDOCR REV, V9, P450, DOI 10.1210/edrv-9-4-450; SAWIN CT, 1989, JAMA-J AM MED ASSOC, V261, P2653, DOI 10.1001/jama.261.18.2653; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; SPEISER PW, 1990, J CLIN ENDOCR METAB, V70, P838, DOI 10.1210/jcem-70-4-838; TAKASU N, 1992, NEW ENGL J MED, V326, P513, DOI 10.1056/NEJM199202203260803; UIBO R, 1994, J CLIN ENDOCR METAB, V78, P323, DOI 10.1210/jc.78.2.323; VERHOEVEN GFM, 1979, METABOLISM, V28, P253, DOI 10.1016/0026-0495(79)90072-6; VICKERY BH, 1986, ENDOCR REV, V7, P115, DOI 10.1210/edrv-7-1-115; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403	27	5	6	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					624	627		10.1001/jama.285.5.624	http://dx.doi.org/10.1001/jama.285.5.624			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176870	Bronze			2022-12-24	WOS:000166714200023
J	Friedrich, RW; Laurent, G				Friedrich, RW; Laurent, G			Dynamic optimization of odor representations by slow temporal patterning of mitral cell activity	SCIENCE			English	Article							RAT OLFACTORY-BULB; OSCILLATING NEURAL ASSEMBLIES; INTRACELLULAR-POTENTIALS; SINGLE NEURONS; TUFTED CELLS; STIMULATION; DISCRIMINATION; COMBINATORIAL; INFORMATION; INTENSITY	Mitral cells (MCs) in the olfactory bulb (OB) respond to odors with slow temporal firing patterns. The representation of each odor by activity patterns across the MC population thus changes continuously throughout a stimulus, in an odor-specific manner. In the zebrafish OB, we found that this distributed temporal patterning progressively reduced the similarity between ensemble representations of related odors, thereby making each odor's representation more specific over time. The tuning of individual MCs was not sharpened during this process. Hence, the individual responses of MCs did not become more specific, but the odor-coding MC assemblies changed such that their overlap decreased. This optimization of ensemble representations did not occur among olfactory afferents but resulted from OB circuit dynamics. Time can therefore gradually optimize stimulus representations in a sensory network.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, MC 139-74, Pasadena, CA 91125 USA.		Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Friedrich, Rainer/0000-0001-9107-0482				ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Carr W.E.S., 1988, P3; Dan Y, 1996, J NEUROSCI, V16, P3351; DuchampViret P, 1997, PROG NEUROBIOL, V53, P561, DOI 10.1016/S0301-0082(97)00049-X; EECKMAN FH, 1990, BRAIN RES, V528, P238, DOI 10.1016/0006-8993(90)91663-2; FRIEDRICH R, UNPUB; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; HAMILTON KA, 1985, BRAIN RES, V338, P181, DOI 10.1016/0006-8993(85)90265-3; HAMILTON KA, 1989, J NEUROPHYSIOL, V62, P609, DOI 10.1152/jn.1989.62.3.609; HARRISON TA, 1986, J NEUROPHYSIOL, V56, P1571, DOI 10.1152/jn.1986.56.6.1571; HARTLINE HK, 1957, J GEN PHYSIOL, V40, P357, DOI 10.1085/jgp.40.3.357; HASEGAWA T, 1994, COMP BIOCHEM PHYS A, V108, P17, DOI 10.1016/0300-9629(94)90048-5; Jvreskog, 1996, APPL FACTOR ANAL NAT; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P695, DOI 10.1113/jphysiol.1974.sp010772; KAUER JS, 1991, TRENDS NEUROSCI, V14, P79, DOI 10.1016/0166-2236(91)90025-P; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; MAIR RG, 1982, J PHYSIOL-LONDON, V326, P341, DOI 10.1113/jphysiol.1982.sp014197; MANCIA M, 1962, ARCH ITAL BIOL, V100, P449; MATHIESON WB, 1988, J COMP PHYSIOL A, V163, P489, DOI 10.1007/BF00604903; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; MEREDITH M, 1978, J GEN PHYSIOL, V71, P615, DOI 10.1085/jgp.71.6.615; MICHEL WC, UNPUB; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Motokizawa F, 1996, EXP BRAIN RES, V112, P24; MOUNTCASTLE VB, 1968, MED PHYSIOL, V2, P1372; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; SATOU M, 1990, PROG NEUROBIOL, V34, P115, DOI 10.1016/0301-0082(90)90004-Z; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; YOUNG ED, 1984, HEARING SCI, P423	37	333	337	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					889	894		10.1126/science.291.5505.889	http://dx.doi.org/10.1126/science.291.5505.889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11157170				2022-12-24	WOS:000166771700049
J	Hooper, LV; Wong, MH; Thelin, A; Hansson, L; Falk, PC; Gordon, JI				Hooper, LV; Wong, MH; Thelin, A; Hansson, L; Falk, PC; Gordon, JI			Molecular analysis of commensal host-microbial relations hips in the intestine	SCIENCE			English	Article							GENE-EXPRESSION; ECOSYSTEM; ANGIOGENIN; INITIATION; PROTEIN; MOUSE; MICE	Human beings contain complex societies of indigenous microbes, yet little is known about how resident bacteria shape our physiology. We colonized germfree mice with Bacteroides thetaiotaomicron, a prominent component of the normal mouse and human intestinal microflora. Global intestinal transcriptional responses to colonization were observed with DNA microarrays, and the cellular origins of selected responses were established by laser-capture microdissection. The results reveal that this commensal bacterium modulates expression of genes involved in several important intestinal functions, including nutrient absorption, mucosal barrier fortification, xenobiotic metabolism, angiogenesis, and postnatal intestinal maturation. These findings provide perspectives about the essential nature of the interactions between resident microorganisms and their hosts.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; AstraZeneca R&D, SE-43183 Molndal, Sweden	Washington University (WUSTL); AstraZeneca	Gordon, JI (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	jgordon@molecool.wustl.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, R37DK030292] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK30292] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; CHINSKY JM, 1990, DIFFERENTIATION, V42, P172, DOI 10.1111/j.1432-0436.1990.tb00759.x; De Lisle RC, 1998, AM J PHYSIOL-GASTR L, V275, pG219, DOI 10.1152/ajpgi.1998.275.2.G219; Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998; Fu XY, 1999, GROWTH FACTORS, V17, P125, DOI 10.3109/08977199909103521; Fu XY, 1997, MOL CELL BIOL, V17, P1503, DOI 10.1128/MCB.17.3.1503; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; HUSEBYE E, 1994, DIGEST DIS SCI, V39, P946, DOI 10.1007/BF02087542; Ingelman-Sundberg M, 1999, TRENDS PHARMACOL SCI, V20, P342, DOI 10.1016/S0165-6147(99)01363-2; Johnstone RW, 2000, TRENDS BIOCHEM SCI, V25, P1, DOI 10.1016/S0968-0004(99)01493-0; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; KRASINSKI SD, 1994, AM J PHYSIOL-GASTR L, V267, pG584, DOI 10.1152/ajpgi.1994.267.4.G584; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Liu MT, 1997, J NEUROSCI, V17, P4764; Lowe ME, 1998, J BIOL CHEM, V273, P31215, DOI 10.1074/jbc.273.47.31215; LUK GD, 1980, SCIENCE, V210, P195, DOI 10.1126/science.6774420; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Nilsson J, 1997, EUR J BIOCHEM, V250, P223, DOI 10.1111/j.1432-1033.1997.0223a.x; Nobile V, 1996, P NATL ACAD SCI USA, V93, P4331, DOI 10.1073/pnas.93.9.4331; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Steinert PM, 1999, MOL BIOL CELL, V10, P4247, DOI 10.1091/mbc.10.12.4247; Steuerwald N, 1999, MOL HUM REPROD, V5, P1034, DOI 10.1093/molehr/5.11.1034; Thim L, 2000, REGUL PEPTIDES, V90, P61, DOI 10.1016/S0167-0115(00)00110-5; USHIJIMA T, 1983, MICROBIOL IMMUNOL, V27, P985, DOI 10.1111/j.1348-0421.1983.tb02929.x; WOSTMANN BS, 1983, LAB ANIM SCI, V33, P46	26	1497	1686	9	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2001	291	5505					881	884		10.1126/science.291.5505.881	http://dx.doi.org/10.1126/science.291.5505.881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11157169				2022-12-24	WOS:000166771700047
J	Tang, DG; Tokumoto, YM; Apperly, JA; Lloyd, AC; Raff, MC				Tang, DG; Tokumoto, YM; Apperly, JA; Lloyd, AC; Raff, MC			Lack of replicative senescence in cultured rat - Oligodendrocyte precursor cells	SCIENCE			English	Article							THYROID-HORMONE; OPTIC-NERVE; P16(INK4A)/CDKN2A; PROGRESSION; INHIBITORS; NUMBER; CANCER; P53	Most mammalian somatic cells are thought to have a limited proliferative capacity because they permanently stop dividing after a finite number of divisions in culture, a state termed replicative cell senescence. Here we show that most oligodendrocyte precursor cells purified from postnatal rat optic nerve can proliferate indefinitely in serum-free culture if prevented from differentiating; various cell cycle-inhibitory proteins increase, but the cells do not stop dividing. The cells maintain high telomerase activity and p53- and Rb-dependent cell cycle checkpoint responses, and serum or genotoxic drugs induce them to acquire a senescence-like phenotype. Our findings suggest that some normal rodent precursor cells have an unlimited proliferative capacity if cultured in conditions that avoid both differentiation and the activation of checkpoint responses that arrest the cell cycle.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London	Tang, DG (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX 78957 USA.	dtang@sprd1.mdacc.tmc.edu	Messier, Claude/A-2322-2008; Tang, Dean/AAI-3457-2020	Messier, Claude/0000-0002-4791-1763; Tang, Dean/0000-0001-5029-1174				BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Chang BD, 1999, CANCER RES, V59, P3761; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; Gao FB, 1998, DEV BIOL, V197, P54, DOI 10.1006/dbio.1998.8877; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Lloyd AC, 1998, CURR OPIN GENET DEV, V8, P43, DOI 10.1016/S0959-437X(98)80060-9; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Raff MC, 1998, INT J DEV BIOL, V42, P263; RAFF MC, 1993, NATURE, V303, P396; Ruas M, 1999, ONCOGENE, V18, P5423, DOI 10.1038/sj.onc.1202918; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592	26	180	187	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					868	871		10.1126/science.1056780	http://dx.doi.org/10.1126/science.1056780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11157165				2022-12-24	WOS:000166771700043
J	De Wals, P; De Serres, G; Niyonsenga, T				De Wals, P; De Serres, G; Niyonsenga, T			Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYSACCHARIDE VACCINE; NEISSERIA-MENINGITIDIS; IMMUNOLOGICAL MEMORY; VIRULENT CLONE; GROUP-A; CANADA; INDUCTION; EMERGENCE; CHILDREN; EFFICACY	Context An outbreak of meningococcal disease in Quebec province prompted a mass immunization program. The impact of this campaign on the epidemiology of meningococcal disease has not been studied. Objectives To study the impact of a mass immunization campaign using polysaccharide vaccine on the epidemiology of meningococcal disease (MCD) and to assess serogroup C vaccine effectiveness IVE), Design, setting, and Subjects Analysis of MCD cases reported in Quebec from 1990 to 1998, before and after the mass immunization campaign was conducted during the winter of 1992-1993, when 84% of residents aged 6 months to 20 years (the target population, approximately 1.9 million individuals) were vaccinated, Main Outcome Measures Incidence of MCD in 1990-1998; incidence of culture-proven serogroup C MCD between April 1, 1993, and March 31, 1998, compared among vaccinated and unvaccinated persons in the target population. Results The incidence of serogroup C disease decreased after the mass immunization campaign, from 1.4 per 100000 in 1990-1992 to 0.3 per 100000 in 1993-1998, and the overall incidence of other serogroups remained stable at 0.7 per 100000, with a small increase in the proportion of cases caused by serogroup Y (P=.009). Protection from serogroup C MCD was indicated in the first 2 years after vaccine administration (VE, 65%; 95% confidence interval [CI], 20%-84%), but not in the next 3 years (VE, 0%; 95% CI, -5% to 65%), Vaccine effectiveness was strongly related to age at vaccination: 83% (95% CI, 39%-96%) for ages 15 through 20 years, 75% (95% CI,- 17% to 93%) for ages 10 through 14 years, and 41% (95% CI, -106% to 79%) for ages 2 through 9 years. There was no evidence of protection in children younger than 2 years; all 8 MCD cases in this age group occurred in vaccinees. Conclusions Serogroup C polysaccharide vaccine is effective for controlling outbreaks in teenaged individuals but should not be used in children younger than 2 years. The mass campaign did not induce significant serogroup switching.	Univ Sherbrooke, Dept Community Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada; Sherbrooke Univ Hosp Ctr, Clin Res Ctr, Sherbrooke, PQ, Canada; Univ Laval, Quebec Univ Hosp Ctr, Publ Hlth Res Unit, Quebec City, PQ, Canada	University of Sherbrooke; University of Sherbrooke; Laval University	De Wals, P (corresponding author), Univ Sherbrooke, Dept Community Hlth Sci, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.		Niyonsenga, Theo/C-3759-2014	Niyonsenga, Theo/0000-0002-6723-0316				*ADV COMM EP, 1991, CAN DIS WKLY REP S3, V17, P29; ARTENSTEIN MS, 1970, NEW ENGL J MED, V282, P417, DOI 10.1056/NEJM197002192820803; ASHTON FE, 1991, J CLIN MICROBIOL, V29, P2489, DOI 10.1128/JCM.29.11.2489-2493.1991; Cartwright K, 1995, MENINGOCOCCAL DIS; *CYT SOFTW CORP, 1999, STATX 4 WIND; DEVINE JF, 1970, AM J EPIDEMIOL, V92, P25; DeWals P, 1996, B WORLD HEALTH ORGAN, V74, P407; Erickson L, 1998, CLIN INFECT DIS, V26, P1159, DOI 10.1086/520303; GOLD R, 1977, J INFECT DIS, V136, pS31, DOI 10.1093/infdis/136.Supplement.S31; GOLD R, 1971, B WORLD HEALTH ORGAN, V45, P279; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1973, J INFECT DIS, V128, P769, DOI 10.1093/infdis/128.6.769; GOTSCHLICH EC, 1969, J EXP MED, V129, P1385, DOI 10.1084/jem.129.6.1385; Granoff DM, 1998, J INFECT DIS, V178, P870, DOI 10.1086/515346; Kertesz DA, 1998, J INFECT DIS, V177, P1754, DOI 10.1086/517439; King WJ, 1996, J PEDIATR-US, V128, P196, DOI 10.1016/S0022-3476(96)70389-X; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; Lavigne P, 1992, Can Commun Dis Rep, V18, P113; Leach A, 1997, J INFECT DIS, V175, P200, DOI 10.1093/infdis/175.1.200; LEPOW ML, 1977, PEDIATRICS, V60, P673; MacDonald NE, 1998, JAMA-J AM MED ASSOC, V280, P1685, DOI 10.1001/jama.280.19.1685; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; PELTOLA H, 1985, PEDIATRICS, V76, P91; Richmond P, 2000, J INFECT DIS, V181, P761, DOI 10.1086/315284; Rivest D, 1999, CAN J PUBLIC HEALTH, V90, P250, DOI 10.1007/BF03404126; Rosenstein N, 1998, JAMA-J AM MED ASSOC, V279, P435, DOI 10.1001/jama.279.6.435; Salleras L, 1999, VACCINE, V17, pS56, DOI 10.1016/S0264-410X(99)00294-7; SAS Institute Inc, 1997, SAS STAT SOFTW CHANG; Sbyrakis S, 1999, LANCET, V354, P1733, DOI 10.1016/S0140-6736(05)76724-6; STEIN KE, 1992, J INFECT DIS, V165, P549; TAUNAY A E, 1978, Revista do Instituto Adolfo Lutz, V38, P77; *VACC PROGR GROUP, 1999, COMM DIS REP CDR WKL, V9, P261; Vogel U, 2000, NEW ENGL J MED, V342, P219, DOI 10.1056/NEJM200001203420319; WHALEN CM, 1995, JAMA-J AM MED ASSOC, V273, P390, DOI 10.1001/jama.273.5.390; Zhang Q, 2000, INFECT IMMUN, V68, P2692, DOI 10.1128/IAI.68.5.2692-2697.2000	35	66	73	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2001	285	2					177	181		10.1001/jama.285.2.177	http://dx.doi.org/10.1001/jama.285.2.177			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389FB	11176810	Bronze			2022-12-24	WOS:000166227000025
J	Anttila, T; Saikku, P; Koskela, P; Bloigu, A; Dillner, J; Ikaheimo, I; Jellum, E; Lehtinen, M; Lenner, P; Hakulinen, T; Narvanen, A; Pukkala, E; Thoresen, S; Youngman, L; Paavonen, J				Anttila, T; Saikku, P; Koskela, P; Bloigu, A; Dillner, J; Ikaheimo, I; Jellum, E; Lehtinen, M; Lenner, P; Hakulinen, T; Narvanen, A; Pukkala, E; Thoresen, S; Youngman, L; Paavonen, J			Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYMERASE-CHAIN-REACTION; HUMAN-PAPILLOMAVIRUS; IN-SITU; SEROVAR DETERMINATION; INFECTION; ANTIBODIES; DNA; IMMUNOTYPES; PERSISTENCE; STRAINS	Context Human papillomavirus (HPV) infection has been established as a cause of cervical cancer. Epidemiologic studies suggest that Chlamydia trachomatis infection. also confers increased risk for cervical squamous cell carcinoma (SCC). Whether this risk is serotype-specific is unknown. Objective To study the association between exposure to different C trachomatis serotypes and subsequent development of cervical SCC. Design and Setting Longitudinal, nested case-control study within a cohort of 530000 women who provided samples to serum banks in Finland, Norway, and Sweden, The data files were linked to respective national cancer registries. Subjects One hundred twenty-eight women who had developed invasive cervical SCC at least 12 months following serum donation. Each case had 3 matched controls. Main Outcome Measure Risk for the development of cervical SCC by Ige antibodies to 10 different C trachomatis serotypes, adjusted for antibodies to HPV types 16, 18, and 33 and for serum cotinine levels. Results Of specific C trachomatis serotypes, serotype CI was most strongly associated with SCC (adjusted odds ratio [OR], 6.6; 95 % confidence interval [CI], 1.6-27.0), Other serotypes associated with SCC were I (OR, 3.8; 95% CI, 1.3-11.0) and D (OR, 2.7; 95% CI, 1.3-5.6). Presence of serum IgG antibodies to more than 1 serotype increased the adjusted ORs for SCC (P<.001 for trend). Conclusions Chlamydia trachomatis serotype C is most strongly associated with subsequent development of cervical SCC. Increasing numbers of exposures to different C trachomatis serotypes also increases risk, Our results strengthen the evidence that there is a link between past C trachomatis infection and cervical SCC.	Univ Helsinki, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; Natl Publ Hlth Inst, Oulu, Finland; Univ Oulu, Dept Med Microbiol, Oulu, Finland; Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden; Oulu Univ Hosp, Microbiol Lab, Oulu, Finland; Univ Oslo, Rikshosp, Inst Clin Biochem, N-0027 Oslo, Norway; Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland; Umea Univ, Dept Oncol, Umea, Sweden; Univ Helsinki, Dept Publ Hlth, FIN-00290 Helsinki, Finland; Univ Kuopio, Dept Biochem, FIN-70211 Kuopio, Finland; Finnish Canc Registry, FIN-00170 Helsinki, Finland; Canc Registry Norway, Oslo, Norway; Univ Oxford, Clin Trial Serv Unit, Oxford, England	University of Helsinki; Finland National Institute for Health & Welfare; University of Oulu; Karolinska Institutet; University of Oulu; University of Oslo; National Hospital Norway; Tampere University; Umea University; University of Helsinki; Finland National Institute for Health & Welfare; University of Eastern Finland; Finnish Cancer Registry; University of Oslo; University of Oxford	Paavonen, J (corresponding author), Univ Helsinki, Dept Obstet & Gynecol, Haartmaninkatu 2, FIN-00290 Helsinki, Finland.	jorma.paavonen@helsinki.fi	Narvanen, Ale/A-6002-2009	Paavonen, Jorma/0000-0003-4775-606X; lehtinen, matti/0000-0002-9481-0535				AnderssonEllstrom A, 1996, SEX TRANSM DIS, V23, P234, DOI 10.1097/00007435-199605000-00013; BARDY AH, 1993, BRIT J OBSTET GYNAEC, V100, P721, DOI 10.1111/j.1471-0528.1993.tb14262.x; BARNES RC, 1987, J INFECT DIS, V156, P953, DOI 10.1093/infdis/156.6.953; BARNES RC, 1985, J INFECT DIS, V152, P985, DOI 10.1093/infdis/152.5.985; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; BRESLOW N, 1980, IARC MON EV CARC RIS, V32; Chow WH, 1998, CANCER RES, V58, P588; DEAN D, 1995, J INFECT DIS, V172, P1013, DOI 10.1093/infdis/172.4.1013; DEAN D, 1998, CHLAMYDIAL INFECT, P39; DILLNER J, 1994, CANCER RES, V54, P134; Dillner J, 1997, J NATL CANCER I, V89, P1293, DOI 10.1093/jnci/89.17.1293; Dillner J, 1996, J INFECT DIS, V173, P1394, DOI 10.1093/infdis/173.6.1394; Eck M, 1997, GASTROENTEROLOGY, V112, P1482, DOI 10.1016/S0016-5085(97)70028-3; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; *IARC, 1995, IARC MON EV CARC RIS, V64; ITO JI, 1990, INFECT IMMUN, V58, P2021, DOI 10.1128/IAI.58.6.2021-2023.1990; JELLUM E, 1995, ENVIRON HEALTH PERSP, V103, P85, DOI 10.2307/3432566; Josefsson AM, 2000, LANCET, V355, P2189, DOI 10.1016/S0140-6736(00)02401-6; Koskela P, 2000, INT J CANCER, V85, P35, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;35::AID-IJC6&gt;3.0.CO;2-A; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; LAN J, 1995, J CLIN MICROBIOL, V33, P3194, DOI 10.1128/JCM.33.12.3194-3197.1995; Lehtinen M, 1996, BMJ-BRIT MED J, V312, P537, DOI 10.1136/bmj.312.7030.537; Lie AK, 1997, APMIS, V105, P115, DOI 10.1111/j.1699-0463.1997.tb00549.x; Lin JSL, 1998, J INFECT DIS, V178, P1707, DOI 10.1086/314485; MAYER J, 1993, INFECT IMMUN, V61, P491, DOI 10.1128/IAI.61.2.491-497.1993; MIYASHITA N, 1992, J CLIN MICROBIOL, V30, P2911, DOI 10.1128/JCM.30.11.2911-2916.1992; MONCAN T, 1990, RES MICROBIOL, V141, P695, DOI 10.1016/0923-2508(90)90063-V; Narvanen A, 1997, Infect Dis Obstet Gynecol, V5, P349; NEWHALL WJ, 1986, J CLIN MICROBIOL, V23, P333, DOI 10.1128/JCM.23.2.333-338.1986; Paavonen J, 1988, Obstet Gynecol Surv, V43, P373, DOI 10.1097/00006254-198807000-00001; POOLE E, 1992, INFECT IMMUN, V60, P1089, DOI 10.1128/IAI.60.3.1089-1094.1992; PUOLAKKAINEN M, 1986, J CLIN MICROBIOL, V23, P924, DOI 10.1128/JCM.23.5.924-928.1986; ROSIN MP, 1994, CANCER RES, V54, pS1929; SAIKKU P, 1987, ACTA PATH MICRO IM B, V95, P131; Schlott T, 1998, J HISTOCHEM CYTOCHEM, V46, P1017, DOI 10.1177/002215549804600905; TEPPO L, 1994, ACTA ONCOL, V33, P365, DOI 10.3109/02841869409098430; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; WANG SP, 1991, J INFECT DIS, V163, P403, DOI 10.1093/infdis/163.2.403; WANG SP, 1970, AM J OPHTHALMOL, V70, P367, DOI 10.1016/0002-9394(70)90096-6; WORKOWSKI KA, 1992, J INFECT DIS, V166, P1445, DOI 10.1093/infdis/166.6.1445	42	258	287	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2001	285	1					47	51		10.1001/jama.285.1.47	http://dx.doi.org/10.1001/jama.285.1.47			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387GH	11150108	hybrid			2022-12-24	WOS:000166114500023
J	Hestmark, G				Hestmark, G			Temptations of the tree - A perennial image of life, history and enlightenment.	NATURE			English	Editorial Material									Univ Oslo, Dept Biol, N-0316 Oslo, Norway	University of Oslo	Hestmark, G (corresponding author), Univ Oslo, Dept Biol, N-0316 Oslo, Norway.								0	14	14	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					911	911		10.1038/35050204	http://dx.doi.org/10.1038/35050204			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140658	Bronze			2022-12-24	WOS:000165951100024
J	Premkumar, LS; Ahern, GP				Premkumar, LS; Ahern, GP			Induction of vanilloid receptor channel activity by protein kinase C	NATURE			English	Article							ROOT GANGLION NEURONS; SENSORY NEURONS; CAPSAICIN RECEPTOR; PEPTIDE RELEASE; IN-VITRO; BRADYKININ; ACTIVATION; HEAT; CURRENTS; SENSITIZATION	Capsaicin or vanilloid receptors (VRs) participate in the sensation of thermal and inflammatory pain(1-3). The cloned (VR1) and native VRs are non-selective cation channels directly activated by harmful heat, extracellular protons and vanilloid compounds(4-8). However, considerable attention has been focused on identifying other signalling pathways in VR activation; it is known that VR1 is also expressed in non-sensory tissue(1,9) and may mediate inflammatory rather than acute thermal pain(3). Here we show that activation of protein kinase C (PKC) induces VR1 channel activity at room temperature in the absence of any other agonist. We also observed this effect in native VRs from sensory neurons, and phorbol esters induced a vanilloid-sensitive Ca2+ rise in these cells. Moreover, the pro-inflammatory peptide, bradykinin, and the putative endogenous ligand, anandamide, respectively induced and enhanced VR activity, in a PKC-dependent manner. These results suggest that PKC may link a range of stimuli to the activation of VRs.	So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62702 USA	Southern Illinois University System; Southern Illinois University	Premkumar, LS (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62702 USA.							Barber LA, 1996, J NEUROCHEM, V67, P72; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BURGESS GM, 1989, J NEUROSCI, V9, P3314; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; De Petrocellis L, 1995, BIOCHEM MOL BIOL INT, V36, P1127; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; DRAY A, 1990, NEUROSCI LETT, V110, P52, DOI 10.1016/0304-3940(90)90786-9; DRAY A, 1988, NEUROSCI LETT, V91, P301, DOI 10.1016/0304-3940(88)90697-0; DUNN PM, 1990, BRIT J PHARMACOL, V100, P656, DOI 10.1111/j.1476-5381.1990.tb15863.x; Frayer SM, 1999, NEUROSCI LETT, V265, P17, DOI 10.1016/S0304-3940(99)00090-7; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Kessler F, 1999, PAIN, V83, P289, DOI 10.1016/S0304-3959(99)00108-6; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Mizumura K, 1997, NEUROSCI LETT, V237, P29, DOI 10.1016/S0304-3940(97)00793-3; Oh U, 1996, J NEUROSCI, V16, P1659; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Szallasi A, 1999, PHARMACOL REV, V51, P159; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; WOOD JN, 1988, J NEUROSCI, V8, P3208; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	27	631	654	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					985	990		10.1038/35050121	http://dx.doi.org/10.1038/35050121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140687				2022-12-24	WOS:000165951100053
J	Lever, MA; Th'ng, JPH; Sun, XJ; Hendzel, MJ				Lever, MA; Th'ng, JPH; Sun, XJ; Hendzel, MJ			Rapid exchange of histone H1.1 on chromatin in living human cells	NATURE			English	Article							H3 PHOSPHORYLATION; LINKER HISTONES; IN-VIVO; CHROMOSOME CONDENSATION; MOUSE FIBROBLASTS; GENE-EXPRESSION; KINASE-ACTIVITY; OKADAIC ACID; HELA-CELLS; TRANSCRIPTION	The considerable length of DNA in eukaryotic genomes requires packaging into chromatin to rt inside the small dimensions of the cell nucleus. Histone H1 functions in the compaction of chromatin into higher order structures derived from the repeating 'beads on a string' nucleosome polymer. Modulation of H1 binding activity is thought to be an important step in the potentiation/depotentiation of chromatin structure for transcription(1-4). It is generally accepted that H1 binds less tightly than other histones to DNA in chromatin and can readily exchange in living cells(5-8). Fusion proteins of Histone H1 and green fluorescent protein (GFP) have been shown(9) to associate with chromatin in an apparently identical fashion to native histone H1. This provides a means by which to study histone H1-chromatin interactions in living cells. Here we have used human cells with a stably integrated H1.1-GFP fusion protein to monitor histone H1 movement directly by fluorescence recovery after photobleaching in living cells. We rnd that exchange is rapid in both condensed and decondensed chromatin, occurs throughout the cell cycle, and does not require fibre-fibre interactions. Treatment with drugs that alter protein phosphorylation significantly reduces exchange rates. Our results show that histone H1 exchange in vivo is rapid, occurs through a soluble intermediate, and is modulated by the phosphorylation of a protein or proteins as yet to be determined.	Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; Univ Alberta, Fac Med & Dent, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; NW Ontario Reg Canc Ctr, Thunder Bay, ON P7A 7T1, Canada	University of Alberta; University of Alberta	Hendzel, MJ (corresponding author), Univ Alberta, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.		Hendzel, Michael/C-3391-2009	Hendzel, Michael/0000-0002-9603-7945				Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Chadee DN, 1997, J BIOL CHEM, V272, P8113, DOI 10.1074/jbc.272.13.8113; CHADEE DN, 1995, J BIOL CHEM, V270, P20098, DOI 10.1074/jbc.270.34.20098; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; EICK S, 1989, EUR J CELL BIOL, V49, P110; Gunjan A, 1999, J BIOL CHEM, V274, P37950, DOI 10.1074/jbc.274.53.37950; GUO XW, 1995, EMBO J, V14, P976, DOI 10.1002/j.1460-2075.1995.tb07078.x; HENDZEL MJ, 1990, BIOCHEM J, V271, P67, DOI 10.1042/bj2710067; JIN YJ, 1986, J BIOL CHEM, V261, P5805; Kruhlak MJ, 2000, J CELL BIOL, V150, P41, DOI 10.1083/jcb.150.1.41; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; LI W, 1993, BIOCHEM J, V296, P737, DOI 10.1042/bj2960737; LOUTERS L, 1985, BIOCHEMISTRY-US, V24, P3080, DOI 10.1021/bi00334a002; LU MJ, 1994, CHROMOSOMA, V103, P111; PARSEGHIAN MH, 1994, CHROMOSOMA, V103, P198, DOI 10.1007/BF00368013; PAULSON JR, 1994, J CELL SCI, V107, P267; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pruss D, 1996, SCIENCE, V274, P614, DOI 10.1126/science.274.5287.614; ROBERGE M, 1990, J CELL BIOL, V111, P1753, DOI 10.1083/jcb.111.5.1753; ROTH SY, 1992, TRENDS BIOCHEM SCI, V17, P93, DOI 10.1016/0968-0004(92)90243-3; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; Talasz H, 1998, J BIOL CHEM, V273, P32236, DOI 10.1074/jbc.273.48.32236; THNG JPH, 1994, J BIOL CHEM, V269, P9568; THOMAS JO, 1983, EUR J BIOCHEM, V134, P109, DOI 10.1111/j.1432-1033.1983.tb07538.x; Thomas JO, 1999, CURR OPIN CELL BIOL, V11, P312, DOI 10.1016/S0955-0674(99)80042-8; Wolffe AP, 1997, BIOESSAYS, V19, P249, DOI 10.1002/bies.950190311; WU LH, 1986, J CELL BIOL, V103, P465, DOI 10.1083/jcb.103.2.465; ZLATANOVA J, 1992, J CELL SCI, V103, P889	30	326	333	0	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2000	408	6814					873	876		10.1038/35048603	http://dx.doi.org/10.1038/35048603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130728				2022-12-24	WOS:000165831300054
J	Tabata, S; Kaneko, T; Nakamura, Y; Kotani, H; Kato, T; Asamizu, E; Miyajima, N; Sasamoto, S; Kimura, T; Hosouchi, T; Kawashima, K; Kohara, M; Matsumoto, M; Matsuno, A; Muraki, A; Nakayama, S; Nakazaki, N; Naruo, K; Okumura, S; Shinpo, S; Takeuchi, C; Wada, T; Watanabe, A; Yamada, M; Yasuda, M; Sato, S; de la Bastide, M; Huang, E; Spiegel, L; Gnoj, L; O'Shaughnessy, A; Preston, R; Habermann, K; Murray, J; Johnson, D; Rohlrng, T; Nelson, J; Stoneking, T; Pepin, K; Spieth, J; Sekhon, M; Armstrong, J; Becker, M; Belter, E; Cordum, H; Cordes, M; Courtney, L; Courtney, W; Dante, M; Du, H; Edwards, J; Fryman, J; Haakensen, B; Lamar, E; Latreille, P; Leonard, S; Meyer, R; Mulvaney, E; Ozersky, P; Riley, A; Strowmatt, C; Wagner-McPherson, C; Wollam, A; Yoakum, M; Bell, M; Dedhia, N; Parnell, L; Shah, R; Rodriguez, M; See, LH; Vil, D; Baker, J; Kirchoff, K; Toth, K; King, L; Bahret, A; Miller, B; Marra, M; Martienssen, R; McCombie, WR; Wilson, RK; Murphy, G; Bancroft, I; Volckaert, G; Wambutt, R; Dusterhoft, A; Stiekema, W; Pohl, T; Entian, KD; Terryn, N; Hartley, N; Bent, E; Johnson, S; Langham, SA; McCullagh, B; Robben, J; Grymonprez, B; Zimmermann, W; Ramsperger, U; Wedler, H; Balke, K; Wedler, E; Peters, S; van Staveren, M; Dirkse, W; Mooijman, P; Lankhorst, RK; Weitzenegger, T; Bothe, G; Rose, M; Hauf, J; Berneiser, S; Hempel, S; Feldpausch, M; Lamberth, S; Villarroel, R; Gielen, J; Ardiles, W; Bents, O; Lemcke, K; Kolesov, G; Mayer, K; Rudd, S; Schoof, H; Schueller, C; Zaccaria, P; Mewes, HW; Bevan, M				Tabata, S; Kaneko, T; Nakamura, Y; Kotani, H; Kato, T; Asamizu, E; Miyajima, N; Sasamoto, S; Kimura, T; Hosouchi, T; Kawashima, K; Kohara, M; Matsumoto, M; Matsuno, A; Muraki, A; Nakayama, S; Nakazaki, N; Naruo, K; Okumura, S; Shinpo, S; Takeuchi, C; Wada, T; Watanabe, A; Yamada, M; Yasuda, M; Sato, S; de la Bastide, M; Huang, E; Spiegel, L; Gnoj, L; O'Shaughnessy, A; Preston, R; Habermann, K; Murray, J; Johnson, D; Rohlrng, T; Nelson, J; Stoneking, T; Pepin, K; Spieth, J; Sekhon, M; Armstrong, J; Becker, M; Belter, E; Cordum, H; Cordes, M; Courtney, L; Courtney, W; Dante, M; Du, H; Edwards, J; Fryman, J; Haakensen, B; Lamar, E; Latreille, P; Leonard, S; Meyer, R; Mulvaney, E; Ozersky, P; Riley, A; Strowmatt, C; Wagner-McPherson, C; Wollam, A; Yoakum, M; Bell, M; Dedhia, N; Parnell, L; Shah, R; Rodriguez, M; See, LH; Vil, D; Baker, J; Kirchoff, K; Toth, K; King, L; Bahret, A; Miller, B; Marra, M; Martienssen, R; McCombie, WR; Wilson, RK; Murphy, G; Bancroft, I; Volckaert, G; Wambutt, R; Dusterhoft, A; Stiekema, W; Pohl, T; Entian, KD; Terryn, N; Hartley, N; Bent, E; Johnson, S; Langham, SA; McCullagh, B; Robben, J; Grymonprez, B; Zimmermann, W; Ramsperger, U; Wedler, H; Balke, K; Wedler, E; Peters, S; van Staveren, M; Dirkse, W; Mooijman, P; Lankhorst, RK; Weitzenegger, T; Bothe, G; Rose, M; Hauf, J; Berneiser, S; Hempel, S; Feldpausch, M; Lamberth, S; Villarroel, R; Gielen, J; Ardiles, W; Bents, O; Lemcke, K; Kolesov, G; Mayer, K; Rudd, S; Schoof, H; Schueller, C; Zaccaria, P; Mewes, HW; Bevan, M		Kazusa DNA Res Inst; Cold Spring Harbor Washington Univ; European Union Arabidopsis Genome	Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana	NATURE			English	Article							STRUCTURAL-ANALYSIS; GENOME ANALYSIS; DNA; PREDICTION; PROTEIN; REGION; KNOB	The genome of the model plant Arabidopsis thaliana has been sequenced by an international collaboration, The Arabidopsis Genome Initiative. Here we report the complete sequence of chromosome 5. This chromosome is 26 megabases long; it is the second largest Arabidopsis chromosome and represents 21% of the sequenced regions of the genome. The sequence of chromosomes 2 and 4 have been reported previously(1,2) and that of chromosomes 1 and 3, together with an analysis of the complete genome sequence, are reported in this issue(3-5). Analysis of the sequence of chromosome 5 yields further insights into centromere structure and the sequence determinants of heterochromatin condensation. The 5,874 genes encoded on chromosome 5 reveal several new functions in plants, and the patterns of gene organization provide insights into the mechanisms and extent of genome evolution in plants.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Kazusa DNA Res Inst, Chiba 292, Japan; Cold Spring Harbor Lab, Lita Annenberg Hazen Genome Ctr, Cold Spring Harbor, NY 11724 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Cold Spring Harbor Lab, Plant Biol Grp, Cold Spring Harbor, NY 11724 USA; Katholieke Univ Leuven, Lab Gene Technol, B-3001 Louvain, Belgium; AGOWA GmbH, D-12489 Berlin, Germany; QIAGEN GmbH, D-40724 Hilden, Germany; Plant Res Int, Greenom, NL-6700 AA Wageningen, Netherlands; GATC GmbH, D-78467 Constance, Germany; SRD GmbH, D-61440 Oberursel, Germany; Univ Ghent, Dept Plant Genet, B-9000 Ghent, Belgium; GSF Forschungszentrum Umwelt & Gesundheit, Munich Informat Ctr Prot Sequence, Max Planck Inst Biochem, D-82152 Munich, Germany; Inst Plant Genet & Crop Plant Res, D-06466 Gatersleben, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Kazusa DNA Research Institute; Cold Spring Harbor Laboratory; Washington University (WUSTL); Cold Spring Harbor Laboratory; KU Leuven; QIAGEN GmbH; Ghent University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Bevan, M (corresponding author), John Innes Ctr Plant Sci Res, Colney Lane, Norwich NR4 7UH, Norfolk, England.	michael.bevan@bbsrc.ac.uk	Mayer, Klaus FX/M-7941-2015; Klein Lankhorst, René/HGD-0360-2022; Wilson, Richard K./AAF-4139-2019; Rudd, Stephen A/A-6434-2013; Bancroft, Ian/AAH-3831-2020; Entian, Karl-Dieter/D-3080-2011; Marra, Marco A/B-5987-2008; Sato, Shusei/A-3616-2015; Schoof, Heiko/Y-7073-2018; Nakamura, Yasukazu/T-9038-2019; Mewes, Hans-Werner/A-8204-2019	Mayer, Klaus FX/0000-0001-6484-1077; Wilson, Richard K./0000-0002-1992-1358; Rudd, Stephen A/0000-0002-0344-7487; Marra, Marco A/0000-0001-7146-7175; Sato, Shusei/0000-0002-0293-5366; Schoof, Heiko/0000-0002-1527-3752; Kolesov, Grigory/0000-0001-5637-6371; Mewes, Hans-Werner/0000-0002-9713-6398; McCombie, W. Richard/0000-0003-1899-0682; Nakamura, Yasukazu/0000-0002-6782-5715; Bancroft, Ian/0000-0001-7707-1171				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ananiev EV, 1998, GENETICS, V149, P2025; BORODOVSKY M, 1994, COMPUT CHEM, V18, P259, DOI 10.1016/0097-8485(94)85022-4; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CHOI S, 1995, WEEDS WORLD, V2, P17; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Fransz P, 1998, PLANT J, V13, P867, DOI 10.1046/j.1365-313X.1998.00086.x; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; Frishman D, 1997, TRENDS GENET, V13, P415, DOI 10.1016/S0168-9525(97)01224-9; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kotani H, 1999, DNA Res, V6, P381, DOI 10.1093/dnares/6.6.381; LIMADEFARIER A, 1983, MOL EVOLUTION ORG CH; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; LUI YG, 1995, PLANT J, V7, P351; LUI YG, 1999, P NATL ACAD SCI USA, V96, P6535; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; McCombie WR, 2000, CELL, V100, P377, DOI 10.1016/S0092-8674(00)80673-X; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Royet J, 1998, EMBO J, V17, P7351, DOI 10.1093/emboj/17.24.7351; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Salanoubat M, 2000, NATURE, V408, P820, DOI 10.1038/35048706; Sato S, 2000, DNA RES, V7, P31, DOI 10.1093/dnares/7.1.31; Sato S, 1997, DNA Res, V4, P215, DOI 10.1093/dnares/4.3.215; Theologis A, 2000, NATURE, V408, P816, DOI 10.1038/35048500; Tutois S, 1999, CHROMOSOME RES, V7, P143, DOI 10.1023/A:1009211603248; Wakasugi T, 1997, P NATL ACAD SCI USA, V94, P5967, DOI 10.1073/pnas.94.11.5967	28	132	1277	14	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2000	408	6814					823	826						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130714				2022-12-24	WOS:000165831300040
J	Theologis, A; Ecker, JR; Palm, CJ; Federspiel, NA; Kaul, S; White, O; Alonso, J; Altafi, H; Araujo, R; Bowman, CL; Brooks, SY; Buehler, E; Chan, A; Chao, QM; Chen, HM; Cheuk, RF; Chin, CW; Chung, MK; Conn, L; Conway, AB; Conway, AR; Creasy, TH; Dewar, K; Dunn, P; Etgu, P; Feldblyum, TV; Feng, JD; Fong, B; Fujii, CY; Gill, JE; Goldsmith, AD; Haas, B; Hansen, NF; Hughes, B; Huizar, L; Hunter, JL; Jenkins, J; Johnson-Hopson, C; Khan, S; Khaykin, E; Kim, CJ; Koo, HL; Kremenetskaia, I; Kurtz, DB; Kwan, A; Lam, B; Langin-Hooper, S; Lee, A; Lee, JM; Lenz, CA; Li, JH; Li, YP; Lin, XY; Liu, SX; Liu, ZA; Luros, JS; Maiti, R; Marziali, A; Militscher, J; Miranda, M; Nguyen, M; Nierman, WC; Osborne, BI; Pai, G; Peterson, J; Pham, PK; Rizzo, M; Rooney, T; Rowley, D; Sakano, H; Salzberg, SL; Schwartz, JR; Shinn, P; Southwick, AM; Sun, H; Tallon, LJ; Tambunga, G; Toriumi, MJ; Town, CD; Utterback, T; Van Aken, S; Vaysberg, M; Vysotskaia, VS; Walker, M; Wu, DY; Yu, GX; Fraser, CM; Venter, JC; Davis, RW				Theologis, A; Ecker, JR; Palm, CJ; Federspiel, NA; Kaul, S; White, O; Alonso, J; Altafi, H; Araujo, R; Bowman, CL; Brooks, SY; Buehler, E; Chan, A; Chao, QM; Chen, HM; Cheuk, RF; Chin, CW; Chung, MK; Conn, L; Conway, AB; Conway, AR; Creasy, TH; Dewar, K; Dunn, P; Etgu, P; Feldblyum, TV; Feng, JD; Fong, B; Fujii, CY; Gill, JE; Goldsmith, AD; Haas, B; Hansen, NF; Hughes, B; Huizar, L; Hunter, JL; Jenkins, J; Johnson-Hopson, C; Khan, S; Khaykin, E; Kim, CJ; Koo, HL; Kremenetskaia, I; Kurtz, DB; Kwan, A; Lam, B; Langin-Hooper, S; Lee, A; Lee, JM; Lenz, CA; Li, JH; Li, YP; Lin, XY; Liu, SX; Liu, ZA; Luros, JS; Maiti, R; Marziali, A; Militscher, J; Miranda, M; Nguyen, M; Nierman, WC; Osborne, BI; Pai, G; Peterson, J; Pham, PK; Rizzo, M; Rooney, T; Rowley, D; Sakano, H; Salzberg, SL; Schwartz, JR; Shinn, P; Southwick, AM; Sun, H; Tallon, LJ; Tambunga, G; Toriumi, MJ; Town, CD; Utterback, T; Van Aken, S; Vaysberg, M; Vysotskaia, VS; Walker, M; Wu, DY; Yu, GX; Fraser, CM; Venter, JC; Davis, RW			Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana	NATURE			English	Article							GENOME SEQUENCE; DNA; LIBRARY; GENES; CONSTRUCTION; REGIONS; SYSTEM; TOOL; MAP	The genome of the flowering plant Arabidopsis thaliana has five chromosomes(1,2). Here we report the sequence of the largest, chromosome 1, in two contigs of around 14.2 and 14.6 megabases. The contigs extend from the telomeres to the centromeric borders, regions rich in transposons, retrotransposons and repetitive elements such as the 180-base-pair repeat. The chromosome represents 25% of the genome and contains about 6,850 open reading frames, 236 transfer RNAs (tRNAs) and 12 small nuclear RNAs. There are two clusters of tRNA genes at different places on the chromosome. One consists of 27 tRNA Pro genes and the other contains 27 tandem repeats of tRNA(Tyr)-tRNA(Tyr)-tRNA(Ser) genes. Chromosome 1 contains about 300 gene families with clustered duplications. There are also many repeat elements, representing 8% of the sequence.	Univ Calif Berkeley, USDA, Ctr Plant Gene Express, Albany, CA 94710 USA; Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA; Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Inst Genom Res, Rockville, MD 20850 USA	United States Department of Agriculture (USDA); University of California System; University of California Berkeley; University of Pennsylvania; Stanford University; J. Craig Venter Institute	Theologis, A (corresponding author), Univ Calif Berkeley, USDA, Ctr Plant Gene Express, 800 Buchanan St, Albany, CA 94710 USA.	theo@nature.berkeley.edu; ecker@salk.edu	Salzberg, Steven/Q-6514-2019; Alonso, Jose M/K-6826-2014; Salzberg, Steven L/F-6162-2011; Ecker, Joseph R/B-9144-2008	Salzberg, Steven/0000-0002-8859-7432; Alonso, Jose M/0000-0001-7087-1571; Salzberg, Steven L/0000-0002-8859-7432; Ecker, Joseph R/0000-0001-5799-5895; Chen, Huaming/0000-0001-5289-7882; Fraser, Claire/0000-0003-1462-2428; Buehler, Eugen/0000-0001-7167-676X; Sakano, Hitomi/0000-0002-7471-8352				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BEIER D, 1991, MOL GEN GENET, V225, P72, DOI 10.1007/BF00282644; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHOI S, 1995, PLANT MOL BIOL REP, V13, P124, DOI 10.1007/BF02668782; Chory J, 2000, PLANT PHYSIOL, V123, P423, DOI 10.1104/pp.123.2.423; Conner JA, 1998, PLANT CELL, V10, P801, DOI 10.1105/tpc.10.5.801; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; CREUSOT F, 1995, PLANT J, V8, P763, DOI 10.1046/j.1365-313X.1995.08050763.x; Dietrich FS, 1997, NATURE, V387, P78, DOI 10.1038/387s078; ECKER J R, 1990, Methods (Orlando), V1, P186, DOI 10.1016/S1046-2023(05)80134-3; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; EWENS WJ, 1991, GENOMICS, V11, P799, DOI 10.1016/0888-7543(91)90003-W; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Frishman D, 1997, TRENDS GENET, V13, P415, DOI 10.1016/S0168-9525(97)01224-9; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GOODMAN HM, 1995, P NATL ACAD SCI USA, V92, P10831, DOI 10.1073/pnas.92.24.10831; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; Marziali A, 1999, GENOME RES, V9, P457; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; MEYEROWITZ EM, 1994, ARABIDOPSIS, P21; Mozo T, 1998, MOL GEN GENET, V258, P562, DOI 10.1007/s004380050769; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; Oefner PJ, 1996, NUCLEIC ACIDS RES, V24, P3879, DOI 10.1093/nar/24.20.3879; RICHARDS EJ, 1992, NUCLEIC ACIDS RES, V20, P4039, DOI 10.1093/nar/20.15.4039; ROTTMANN WH, 1991, J MOL BIOL, V222, P937, DOI 10.1016/0022-2836(91)90587-V; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; Salanoubat M, 2000, NATURE, V408, P820, DOI 10.1038/35048706; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; Tabata S, 2000, NATURE, V408, P823, DOI 10.1038/35048507; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0	43	162	4408	9	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2000	408	6814					816	820		10.1038/35048500	http://dx.doi.org/10.1038/35048500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130712				2022-12-24	WOS:000165831300038
J	Zhang, FC; Zhou, ZH				Zhang, FC; Zhou, ZH			A primitive enantiornithine bird and the origin of feathers	SCIENCE			English	Article							YIXIAN FORMATION; EVOLUTION; DINOSAUR; SKULL; ARCHAEOPTERYX; SPAIN	A fossil enantiornithine bird, Protopteryx fengningensis gen. et sp. nov., was collected from the Early Cretaceous Yixian Formation of Northern China. it provides fossil evidence of a triosseal canal in early birds. The manus and the alular digit are long, as in Archaeopteryx and Confuciusornis, but are relatively short in other enantiornithines. The alula or bastard wing is attached to an unreduced alular digit. The two central tail feathers are scalelike without branching. This type of feather may suggest that modern feathers evolved through the following stages: (i) elongated scale, (ii) central shaft, (iii) barbs, and finally (iv) barbules and barbicel.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Zhang, FC (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	fuchengzhang@yeah.net						Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; BOCK WJ, 1986, MEM CALIF ACAD SCI, V8, P57; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; CHIAPPE LM, 1995, NATURE, V378, P349, DOI 10.1038/378349a0; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chiappe Luis M., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P203; DYCK J, 1985, ZOOL SCR, V14, P137, DOI 10.1111/j.1463-6409.1985.tb00184.x; Feduccia A, 1999, ORIGIN EVOLUTION BIR, P1; GILL FB, 1994, ORNITHOLOGY, P65; Ginn H.B., 1983, BTO Guide, P1; Griffith Peter J., 1996, Archaeopteryx, V14, P1; Hou LH, 1999, NATURE, V399, P679, DOI 10.1038/21411; Hou Lian-Hai, 1999, Vertebrata Palasiatica, V37, P88; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jones TD, 2000, SCIENCE, V288, P2202, DOI 10.1126/science.288.5474.2202; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; LUCAS AM, 1972, AGR HDB, V362, P1; Martin Larry D., 1995, Courier Forschungsinstitut Senckenberg, V181, P23; Martin LD, 1997, NATURE, V389, P556, DOI 10.1038/39228; MARTIN LD, 1980, AUK, V97, P86; Mayr E., 1960, EVOLUTION DARWIN, P349; Ostrom J.H., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P1; OSTROM JH, 1974, Q REV BIOL, V49, P27, DOI 10.1086/407902; Ostrom John H., 1997, P301; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; REGAL PJ, 1975, Q REV BIOL, V50, P35, DOI 10.1086/408299; Sanz JL, 1996, NATURE, V382, P442, DOI 10.1038/382442a0; Sanz JL, 1997, SCIENCE, V276, P1543, DOI 10.1126/science.276.5318.1543; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Storer R.W., 1960, P 12 INT ORN C, V2, P694; WALKER CA, 1981, NATURE, V292, P51, DOI 10.1038/292051a0; Wellnhofer P., 1974, Palaeontographica Abt A, V147, P169; WELLNHOFER P, 1992, PAPERS AVIAN PALEONT, P3; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; ZHOU Z, 1995, COUR FORSCHUNGSINST, V181, P9; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P111	37	186	224	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2000	290	5498					1955	1959		10.1126/science.290.5498.1955	http://dx.doi.org/10.1126/science.290.5498.1955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382EL	11110660				2022-12-24	WOS:000165810000043
J	Etkin, A				Etkin, A			Drugs and therapeutics in the age of the genome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROTEIN		Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Etkin, A (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.		Etkin, Amit/ABD-5761-2021					Abbott A, 1999, NATURE, V402, P715, DOI 10.1038/45350; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; CHEE M, 1996, SCIENCE, V274, P548; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Sander C, 2000, SCIENCE, V287, P1977, DOI 10.1126/science.287.5460.1977	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2000	284	21					2786	2787		10.1001/jama.284.21.2786	http://dx.doi.org/10.1001/jama.284.21.2786			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377JB	11105190	hybrid			2022-12-24	WOS:000165509500037
J	Walton, D; Farmer, P				Walton, D; Farmer, P			The new white plague	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TUBERCULOSIS		Harvard Univ, Boston, MA 02115 USA	Harvard University	Walton, D (corresponding author), Harvard Univ, Boston, MA 02115 USA.							Becerra MC, 2000, INT J TUBERC LUNG D, V4, P108; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P661; Cohn DL, 1997, CLIN INFECT DIS   S1, V24, P121; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; FARMER PE, 1999, TUBERCULOSIS COMPREH; Heifets LB, 1999, INT J TUBERC LUNG D, V3, P564; *WHO, 1997, TB TREATMENT OB 0324; World Health Organization, 1998, WHO PUBL, VMSA/MDN/98.2, P55	9	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2000	284	21					2789	2789		10.1001/jama.284.21.2789	http://dx.doi.org/10.1001/jama.284.21.2789			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377JB	11105192	hybrid			2022-12-24	WOS:000165509500039
J	Hennequin, H; Morin, C; Feine, JS				Hennequin, H; Morin, C; Feine, JS			Pain expression and stimulus localisation in individuals with Down's syndrome	LANCET			English	Article							SEX-DIFFERENCES; STIMULATION; INFANTS; RESPONSIVENESS; DISABILITIES; BIRTHS	Background Individuals with Down's syndrome do not always exhibit signs of distress in reaction to noxious stimuli comparable with the general population. This pilot study was designed to measure the ability of individuals with Down's syndrome to detect and express sensation in comparison with healthy volunteers. Methods In the first test, the latency of pain detection to self-administered cold stimuli on the wrist and on the temple was measured. The second test was designed to assess ability to localise cold stimuli on sites on the hand, on the face, and in the mouth. Findings 75 control individuals and 26 individuals with Down's syndrome were tested. individuals with Down's syndrome had significantly longer median latencies than controls: Down's syndrome median (quartiles) 28.7 s (1st 18.0, 3rd 47.6); controls 20.6 s (1st 12.4, 3rd 31.0); p=0.0005. in addition, more individuals with Down's syndrome had difficulties in localising the cold stimulus. The differences in distribution for precise localisation were significant for the hand (Down's syndrome [p<0.0005] 54%; control 99%), the mouth (31%; 84%), and the face (54%; 97%). Interpretation Individuals with Down's syndrome are not insensitive to pain. However, they do express pain or discomfort more slowly and less precisely than the general population. This implies that medical teams managing these patients should use pain-control procedures, even in the absence of obvious pain manifestations.	Univ Auvergne, Fac Chirurg Dent, Lab Physiol Orofaciale, F-63000 Clermont Ferrand, France; McGill Univ, Fac Med, Dept Oncol, Montreal, PQ H3A 2B2, Canada; McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Aerosp Med Res Unit, Montreal, PQ H3A 2B2, Canada	Universite Clermont Auvergne (UCA); McGill University; McGill University	Hennequin, H (corresponding author), Univ Auvergne, Fac Chirurg Dent, Lab Physiol Orofaciale, F-63000 Clermont Ferrand, France.	martine.hennequin@u-clermont1.fr	Hennequin, Martine/AAB-3004-2021	Hennequin, Martine/0000-0001-8173-2606				Astin M, 1996, SOC SCI MED, V42, P1457, DOI 10.1016/0277-9536(95)00253-7; BARNET AB, 1971, DEV MED CHILD NEUROL, V13, P321; BIERSDORFF KK, 1994, AM J MENT RETARD, V98, P619; Bromley J, 1998, J INTELL DISABIL RES, V42, P72, DOI 10.1046/j.1365-2788.1998.00078.x; CLARK DL, 1977, SCIENCE, V196, P1228, DOI 10.1126/science.300899; FEINE JS, 1991, PAIN, V44, P255, DOI 10.1016/0304-3959(91)90094-E; FRYERS T, 1986, J MENT DEFIC RES, V30, P101; GEDYE A, 1990, J MENT DEFIC RES, V34, P195; GIBSON SJ, 1995, RAIN REV, V2, P111; Giusiano B, 1995, METHOD INFORM MED, V34, P498; GOODKIN F, 1980, EARLY HUM DEV, V4, P373, DOI 10.1016/0378-3782(80)90042-0; Hahn J A, 1993, Paediatr Perinat Epidemiol, V7, P450, DOI 10.1111/j.1365-3016.1993.tb00426.x; Henderson S., 1987, CURRENT APPROACHES D, P187; HUETHER CA, 1983, AM J PUBLIC HEALTH, V73, P1186, DOI 10.2105/AJPH.73.10.1186; ISHII N, 1988, ARCH DERMATOL, V124, P564, DOI 10.1001/archderm.124.4.564; KUMAZAWA T, 1977, J PHYSIOL-LONDON, V273, P179, DOI 10.1113/jphysiol.1977.sp012088; LAUTENBACHER S, 1993, PAIN, V53, P255, DOI 10.1016/0304-3959(93)90221-A; LIND J, 1970, DEV MED CHILD NEUROL, V12, P478; Martinez-Cue C, 1999, NEUROREPORT, V10, P1119, DOI 10.1097/00001756-199904060-00039; MCGRATH PA, 1993, PAIN INFANTS CHILDRE, P39; MEH D, 1994, J NEUROL SCI, V127, P164, DOI 10.1016/0022-510X(94)90069-8; MERSKEY H, 1994, CLASSIFICATION CHRON, P213; MYERS BA, 1991, J NERV MENT DIS, V179, P609, DOI 10.1097/00005053-199110000-00004; Radovich F, 1991, Minerva Stomatol, V40, P701; Stoll C, 1998, ANN GENET-PARIS, V41, P44; SVENSSON P, 1992, PAIN, V49, P233, DOI 10.1016/0304-3959(92)90147-4; THRUSH DC, 1973, BRAIN, V96, P591, DOI 10.1093/brain/96.3.591	27	81	81	2	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2000	356	9245					1882	1887		10.1016/S0140-6736(00)03259-1	http://dx.doi.org/10.1016/S0140-6736(00)03259-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	379WD	11130384				2022-12-24	WOS:000165665400011
J	Warner, JT				Warner, JT			Reliability of indices of weight and height in assessment of nutritional state in children	LANCET			English	Editorial Material									John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England	University of Oxford	Warner, JT (corresponding author), John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.							FUNG KP, 1990, ARCH DIS CHILD, V65, P1516; Oguz A, 1999, PEDIATR HEMAT ONCOL, V16, P35, DOI 10.1080/088800199277579; Poustie VJ, 2000, ARCH DIS CHILD, V83, P183, DOI 10.1136/adc.83.2.183; Warner JT, 1997, ANN HUM BIOL, V24, P209, DOI 10.1080/03014469700004942	4	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 18	2000	356	9243					1703	1704		10.1016/S0140-6736(00)03201-3	http://dx.doi.org/10.1016/S0140-6736(00)03201-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	376MX	11095255				2022-12-24	WOS:000165462300006
J	Goldman, KA				Goldman, KA			Genetic technologies - Bioengineered food - Safety and labeling	SCIENCE			English	Article									Georgetown Univ, Ctr Law, Washington, DC 20001 USA; Natl Sci Fdn, Arlington, VA 22230 USA	Georgetown University; National Science Foundation (NSF)	Goldman, KA (corresponding author), Georgetown Univ, Ctr Law, Washington, DC 20001 USA.							*EC RES SERV, 2000, BIOT CORN SOYB CHANG; *EPA, 2000, FED REGISTER, V65, P55929; *EPA, 2000, CRY9C FOOD ALL ASS B; *FDA, 1994, FED REGISTER, V59, P26700; *FDA, 2000, HHS NEWS        0503; Ferber D, 1999, SCIENCE, V286, P1662, DOI 10.1126/science.286.5445.1662; GOLDMAN KA, 2000, GEORGETOWN INT ENV L, V12, P717; Henney JE., 2000, FDA CONSUM, V4, P18; POLLACK A, 2000, NY TIMES        1228, pC1; SMITH N, 2000, UNPUB BASIC RES; U.S. Food and Drug Administration, 1992, FED REGISTER, V57, P22984; *USDA, 2000, 014700 USDA; 1994, FED REG, V59, P60496; 1998, FED REG, V63, P28258; 1996, FED REG, V61, P40340; 1997, FED REG, V62, P52505; 1995, FED REG, V60, P21725; 1997, FED REG, V62, P17717; 1997, FED REG, V62, P17720; 1996, FED REG, V61, P40338	20	6	6	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 20	2000	290	5491					457	+		10.1126/science.290.5491.457	http://dx.doi.org/10.1126/science.290.5491.457			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11183767				2022-12-24	WOS:000089946000030
J	Smith, O				Smith, O			Cancer - The killer instinct of a p53 target	SCIENCE			English	Editorial Material																		Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8	1	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 6	2000	290	5489					67	67		10.1126/science.290.5489.67	http://dx.doi.org/10.1126/science.290.5489.67			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11183152				2022-12-24	WOS:000089724800032
J	Khan, LK; Serdula, MK; Bowman, BA; Williamson, DF				Khan, LK; Serdula, MK; Bowman, BA; Williamson, DF			Use of prescription weight loss pills among US adults in 1996-1998	ANNALS OF INTERNAL MEDICINE			English	Article							PREVALENCE	Background: Pharmacotherapy is recommended for the treatment of obese persons with a body mass index of 30 kg/m(2) or higher or a body mass index of at least 27 kg/m(2) plus an obesity-related comorbid condition. Objective: To estimate the prevalence of use of prescription weight loss pills in the United States in 1996-1998. Design: 1998 Behavioral Risk Factor Surveillance System, a nationally representative telephone survey. Setting: United States. Participants: 139 779 adults 18 years of age and older. Measurements: Self-reported pill use for 1996-1998, body mass index (current and before pill use), age, sex, and race or ethnicity. Results: The 2-year prevalence of pill use was 2.5% (95% CI, 2.1% to 2.9%); or 4.6 million U.S. adults. Use was higher in women than in men (4.0% vs. 0.9%, respectively) and highest among Hispanic respondents (3.2%). Of pill users, 25% were not overweight (body mass index < 27 kg/m(2)) before using pills. Conclusions: Nearly 5 million U.S. adults used prescription weight loss pills in 1996-1998. However, one quarter of users were not overweight. suggesting that weight loss pills may be inappropriately used, especially among women, white persons, and Hispanic persons.	Ctr Dis Control & Prevent, Div Nutr & Phys Activ, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Khan, LK (corresponding author), Ctr Dis Control & Prevent, Div Nutr & Phys Activ, 4770 Buford Highway NE,Mailstop K29, Atlanta, GA 30341 USA.	LDK7@cdc.gov						Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; *IMS AM LTD NAT PR, 1997, BAS DAT REP IMS AM L; LUMPKIN MM, 1997, FDA B, V27, P2; McKee MD, 1999, J FAM PRACTICE, V48, P993; *MMWR, 1997, MMWR-MORBID MORTAL W, V46, P1061; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; NELSON DE, 1998, P SECT SURV METH AM; ORADELL NJ, 1997, MED EC; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353; Shah BV, 1997, SUDAAN USERS MANUAL	14	34	34	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2001	134	4					282	286		10.7326/0003-4819-134-4-200102200-00011	http://dx.doi.org/10.7326/0003-4819-134-4-200102200-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403NW	11182838				2022-12-24	WOS:000167050200004
J	Nielsen, GL; Sorensen, HT; Larsen, H; Pedersen, L				Nielsen, GL; Sorensen, HT; Larsen, H; Pedersen, L			Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study	BRITISH MEDICAL JOURNAL			English	Article							ASPIRIN	Objective To estimate th risk of adverse birth outcome in women who take non-steroidal anti-inflammatory drugs during pregnancy. Design and setting Population based cohort study and a case-control study, both based on data from a prescription registry, the Danish birth registry, and cone country's hospital discharge registry. Participants Cohort study: 1462 pregnant women who had taken up prescriptions for non-steroidal anti-inflammatory drugs in the period from 30 days before conception to birth and 17 259 pregnant women who were not prescribed any drugs during pregnancy. Case-control study: 4268 women who had miscarriages, of whom 63 had taken non-steroidal anti-inflammatory drugs, and 29 750 primiparous controls who had live births. Main outcome measures Incidences of congenital abnormality, low birth weight, preterm birth, and miscarriage. Results Odds ratios for congenital abnormality, low birth weight, and preterm birth among women who took up prescriptions for no-steroidal anti-inflammatory drugs were 1.27 (95% confidence integral 0.93 to 1.75 (0.79 (0.45 to 1.38), and 1.05 (0.80 to 1.39) respectively. Odds ratios for the taking up of prescriptions in the weeks before miscarriage ranged from 6.99 (2.75 to 17.74) when prescriptions were taken up during the last week before the miscarriage to 2.69 (1.81 to 4.00) when taken up between 7 and 9 weeks before. The risk estimates were no different when the analysis was restricted to missed abortions. Conclusions Use of non-steroidal anti-inflammatory drugs during pregnancy does not seem of increase the risk of adverse birth outcome but is associated wit increased risk of miscarriage.	Odder Hosp, Dept Med, DK-8300 Odder, Denmark; Aarhus Univ Hosp, Dept Clin Epidemiol & Med 5, DK-8000 Aarhus C, Denmark; Aalborg Univ Hosp, Dept Clin Epidemiol & Med 5, DK-8000 Aarhus C, Denmark; Danish Epidemiol Sci Ctr, Inst Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; Aalborg Hosp, Dept Obstet & Gynaecol & Med M, DK-9000 Aalborg, Denmark	Aarhus University; Aalborg University; Aarhus University; Aalborg University; Aalborg University Hospital	Nielsen, GL (corresponding author), Odder Hosp, Dept Med, DK-8300 Odder, Denmark.		Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040				Andersen TF, 1999, DAN MED BULL, V46, P263; BEROYZ G, 1994, LANCET, V343, P619; BONATI M, 1990, EUR J CLIN PHARMACOL, V38, P323; BRIGGS CG, 1998, DRUGS PREGNANCY LACT, P524; Gaist D, 1997, DAN MED BULL, V44, P445; Golding J, 1998, BRIT J OBSTET GYNAEC, V105, P293, DOI 10.1111/j.1471-0528.1998.tb10089.x; HERTZPICCIOTTO I, 1990, EPIDEMIOL REV, V12, P108, DOI 10.1093/oxfordjournals.epirev.a036049; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; MITCHEL AA, 1995, PHARMACOEPIDEMIOLOGY, P598; Nielsen G L, 1997, Int J Risk Saf Med, V10, P203, DOI 10.3233/JRS-1997-10309; Norton ME, 1997, TERATOLOGY, V56, P282, DOI 10.1002/(SICI)1096-9926(199710)56:4<282::AID-TERA7>3.0.CO;2-0; Olesen C, 1999, EUR J CLIN PHARMACOL, V55, P139, DOI 10.1007/s002280050608; Olsen JH, 1997, HYPERTENSION, V29, P1091, DOI 10.1161/01.HYP.29.5.1091; Ostensen M, 1998, DRUG SAFETY, V19, P389; SHAPIRO S, 1970, LANCET, V1, P1375; TURNER G, 1975, LANCET, V2, P338; WERLER MM, 1989, NEW ENGL J MED, V321, P1639, DOI 10.1056/NEJM198912143212404	18	203	211	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	2001	322	7281					266	270		10.1136/bmj.322.7281.266	http://dx.doi.org/10.1136/bmj.322.7281.266			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401FM	11157526	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000166917600026
J	Mathon, NF; Malcolm, DS; Harrisingh, MC; Cheng, LL; Lloyd, AC				Mathon, NF; Malcolm, DS; Harrisingh, MC; Cheng, LL; Lloyd, AC			Lack of replicative senescence in normal rodent glia	SCIENCE			English	Article							TELOMERASE ACTIVITY; CELLS; P16(INK4A); INHIBITORS; RAS	Replicative senescence is thought to be an intrinsic mechanism for Limiting the proliferative Life-span of normal somatic cells. We show here that rat Schwann cells can be expanded indefinitely in culture while maintaining checkpoints normally Lost during the immortalization process. These findings demonstrate that senescence is not an inevitable consequence of extended proliferation in culture.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London	Lloyd, AC (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	alison.lloyd@ucl.ac.uk						Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; CHENG L, 1995, J CELL BIOL, V129, P789, DOI 10.1083/jcb.129.3.789; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Lloyd AC, 1998, CURR OPIN GENET DEV, V8, P43, DOI 10.1016/S0959-437X(98)80060-9; MATHON NF, UNPUB; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	14	149	152	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					872	875		10.1126/science.1056782	http://dx.doi.org/10.1126/science.1056782			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11157166				2022-12-24	WOS:000166771700044
J	Baker, PA; Seltzer, GO; Fritz, SC; Dunbar, RB; Grove, MJ; Tapia, PM; Cross, SL; Rowe, HD; Broda, JP				Baker, PA; Seltzer, GO; Fritz, SC; Dunbar, RB; Grove, MJ; Tapia, PM; Cross, SL; Rowe, HD; Broda, JP			The history of South American tropical precipitation for the past 25,000 years	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; LAKE-TITICACA; ATLANTIC-OCEAN; ICE-AGE; CLIMATE; HOLOCENE; BOLIVIA; CALIBRATION; CIRCULATION; VARIABILITY	Long sediment cores recovered from the deep portions of Lake Titicaca are used to reconstruct the precipitation history of tropical South America for the past 25,000 years. Lake Titicaca was a deep, fresh, and continuously overflowing Lake during the Last glacial stage, from before 25,000 to 15,000 calibrated years before the present (cal yr B.P.), signifying that during the Last glacial maximum (LGM), the Altiplano of Bolivia and Peru and much of the Amazon basin were wetter than today. The LGM in this part of the Andes is dated at 21,000 cal yr B.P., approximately coincident with the global LGM. Maximum aridity and Lowest Lake Level occurred in the early and middle Holocene (8000 to 5500 cat yr B.P.) during a time of Low summer insolation. Today, rising Levels of Lake Titicaca and wet conditions in Amazonia are correlated with anomalously cold sea-surface temperatures in the northern equatorial Atlantic. Likewise, during the deglacial and Holocene periods, there were several millennial-scale wet phases on the Altiplano and in Amazonia that coincided with anomalously cold periods in the equatorial and high-latitude North Atlantic, such as the Younger Dryas.	Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA; Syracuse Univ, Dept Earth Sci, Syracuse, NY 13244 USA; Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA; Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Duke University; Syracuse University; University of Nebraska System; University of Nebraska Lincoln; Stanford University; Woods Hole Oceanographic Institution	Baker, PA (corresponding author), Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA.		Tapia, Pedro/GYR-1147-2022	Tapia, Pedro M/0000-0002-0708-4468; Dunbar, Robert/0000-0002-9728-5609; Rowe, Harry/0000-0002-1665-6261				Abbott MB, 1997, QUATERNARY RES, V47, P169, DOI 10.1006/qres.1997.1881; [Anonymous], [No title captured]; Argollo J, 2000, QUATERN INT, V72, P37, DOI 10.1016/S1040-6182(00)00019-7; BAKER P, IN PRESS NATURE; Bard E, 1998, GEOCHIM COSMOCHIM AC, V62, P2025, DOI 10.1016/S0016-7037(98)00130-6; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Baucom PC, 1999, J SEDIMENT RES, V69, P597, DOI 10.2110/jsr.69.597; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Chang P, 1997, NATURE, V385, P516, DOI 10.1038/385516a0; COLLINVAUX PA, 2000, QUAT SCI REV, V19; Cross SL, 2000, HOLOCENE, V10, P21, DOI 10.1191/095968300671452546; CROSS SL, IN PRESS QUAT RES; Curtis J. H., 1993, CLIMATE CHANGE CONTI, P135, DOI [10.1029/GM078p0135, DOI 10.1029/GM078P0135]; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; Enfield DB, 1997, J GEOPHYS RES-OCEANS, V102, P929, DOI 10.1029/96JC03296; Haberle SG, 1999, QUATERNARY RES, V51, P27, DOI 10.1006/qres.1998.2020; HASTENRATH S, 1978, J ATMOS SCI, V35, P2222, DOI 10.1175/1520-0469(1978)035<2222:OMOTCA>2.0.CO;2; HASTENRATH S, 1997, Q J R METEOROL SOC, V110, P77; Ledru MP, 1998, QUATERNARY RES, V49, P233, DOI 10.1006/qres.1997.1953; Melice JL, 1998, CLIM DYNAM, V14, P117, DOI 10.1007/s003820050213; Mix AC, 1999, PALEOCEANOGRAPHY, V14, P350, DOI 10.1029/1999PA900012; Mourguiart P, 1998, PALAEOGEOGR PALAEOCL, V143, P51, DOI 10.1016/S0031-0182(98)00068-6; Nobre P, 1996, J CLIMATE, V9, P2464, DOI 10.1175/1520-0442(1996)009<2464:VOSSTW>2.0.CO;2; Rajagopalan B, 1998, GEOPHYS RES LETT, V25, P3967, DOI 10.1029/1998GL900065; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; SELTZER GO, 1992, J QUATERNARY SCI, V7, P87, DOI 10.1002/jqs.3390070202; Seltzer GO, 1998, GEOLOGY, V26, P167, DOI 10.1130/0091-7613(1998)026<0167:HRSRPF>2.3.CO;2; SERVANT M, 1995, CR ACAD SCI II, V320, P729; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Sutton RT, 2000, J CLIMATE, V13, P3261, DOI 10.1175/1520-0442(2000)013<3261:TEOCVI>2.0.CO;2; Sylvestre F, 1999, QUATERNARY RES, V51, P54, DOI 10.1006/qres.1998.2017; THOMPSON LG, 1986, SCIENCE, V234, P361, DOI 10.1126/science.234.4774.361; Webster P., 1983, LARGE SCALE DYNAMICA, P235; WIRRMANN D, 1987, PALAEOGEOGR PALAEOCL, V59, P315, DOI 10.1016/0031-0182(87)90088-5; Xie SP, 1998, GEOPHYS RES LETT, V25, P2185, DOI 10.1029/98GL01525; Zhou JY, 1998, J CLIMATE, V11, P1020, DOI 10.1175/1520-0442(1998)011<1020:DAMCEO>2.0.CO;2	37	534	564	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2001	291	5504					640	643		10.1126/science.291.5504.640	http://dx.doi.org/10.1126/science.291.5504.640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11158674	Green Submitted			2022-12-24	WOS:000166616000040
J	Iso, H; Rexrode, KM; Stampfer, MJ; Manson, JE; Colditz, GA; Speizer, FE; Hennekens, CH; Willett, WC				Iso, H; Rexrode, KM; Stampfer, MJ; Manson, JE; Colditz, GA; Speizer, FE; Hennekens, CH; Willett, WC			Intake of fish and omega-3 fatty acids and risk of stroke in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOD FREQUENCY QUESTIONNAIRE; EICOSAPENTAENOIC ACID; CARDIOVASCULAR-DISEASE; PLATELET-FUNCTION; BLOOD-VISCOSITY; OIL; CONSUMPTION; HUMANS; MEN; ATHEROSCLEROSIS	Context Some prospective studies have shown an inverse association between fish intake and risk of stroke, but none has examined the relationship of fish and omega-3 polyunsaturated fatty acid intake with risk of specific stroke subtypes. Objective To examine the association between fish and omega-3 polyunsaturated fatty acid intake and risk of stroke subtypes in women. Design, Setting, and Subjects Prospective cohort study of women in the Nurses' Health Study cohort, aged 34 to 59 years in 1980, who were free from prior diagnosed cardiovascular disease, cancer, and history of diabetes and hypercholesterolemia and who completed a food frequency questionnaire including consumption of fish and other frequently eaten foods. The 79839 women who met our eligibility criteria were followed up for 14 years. Main Outcome Measure Relative risk of stroke in 1980-1994 compared by category of fish intake and quintile of omega-3 polyunsaturated fatty acid intake. Results After 1 086 261 person-years of follow-up, 574 incident strokes were documented, including 119 subarachnoid hemorrhages, 62 intraparenchymal hemorrhages, 303 ischemic strokes (264 thrombotic and 39 embolic infarctions), and 90 strokes of undetermined type. Among thrombotic infarctions, 90 large-artery occlusive infarctions and 142 lacunar infarctions were identified. Compared with women who ate fish less than once per month, those with higher intake of fish had a lower risk of total stroke: the multivariate relative risks (RRs), adjusted for age, smoking, and other cardiovascular risk factors, were 0.93 (95% confidence interval [CI], 0.65-1.34) for fish consumption 1 to 3 times per month, 0.78 (95% CI, 0.55-1.12) for once per week, 0.73 (95% CI, 0.47-1.14) for 2 to 4 times per week, and 0.48 (95% CI, 0.21-1.06) for 5 or more times per week (P for trend = .06). Among stroke subtypes, a significantly reduced risk of thrombotic infarction was found among women who ate fish 2 or more times per week (multivariate RR, 0.49; 95% CI, 0.26-0.93). Women in the highest quintile of intake of long-chain omega-3 polyunsaturated fatty acids had reduced risk of total stroke and thrombotic infarction, with multivariate RRs of 0.72 (95 % CI, 0.53-0.99) and 0.67 (95% CI, 0.42-1.07), respectively. When stratified by aspirin use, fish and omega-3 polyunsaturated fatty acid intakes were inversely associated with risk of thrombotic infarction, primarily among women who did not regularly take aspirin. There was no association between fish or omega-3 polyunsaturated fatty acid intake and risk of hemorrhagic stroke. Conclusions Our data indicate that higher consumption of fish and omega-3 polyunsaturated fatty acids is associated with a reduced risk of thrombotic infarction, primarily among women who do not take aspirin regularly, but is not related to risk of hemorrhagic stroke.	Brigham & Womens Hosp, Div Prevent Med, Dept Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Univ Miami, Sch Med, Dept Epidemiol & Publ Hlth Med, Miami, FL USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Miami	Rexrode, KM (corresponding author), Brigham & Womens Hosp, Div Prevent Med, Dept Med, 900 Commonwealth Ave,3rd Floor, Boston, MA 02215 USA.		Rexrode, Kathryn M/I-1177-2018; Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Rexrode, Kathryn/0000-0003-3387-8429; Iso, Hiroyasu/0000-0002-9241-7289	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NCI NIH HHS [CA40346] Funding Source: Medline; NHLBI NIH HHS [HL34594] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON CS, 1993, MED J AUSTRALIA, V158, P85, DOI 10.5694/j.1326-5377.1993.tb137529.x; BAMFORD JM, 1988, STROKE, V19, P1074, DOI 10.1161/01.STR.19.9.1074; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; BELL DSH, 1994, DIABETES CARE, V17, P213, DOI 10.2337/diacare.17.3.213; BRUCKNER G, 1987, ATHEROSCLEROSIS, V66, P237, DOI 10.1016/0021-9150(87)90067-0; *CONS FOOD EC I, 1976, COMPOSITION FOODS HD, V8; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; FESKENS EJM, 1991, DIABETES CARE, V14, P935, DOI 10.2337/diacare.14.11.935; FOX PL, 1988, SCIENCE, V241, P453, DOI 10.1126/science.3393911; GANDOLFO C, 1988, ACTA NEUROL SCAND, V77, P22, DOI 10.1111/j.1600-0404.1988.tb06968.x; Gillum RF, 1996, ARCH INTERN MED, V156, P537, DOI 10.1001/archinte.156.5.537; HEROLD PM, 1986, AM J CLIN NUTR, V43, P566, DOI 10.1093/ajcn/43.4.566; HOSTMARK AT, 1988, BRIT MED J, V297, P180, DOI 10.1136/bmj.297.6642.180; HUNTER DJ, 1992, AM J EPIDEMIOL, V135, P418, DOI 10.1093/oxfordjournals.aje.a116302; Iso H, 2000, ANN EPIDEMIOL, V10, P81, DOI 10.1016/S1047-2797(99)00040-X; KERI SO, 1994, STROKE, V25, P328; KNAPP HR, 1986, NEW ENGL J MED, V314, P937, DOI 10.1056/NEJM198604103141501; KNAPP HR, 1989, NEW ENGL J MED, V320, P1037, DOI 10.1056/NEJM198904203201603; KRISTENSEN MO, 1983, ACTA NEUROCHIR, V67, P37, DOI 10.1007/BF01401666; KROMANN N, 1980, ACTA MED SCAND, V208, P401; LANDS WEM, 1985, PROSTAGLANDINS, V30, P819, DOI 10.1016/0090-6980(85)90010-3; LEAF A, 1988, NEW ENGL J MED, V318, P549, DOI 10.1056/NEJM198803033180905; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; MASOTTI G, 1979, LANCET, V2, P1213; MORRIS MC, 1995, AM J EPIDEMIOL, V142, P166, DOI 10.1093/oxfordjournals.aje.a117615; Orencia AJ, 1996, STROKE, V27, P204, DOI 10.1161/01.STR.27.2.204; RAPER NR, 1992, J AM COLL NUTR, V11, P304; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; TERANO T, 1983, ATHEROSCLEROSIS, V46, P321, DOI 10.1016/0021-9150(83)90181-8; THORNGREN M, 1984, BRIT J HAEMATOL, V58, P567, DOI 10.1111/j.1365-2141.1984.tb06103.x; VONSCHACKY C, 1985, J CLIN INVEST, V76, P1626, DOI 10.1172/JCI112147; VONSCHACKY C, 1985, J LIPID RES, V26, P457; Weinfeld, 1981, STROKE S1, V12, pI13; WILHELMSEN L, 1984, NEW ENGL J MED, V311, P501, DOI 10.1056/NEJM198408233110804; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WOODCOCK BE, 1984, BRIT MED J, V288, P592, DOI 10.1136/bmj.288.6417.592	40	317	330	0	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2001	285	3					304	312		10.1001/jama.285.3.304	http://dx.doi.org/10.1001/jama.285.3.304			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390XD	11176840	Bronze			2022-12-24	WOS:000166324300021
J	Plotz, FB; van Vught, H; Uiterwaal, CSPM; Riedijk, M; van der Ent, CK				Plotz, FB; van Vught, H; Uiterwaal, CSPM; Riedijk, M; van der Ent, CK			Exercise-induced oxygen desaturation as a late complication of meningococcal septic shock syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Univ Utrecht, Med Ctr, Dept Pediat Intens Care, Utrecht, Netherlands; Univ Utrecht, Med Ctr, Julius Ctr Patient Oriented Res, Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Pediat Pulm, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University	Plotz, FB (corresponding author), Univ Utrecht, Med Ctr, Dept Pediat Intens Care, Utrecht, Netherlands.							Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Campbell WN, 1997, CLIN INFECT DIS, V24, P452, DOI 10.1093/clinids/24.3.452; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; de Kleijn ED, 1998, EUR J PEDIATR, V157, P869, DOI 10.1007/s004310050958; GEMKE RJBJ, 1994, ARCH DIS CHILD, V71, P291, DOI 10.1136/adc.71.4.291; van Brakel MJM, 2000, EUR J PEDIATR, V159, P232, DOI 10.1007/s004310050060	6	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2001	285	3					293	294		10.1001/jama.285.3.293-a	http://dx.doi.org/10.1001/jama.285.3.293-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390XD	11176838				2022-12-24	WOS:000166324300019
J	Maiwald, M; von Herbay, A; Persing, DH; Mitchell, PS; Abdelmalek, MF; Thorvilson, JN; Fredricks, DN; Relman, DA				Maiwald, M; von Herbay, A; Persing, DH; Mitchell, PS; Abdelmalek, MF; Thorvilson, JN; Fredricks, DN; Relman, DA			Tropheryma whippelii DNA is rare in the intestinal mucosa of patients without other evidence of Whipple disease	ANNALS OF INTERNAL MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; BACTERIUM; BACILLUS; DIAGNOSIS	Background: Little is known about the pathogenesis of Whipple disease, the reservoirs of Tropheryma whippelii, and the proportion of persons harboring the bacterium without "classic" intestinal abnormalities. Objective: To assess the presence of T. whippelii in patients undergoing upper endoscopy for a variety of indications. Design: Prospective and routine diagnostic examination of patients. Setting: Three academic medical centers in California; Minnesota; and Heidelberg, Germany. Patients: 342 patients undergoing endoscopy for evaluation of dyspepsia or possible peptic ulcer (group A, 173 patients), malabsorption (group B, 37 patients), or clinical suspicion of Whipple disease (group C, 132 patients). Measurements: Small-intestinal biopsy specimens were tested by polymerase chain reaction for T. whippelii DNA and examined for histopathologic abnormalities. Results: All patients with negative histologic findings also had negative results for T. whippelii DNA. Conclusions: T. whippelii occurs only rarely in intestinal mucosa that lacks histopathologic evidence of Whipple disease. The human small intestinal mucosa is an unlikely reservoir for this organism.	Vet Affairs Palo Alto Hlth Care Syst 154T, Palo Alto, CA 94304 USA; Stanford Univ, Stanford, CA 94305 USA; Heidelberg Univ, Inst Pathol, D-6900 Heidelberg, Germany; Mayo Clin, Rochester, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Ruprecht Karls University Heidelberg; Mayo Clinic	Relman, DA (corresponding author), Vet Affairs Palo Alto Hlth Care Syst 154T, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	relman@cmgm.stanford.edu	Abdelmalek, Manal F/AAW-2203-2020	Relman, David A./0000-0001-8331-1354; Abdelmalek, Manal/0000-0002-5001-8618; Fredricks, David/0000-0003-2735-6800; Maiwald, Matthias/0000-0001-5448-8417	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K11AI001360] Funding Source: NIH RePORTER; NIAID NIH HHS [K11 AI01360] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Dobbins 3rd WO, 1987, WHIPPLES DIS; Ehrbar HU, 1999, LANCET, V353, P2214, DOI 10.1016/S0140-6736(99)01776-6; Maiwald M, 1996, INT J SYST BACTERIOL, V46, P1078, DOI 10.1099/00207713-46-4-1078; Maiwald M, 1998, APPL ENVIRON MICROB, V64, P760; Marth T, 1997, GASTROENTEROLOGY, V113, P442, DOI 10.1053/gast.1997.v113.pm9247462; MOORTHY S, 1977, GUT, V18, P152, DOI 10.1136/gut.18.2.152; O'Duffy JD, 1999, ARTHRITIS RHEUM, V42, P812, DOI 10.1002/1529-0131(199904)42:4<812::AID-ANR27>3.0.CO;2-S; Persing D.H., 1993, DIAGNOSTIC MOL MICRO; Pron B, 1999, EUR J CLIN MICROBIOL, V18, P62, DOI 10.1007/s100960050228; Ramzan NN, 1997, ANN INTERN MED, V126, P520, DOI 10.7326/0003-4819-126-7-199704010-00004; Raoult D, 2000, NEW ENGL J MED, V342, P620, DOI 10.1056/NEJM200003023420903; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; RELMAN DA, 1995, INFECT GASTROINTESTI; RICKMAN LS, 1995, NEW ENGL J MED, V332, P363, DOI 10.1056/NEJM199502093320604; Street S, 1999, LANCET, V354, P1178, DOI 10.1016/S0140-6736(99)03065-2; vonHerbay A, 1997, SCAND J GASTROENTERO, V32, P52, DOI 10.3109/00365529709025063; vonHerbay A, 1996, VIRCHOWS ARCH, V429, P335; vonHerbay A, 1996, GASTROENTEROLOGY, V110, P1735, DOI 10.1053/gast.1996.v110.pm8964398; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z	19	51	53	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2001	134	2					115	119		10.7326/0003-4819-134-2-200101160-00011	http://dx.doi.org/10.7326/0003-4819-134-2-200101160-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391KW	11177314				2022-12-24	WOS:000166356000004
J	Reim, K; Mansour, M; Varoqueaux, F; McMahon, HT; Sudhof, TC; Brose, N; Rosenmund, C				Reim, K; Mansour, M; Varoqueaux, F; McMahon, HT; Sudhof, TC; Brose, N; Rosenmund, C			Complexins regulate a late step in Ca2+-dependent neurotransmitter release	CELL			English	Article							MEMBRANE-FUSION; SNARE COMPLEX; EXOCYTOSIS; PROTEINS; SYNAPTOTAGMIN; VESICLES; PROBABILITY; TERMINALS; SYNAPHIN; SYNAPSES	Synaptic vesicle fusion at synapses is triggered by increases in cytosolic Ca2+ levels. However, the identity of the Ca2+ sensor and the transduction mechanism of the Ca2+ trigger are unknown. We show that Complexins, stoichiometric components of the exocytotic core complex, are important regulators of transmitter release at a step immediately preceding vesicle fusion. Neurons lacking Complexins show a dramatically reduced transmitter release efficiency due to decreased Ca2+ sensitivity of the synaptic secretion process. Analyses of mutant neurons demonstrate that Complexins are acting at or following the Ca2+-triggering step of fast synchronous transmitter release by regulating the exocytotic Ca2+ sensor, its interaction with the core complex fusion machinery, or the efficiency of the fusion apparatus itself.	Max Planck Inst Expt Med, Abt Neurogenet, AG Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dept Mol Genet, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA	Max Planck Society; Max Planck Society; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Brose, N (corresponding author), Max Planck Inst Expt Med, Abt Neurogenet, AG Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.		Rosenmund, Christian/AAC-3596-2020; Varoqueaux, Frederique/AAC-1834-2021	Rosenmund, Christian/0000-0002-3905-2444; Varoqueaux, Frederique/0000-0002-3614-3121				Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; CALAKOS N, 1999, ANNU REV PHYSIOL, V61, P753; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Itakura M, 1999, BIOCHEM BIOPH RES CO, V265, P691, DOI 10.1006/bbrc.1999.1756; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Ono S, 1998, EUR J NEUROSCI, V10, P2143, DOI 10.1046/j.1460-9568.1998.00225.x; PABST S, 2000, IN PRESS J BIOL CHEM; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi S, 1999, EUR J NEUROSCI, V11, P2359, DOI 10.1046/j.1460-9568.1999.00652.x; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Yamada M, 1999, NEUROSCIENCE, V93, P7, DOI 10.1016/S0306-4522(99)00104-9; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	26	355	373	0	30	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2001	104	1					71	81		10.1016/S0092-8674(01)00192-1	http://dx.doi.org/10.1016/S0092-8674(01)00192-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163241	Green Published, Bronze			2022-12-24	WOS:000166882300008
J	Kraemer, S				Kraemer, S			The fragile male	BRITISH MEDICAL JOURNAL			English	Article							GENDER DIFFERENCES; SEX; ALEXITHYMIA; BEHAVIOR; MEN		Tavistock & Portman NHS Trust, Child & Family Dept, London NW3 5BA, England		Kraemer, S (corresponding author), Tavistock & Portman NHS Trust, Child & Family Dept, London NW3 5BA, England.							ADAM K, 1995, ATTACHMENT THEORY SO, P327; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; BERRY JW, 1966, INT J PSYCHOL, V1, P207, DOI 10.1080/00207596608247156; Christensen K, 2000, BLOOD, V95, P2449, DOI 10.1182/blood.V95.7.2449.007k06_2449_2451; CICCHETTI D, 1994, DEV PSYCHOPATHOL, V6, P533, DOI 10.1017/S0954579400004673; Dabbs JM, 1998, EVOL HUM BEHAV, V19, P89, DOI 10.1016/S1090-5138(97)00107-4; Darwin C., 1871, P423; *DEP ED EMPL, 1999, STAT B DEP ED EMPL, V35; EARLS F, 1987, PSYCHIATRIC DEV, V1, P1; FABES RA, 1994, CHILD DEV, V65, P1678, DOI 10.2307/1131287; FEINGOLD A, 1988, AM PSYCHOL, V43, P95, DOI 10.1037/0003-066X.43.2.95; Fergusson DM, 1997, NEW ZEAL J EDUC STUD, V32, P83; Fischbein S., 1997, SCAND J EDUC RES, V41, P73, DOI 10.1080/0031383970410105; FIVUSH R, 1989, SEX ROLES, V20, P675, DOI 10.1007/BF00288079; Freeman RD, 2000, DEV MED CHILD NEUROL, V42, P436, DOI 10.1017/S0012162200000839; GUALTIERI T, 1985, BEHAV BRAIN SCI, V8, P427, DOI 10.1017/S0140525X00001023; Hansen D, 1999, BRIT MED J, V319, P548, DOI 10.1136/bmj.319.7209.548; HOPKINS WD, 1993, DEV PSYCHOBIOL, V26, P219, DOI 10.1002/dev.420260405; Kelleher MJ, 1998, BRIT J PSYCHIAT, V173, P196, DOI 10.1192/bjp.173.3.196; KINDLON D, 1999, RAISING CAIN PROTECT, V11; KONG MA, 1986, SOC SCI MED, V22, P15; KRAEMER S, 1991, FAM PROCESS, V30, P377, DOI 10.1111/j.1545-5300.1991.00377.x; Krugman S, 1995, NEW PSYCHOL MEN, P91; LABARTHE JC, 1977, ARCH DIS CHILD, V77, P140; Lavoie ME, 1998, PSYCHOPHYSIOLOGY, V35, P679; MALATESTA CZ, 1982, CHILD DEV, V53, P991, DOI 10.2307/1129139; MASTERS MS, 1993, BEHAV GENET, V23, P337, DOI 10.1007/BF01067434; McClure GMG, 2000, BRIT J PSYCHIAT, V176, P64, DOI 10.1192/bjp.176.1.64; MCCORMICK A, 1995, SER MB5, V3; Meltzer H., 2000, MENTAL HLTH CHILDREN; Mizuno R, 2000, LANCET, V356, P738, DOI 10.1016/S0140-6736(00)02637-4; MURRAY L, 1993, J CHILD PSYCHOL PSYC, V34, P1083, DOI 10.1111/j.1469-7610.1993.tb01775.x; *OFF NAT STAT, 1998, SER DH3, V29; OUNSTED C, 1972, GENDER DIFFERENCES T; Parker JDA, 1999, PSYCHOSOM MED, V61, P464, DOI 10.1097/00006842-199907000-00010; ROGERS LJ, 1999, SEXING BRAIN; Rout U, 1999, PSYCHOL HEALTH MED, V4, P345, DOI DOI 10.1080/135485099106081; RUTTER M, 1975, J CHILD PSYCHOL PSYC, V16, P181, DOI 10.1111/j.1469-7610.1975.tb01269.x; Rutter M, 1999, J CHILD PSYCHOL PSYC, V40, P19, DOI 10.1111/1469-7610.00423; Rutter M., 1998, ANTISOCIAL BEHAV YOU; SACKETT GP, 1972, DEV PSYCHOL, V6, P260, DOI 10.1037/h0032081; Scourfield J, 1999, BRIT J PSYCHIAT, V175, P559, DOI 10.1192/bjp.175.6.559; SHETTLES LB, 1961, OBSTET GYNECOL, V18, P122; Sinclair D, 1998, BRIT J PSYCHIAT, V172, P58, DOI 10.1192/bjp.172.1.58; SINGER JE, 1968, CHILD DEV, V39, P103, DOI 10.2307/1127362; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; TAYLOR DC, 1985, BEHAV BRAIN SCI, V8, P459, DOI 10.1017/S0140525X00001254; TAYLOR DC, 1985, HUMAN SEXUAL DIMORPH, P169; Taylor E., 1994, CHILD ADOLESCENT PSY, P285; Trevarthen C., 1999, IMITATION INFANCY PP, P127; TRONICK EZ, 1989, CHILD DEV, V60, P85, DOI 10.2307/1131074; TRONICK EZ, 1997, POSTPARTUM DEPRESSIO, P61; Tudiver F, 1999, J FAM PRACTICE, V48, P47; VERBRUGGE LM, 1985, J HEALTH SOC BEHAV, V26, P156, DOI 10.2307/2136750; Zaslow Martha J., 1986, ADV DEV PSYCHOL, P285; 2000, GUARDIAN        0101, P2	56	284	286	1	18	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 23	2000	321	7276					1609	1612		10.1136/bmj.321.7276.1609	http://dx.doi.org/10.1136/bmj.321.7276.1609			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	387RA	11124200	Green Published			2022-12-24	WOS:000166134500036
J	Maslin, MA; Burns, SJ				Maslin, MA; Burns, SJ			Reconstruction of the Amazon Basin effective moisture availability over the past 14,000 years	SCIENCE			English	Article							TROPICAL SOUTH-AMERICA; LAST GLACIAL MAXIMUM; NORTHEASTERN BRAZIL; ISOTOPE RECORDS; CLIMATE-CHANGE; ICE; HOLOCENE; FOREST; MODEL; TIME	Quantifying the moisture history of the Amazon Basin is essential for understanding the cause of rain forest diversity and its potential as a methane source. We reconstructed the Amazon River outflow history for the past 14,000 years to provide a moisture budget for the river drainage basin. The oxygen isotopic composition of planktonic foraminifera recovered from a marine sediment core in a region of Amazon River discharge shows that the Amazon Basin was extremely dry during the Younger Dryas, with the discharge reduced by at least 40% as compared with that of today. After the Younger Dryas, a meltwater-driven discharge event was followed by a steady increase in the Amazon Basin effective moisture throughout the Holocene.	UCL, Dept Geog, Environm Change Res Ctr, London WC1H 0AP, England; Univ Bern, Inst Geol, Stable Isotope Lab, CH-3012 Bern, Switzerland	University of London; University College London; University of Bern	Maslin, MA (corresponding author), UCL, Dept Geog, Environm Change Res Ctr, 26 Bedford Way, London WC1H 0AP, England.	mmaslin@geog.ucl.ac.uk	Burns, Stephen/H-9419-2013	Maslin, Mark/0000-0001-9957-3463				Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992; Arz HW, 1999, EARTH PLANET SC LETT, V167, P105, DOI 10.1016/S0012-821X(99)00025-4; BAKER P, 1999, OS S, V80, pF87; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; CLAPPERTON CM, 1998, QUAT P, V6, P65; Colinvaux PA, 1998, GLOBAL ECOL BIOGEOGR, V7, P95, DOI 10.2307/2997812; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Durham E., 1997, THESIS U COLL LONDON; Flood R.D., 1995, P OCEAN DRILLING PRO, V155; Grootes P. M., 1993, GEOPH MONOG SERIES, V78, P37; Haberle SG, 1999, QUATERNARY RES, V51, P27, DOI 10.1006/qres.1998.2020; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Harris SE, 1999, QUATERNARY RES, V51, P14, DOI 10.1006/qres.1998.2008; Hooghiemstra H, 1998, EARTH-SCI REV, V44, P147, DOI 10.1016/S0012-8252(98)00027-0; Hostetler SW, 1999, NATURE, V399, P673, DOI 10.1038/21401; *INT AT EN AG, 1992, TECH REP SER INT AT, V331; Levitus S., 1994, WORLD OCEAN ATLAS 19, V3; Lorenz S, 1996, GEOL RUNDSCH, V85, P513, DOI 10.1007/s005310050092; Maslin M, 1998, GEOL SOC SPEC PUBL, V131, P111, DOI 10.1144/GSL.SP.1998.131.01.09; Mitsch W. J., 1993, WETLANDS; Mix AC, 1999, PALEOCEANOGRAPHY, V14, P350, DOI 10.1029/1999PA900012; Riehl H., 1979, CLIMATE WEATHER TROP; Schneider R.R., 1997, Proceedings of the Ocean Drilling Program Scientific Results, V155, P319; Seltzer G, 2000, GEOLOGY, V28, P35; Severinghaus JP, 1999, SCIENCE, V286, P930, DOI 10.1126/science.286.5441.930; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; Sylvestre F, 1999, QUATERNARY RES, V51, P54, DOI 10.1006/qres.1998.2017; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; Thompson LG, 2000, J QUATERNARY SCI, V15, P377, DOI 10.1002/1099-1417(200005)15:4<377::AID-JQS542>3.0.CO;2-L	30	141	145	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2000	290	5500					2285	+						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125137				2022-12-24	WOS:000165995800037
J	Salih, A; Larkum, A; Cox, G; Kuhl, M; Hoegh-Guldberg, O				Salih, A; Larkum, A; Cox, G; Kuhl, M; Hoegh-Guldberg, O			Fluorescent pigments in corals are photoprotective	NATURE			English	Article							ULTRAVIOLET-RADIATION; PHOTOSYNTHESIS; PHOTOINHIBITION; ADAPTATION	All reef-forming corals depend on the photosynthesis performed by their algal symbiont, and such corals are therefore restricted to the photic zone. The intensity of light in this zone declines over several orders of magnitude-from high and damaging levels at the surface to extreme shade conditions at the lower limit(1). The ability of corals to tolerate this range implies effective mechanisms for light acclimation and adaptation(2). Here we show that the fluorescent pigments(3-9) (FPs) of corals provide a photobiological system for regulating the light environment of coral host tissue. Previous studies have suggested that under low light, FPs may enhance light availability(4,5). We now report that in excessive sunlight FPs are photoprotective; they achieve this by dissipating excess energy at wavelengths of low photosynthetic activity, as well as by reflecting of visible and infrared light by FP-containing chromatophores. We also show that FPs enhance the resistance to mass bleaching of corals during periods of heat stress, which has implications for the effect of environmental stress on the diversity of reef-building corals, such as enhanced survival of a broad range of corals allowing maintenance of habitat diversity.	Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Univ Sydney, Electron Microscope Unit, Sydney, NSW 2006, Australia; Univ Copenhagen, Marine Biol Lab, DK-3100 Hornbaek, Denmark	University of Sydney; University of Sydney; University of Copenhagen	Salih, A (corresponding author), Univ Sydney, Sch Biol Sci, A08, Sydney, NSW 2006, Australia.	anya@emu.usyd.edu.au	Hoegh-Guldberg, Ove/H-6169-2011; Hoegh-Guldberg, Ove/ABA-5420-2020; Kühl, Michael/A-1977-2009	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Kühl, Michael/0000-0002-1792-4790				Brown BE, 2000, NATURE, V404, P142, DOI 10.1038/35004657; Brown BE, 1999, CORAL REEFS, V18, P99; Dove SG, 1995, BIOL BULL, V189, P288, DOI 10.2307/1542146; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Dunlap WC, 1998, J PHYCOL, V34, P418, DOI 10.1046/j.1529-8817.1998.340418.x; Falkowski P.G., 1990, P89; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HOEGHGULDBERG O, 1999, MAR ECOL-PROG SER, V22, P520; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; JOKIEL PL, 1980, SCIENCE, V207, P1069, DOI 10.1126/science.207.4435.1069; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kawaguti S., 1969, Micronesica, V5, P313; Kawaguti S, 1944, CONTR PALAO TROP BIO, V2, P616; KUHL M, 1992, LIMNOL OCEANOGR, V37, P1813; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Salih A, 1998, P AUSTR COR REEF SOC, P217; SALIH A, 1998, P AUST COR REEF SOC, P206; SCHLICHTER D, 1986, MAR BIOL, V91, P403, DOI 10.1007/BF00428634; Schreiber U, 1997, PLANT CELL PHYSIOL, V38, P945, DOI 10.1093/oxfordjournals.pcp.a029256; Shick JM, 1996, GLOBAL CHANGE BIOL, V2, P527, DOI 10.1111/j.1365-2486.1996.tb00065.x; SHIMOMURA O, 1962, AEQUOREA J CELL COMP, V77, P305; TAKABAYASHI M, 1995, MAR BIOL, V123, P705, DOI 10.1007/BF00349113; Veron JEN, 1986, CORALS AUSTR INDOPAC	30	466	477	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2000	408	6814					850	853		10.1038/35048564	http://dx.doi.org/10.1038/35048564			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130722				2022-12-24	WOS:000165831300048
J	Hermosura, MC; Takeuchi, H; Fleig, A; Riley, AM; Potter, BVL; Hirata, M; Penner, R				Hermosura, MC; Takeuchi, H; Fleig, A; Riley, AM; Potter, BVL; Hirata, M; Penner, R			InsP(4) facilitates store-operated calcium influx by inhibition of InsP(3) 5-phosphatase	NATURE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CURRENT I-CRAC; ACINAR-CELLS; PROTEIN-KINASE; TRISPHOSPHATE; 1,3,4,5-TETRAKISPHOSPHATE; ACTIVATION; DEPLETION; LYMPHOCYTES; METABOLISM	Receptor-mediated generation of inositol 1,4,5-trisphosphate (InsP(3)) initiates Ca2+ release from intracellular stores and the subsequent activation of store-operated calcium influx(1). InsP(3) is metabolized within seconds by 5-phosphatase and 3-kinase(2), yielding Ins(1,4)P-2 and inositol 1,3,4,5-tetrakisphosphate (InsP(4)), respectively. Some studies have suggested that InsP(4) controls Ca2+ influx in combination with InsP(3) (refs 3 and 4), but another study did not find the same result(5). Some of the apparent conflicts between these previous studies have been resolved(6); however, the physiological function of InsP(4) remains elusive(7,8). Here we have investigated the function of InsP(4) in Ca2+ influx in the mast cell line RBL-2H3, and we show that InsP(4) inhibits InsP(3) metabolism through InsP(3) 5-phosphatase, thereby facilitating the activation of the store-operated Ca2+ current I-CRAC (ref. 9). Physiologically, this mechanism opens a discriminatory time window for coincidence detection that enables selective facilitation of Ca2+ influx by appropriately timed low-level receptor stimulation. At higher concentrations, InsP(4) acts as an inhibitor of InsP(3) receptors, enabling InsP(4) to act as a potent bi-modal regulator of cellular sensitivity to InsP(3), which provides both facilitatory and inhibitory feedback on Ca2+ signalling.	Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; Kyushu Univ, Grad Sch Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; Kyushu Univ, Stn Collaborat Res, Fukuoka 8128582, Japan; Univ Bath, Dept Pharm & Pharmacol, Wolfson Lab Med Chem, Bath BA2 7AY, Avon, England	The Queen's Medical Center; University of Hawaii System; University of Hawaii System; Kyushu University; Kyushu University; University of Bath	Potter, BVL (corresponding author), Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA.	prsbvlp@bath.ac.uk; rpenner@hawaii.edu	Potter, Barry VL/A-1845-2012; Riley, Andrew M/F-3526-2013; Potter, Barry/AAX-4781-2020	Riley, Andrew M/0000-0001-9003-3540; Penner, Reinhold/0000-0002-5366-1537; Fleig, Andrea/0000-0001-8396-7249				BALLA T, 1991, J BIOL CHEM, V266, P24719; BIRD GS, 1991, NATURE, V352, P162, DOI 10.1038/352162a0; Bird GSJ, 1996, J BIOL CHEM, V271, P6766, DOI 10.1074/jbc.271.12.6766; Broad LM, 1999, J BIOL CHEM, V274, P32881, DOI 10.1074/jbc.274.46.32881; Communi D, 1999, J BIOL CHEM, V274, P14734, DOI 10.1074/jbc.274.21.14734; CONNOLLY TM, 1987, J BIOL CHEM, V262, P2146; Cullen PJ, 1998, BBA-MOL CELL BIOL L, V1436, P35, DOI 10.1016/S0005-2760(98)00149-0; DASILVA CP, 1994, J BIOL CHEM, V269, P12521; DeSmedt F, 1997, J BIOL CHEM, V272, P17367, DOI 10.1074/jbc.272.28.17367; DESMEDT H, 1994, J BIOL CHEM, V269, P21691; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; Glitsch MD, 2000, J PHYSIOL-LONDON, V523, P283, DOI 10.1111/j.1469-7793.2000.t01-2-00283.x; GUILLEMETTE G, 1990, EUR J PHARM-MOLEC PH, V188, P251, DOI 10.1016/0922-4106(90)90009-M; Hirata M, 1997, BIOCHEM J, V328, P93, DOI 10.1042/bj3280093; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; HUGHES AR, 1988, J BIOL CHEM, V263, P10314; IRVINE RF, 1986, BIOCHEM J, V240, P917, DOI 10.1042/bj2400917; JONES SVP, 1991, FEBS LETT, V289, P47, DOI 10.1016/0014-5793(91)80905-I; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; MORRIS AP, 1987, NATURE, V330, P653, DOI 10.1038/330653a0; PAREKH AB, 1995, P NATL ACAD SCI USA, V92, P7907, DOI 10.1073/pnas.92.17.7907; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 1997, CELL, V89, P973, DOI 10.1016/S0092-8674(00)80282-2; Riley AM, 1997, ANGEW CHEM INT EDIT, V36, P1472, DOI 10.1002/anie.199714721; SAFRANY ST, 1994, BIOCHEMISTRY-US, V33, P10763, DOI 10.1021/bi00201a025; Smith PM, 2000, BIOCHEM J, V347, P77, DOI 10.1042/0264-6021:3470077; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; WORLEY PF, 1987, J BIOL CHEM, V262, P12132; Yoshimura K, 1999, CELL SIGNAL, V11, P117, DOI 10.1016/S0898-6568(98)00043-6	29	87	87	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2000	408	6813					735	740		10.1038/35047115	http://dx.doi.org/10.1038/35047115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130077				2022-12-24	WOS:000165815200053
J	Wassell, JT; Gardner, LI; Landsittel, DP; Johnston, JJ; Johnston, JM				Wassell, JT; Gardner, LI; Landsittel, DP; Johnston, JJ; Johnston, JM			A prospective study of back belts for prevention of back pain and injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Despite scientific uncertainties about effectiveness, wearing back belts in the hopes of preventing costly and disabling low back injury in employees is becoming common in the workplace. Objective To evaluate the effectiveness of using back belts in reducing back injury claims and low back pain. Design and Setting Prospective cohort study. from April 1996 through April 1998, we identified material-handing employees in 160 new retail merchandise stores (89 required back belt use; 71 had voluntary back belt use) in 30 states (from New Hampshire to Michigan in the north and from Florida to Texas in the south); data collection ended December 1998, median follow-up was 6 1/2 months. Participants A referred sample of 13 873 material handling employees provided 9377 baseline interviews and 6311 (67%) follow-up interviews; 206 (1.4%) refused baseline interview. Main Outcome Measurer Incidence rate of material-handling back injury workers' compensation claims and 6-month incidence rate of self-reported low back pain. Results Neither frequent back belt use nor a belt-requirement store policy was significantly associated with back injury claim rates or self-reported back pain. Rate ratios comparing back injury claims of those who reported wearing back belts usually every day and once or twice a week vs those who reported wearing belts never or once or twice a month were 1.22 (95% confidence interval [CI], 0.87-1.70) and 0.95 (95% CI, 0.56-1.59), respectively. The respective odds ratios for low back pain incidence were 0.97 (95% CI, 0.83-1.13) and 0.92 (95% CI, 0.73-1.16). Conclusions In the largest prospective cohort study of back belt use, adjusted for multiple individual risk factors, neither frequent back belt use nor a store policy that required belt use was associated with reduced incidence of back injury claims or low back pain.	NIOSH, Ctr Dis Control & Prevent, Div Safety Res, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Wassell, JT (corresponding author), NIOSH, Ctr Dis Control & Prevent, Div Safety Res, 1095 Willowdale Rd, Morgantown, WV 26505 USA.			Johnston, Janet/0000-0001-8738-9677				BIGOS SJ, 1994, CLIN PRACTICE GUIDEL, V14; *CYTEL SOFTW CORP, 1999, STATX 4 WIND STAT SO; GARDNER LI, 1997, INT J OCCUP ENV HEAL, V3, P236; KALLENBERG AL, 1986, AM WORK NATL SURVEYS; Kraus, 1996, Int J Occup Environ Health, V2, P264; LABAR G, 1996, OCCUP HAZARDS, V58, P33; Murphy PL, 1999, SPINE, V24, P691, DOI 10.1097/00007632-199904010-00015; Pan C S, 1999, Int J Occup Environ Health, V5, P79; REDDELL CR, 1992, APPL ERGON, V23, P319, DOI 10.1016/0003-6870(92)90293-5; *SAS I INC, 1998, STAT AN SYST VERS 7; *US BUR LAB STAT, 1998, NUMB NONF OCC INJ IL; van Poppel MNM, 1998, JAMA-J AM MED ASSOC, V279, P1789, DOI 10.1001/jama.279.22.1789; WALSH NE, 1990, AM J PHYS MED REHAB, V69, P245, DOI 10.1097/00002060-199010000-00004	13	49	50	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2000	284	21					2727	2732		10.1001/jama.284.21.2727	http://dx.doi.org/10.1001/jama.284.21.2727			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377JB	11105177				2022-12-24	WOS:000165509500026
J	Graziano, MSA; Cooke, DF; Taylor, CSR				Graziano, MSA; Cooke, DF; Taylor, CSR			Coding the location of the arm by sight	SCIENCE			English	Article							PARIETAL CORTEX; MOVEMENT; MONKEY; AREA-5; SHAPE; REPRESENTATIONS; PROPRIOCEPTION; PERCEPTION; NEURONS; VISION	Area 5 in the parietal Lobe of the primate brain is thought to be involved in monitoring the posture and movement of the body. In this study, neurons in monkey area 5 were found to encode the position of the monkey's arm while it was covered from view. The same neurons also responded to the position of a visible, realistic false arm. The neurons were not sensitive to the sight of unrealistic substitutes for the arm and were able to distinguish a right from a Left arm. These neurons appear to combine visual and somatosensory signals in order to monitor the configuration of the limbs. They could form the basis of the complex body schema that we constantly use to adjust posture and guide movement.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Graziano, MSA (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.		Cooke, Dylan F./O-9954-2019	Cooke, Dylan F./0000-0002-5976-705X	PHS HHS [11347] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Balint R, 1909, MON PSYCHIATR NEUROL, V25, P51; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; COLBY CL, 1991, NEUROPSYCHOLOGIA, V29, P517, DOI 10.1016/0028-3932(91)90008-V; CRASKE B, 1984, J EXP PSYCHOL HUMAN, V10, P307, DOI 10.1037/0096-1523.10.2.307; Darian-Smith, 1984, HDB PHYSL 2 1, V3, P789; DUFFY FH, 1971, SCIENCE, V172, P273, DOI 10.1126/science.172.3980.273; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GEORGOPOULOS AP, 1985, BEHAV BRAIN RES, V18, P159, DOI 10.1016/0166-4328(85)90071-3; Ghez Claude, 1995, P549; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; HAY JC, 1965, PSYCHON SCI, V2, P215, DOI 10.3758/BF03343413; Iriki A, 1996, NEUROREPORT, V7, P2325; KALASKA JF, 1990, EXP BRAIN RES, V80, P351; Kolb B., 2015, FUNDAMENTALS HUMAN N; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; Moore T, 1999, SCIENCE, V285, P1914, DOI 10.1126/science.285.5435.1914; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; PRABLANC C, 1979, BIOL CYBERN, V35, P183, DOI 10.1007/BF00337063; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; SAKATA H, 1973, BRAIN RES, V64, P85, DOI 10.1016/0006-8993(73)90172-8; SEKIYAMA K, 1982, PERCEPT PSYCHOPHYS, V32, P89, DOI 10.3758/BF03204268; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Ungerleider LG., 1982, ANAL VISUAL BEHAV, P549	30	400	402	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2000	290	5497					1782	1786		10.1126/science.290.5497.1782	http://dx.doi.org/10.1126/science.290.5497.1782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379FY	11099420				2022-12-24	WOS:000165632400048
J	Singer, PA; Martin, DK; Giacomini, M; Purdy, L				Singer, PA; Martin, DK; Giacomini, M; Purdy, L			Priority setting for new technologies in medicine: qualitative case study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-CARE; FAIR PROCEDURES; MANAGED CARE	Objective To describe priority setting for new technologies in medicine. Design Qualitative study using case studies and grounded theory. Setting Two committees advising on priorities for new technologies in cancer and cardiac care in Ontario, Canada. Participants The two committees and their 26 members. Main outcome measures Accounts of priority setting decision making gathered by reviewing documents, interviewing members, and observing meetings. Results Six interrelated domains were identified for priority setting for new technologies in medicine: the institution sin which the decision are made, the people who make the decisions, the factors they consider, the reasons for the decisions, the process of decision making,and the appeals mechanism for challenging the decisions. Conclusion These domains constitute a model of priority etting for new technologies in medicine. The next step will be to harmonise this description of how priority setting decisions are made with ethical accounts of how they should be made.	Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada; McMaster Univ, Hamilton, ON L8N 3Z5, Canada	University of Toronto; McMaster University	Singer, PA (corresponding author), Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada.	peter.singer@utoronto.ca	Giacomini, Mauro/D-3194-2013	Giacomini, Mauro/0000-0001-5646-2034				*CARD CAR NETW ONT, 1998, FIN REP REC; Daniels N, 1998, HASTINGS CENT REP, V28, P27, DOI 10.2307/3527569; Daniels N, 1997, PHILOS PUBLIC AFF, V26, P303, DOI 10.1111/j.1088-4963.1997.tb00082.x; Daniels N, 1998, HEALTH AFFAIR, V17, P50, DOI 10.1377/hlthaff.17.5.50; Foy R, 1999, BRIT MED J, V318, P456, DOI 10.1136/bmj.318.7181.456; Green J, 1999, BRIT MED J, V319, P421; Ham C, 1999, BMJ-BRIT MED J, V319, P1258, DOI 10.1136/bmj.319.7219.1258; Ham C, 1997, HEALTH POLICY, V42, P49, DOI 10.1016/S0168-8510(97)00054-7; Holm S, 1998, BRIT MED J, V317, P1000, DOI 10.1136/bmj.317.7164.1000; Hope T, 1998, BRIT MED J, V317, P1067; Klein R, 1998, BMJ-BRIT MED J, V317, P959, DOI 10.1136/bmj.317.7164.959; Klein RDP, 1996, MANAGING SCARCITY PR; MARTIN DK, IN PRESS PRIORITIES; NEWHOUSE JP, 1992, J ECON PERSPECT, V6, P3, DOI 10.1257/jep.6.3.3; Singer P A, 1997, ACP J Club, V127, pA16; Strauss A., 1990, BASICS QUALITATIVE R; YIN RK, 1994, STUDY RES DESIGN MET, P13	17	94	95	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2000	321	7272					1316	1319		10.1136/bmj.321.7272.1316	http://dx.doi.org/10.1136/bmj.321.7272.1316			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	378BK	11090513	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000165561600024
J	Schulman, BA; Carrano, AC; Jeffrey, PD; Bowen, Z; Kinnucan, ERE; Finnin, MS; Elledge, SJ; Harper, JW; Pagano, M; Pavietich, NP				Schulman, BA; Carrano, AC; Jeffrey, PD; Bowen, Z; Kinnucan, ERE; Finnin, MS; Elledge, SJ; Harper, JW; Pagano, M; Pavietich, NP			Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex	NATURE			English	Article							LEUCINE-RICH REPEATS; F-BOX; CELL-CYCLE; PROTEOLYSIS MACHINERY; MEDIATED DEGRADATION; CRYSTAL-STRUCTURE; S-PHASE; PROTEIN; INHIBITOR; P45(SKP2)	F-box proteins are members of a large family that regulates the cell cycle, the immune response, signalling cascades and developmental programmes by targeting proteins, such as cyclins, cyclin-dependent kinase inhibitors, I kappaB alpha and beta -catenin, for ubiquitination (reviewed in refs 1-3). F-box proteins are the substrate-recognition components of SCF (Skp1-Cullin-F-box protein) ubiquitin-protein ligases(4,5). They bind the SCF constant catalytic core by means of the F-box motif interacting with Skp1, and they bind substrates through their variable protein-protein interaction domains(6). The large number of F-box proteins is thought to allow ubiquitination of numerous, diverse substrates(6). Most organisms have several Skp1 family members, but the function of these Skp1 homologues and the rules of recognition between different F-box and Skp1 proteins remain unknown. Here we describe the crystal structure of the human F-box protein Skp2 bound to Skp1. Skp1 recruits the F-box protein through a bipartite interface involving both the F-box and the substrate-recognition domain. The structure raises the possibility that different Skp1 family members evolved to function with different subsets of F-box proteins, and suggests that the F-box protein may not only recruit substrate, but may also position it optimally for the ubiquitination reaction.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA; NYU, Med Ctr, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; New York University; New York University; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Pavietich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	Nikola@xray2.mskcc.org		pagano, michele/0000-0003-3210-2442; Jeffrey, Philip/0000-0002-4351-5341; Finnin, Michael/0000-0003-2794-2703; Harper, Jeffrey/0000-0002-6944-7236	NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG011085] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Li FN, 1997, EMBO J, V16, P5629, DOI 10.1093/emboj/16.18.5629; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Russell ID, 1999, J CELL BIOL, V145, P933, DOI 10.1083/jcb.145.5.933; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	30	452	484	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2000	408	6810					381	386		10.1038/35042620	http://dx.doi.org/10.1038/35042620			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099048				2022-12-24	WOS:000165296000051
J	Anhalt, GJ; Diaz, LA				Anhalt, GJ; Diaz, LA			Research advances in pemphigus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLIACEUS FOGO-SELVAGEM; HIGH-DOSE CYCLOPHOSPHAMIDE; SEVERE AUTOIMMUNE-DISEASE; STEM-CELL RESCUE; PARANEOPLASTIC PEMPHIGUS; VULGARIS ANTIGEN; PASSIVE TRANSFER; AUTOANTIBODIES; MICE; CADHERIN	Pemphigus is an autoimmune disorder, known to be caused by autoantibodies directed against critical adhesion molecules of squamous epithelial cells, the desmogleins. These autoantibodies induce blistering of skin and mucosal surfaces and lead to severe morbidity and, potentially, death. Key factors include associated major histocompatibility complex class II genes, the structure of the desmoglein antigens, and the role of autoantibody in impairing cellular adhesion. This article discusses the precise structure of the major histocompatibility complex class II gene-peptide-T-cell receptor complex involved and of the environmental and genetic factors that induce autoimmunity against desmoglein 1. Discovery of antigen-specific immunotherapy and insight into environmental factors that initiate autoimmunity in genetically susceptible individuals are needed.	Johns Hopkins Univ, Sch Med, Div Dermatoimmunol, Baltimore, MD 21205 USA; Univ N Carolina, Dept Dermatol, Chapel Hill, NC USA	Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Anhalt, GJ (corresponding author), Johns Hopkins Univ, Sch Med, Div Dermatoimmunol, 720 Rutland Ave,Room 771, Baltimore, MD 21205 USA.				NIAMS NIH HHS [R01 AR032081] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AHMED AR, 1991, P NATL ACAD SCI USA, V88, P7658; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 2000, J CLIN INVEST, V105, P625, DOI 10.1172/JCI8748; AMAGAI M, 1992, J CLIN INVEST, V90, P919, DOI 10.1172/JCI115968; ANHALT GJ, 1986, J IMMUNOL, V136, P113; ANHALT GJ, 1990, NEW ENGL J MED, V323, P1729, DOI 10.1056/NEJM199012203232503; ANHALT GJ, 1982, NEW ENGL J MED, V306, P1189, DOI 10.1056/NEJM198205203062001; Aoyama Y, 1999, EUR J IMMUNOL, V29, P2233, DOI 10.1002/(SICI)1521-4141(199907)29:07<2233::AID-IMMU2233>3.0.CO;2-4; BEUTNER EH, 1964, P SOC EXP BIOL MED, V117, P505; Brodsky RA, 1998, ANN INTERN MED, V129, P1031, DOI 10.7326/0003-4819-129-12-199812150-00007; BUXTON RS, 1993, J CELL BIOL, V121, P481, DOI 10.1083/jcb.121.3.481; DIAZ LA, 1989, J AM ACAD DERMATOL, V20, P657, DOI 10.1016/S0190-9622(89)70079-7; DIAZ LA, 1989, J INVEST DERMATOL, V92, P4, DOI 10.1111/1523-1747.ep13070394; EYRE RW, 1987, J EXP MED, V165, P1719, DOI 10.1084/jem.165.6.1719; EYRE RW, 1988, J CLIN INVEST, V81, P807, DOI 10.1172/JCI113387; KOCH PJ, 1990, EUR J CELL BIOL, V53, P1; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; KORMAN NJ, 1991, J INVEST DERMATOL, V96, P273, DOI 10.1111/1523-1747.ep12464471; LABIB RS, 1991, J INVEST DERMATOL, V96, P144, DOI 10.1111/1523-1747.ep12515943; Mahoney MG, 1999, J INVEST DERMATOL, V113, P22, DOI 10.1046/j.1523-1747.1999.00632.x; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Moraes ME, 1997, TISSUE ANTIGENS, V49, P35, DOI 10.1111/j.1399-0039.1997.tb02707.x; Nousari HC, 1999, LANCET, V354, P667, DOI 10.1016/S0140-6736(99)03007-X; Nousari HC, 1999, J AM ACAD DERMATOL, V40, P750, DOI 10.1016/S0190-9622(99)70157-X; Nousari HC, 1999, NEW ENGL J MED, V340, P1406, DOI 10.1056/NEJM199905063401805; ROSCOE JT, 1985, J INVEST DERMATOL, V85, P538, DOI 10.1111/1523-1747.ep12277362; SINHA AA, 1988, SCIENCE, V239, P1026, DOI 10.1126/science.2894075; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; STANLEY JR, 1989, J CLIN INVEST, V83, P1443, DOI 10.1172/JCI114036; Warren KG, 1997, J NEUROL SCI, V152, P31, DOI 10.1016/S0022-510X(97)00130-5; WARREN SJ, IN PRESS N ENGL J ME; WUCHERPFENNIG KW, 1995, P NATL ACAD SCI USA, V92, P11935, DOI 10.1073/pnas.92.25.11935	32	43	46	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					652	654		10.1001/jama.285.5.652	http://dx.doi.org/10.1001/jama.285.5.652			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176877				2022-12-24	WOS:000166714200030
J	Kaji, EH; Leiden, JM				Kaji, EH; Leiden, JM			Gene and stem cell therapies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; FAMILIAL HYPERCHOLESTEROLEMIA; BONE-MARROW; IN-VIVO; IDENTIFICATION; BRAIN; MICE; TRANSPLANTATION; RETINOBLASTOMA; DIFFERENTIATE	Gene and stem cell therapies hold promise for the treatment of a wide variety of inherited and acquired human diseases. Identification of genes involved in human disease and development of novel vectors and devices for delivering therapeutic genes to different tissues in vivo have resulted in significant progress in the area of gene therapy. Isolation of stem cells from organs formerly thought to have no regenerative potential, the demonstration of stem cell plasticity, and the creation of human embryonic stem cells clearly demonstrate the feasibility of human stem cell therapy. Much additional work remains to be done in the areas of vector development and stem cell biology before the full therapeutic potential of these approaches can be realized. Of equal importance, the ethical issues surrounding gene- and cell-based therapies must be confronted.	Abbott Labs, Dept Execut, Abbott Pk, IL 60064 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Vet Affairs Boston Healthcare Syst, Jamaica Plain, MA USA	Abbott Laboratories; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Leiden, JM (corresponding author), Abbott Labs, Dept Execut, Bldg AP6D,100 Abbott Pk Rd, Abbott Pk, IL 60064 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048987] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK48987-07] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2000, Nature, V405, P599; BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Binley K, 1999, GENE THER, V6, P1721, DOI 10.1038/sj.gt.3301001; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bohl D, 1997, NAT MED, V3, P299, DOI 10.1038/nm0397-299; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; CHANG MW, 1995, SCIENCE, V267, P518, DOI 10.1126/science.7824950; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; KASAHARA N, 1994, SCIENCE, V266, P1373, DOI 10.1126/science.7973726; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; KNOWLES MR, 1995, NEW ENGL J MED, V333, P823, DOI 10.1056/NEJM199509283331302; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Losordo DW, 1998, CIRCULATION, V98, P2800, DOI 10.1161/01.CIR.98.25.2800; Marshall DJ, 2000, MOL THER, V1, P423, DOI 10.1006/mthe.2000.0059; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monahan PE, 2000, GENE THER, V7, P24, DOI 10.1038/sj.gt.3301109; MORGAN JE, 1994, HUM GENE THER, V5, P165, DOI 10.1089/hum.1994.5.2-165; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Perry D, 2000, SCIENCE, V287, P1423, DOI 10.1126/science.287.5457.1423; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Restifo NP, 2000, GENE THER, V7, P89, DOI 10.1038/sj.gt.3301117; Roelvink PW, 1999, SCIENCE, V286, P1568, DOI 10.1126/science.286.5444.1568; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Thomson JA, 1998, SCIENCE, V282, P1827; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Vile RG, 2000, GENE THER, V7, P2, DOI 10.1038/sj.gt.3301084; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 1997, NATURE, V386, P200, DOI 10.1038/386200a0; Ye XH, 1999, SCIENCE, V283, P88, DOI 10.1126/science.283.5398.88; Young FE, 2000, SCIENCE, V287, P1424, DOI 10.1126/science.287.5457.1424	48	60	77	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					545	550		10.1001/jama.285.5.545	http://dx.doi.org/10.1001/jama.285.5.545			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176856	Bronze			2022-12-24	WOS:000166714200009
J	McGrath, PD; Wennberg, DE; Dickens, JD; Siewers, AE; Lucas, FL; Malenka, DJ; Kellett, MA; Ryan, TJ				McGrath, PD; Wennberg, DE; Dickens, JD; Siewers, AE; Lucas, FL; Malenka, DJ; Kellett, MA; Ryan, TJ			Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLLEGE-OF-CARDIOLOGY; NORTHERN NEW-ENGLAND; ANGIOPLASTY VOLUME; SURGICAL VOLUME; TASK-FORCE; ASSOCIATION; MORTALITY; SURGERY; EXPERIENCE; CALIFORNIA	Context Studies have found an association between physician and institution procedure volume for percutaneous coronary interventions (PCIs) and patient outcomes, but whether implementation of coronary stents has allowed low-volume physicians and centers to achieve outcomes similar to their high-volume counterparts is unknown. Objective To assess the relationship between physician and hospital PCI volumes and patient outcomes following PCIs, given the availability of coronary stents. Design, Setting, and Participants Analysis of data from Medicare National Claims History files for 167208 patients aged 65 to 99 years who had PCIs performed by 6534 physicians at 1003 hospitals during 1997, Of these procedures, 57.7% involved coronary stents. Main Outcome Measures Rates of coronary artery bypass graft (CABG) surgery and 30-day mortality occurring during the index episode of care, stratified by physician and hospital PCI volume. Results Overall unadjusted rates of CABG during the index hospitalization and 30-day mortality were 1.87% and 3.30%, respectively. After adjustment for case mix, patients treated by low-volume (<30 Medicare procedures) physicians had an increased risk of CABG vs patients treated by high-volume (>60 Medicare procedures) physicians (2.25% vs 1.55%; P<.001), but there was no difference in 30-day mortality rates (3.25% vs 3.39%; P=.27), Patients treated at low-volume (<80 Medicare procedures) centers had an increased risk of 30-day mortality vs patients treated at high-volume (>160 Medicare procedures) centers (4.29% vs 3.15%; P<.001), but there was no difference in the risk of CABG (1.83% vs 1.83 %; P=.96). In patients who received coronary stents, the CABG rate was 1.20% vs 2.78% for patients not receiving stents, and the 30-day mortality rate was 2.83 % vs 3.94%, Among patients who received stents, those treated at low-volume centers had an increased risk of 30-day mortality vs those treated at high-volume centers, whereas those treated by low-volume physicians had an increased risk of CABG vs those treated by high-volume physicians. Conclusion In the era of coronary stents, Medicare patients treated by high-volume physicians and at high-volume centers experience better outcomes following PCIs.	Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA; Maine Med Ctr, Dept Med, Div Cardiol, Portland, ME 04102 USA; Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH USA; Dartmouth Hitchcock Med Ctr, Cardiol Sect, Lebanon, NH 03766 USA	Maine Medical Center; Maine Medical Center; Dartmouth College; Dartmouth College	McGrath, PD (corresponding author), Maine Med Ctr, Ctr Outcomes Res & Evaluat, 22 Bramhall St, Portland, ME 04102 USA.							*AM MED ASS, 1995, PHYS CURR PROC TERM; BUNKER JP, 1982, SURG CLIN N AM, V62, P657; Califf RM, 1996, CIRCULATION, V93, P403, DOI 10.1161/01.CIR.93.3.403; Fleiss J. L., 1981, STAT METHODS RATES P, V2; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; Hirshfeld JW, 1998, J AM COLL CARDIOL, V31, P722; Jollis JG, 1997, CIRCULATION, V95, P2485, DOI 10.1161/01.CIR.95.11.2485; JOLLIS JG, 1994, NEW ENGL J MED, V331, P1625, DOI 10.1056/NEJM199412153312406; Kahn HA, 1989, STAT METHODS EPIDEMI; Kastrati A, 1998, J AM COLL CARDIOL, V32, P970, DOI 10.1016/S0735-1097(98)00334-9; KATO NS, 1996, CIRCULATION S1, V94, P532; KIMMEL SE, 1995, JAMA-J AM MED ASSOC, V274, P1137, DOI 10.1001/jama.274.14.1137; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Malenka DJ, 1999, J AM COLL CARDIOL, V34, P1471, DOI 10.1016/S0735-1097(99)00393-9; Maynard C, 1999, Eff Clin Pract, V2, P108; McGrath P, 1998, J AM COLL CARDIOL, V31, P570, DOI 10.1016/S0735-1097(97)00541-X; McGrath PD, 1999, J AM COLL CARDIOL, V34, P674, DOI 10.1016/S0735-1097(99)00257-0; PHILLIPS KA, 1995, MED CARE, V33, P502, DOI 10.1097/00005650-199505000-00005; Ritchie JL, 1999, AM HEART J, V138, P437, DOI 10.1016/S0002-8703(99)70144-4; RITCHIE JL, 1993, CIRCULATION, V88, P2735, DOI 10.1161/01.CIR.88.6.2735; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; RYAN TJ, 1993, CIRCULATION, V88, P2987, DOI 10.1161/01.CIR.88.6.2987; RYAN TJ, 1988, CIRCULATION, V78, P486, DOI 10.1161/01.CIR.78.2.486; RYAN TJ, 1995, JAMA-J AM MED ASSOC, V274, P1169, DOI 10.1001/jama.274.14.1169; *SAS I INC, 1986, STAT AN SYST SAS; SHOWSTACK JA, 1987, JAMA-J AM MED ASSOC, V257, P785, DOI 10.1001/jama.257.6.785; *STAT CORP, 2000, STAT 6 0; *US DEP HHS CDCP, 1997, 1994 NAT HLTH INT SU; World Health Organization, 1977, INT CLASS DIS; ZELEN J, 1991, NEW YORK STATE J MED, V91, P290	32	220	222	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2000	284	24					3139	3144		10.1001/jama.284.24.3139	http://dx.doi.org/10.1001/jama.284.24.3139			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385FZ	11135777	Bronze			2022-12-24	WOS:000165994100031
J	Bunger, MK; Wilsbacher, LD; Moran, SM; Clendenin, C; Radcliffe, LA; Hogenesch, JB; Simon, MC; Takahashi, JS; Bradfield, CA				Bunger, MK; Wilsbacher, LD; Moran, SM; Clendenin, C; Radcliffe, LA; Hogenesch, JB; Simon, MC; Takahashi, JS; Bradfield, CA			Mop3 is an essential component of the master circadian pacemaker in mammals	CELL			English	Article							DROSOPHILA CLOCK GENE; SUPRACHIASMATIC NUCLEUS; PROTEIN BMAL1; CDNA CLONING; COMMON VOLE; DOUBLE-TIME; RHYTHMS; PAS; TRANSCRIPTION; LIGHT	Circadian oscillations in mammalian physiology and behavior are regulated by an endogenous biological clock. Here we show that loss of the PAS protein MOP3 (also known as BMAL1) in mice results in immediate and complete loss of circadian rhythmicity in constant darkness. Additionally, locomotor activity in light-dark (LD) cycles is impaired and activity revels are reduced in Mop3(-/-) mice. Analysis of Period gene expression in the suprachiasmatic nucleus (SCN) indicates that these behavioral phenotypes arise from loss of circadian function at the molecular level. These results provide genetic evidence that MOP3 is the bona fide heterodimeric partner of mCLOCK. Furthermore, these data demonstrate that MOP3 is a nonredundant and essential component of the circadian pacemaker in mammals.	Univ Wisconsin, Sch Med, McArdle Lab Canc Res, Madison, WI 53706 USA; Northwestern Univ, Howard Hughes Med Inst, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Univ Chicago, Howard Hughes Med Inst, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Northwestern University; Howard Hughes Medical Institute; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Bradfield, CA (corresponding author), Univ Wisconsin, Sch Med, McArdle Lab Canc Res, Madison, WI 53706 USA.	bradfield@oncology.wisc.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012; Simon, Celeste/AAG-3941-2021	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; 	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P30-CA07175] Funding Source: Medline; NIEHS NIH HHS [ES05703, R37 ES005703, R01 ES005703, F32 ES005703] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES005703, R29ES005703, R01ES005703, R37ES005703] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GERKEMA MP, 1993, J BIOL RHYTHM, V8, P151, DOI 10.1177/074873049300800205; GERKEMA MP, 1990, J BIOL RHYTHM, V5, P81, DOI 10.1177/074873049000500201; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hogenesch JB, 2000, J NEUROSCI, V20, part. no.; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Ikeda M, 2000, BIOCHEM BIOPH RES CO, V275, P493, DOI 10.1006/bbrc.2000.3248; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kay SA, 1997, SCIENCE, V276, P753, DOI 10.1126/science.276.5313.753; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 1999, MOL CELL BIOL, V19, P5316; LEHMANN U, 1977, International Journal of Chronobiology, V4, P223; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; REDIN U, 1999, J COMP PHYSIOL A, V184, P429; REDIN U, 1999, J COMP PHYSIOL A, V184, P439; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Ripperger JA, 2000, GENE DEV, V14, P679; ROSBASH M, 1995, CURR OPIN GENET DEV, V5, P662, DOI 10.1016/0959-437X(95)80037-9; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; SCHWARTZ WJ, 1991, PHYSIOL BEHAV, V49, P1283, DOI 10.1016/0031-9384(91)90364-T; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Takahata S, 1998, BIOCHEM BIOPH RES CO, V248, P789, DOI 10.1006/bbrc.1998.9012; Tamaru T, 2000, J NEUROSCI, V20, P7525; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wachulec M, 1997, J BIOL RHYTHM, V12, P226, DOI 10.1177/074873049701200304; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Wilsbacher LD, 1998, CURR OPIN GENET DEV, V8, P595, DOI 10.1016/S0959-437X(98)80017-8; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yu WJ, 1999, BIOCHEM BIOPH RES CO, V260, P760, DOI 10.1006/bbrc.1999.0970; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	60	1108	1152	2	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2000	103	7					1009	1017		10.1016/S0092-8674(00)00205-1	http://dx.doi.org/10.1016/S0092-8674(00)00205-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163178	Green Accepted, Bronze			2022-12-24	WOS:000166040600005
J	Jones, A; Pill, R; Adams, S				Jones, A; Pill, R; Adams, S			Qualitative study of views of health professionals and patients on guided self management plans for asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To explore the views held by general practitioners, practice nurses, and patients about the role of guided self management plans in asthma care. Design Qualitative study using nine focus groups that each met on two occasions. Setting South Wales. Subjects 13 asthma nurses, 11 general practitioners (six with an interest in asthma), and 32 patients (13 adults compliant with treatment, 12 non-compliant adults, and seven teenagers). Results Neither health professionals nor patients were enthusiastic about guided self management plans, and, although for different reasons, almost all participants were ambivalent about their usefulness or relevance. Most professionals opposed their use. Few patients reported sustained use, and most felt that plans were largely irrelevant to them. The attitudes associated with these views reflect the gulf between the professionals' concept of the "responsible asthma patient" and the patients' view. Conclusions Attempts to introduce self guided management plans in primary care are unlikely to be successful. A more patient centred, patient negotiated plan is needed for asthma care in the community.	Cardiff Univ, Ctr Hlth, Dept Gen Practice, Cardiff CF26 9PN, S Glam, Wales; Univ Swansea, Sch Social Sci & Int Dev, Swansea SA2 8PP, W Glam, Wales	Cardiff University; Swansea University	Jones, A (corresponding author), Princess St Surg, Swansea SA4 2US, W Glam, Wales.	research@gors.freeserve.co.uk						Adams S, 1997, SOC SCI MED, V45, P189, DOI 10.1016/S0277-9536(96)00333-4; [Anonymous], 1993, BRIT MED J, V306, P776; Ayres JG, 1996, EUR RESPIR J, V9, P886, DOI 10.1183/09031936.96.09050886; GIBSON PG, 2000, COCHRANE LIB; Guba E. G., 1989, 4 GENERATION EVALUAT; HAUGHNEY J, 1997, AIRWAYS, V4, P2; JONES KP, 1995, THORAX, V50, P851, DOI 10.1136/thx.50.8.851; Lahdensuo A, 1999, BMJ-BRIT MED J, V319, P759, DOI 10.1136/bmj.319.7212.759; LEVY M, 1999, ED SELF MANAGEMENT A, P63; Neville RG, 1999, THORAX, V54, P813, DOI 10.1136/thx.54.9.813; Partridge MR, 1990, RES CLIN FORUMS, V15, P65; ROLLNICK S, 1993, BRIT MED J, V307, P188, DOI 10.1136/bmj.307.6897.188; YOON R, 1993, THORAX, V48, P1110, DOI 10.1136/thx.48.11.1110	13	103	104	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2000	321	7275					1507	1510		10.1136/bmj.321.7275.1507	http://dx.doi.org/10.1136/bmj.321.7275.1507			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385GF	11118179	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000165994700027
J	Harmer, SL; Hogenesch, LB; Straume, M; Chang, HS; Han, B; Zhu, T; Wang, X; Kreps, JA; Kay, SA				Harmer, SL; Hogenesch, LB; Straume, M; Chang, HS; Han, B; Zhu, T; Wang, X; Kreps, JA; Kay, SA			Orchestrated transcription of key pathways in Arabidopsis by the circadian clock	SCIENCE			English	Article							HIGHER-PLANTS; GENE; THALIANA; METABOLISM; PROTEIN; MUTANTS; STARCH	Like most organisms, plants have endogenous biological clocks that coordinate internal events with the external environment. We used high-density oligonucleotide microarrays to examine gene expression in Arabidopsis and found that 6% of the more than 8000 genes on the array exhibited circadian changes in steady-state messenger RNA Levers. Clusters of circadian-regulated genes were found in pathways involved in plant responses to Light and other key metabolic pathways. Computational analysis of cycling genes allowed the identification of a highly conserved promoter motif that we found to be required for circadian control of gene expression. Our study presents a comprehensive view of the temporal compartmentalization of physiological pathways by the circadian clock in a eukaryote.	Scripps Res Inst, Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Univ Virginia, Dept Internal Med, Div Endocrinol & Metab, NSF Ctr Biol Timing,Ctr Biomath Technol, Charlottesville, VA 22904 USA; Novartis Agr Discovery Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis; National Science Foundation (NSF); University of Virginia; Novartis	Kay, SA (corresponding author), Scripps Res Inst, Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Rosa, Bruce/F-6393-2010; Harmer, Sarah/G-5572-2016; Zhu, Tong/G-5202-2011; Kay, Steve A/F-6025-2011	Harmer, Sarah/0000-0002-5627-5500; Zhu, Tong/0000-0002-8732-3499; Kay, Steve A/0000-0002-0402-2878; Harmer, Stacey/0000-0001-6813-6682	NIDDK NIH HHS [R01 DK51562] Funding Source: Medline; NIGMS NIH HHS [5F32GM20118-02] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020118] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beator J, 1996, CHRONOBIOL INT, V13, P319, DOI 10.3109/07420529609012657; BOREVITZ JO, IN PRESS PLANT CELL; CHATTERTON NJ, 1979, PLANT PHYSIOL, V64, P749, DOI 10.1104/pp.64.5.749; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 1997, ANNU REV CELL DEV BI, V13, P171, DOI 10.1146/annurev.cellbio.13.1.171; Cutler S, 1997, CURR BIOL, V7, pR108, DOI 10.1016/S0960-9822(06)00050-9; Daniels MJ, 1996, PLANT CELL, V8, P587, DOI 10.1105/tpc.8.4.587; Darwin C, 1880, POWER MOVEMENT PLANT; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gibson LCD, 1996, PLANT PHYSIOL, V111, P61, DOI 10.1104/pp.111.1.61; Goddijn OJM, 1999, TRENDS PLANT SCI, V4, P315, DOI 10.1016/S1360-1385(99)01446-6; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Koprivova A, 2000, PLANT PHYSIOL, V122, P737, DOI 10.1104/pp.122.3.737; Kreps JA, 1997, PLANT CELL, V9, P1235, DOI 10.1105/tpc.9.7.1235; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; LANDRY LG, 1995, PLANT PHYSIOL, V109, P1159, DOI 10.1104/pp.109.4.1159; LI JY, 1993, PLANT CELL, V5, P171, DOI 10.1105/tpc.5.2.171; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Lorberth R, 1998, NAT BIOTECHNOL, V16, P473, DOI 10.1038/nbt0598-473; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; PALME K, COMMUNICATION; RIKIN A, 1993, PLANT PHYSIOL, V101, P31, DOI 10.1104/pp.101.1.31; Samach A, 2000, BIOESSAYS, V22, P38, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;38::AID-BIES8&gt;3.0.CO;2-L; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shirley BW, 1996, TRENDS PLANT SCI, V1, P377, DOI 10.1016/S1360-1385(96)80312-8; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Taiz L., 1998, PLANT PHYSIOL, P543; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660	34	1226	1293	4	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2000	290	5499					2110	2113		10.1126/science.290.5499.2110	http://dx.doi.org/10.1126/science.290.5499.2110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	383ER	11118138				2022-12-24	WOS:000165870600046
J	Berger, A				Berger, A			Science commentary: Renal function - and how to assess it	BRITISH MEDICAL JOURNAL			English	Article																		CAMERON JS, 1998, OXFORD TXB CLIN NEPH	1	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 9	2000	321	7274					1444	1444		10.1136/bmj.321.7274.1444	http://dx.doi.org/10.1136/bmj.321.7274.1444			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	382XH	11110736	Green Published, Bronze			2022-12-24	WOS:000165852300026
J	Shaulian, E; Schreiber, M; Piu, F; Beeche, M; Wagner, EF; Karin, M				Shaulian, E; Schreiber, M; Piu, F; Beeche, M; Wagner, EF; Karin, M			The mammalian UV response: c-jun induction is required for exit from p53-imposed growth arrest	CELL			English	Article							CELL-CYCLE PROGRESSION; HUMAN FIBROBLASTS; PROTEIN-KINASE; G(1) ARREST; DNA-DAMAGE; IONIZING-RADIATION; EMBRYO FIBROBLASTS; ACTIVATION DOMAIN; ULTRAVIOLET-LIGHT; GENOTOXIC STRESS	The mammalian UV response results in rapid and dramatic induction of c-jun. Induction of a protooncogene, normally involved in mitogenic responses, by a genotoxic agent that causes growth arrest seems paradoxical. We now provide an explanation for the role of c-Jun in the UV response of mouse fibroblasts. c-Jun is necessary for cell-cycle reentry of UV-irradiated cells, but does not participate in the response to ionizing radiation. Cells lacking c-Jun undergo prolonged cell-cycle arrest, but resist apoptosis, whereas cells that express c-Jun constitutively do not arrest and undergo apoptosis. This function of c-Jun is exerted through negative regulation of p53 association with the p21 promoter. Cells lacking c-Jun exhibit prolonged p21 induction, whereas constitutive c-Jun inhibits UV-mediated p21 induction.	Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Res Inst Mol Biol, A-1030 Vienna, Austria; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Salk Institute	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Martin, Schreiber/F-2175-2013	Martin, Schreiber/0000-0003-1102-7789; Wagner, Erwin F/0000-0001-7872-0196; Shaulian, Eitan/0000-0001-6242-6849	NCI NIH HHS [CA76188] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076188] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; ANGEL P, 1995, PROG GENE EXPRESS, V1, P62; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bissonnette N, 1998, ONCOGENE, V16, P3461, DOI 10.1038/sj.onc.1201899; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; BUSCHER M, 1988, ONCOGENE, V3, P301; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fang L, 1999, ONCOGENE, V18, P2789, DOI 10.1038/sj.onc.1202615; Finkel E, 1999, SCIENCE, V286, P2256, DOI 10.1126/science.286.5448.2256; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Friedberg E.C., 2016, DNA REPAIR MUTAGENES, V33, P35; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; HERR I, 1994, CARCINOGENESIS, V15, P1105, DOI 10.1093/carcin/15.6.1105; HERRLICH P, 1992, REV PHYSIOL BIOCH P, V119, P187; Herrlich P, 1997, BIOL CHEM, V378, P1217; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HOLBROOK NJ, 1991, NEW BIOL, V3, P825; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KARIN M, 1989, GENES SIGNAL TRANSDU, P415; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KAUFMANN WK, 1994, MUTAT RES, V314, P67, DOI 10.1016/0921-8777(94)90062-0; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Ko JL, 1996, GENE DEV, V10, P1054; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Loignon M, 1997, CANCER RES, V57, P3390; Lu X, 1996, ONCOGENE, V13, P413; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; METTOUCHI A, 1994, EMBO J, V13, P5668, DOI 10.1002/j.1460-2075.1994.tb06905.x; NAGASAWA H, 1983, MUTAT RES, V109, P297, DOI 10.1016/0027-5107(83)90054-4; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; SACHSENMAIER C, 1994, CELL, V78, P963, DOI 10.1016/0092-8674(94)90272-0; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 1999, J BIOL CHEM, V274, P29595, DOI 10.1074/jbc.274.42.29595; Sheikh MS, 1997, ONCOGENE, V14, P1875, DOI 10.1038/sj.onc.1201004; Tsao YP, 1996, J VIROL, V70, P7535, DOI 10.1128/JVI.70.11.7535-7539.1996; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Woo RA, 1998, NATURE, V394, P700, DOI 10.1038/29343; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242	64	250	253	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 8	2000	103	6					897	907		10.1016/S0092-8674(00)00193-8	http://dx.doi.org/10.1016/S0092-8674(00)00193-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136975	Bronze			2022-12-24	WOS:000165801300009
J	Grimson, MJ; Coates, JC; Reynolds, JP; Shipman, M; Blanton, RL; Harwood, AJ				Grimson, MJ; Coates, JC; Reynolds, JP; Shipman, M; Blanton, RL; Harwood, AJ			Adherens junctions and beta-catenin-mediated cell signalling in a non-metazoan organism	NATURE			English	Article							TRANSCRIPTION FACTOR LEF-1; DICTYOSTELIUM-DISCOIDEUM; CYTOPLASMIC DOMAIN; ADHESION MOLECULE; C-ELEGANS; PROTEIN; VACUOLE; BINDING; SPECIFICATION; INHERITANCE	Mechanical forces between cells have a principal role in the organization of animal tissues. Adherens junctions are an important component of these tissues, connecting cells through their actin cytoskeleton and allowing the assembly of tensile structures(1-4). At least one adherens junction protein, beta -catenin, also acts as a signalling molecule, directly regulating gene expression(5-7). To date, adherens junctions have only been detected in metazoa, and therefore we looked for them outside the animal kingdom to examine their evolutionary origins. The non-metazoan Dictyostelium discoideum forms a multicellular, differentiated structure(8). Here we describe the discovery of actin-associated intercellular junctions in Dictyostelium. We have isolated a gene encoding a beta -catenin homologue, aardvark, which is a component of the junctional complex, and, independently, is required for cell signalling. Our discovery of adherens junctions outside the animal kingdom shows that the dual role of beta -catenin in cell-cell adhesion and cell sig-nailing evolved before the origins of metazoa.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	University of London; University College London; Texas Tech University System; Texas Tech University	Harwood, AJ (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	a.harwood@ucl.ac.uk	Coates, Juliet C/A-3608-2013; Harwood, Adrian/A-4350-2010	Coates, Juliet C/0000-0002-2381-0298; Harwood, Adrian/0000-0003-3124-5169				Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Fleckenstein D, 1998, J CELL SCI, V111, P3109; HARWOOD AJ, 1995, CELL, V80, P139, DOI 10.1016/0092-8674(95)90458-1; HOWARD PK, 1988, NUCLEIC ACIDS RES, V16, P2613, DOI 10.1093/nar/16.6.2613; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Kim L, 1999, CELL, V99, P399, DOI 10.1016/S0092-8674(00)81526-3; Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morio T, 1998, DNA Res, V5, P335, DOI 10.1093/dnares/5.6.335; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pan XZ, 1998, J CELL SCI, V111, P2137; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; Plyte SE, 1999, DEVELOPMENT, V126, P325; Raper KB, 1935, J AGRIC RES, V50, P0135; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Sokol SY, 1999, CURR OPIN GENET DEV, V9, P405, DOI 10.1016/S0959-437X(99)80061-6; Stevenson BR, 1989, CURR OPIN CELL BIOL, V1, P884, DOI 10.1016/0955-0674(89)90054-9; STRAFSTROM J, 1988, PLANTA, V174, P321; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; WILLIAMS JG, 1989, CELL, V59, P1157, DOI 10.1016/0092-8674(89)90771-X	27	108	113	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2000	408	6813					727	731		10.1038/35047099	http://dx.doi.org/10.1038/35047099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130075				2022-12-24	WOS:000165815200051
J	Hemmi, H; Takeuchi, O; Kawai, T; Kaisho, T; Sato, S; Sanjo, H; Matsumoto, M; Hoshino, K; Wagner, H; Takeda, K; Akira, S				Hemmi, H; Takeuchi, O; Kawai, T; Kaisho, T; Sato, S; Sanjo, H; Matsumoto, M; Hoshino, K; Wagner, H; Takeda, K; Akira, S			A Toll-like receptor recognizes bacterial DNA	NATURE			English	Article							CELL WALL COMPONENTS; DENDRITIC CELLS; CUTTING EDGE; CPG-DNA; DROSOPHILA TOLL; ACTIVATION; MATURATION; MOTIFS; MICE; TLR4	DNA from bacteria has stimulatory effects on mammalian immune cells(1-3) which depend on the presence of unmethylated CpG dinucleotides in the bacterial DNA. In contrast, mammalian DNA has a low frequency of CpG dinucleotides, and these are mostly methylated; therefore, mammalian DNA does not have immune-stimulatory activity. CpG DNA induces a strong T-helper-1-like inflammatory response(4-7). Accumulating evidence has revealed the therapeutic potential of CpG DNA as adjuvants for vaccination strategies for cancer, allergy and infectious diseasess(8-10). Despite its promising clinical use, the molecular mechanism by which CpG DNA activates immune cells remains unclear. Here we show that cellular response to CpG DNA is mediated by a Toll-like receptor, TLR9. TLR9-deficient (TLR9(-/-)) mice did not show any response to CpG DNA, including proliferation of splenocytes, inflammatory Cytokine production from macrophages and maturation of dendritic cells. TLR9(-/-) mice showed resistance to the lethal effect of CPG DNA without any elevation of serum pro-inflammatory cytokine levels. The in vivo CpG-DNA-mediated T-helper type-1 response was also abolished in TLR9(-/-) mice. Thus, vertebrate immune systems appear to have evolved a specific Toll-like receptor that distinguishes bacterial DNA from self-DNA.	Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Osaka, Japan; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany	Osaka University; Japan Science & Technology Agency (JST); Technical University of Munich	Akira, S (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Host Def, 3-1 Yamada Oka, Osaka 5650871, Japan.		Takeda, Kiyoshi/C-9331-2009; Hoshino, Katsuaki/L-9162-2014; Hoshino, Katsuaki/AAE-2830-2022; Takeuchi, Osamu/AAG-9359-2019; Takeuchi, Osamu/D-6007-2011; Kaisho, Tsuneyasu/B-4130-2012; Akira, Shizuo/C-3134-2009	Hoshino, Katsuaki/0000-0003-0493-4815; Hoshino, Katsuaki/0000-0003-0493-4815; Takeuchi, Osamu/0000-0002-1260-6232; Sato, Shintaro/0000-0001-5156-3354; Kawai, Taro/0000-0001-7510-4662				Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 1999, EMBO J, V18, P6973, DOI 10.1093/emboj/18.24.6973; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jakob T, 1998, J IMMUNOL, V161, P3042; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Klinman DM, 1999, IMMUNITY, V11, P123, DOI 10.1016/S1074-7613(00)80087-4; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Krieg AM, 1996, TRENDS MICROBIOL, V4, P73, DOI 10.1016/0966-842X(96)81515-0; Krieg AM, 2000, CURR OPIN IMMUNOL, V12, P35, DOI 10.1016/S0952-7915(99)00048-5; Liang H, 2000, J IMMUNOL, V165, P1438, DOI 10.4049/jimmunol.165.3.1438; Lipford GB, 2000, J IMMUNOL, V165, P1228, DOI 10.4049/jimmunol.165.3.1228; Lipford GB, 1998, TRENDS MICROBIOL, V6, P496, DOI 10.1016/S0966-842X(98)01408-5; Macfarlane DE, 1998, J IMMUNOL, V160, P1122; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8; Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wagner H, 1999, ADV IMMUNOL, V73, P329, DOI 10.1016/S0065-2776(08)60790-7; Yamamoto S, 2000, SPRINGER SEMIN IMMUN, V22, P11, DOI 10.1007/s002810000019; Yi AK, 1998, J IMMUNOL, V161, P4493; Yoshimura A, 1999, J IMMUNOL, V163, P1	31	4996	5378	17	531	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2000	408	6813					740	745		10.1038/35047123	http://dx.doi.org/10.1038/35047123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130078				2022-12-24	WOS:000165815200054
J	Peng, CY; Manning, L; Albertson, R; Doe, CQ				Peng, CY; Manning, L; Albertson, R; Doe, CQ			The tumour-suppressor genes lgl and dlg regulate basal protein targeting in Drosophila neuroblasts	NATURE			English	Article							II HEAVY-CHAIN; ASYMMETRIC LOCALIZATION; CELL; PROSPERO; MITOSIS; MELANOGASTER; MECHANISM; DIVISIONS; TOMOSYN; MIRANDA	Drosophila neuroblasts are a model system for studying asymmetric cell division: they divide unequally to produce an apical neuroblast and a basal ganglion mother cell that differ in size, mitotic activity and developmental potential. During neuroblast mitosis, an apical protein complex orients the mitotic spindle and targets determinants of cell fate to the basal cortex(1), but the mechanism of each process is unknown. Here we show that the tumour-suppressor genes lethal giant larvae (lgl) and discs large (dlg) regulate basal protein targeting, but not apical complex formation or spindle orientation, in both embryonic and larval neuroblasts. Dlg protein is apically enriched and is required for maintaining cortical localization of Lgl protein. Basal protein targeting requires microfilament and myosin function, yet the lgl phenotype is strongly suppressed by reducing levels of myosin II. We conclude that Dlg and Lgl promote, and myosin II inhibits, actomyosin-dependent basal protein targeting in neuroblasts.	Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Inst Neurosci, Inst Mol Biol, 1254, Eugene, OR 97403 USA.							Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Chou TB, 1996, GENETICS, V144, P1673; DOE CQ, IN PRESS CURR OPIN C; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; HAJJAR RJ, 1994, AM J PHYSIOL, V267, pH100, DOI 10.1152/ajpheart.1994.267.1.H100; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Jan YN, 1999, NAT CELL BIOL, V1, pE42, DOI 10.1038/10036; Kagami M, 1998, GENETICS, V149, P1717; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Manfruelli P, 1996, DEVELOPMENT, V122, P2283; Manning L, 1999, DEVELOPMENT, V126, P2063; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Skeath JB, 1998, DEVELOPMENT, V125, P1857; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; STRAND D, 1995, ONCOGENE, V11, P291; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	25	284	292	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2000	408	6812					596	600		10.1038/35046094	http://dx.doi.org/10.1038/35046094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117748				2022-12-24	WOS:000165548600121
J	Slotow, R; van Dyk, G; Poole, J; Page, B; Klocke, A				Slotow, R; van Dyk, G; Poole, J; Page, B; Klocke, A			Older bull elephants control young males	NATURE			English	Article							LOXODONTA-AFRICANA; MUSTH; BEHAVIOR		Univ KwaZulu Natal, Sch Life & Environm Sci, ZA-4041 Durban, South Africa; North West Parks & Tourism Board, Mogwase, South Africa	University of Kwazulu Natal	Slotow, R (corresponding author), Univ KwaZulu Natal, Sch Life & Environm Sci, George Campbell Bldg, ZA-4041 Durban, South Africa.	slotow@biology.und.ac.za	Page, Bruce R/G-1245-2010; Slotow, Rob/AAM-9053-2020	Page, Bruce R/0000-0001-7979-5229; Slotow, Rob/0000-0001-9469-1508				PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; POOLE JH, 1981, NATURE, V292, P830, DOI 10.1038/292830a0; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; POOLE JH, 1984, J REPROD FERTIL, V70, P255; Rasmussen LEL, 1996, J MAMMAL, V77, P422, DOI 10.2307/1382819; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8	7	103	109	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2000	408	6811					425	426		10.1038/35044191	http://dx.doi.org/10.1038/35044191			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100713				2022-12-24	WOS:000165429800032
J	Denamur, E; Lecointre, G; Darlu, P; Tenaillon, O; Acquaviva, C; Sayada, C; Sunjevaric, I; Rothstein, R; Elion, J; Taddei, F; Radman, M; Matic, I				Denamur, E; Lecointre, G; Darlu, P; Tenaillon, O; Acquaviva, C; Sayada, C; Sunjevaric, I; Rothstein, R; Elion, J; Taddei, F; Radman, M; Matic, I			Evolutionary implications of the frequent horizontal transfer of mismatch repair genes	CELL			English	Article							ESCHERICHIA-COLI STRAINS; SALMONELLA-TYPHIMURIUM; MUTATION-RATES; PHYLOGENETIC ANALYSIS; ADAPTIVE EVOLUTION; RECOMBINATION; DNA; BACTERIA; POPULATIONS; MUTATORS	Mutation and subsequent recombination events create genetic diversity, which is subjected to natural selection. Bacterial mismatch repair (MMR) deficient mutants, exhibiting high mutation and homeologous recombination rates, are frequently found in natural populations. Therefore, we have explored the possibility that MMR deficiency emerging in nature has left some "imprint" in the sequence of bacterial genomes. Comparative molecular phylogeny of MMR genes from natural Escherichia coli isolates shows that, compared to housekeeping genes, individual functional MMR genes exhibit high sequence mosaicism derived from diverse phylogenetic lineages. This apparent horizontal gene transfer correlates with hyperrecombination phenotype of MMR-deficient mutators. The sequence mosaicism of MMR genes may be a hallmark of a mechanism of adaptive evolution that involves modulation of mutation and recombination rates by recurrent losses and reacquisitions of MMR gene functions.	Univ Paris 05, INSERM, Fac Med Necker Enfants Malad, F-75730 Paris 15, France; Hop Robert Debre, INSERM, U458, F-75935 Paris 19, France; Museum Natl Hist Nat, Serv Systemat Mol, GDR CNRS 1005, F-75231 Paris 05, France; INSERM, U155, F-94276 Le Kremlin Bicetre, France; Genopole, ACTGene Rech & Dev, F-91035 Evry, France; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); Genopole; UDICE-French Research Universities; Universite Paris Saclay; Columbia University	Radman, M (corresponding author), Univ Paris 05, INSERM, Fac Med Necker Enfants Malad, 156 Rue Vaugirard, F-75730 Paris 15, France.	radman@necker.fr	Tenaillon, Olivier/L-9857-2017; Elion, Jacques/A-1048-2014; Radman, Miroslav/HDM-5955-2022	Elion, Jacques/0000-0002-8407-1783; Radman, Miroslav/0000-0002-7034-4365; Rothstein, Rodney/0000-0002-4107-9654; Radman, Miroslav/0000-0003-0216-3148; Tenaillon, Olivier/0000-0002-3796-1601				BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; BIANCHI ME, 1983, CELL, V35, P511, DOI 10.1016/0092-8674(83)90185-X; Bingen E, 1998, J INFECT DIS, V177, P642, DOI 10.1086/514217; Boe L, 2000, MUTAT RES-FUND MOL M, V448, P47, DOI 10.1016/S0027-5107(99)00239-0; Boyd EF, 1998, J BACTERIOL, V180, P1159, DOI 10.1128/JB.180.5.1159-1165.1998; Bregeon D, 1999, J GENET, V78, P21, DOI 10.1007/BF02994699; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; DESJARDINS P, 1995, J MOL EVOL, V41, P440, DOI 10.1007/BF00160315; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fowler RG, 1997, FEMS MICROBIOL REV, V21, P43, DOI 10.1111/j.1574-6976.1997.tb00344.x; FUNCHAIN P, 2000, IN PRESS GENETICS; GLICKMAN BW, 1980, P NATL ACAD SCI-BIOL, V77, P1063, DOI 10.1073/pnas.77.2.1063; GROSS MD, 1981, MUTAT RES, V91, P107, DOI 10.1016/0165-7992(81)90081-6; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Horst JP, 1999, TRENDS MICROBIOL, V7, P29, DOI 10.1016/S0966-842X(98)01424-3; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; KAHN PL, 1968, J BACTERIOL, V96, P205; KALTENBOECK B, 1993, J BACTERIOL, V175, P487, DOI 10.1128/JB.175.2.487-502.1993; LeClerc JE, 1998, MUTAT RES-FUND MOL M, V400, P89; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Lecointre G, 1998, MOL BIOL EVOL, V15, P1685, DOI 10.1093/oxfordjournals.molbev.a025895; LI J, 1994, P NATL ACAD SCI USA, V91, P2552, DOI 10.1073/pnas.91.7.2552; LICHTEN M, 1984, P NATL ACAD SCI-BIOL, V81, P7180, DOI 10.1073/pnas.81.22.7180; LOVETT ST, 1988, GENETICS, V120, P37; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Majewski J, 2000, J BACTERIOL, V182, P1016, DOI 10.1128/JB.182.4.1016-1023.2000; Mao EF, 1997, J BACTERIOL, V179, P417, DOI 10.1128/jb.179.2.417-422.1997; MARKLUND BI, 1992, MOL MICROBIOL, V6, P2225, DOI 10.1111/j.1365-2958.1992.tb01399.x; MATIC I, 1995, CELL, V80, P507, DOI 10.1016/0092-8674(95)90501-4; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833; Matic I, 1996, TRENDS MICROBIOL, V4, P69, DOI 10.1016/0966-842X(96)81514-9; MAYNARDSMITH J, 1991, NATURE, V349, P29; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; MICKEVICH MF, 1981, SYST ZOOL, V30, P351, DOI 10.2307/2413255; MILKMAN R, 1993, GENETICS, V133, P455; MILKMAN R, 1995, SYMP SOC GEN MICROBI, V52, P127; Miller J.H., 1972, EXPT MOL GENETICS; MILLER JF, 1991, METHODS ENZYMOLOGY, V204; Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; MYERS RS, 1994, ANNU REV GENET, V28, P49, DOI 10.1146/annurev.ge.28.120194.000405; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; Otto SP, 1998, TRENDS ECOL EVOL, V13, P145, DOI 10.1016/S0169-5347(97)01260-3; PANG PP, 1985, J BACTERIOL, V163, P1007, DOI 10.1128/JB.163.3.1007-1015.1985; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; RADMAN M, 1993, CHROMOSOMA, V102, P369, DOI 10.1007/BF00360400; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; SANDERSON KE, 1972, BACTERIOL REV, V36, P608, DOI 10.1128/MMBR.36.4.608-637.1972; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SHEN P, 1986, GENETICS, V112, P441; SHEN P, 1989, MOL GEN GENET, V218, P358, DOI 10.1007/BF00331291; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Swofford D, 1993, PHYLOGENETIC ANAL US; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Tenaillon O, 1999, GENETICS, V152, P485; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238; Zahrt TC, 1997, P NATL ACAD SCI USA, V94, P9786, DOI 10.1073/pnas.94.18.9786; ZAWADZKI P, 1995, GENETICS, V140, P917	67	192	198	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 22	2000	103	5					711	721		10.1016/S0092-8674(00)00175-6	http://dx.doi.org/10.1016/S0092-8674(00)00175-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	375ZJ	11114328	Bronze			2022-12-24	WOS:000165433100004
J	van den Biggelaar, AHJ; van Ree, R; Rodrigues, LC; Lell, B; Deelder, AM; Kremsner, PG; Yazdanbakhsh, M				van den Biggelaar, AHJ; van Ree, R; Rodrigues, LC; Lell, B; Deelder, AM; Kremsner, PG; Yazdanbakhsh, M			Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10	LANCET			English	Article							HUMAN LYMPHATIC FILARIASIS; ALLERGIC REACTIVITY; CYTOKINE CONTROL; CELL RESPONSES; ASTHMA; MODULATION; ACTIVATION; INDUCTION; ANTIBODY; CD4(+)	Background Most of the effort directed at understanding the role infections have in preventing allergy has focused on bacteria and viruses and their ability to divert the immune system towards T-helper-1 responses and away from proallergic T-helper-2 responses. However, helminth infections, highly prevalent in large parts of the developing world, where allergy is uncommon, stimulate strong T-helper-2 responses. We investigated the influence of chronic helminth infections on the prevalence of atopy and aimed to understand the relation at a detailed immunological level. Methods 520 Gabonese schoolchildren were tested for shin reaction to house-dust mite and other allergens, for Schistosoma haematobium eggs In urine, and for microfilariae in blood samples. Total and mite-specific IgE antibodies were measured. A subsample selected on the basis of their skin test to house-dust mite received detailed immunological investigations. Findings Children with urinary schistosomiasis had a lower prevalence of a positive skin reaction to house-dust mite than those free of this infection (odds ratio 0.32 [95% CI 0.16-0.63]). The degree of sensitisation to house-dust mite could not explain this difference in skin-prick positivity. Schistosome-antigen-specific concentrations of interleukin-10 were significantly higher in infected children, and higher specific concentrations of this anti-inflammatory cytokine were negatively associated with the outcome of skin-test reactivity to mite (0.53 [0.30-0.96]). No association between polyclonal IgE antibodies and skin-test results was found. Interpretation The anti-inflammatory cytokine, interleukin-10, induced in chronic schistosomiasis, appears central to suppressing atopy in African children.	Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 ZA Leiden, Netherlands; CLB, Dept Allergy, Amsterdam, Netherlands; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; Univ Tubingen, Inst Trop Med, Dept Parasitol, D-72074 Tubingen, Germany; Albert Schweitzer Hosp, Res Unit, Lambarene, Gabon	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; London School of Hygiene & Tropical Medicine; Eberhard Karls University of Tubingen	Yazdanbakhsh, M (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, L4-Q,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.		Yazdanbakhsh, Maria/AAI-3996-2020; RODRIGUES, LAURA CUNHA/AAO-4130-2021	Yazdanbakhsh, Maria/0000-0002-7666-1441; Rodrigues, Laura Cunha/0000-0001-9008-660X				Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Alm JS, 1999, LANCET, V353, P1485, DOI 10.1016/S0140-6736(98)09344-1; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Cookson WOCM, 1997, SCIENCE, V275, P41, DOI 10.1126/science.275.5296.41; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; DREBORG S, 1993, ALLERGY, V48, P49, DOI 10.1111/j.1398-9995.1993.tb04756.x; Edwards-Smith CJ, 1999, HEPATOLOGY, V30, P526, DOI 10.1002/hep.510300207; GODFREY RC, 1976, NATURE, V259, P484, DOI 10.1038/259484a0; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; HAGEL I, 1993, PARASITE IMMUNOL, V15, P311, DOI 10.1111/j.1365-3024.1993.tb00615.x; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; Holt PG, 1999, NATURE, V402, pB12; HUSSAIN R, 1992, J IMMUNOL, V148, P2731; JARRETT E, 1974, NATURE, V251, P613, DOI 10.1038/251613a0; JARRETT E, 1980, NATURE, V283, P302, DOI 10.1038/283302a0; KING CL, 1993, J CLIN INVEST, V92, P1667, DOI 10.1172/JCI116752; King CL, 1996, J IMMUNOL, V156, P4715; Lim S, 1998, LANCET, V352, P113, DOI 10.1016/S0140-6736(98)85018-6; Macaubas C, 1999, CLIN EXP ALLERGY, V29, P1223; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; Schuurman J, 1997, J ALLERGY CLIN IMMUN, V99, P545, DOI 10.1016/S0091-6749(97)70083-6; Shaheen SO, 1996, LANCET, V347, P1792, DOI 10.1016/S0140-6736(96)91617-7; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; STRACHAN DP, 1989, BRIT MED J, V351, P1225; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; YAZDANBAKHSH M, 1993, EUR J IMMUNOL, V23, P3312, DOI 10.1002/eji.1830231238; YEMANEBERHAN H, 1997, LANCET, V350, P400	30	525	541	0	42	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 18	2000	356	9243					1723	1727		10.1016/S0140-6736(00)03206-2	http://dx.doi.org/10.1016/S0140-6736(00)03206-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	376MX	11095260				2022-12-24	WOS:000165462300011
J	Burslem, DFRP; Garwood, NC; Thomas, SC				Burslem, DFRP; Garwood, NC; Thomas, SC			Ecology - Tropical forest diversity - The plot thickens	SCIENCE			English	Editorial Material							PRODUCTS; TREES		Univ Aberdeen, Dept Plant & Soil Sci, Aberdeen AB24 3UU, Scotland; Nat Hist Museum, Dept Bot, London SW7 5BD, England; Univ Toronto, Fac Forestry, Toronto, ON M5S 3B3, Canada	University of Aberdeen; Natural History Museum London; University of Toronto	Burslem, DFRP (corresponding author), Univ Aberdeen, Dept Plant & Soil Sci, Aberdeen AB24 3UU, Scotland.		THOMAS, Sean C./B-6089-2008; Burslem, David FRP/F-1204-2019	THOMAS, Sean C./0000-0002-0686-2483; Burslem, David FRP/0000-0001-6033-0990				Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 1996, J ECOL, V84, P549, DOI 10.2307/2261477; Condit R, 1998, TROPICAL FOREST CENS; Dalling JW, 1998, ECOLOGY, V79, P564, DOI 10.1890/0012-9658(1998)079[0564:DPASBD]2.0.CO;2; Davies SJ, 1998, ECOLOGY, V79, P2292, DOI 10.1890/0012-9658(1998)079[2292:PONPMS]2.0.CO;2; GODOY R, 1993, ECON BOT, V47, P220, DOI 10.1007/BF02862288; GUNATILLEKE IAUN, 1993, ECON BOT, V47, P282, DOI 10.1007/BF02862295; HALL P, 1993, ECON BOT, V47, P234, DOI 10.1007/BF02862289; *NAN TECHN U, 2000, EXPL FOR DIV CHANG S; Nason JD, 1998, NATURE, V391, P685, DOI 10.1038/35607; Thomas SC, 1999, ECOLOGY, V80, P1607	11	30	31	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2001	291	5504					606	607		10.1126/science.1055873	http://dx.doi.org/10.1126/science.1055873			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11158665				2022-12-24	WOS:000166616000031
J	Smith, SD; Wheeler, MA; Plescia, J; Colberg, JW; Weiss, RM; Altieri, DC				Smith, SD; Wheeler, MA; Plescia, J; Colberg, JW; Weiss, RM; Altieri, DC			Urine detection of survivin and diagnosis of bladder cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTI-APOPTOSIS GENE; MESSENGER-RNA; PROGNOSIS	Context Dysregulation of apoptosis may favor onset and progression of cancer and influence response to therapy. Survivin is an inhibitor of apoptosis that is selectively overexpressed in common human cancers, but not in normal tissues, and that correlates with aggressive disease and unfavorable outcomes, Objective To investigate the potential suitability of survivin detection in urine as a novel predictive/prognostic molecular marker of bladder cancer, Design, Setting, and Patients Survey of urine specimens from 5 groups: healthy volunteers (n=17) and patients with nonneoplastic urinary tract disease (n=30), genitourinary cancer (n=30), new-onset or recurrent bladder cancer (n=46), or treated bladder cancer (n=35), recruited from 2 New England urology clinics. Main Outcome Measures Detectable survivin levels, analyzed by a novel detection system and confirmed by Western blot and reverse transcriptase polymerase chain reaction (RT-PCR), in urine samples of the 5 participant groups. Results Survivin was detected in the urine samples of all 46 patients with new or recurrent bladder cancer using a novel detection system (31 of 31) and RT-PCR (15 of ? 5) methods. Survivin was not detected in the urine samples of 32 of 35 patients treated for bladder cancer and having negative cystoscopy results. None of the healthy volunteers or patients with prostate, kidney, vaginal, or cervical cancer had detectable survivin in urine samples, Of the 30 patients with nonneoplastic urinary tract disease, survivin was detected in 3 patients who had bladder abnormalities noted using cystoscopy and in 1 patient with an increased prostate-specific antigen level. Patients with low-grade bladder cancer had significantly lower urine survivin levels than patients with carcinoma in situ (P=.002). Conclusions Highly sensitive and specific determination of urine survivin appears to provide a simple, noninvasive diagnostic test to identify patients with new or recurrent bladder cancer.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Surg, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pathol, New Haven, CT 06536 USA	Yale University; Yale University	Altieri, DC (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Surg, BCMM436B,295 Congress Ave, New Haven, CT 06536 USA.				NATIONAL CANCER INSTITUTE [R01CA078810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK038311, K08DK002499, R01DK047548, R01DK038311] Funding Source: NIH RePORTER; NCI NIH HHS [CA78810] Funding Source: Medline; NIDDK NIH HHS [DK02499, DK38311, DK47548] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adida C, 1998, LANCET, V351, P882, DOI 10.1016/S0140-6736(05)70294-4; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Brown FM, 2000, UROL CLIN N AM, V27, P25, DOI 10.1016/S0094-0143(05)70231-7; Dawson C, 1996, BRIT MED J, V312, P1090; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Gazzaniga P, 1996, INT J CANCER, V69, P100, DOI 10.1002/(SICI)1097-0215(19960422)69:2<100::AID-IJC5>3.0.CO;2-4; Grossman D, 1999, J INVEST DERMATOL, V113, P1076, DOI 10.1046/j.1523-1747.1999.00776.x; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; Kawasaki H, 1998, CANCER RES, V58, P5071; Lara PC, 1999, INT J RADIAT ONCOL, V43, P1015, DOI 10.1016/S0360-3016(98)00472-6; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lokeshwar VB, 2000, J UROLOGY, V163, P348, DOI 10.1016/S0022-5347(05)68050-0; Monzo M, 1999, J CLIN ONCOL, V17, P2100, DOI 10.1200/JCO.1999.17.7.2100; Ozen Haluk, 1998, Current Opinion in Oncology, V10, P273; Ramakumar S, 1999, J UROLOGY, V161, P388, DOI 10.1016/S0022-5347(01)61899-8; Reed JC, 1999, J CLIN ONCOL, V17, P2941, DOI 10.1200/JCO.1999.17.9.2941; Stein JP, 1998, J UROLOGY, V160, P645, DOI 10.1016/S0022-5347(01)62747-2; Swana HS, 1999, NEW ENGL J MED, V341, P452, DOI 10.1056/NEJM199908053410614; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487	20	217	276	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2001	285	3					324	328		10.1001/jama.285.3.324	http://dx.doi.org/10.1001/jama.285.3.324			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390XD	11176843	Bronze			2022-12-24	WOS:000166324300024
J	Lee, KY; Peters, MC; Anderson, KW; Mooney, DJ				Lee, KY; Peters, MC; Anderson, KW; Mooney, DJ			Controlled growth factor release from synthetic extracellular matrices	NATURE			English	Article							PROTEIN DELIVERY; POLYMER MATRICES; TISSUE; HYDROGELS; INVIVO	Polymeric matrices can be used to grow new tissues and organs(1,2), and the delivery of growth factors from these matrices is one method to regenerate tissues(3,4). A problem with engineering tissues that exist in a mechanically dynamic environment, such as bone, muscle and blood vessels(5,6), is that most drug delivery systems have been designed to operate under static conditions. We thought that polymeric matrices, which release growth factors in response to mechanical signals, might provide a new approach to guide tissue formation in mechanically stressed environments. Critical design features for this type of system include the ability to undergo repeated deformation, and a reversible binding of the protein growth factors to polymeric matrices to allow for responses to repeated stimuli. Here we report a model delivery system that can respond to mechanical signalling and upregulate the release of a growth factor to promote blood vessel formation. This approach may rnd a number of applications, including regeneration and engineering of new tissues and more general drug-delivery applications.	Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mooney, DJ (corresponding author), Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.			Lee, Kuen Yong/0000-0002-5759-5952; Mooney, David/0000-0001-6299-1194				Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0; CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0; Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2; EDELMAN ER, 1987, J BIOMED MATER RES, V21, P339, DOI 10.1002/jbm.820210307; Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; KWON IC, 1991, NATURE, V354, P291, DOI 10.1038/354291a0; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Langer R, 1998, NATURE, V392, P5; MITRAGOTRI S, 1995, SCIENCE, V269, P850, DOI 10.1126/science.7638603; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824; Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092; Williams B, 1998, J HYPERTENS, V16, P1921, DOI 10.1097/00004872-199816121-00011	20	433	459	3	124	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					998	1000		10.1038/35050141	http://dx.doi.org/10.1038/35050141			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140690	Green Published			2022-12-24	WOS:000165951100056
J	Amin, S; Zhang, YQ; Sawin, DT; Evans, SR; Hannan, MT; Kiel, DP; Wilson, PWF; Felson, DT				Amin, S; Zhang, YQ; Sawin, DT; Evans, SR; Hannan, MT; Kiel, DP; Wilson, PWF; Felson, DT			Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the framingham study	ANNALS OF INTERNAL MEDICINE			English	Article							IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; SEX STEROID-LEVELS; AROMATASE DEFICIENCY; RISK-FACTORS; OSTEOPOROTIC FRACTURES; PHYSICAL-ACTIVITY; ESTROGEN THERAPY; TESTICULAR AXIS; HIP-FRACTURES; HEALTHY-MEN	Background: Both hypogonadism and low estrogen levels adversely affect bone health in young men. In elderly men, who are at greatest risk for osteoporotic fracture, the influence of hypogonadism on bone mineral density remains unclear, as does the relative effect of estrogen status compared to hypogonadism. Objective: To examine the relation of hypogonadism and estrogen status to bone mineral density in elderly men. Design: Community-based, prospective cohort study. Setting: Framingham, Massachusetts. Patients: Male participants of the Framingham Study. Measurements: Total testosterone, total estradiol, and luteinizing hormone were measured in participants at all four biennial examinations from 1981 to 1989. Values from at least three of four examinations were averaged. Hypogonadism was defined as a mean testosterone level less than 10.4 nmol/L (<3.0 ng/mL) or a mean luteinizing hormone level of 20 IU/L or greater. An alternate definition of hypogonadism based only on a mean testosterone level less than 10.4 nmol/L (<3.0 ng/mL) was also used. In 1988-1989, bone mineral density was measured at the proximal femur (femoral neck, Ward triangle, and trochanter) and lumbar spine by using dual-photon absorptiometry and at the radial shaft by using single-photon absorptiometry. The association of hypogonadism with bone mineral density was examined with adjustment for confounders, including estradiol levels. A similar model that adjusted for hypogonadism was used to examine the association of estradiol level (ranked as quartiles) with bone mineral density. Results: of 448 men with bone mineral density measurements, 405 had evaluable hormone levels (mean age, 75.7 years [range, 68 to 96 years]); 71 (17.5%) of the 405 men were hypogonadal. Bone mineral density at any site did not significantly differ in hypogonadal men compared with eugonadal men (for example, bone mineral density at the femoral neck was 0.89 g/cm(2) vs. 0.87 g/cm(2), respectively; P > 0.2), even when alternate definitions of hypogonadism were used. In contrast, compared with the lowest estradiol quartile, men with higher estradiol levels had greater mean bone mineral density at all sites (for example, bone mineral density at the femoral neck was 0.84 g/cm(2), 0.88 g/cm(2), 0.86 g/cm(2), and 0.91 g/cm(2) from the lowest to the highest estradiol quartile; P for trend = 0.002). The difference in mean bone mineral density between men in the lowest and those in the highest estradiol quartile levels was similar to the effect of 10 years of aging on bone mineral density. Conclusions: In elderly men, hypogonadism related to aging has little influence on bone mineral density, but serum estradiol levels have a strong and positive association with bone mineral density.	Boston Univ, Sch Med, Multipurpose Arthrit & Musculoskeletal Dis Ctr, Boston, MA 02118 USA; Hebrew Rehabil Ctr Aged, Res & Training Inst, Boston, MA 02131 USA; Harvard Univ, Sch Med, Div Aging, Boston, MA 02115 USA; Vet Adm Headquarters, Washington, DC USA; NHLBI, Framingham Heart Study, Framingham, MA USA	Boston University; Harvard University; Harvard Medical School; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Amin, S (corresponding author), Mayo Clin, Div Rheumatol, 200 1st St SW, Rochester, MN 55905 USA.		Wilson, Peter W.F./J-2455-2016	Zhang, Yuqing/0000-0001-7954-1149; Felson, David/0000-0002-2668-2447; Kiel, Douglas/0000-0001-8474-0310	NHLBI NIH HHS [N01-HC-38038] Funding Source: Medline; NIAMS NIH HHS [AR/AG41398, AR20613] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041398, P60AR020613] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anderson FH, 1997, J BONE MINER RES, V12, P472, DOI 10.1359/jbmr.1997.12.3.472; BAILLIE SP, 1992, AGE AGEING, V21, P139, DOI 10.1093/ageing/21.2.139; Bilezikian JP, 1998, NEW ENGL J MED, V339, P599, DOI 10.1056/NEJM199808273390905; Carani C, 1997, NEW ENGL J MED, V337, P91, DOI 10.1056/NEJM199707103370204; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Center JR, 1999, J CLIN ENDOCR METAB, V84, P3626, DOI 10.1210/jc.84.10.3626; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Diamond TH, 1997, MED J AUSTRALIA, V167, P412, DOI 10.5694/j.1326-5377.1997.tb126646.x; DRINKA PJ, 1993, CALCIFIED TISSUE INT, V52, P67, DOI 10.1007/BF00675629; DRINKA PJ, 1993, SOUTHERN MED J, V86, P1264, DOI 10.1097/00007611-199311000-00017; Ettinger B, 1998, J CLIN ENDOCR METAB, V83, P2239, DOI 10.1210/jc.83.7.2239; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; FELSON DT, 1995, AM J EPIDEMIOL, V142, P485, DOI 10.1093/oxfordjournals.aje.a117664; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Ferrini RL, 1998, AM J EPIDEMIOL, V147, P750; FINKELSTEIN JS, 1987, ANN INTERN MED, V106, P354, DOI 10.7326/0003-4819-106-3; FINKELSTEIN JS, 1989, J CLIN ENDOCR METAB, V69, P776, DOI 10.1210/jcem-69-4-776; FORESTA C, 1984, HORM RES, V19, P18, DOI 10.1159/000179855; GRAY A, 1991, J CLIN ENDOCR METAB, V73, P1016, DOI 10.1210/jcem-73-5-1016; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; GRIFFIN JE, 1994, HARRISONS PRINCIPLES, V1, P2006; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; HANNAN MT, 1992, J BONE MINER RES, V7, P547; JACKSON JA, 1990, MEDICINE, V69, P137, DOI 10.1097/00005792-199005000-00002; JACQUES PF, 1993, AM J CLIN NUTR, V57, P182, DOI 10.1093/ajcn/57.2.182; Janssen JMMF, 1999, J CELL BIOCHEM, V75, P528; JONES G, 1994, BRIT MED J, V309, P691, DOI 10.1136/bmj.309.6956.691; KANNEL WB, 1985, AM HEART J, V109, P876, DOI 10.1016/0002-8703(85)90653-2; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; MATSUMOTO AM, 1987, BAILLIERE CLIN ENDOC, V1, P71, DOI 10.1016/S0950-351X(87)80053-8; MEIER DE, 1987, J AM GERIATR SOC, V35, P189, DOI 10.1111/j.1532-5415.1987.tb02308.x; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689; MURPHY S, 1993, BONE MINER, V20, P133, DOI 10.1016/S0169-6009(08)80022-0; MYERS AH, 1991, AM J EPIDEMIOL, V134, P1128, DOI 10.1093/oxfordjournals.aje.a116016; NEVITT MC, 1994, RHEUM DIS CLIN N AM, V20, P535; Orwoll ES, 1998, ENDOCRIN METAB CLIN, V27, P349, DOI 10.1016/S0889-8529(05)70009-8; PREECE MA, 1974, CLIN CHIM ACTA, V54, P235, DOI 10.1016/0009-8981(74)90241-1; Rapado A, 1999, CALCIFIED TISSUE INT, V65, P417, DOI 10.1007/s002239900726; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; SCANE AC, 1993, CLIN ENDOCRINOL, V38, P15, DOI 10.1111/j.1365-2265.1993.tb00965.x; SEEMAN E, 1983, AM J MED, V75, P977, DOI 10.1016/0002-9343(83)90878-1; Shozu M, 1998, MOL CELL ENDOCRINOL, V139, P117, DOI 10.1016/S0303-7207(98)00069-0; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; SLEMENDA CW, 1992, ANN INTERN MED, V117, P286, DOI 10.7326/0003-4819-117-4-286; Slemenda CW, 1997, J CLIN INVEST, V100, P1755, DOI 10.1172/JCI119701; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P1966, DOI 10.1210/jc.84.6.1966; STANLEY HL, 1991, J AM GERIATR SOC, V39, P766, DOI 10.1111/j.1532-5415.1991.tb02698.x; STEPAN JJ, 1989, J CLIN ENDOCR METAB, V69, P523; Taaffe DR, 1999, AGING CLIN EXP RES, V11, P4, DOI 10.1007/BF03399630; TAXAL P, 1998, BONE, V23, pS178; TENOVER JL, 1995, PHARM BIOL CLILN APP, P310; TENOVER JS, 1992, J CLIN ENDOCR METAB, V75, P1092, DOI 10.1210/jc.75.4.1092; TSITOURAS PD, 1982, J GERONTOL, V37, P288, DOI 10.1093/geronj/37.3.288; van Staa T, 1997, AM J MED, V103, P462, DOI 10.1016/S0002-9343(97)00242-8; VANDERSCHUEREN D, 1995, CALCIFIED TISSUE INT, V56, P341, DOI 10.1007/BF00301598; VERMEULEN A, 1995, HORM RES, V43, P25, DOI 10.1159/000184233; WASNICH R, 1990, BRIT MED J, V301, P1303, DOI 10.1136/bmj.301.6764.1303; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	65	211	216	0	269	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 19	2000	133	12					951	963		10.7326/0003-4819-133-12-200012190-00010	http://dx.doi.org/10.7326/0003-4819-133-12-200012190-00010			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	384NT	11119396				2022-12-24	WOS:000165952300003
J	White, HD				White, HD			Thrombolytic therapy in the elderly	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; OLDER; ANGIOPLASTY; TRIALS; AGE		Green Lane Hosp, Cardiovasc Res Unit, Auckland 1030, New Zealand		White, HD (corresponding author), Green Lane Hosp, Cardiovasc Res Unit, Private Bag 92189, Auckland 1030, New Zealand.							[Anonymous], 1988, LANCET, V2, P349; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Ayanian JZ, 2000, CIRCULATION, V101, P2224, DOI 10.1161/01.CIR.101.19.2224; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Berger AK, 2000, J AM COLL CARDIOL, V36, P366, DOI 10.1016/S0735-1097(00)00723-3; Berger AK, 1999, JAMA-J AM MED ASSOC, V282, P341, DOI 10.1001/jama.282.4.341; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Holmes DR, 1999, J AM COLL CARDIOL, V33, P412, DOI 10.1016/S0735-1097(98)00579-8; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Lesnefsky EJ, 1996, J AM COLL CARDIOL, V28, P331, DOI 10.1016/0735-1097(96)00148-9; Lundergan CF, 1998, J AM COLL CARDIOL, V32, P641, DOI 10.1016/S0735-1097(98)00278-2; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Thiemann DR, 2000, CIRCULATION, V101, P2239, DOI 10.1161/01.CIR.101.19.2239; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; White HD, 1996, CIRCULATION, V94, P1826, DOI 10.1161/01.CIR.94.8.1826; White HD, 1998, CIRCULATION, V97, P1632, DOI 10.1161/01.CIR.97.16.1632	16	113	122	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2000	356	9247					2028	2030		10.1016/S0140-6736(00)03397-3	http://dx.doi.org/10.1016/S0140-6736(00)03397-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385GB	11145486				2022-12-24	WOS:000165994300006
J	Shams, L; Kamitani, Y; Shimojo, S				Shams, L; Kamitani, Y; Shimojo, S			Illusions - What you see is what you hear	NATURE			English	Article									CALTECH, Div Biol, Pasadena, CA 91125 USA; NTT, Commun Sci Labs, Human & Informat Sci Lab, Kanagawa 2430198, Japan	California Institute of Technology; Nippon Telegraph & Telephone Corporation	Shams, L (corresponding author), CALTECH, Div Biol, MC 139-74, Pasadena, CA 91125 USA.							MEREDITH MA, 1987, J NEUROSCI, V7, P3215; SALDANA HM, 1993, PERCEPT PSYCHOPHYS, V54, P406, DOI 10.3758/BF03205276; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; WALLACE MT, 1994, J NEUROPHYSIOL, V71, P429, DOI 10.1152/jn.1994.71.1.429	5	756	768	2	127	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2000	408	6814					788	788		10.1038/35048669	http://dx.doi.org/10.1038/35048669			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130706	Bronze			2022-12-24	WOS:000165831300031
J	Mezey, E; Chandross, KJ; Harta, G; Maki, RA; McKercher, SR				Mezey, E; Chandross, KJ; Harta, G; Maki, RA; McKercher, SR			Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; ADULT MAMMALIAN FOREBRAIN; IN-VIVO; RAT; DIFFERENTIATE; ASTROCYTES; MICE; NEUN; IDENTIFICATION	Bone marrow stern cells give rise to a variety of hematopoietic Lineages and repopulate the blood throughout adult Life. We show that, in a strain of mice incapable of developing colts of the myeloid and Lymphoid lineages,transplanted adult bone marrow cells migrated into the brain and differentiated into cells that expressed neuron-specific antigens. These findings raise the possibility that bone marrow-derived cells may provide an alternative source of neurons in patients with neurodegenerative diseases or central nervous system injury.	NINDS, Basic Neurosci Program, NIH, Bethesda, MD 20892 USA; NINDS, Lab Dev Neurogenet, NIH, Bethesda, MD 20892 USA; Burnham Inst, La Jolla, CA 92037 USA; Neurocrine Biosci, San Diego, CA 92121 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Sanford Burnham Prebys Medical Discovery Institute; Neurocrine Biosciences	Mezey, E (corresponding author), NINDS, Basic Neurosci Program, NIH, Bethesda, MD 20892 USA.		Mezey, Eva/A-8105-2008	Mezey, Eva/0000-0002-5907-4691	NIAID NIH HHS [AI30656] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002996, Z01NS002528, ZIANS002528] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberts B., 2017, MOL BIOL CELL; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; BARNETT SC, 1993, DEV BIOL, V155, P337, DOI 10.1006/dbio.1993.1033; Bjorklund A, 1999, NATURE, V397, P569, DOI 10.1038/17495; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Chandross KJ, 1999, J NEUROSCI, V19, P759, DOI 10.1523/jneurosci.19-02-00759.1999; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; HEUMANN D, 1977, J HIRNFORSCH, V18, P483; Hickey WF, 1999, SEMIN IMMUNOL, V11, P125, DOI 10.1006/smim.1999.0168; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Knopf PM, 1998, J IMMUNOL, V161, P692; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; LING EA, 1973, J COMP NEUROL, V149, P73, DOI 10.1002/cne.901490105; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Luskin MB, 1998, J NEUROBIOL, V36, P221; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; MORRISON SJ, 1995, P ASSOC AM PHYSICIAN, V107, P187; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Mujtaba T, 1998, DEV BIOL, V200, P1, DOI 10.1006/dbio.1998.8913; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nardi NB, 1999, BRAZ J MED BIOL RES, V32, P601, DOI 10.1590/S0100-879X1999000500014; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Reynolds R, 1997, J NEUROSCI RES, V47, P455, DOI 10.1002/(SICI)1097-4547(19970301)47:5<455::AID-JNR1>3.0.CO;2-G; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; Schwanzel-Fukuda M, 1999, MICROSC RES TECHNIQ, V44, P2, DOI 10.1002/(SICI)1097-0029(19990101)44:1<2::AID-JEMT2>3.0.CO;2-4; THEELE DP, 1993, GLIA, V7, P5, DOI 10.1002/glia.440070104; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; VINORES SA, 1984, J HISTOCHEM CYTOCHEM, V32, P1295, DOI 10.1177/32.12.6389693; Watson JD., 1976, MOL BIOL GENE, V3; Weiss S, 1996, J NEUROSCI, V16, P7599; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Weiss S, 1998, J NEUROBIOL, V36, P307, DOI 10.1002/(SICI)1097-4695(199808)36:2<307::AID-NEU14>3.0.CO;2-A; Williams KC, 1995, CURR TOP MICROBIOL, V202, P221; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C	43	1450	1694	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2000	290	5497					1779	1782		10.1126/science.290.5497.1779	http://dx.doi.org/10.1126/science.290.5497.1779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379FY	11099419				2022-12-24	WOS:000165632400047
J	Adrian, L; Szewzyk, U; Wecke, J; Gorisch, H				Adrian, L; Szewzyk, U; Wecke, J; Gorisch, H			Bacterial dehalorespiration with chlorinated benzenes	NATURE			English	Article							REDUCTIVE DECHLORINATION; TRICHLOROBENZENE; ENRICHMENT; CONSORTIUM; CULTURE; WATER	Chlorobenzenes are toxic, highly persistent and ubiquitously distributed environmental contaminants that accumulate in the food chain(1). The only known microbial transformation of 1,2,3,5-tetrachlorobenzene (TeCB) and higher chlorinated benzenes is the reductive dechlorination to lower chlorinated benzenes under anaerobic conditions observed with mixed bacterial cultures(2-4). The lower chlorinated benzenes can subsequently be mineralized by aerobic bacteria. Here we describe the isolation of the oxygen-sensitive strain CBDB1, a pure culture capable of reductive dechlorination of chlorobenzenes. Strain CBDB1 is a highly specialized bacterium that stoichiometrically dechlorinates 1,2,3-trichlorobenzene (TCB), 1,2,4-TCB, 1,2,3,4-TeCB, 1,2,3,5-TeCB and 1,2,4,5-TeCB to dichlorobenzenes or 1,3,5-TCB. The presence of chlorobenzene as an electron acceptor and hydrogen as an electron donor is essential for growth, and indicates that strain CBDB1 meets its energy needs by a dehalorespiratory process. According to their 16S rRNA gene sequences, strain CBDB1, Dehalococcoides ethenogenes(5) and several uncultivated bacteria forma new bacterial cluster, of which strain CBDB1 is the first, so far, to thrive on a purely synthetic medium.	Tech Univ Berlin, Fachgebiet Tech Biochem, D-13353 Berlin, Germany; Tech Univ Berlin, Fachgebiet Okol Mikroorganismen, D-13353 Berlin, Germany; Robert Koch Inst, D-13353 Berlin, Germany	Technical University of Berlin; Technical University of Berlin; Robert Koch Institute	Adrian, L (corresponding author), Tech Univ Berlin, Fachgebiet Tech Biochem, D-13353 Berlin, Germany.	lorenz.adrian@tu-berlin.de	Adrian, Lorenz/A-4443-2012	Adrian, Lorenz/0000-0001-8205-0842				Adrian L, 1998, APPL ENVIRON MICROB, V64, P496; ADRIAN L, IN PRESS BIODEGRADAT; Bade K, 2000, FEMS MICROBIOL ECOL, V32, P215, DOI 10.1111/j.1574-6941.2000.tb00714.x; BEURSKENS JEM, 1994, ENVIRON SCI TECHNOL, V28, P701, DOI 10.1021/es00053a026; BOSMA TNP, 1988, FEMS MICROBIOL ECOL, V53, P223, DOI 10.1111/j.1574-6968.1988.tb02668.x; FATHEPURE BZ, 1988, APPL ENVIRON MICROB, V54, P327, DOI 10.1128/AEM.54.2.327-330.1988; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; HOLLIGER C, 1992, APPL ENVIRON MICROB, V58, P1636, DOI 10.1128/AEM.58.5.1636-1644.1992; Holliger C, 1998, FEMS MICROBIOL REV, V22, P383, DOI 10.1016/S0168-6445(98)00030-8; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Kalmbach S, 1997, APPL ENVIRON MICROB, V63, P4164, DOI 10.1128/AEM.63.11.4164-4170.1997; Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; Middeldorp PJM, 1997, APPL ENVIRON MICROB, V63, P1225, DOI 10.1128/AEM.63.4.1225-1229.1997; OLIVER BG, 1982, ENVIRON SCI TECHNOL, V16, P532, DOI 10.1021/es00102a019; PFENNIG N, 1978, INT J SYST BACTERIOL, V28, P283, DOI 10.1099/00207713-28-2-283; TIEDJE JM, 1987, DEV IND MICROBIOL, V27, P117; von Wintzingerode F, 1999, APPL ENVIRON MICROB, V65, P283; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008	19	337	358	1	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2000	408	6812					580	583		10.1038/35046063	http://dx.doi.org/10.1038/35046063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117744				2022-12-24	WOS:000165548600117
J	Nishiyama, M; Hong, K; Mikoshiba, K; Poo, M; Kato, K				Nishiyama, M; Hong, K; Mikoshiba, K; Poo, M; Kato, K			Calcium stores regulate the polarity and input specificity of synaptic modfication	NATURE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL SLICES; DEPRESSION; MEMORY; CA2+; MECHANISM; INDUCTION; CHANNELS; RECEPTOR; NEURONS	Activity-induced synaptic modification is essential for the development and plasticity of the nervous system(1-3). Repetitive correlated activation of pre- and postsynaptic neurons can induce persistent enhancement or decrement of synaptic efficacy, commonly referred to as long-term potentiation or depression(2,3) (LTP or LTD). An important unresolved issue is whether and to what extent LTP and LTD are restricted to the activated synapses(4-8). Here we show that, in the CA1 region of the hippocampus, reduction of postsynaptic calcium influx by partial blockade of NMDA (N-methyl-D-aspartate) receptors results in a conversion of LTP to LTD and a loss of input specificity normally associated with LTP, with LTD appearing at heterosynaptic inputs. The induction of LTD at homo- and heterosynaptic sites requires functional ryanodine receptors and inositol triphosphate (InsP(3)) receptors, respectively. Functional blockade or genetic deletion of type 1 InsP(3) receptors led to a conversion of LTD to LTP and elimination of heterosynaptic LTD, whereas blocking ryanodine receptors eliminated only homosynaptic LTD. Thus, postsynaptic Ca2+, deriving from Ca2+ influx and differential release of Ca2+ from internal stores through ryanodine and InsP(3) receptors, regulates both the polarity and input specificity of activity-induced synaptic modification.	Japan Sci & Technol Corp, Exploratory Res Adv Technol, Mikoshiba Calciosignal Net Project, Tokyo 1130021, Japan; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	Japan Science & Technology Agency (JST); University of California System; University of California San Diego	Poo, M (corresponding author), NYU, Sch Med, Dept Biochem, 550 1st Ave, New York, NY 10016 USA.		Mikoshiba, Katsuhiko/N-7943-2015					ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Cordoba-Rodriguez R, 1999, P NATL ACAD SCI USA, V96, P7650, DOI 10.1073/pnas.96.14.7650; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Futatsugi A, 1999, NEURON, V24, P701, DOI 10.1016/S0896-6273(00)81123-X; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Staubli UV, 1996, BRAIN RES, V714, P169, DOI 10.1016/0006-8993(95)01523-X; Tao HZW, 2000, J NEUROSCI, V20, P3233, DOI 10.1523/JNEUROSCI.20-09-03233.2000; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	30	473	482	2	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2000	408	6812					584	588		10.1038/35046067	http://dx.doi.org/10.1038/35046067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117745				2022-12-24	WOS:000165548600118
J	Tu, BP; Ho-Schleyer, SC; Travers, KJ; Weissman, JS				Tu, BP; Ho-Schleyer, SC; Travers, KJ; Weissman, JS			Biochemical basis of oxidative protein folding in the endoplasmic reticulum	SCIENCE			English	Article							DISULFIDE-BOND FORMATION; SACCHAROMYCES-CEREVISIAE; GLUTATHIONE; ISOMERASE; YEAST; GENE; PATHWAY; TRANSPORT; SYSTEM; ERO1P	The endoplasmic reticulum (ER) supports disulfide bond formation by a poorly understood mechanism requiring protein disulfide isomerase (PDI) and ERO1. In yeast, Ero1p-mediated oxidative folding was shown to depend on cellular flavin adenine dinucleotide (FAD) levels but not on ubiquinone or heme and Ero1p was shown to be a FAD-binding protein. We reconstituted efficient oxidative folding in vitro using FAD, PDI, and Ero1p. Disulfide formation proceeded by direct delivery of oxidizing equivalents from Ero1p to folding substrates via PDI. This kinetic shuttling of oxidizing equivalents could allow the ER to support rapid disulfide formation while maintaining the ability to reduce and rearrange incorrect disulfide bonds.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Weissman, Jonathan/0000-0003-2445-670X				ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; ASTIN AM, 1977, BIOCHEM J, V166, P275, DOI 10.1042/bj1660275; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; HORAZDOVSKY BF, 1993, J BIOL CHEM, V268, P4953; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Poon WW, 1997, MOL ASPECTS MED, V18, pS121; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; TU BP, UNPUB; WU M, 1995, MOL CELL BIOL, V15, P264, DOI 10.1128/MCB.15.1.264; ZIEGLER DM, 1977, TRENDS BIOCHEM SCI, V2, P79, DOI 10.1016/0968-0004(77)90042-1	25	345	355	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2000	290	5496					1571	1574		10.1126/science.290.5496.1571	http://dx.doi.org/10.1126/science.290.5496.1571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376EX	11090354	Green Published			2022-12-24	WOS:000165446200049
J	Wilkening, KE; Barrie, LA; Engle, M				Wilkening, KE; Barrie, LA; Engle, M			Atmospheric science - Trans-Pacific air pollution	SCIENCE			English	Editorial Material									Univ No British Columbia, Int Studies Program, Prince George, BC V2N 4Z9, Canada; Pacific NW Natl Lab, Walla Walla, WA 99362 USA; US EPA, Off Int Act, Washington, DC 20460 USA	University of Northern British Columbia; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Environmental Protection Agency	Wilkening, KE (corresponding author), Univ No British Columbia, Int Studies Program, Prince George, BC V2N 4Z9, Canada.							AMAP, 1998, AMAP ASS REP ARCT PO; Anthony RG, 1999, ENVIRON TOXICOL CHEM, V18, P2054, DOI 10.1002/etc.5620180925; Bailey R, 2000, J GEOPHYS RES-ATMOS, V105, P11805, DOI 10.1029/1999JD901180; Blais JM, 1998, NATURE, V395, P585, DOI 10.1038/26944; DUCE RA, 1980, SCIENCE, V209, P1522, DOI 10.1126/science.209.4464.1522; Edmonds R.L., 1998, SCI MONOGRAPH US DEP; Hoell JM, 1996, J GEOPHYS RES-ATMOS, V101, P1641, DOI 10.1029/95JD00622; HOELL M, 1997, J GEOPHYS RES, V102, P28223; Jacob DJ, 1999, GEOPHYS RES LETT, V26, P2175, DOI 10.1029/1999GL900450; Jaffe D, 1999, GEOPHYS RES LETT, V26, P711, DOI 10.1029/1999GL900100; JAFFE D, IN PRESS J GEOPHYS R; KOTCHENRUTHER R, IN PRESS J GEOPHYS R; MACDONALD RW, 2000, HLTH FRASER RIVER EQ, V1, P23; Perry KD, 1999, J GEOPHYS RES-ATMOS, V104, P18521, DOI 10.1029/1998JD100083; Ross PS, 2000, MAR POLLUT BULL, V40, P504, DOI 10.1016/S0025-326X(99)00233-7; YIENGER JJ, IN PRESS J GEOPHYS R	16	166	173	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 6	2000	290	5489					65	+		10.1126/science.290.5489.65	http://dx.doi.org/10.1126/science.290.5489.65			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	361LP	11183151				2022-12-24	WOS:000089724800031
J	Cowan, WM; Kandel, ER				Cowan, WM; Kandel, ER			Prospects for neurology and psychiatry	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CEREBRAL-BLOOD-FLOW; PREFRONTAL CORTEX; SCHIZOPHRENIA; SUSCEPTIBILITY; NEUROPATHOLOGY; DENSITY; NEURONS	Neurological and psychiatric illnesses are among the most common and most serious health problems in developed societies. The most promising advances in neurological and psychiatric diseases will require advances in neuroscience for their elucidation, prevention, and treatment. Technical advances have improved methods for identifying brain regions involved during various types of cognitive activity, for tracing connections between parts of the brain, for visualizing individual neurons in living brain preparations, for recording the activities of neurons, and for studying the activity of single-ion channels and the receptors for various neurotransmitters, The most significant advances in the past 20 years have come from the application to the nervous system of molecular genetics and molecular cell biology, Discovery of the monogenic disorder responsible for Huntington disease and understanding its pathogenesis can serve as a paradigm for unraveling the much more complex, polygenic disorders responsible for such psychiatric diseases as schizophrenia, manic depressive illness, and borderline personality disorder. Thus, a new degree of cooperation between neurology and psychiatry is likely to result, especially for the treatment of patients with illnesses such as autism, mental retardation, cognitive disorders associated with Alzheimer and Parkinson disease that overlap between the 2 disciplines.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Howard Hughes Med Inst, Chevy Chase, MD USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.							Albright TD, 2000, NEURON, V25, pS1, DOI 10.1016/S0896-6273(00)80912-5; Barinaga M, 2000, SCIENCE, V287, P1421, DOI 10.1126/science.287.5457.1421; Bassett AS, 2000, AM J MED GENET, V97, P45, DOI 10.1002/(SICI)1096-8628(200021)97:1<45::AID-AJMG6>3.0.CO;2-9; Bassett AS, 1999, BIOL PSYCHIAT, V46, P882, DOI 10.1016/S0006-3223(99)00114-6; BASSETT AS, 1988, LANCET, V1, P799; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.3.CO;2-H; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Cowan WM, 2000, ANNU REV NEUROSCI, V23, P343, DOI 10.1146/annurev.neuro.23.1.343; *DAN ALL BRAIN IN, 2000, PROGR REP BRAIN RES; DANIEL DG, 1991, BIOL PSYCHIAT, V30, P887, DOI 10.1016/0006-3223(91)90003-5; Daviss SR, 1995, PSYCHIAT RES, V59, P81, DOI 10.1016/0165-1781(95)02720-3; DOLAN RJ, 1995, NATURE, V378, P180, DOI 10.1038/378180a0; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; EARLY TS, 1987, P NATL ACAD SCI USA, V84, P561, DOI 10.1073/pnas.84.2.561; EARLY TS, 1989, PSYCHIAT DEV, V7, P109; Fricker J, 1999, MOL MED TODAY, V5, P144, DOI 10.1016/S1357-4310(99)01454-9; Glantz LA, 1997, ARCH GEN PSYCHIAT, V54, P943; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; John E.R, 1967, NEUROSCIENCES STUDY, P690; Karayiorgou M, 1999, BIOL PSYCHIAT, V45, P1178, DOI 10.1016/S0006-3223(98)00319-9; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Lewis DA, 2000, NEUROSCIENTIST, V6, P208, DOI 10.1177/107385840000600311; Lindvall O, 1999, NAT BIOTECHNOL, V17, P635, DOI 10.1038/10844; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; Pearlson GD, 1999, BIOL PSYCHIAT, V46, P627, DOI 10.1016/S0006-3223(99)00071-2; Ptacek LJ, 1997, NEUROMUSCULAR DISORD, V7, P250, DOI 10.1016/S0960-8966(97)00046-1; PULVER AE, 1994, AM J MED GENET, V54, P36, DOI 10.1002/ajmg.1320540108; Rowley JD, 1999, SEMIN HEMATOL, V36, P59; Schmitt F. O., 1979, NEUROSCIENCES 4 STUD; SCHMITT FO, 1973, NEUROSCIENCES 3 STUD; Schmitt FO, 1970, NEUROSCIENCES 2 STUD; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	39	58	59	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					594	600		10.1001/jama.285.5.594	http://dx.doi.org/10.1001/jama.285.5.594			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176865	Bronze			2022-12-24	WOS:000166714200018
J	Jakes, RW; Khaw, KT; Day, NE; Bingham, S; Welch, A; Oakes, S; Luben, R; Dalzell, N; Reeve, J; Wareham, NJ				Jakes, RW; Khaw, KT; Day, NE; Bingham, S; Welch, A; Oakes, S; Luben, R; Dalzell, N; Reeve, J; Wareham, NJ			Patterns of physical activity and ultrasound attenuation by heel hone among Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BONE-DENSITY; CONTROLLED TRIAL; EXERCISE; PREDICTION; FRACTURES; WOMEN; SITES; MASS	Objectives To study associations between patterns of physical activity and ultrasound attenuation by the heel bone in men and women. Design Cross sectional, population based study. Setting Norfolk. Participants 2296 men and 2914 women aged 45-74 registered wit general practices participating in European Prospective Investigation into Cancer (EPIC Norfolk). Results Self reported time spent in high impact physical activity was strongly and positively associated with ultrasound attentuation by the heel bone, independently of age, weight, and other cofounding factors. Men who reported participating in greater than or equal to2 hours/week of high impact activity had 9.5% higher ultrasound attenuation than men who reported no activity of this type. Women who reported any high impact activity had 3.4% higher ultrasound attentuation than those who reported none. In women this effect was similar in size to that of age difference of four years. Moderate impact activity had no effect. However, climbing stairs was strongly independently associated wit ultrasound attenuation in women. There was a significant negative association in women between time spent watching television or video and heel bone ultrasound attenuation. Conclusions High impact physical activity is independently associated with ultrasound attenuation by the heel gone in men and women. As low ultrasound attenuation has been shown to predict increased risk of hip fracture, interventions to promote participation in high impact activities may help preserve bone density and reduce the risk of fracture. However, in older people such interventions may be inappropriate as the could increase the likelihood of falls.	Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England; Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; Univ Cambridge, Strangeways Res Lab, Dept Med, Cambridge CB1 8RN, England; Dunn Human Nutr Unit, Cambridge CB2 2XY, England	University of Cambridge; University of Cambridge; University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Wareham, NJ (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England.	njw1004@medschl.cam.ac.uk	Luben, Robert N/H-5519-2015; Reeve, Jonathan/C-7551-2012; Welch, Ailsa Ann/A-4850-2008; Khaw, Kay-Tee/AAZ-3209-2021	Luben, Robert N/0000-0002-5088-6343; Reeve, Jonathan/0000-0002-4364-2682; Welch, Ailsa Ann/0000-0002-6702-3704; 				Baran D T, 1991, Osteoporos Int, V1, P110, DOI 10.1007/BF01880452; BASSEY EJ, 1994, OSTEOPOROSIS INT, V4, P72, DOI 10.1007/BF01623226; Bassey EJ, 1997, J BIOMECH, V30, P213, DOI 10.1016/S0021-9290(96)00043-7; CASPERSEN CJ, 1989, EXERCISE SPORT SCI R, V17, P423; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; DONALDSON CL, 1970, METAB CLIN EXP, V19, P1074; Ebrahim S, 1997, AGE AGEING, V26, P253, DOI 10.1093/ageing/26.4.253; KROLNER B, 1983, CLIN SCI, V64, P541, DOI 10.1042/cs0640541; LANYON LE, 1992, J BONE MINER RES, V7, pS369, DOI 10.1002/jbmr.5650071403; Lanyon LE, 1996, BONE, V18, pS37, DOI 10.1016/8756-3282(95)00378-9; Layne JE, 1999, MED SCI SPORT EXER, V31, P25, DOI 10.1097/00005768-199901000-00006; MCCLOSKEY EV, 1990, CLIN SCI, V78, P227, DOI 10.1042/cs0780227; NIGG BM, 1985, SPORTS MED, V2, P367, DOI 10.2165/00007256-198502050-00005; Pluijm SMF, 1999, OSTEOPOROSIS INT, V9, P550, DOI 10.1007/s001980050275; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Wareham NJ, 1998, INT J OBESITY, V22, pS30; Wolff I, 1999, OSTEOPOROSIS INT, V9, P1, DOI 10.1007/s001980050109	18	31	32	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2001	322	7279					140	143		10.1136/bmj.322.7279.140	http://dx.doi.org/10.1136/bmj.322.7279.140			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	396AZ	11159572	Green Published			2022-12-24	WOS:000166615300026
J	Kaya, H; Shibahara, K; Taoka, K; Iwabuchi, M; Stillman, B; Araki, T				Kaya, H; Shibahara, K; Taoka, K; Iwabuchi, M; Stillman, B; Araki, T			FASCIATA genes for chromatin assembly factor-1 in Arabidopsis maintain the cellular organization of apical meristems	CELL			English	Article							DNA-REPLICATION; RADIAL ORGANIZATION; SHOOT; ROOT; INHERITANCE; PROTEIN; FATE; REGULATOR; HISTONES; DIVISION	Postembryonic development of plants depends on the activity of apical meristems established during embryogenesis. The shoot apical meristem (SAM) and the root apical meristem (RAM) have similar but distinct cellular organization. Arabidopsis FASCIATA1 (FAS1) and FAS2 genes maintain the cellular and functional organization of both SAM and RAM, and FAS gene products are subunits of the Arabidopsis counterpart of chromatin assembly factor-1 (CAF-1). fas mutants are defective in maintenance of the expression states of WUSCHEL (WUS) in SAM and SCARECROW (SCR) in RAM. We suggest that CAF-1 plays a critical role in the organization of SAM and RAM during postembryonic development by facilitating stable maintenance of gene expression states.	Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Japan Sci & Technol Corp, TOREST, Tokyo, Japan	Kyoto University; Cold Spring Harbor Laboratory; Japan Science & Technology Agency (JST)	Araki, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan.	taraqui@gr.bot.kyoto-u.ac.jp	Araki, Takashi/G-1760-2013	Araki, Takashi/0000-0002-3616-1493; Kaya, Hidetaka/0000-0003-4711-8236; Stillman, Bruce/0000-0002-9453-4091	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [CA13106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ach RA, 1997, PLANT CELL, V9, P1595, DOI 10.1105/tpc.9.9.1595; AXELOS M, 1992, PLANT PHYSIOL BIOCH, V30, P123; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Braissant O, 1998, BIOCHEMICA, V1, P10; BULGER M, 1995, P NATL ACAD SCI USA, V92, P11726, DOI 10.1073/pnas.92.25.11726; CHABOUTE ME, 1987, PLANT MOL BIOL, V8, P179, DOI 10.1007/BF00025329; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; DOLAN L, 1993, DEVELOPMENT, V119, P71; Enomoto S, 1997, GENE DEV, V11, P358, DOI 10.1101/gad.11.3.358; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; GORTER CJ, 1965, ENCY PLANT PHYSL, V15, P330; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; JURGENS G, 1994, ARABIDOPSIS, P297; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kaya H, 2000, PLANT CELL PHYSIOL, V41, P1055, DOI 10.1093/pcp/pcd032; Keddie JS, 1998, PLANT CELL, V10, P877, DOI 10.1105/tpc.10.6.877; Kenzior AL, 1998, FEBS LETT, V440, P425, DOI 10.1016/S0014-5793(98)01500-2; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; LEYSER HMO, 1992, DEVELOPMENT, V116, P397; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; Monson EK, 1997, P NATL ACAD SCI USA, V94, P13081, DOI 10.1073/pnas.94.24.13081; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ohtsubo N, 1997, PLANT J, V11, P1219, DOI 10.1046/j.1365-313X.1997.11061219.x; Okanami M, 1998, NUCLEIC ACIDS RES, V26, P2638, DOI 10.1093/nar/26.11.2638; Reinholz E, 1966, ARAB INF SERV, V3, P19; Ridgway P, 2000, J CELL SCI, V113, P2647; RUGGIERI R, 1989, P NATL ACAD SCI USA, V86, P8778, DOI 10.1073/pnas.86.22.8778; Running MP, 1995, METHOD CELL BIOL, V49, P217, DOI 10.1016/S0091-679X(08)61456-9; Scheres B, 1996, PLANT PHYSIOL, V111, P959, DOI 10.1104/pp.111.4.959; SCHERES B, 1995, DEVELOPMENT, V121, P53; Schiefelbein JW, 1994, ARABIDOPSIS, P335; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Serrano-Cartagena J, 1999, MOL GEN GENET, V261, P725, DOI 10.1007/s004380050016; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shibahara K, 2000, P NATL ACAD SCI USA, V97, P7766, DOI 10.1073/pnas.97.14.7766; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Taoka K, 1999, PLANT J, V18, P611, DOI 10.1046/j.1365-313x.1999.00486.x; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Verreault A, 2000, GENE DEV, V14, P1430; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	51	372	395	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2001	104	1					131	142		10.1016/S0092-8674(01)00197-0	http://dx.doi.org/10.1016/S0092-8674(01)00197-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163246	Bronze			2022-12-24	WOS:000166882300013
J	Rutter, CM; Mandelson, MT; Laya, MB; Seger, DJ; Taplin, S				Rutter, CM; Mandelson, MT; Laya, MB; Seger, DJ; Taplin, S			Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAMMOGRAPHIC PARENCHYMAL PATTERNS; CANCER RISK; SCREENING MAMMOGRAPHY; ESTROGEN; SENSITIVITY	Context Initiation of hormone replacement therapy (HRT) has been shown to increase breast density. Evidence exists that increased breast density decreases mammographic sensitivity. The effects on breast density of discontinuing and continuing HRT have not been studied systematically. Objective To examine the effects of initiation, discontinuation, and continued use of HRT on breast density in postmenopausal women. Design, Setting, and Participants Observational cohort study of 5212 naturally postmenopausal women aged 40 to 96 years and enrolled in a large health maintenance organization in western Washington State who had 2 screening mammograms between 1996 and 1998. Main Outcome Measures Breast density, assessed using the clinical radiologists' BI-RADS 4-point scale, compared among women who did not use HRT before either mammogram (nonusers); who used HRT before the first but not before the second mammogram (discontinuers); who used HRT before the second but not before the first mammogram (initiators); and who used HRT prior to both mammograms (continuing users). Results Relative to nonusers, women who initiated HRT were more likely to show increases in breast density (relative risk [RR], 2.57; 95% confidence interval [CI], 2.12-3.08), while women who discontinued HRT use were more likely to show decreases in density (RR, 1.81;95% CI, 1.06-2.98) and women who continued to use HRT were more likely to show both increases in density (RR, 1.33; 95% CI, 1.13-1.55) and sustained high density (RR, 1.45; 95% CI, 1.33-1.58). Conclusions These results indicate that breast density changes associated with HRT are dynamic, increasing with initiation, and decreasing with discontinuation.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; Univ Washington, Dept Biostat, Div Gen Internal Med, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Div Gen Internal Med, Seattle, WA 98195 USA; Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA 98195 USA; Univ Washington, Dept Family Med, Div Gen Internal Med, Seattle, WA 98195 USA	Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rutter, CM (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.		Rutter, Carolyn/AAZ-3677-2021		NATIONAL CANCER INSTITUTE [K07CA071869] Funding Source: NIH RePORTER; NCI NIH HHS [CA71869, U01 CA637731] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BASSETT LW, 1998, AM COLL RADIOLOGY AC; BERKOWITZ JE, 1990, RADIOLOGY, V174, P199, DOI 10.1148/radiology.174.1.2152982; BLAND KI, 1980, CANCER, V45, P3027, DOI 10.1002/1097-0142(19800615)45:12<3027::AID-CNCR2820451225>3.0.CO;2-2; Buist DSM, 1999, AM J EPIDEMIOL, V149, P275; Gabrielsson J, 1996, Acta Obstet Gynecol Scand Suppl, V163, P26; Greendale GA, 1999, ANN INTERN MED, V130, P262, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00003; KAUFMAN Z, 1991, CLIN RADIOL, V43, P389, DOI 10.1016/S0009-9260(05)80566-5; Kavanagh AM, 2000, LANCET, V355, P270, DOI 10.1016/S0140-6736(99)07319-5; Laya MB, 1996, J NATL CANCER I, V88, P643, DOI 10.1093/jnci/88.10.643; LAYA MB, 1995, RADIOLOGY, V196, P433, DOI 10.1148/radiology.196.2.7617857; Litherland JC, 1999, CLIN RADIOL, V54, P285, DOI 10.1016/S0009-9260(99)90555-X; Lundstrom E, 1999, AM J OBSTET GYNECOL, V181, P348, DOI 10.1016/S0002-9378(99)70560-0; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; OZA AM, 1993, EPIDEMIOL REV, V15, P196, DOI 10.1093/oxfordjournals.epirev.a036105; SAFTLAS AF, 1987, EPIDEMIOL REV, V9, P146, DOI 10.1093/oxfordjournals.epirev.a036300; SAFTLAS AF, 1991, CANCER, V67, P2833, DOI 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U; Seradour B, 1999, J MED SCREEN, V6, P99, DOI 10.1136/jms.6.2.99; SINCLAIR JC, 1994, J CLIN EPIDEMIOL, V47, P881, DOI 10.1016/0895-4356(94)90191-0; STOMPER PC, 1990, RADIOLOGY, V174, P487, DOI 10.1148/radiology.174.2.2136958; Taplin SH, 1997, CANCER EPIDEM BIOMAR, V6, P625; WARNER E, 1992, CANCER DETECT PREV, V16, P67	21	196	201	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2001	285	2					171	176		10.1001/jama.285.2.171	http://dx.doi.org/10.1001/jama.285.2.171			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	389FB	11176809	Bronze			2022-12-24	WOS:000166227000024
J	Witte, DR; Bots, ML; Hoes, AW; Grobbee, DE				Witte, DR; Bots, ML; Hoes, AW; Grobbee, DE			Cardiovascular mortality in Dutch men during 1996 European football championship: longitudinal population study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIRCADIAN VARIATION; SEXUAL-ACTIVITY; TRIGGERS; RISK; EARTHQUAKE; ONSET; CIVILIANS; STROKE; DEATH	Objective To investigate whether an important football match increases stress to such an extent that it triggers acute myocardial infarction and stroke. Design Longitudinal study of mortality around 22 June 1996 (the day the Dutch football team was eliminated from the European football championship). Mortality on 22 June was compared with the five days before and after the match and in the same period in 1995 and 1997. Setting Netherlands. Subjects Dutch population aged 45 years or over in June 1996. Main outcome measures All cause mortality and mortality due to coronary heart disease and stroke. Results Mortality from coronary heart disease and stroke was increased in men on the day of the match (relative risk 1.51, 95% confidence interval 1.08 to 2.09). No clear rise in mortality was observed for women (1.11, 0.80 to 1.56). Among men, about 14 excess cardiovascular deaths occurred on the day of the match. Conclusion Important sporting events may provoke a sufficient level of stress to trigger symptomatic cardiovascular disease. The difference between men and women requires further investigation.	Univ Med Ctr Utrecht, Julius Ctr Gen Practice & Patient Oriented Res, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Grobbee, DE (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Gen Practice & Patient Oriented Res, Huispostnummer D01-335, NL-3584 CX Utrecht, Netherlands.	D.E.Grobbee@jc.azu.nl	Witte, Daniel R/C-1722-2008; Grobbee, Diederick/C-7651-2014; Witte, Daniel/AAF-9535-2019	Witte, Daniel R/0000-0002-0769-2922; Grobbee, Diederick/0000-0003-4472-4468; Witte, Daniel/0000-0002-0769-2922				BEHAR S, 1993, AM J MED, V94, P395, DOI 10.1016/0002-9343(93)90150-N; BERGOVEC M, 1992, LANCET, V339, P303, DOI 10.1016/0140-6736(92)91370-N; Brown DL, 1999, AM HEART J, V137, P830, DOI 10.1016/S0002-8703(99)70406-0; Evans C, 2000, BRIT MED J, V320, P218, DOI 10.1136/bmj.320.7229.218; Haapaniemi H, 1996, STROKE, V27, P1023, DOI 10.1161/01.STR.27.6.1023; HILLBOM M, 1995, STROKE, V26, P40, DOI 10.1161/01.STR.26.1.40; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; Leor J, 1996, AM J CARDIOL, V77, P1230, DOI 10.1016/S0002-9149(96)00169-5; MEISEL SR, 1991, LANCET, V338, P660, DOI 10.1016/0140-6736(91)91234-L; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; MULLER JE, 1994, J AM COLL CARDIOL, V23, P809, DOI 10.1016/0735-1097(94)90772-2; Muller JE, 1996, JAMA-J AM MED ASSOC, V275, P1405, DOI 10.1001/jama.275.18.1405; Muller JE, 1999, AM J CARDIOL, V84, p2N; *NOS, 1996, MAAND KIJK LUIST TEL; RIDKER PM, 1990, CIRCULATION, V82, P897, DOI 10.1161/01.CIR.82.3.897; Spencer FA, 1998, J AM COLL CARDIOL, V31, P1226, DOI 10.1016/S0735-1097(98)00098-9; SUZUKI S, 1995, LANCET, V345, P981, DOI 10.1016/S0140-6736(95)90727-0; TOFLER GH, 1990, AM J CARDIOL, V66, P22, DOI 10.1016/0002-9149(90)90729-K; TRICHOPOULOS D, 1983, LANCET, V1, P441; WILLICH SN, 1990, AM J CARDIOL, V66, pG15, DOI 10.1016/0002-9149(90)90387-G; WILLICH SN, 1989, CIRCULATION, V80, P853, DOI 10.1161/01.CIR.80.4.853; WILLICH SN, 1993, CIRCULATION, V87, P1442, DOI 10.1161/01.CIR.87.5.1442; WROE SJ, 1992, BRIT MED J, V304, P155, DOI 10.1136/bmj.304.6820.155	23	112	116	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2000	321	7276					1552	1554		10.1136/bmj.321.7276.1552	http://dx.doi.org/10.1136/bmj.321.7276.1552			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387RA	11124170	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000166134500007
J	Downs, JA; Lowndes, NF; Jackson, SP				Downs, JA; Lowndes, NF; Jackson, SP			A role for Saccharomyces cerevisiae histone H2A in DNA repair	NATURE			English	Article							DOUBLE-STRAND BREAKS; DEPENDENT PROTEIN-KINASE; CHECKPOINT PATHWAYS; CHROMATIN STRUCTURE; DAMAGE CHECKPOINT; BUDDING YEAST; IN-VIVO; NUCLEOSOME; RAD53; GENES	Histone proteins associate with and compact eukaryotic nuclear DNA to form chromatin. The basic unit of chromatin is the nucleosome, which is made up of 146 base pairs of DNA wrapped around two of each of four core histones(1), H2A, H2B, H3 and H4. Chromatin structure and its regulation are important in transcription and DNA replication(2-4). We therefore thought that DNA-damage signalling and repair components might also modulate chromatin structure. Here we have characterized a conserved motif in the carboxy terminus of the core histone H2A from Saccharomyces cerevisiae that contains a consensus phosphorylation site for phosphatidylinositol-3-OH kinase related kinases (PIKKs). This motif is important for survival in the presence of agents that generate DNA double-strand breaks, and the phosphorylation of this motif in response to DNA damage is dependent on the PIKK family member Mec1. The motif is not necessary for Mec1-dependent cell-cycle or transcriptional responses to DNA damage, but is required for efficient DNA double-strand break repair by non-homologous end joining. In addition, the motif has a role in determining higher order chromatin structure. Thus, phosphorylation of a core histone in response to DNA damage may cause an alteration of chromatin structure that facilitates DNA repair.	Univ Cambridge, Wellcome Trust & Canc Res Campaign, Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QR, England; Imperial Canc Res Fund, Clare Hall Labs, CDC Lab, Potters Bar EN6 3LD, Herts, England	University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res Campaign, Inst Canc & Dev Biol, Tennis Court Rd, Cambridge CB2 1QR, England.		Lowndes, Noel F/B-9084-2008; Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Lowndes, Noel F/0000-0002-3216-4427; Jackson, Stephen Philip/0000-0001-9317-7937; Downs, Jessica/0000-0002-6600-849X				Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Astrom SU, 1999, NATURE, V397, P310, DOI 10.1038/16833; BANNISTER AJ, 1993, NUCLEIC ACIDS RES, V21, P1289, DOI 10.1093/nar/21.5.1289; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; de la Torre-Ruiz MA, 1998, EMBO J, V17, P2687, DOI 10.1093/emboj/17.9.2687; ELLEDGE SJ, 1993, BIOESSAYS, V15, P333, DOI 10.1002/bies.950150507; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lewis LK, 1999, GENETICS, V152, P1513; Longhese MP, 1998, EMBO J, V17, P5525, DOI 10.1093/emboj/17.19.5525; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; SCHWARTZ JL, 1989, MUTAT RES, V216, P111, DOI 10.1016/0165-1161(89)90011-3; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; USACHENKO SI, 1994, P NATL ACAD SCI USA, V91, P6845, DOI 10.1073/pnas.91.15.6845; Wechser MA, 1997, EMBO J, V16, P2086, DOI 10.1093/emboj/16.8.2086; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; WORCEL A, 1981, P NATL ACAD SCI-BIOL, V78, P1461, DOI 10.1073/pnas.78.3.1461	27	503	521	1	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					1001	1004		10.1038/35050000	http://dx.doi.org/10.1038/35050000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140636				2022-12-24	WOS:000165951100057
J	Losos, JB; Schluter, D				Losos, JB; Schluter, D			Analysis of an evolutionary species-area relationship	NATURE			English	Article							BIOGEOGRAPHY; VICARIANCE; DISPERSAL; DIVERSITY	Large islands typically have more species than comparable smaller islands. Ecological theories, the most influential being the equilibrium theory of island biogeography(1), explain the species-area relationship as the outcome of the effect of area on immigration and extinction rates. However, these theories do not apply to taxa on land masses, including continents and large islands, that generate most of their species in situ. In this case, species-area relationships should be driven by higher speciation rates in larger areas(2-6), a theory that has never been quantitatively tested. Here we show that Anolis lizards on Caribbean islands meet several expectations of the evolutionary theory. Within-island speciation exceeds immigration as a source of new species on all islands larger than 3,000 km(2), whereas speciation is rare on smaller islands. Above this threshold island size, the rate of species proliferation increases with island area, a process that results principally from the positive effects of area on speciation rate. Also as expected, the slope of the species-area relationship jumps sharply above the threshold. Although Anolis lizards have been present on large Caribbean islands for over 30 million years, there are indications that the current number of species still falls below the speciation-extinction equilibrium.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Ctr Biodivers Res, Vancouver, BC V6T 1Z4, Canada	Washington University (WUSTL); University of British Columbia; University of British Columbia	Losos, JB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	losos@biology.wustl.edu	Villsen, Kurt/C-7965-2015	Schluter, Dolph/0000-0003-1683-7836				Bauer A.M., 1989, TUATARA, V30, P39; Brown J.H., 1998, BIOGEOGRAPHY; Case T., 1983, P307; CREER DA, IN PRESS J HERP; Crother BI, 1996, HERPETOLOGICA, V52, P440; DIAMOND JM, 1977, SYST ZOOL, V26, P263, DOI 10.2307/2412673; Donovan Stephen, 1994, CARIBBEAN GEOLOGY IN; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Futuyma DJ., 1998, EVOL BIOL; Hedges SB, 1996, HERPETOLOGICA, V52, P466; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Jackman Todd, 1997, P535; Jackman TR, 1999, SYST BIOL, V48, P254, DOI 10.1080/106351599260283; Lomolino MV, 2000, J BIOGEOGR, V27, P17, DOI 10.1046/j.1365-2699.2000.00377.x; Losos JB, 1996, PHILOS T R SOC B, V351, P847, DOI 10.1098/rstb.1996.0079; MAC ARTHUR ROBERT H., 1967; MacArthur R. H., 1969, Biological Journal of the Linnean Society, V1, P19, DOI 10.1111/j.1095-8312.1969.tb01809.x; Mayr E., 1963, ANIMAL SPECIES EVOLU; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Pimm S.L., 1991, BALANCE NATURE; Rand A. S., 1969, Breviora, VNo. 319, P1; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzwieg M.L., 1975, P121; Schluter D, 1996, AM NAT, V148, pS40, DOI 10.1086/285901; SCHNEIDER CJ, IN PRESS J HERP; SHOCHAT D, 1981, COMP BIOCHEM PHYS A, V68, P67, DOI 10.1016/0300-9629(81)90319-4; TOFT CA, 1983, OIKOS, V41, P411, DOI 10.2307/3544101; Wagner W. L., 1995, HAWAIIAN BIOGEOGRAPH; WILLIAMS EE, 1983, STUDIES MODEL ORGANI, P326	30	422	434	2	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2000	408	6814					847	850		10.1038/35048558	http://dx.doi.org/10.1038/35048558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130721				2022-12-24	WOS:000165831300047
J	Spyer, G; Hattersley, AT; MacDonald, IA; Amiel, S; MacLeod, KM				Spyer, G; Hattersley, AT; MacDonald, IA; Amiel, S; MacLeod, KM			Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes	LANCET			English	Article							GLYCEMIC CONTROL; PROTECTIVE RESPONSES; COUNTERREGULATION; INSULIN; NEUROENDOCRINE; MELLITUS	Background Intensive treatment to achieve goad glycaemic control in diabetic patients is limited by a high frequency of hypoglycaemia. The glucose concentrations at which symptoms and release of counter-regulatory hormones takes place have not been studied in patients with well controlled type-a diabetes. Methods We studied seven well controlled, non-insulin treated, type-2 diabetic patients (mean HbA(1c) [corrected according to Diabetes Control and Complications Trial] 7.4%, SD 1.0) and seven healthy controls matched for age, sex, and body mass index with a stepped hyperinsulinaemic hypoglycaemic glucose clamp. Symptoms, cognitive function, and counter-regulatory hormone concentrations were measured at each glucose plateau, and the glucose value at which there was a significant change from baseline was calculated. Findings Symptom response took place at higher whole-blood glucose concentrations in diabetic patients than in controls. Counter-regulatory release of epinephrine, norepinephrine, growth hormone, and cortisol showed a similar pattern-eg, at blood glucose concentrations of 3.8 mmol/L [SD 0.4] vs 2.6 [0.3] for epinephrine. Interpretation Glucose thresholds for counter-regulatory hormone secretion are altered in well controlled type-2 diabetic patients, so that both symptoms and counterregulatory hormone release can take place at normal glucose values. This effect might protect type-2 diabetic patients against episodes of profound hypoglycaemia and make the achievement of normoglycaemia more challenging in clinical practice.	Sch Postgrad Med & Hlth Sci, Dept Vasc Med & Diabet Res, Exeter EX2 5AX, Devon, England; Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England; Kings Coll London, Sch Med & Dent, Dept Med, London SE5, England	University of Exeter; University of Nottingham	MacLeod, KM (corresponding author), Sch Postgrad Med & Hlth Sci, Dept Vasc Med & Diabet Res, Exeter EX2 5AX, Devon, England.	K.M.Macleod@exeter.ac.uk	MacLeod, Kenneth/GWU-8940-2022	Hattersley, Andrew/0000-0001-5620-473X; Macdonald, Ian/0000-0002-7540-9850				AMIEL SA, 1987, NEW ENGL J MED, V316, P1376, DOI 10.1056/NEJM198705283162205; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; BODEN G, 1983, DIABETES, V32, P1055, DOI 10.2337/diabetes.32.11.1055; BOLLI GB, 1984, J CLIN INVEST, V73, P1532, DOI 10.1172/JCI111359; CUNNAH D, 1987, J ENDOCRINOL, V113, P123, DOI 10.1677/joe.0.1130123; Forster CD, 1999, BIOMED CHROMATOGR, V13, P209, DOI 10.1002/(SICI)1099-0801(199905)13:3<209::AID-BMC820>3.0.CO;2-Z; GERICH JE, 1993, HYPOGLYCAEMIA DIABET, P253; HELLER SR, 1987, DIABETOLOGIA, V30, P924, DOI 10.1007/BF00295875; HELLER SR, 1991, DIABETES, V40, P223, DOI 10.2337/diabetes.40.2.223; Korzon-Burakowska A, 1998, DIABETES CARE, V21, P283, DOI 10.2337/diacare.21.2.283; Levy CJ, 1998, DIABETES CARE, V21, P1330, DOI 10.2337/diacare.21.8.1330; LIU D, 1992, DIABETOLOGIA, V35, P287, DOI 10.1007/BF00400932; Matyka K, 1997, DIABETES CARE, V20, P135, DOI 10.2337/diacare.20.2.135; POLONSKY KS, 1984, DIABETES, V33, P1112, DOI 10.2337/diabetes.33.11.1112; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	16	88	88	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 9	2000	356	9246					1970	1974		10.1016/S0140-6736(00)03322-5	http://dx.doi.org/10.1016/S0140-6736(00)03322-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383DJ	11130525				2022-12-24	WOS:000165867600011
J	Motohashi, H; Katsuoka, F; Shavit, JA; Engel, JD; Yamamoto, M				Motohashi, H; Katsuoka, F; Shavit, JA; Engel, JD; Yamamoto, M			Positive or negative MARE-dependent transcriptional regulation is by the abundance of small Maf proteins	CELL			English	Article							ERYTHROLEUKEMIA CELL-DIFFERENTIATION; LEUCINE ZIPPER PROTEIN; FACTOR NF-E2; IN-VITRO; V-MAF; FAMILY; GENE; EXPRESSION; MEGAKARYOCYTES; ONCOGENE	The small Maf transcription factor proteins bind to Maf Recognition Elements (MAREs) by dimerizing with CNC proteins or themselves. We undertook experiments to clarify the functional relationship between the small Mafs and their partners in vivo. Embryos expressing abundant transgene-derived MafK died of severe anemia, while lines expressing lower levels of small Maf lived to adulthood. Megakaryocytes from the latter overexpressing lines exhibited reduced proplatelet formation and MARE-dependent transcription, phenocopying mafG null mutant mice. When the mafG null mutants were bred to small Maf-overexpressing transgenic animals, both loss- and gain-of-function phenotypes were reversed. These results provide direct in vivo evidence that transcriptional regulation through MARE elements hinges on an exquisitely sensitive balance of activating CNC molecules and their small Maf partners.	Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058577, Japan; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	University of Tsukuba; University of Tsukuba; Northwestern University	Yamamoto, M (corresponding author), Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	masi@tara.tsukuba.ac.jp	Yamamoto, Masayuki/A-4873-2010; Motohashi, Hozumi/AAZ-2628-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Katsuoka, Fumiki/0000-0003-0939-7887	NATIONAL CANCER INSTITUTE [R01CA080088] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA80088] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ANDREWS NC, 1993, P NATL ACAD SCI USA, V90, P11488, DOI 10.1073/pnas.90.24.11488; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CHOI ES, 1995, BLOOD, V85, P402; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; Deveaux S, 1997, EMBO J, V16, P5654, DOI 10.1093/emboj/16.18.5654; DIGNAM JD, 1990, METHOD ENZYMOL, V182, P194; ENGEL JD, 1994, NATURE, V367, P516; Farmer SC, 1997, GENE DEV, V11, P786, DOI 10.1101/gad.11.6.786; FUJIWARA KT, 1993, ONCOGENE, V8, P2371; IGARASHI K, 1995, J BIOL CHEM, V270, P7615, DOI 10.1074/jbc.270.13.7615; IGARASHI K, 1995, P NATL ACAD SCI USA, V92, P7445, DOI 10.1073/pnas.92.16.7445; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; KATAOKA K, 1993, J VIROL, V67, P2133, DOI 10.1128/JVI.67.4.2133-2141.1993; KATAOKA K, 1994, MOL CELL BIOL, V14, P7581, DOI 10.1128/MCB.14.11.7581; KATAOKA K, 1995, MOL CELL BIOL, V15, P2180; Katsuoka F, 2000, EMBO J, V19, P2980, DOI 10.1093/emboj/19.12.2980; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kotkow KJ, 1996, P NATL ACAD SCI USA, V93, P3514, DOI 10.1073/pnas.93.8.3514; Kuroha T, 1998, J BIOCHEM-TOKYO, V123, P376; Lecine P, 1998, J BIOL CHEM, V273, P7572, DOI 10.1074/jbc.273.13.7572; Lecine P, 1998, BLOOD, V92, P1608, DOI 10.1182/blood.V92.5.1608.417k27_1608_1616; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; MOHLER J, 1991, MECH DEVELOP, V34, P3, DOI 10.1016/0925-4773(91)90086-L; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Motohashi H, 1998, GENES CELLS, V3, P671, DOI 10.1046/j.1365-2443.1998.00222.x; Motohashi H, 1996, GENES CELLS, V1, P223, DOI 10.1046/j.1365-2443.1996.d01-230.x; Motohashi H, 1997, NUCLEIC ACIDS RES, V25, P2953, DOI 10.1093/nar/25.15.2953; Nagai T, 1998, J BIOL CHEM, V273, P5358, DOI 10.1074/jbc.273.9.5358; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; NISHIZAWA M, 1989, P NATL ACAD SCI USA, V86, P7711, DOI 10.1073/pnas.86.20.7711; Onodera K, 1999, J BIOL CHEM, V274, P21162, DOI 10.1074/jbc.274.30.21162; Onodera K, 2000, EMBO J, V19, P1335, DOI 10.1093/emboj/19.6.1335; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Shavit JA, 1998, GENE DEV, V12, P2164, DOI 10.1101/gad.12.14.2164; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; Suwabe N, 1998, BLOOD, V92, P4108, DOI 10.1182/blood.V92.11.4108.423k29_4108_4118; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611	44	121	122	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 8	2000	103	6					865	875		10.1016/S0092-8674(00)00190-2	http://dx.doi.org/10.1016/S0092-8674(00)00190-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136972	Bronze			2022-12-24	WOS:000165801300006
J	Worthylake, DK; Rossman, KL; Sondek, J				Worthylake, DK; Rossman, KL; Sondek, J			Crystal structure of Rac1 in complex with the guanine nucleotide exchange region of Tiam1	NATURE			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; RHO-FAMILY; DBL FAMILY; ACTIVATION; PROTEIN; RAS; INVASION; BINDING; GTPASE; CELL	The principal guanine nucleotide exchange factors for Rho family G proteins contain tandem Dbl-homology (DH) and pleckstrin-homology (PH) domains that catalyse nucleotide exchange and the activation of G proteins. Here we have determined the crystal structure of the DH and PH domains of the T-lymphoma invasion and metastasis factor 1 (Tiam1) protein in complex with its cognate Rho family G protein, Rac1. The two switch regions of Rac1 are stabilized in conformations that disrupt both magnesium binding and guanine nucleotide interaction. The resulting cleft in Rac1 is devoid of nucleotide and highly exposed to solvent. The PH domain of Tiam1 does not contact Rac1, and the position and orientation of the PH domain is markedly altered relative to the structure of the uncomplexed, GTPase-free DH/PH element from Sos1. The Tiam1/Rac1 structure highlights the interactions that catalyse nucleotide exchange on Rho family G proteins, and illustrates structural determinants dictating specificity between individual Rho family members and their associated Dbl-related guanine nucleotide exchange factors.	Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sondek, J (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.			Sondek, John/0000-0002-1127-8310				Aghazadeh B, 1998, NAT STRUCT BIOL, V5, P1098, DOI 10.1038/4209; Anborgh PH, 1999, MOL CELL BIOL, V19, P4611; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blomberg N, 1997, FOLD DES, V2, P343, DOI 10.1016/S1359-0278(97)00048-5; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; HABETS GGM, 1995, ONCOGENE, V10, P1371; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubiseski TJ, 1997, J BIOL CHEM, V272, P1799, DOI 10.1074/jbc.272.3.1799; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1991, MAXIMUM LIKELIHOOD R; OTWINOWSKI Z, 1993, DATA COLLECTION PROC; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Sheldrick G.M, 1986, SHELXS86 PROGRAM CRY; Shimizu T, 2000, J BIOL CHEM, V275, P18311, DOI 10.1074/jbc.M910274199; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; ZHENG Y, 1994, J BIOL CHEM, V269, P2369; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181	43	290	303	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2000	408	6813					682	688		10.1038/35047014	http://dx.doi.org/10.1038/35047014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130063				2022-12-24	WOS:000165815200039
J	Henney, JE				Henney, JE			Shock wave for heel pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	22	25	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2000	284	21					2711	2711		10.1001/jama.284.21.2711-c	http://dx.doi.org/10.1001/jama.284.21.2711-c			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377JB	11105160				2022-12-24	WOS:000165509500005
J	Hoek, RM; Ruuls, SR; Murphy, CA; Wright, GJ; Goddard, R; Zurawski, SM; Blom, B; Homola, ME; Streit, WJ; Brown, MH; Barclay, AN; Sedgwick, JD				Hoek, RM; Ruuls, SR; Murphy, CA; Wright, GJ; Goddard, R; Zurawski, SM; Blom, B; Homola, ME; Streit, WJ; Brown, MH; Barclay, AN; Sedgwick, JD			Down-regulation of the macrophage lineage through interaction with OX2 (CD200)	SCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MICROGLIAL CELLS; GENE; MICE; LOCALIZATION; GLYCOPROTEIN; ARTHRITIS; MHC	OX2 (CD200) is a broadly expressed membrane glycoprotein, shown here to be important for regulation of the macrophage Lineage. In mice lacking CD200, macrophage lineage cells, including brain microglia, exhibited an activated phenotype and were more numerous. Upon facial nerve transection, damaged CD200-deficient neurons elicited an accelerated microglial response. Lack of CD200 resulted in a more rapid onset of experimental autoimmune encephalomyelitis (EAE). Outside the brain, disruption of CD200-CD200 receptor interaction precipitated susceptibility to collagen-induced arthritis(CIA) in mice normally resistant to this disease. Thus, in diverse tissues OX2 delivers an inhibitory signal for the macrophage Lineage.	DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; Univ Florida, Inst Brain, Gainesville, FL 32610 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; University of Oxford; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Sedgwick, JD (corresponding author), DNAX Res Inst Mol & Cellular Biol Inc, 901 Calif Ave, Palo Alto, CA 94304 USA.			Wright, Gavin/0000-0003-0537-0863				Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; BARCLAY AN, 1981, IMMUNOLOGY, V44, P727; Bates EEM, 1998, MOL IMMUNOL, V35, P513, DOI 10.1016/S0161-5890(98)00045-5; Borriello F, 1998, MAMM GENOME, V9, P114, DOI 10.1007/s003359900700; Campbell IK, 1997, ANN RHEUM DIS, V56, P364, DOI 10.1136/ard.56.6.364; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; HOEK RM, UNPUB; JONSSON R, 1986, J IMMUNOL METHODS, V88, P109, DOI 10.1016/0022-1759(86)90058-X; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; KRAAL G, 1986, IMMUNOLOGY, V58, P665; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lemckert FA, 1997, NUCLEIC ACIDS RES, V25, P917, DOI 10.1093/nar/25.4.917; McColl SR, 1998, J IMMUNOL, V161, P6421; PERRY VH, 1988, TRENDS NEUROSCI, V11, P273, DOI 10.1016/0166-2236(88)90110-5; Preston S, 1997, EUR J IMMUNOL, V27, P1911, DOI 10.1002/eji.1830270814; RAINE CS, 1984, LAB INVEST, V50, P608; Riminton DS, 1998, J EXP MED, V187, P1517, DOI 10.1084/jem.187.9.1517; SEDGWICK JD, 1993, J EXP MED, V177, P1145, DOI 10.1084/jem.177.4.1145; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; WATSON WC, 1985, J EXP MED, V162, P1878, DOI 10.1084/jem.162.6.1878; WEBB M, 1984, J NEUROCHEM, V43, P1061, DOI 10.1111/j.1471-4159.1984.tb12844.x; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; 2000, 7 WORKSH C HUM LEUK	24	760	815	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2000	290	5497					1768	1771		10.1126/science.290.5497.1768	http://dx.doi.org/10.1126/science.290.5497.1768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379FY	11099416				2022-12-24	WOS:000165632400044
J	Primatesta, P; Poulter, NR				Primatesta, P; Poulter, NR			Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; CHOLESTEROL; PREVENTION; PRAVASTATIN; RISK; MEN	Objective To evaluate the prevalence of the use of lipid lowering agents and its relation to blood lipid concentrations in English adults. Design Cross sectional survey. Setting England, 1998. Participants Nationally representative sample of 13 586 adults (aged greater than or equal to 16 years) living in non-institutional households. Main outcome measures Mean blood concentrations of total cholesterol and high density lipoprotein (HDL) cholesterol, and the ratio of total cholesterol to HDL cholesterol, in participants classified by age and sex; prevalence of raised total cholesterol concentrations and increased ratio of total to HDL cholesterol; prevalence of use of lipid lowering agents and the lipid concentrations of people taking them. Results Mean total cholesterol concentrations were 5.47 (SE 0.02) mmol/l in men and 5.59 (0.02) mmol/l in women. Mean HDL cholesterol concentrations were 1.28 (0.01) mmol/l in men and 1.55 (0.01) mmol/l in women. Overall, of 10 569 adults who had a valid cholesterol measurement taken 7133 (67.5%; 95% confidence interval 66.5% to 68.4%) had a total cholesterol concentration greater than or equal to5 mmol/l, 2804 (26.5%; 25.7% to 27.4%) had a ratio of total cholesterol to HDL cholesterol greater than or equal to5 mmol/l, and 237 (2.2%; 1.9% to 2.5%) reported taking lipid lowering drugs. Of 117 participants with no history of cardiovascular disease but whose estimated 10 year risk of coronary heart disease was greater than or equal to 30% and whose total cholesterol concentration was greater than or equal to5 mmol/l, four (3%) were taking lipid lowering drugs. Of 385 adults aged 16-75 with a history of coronary heart disease and eligible for lipid lowering treatment, 114 (30%; 25%, to 34%) were taking lipid lowering drugs, of whom only 50 (44%; 35% to 53%) had a total cholesterol concentration <5 mmo/l. Conclusions Despite the high prevalence of dyslipidaemia in English adults, the proportion of adults taking lipid lowering drugs in 1998 was only 2.2%. Rates of treatment were low among high risk patients eligible for primary prevention with lipid lowering drugs, and less than one third of patients with established cardiovascular disease received such treatment.	UCL Royal Free & Univ Coll Med Sch, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Imperial Coll Sch Med, Dept Clin Pharmacol, Cardiovasc Studies Unit, London W2 1PG, England	University of London; University College London; UCL Medical School; Imperial College London	Primatesta, P (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England.	paolap@public-health.uclac.uk						ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; BETTERIDGE DJ, 1993, POSTGRAD MED J, V69, P359, DOI 10.1136/pgmj.69.811.359; *BRIT HEART FDN HL, 2000, EUR CARD DIS STAT; CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; ERENS B, 1999, HLTH SURVEY ENGLAND, V1; Erens B, 1999, HLTH SURVEY ENGLAND, V2; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; *NAT SERV FRAM COR, 2000, MOD STAND SERV MOD 2; *NHS EX, 1997, STAND MED ADV COMM U; OLIVER MF, 1991, LANCET, V337, P1529, DOI 10.1016/0140-6736(91)93208-Q; PEDERSEN TR, 1994, LANCET, V344, P1383; RAVNSKOV U, 1992, BMJ-BRIT MED J, V305, P15, DOI 10.1136/bmj.305.6844.15; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wood D, 1998, HEART, V80, pS1; World Health Organization, 1998, WORLD HLTH STAT ANN	20	113	115	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 25	2000	321	7272					1322	1325		10.1136/bmj.321.7272.1322	http://dx.doi.org/10.1136/bmj.321.7272.1322			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378BK	11090516	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000165561600027
J	Proshlyakov, DA; Pressler, MA; DeMaso, C; Leykam, JF; DeWitt, DL; Babcock, GT				Proshlyakov, DA; Pressler, MA; DeMaso, C; Leykam, JF; DeWitt, DL; Babcock, GT			Oxygen activation and reduction in respiration: Involvement of redox-active tyrosine 244	SCIENCE			English	Article							CYTOCHROME-C-OXIDASE; HYDROGEN-PEROXIDE; PROTON TRANSLOCATION; MECHANISM; IODINATION; IDENTIFICATION; RADICALS; SITE	Cytochrome oxidase activates and reduces O-2 to water to sustain respiration and uses the energy released to drive proton translocation and adenosine 5'-triphosphate synthesis. A key intermediate in this process, P, lies at the junction of the O-2-reducing and proton-pumping functions. We used radioactive iodide labeling followed by peptide mapping to gain insight into the structure of P. We show that the cross-linked histidine 240-tyrosine 244 (His(240)-Tyr(244) species is redox active in P formation, which establishes its structure as Fe-IV=O/(CuB2+H240)-Y-244. Thus, energy transfer from O-2 to the protein moiety is used as a strategy to avoid toxic intermediates and to control energy utilization in subsequent proton-pumping events.	Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Babcock, GT (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	babcock@cem.msu.edu			NIGMS NIH HHS [GM57323, GM25480] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025480] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babcock GT, 1999, P NATL ACAD SCI USA, V96, P12971, DOI 10.1073/pnas.96.23.12971; BLOMBERG MR, IN PRESS J AM CHEM S; Blomberg MRA, 2000, J INORG BIOCHEM, V80, P261, DOI 10.1016/S0162-0134(00)00080-5; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; Chen YR, 1999, J BIOL CHEM, V274, P3308, DOI 10.1074/jbc.274.6.3308; CLORE GM, 1980, BIOCHEM J, V185, P155, DOI 10.1042/bj1850155; DEME D, 1985, ARCH BIOCHEM BIOPHYS, V236, P559, DOI 10.1016/0003-9861(85)90659-9; FABIAN M, 1995, BIOCHEMISTRY-US, V34, P13802, DOI 10.1021/bi00042a011; HENSEL S, 1990, BIOL CHEM H-S, V371, P411, DOI 10.1515/bchm3.1990.371.1.411; Himo F, 2000, INT J QUANTUM CHEM, V76, P714, DOI 10.1002/(SICI)1097-461X(2000)76:6<714::AID-QUA4>3.0.CO;2-F; Kitagawa T, 1997, PROG INORG CHEM, V45, P431; Koppenhofer A, 2000, BIOCHEMISTRY-US, V39, P4028, DOI 10.1021/bi991912k; Libby RD, 1996, J BIOL CHEM, V271, P21820, DOI 10.1074/jbc.271.36.21820; MacMillan F, 1999, BIOCHEMISTRY-US, V38, P9179, DOI 10.1021/bi9911987; McCauley KM, 2000, J AM CHEM SOC, V122, P2403, DOI 10.1021/ja993774s; Michel H, 1999, NATURE, V402, P602, DOI 10.1038/45133; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; MOODY AJ, 1994, EUR J BIOCHEM, V226, P731, DOI 10.1111/j.1432-1033.1994.tb20102.x; MOODY AJ, 1991, BIOCHIM BIOPHYS ACTA, V1059, P189, DOI 10.1016/S0005-2728(05)80204-X; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Rigby SEJ, 2000, BIOCHEMISTRY-US, V39, P5921, DOI 10.1021/bi992614q; ROMAN R, 1972, BIOCHEMISTRY-US, V11, P2076, DOI 10.1021/bi00761a013; SUN WM, 1993, BIOCHEMISTRY-US, V32, P1324, DOI 10.1021/bi00056a018; TAKAHASHI Y, 1989, BIOCHIM BIOPHYS ACTA, V973, P138, DOI 10.1016/S0005-2728(89)80414-1; Taurog A, 1996, ARCH BIOCHEM BIOPHYS, V330, P24, DOI 10.1006/abbi.1996.0222; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; Wikstrom M, 2000, BIOCHEMISTRY-US, V39, P3515, DOI 10.1021/bi9925322; WIKSTROM M, 1989, NATURE, V338, P776, DOI 10.1038/338776a0; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	30	259	266	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2000	290	5496					1588	1591		10.1126/science.290.5496.1588	http://dx.doi.org/10.1126/science.290.5496.1588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376EX	11090359				2022-12-24	WOS:000165446200054
J	Weichenrieder, O; Wild, K; Strub, K; Cusack, S				Weichenrieder, O; Wild, K; Strub, K; Cusack, S			Structure and assembly of the Alu domain of the mammalian signal recognition particle	NATURE			English	Article							SRP-RNA; PROTEIN TRANSLOCATION; CRYSTAL-STRUCTURE; ENDOPLASMIC-RETICULUM; HAMMERHEAD RIBOZYME; ELONGATION ARREST; SRP9/14 SUBUNIT; BINDING-SITES; 7SL RNA; ELEMENTS	The Alu domain of the mammalian signal recognition particle (SRP) comprises the heterodimer of proteins SRP9 and SRP14 bound to the 5' and 3' terminal sequences of SRP RNA. It retards the ribosomal elongation of signal-peptide-containing proteins before their engagement with the translocation machinery in the endoplasmic reticulum. Here we report two crystal structures of the heterodimer SRP9/14 bound either to the 5' domain or to a construct containing both 5' and 3' domains. We present a model of the complete Alu domain that is consistent with extensive biochemical data. SRP9/14 binds strongly to the conserved core of the 5' domain, which forms a U-turn connecting two helical stacks. Reversible docking of the more weakly bound 3' domain might be functionally important in the mechanism of translational regulation. The Alu domain structure is probably conserved in other cytoplasmic ribonucleoprotein particles and retroposition intermediates containing SRP9/14-bound RNAs transcribed from Alu repeats or related elements in genomic DNA.	European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; Univ Geneva, Dept Biol Cellulaire, CH-1211 Geneva, Switzerland	European Molecular Biology Laboratory (EMBL); University of Geneva	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, BP 156X, F-38042 Grenoble 9, France.			Weichenrieder, Oliver/0000-0001-5818-6248; Cusack, Stephen/0000-0002-9324-0796				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; ANDREWS DW, 1987, EMBO J, V6, P3471, DOI 10.1002/j.1460-2075.1987.tb02671.x; Birse DEA, 1997, EMBO J, V16, P3757, DOI 10.1093/emboj/16.13.3757; Bovia F, 1997, NUCLEIC ACIDS RES, V25, P318, DOI 10.1093/nar/25.2.318; BOVIA F, 1995, MOL BIOL CELL, V6, P471, DOI 10.1091/mbc.6.4.471; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chang DY, 1997, NUCLEIC ACIDS RES, V25, P1117, DOI 10.1093/nar/25.6.1117; Chang DY, 1996, NUCLEIC ACIDS RES, V24, P4165, DOI 10.1093/nar/24.21.4165; Chen YH, 1998, J BIOL CHEM, V273, P35023, DOI 10.1074/jbc.273.52.35023; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Cusack S, 1998, NAT STRUCT BIOL, V5, P634, DOI 10.1038/1325; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Emde G, 1997, RNA, V3, P538; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; GUNDELFINGER ED, 1983, NUCLEIC ACIDS RES, V11, P7363, DOI 10.1093/nar/11.21.7363; Jacobson MR, 1998, P NATL ACAD SCI USA, V95, P7981, DOI 10.1073/pnas.95.14.7981; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kazazian HH, 1998, CURR OPIN GENET DEV, V8, P343, DOI 10.1016/S0959-437X(98)80092-0; Kremerskothen J, 1998, NEUROSCI LETT, V245, P123, DOI 10.1016/S0304-3940(98)00215-8; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mighell AJ, 1997, FEBS LETT, V417, P1, DOI 10.1016/S0014-5793(97)01259-3; Nakamura K, 1999, J BIOL CHEM, V274, P13569, DOI 10.1074/jbc.274.19.13569; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; RAPOPORT TA, 1987, J MOL BIOL, V195, P621, DOI 10.1016/0022-2836(87)90186-0; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; SIEGEL V, 1988, P NATL ACAD SCI USA, V85, P1801, DOI 10.1073/pnas.85.6.1801; STRUB K, 1990, MOL CELL BIOL, V10, P777, DOI 10.1128/MCB.10.2.777; STRUB K, 1989, P NATL ACAD SCI USA, V86, P9747, DOI 10.1073/pnas.86.24.9747; Strub K, 1999, RNA, V5, P1333, DOI 10.1017/S1355838299991045; STRUB K, 1991, MOL CELL BIOL, V11, P3949, DOI 10.1128/MCB.11.8.3949; Thomas Y, 1997, NUCLEIC ACIDS RES, V25, P1920, DOI 10.1093/nar/25.10.1920; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Weichenrieder O, 1997, RNA, V3, P1262; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Zwieb C, 1996, FOLD DES, V1, P315, DOI 10.1016/S1359-0278(96)00044-2	47	138	144	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					167	173		10.1038/35041507	http://dx.doi.org/10.1038/35041507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089964	Green Published			2022-12-24	WOS:000165180400036
J	Yancik, R; Wesley, MN; Ries, LAG; Havlik, RJ; Edwards, BK; Yates, JW				Yancik, R; Wesley, MN; Ries, LAG; Havlik, RJ; Edwards, BK; Yates, JW			Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LYMPH-NODE DISSECTION; AXILLARY DISSECTION; WOMEN; CARE; SURVIVAL; PATTERNS; IMPACT	Context Postmenopausal women aged 55 years and older have 66% of incident breast tumors and experience 77% of breast cancer mortality, but other age-related health problems may affect tumor prognosis and treatment decisions. Objective To document the comorbidity burden of postmenopausal breast cancer patients and evaluate its relationship with age on disease stage, treatment, and early mortality. Design and Setting Data were collected on breast cancer patients' comorbidities by retrospective hospital medical records review and merged with information on patients' tumor characteristics collected from 6 regional National Cancer Institute Surveillance, Epidemiology, and End Results cancer registries. Patients were followed up until death or for 30 months from breast cancer diagnosis. Participants Population-based random sample of 1800 postmenopausal breast cancer patients diagnosed in 1992 stratified by 3 age groups: 55 to 64 years, 65 to 74 years, and 75 years and older. Main Outcome Measures Extent of disease, therapy received, comorbidity, cause of death, and survival. Results Seventy-three percent (1312 of 1800) of the sample was diagnosed with stage I and II breast cancer, 10% (n=188) with stage III and IV breast cancer, and 17% (n=300) did not have a stage assignment. Of the 1017 patients with stage I and stage II node-negative breast cancer, 95% received therapy in agreement with the National Institutes of Health consensus statement recommendation for early-stage breast cancer. Patients in older age groups were less likely to:receive therapy consistent with the consensus statement (P<.001), and women aged 70 years and older were significantly less likely to receive axillary lymph node dissection as determined by logistic regression analysis (P<.01). Diabetes, renal failure, stroke, liver disease, a previous malignant tumor, and smoking were significant in predicting early mortality in a statistical model that included age and disease stage. Breast cancer was the underlying cause of death for 135 decedents (51.3%). Heart disease (n=45, 17.1%) and previous cancers (n=22, 8.4%) were the next major underlying causes. In the 30-month follow-up period, 263 patients (15%) died. Conclusion Patient care decisions occur in the context of breast cancer and other age-related conditions. Comorbidity in older patients may limit the ability to obtain prognostic information (ie, axillary lymph node dissection), tends to minimize treatment options (eg, breast-conserving therapy), and increases the risk of death from causes other than breast cancer.	NIA, Canc Sect, Geriatr Program, NIH, Bethesda, MD 20892 USA; NIA, Epidemiol Biometry & Demog Program, NIH, Bethesda, MD 20892 USA; NCI, Surveillance Res Program, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA; Informat Management Serv Inc, Silver Spring, MD USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Roswell Park Cancer Institute	Yancik, R (corresponding author), NIA, Canc Sect, Geriatr Program, NIH, Bethesda, MD 20892 USA.							*ACS, 2001, FACTS FIG 2001; ALLEN C, 1986, J AM GERIATR SOC, V34, P637, DOI 10.1111/j.1532-5415.1986.tb04904.x; American Joint Committee on Cancer, 1992, MAN STAG CANC; [Anonymous], 1996, US BUREAU CENSUS CUR; AUGUST DA, 1994, ANN SURG ONCOL, V1, P45, DOI 10.1007/BF02303540; BallardBarbash R, 1996, JNCI-J NATL CANCER I, V88, P716, DOI 10.1093/jnci/88.11.716; BERGMAN L, 1991, BREAST CANCER RES TR, V18, P189, DOI 10.1007/BF01990035; Busch E, 1996, CANCER, V78, P101, DOI 10.1002/(SICI)1097-0142(19960701)78:1<101::AID-CNCR15>3.0.CO;2-3; CABANES PA, 1992, LANCET, V339, P1245, DOI 10.1016/0140-6736(92)91591-U; CADY B, 1994, CANCER, V73, P505, DOI 10.1002/1097-0142(19940201)73:3<505::AID-CNCR2820730302>3.0.CO;2-B; CHU J, 1987, J GERONTOL, V42, P185, DOI 10.1093/geronj/42.2.185; COX DR, 1972, J R STAT SOC B, V34, P187; Cox DR., 1970, ANAL BINARY DATA; Du XL, 1999, BREAST CANCER RES TR, V53, P137, DOI 10.1023/A:1006170811237; Goodwin JS, 1996, JNCI-J NATL CANCER I, V88, P1031, DOI 10.1093/jnci/88.15.1031; GREENFIELD S, 1987, JAMA-J AM MED ASSOC, V257, P2766, DOI 10.1001/jama.257.20.2766; Guralnik JM, 1996, ANN EPIDEMIOL, V6, P376, DOI 10.1016/S1047-2797(96)00060-9; Havlik RJ, 1994, CANCER S, V74, P2102; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KUZNETSOVA M, 1995, RADIOLOGY, V197, P507, DOI 10.1148/radiology.197.2.7480703; LIN PP, 1993, J CLIN ONCOL, V11, P1536, DOI 10.1200/JCO.1993.11.8.1536; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Newschaffer CJ, 1996, ARCH INTERN MED, V156, P85, DOI 10.1001/archinte.156.1.85; *NIH, 1990, TREATM EARL STAG BRE, V8, P1; Piccirillo JF, 1996, CANCER, V77, P834, DOI 10.1002/(SICI)1097-0142(19960301)77:5<834::AID-CNCR5>3.3.CO;2-Z; Ries LAG .M.K.C, 2001, SEER CANC STAT REV 1; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; SATARIANO WA, 1992, J GERONTOL, V47, P24; Satariano WA, 1989, CANC ELDERLY APPROAC, P71; Seeman T E, 1989, J Aging Health, V1, P50, DOI 10.1177/089826438900100104; SILLIMAN RA, 1993, JNCI-J NATL CANCER I, V85, P190, DOI 10.1093/jnci/85.3.190; SILLIMAN RA, 1989, J GERONTOL, V44, P46; STEINFELD AD, 1989, J AM GERIATR SOC, V347, P335; Sun A, 1998, RADIOTHER ONCOL, V48, P191, DOI 10.1016/S0167-8140(98)00029-2; TRIMBLE EL, 1994, CANCER, V74, P2208, DOI 10.1002/1097-0142(19941001)74:7+<2208::AID-CNCR2820741737>3.0.CO;2-#; Warmuth MA, 1998, CANCER, V83, P1362, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1362::AID-CNCR13>3.0.CO;2-2; West DW, 1996, ANN EPIDEMIOL, V6, P413, DOI 10.1016/S1047-2797(96)00096-8; WETLE T, 1987, JAMA-J AM MED ASSOC, V258, P516, DOI 10.1001/jama.1987.03400040114035; Yancik R, 1996, ANN EPIDEMIOL, V6, P399, DOI 10.1016/S1047-2797(96)00063-4; YANCIK R, 1989, CANCER, V63, P976, DOI 10.1002/1097-0142(19890301)63:5<976::AID-CNCR2820630532>3.0.CO;2-A	41	662	678	1	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2001	285	7					885	892		10.1001/jama.285.7.885	http://dx.doi.org/10.1001/jama.285.7.885			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402BE	11180731	Bronze			2022-12-24	WOS:000166965500025
J	Lie, RT; Wilcox, AJ; Skjaerven, R				Lie, RT; Wilcox, AJ; Skjaerven, R			Survival and reproduction among males with birth defects and risk of recurrence in their children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Few systematic data exist on survival and reproduction among males with birth defects and their contribution to occurrence of birth defects in the next generation. Objective To estimate survival of males with registered birth defects, their subsequent reproduction rates, and their risk of transmitting birth defects to their offspring. Design and Setting Population-based cohort study of data from the Medical Birth Registry of Norway. Subjects A total of 486207 males born in Norway between 1967 and 1982, 12292 of whom had a recorded birth defect. Main Outcome Measures Survival rates through 1992, reproduction rates through 1998, and risk of birth defects among offspring of males with vs without birth defects. Results Survival through 1992 was lower among males with birth defects (84% vs 97%). Compared with males without birth defects, affected males were 28% less likely to have had a child. Among offspring of affected males, 5.1% had a registered birth defect compared with 2.1% of offspring of males without birth defects (relative risk [RR], 2.4; 95% confidence interval [CI], 1.9-3.0), Offspring of affected fathers had an increased risk of the same defect as their fathers (RR, 6.5; 95% CI, 4.0-10.4) and an increased risk of dissimilar defects (RR, 1.8; 95% CI, 1.3-2.5). Conclusions Compared with unaffected males, males with birth defects have higher mortality and survivors are less likely to have a child. Fathers with birth defects are significantly more likely than unaffected fathers to have an affected child.	Univ Bergen, Med Birth Registry Norway, N-5021 Bergen, Norway; Univ Bergen, Sect Med Stat, N-5021 Bergen, Norway; NIEHS, Res Triangle Pk, NC 27709 USA	University of Bergen; University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Lie, RT (corresponding author), Univ Bergen, Sect Med Stat, Amauer Hansens Bldg, N-5021 Bergen, Norway.		Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049027, Z01ES049027] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; CHATKUPT S, 1992, AM J MED GENET, V44, P508, DOI 10.1002/ajmg.1320440426; Chung C S, 1975, Birth Defects Orig Artic Ser, V11, P1; LIE RT, 1994, NEW ENGL J MED, V331, P1, DOI 10.1056/NEJM199407073310101; LIE RT, 1994, BIOMETRICS, V50, P433, DOI 10.2307/2533386; METHA C, 1999, STATXACT WINDOWS; NORA JJ, 1987, AM J CARDIOL, V59, P459, DOI 10.1016/0002-9149(87)90956-8; Norusis M J, 1993, SPSS WINDOWS ADV STA; Rothman K, 1986, MODERN EPIDEMIOLOGY; Skjaerven R, 1999, NEW ENGL J MED, V340, P1057, DOI 10.1056/NEJM199904083401401; *STAT NORW, 1995, POP STAT 1994, V3; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	12	41	41	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2001	285	6					755	760		10.1001/jama.285.6.755	http://dx.doi.org/10.1001/jama.285.6.755			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399MP	11176913				2022-12-24	WOS:000166817200032
J	Berset, T; Hoier, EF; Battu, G; Canevascini, S; Hajnal, A				Berset, T; Hoier, EF; Battu, G; Canevascini, S; Hajnal, A			Notch inhibition of RAS signaling through MAP kinase phosphatase LIP-1 during C-elegans vulval development	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; CELL FATE; INDUCTION; PROTEIN; EGFR; SPECIFICITY; EXPRESSION; PATHWAYS; ENCODES; DEFINES	During Caenorhabditis elegans vulval development, a signal from the anchor cell stimulates the RTK/RAS/MAPK (receptor tyrosine kinase/RAS/mitogen-activated protein kinase) signaling pathway in the closest vulval precursor cell P6.p to induce the primary fate. A Lateral signal from P6.p then activates the Notch signaling pathway in the neighboring tells P5.p and P7.p to prevent them from adopting the primary fate and to specify the secondary fate. The MAP kinase phosphatase LIP-1 mediates this lateral inhibition of the primary fate. LIN-12/NOTCH up-regulates lip-1 transcription in P5.p and P7.p where LIP-1 inactivates the MAP kinase to inhibit primary fate specification. LIP-1 thus Links the two signaling pathways to generate a pattern.	Univ Zurich, Dept Pathol, Div Canc Res, CH-8091 Zurich, Switzerland	University of Zurich	Hajnal, A (corresponding author), Univ Zurich, Dept Pathol, Div Canc Res, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.			Hajnal, Alex/0000-0002-4098-3721				ALESSI DR, 1995, METHOD ENZYMOL, V255, P279; Ambros V, 1999, DEVELOPMENT, V126, P1947; AROIAN RV, 1994, EMBO J, V13, P360, DOI 10.1002/j.1460-2075.1994.tb06269.x; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Beitel GJ, 1995, GENE DEV, V9, P3149, DOI 10.1101/gad.9.24.3149; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Christensen S, 1996, DEVELOPMENT, V122, P1373; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; FERGUSON EL, 1989, GENETICS, V123, P109; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Hajnal A, 1997, GENE DEV, V11, P2715, DOI 10.1101/gad.11.20.2715; Ikeya T, 1999, DEVELOPMENT, V126, P4455; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; Lackner MR, 1998, GENETICS, V150, P103; LACKNER MR, 1994, GENE DEV, V8, P160, DOI 10.1101/gad.8.2.160; Price JV, 1997, GENETICS, V147, P1139; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; SIMSKE JS, 1995, NATURE, V375, P142, DOI 10.1038/375142a0; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; TUCK S, 1995, GENE DEV, V9, P341, DOI 10.1101/gad.9.3.341; WU Y, 1994, GENE DEV, V8, P147, DOI 10.1101/gad.8.2.147; zur Lage P, 1999, DEVELOPMENT, V126, P3149	25	206	227	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					1055	1058		10.1126/science.1055642	http://dx.doi.org/10.1126/science.1055642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11161219				2022-12-24	WOS:000166860100048
J	Gu, LQ; Cheley, S; Bayley, H				Gu, LQ; Cheley, S; Bayley, H			Capture of a single molecule in a nanocavity	SCIENCE			English	Article							STAPHYLOCOCCAL ALPHA-HEMOLYSIN; POLYMER-CHAIN; PROTEIN; PORE; ANALYTES	We describe a heptameric protein pore that has been engineered to accommodate two different cyclodextrin adapters simultaneously within the Lumen of a transmembrane beta barrel. The volume between the adapters is a cavity of similar to 4400 cubic angstroms. Analysis of single-channel recordings reveals that individual charged organic molecules can be pulled into the cavity by an electrical potential. Once trapped, an organic molecule shuttles back and forth between the adapters for hundreds of milliseconds. Such self-assembling nanostructures are of interest for the fabrication of multianalyte sensors and could provide a means to control chemical reactions.	Texas A&M Univ, Syst Hlth Sci Ctr, Dept Med Biochem & Genet, College Stn, TX 77843 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station	Bayley, H (corresponding author), Texas A&M Univ, Syst Hlth Sci Ctr, Dept Med Biochem & Genet, College Stn, TX 77843 USA.	bayley@tamu.edu		Bayley, Hagan/0000-0003-2499-6116				Bayley H, 2000, ADV MATER, V12, P139, DOI 10.1002/(SICI)1521-4095(200001)12:2<139::AID-ADMA139>3.3.CO;2-H; Braha O, 2000, NAT BIOTECHNOL, V18, P1005, DOI 10.1038/79275; Gu LQ, 2000, BIOPHYS J, V79, P1967, DOI 10.1016/S0006-3495(00)76445-9; Gu LQ, 2000, P NATL ACAD SCI USA, V97, P3959, DOI 10.1073/pnas.97.8.3959; Gu LQ, 1999, NATURE, V398, P686, DOI 10.1038/19491; Hille B., 1991, IONIC CHANNELS EXCIT; Howorka S, 2000, J AM CHEM SOC, V122, P2411, DOI 10.1021/ja993221h; Moczydlowski E., 1986, ION CHANNEL RECONSTI, P75; Movileanu L, 2000, NAT BIOTECHNOL, V18, P1091, DOI 10.1038/80295; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Olenyuk B, 1999, NATURE, V398, P796, DOI 10.1038/19740; Rebek J, 2000, CHEM COMMUN, P637, DOI 10.1039/a910339m; Rudkevich DM, 1999, EUR J ORG CHEM, V1999, P1991; Sanchez-Quesada J, 2000, J AM CHEM SOC, V122, P11757, DOI 10.1021/ja002436k; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555; Takeda N, 1999, NATURE, V398, P794, DOI 10.1038/19734; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687	18	131	160	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2001	291	5504					636	640		10.1126/science.291.5504.636	http://dx.doi.org/10.1126/science.291.5504.636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11158673				2022-12-24	WOS:000166616000039
J	Weiss, H; Bradley, RS				Weiss, H; Bradley, RS			Archaeology - What drives societal collapse?	SCIENCE			English	Editorial Material									Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; Yale Univ, Dept Near Eastern Languages & Civilizat, New Haven, CT 06520 USA; Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA	Yale University; Yale University; University of Massachusetts System; University of Massachusetts Amherst	Weiss, H (corresponding author), Yale Univ, Dept Anthropol, New Haven, CT 06520 USA.		Bradley, Raymond S/P-9358-2015	Bradley, Raymond S/0000-0002-4032-9519				Adams RMcC, 1981, HEARTLAND CITIES; Bar-Matthews M, 1999, EARTH PLANET SC LETT, V166, P85, DOI 10.1016/S0012-821X(98)00275-1; Bar-Yosef O, 2000, RADIOCARBON, V42, P23, DOI 10.1017/S0033822200053029; Belfer-Cohen, 1997, PALEORIENT, V23, P71, DOI 10.3406/paleo.1997.4653; BENNER M, 2001, INTERHEMISPHERIC CLI, P87; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; DEAN JS, 1993, THEMES SW PREHISTORY, P53; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Kolata AL, 2000, ANTIQUITY, V74, P424, DOI 10.1017/S0003598X00059512; Kozlowski SK., 1999, BAR INT SERIES, V760; Lemcke G, 1997, NATO ASI SER SER I, V49, P653; SHIMADA I, 1991, WORLD ARCHAEOL, V22, P247, DOI 10.1080/00438243.1991.9980145; Weiss H., 2000, ENV DISASTER ARCHAEO, V7, P75	13	371	420	6	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2001	291	5504					609	610		10.1126/science.1058775	http://dx.doi.org/10.1126/science.1058775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11158667				2022-12-24	WOS:000166616000033
J	Muravyova, E; Golovnin, A; Gracheva, E; Parshikov, A; Belenkaya, T; Pirrotta, V; Georgiev, P				Muravyova, E; Golovnin, A; Gracheva, E; Parshikov, A; Belenkaya, T; Pirrotta, V; Georgiev, P			Loss of insulator activity by paired Su(Hw) chromatin insulators	SCIENCE			English	Article							ENHANCER-PROMOTER INTERACTIONS; YELLOW LOCUS; DROSOPHILA; PROTEIN; TRANSCRIPTION; EXPRESSION; ELEMENT; SPECIFICATION; REPRESSION; SUPPRESSOR	Chromatin insulators are regulatory elements that block the action of transcriptional enhancers when interposed between enhancer and promoter. The Drosophila Suppressor of Hairy wing [Su(Hw)] protein binds the Su(Hw) insulator and prevents enhancer-promoter interaction by a mechanism that is not understood. We show that when two copies of the Su(Hw) insulator element, instead of a single one, are inserted between enhancer and promoter, insulator activity is neutralized and the enhancer-promoter interaction may instead be facilitated. This paradoxical phenomenon could be explained by interactions between protein complexes bound at the insulators.	Univ Geneva, Dept Zool, CH-1211 Geneva, Switzerland; Russian Acad Sci, Inst Gene Biol, Biomed Ctr Oslo, Moscow 117334, Russia; Russian Acad Sci, Inst Gene Biol, Dept Control Genet Proc, Moscow 117334, Russia	University of Geneva; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Pirrotta, V (corresponding author), Univ Geneva, Dept Zool, CH-1211 Geneva, Switzerland.	pirrotta@zoo.unige.ch		Georgiev, Pavel/0000-0002-6509-3194				CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; Cai HN, 2001, SCIENCE, V291, P493, DOI 10.1126/science.291.5503.493; Gause M, 1998, GENETICS, V149, P1393; Georgiev P, 1996, GENETICS, V142, P425; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; GEYER PK, 1987, GENE DEV, V1, P996, DOI 10.1101/gad.1.9.996; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Hagstrom K, 1996, GENE DEV, V10, P3202, DOI 10.1101/gad.10.24.3202; HOLDRIDGE C, 1991, MOL CELL BIOL, V11, P1894, DOI 10.1128/MCB.11.4.1894; JACK J, 1991, DEVELOPMENT, V113, P735; Mihaly J, 1998, CELL MOL LIFE SCI, V54, P60, DOI 10.1007/s000180050125; QIAN S, 1992, GENETICS, V131, P79; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Scott KS, 1995, EMBO J, V14, P6258, DOI 10.1002/j.1460-2075.1995.tb00316.x; Zhou JM, 1996, GENE DEV, V10, P3195, DOI 10.1101/gad.10.24.3195; Zhou JM, 1999, CELL, V99, P567, DOI 10.1016/S0092-8674(00)81546-9	18	162	168	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2001	291	5503					495	498		10.1126/science.291.5503.495	http://dx.doi.org/10.1126/science.291.5503.495			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11161206				2022-12-24	WOS:000166487500045
J	Nachury, MV; Maresca, TJ; Salmon, WG; Waterman-Storer, CM; Heald, R; Weis, K				Nachury, MV; Maresca, TJ; Salmon, WG; Waterman-Storer, CM; Heald, R; Weis, K			Importin beta is a mitotic target of the small GTPase ran in spindle assembly	CELL			English	Article							NUCLEAR-PORE COMPLEX; XENOPUS EGG EXTRACTS; KINESIN-RELATED PROTEIN; MICROTUBULE ASTERS; SELF-ORGANIZATION; BOUND RAN; NUMA; BINDING; CELL; CHROMATIN	The GTPase Ran has recently been shown to stimulate microtubule polymerization in mitotic extracts, but its mode of action is not understood. Here we show that the mitotic role of Ran is largely mediated by the nuclear transport factor importin beta. Importin beta inhibits spindle formation in vitro and in vivo and sequesters an aster promoting activity (APA) that consists of multiple, independent factors. One component of APA is the microtubule-associated protein NuMA. NuMA and other APA components are discharged from importin beta by RanGTP and induce spindle-like structures in the absence of centrosomes, chromatin, or Ran. We propose that RanGTP functions in mitosis as in interphase by locally releasing cargoes from transport factors. In mitosis, this promotes spindle assembly by organizing microtubules in the vicinity of chromosomes.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cell & Dev Biol, Berkeley, CA 94720 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; Scripps Research Institute; Scripps Research Institute	Heald, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Cell & Dev Biol, Berkeley, CA 94720 USA.	heald@socrates.berkeley.edu; kweis@uclink4.berkeley.edu	Nachury, Maxence/A-8759-2008; Nachury, Maxence/H-3695-2019; Weis, Karsten/F-5719-2011	Nachury, Maxence/0000-0003-4918-1562; Nachury, Maxence/0000-0003-4918-1562; Weis, Karsten/0000-0001-7224-925X; Salmon, Wendy/0000-0002-0036-597X; Waterman, Clare/0000-0001-6142-6775; Heald, Rebecca/0000-0001-6671-6528	NIGMS NIH HHS [GM57839, GM61804] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061804, R01GM057839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen SSL, 1999, INT REV CYTOL, V187, P51; Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; Andersen SSL, 1997, J CELL BIOL, V139, P975, DOI 10.1083/jcb.139.4.975; Azuma Y, 2000, CURR OPIN CELL BIOL, V12, P302, DOI 10.1016/S0955-0674(00)00093-4; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chi NC, 1997, J BIOL CHEM, V272, P6818, DOI 10.1074/jbc.272.10.6818; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dogterom M, 1996, J CELL BIOL, V133, P125, DOI 10.1083/jcb.133.1.125; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; GARD DL, 1992, DEV BIOL, V151, P516, DOI 10.1016/0012-1606(92)90190-R; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; GuethHallonet C, 1996, EXP CELL RES, V225, P207, DOI 10.1006/excr.1996.0171; Heald R, 2000, CELL, V102, P399, DOI 10.1016/S0092-8674(00)00044-1; Heald R, 2000, TRENDS CELL BIOL, V10, P1, DOI 10.1016/S0962-8924(99)01691-8; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; HUITOREL P, 1988, J CELL BIOL, V106, P151, DOI 10.1083/jcb.106.1.151; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; HYMAN AA, 1991, J CELL SCI, P125; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; KLEBE C, 1993, BIOCHEMISTRY-US, V32, P11923, DOI 10.1021/bi00095a023; Koepp DM, 1998, BBA-REV CANCER, V1377, pM39, DOI 10.1016/S0304-419X(97)00036-X; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; LYDERSEN BK, 1980, CELL, V22, P489, DOI 10.1016/0092-8674(80)90359-1; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matthies HJG, 1996, J CELL BIOL, V134, P455, DOI 10.1083/jcb.134.2.455; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; NICKLAS RB, 1985, J CELL BIOL, V100, P1, DOI 10.1083/jcb.100.1.1; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Palacios I, 1997, EMBO J, V16, P6783, DOI 10.1093/emboj/16.22.6783; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Saredi A, 1996, J CELL SCI, V109, P619; TANG TK, 1994, J CELL SCI, V107, P1389; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Weis K, 1998, TRENDS BIOCHEM SCI, V23, P185, DOI 10.1016/S0968-0004(98)01204-3; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 1999, J CELL SCI, V112, P2453	59	313	321	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2001	104	1					95	106		10.1016/S0092-8674(01)00194-5	http://dx.doi.org/10.1016/S0092-8674(01)00194-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163243	Bronze			2022-12-24	WOS:000166882300010
J	Orth-Gomer, K; Wamala, SP; Horsten, M; Schenck-Gustafsson, K; Schneiderman, N; Mittleman, MA				Orth-Gomer, K; Wamala, SP; Horsten, M; Schenck-Gustafsson, K; Schneiderman, N; Mittleman, MA			Marital stress worsens prognosis in women with coronary heart disease - The Stockholm Female Coronary Risk Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; SOCIAL SUPPORT; PSYCHOLOGICAL STRESS; DECISION LATITUDE; JOB STRAIN; FOLLOW-UP; HOSTILITY; NEUROENDOCRINE; MORTALITY	Context Psychosocial stress has been associated with incidence of coronary heart disease (CHD) in men, but the prognostic impact of such stress rarely has been studied in women. Objective To investigate the prognostic impact of psychosocial work stress and marital stress among women with CHD. Design and setting Population-based, prospective follow-up study conducted in the city of Stockholm, Sweden. Participants A total of 292 consecutive female patients aged 30 to 65 years (n = 279 working or cohabiting with a male partner) who were hospitalized for acute myocardial infarction or unstable angina pectoris between February 1991 and February 1994. Patients were followed up from the date of clinical examination until August 1997 (median, 4.8 years). Main Outcome Measures Recurrent coronary events, including cardiac death, acute myocardial infarction, and revascularization procedures, by marital stress (assessed using the Stockholm Marital Stress Scale, a structured interview) and by work stress (assessed using the ratio of work demand to work control). Results Among women who were married or cohabiting with a male partner (n = 187), marital stress was associated with a 2.9-fold (95% confidence interval [CI], 1.3-6.5) increased risk of recurrent events after adjustment for age, estrogen status, education level, smoking, diagnosis at index event, diabetes mellitus, systolic blood pressure, smoking, triglyceride level, high-density lipoprotein cholesterol level, and left ventricular dysfunction, Among working women (n = 200), work stress did not significantly predict recurrent coronary events (hazard ratio, 1.6; 95% CI, 0.8-3.3). Conclusions Our results indicate that marital stress but not work stress predicts poor prognosis in women aged 30 to 65 years with CHD. These findings differ from previous findings in men and suggest that specific preventive measures be tailored to the needs of women with CHD.	Karolinska Inst, Dept Publ Hlth Sci, Div Prevent Med, SE-17176 Stockholm, Sweden; Karolinska Hosp, Dept Med, Div Cardiol, S-10401 Stockholm, Sweden; Univ Miami, Behav Med Res Ctr, Dept Psychol, Miami, FL 33152 USA; Harvard Univ, Sch Publ Hlth, Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Miami; Harvard University; Beth Israel Deaconess Medical Center; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Orth-Gomer, K (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Prevent Med, Norrbacka Plan 7, SE-17176 Stockholm, Sweden.	K.Orth-Gomer@phs.ki.se	; Tanne, David/F-2560-2010	Mittleman, Murray/0000-0001-9788-7274; Tanne, David/0000-0002-6699-2220; Schenck-Gustafsson, Karin/0000-0002-3659-5101	NHLBI NIH HHS [HL45785] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045785] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Khalili F, 2000, AM J CARDIOL, V86, P211, DOI 10.1016/S0002-9149(00)00858-4; ALFREDSSON L, 1985, INT J EPIDEMIOL, V14, P378, DOI 10.1093/ije/14.3.378; ALFREDSSON L, 1997, SOCIALSTYRELSEN, P84; BERKMAN LF, 1992, ANN INTERN MED, V117, P1003, DOI 10.7326/0003-4819-117-12-1003; BLUMENTHAL JA, 1987, BRIT J MED PSYCHOL, V60, P349, DOI 10.1111/j.2044-8341.1987.tb02754.x; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Brown PC, 1998, ANN BEHAV MED, V20, P286, DOI 10.1007/BF02886378; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; EAKER ED, 1992, AM J EPIDEMIOL, V135, P854, DOI 10.1093/oxfordjournals.aje.a116381; EAKER ED, 1993, CIRCULATION, V88, P1999, DOI 10.1161/01.CIR.88.4.1999; Eaker Elaine D., 1998, Cardiology Clinics, V16, P103, DOI 10.1016/S0733-8651(05)70387-8; FRANKENHAEUSER M, 1989, J ORGAN BEHAV, V10, P321, DOI 10.1002/job.4030100404; FUKUDO S, 1992, CIRCULATION, V85, P2045, DOI 10.1161/01.CIR.85.6.2045; GILLUM RF, 1984, AM HEART J, V108, P150, DOI 10.1016/0002-8703(84)90558-1; HAMMAR N, 1991, INT J EPIDEMIOL, V20, P114, DOI 10.1093/ije/20.1.114; Horsten M, 2000, EUR HEART J, V21, P1072, DOI 10.1053/euhj.1999.2012; Horsten M, 1999, PSYCHOSOM MED, V61, P49, DOI 10.1097/00006842-199901000-00009; Horsten M, 1999, J CARDIOVASC RISK, V6, P391; ILFELD FW, 1980, J NERV MENT DIS, V168, P375, DOI 10.1097/00005053-198006000-00010; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; KARASEK R, 1981, AM J PUBLIC HEALTH, V71, P694, DOI 10.2105/AJPH.71.7.694; Kiecolt-Glaser JK, 1998, ANN NY ACAD SCI, V840, P656, DOI 10.1111/j.1749-6632.1998.tb09604.x; Knox SS, 1998, AM J CARDIOL, V82, P1192, DOI 10.1016/S0002-9149(98)00599-2; Luecken LJ, 1997, PSYCHOSOM MED, V59, P352, DOI 10.1097/00006842-199707000-00003; LUNDBERG U, 1994, SCAND J PSYCHOL, V35, P315, DOI 10.1111/j.1467-9450.1994.tb00956.x; LUNDBERG U, 1999, J OCCUP HEALTH, V4, P1; Markovitz JH, 1996, PSYCHOSOM MED, V58, P143, DOI 10.1097/00006842-199603000-00008; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; Moser V, 1996, 268 SWED NAT I PSYCH; Orth-Gomer K, 1998, EUR HEART J, V19, P1648, DOI 10.1053/euhj.1998.1190; Orth-Gomer K, 1997, Lakartidningen, V94, P635; Orth-Gomer K, 1997, WOMEN HEART DIS, P407; ORTHGOMER K, 1993, PSYCHOSOM MED, V55, P37, DOI 10.1097/00006842-199301000-00007; OrthGomer K, 1997, CIRCULATION, V95, P329; ORTHGOMER K, 1987, J CHRON DIS, V40, P949, DOI 10.1016/0021-9681(87)90145-7; ORTHGOMER K, 1979, J PSYCHOSOM RES, V23, P165, DOI 10.1016/0022-3999(79)90001-1; PEARLIN L, 1979, RES COMMUNITY MENTAL; Pike JL, 1997, PSYCHOSOM MED, V59, P447, DOI 10.1097/00006842-199707000-00015; POPE MK, 1991, PSYCHOSOM MED, V53, P386, DOI 10.1097/00006842-199107000-00004; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; SCHNALL PL, 1994, ANNU REV PUBL HEALTH, V15, P381, DOI 10.1146/annurev.pu.15.050194.002121; SHUMAKER SA, 1991, HEALTH PSYCHOL, V10, P102, DOI 10.1037/0278-6133.10.2.102; SLOAN RP, 1994, AM J CARDIOL, V74, P298, DOI 10.1016/0002-9149(94)90382-4; SMITH KE, 1999, 32 US BUR CENS POP D; Smith TW, 1999, PSYCHOSOM MED, V61, P436, DOI 10.1097/00006842-199907000-00005; SPANIER GB, 1996, J MARRIAGE FAM, P15; *STAT CORP, 1997, STAT STAT SOFTW; *STAT SWED, 1998, PA TAL KVINN MAN; Suarez EC, 1998, PSYCHOSOM MED, V60, P78, DOI 10.1097/00006842-199801000-00017; THEORELL T, 1991, INT J CARDIOL, V30, P61, DOI 10.1016/0167-5273(91)90125-9; Theorell T, 1998, AM J PUBLIC HEALTH, V88, P382, DOI 10.2105/AJPH.88.3.382; US Dept of Health and Human Services . International Classification of Diseases, 1988, INT CLASS DIS; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; vonDras DD, 1996, INT J AGING HUM DEV, V43, P199, DOI 10.2190/M0GP-7R75-AQJ6-Q17H; Wamala SP, 1999, AM J PUBLIC HEALTH, V89, P315, DOI 10.2105/AJPH.89.3.315; Wamala SP, 2000, SOC SCI MED, V51, P481, DOI 10.1016/S0277-9536(00)00006-X; *WHO REG OFF EUR, 1976, MYOC INF COMM REG RE; Williams Redford B., 1996, Cardiology Clinics, V14, P97; WOLK MJ, 1972, CIRCULATION, V45, P1125, DOI 10.1161/01.CIR.45.5.1125	60	382	392	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2000	284	23					3008	3014		10.1001/jama.284.23.3008	http://dx.doi.org/10.1001/jama.284.23.3008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	382VC	11122587	Bronze			2022-12-24	WOS:000165847200025
J	Stuphorn, V; Taylor, TL; Schall, JD				Stuphorn, V; Taylor, TL; Schall, JD			Performance monitoring by the supplementary eye field	NATURE			English	Article							ANTERIOR CINGULATE CORTEX; NEURONAL-ACTIVITY; ERROR-DETECTION; COUNTERMANDING SACCADES; NEURAL SYSTEM; MOVEMENTS; MACAQUE; THOUGHT	Intelligent behaviour requires self-control based on the consequences of actions. The countermanding task is designed to study self-control; it requires subjects to withhold planned movements in response to an imperative stop signal, which they can do with varying success. In humans, the medial frontal cortex has been implicated in the supervisory control of action(1-3). In monkeys, the supplementary eye field in the dorsomedial frontal cortex is involved in producing eye movements, but its precise function has not been clarified(4). To investigate the role of the supplementary eye field in the control of eye movements, we recorded neural activity in macaque monkeys trained to perform an eye movement countermanding task. Distinct groups of neurons were active after errors, after successful withholding of a partially prepared movement, or in association with reinforcement. These three forms of activation could not be explained by sensory or motor factors. Our results lead us to put forward the hypothesis that the supplementary eye field contributes to monitoring the context and consequences of eye movements.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA	Vanderbilt University	Schall, JD (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA.							Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; BOTVINICK MM, IN PRESS PSYCHOL REV; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; COLES MGH, 1995, ACTA PSYCHOL, V90, P129, DOI 10.1016/0001-6918(95)00020-U; DEHAENE S, 1994, PSYCHOL SCI, V5, P385; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; FALKENSTEIN M, 1995, EVOKED POTENTIAL, V96, P36, DOI 10.1016/0013-4694(94)00182-K; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GEMBA H, 1986, NEUROSCI LETT, V70, P223, DOI 10.1016/0304-3940(86)90467-2; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HANES DP, 1995, VISUAL NEUROSCI, V12, P929, DOI 10.1017/S0952523800009482; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; Heinen S. J., 1998, Society for Neuroscience Abstracts, V24, P1147; LOGAN GD, 1985, ACTA PSYCHOL, V60, P193, DOI 10.1016/0001-6918(85)90055-1; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004; Posner MI, 1998, ATTENTIVE BRAIN, P401; Sadeghpour S., 1998, Society for Neuroscience Abstracts, V24, P522; Schall J. D., 1998, Society for Neuroscience Abstracts, V24, P172; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P530, DOI 10.1152/jn.1991.66.2.530; Schall JD, 1997, CEREBR CORT, V12, P527; Schiller PH, 1998, NAT NEUROSCI, V1, P248, DOI 10.1038/693; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; [No title captured]	30	303	306	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2000	408	6814					857	860		10.1038/35048576	http://dx.doi.org/10.1038/35048576			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130724				2022-12-24	WOS:000165831300050
J	Rubin, KH; Fletcher, CH; Sherman, C				Rubin, KH; Fletcher, CH; Sherman, C			Fossiliferous Lana'i deposits formed by multiple events rather than a single giant tsunami	NATURE			English	Article							LAST INTERGLACIAL PERIOD; SEA-LEVEL; TH-230 AGES; HAWAII; CORALS; OAHU; ISLAND; WAVE; DIAGENESIS; SUBSIDENCE	Giant tsunamis, generated by submarine landslides in the Hawaiian Islands, have been thought to be responsible for the deposition of chaotic gravels high on the southern coastal slopes of the islands of Lana'i and Moloka'i, Hawaii. Here we investigate this hypothesis, using uranium-thorium dating of the Hulopoe gravel (on Lana'i) and a study of stratigraphic relationships, such as facies changes and hiatuses, within the deposit. The Hulopoe gravel contains corals of two age groups, representing marine isotope stages be and 7 (similar to 135,000 and 240,000 years ago, respectively), with significant geographical and stratigraphic ordering. We show that the Hulopoe gravel was formed by multiple depositional events, separated by considerable periods of time, thus invalidating the main premise of the 'giant wave' hypothesis. Instead, the gravels were probably deposited during interglacial periods (when sea level was relatively high) by typical Hawaiian shoreline processes such as seasonal wave patterns, storm events and possibly 'normal' tsunamis, and reached their present height by uplift: of Lana'i.	Univ Hawaii, Dept Geol & Geophys, SOEST, Honolulu, HI 96822 USA	University of Hawaii System	Rubin, KH (corresponding author), Univ Hawaii, Dept Geol & Geophys, SOEST, 2525 Correa Rd, Honolulu, HI 96822 USA.		Rubin, Kenneth H/B-3685-2008	Rubin, Kenneth H/0000-0002-8554-1337; Sherman, Clark/0000-0003-0758-7900				Bard E, 1996, GEOPHYS RES LETT, V23, P1473, DOI 10.1029/96GL01279; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; Bruckner H., 1989, ESSENER GEOGRAPHISCH, V17, P291; CHEN JH, 1986, EARTH PLANET SC LETT, V80, P241, DOI 10.1016/0012-821X(86)90108-1; Chen X., 1991, PLASMA CHEM PLASMA P, V11, P103; Cox D. C., 1985, LANAI EARTHQUAKE FEB; EDWARDS RL, 1986, EARTH PLANET SC LETT, V81, P175; Felton EA, 2000, PURE APPL GEOPHYS, V157, P1257, DOI 10.1007/s000240050025; Fletcher CH, 1996, J SEDIMENT RES, V66, P632; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; Grigg RW, 1997, MAR GEOL, V141, P11, DOI 10.1016/S0025-3227(97)00069-8; HAMELIN B, 1991, EARTH PLANET SC LETT, V106, P169, DOI 10.1016/0012-821X(91)90070-X; HARMON RS, 1983, PALAEOGEOGR PALAEOCL, V44, P41, DOI 10.1016/0031-0182(83)90004-4; HENDERSON GM, 1993, EARTH PLANET SC LETT, V115, P65, DOI 10.1016/0012-821X(93)90213-S; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Johnson C, 1994, SCI TSUNAMI HAZARDS, V12, P33; McMurtry GM, 1999, J VOLCANOL GEOTH RES, V94, P35, DOI 10.1016/S0377-0273(99)00097-9; Moore AL, 2000, GEOLOGY, V28, P247, DOI 10.1130/0091-7613(2000)028<0247:LFIOGA>2.3.CO;2; MOORE GW, 1988, GEOL SOC AM SPEC PAP, V229, P101; MOORE JG, 1984, SCIENCE, V226, P1312, DOI 10.1126/science.226.4680.1312; MOORE JG, 1984, J GEOL, V92, P752, DOI 10.1086/628910; MOORE JG, 1994, GEOL SOC AM BULL, V106, P962, DOI 10.1130/0016-7606(1994)106<0962:CDBAGW>2.3.CO;2; MOORE JG, 1987, VOLCANISM HAWAII, P85; MUHS DR, 1994, MAR GEOL, V118, P315, DOI 10.1016/0025-3227(94)90091-4; Nisbet EG, 1998, NATURE, V392, P329, DOI 10.1038/32765; RUBIN KH, IN PRESS CHEM GEOL; RUBIN KH, 1995, T AM GEOPHYS UNION, V76, pF307; SAWSON AG, 2000, PURE APPL GEOPHYS, V157, P875; Sherman CE, 1999, J SEDIMENT RES, V69, P1083, DOI 10.2110/jsr.69.1083; Smith JR, 2000, PURE APPL GEOPHYS, V157, P1097, DOI 10.1007/s000240050019; Stearns H.T., 1978, BISHOP MUSEUM B, V237, P57; Stearns H. T., 1940, HAWAII DIV HYDROGRAP, V6, P1; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; SZABO BJ, 1994, SCIENCE, V266, P93, DOI 10.1126/science.266.5182.93; WATTS AB, 1989, J GEOPHYS RES-SOLID, V94, P10473, DOI 10.1029/JB094iB08p10473; WESSEL P, 1994, J GEOPHYS RES-SOL EA, V99, P2747, DOI 10.1029/93JB02876; YOUNG RW, 1992, GEOLOGY, V20, P199, DOI 10.1130/0091-7613(1992)020<0199:CWEOTS>2.3.CO;2	37	47	49	1	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2000	408	6813					675	681		10.1038/35047008	http://dx.doi.org/10.1038/35047008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130062				2022-12-24	WOS:000165815200038
J	Labrenz, M; Druschel, GK; Thomsen-Ebert, T; Gilbert, B; Welch, SA; Kemner, KM; Logan, GA; Summons, RE; De Stasio, G; Bond, PL; Lai, B; Kelly, SD; Banfield, JF				Labrenz, M; Druschel, GK; Thomsen-Ebert, T; Gilbert, B; Welch, SA; Kemner, KM; Logan, GA; Summons, RE; De Stasio, G; Bond, PL; Lai, B; Kelly, SD; Banfield, JF			Formation of sphalerite (ZnS) deposits in natural biofilms of sulfate-reducing bacteria	SCIENCE			English	Article								Abundant, micrometer-scale, spherical aggregates of 2- to 5-nanometer-diameter sphalerite (ZnS) particles formed within natural biofilms dominated by relatively aerotolerant sulfate-reducing bacteria of the family Desulfobacteriaceae. The biofilm zinc concentration is about 10(6) times that of associated groundwater (0.09 to 1.1 parts per million line). Sphalerite also concentrates arsenic (0.01 weight %) and selenium (0.004 weight %). The almost monomineralic product results from buffering of sulfide concentrations at Low values by sphalerite precipitation. These results show how microbes control metal concentrations in groundwater- and wetland-based remediation systems and suggest biological routes for formation of some Low-temperature ZnS deposits.	Oregon State Univ, Dept Geosci, US Geol Survey, Corvallis, OR 97331 USA	Oregon State University; United States Department of the Interior; United States Geological Survey	Banfield, JF (corresponding author), Oregon State Univ, Dept Geosci, US Geol Survey, Corvallis, OR 97331 USA.		Gilbert, Pupa/A-6299-2010; Gilbert, Benjamin/E-3182-2010; Bond, Philip/N-6649-2017; Bond, Philip/C-6046-2009; Summons, Roger Everett/AAL-3789-2020	Gilbert, Pupa/0000-0002-0139-2099; Bond, Philip/0000-0002-9025-4797; Gilbert, Benjamin/0000-0003-0853-0826; Welch, Susan/0000-0002-2890-0065; Banfield, Jill/0000-0001-8203-8771				Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751; BECKING LGM, 1961, ECON GEOL, V56, P259; Benning LG, 2000, CHEM GEOL, V167, P25, DOI 10.1016/S0009-2541(99)00198-9; DEGENS ET, 1972, MINER DEPOSITA, V7, P1; Drury WJ, 1999, WATER ENVIRON RES, V71, P1244, DOI 10.2175/106143096X122375; Ehrlich HL, 1999, GEOMICROBIOL J, V16, P135, DOI 10.1080/014904599270659; Hu MA, 1998, CAN J EARTH SCI, V35, P936, DOI 10.1139/e98-041; Ledin M, 1996, EARTH-SCI REV, V41, P67, DOI 10.1016/0012-8252(96)00016-5; LOGAN GA, 2000, IN PRESS COSMOCHIM A; LUTHER GW, 1980, J SEDIMENT PETROL, V50, P1117; MILLER LP, 1950, BOYCE THOMPSON I CON, V16, P85; Minz D, 1999, APPL ENVIRON MICROB, V65, P4666; Minz D, 1999, APPL ENVIRON MICROB, V65, P4659; Nelson DC, 1996, GEOCHIM COSMOCHIM AC, V60, P3531, DOI 10.1016/0016-7037(96)00221-9; Newman DK, 1998, GEOMICROBIOL J, V15, P255, DOI 10.1080/01490459809378082; Temple KL, 1964, ECON GEOL, V59, P647, DOI DOI 10.2113/GSEC0NGE0.59.4.647; Teske A, 1998, APPL ENVIRON MICROB, V64, P2943; US Environment Protection Agency, 2000, CURR DRINK WAT STAND; VAINSHTEIN M, 1992, APPL MICROBIOL, V125, P554; Widdel F., 1992, PROKARYOTES, DOI 10.1007/978-1-4757-2191-1_2	20	465	517	14	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2000	290	5497					1744	1747		10.1126/science.290.5497.1744	http://dx.doi.org/10.1126/science.290.5497.1744			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379FY	11099408				2022-12-24	WOS:000165632400036
J	Ehleringer, JR; Casale, JF; Lott, MJ; Ford, VL				Ehleringer, JR; Casale, JF; Lott, MJ; Ford, VL			Tracing the geographical origin of cocaine	NATURE			English	Article							DEPTH CHROMATOGRAPHIC ANALYSES; SOUTH-AMERICAN; LEAVES; ILLICIT		Univ Utah, Dept Biol, Stable Isotope Ratio Facil Environm Res, Salt Lake City, UT 84112 USA; US Dept Justice, Drug Enforcement Adm, Special Testing & Res Lab, Mclean, VA 22102 USA	Utah System of Higher Education; University of Utah	Ehleringer, JR (corresponding author), Univ Utah, Dept Biol, Stable Isotope Ratio Facil Environm Res, 257 S 1400 E, Salt Lake City, UT 84112 USA.		Ehleringer, James/G-1780-2010					Ehleringer JR, 1999, FORENSIC SCI INT, V106, P27, DOI 10.1016/S0379-0738(99)00139-5; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Giuliani G, 2000, SCIENCE, V287, P631, DOI 10.1126/science.287.5453.631; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; Moore J M, 1998, Forensic Sci Rev, V10, P13; Moore JM, 1996, J CHROMATOGR A, V756, P193, DOI 10.1016/S0021-9673(96)00651-6; MOORE JM, 1994, J CHROMATOGR A, V659, P163, DOI 10.1016/0021-9673(94)85018-6; MOORE JM, 1994, J CHROMATOGR A, V674, P165, DOI 10.1016/0021-9673(94)85224-3; Roden JS, 2000, GEOCHIM COSMOCHIM AC, V64, P21, DOI 10.1016/S0016-7037(99)00195-7; Vogel J., 1993, STABLE ISOTOPES PLAN, P26; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436	11	118	123	4	50	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2000	408	6810					311	312		10.1038/35042680	http://dx.doi.org/10.1038/35042680			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099029				2022-12-24	WOS:000165296000032
J	Ims, RA; Andreassen, HP				Ims, RA; Andreassen, HP			Spatial synchronization of vole population dynamics by predatory birds	NATURE			English	Article							MICROTUS-OECONOMUS; MUSTELID PREDATORS; TRAVELING WAVES; CYCLES; HYPOTHESIS; MORTALITY; PATTERNS; MAMMALS; PHASE	Northern vole populations exhibit large-scale, spatially synchronous population dynamics(1,2). Such cases of population synchrony provide excellent opportunities for distinguishing between local intrinsic and regional extrinsic mechanisms of population regulation(3). Analyses of large-scale survey data and theoretical modelling(4-6) have indicated several plausible synchronizing mechanisms. It is difficult, however, to determine the most important one without detailed data on local demographic processes(3,7). Here we combine results from two field studies in southeastern Norway-one identifies local demographic mechanisms and landscape-level annual synchrony among 28 enclosed experimental populations and the other examines region-level multi-annual synchrony in open natural populations. Despite fences eliminating predatory mammals and vole dispersal, the growth rates of the experimental populations were synchronized and moreover, perfectly linked with vole abundance in the region. The fates of 481 radio-marked voles showed that bird predation was the synchronizing mechanism. A higher frequency of risky dispersal movements in slowly growing populations appeared to accelerate predation rate. Thus, dispersal may induce a feedback-loop between predation and population growth that enhances synchrony.	Univ Oslo, Dept Biol, Div Zool, N-0316 Oslo, Norway	University of Oslo	Ims, RA (corresponding author), NINA, Polar Environm Ctr, N-9005 Tromso, Norway.							Aars J, 1999, OIKOS, V85, P204, DOI 10.2307/3546487; Andreassen HP, 1998, J ANIM ECOL, V67, P941, DOI 10.1046/j.1365-2656.1998.6760941.x; Bjornstad ON, 1999, ECOLOGY, V80, P622, DOI 10.2307/176640; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; CLOBERT J, IN PRESS CAUSES CONS; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; HANSKI I, 1993, NATURE, V364, P232, DOI 10.1038/364232a0; HANSSON L, 1988, TRENDS ECOL EVOL, V3, P195, DOI 10.1016/0169-5347(88)90006-7; HEIKKILA J, 1994, OIKOS, V70, P245, DOI 10.2307/3545635; Ims RA, 1999, J ANIM ECOL, V68, P839, DOI 10.1046/j.1365-2656.1999.00336.x; IMS RA, 1990, OIKOS, V57, P381, DOI 10.2307/3565968; JOHANNESEN E, 1996, J MAMMAL, V78, P638; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; Korpimaki E, 1998, ECOLOGY, V79, P2448, DOI 10.2307/176834; Krebs CJ, 1996, J MAMMAL, V77, P8, DOI 10.2307/1382705; Lambin X, 1998, P ROY SOC B-BIOL SCI, V265, P1491, DOI 10.1098/rspb.1998.0462; May RM, 1999, NATURE, V398, P371, DOI 10.1038/18769; NORRDAHL K, 1995, P ROY SOC B-BIOL SCI, V261, P49, DOI 10.1098/rspb.1995.0116; Ranta E, 1997, SCIENCE, V278, P1621, DOI 10.1126/science.278.5343.1621; Ranta E, 1997, NATURE, V390, P456, DOI 10.1038/37261; REID DG, 1995, OIKOS, V73, P387, DOI 10.2307/3545963; STEEN H, 1994, ANN ZOOL FENN, V31, P271; STEEN H, 1995, OIKOS, V73, P65, DOI 10.2307/3545726; Steen H, 1996, ECOLOGY, V77, P2365, DOI 10.2307/2265738; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Wolff JO, 1997, J ANIM ECOL, V66, P1, DOI 10.2307/5959	29	181	189	0	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					194	196		10.1038/35041562	http://dx.doi.org/10.1038/35041562			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089971				2022-12-24	WOS:000165180400043
J	Letvin, NL; Bloom, BR; Hoffman, SL				Letvin, NL; Bloom, BR; Hoffman, SL			Prospects for vaccines to protect against AIDS, tuberculosis, and malaria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; CYTOTOXIC T-LYMPHOCYTES; IMMUNE-RESPONSES; DNA; IMMUNIZATION; EFFICACY; VIREMIA; VACCINATION; INDUCTION; MORTALITY	Given the scope of the worldwide health problems caused by the acquired immunodeficiency syndrome, tuberculosis, and malaria, it is imperative that vaccines be developed to prevent these infections. Recent advances in the understanding of these diseases suggest that T-lymphocyte-mediated immunity is important in containing these infections. The application of novel vaccine technologies for eliciting this type of immunity promises to provide successful vaccines for controlling the spread of these deadly infections.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Viral Pathogenesis, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Off Dean, Boston, MA 02115 USA; USN, Med Res Ctr, Malaria Dept, Silver Spring, MD USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; United States Department of Defense; United States Navy	Letvin, NL (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Viral Pathogenesis, 41 Ave Louis Pasteur,Res E 113, Boston, MA 02115 USA.	nletvin@caregroup.harvard.edu						[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Baily G V, 1980, Indian J Med Res, V72 Suppl, P1; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Bloom Barry R., 1994, P531; Blower SM, 1996, SCIENCE, V273, P497, DOI 10.1126/science.273.5274.497; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; HART PD, 1967, BRIT MED J, V1, P587, DOI 10.1136/bmj.1.5540.587; Hoffman S L, 2000, Dev Biol (Basel), V104, P121; Hoffman SL, 1998, NAT MED, V4, P1351, DOI 10.1038/3934; Hoffman SL, 1996, MALARIA VACCINE DEV; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; *JOINT UN PROGR HI, 2000, REP GLOB HIV AIDS EP; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; Letvin NL, 1998, SCIENCE, V280, P1875, DOI 10.1126/science.280.5371.1875; Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; McKinney JD, 1998, BIOMED RES REP, P51; Miller LH, 1998, NAT MED, V4, P520, DOI 10.1038/nm0598supp-520; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; *NIH, 2001, TUB VACC STAT OF THE; *NIH, 2001, BLUEPR TUB VACC DEV; NUSSENZWEIG V, 1985, CELL, V42, P401, DOI 10.1016/0092-8674(85)90093-5; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; PATARROYO ME, 1988, NATURE, V332, P158, DOI 10.1038/332158a0; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; SACHS JD, IN PRESS EC MALARIA; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sedegah M, 2000, J IMMUNOL, V164, P5905, DOI 10.4049/jimmunol.164.11.5905; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; *WHO, 1994, WHOTB97179; World Health Organization, 2000, WORLD HLTH REP 2000; Young DB, 2000, CLIN INFECT DIS, V30, pS254, DOI 10.1086/313871	39	28	29	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					606	611		10.1001/jama.285.5.606	http://dx.doi.org/10.1001/jama.285.5.606			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176867				2022-12-24	WOS:000166714200020
J	Dunne, EF; Fey, PD; Kludt, P; Reporter, R; Mostashari, F; Shillam, P; Wicklund, J; Miller, C; Holland, B; Stamey, E; Barrett, TJ; Rasheed, JK; Tenover, FC; Ribot, EM; Angulo, FJ				Dunne, EF; Fey, PD; Kludt, P; Reporter, R; Mostashari, F; Shillam, P; Wicklund, J; Miller, C; Holland, B; Stamey, E; Barrett, TJ; Rasheed, JK; Tenover, FC; Ribot, EM; Angulo, FJ			Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPANDED-SPECTRUM CEPHALOSPORINS; UNITED-STATES; ESCHERICHIA-COLI; TYPHIMURIUM; CEFOTAXIME; OUTBREAK; THERAPY; GASTROENTERITIS; ENTERITIDIS; INFANTS	Context Ceftriaxone, an expanded-spectrum cephalosporin, is an antimicrobial agent commonly used to treat severe Salmonella infections, especially in children, Ceftriaxone-resistant Salmonella infections have recently been reported in the United States, but the extent of the problem is unknown. Objectives To summarize national surveillance data for ceftriaxone-resistant Salmonella infections in the United States and to describe mechanisms of resistance. Design and Setting Case series and laboratory evaluation of human isolates submitted to the Centers for Disease Control and Prevention from 17 state and community health departments participating in the National Antimicrobial Resistance Monitoring System (NARMS) for enteric bacteria between 1996 and 1998. Patients Patients with ceftriaxone-resistant Salmonella infections between 1996 and 1998 were interviewed and isolates with decreased ceftriaxone susceptibility were further characterized. Main Outcome Measures Exposures and illness outcomes, mechanisms of resistance. Results The prevalence of ceftriaxone-resistant Salmonella was 0.1% (1 of 1326) in 1996, 0.4% (5 of 1301) in 1997, and 0.5% (7 of 1466) in 1998. Ten (77%) of the 13 patients with ceftriaxone-resistant infections were aged 18 years or younger. The patients lived in 8 states (California, Colorado, Kansas. Massachusetts, Maryland, Minnesota, New York, and Oregon). Nine (82%) of 11 patients interviewed did not take antimicrobial agents and 10 (91%) did not travel outside the United States before illness onset. Twelve of the 15 Salmonella isolates with ceftriaxone minimum inhibitory concentrations of 16 mug/mL or higher were serotype Typhimurium but these isolates had different pulsed-field gel electrophoresis patterns. Thirteen of these 15 isolates collected between 1996 and 1998 were positive for a 631-base pair polymerase chain reaction product obtained by using primers specific for the ampC gene of Citrobacter freundii. Conclusions Domestically acquired ceftriaxone-resistant Salmonella has emerged in the United States. Most ceftriaxone-resistant Salmonella isolates had similar AmpC plasmid-mediated resistance.	Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Bacterial & Mycot Dis, Foodborne & Diarrheal Dis Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Angulo, FJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Bacterial & Mycot Dis, Foodborne & Diarrheal Dis Branch, 1600 Clifton Rd,MS A-38, Atlanta, GA 30333 USA.	FAngulo@cdc.gov						ANDERSON ES, 1987, J HYG LONDON, V78, P297; BACHMAN BJ, 1987, ESCHERICHIA COLI SAL, P1197; Barnaud G, 1998, ANTIMICROB AGENTS CH, V42, P2352, DOI 10.1128/AAC.42.9.2352; Bradford PA, 1998, ANTIMICROB AGENTS CH, V42, P1980, DOI 10.1128/AAC.42.8.1980; Bradford PA, 1999, J ANTIMICROB CHEMOTH, V44, P607, DOI 10.1093/jac/44.5.607; BRYAN JP, 1992, ANTIMICROB AGENTS CH, V36, P949, DOI 10.1128/AAC.36.5.949; *CDCP, 2000, FOODN 1998 WEB SIT; *CDCP, 1998, STAND MOL SUBT FOODB; CHERUBIN CE, 1986, ARCH INTERN MED, V146, P2149, DOI 10.1001/archinte.146.11.2149; Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703; *FOOD DRUG ADM USD, 1998, NAT ANT RES MON PROG; Gazouli M, 1998, J ANTIMICROB CHEMOTH, V41, P119, DOI 10.1093/jac/41.1.119; Glynn MK, 1998, NEW ENGL J MED, V338, P1333, DOI 10.1056/NEJM199805073381901; HAMMAMI A, 1991, EUR J CLIN MICROBIOL, V10, P641, DOI 10.1007/BF01975816; Herikstad H, 1997, PEDIATR INFECT DIS J, V16, P904, DOI 10.1097/00006454-199709000-00015; HOLMBERG SD, 1987, REV INFECT DIS, V9, P1065; Horton JM, 1999, CLIN INFECT DIS, V29, P1348, DOI 10.1086/313476; LEE CKK, 1995, DIAGN MICR INFEC DIS, V22, P231, DOI 10.1016/0732-8893(95)00081-K; LEE LA, 1994, J INFECT DIS, V170, P128, DOI 10.1093/infdis/170.1.128; M'Zali FH, 1997, J ANTIMICROB CHEMOTH, V40, P823, DOI 10.1093/jac/40.6.823; MATTHEW M, 1975, J GEN MICROBIOL, V88, P169, DOI 10.1099/00221287-88-1-169; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; MOOSDEEN F, 1989, J ANTIMICROB CHEMOTH, V23, P797, DOI 10.1093/jac/23.5.797; Pitout JDD, 1998, ANTIMICROB AGENTS CH, V42, P1350, DOI 10.1128/AAC.42.6.1350; SANDERS CC, 1993, INFECT DIS CLIN N AM, V7, P411; Shannon K, 1998, LANCET, V352, P490, DOI 10.1016/S0140-6736(05)79231-X; Sinnett D, 1998, BIOTECHNIQUES, V24, P752, DOI 10.2144/98245bm12; Sirinavin S, 1999, CLIN INFECT DIS, V29, P1151, DOI 10.1086/313469; STUTMAN HR, 1994, PEDIATR ANN, V23, P538, DOI 10.3928/0090-4481-19941001-07; Tassios PT, 1999, J CLIN MICROBIOL, V37, P3774, DOI 10.1128/JCM.37.11.3774-3777.1999; TI TY, 1985, ANTIMICROB AGENTS CH, V28, P540, DOI 10.1128/AAC.28.4.540; TORREY S, 1986, J PEDIATR-US, V108, P718, DOI 10.1016/S0022-3476(86)81050-2; *US FDA, 2000, PROP FRAM EV ASS HUM; Wayne P.A, 1997, PERF VOL ANT SUSC FL, Vsixth; WINOKUR PL, 2000, ANTIMICROB AGENTS CH, V44, P1	35	195	202	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2000	284	24					3151	3156		10.1001/jama.284.24.3151	http://dx.doi.org/10.1001/jama.284.24.3151			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385FZ	11135779	Bronze			2022-12-24	WOS:000165994100033
J	Yoshida, Y; Tanaka, S; Umemori, H; Minowa, O; Usui, M; Ikematsu, N; Hosoda, E; Imamura, T; Kuno, J; Yamashita, T; Miyazono, K; Noda, M; Noda, T; Yamamoto, T				Yoshida, Y; Tanaka, S; Umemori, H; Minowa, O; Usui, M; Ikematsu, N; Hosoda, E; Imamura, T; Kuno, J; Yamashita, T; Miyazono, K; Noda, M; Noda, T; Yamamoto, T			Negative regulation of BMP/Smad signaling by Tob in osteoblasts	CELL			English	Article							NERVE GROWTH-FACTOR; BONE-FORMATION; TOB/BTG1 FAMILY; PROTEIN; GENE; SMAD; IDENTIFICATION; COMPONENT; CLONING; BETA	Bone morphogenetic protein (BMP) controls osteoblast proliferation and differentiation through Smad proteins. Here we show that Tob, a member of the emerging family of antiproliferative proteins, is a negative regulator of BMP/Smad signaling in osteoblasts. Mice carrying a targeted deletion of the tob gene have a greater bone mass resulting from increased numbers of osteoblasts. Orthotopic bone formation in response to BMP2 is elevated in tob-deficient mice. Overproduction of Tob represses BMP2-induced, Smad-mediated transcriptional activation. Finally, Tob associates with receptor-regulated Smads (Smad1, 5, and 8) and colocalizes with these Smads in the nuclear bodies upon BMP2 stimulation. The results indicate that Tob negatively regulates osteoblast proliferation and differentiation by suppressing the activity of the receptor-regulated Smad proteins.	Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 113865, Japan; Inst Canc Res, Dept Cell Biol, Toshima Ku, Tokyo 1708455, Japan; Inst Canc Res, Dept Biochem, Toshima Ku, Tokyo 1708455, Japan; Tokyo Med & Dent Univ, Inst Med Res, Dept Mol Pharmacol, Chiyoda Ku, Tokyo 1010062, Japan	University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU)	Yamamoto, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 1088639, Japan.	tyamamot@ims.u-tokyo.ac.jp	Minowa, Osamu/AAM-1238-2020; Tanaka, Shinya/D-3586-2011; Tanaka, Sakae/Y-3061-2019; Noda, Tetsuo/B-1667-2016	Tanaka, Sakae/0000-0001-9210-9414; Usui, Michihiko/0000-0002-5208-1848; Umemori, Hisashi/0000-0001-7198-2062				Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bogdan JA, 1998, BIOCHEM J, V336, P471, DOI 10.1042/bj3360471; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; DENIS CL, 1984, GENETICS, V108, P833; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Eriebacher Adrian, 1995, Cell, V80, P371; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; GhoshChoudhury N, 1996, ENDOCRINOLOGY, V137, P331, DOI 10.1210/en.137.1.331; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Komori T, 1998, CURR OPIN GENET DEV, V8, P494, DOI 10.1016/S0959-437X(98)80123-8; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MALLUCHE HH, 1982, CALCIFIED TISSUE INT, V34, P439, DOI 10.1007/BF02411282; MARKS SC, 1989, AM J MED GENET, V34, P43, DOI 10.1002/ajmg.1320340110; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Matsuda S, 1996, ONCOGENE, V12, P705; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Pardali E, 2000, J BIOL CHEM, V275, P3552, DOI 10.1074/jbc.275.5.3552; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Rouault JP, 1998, J BIOL CHEM, V273, P22563, DOI 10.1074/jbc.273.35.22563; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; ten Dijke P, 2000, TRENDS BIOCHEM SCI, V25, P64, DOI 10.1016/S0968-0004(99)01519-4; TEZUKA K, 1992, BIOCHEM BIOPH RES CO, V186, P911, DOI 10.1016/0006-291X(92)90832-6; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805; Yoshida Y, 1997, GENE, V191, P109, DOI 10.1016/S0378-1119(97)00049-8	42	259	279	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2000	103	7					1085	1097		10.1016/S0092-8674(00)00211-7	http://dx.doi.org/10.1016/S0092-8674(00)00211-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163184	Bronze			2022-12-24	WOS:000166040600011
J	Tomilin, A; Remenyi, A; Lins, K; Bak, H; Leidel, S; Vriend, G; Wilmanns, M; Scholer, HR				Tomilin, A; Remenyi, A; Lins, K; Bak, H; Leidel, S; Vriend, G; Wilmanns, M; Scholer, HR			Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration	CELL			English	Article							CELL-SPECIFIC COACTIVATOR; BINDING TRANSCRIPTION FACTORS; HEAVY-CHAIN PROMOTER; DNA-BINDING; CRYSTAL-STRUCTURE; DOMAIN; OCT-4; PROTEINS; COMPLEX; EXPRESSION	POU domain proteins contain a bipartite DNA binding domain divided by a flexible linker that enables them to adopt various monomer configurations on DNA. The versatility of POU protein operation is additionally conferred at the dimerization level. The POU dimer formed on the PORE (ATTTGAAATGCAAAT) can recruit the transcriptional coactivator OBF-1, whereas POU dimers formed on the consensus MORE (ATGCATATG CAT) or on MOREs from immunoglobulin heavy chain promoters (AT[G/A][C/A]ATATGCAA) fail to interact. An interaction with OBF-1 is precluded since the same Oct-1 residues that form the MORE dimerization interface are also used for OBF-1/Oct-1 interactions on the PORE. Our findings provide a paradigm of how specific POU dimer assemblies can differentially recruit a coregulatory activity with distinct transcriptional readouts.	Univ Penn, New Bolton Ctr, Sch Vet Med,Dept Anim Biol, Ctr Anim Transgenesis & Germ Cells Res, Kennett Square, PA 19348 USA; European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Biocomp Programme, D-69117 Heidelberg, Germany; DESY, EMBL, Hamburg Outstn, D-2263 Hamburg, Germany	University of Pennsylvania; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Scholer, HR (corresponding author), Univ Penn, New Bolton Ctr, Sch Vet Med,Dept Anim Biol, Ctr Anim Transgenesis & Germ Cells Res, Kennett Square, PA 19348 USA.		, HS/AAB-4434-2019; Remenyi, Attila/N-1345-2016; Vriend, Gert/D-6730-2011; Tomilin, Alexey/AAK-3068-2021; Tomilin, Alexey N/C-3361-2014; Leidel, Sebastian/K-9507-2019; Tomilin, Alexey/AAA-8774-2022; Vriend, G./H-8112-2014	, HS/0000-0003-2643-5136; Tomilin, Alexey N/0000-0002-1137-7167; Leidel, Sebastian/0000-0002-0523-6325; Tomilin, Alexey/0000-0002-1137-7167; Remenyi, Attila/0000-0002-8345-1311; Bak, Hanne/0000-0001-9080-4667; Wilmanns, Matthias/0000-0002-4643-5435				Babb R, 1997, MOL CELL BIOL, V17, P7295, DOI 10.1128/MCB.17.12.7295; BERGMAN Y, 1984, P NATL ACAD SCI-BIOL, V81, P7041, DOI 10.1073/pnas.81.22.7041; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Brehm A, 1999, MOL CELL BIOL, V19, P2635; Brehm A, 1997, MOL CELL BIOL, V17, P154, DOI 10.1128/MCB.17.1.154; Brehm A, 1998, APMIS, V106, P114, DOI 10.1111/j.1699-0463.1998.tb01326.x; Cepek KL, 1996, GENE DEV, V10, P2079, DOI 10.1101/gad.10.16.2079; Chasman D, 1999, GENE DEV, V13, P2650, DOI 10.1101/gad.13.20.2650; Gstaiger M, 1996, EMBO J, V15, P2781, DOI 10.1002/j.1460-2075.1996.tb00638.x; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; KEMLER I, 1989, EMBO J, V8, P2001, DOI 10.1002/j.1460-2075.1989.tb03607.x; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; LEBOWITZ JH, 1989, GENE DEV, V3, P1625, DOI 10.1101/gad.3.10.1625; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; LUO Y, 1995, MOL CELL BIOL, V15, P4115; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pesce M, 2000, MOL REPROD DEV, V55, P452, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;452::AID-MRD14&gt;3.0.CO;2-S; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; POELLINGER L, 1989, NATURE, V337, P573, DOI 10.1038/337573a0; Rhee JM, 1998, J BIOL CHEM, V273, P34196, DOI 10.1074/jbc.273.51.34196; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Sauter P, 1998, MOL CELL BIOL, V18, P7397, DOI 10.1128/MCB.18.12.7397; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Stevens S, 2000, J IMMUNOL, V164, P5306, DOI 10.4049/jimmunol.164.10.5306; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; SYLVESTER I, 1994, NUCLEIC ACIDS RES, V22, P901, DOI 10.1093/nar/22.6.901; VERRIJZER CP, 1992, EMBO J, V11, P4993, DOI 10.1002/j.1460-2075.1992.tb05606.x; VERRIJZER CP, 1993, BIOCHIM BIOPHYS ACTA, V1173, P1, DOI 10.1016/0167-4781(93)90237-8; VOSS JW, 1991, GENE DEV, V5, P1309, DOI 10.1101/gad.5.7.1309	37	107	111	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 8	2000	103	6					853	864		10.1016/S0092-8674(00)00189-6	http://dx.doi.org/10.1016/S0092-8674(00)00189-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136971	Bronze			2022-12-24	WOS:000165801300005
J	Angus, DC; Kelley, MA; Schmitz, RJ; White, A; Popovich, J				Angus, DC; Kelley, MA; Schmitz, RJ; White, A; Popovich, J		Comm Manpower Pulm Critical Care	Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease - Can we meet the requirements of an aging population?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE; HEALTH-CARE; PHYSICIAN WORKFORCE; UNITED-STATES; INTERNATIONAL COMPARISONS; RESOURCE UTILIZATION; MEDICARE; OUTCOMES; SURGERY; SYSTEM	Context Two important areas of medicine, care of the critically ill and management of pulmonary disease, are likely to be influenced by the aging of the US population. Objective To estimate current and future requirements for adult critical care and pulmonary medicine physicians in the United States. Design, Setting, and Participants Analysis of existing population, patient, and hospital data sets and prospective, nationally representative surveys of intensive care unit (ICU) directors (n=393) and critical care specialists (intensivists) and pulmonary specialists (pulmonologists) (n=421), conducted from 1996 to 1999. Main Outcome Measures Influence of patient, physician, regional, hospital, and payer characteristics on current practice patterns; forecasted future supply of and demand for specialist care through 2030. Separate models for critical care and pulmonary disease. Base-case projections with sensitivity analyses to estimate the impact of future changes in training and retirement, disease prevalence and management, and health care reform initiatives. Results In 1997, intensivists provided care to 36.8% of all ICU patients, Care in the ICU was provided more commonly by intensivists in regions with high managed care penetration, The current ratio of supply to demand is forecast to remain in rough equilibrium until 2007, Subsequently, demand will grow rapidly while supply will remain near constant, yielding a shortfall of specialist hours equal to 22% of demand by 2020 and 35% by 2030, primarily because of the aging of the US population. Sensitivity analyses suggest that the spread of current health care reform initiatives will either have no effect or worsen this shortfall. A shortfall of pulmonologist time will also occur before 2007 and increase to 35% by 2020 and 46% by 2030, Conclusions We forecast that the proportion of care provided by intensivists and pulmonologists in the United States will decrease below current standards in less than 10 years. While current health care reform initiatives and modification of existing practice patterns may temporarily forestall this problem, most anticipated effects are minor in comparison with the growing disease burden created by the aging US population.	Univ Pittsburgh, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA 15213 USA; Henry Ford Hosp, Dept Med, Detroit, MI 48202 USA; ABT Associates Inc, Math Policy Res, Cambridge, MA 02138 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Henry Ford Health System; Henry Ford Hospital; ABT Associates; Mathematica	Angus, DC (corresponding author), Univ Pittsburgh, Dept Anesthesiol & Crit Care Med, Room 604,Scaife Hall,200 Lothrop St, Pittsburgh, PA 15213 USA.	angusdc@anes.upmc.edu	Angus, Derek C/E-9671-2012					*AG HLTH CAR POL R, 1996, HEALTHC COST UT PROJ; Akaike H., 1998, P 2 INT S INF THEOR, DOI DOI 10.1007/978-1-4612-1694-0_15; Amemiya T., 1985, ADV ECONOMETRICS; Angus DC, 1997, CRIT CARE CLIN, V13, P389, DOI 10.1016/S0749-0704(05)70317-1; Angus DC, 1996, JAMA-J AM MED ASSOC, V276, P1075, DOI 10.1001/jama.276.13.1075; Bion JF, 1998, INTENS CARE MED, V24, P372, DOI 10.1007/s001340050584; Butler Margaret A., 1993, RURAL URBAN CONTINUU; CALLAHAN D, 1998, FALSE HOPE WHY AM QU; Carson SS, 1996, JAMA-J AM MED ASSOC, V276, P322, DOI 10.1001/jama.276.4.322; CHELLURI L, 1992, CRIT CARE MED, V20, P757, DOI 10.1097/00003246-199206000-00010; CHELLURI L, 1995, ARCH INTERN MED, V155, P1013, DOI 10.1001/archinte.155.10.1013; Collett D., 1994, MODELING SURVIVAL DA; COOPER RA, 1995, JAMA-J AM MED ASSOC, V274, P1534, DOI 10.1001/jama.274.19.1534; *COUNC GRAD MED ED, 1996, 8US DEP HHS COUNC GR; *COUNC GRAD MED ED, 1994, REC IMPR ACC HLTH CA; Cox D. R., 1984, ANAL SURVIVAL DATA; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Fuchs VR, 1999, HEALTH AFFAIR, V18, P11, DOI 10.1377/hlthaff.18.1.11; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; Guntupalli KK, 1996, INTENS CARE MED, V22, P625, DOI 10.1007/BF01709737; Hanson CW, 1999, CRIT CARE MED, V27, P270, DOI 10.1097/00003246-199902000-00030; Hart IG, 1997, HEALTH AFFAIR, V16, P55, DOI 10.1377/hlthaff.16.1.55; HINES FK, 1975, AER272 USDA EC RES S; *HLTH RES SERV ADM, 1991, HLTH PERS US; Iglehart JK, 1999, NEW ENGL J MED, V340, P327, DOI 10.1056/NEJM199901283400424; JONASSON O, 1995, JAMA-J AM MED ASSOC, V274, P731; KVETAN V, 1997, INT PERSPECTIVES CRI; LOHR KN, 1996, NATIONS PHYSICIAN WO; Manthous CA, 1997, MAYO CLIN PROC, V72, P391, DOI 10.4065/72.5.391; Meyer GS, 1996, JAMA-J AM MED ASSOC, V276, P689, DOI 10.1001/jama.276.9.689; MILLER RH, 1994, JAMA-J AM MED ASSOC, V271, P1512, DOI 10.1001/jama.271.19.1512; Multz AS, 1998, AM J RESP CRIT CARE, V157, P1468, DOI 10.1164/ajrccm.157.5.9708039; Neilson EG, 1997, J AM SOC NEPHROL, V8, pS1; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; RANDOLPH L, 1997, PHYSICIAN CHARACTERI; Reinhardt UE, 1999, JAMA-J AM MED ASSOC, V281, P462, DOI 10.1001/jama.281.5.462; Rivo ML, 1996, NEW ENGL J MED, V334, P892, DOI 10.1056/NEJM199604043341405; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; SCHROEDER SA, 1994, INQUIRY-J HEALTH CAR, V31, P266; SCHROEDER SA, 1993, NEW ENGL J MED, V328, P961, DOI 10.1056/NEJM199304013281312; SCHWARTZ WB, 1988, NEW ENGL J MED, V318, P892, DOI 10.1056/NEJM198804073181405; STEINWACHS DM, 1986, NEW ENGL J MED, V314, P217, DOI 10.1056/NEJM198601233140406; TARLOV AR, 1995, JAMA-J AM MED ASSOC, V274, P1558, DOI 10.1001/jama.274.19.1558; Theil H., 1971, PRINCIPLES ECONOMETR; Vladeck BC, 1999, NEW ENGL J MED, V340, P1503, DOI 10.1056/NEJM199905133401911; Weiner DM, 1997, UROLOGY, V49, P335, DOI 10.1016/S0090-4295(96)00492-X; WEINER JP, 1994, JAMA-J AM MED ASSOC, V272, P222; White J, 1999, HEALTH AFFAIR, V18, P63, DOI 10.1377/hlthaff.18.1.63; 1997, JAMA, V278, P775	49	716	737	2	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2000	284	21					2762	2770		10.1001/jama.284.21.2762	http://dx.doi.org/10.1001/jama.284.21.2762			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377JB	11105183	Bronze			2022-12-24	WOS:000165509500031
J	Henney, JE				Henney, JE			Drug product problem reports	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	22	25	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2000	284	21					2711	2711		10.1001/jama.284.21.2711-c	http://dx.doi.org/10.1001/jama.284.21.2711-c			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377JB	11105160				2022-12-24	WOS:000165509500007
J	Ohnishi, K; Yoshida, H; Shigeno, K; Nakamura, S; Fujisawa, S; Naito, K; Shinjo, K; Fujita, Y; Matsui, H; Takeshita, A; Sugiyama, S; Satoh, H; Terada, H; Ohno, R				Ohnishi, K; Yoshida, H; Shigeno, K; Nakamura, S; Fujisawa, S; Naito, K; Shinjo, K; Fujita, Y; Matsui, H; Takeshita, A; Sugiyama, S; Satoh, H; Terada, H; Ohno, R			Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia	ANNALS OF INTERNAL MEDICINE			English	Article							REMISSION	Background: Recently, arsenic trioxide has increasingly been used for relapsed acute promyelocytic leukemia, However, it is known to have several adverse effects, including acute cardiac toxicities. Objective: To determine cardiac toxicities resulting from arsenic trioxide therapy in patients with relapsed or refractory acute promyelocytic leukemia. Design: Phase II clinical prospective cohort study. Setting: A university hospital in Hamamatsu, Japan. Patients: 8 patients with relapsed acute promyelocytic leukemia Intervention: Arsenic trioxide, 0.15 mg/kg of body weight, administered daily by 2-hour infusion for a maximum of 60 days, Measurements: Continuous monitoring with ambulatory electrocardiography, Results: Five patients (63%) achieved complete remission. During induction therapy with arsenic trioxide, prolonged QT intervals were observed in all patients. Ventricular premature contractions were noticed during 8 of 12 courses of therapy. Four patients developed nonsustained ventricular tachycardia and required treatment with antiarrhythmic agents. Conclusions: Cardiac toxicity occurs during arsenic trioxide therapy in patients with acute promyelocytic leukemia. Such patients should be monitored for prolonged QT intervals and ventricular arrhythmia.	Hamamatsu Univ Sch Med, Dept Med 3, Hamamatsu, Shizuoka 4313192, Japan; Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan	Hamamatsu University School of Medicine; Aichi Cancer Center	Ohnishi, K (corresponding author), Hamamatsu Univ Sch Med, Dept Med 3, 3600 Handa Cho, Hamamatsu, Shizuoka 4313192, Japan.	kohnishi@hama-med.ac.jp						Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; GOLDSMITH S, 1980, NEW ENGL J MED, V303, P1096, DOI 10.1056/NEJM198011063031905; Huang SY, 1998, BRIT J HAEMATOL, V103, P1092, DOI 10.1046/j.1365-2141.1998.01079.x; KLAASSEN CD, 1996, GOODMAN GILMANS PHAR, P1659; LITTLE RE, 1990, PACE, V13, P164, DOI 10.1111/j.1540-8159.1990.tb05066.x; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; STPETERY J, 1970, AM J DIS CHILD, V120, P367, DOI 10.1001/archpedi.1970.02100090141021	9	144	153	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 5	2000	133	11					881	885		10.7326/0003-4819-133-11-200012050-00012	http://dx.doi.org/10.7326/0003-4819-133-11-200012050-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378LL	11103058				2022-12-24	WOS:000165585800007
J	Hasegawa, RP; Blitz, AM; Geller, NL; Goldberg, ME				Hasegawa, RP; Blitz, AM; Geller, NL; Goldberg, ME			Neurons in monkey prefrontal cortex that track past or predict future performance	SCIENCE			English	Article							DELAYED-RESPONSE TASK; WORKING-MEMORY; SINGLE NEURONS; DOPAMINE; PRIMATE; LESIONS; FIELDS	Although frontal cortex is thought to be important in controlling behavior across Long periods of time, most studies of this area concentrate on neuronal responses instantaneously relevant to the current task. In order to investigate the relationship of frontal activity to behavior over Longer time periods, we trained rhesus monkeys on a difficult oculomotor task. Their performance fluctuated during the day, and the activity of prefrontal neurons, even measured while the monkeys waited for the targets to appear at the beginning of each set of trials, correlated with performance in a probabilistic rather than a determinist manner: neurons reflected past or predicted future performance, much more than they reflected current performance. We suggest that this activity is related to processes such as arousal or motivation that set the tone for behavior rather than controlling it on a millisecond basis, and could result from ascending pathways that utilize slow, second-messenger synaptic processes.	NEI, Sensorimotor Res Lab, Bethesda, MD 20892 USA; NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA; NHLBI, Off Biostat Res, Bethesda, MD 20892 USA; Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Georgetown University	Hasegawa, RP (corresponding author), NEI, Sensorimotor Res Lab, Bldg 10, Bethesda, MD 20892 USA.		Hasegawa, Ryohei/Q-4296-2016	Hasegawa, Ryohei/0000-0001-9102-0434; Blitz, Ari/0000-0002-6763-2112				ARNSTEN AFT, 1984, BRAIN RES, V306, P9, DOI 10.1016/0006-8993(84)90351-2; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Collins P, 1998, J COGNITIVE NEUROSCI, V10, P332, DOI 10.1162/089892998562771; Dorris MC, 2000, J NEUROSCI, V20; FUSTER JM, 1989, PREFONTAL CORTEX; Hasegawa Ryohei, 1999, Society for Neuroscience Abstracts, V25, P366; Levy R, 1999, J NEUROSCI, V19, P5149; *NAT EYE I AN CAR, 1996, GUID CAR US LAB AN; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; PETRIDES M, 1995, J NEUROSCI, V15, P359; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Sawaguchi T, 1998, J NEUROPHYSIOL, V80, P2200, DOI 10.1152/jn.1998.80.4.2200; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; SIEGELBAUM S, 1999, PRINCIPLES NEURAL SC, P229; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795, DOI 10.1152/jn.1997.78.5.2795; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	19	52	53	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2000	290	5497					1786	1789		10.1126/science.290.5497.1786	http://dx.doi.org/10.1126/science.290.5497.1786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379FY	11099421				2022-12-24	WOS:000165632400049
J	Papavasiliou, FN; Schatz, DG				Papavasiliou, FN; Schatz, DG			Cell-cycle-regulated DNA double-strand breaks in somatic hypermutation of immunoglobulin genes	NATURE			English	Article							HEAVY-CHAIN LOCUS; SACCHAROMYCES-CEREVISIAE; MISMATCH REPAIR; RECOMBINATION; ANTIBODY; TRANSCRIPTION; DELETIONS; SEQUENCES; PATHWAYS; RECEPTOR	Targeted hypermutation of immunoglobulin variable region genes occurs in B cells during an immune response(1), and gives rise to families of related mutant antibodies which are then selected for their binding affinity to the immunizing antigen(2). Somatic hypermutation predominantly generates point mutations, many of which occur at specific residues (hotspots)(3). The reaction has been linked to transcription and requires the presence of immunoglobulin enhancers(4-6), but replacement of the variable gene by heterologous sequences, or the variable region promoter by a heterologous promoter, does not interfere with the mutation process(7,8). Here we show the existence of abundant DNA double-strand breaks (DSBs) in hypermutating sequences. Generation of the DSBs is coupled to transcription, enhancer-dependent, and correlates with the appearance of nearby mutations. Furthermore, the DSBs are cell-cycle restricted, being found almost exclusively in cells that have completed, or nearly completed, DNA replication. We propose a model for somatic hypermutation in which mutations are introduced into the DNA during repair of DSBs by homologous recombination. The finding of DSBs during somatic hypermutation may help to explain the chromosomal translocations found in some B-cell tumours.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Schatz, DG (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, Box 208011,310 Cedar St, New Haven, CT 06520 USA.	david.schatz@yale.edu	Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176				BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Goossens T, 1998, P NATL ACAD SCI USA, V95, P2463, DOI 10.1073/pnas.95.5.2463; Goyenechea B, 1997, EMBO J, V16, P3987, DOI 10.1093/emboj/16.13.3987; Hendrickson EA, 1997, AM J HUM GENET, V61, P795, DOI 10.1086/514895; Holbeck SL, 1997, GENETICS, V147, P1017; JEGGO PA, 1990, MUTAT RES, V239, P1, DOI 10.1016/0165-1110(90)90028-A; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Kenter AL, 1999, J EXP MED, V190, P307, DOI 10.1084/jem.190.3.307; Klein U, 1998, IMMUNOL REV, V162, P261; Lo AKF, 1997, ANN NY ACAD SCI, V815, P432, DOI 10.1111/j.1749-6632.1997.tb52095.x; McGill CB, 1998, GENETICS, V148, P1525; Neuberger MS, 1998, IMMUNOL REV, V162, P107, DOI 10.1111/j.1600-065X.1998.tb01434.x; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; STRATHERN JN, 1995, GENETICS, V140, P965; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; TumasBrundage K, 1997, J EXP MED, V185, P239, DOI 10.1084/jem.185.2.239; Vignali DAA, 1996, J EXP MED, V183, P2097, DOI 10.1084/jem.183.5.2097; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; WEISS S, 1987, EMBO J, V6, P927, DOI 10.1002/j.1460-2075.1987.tb04840.x; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; YELAMOS J, 1995, NATURE, V376, P225	30	226	230	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2000	408	6809					216	221		10.1038/35041599	http://dx.doi.org/10.1038/35041599			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089977				2022-12-24	WOS:000165180400049
J	Friedman, MS; Powell, KE; Hutwagner, L; Graham, LM; Teague, WG				Friedman, MS; Powell, KE; Hutwagner, L; Graham, LM; Teague, WG			Impact of changes in transportation and commuting behaviors during the 1996 Summer Olympic Games in Atlanta on air quality and childhood asthma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENVIRONMENTAL-FACTORS; HOSPITAL ADMISSIONS; RESPIRATORY HEALTH; UNITED-KINGDOM; MEXICO-CITY; POLLUTION; CHILDREN; OZONE; PREVALENCE; MORTALITY	Context Vehicle exhaust is a major source of ozone and other air pollutants. Although high ground-level ozone pollution is associated with transient increases in asthma morbidity, the impact of citywide transportation changes on air quality and childhood asthma has not been studied. The alternative transportation strategy implemented during the 1996 Summer Olympic Games in Atlanta, Ga, provided such an opportunity. Objective To describe traffic changes in Atlanta, Ca, during the 1996 Summer Olympic Games and concomitant changes in air quality and childhood asthma events. Design Ecological study comparing the 17 days of the Olympic Games (July 19-August 4, 1996) to a baseline period consisting of the 4 weeks before and 4 weeks after the Olympic Games. Setting and Subjects Children aged 1 to 16 years who resided in the 5 central counties of metropolitan Atlanta and whose data were captured in 1 of 4 databases. Main Outcome Measures Citywide acute care visits and hospitalizations for asthma (asthma events) and nonasthma events, concentrations of major air pollutants, meteorological variables, and traffic counts. Results During the Olympic Games, the number of asthma acute care events decreased 41.6% (4.23 vs 2.47 daily events) in the Georgia Medicaid claims file, 44.1% (1.36 vs 0.76 daily events) in a health maintenance organization database, 11.1% (4.77 vs 4.24 daily events) in 2 pediatric emergency departments, and 19.1% (2.04 vs 1.65 daily hospitalizations) in the Georgia Hospital Discharge Database. The number of nonasthma acute care events in the 4 databases changed -3.1%, +1.3%, -2.1%, and +1.0%, respectively. In multivariate regression analysis, only the reduction in asthma events recorded in the Medicaid database was significant (relative risk, 0.48; 95% confidence interval, 0.44-0.86). Peak daily ozone concentrations decreased 27.9%, from 81.3 ppb during the baseline period to 58.6 ppb during the Olympic Games (P<.001). Peak weekday morning traffic counts dropped 22.5% (P<.001). Traffic counts were significantly correlated with that day's peak ozone concentration (average r=0.36 for all 4 roads examined). Meteorological conditions during the Olympic Games did not differ substantially from the baseline period. Conclusions Efforts to reduce downtown traffic congestion in Atlanta during the Olympic Games resulted in decreased traffic density, especially during the critical morning period. This was associated with a prolonged reduction in ozone pollution and significantly lower rates of childhood asthma events. These data provide support for efforts to reduce air pollution and improve health via reductions in motor vehicle traffic.	Georgia Div Publ Hlth, Epidem Intelligence Serv, Atlanta, GA USA; Georgia Div Publ Hlth, Chron Dis Injury & Environm Epidemiol Sect, Epidemiol & Prevent Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA USA; Morehouse Sch Med, Dept Pediat, Atlanta, GA 30310 USA; Egleston Childrens Hosp, Div Pediat Pulm & Crit Care, Atlanta, GA USA; Georgia Pediat Pulm Associates, Atlanta, GA USA; Emory Univ, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Morehouse School of Medicine; Emory University	Friedman, MS (corresponding author), Ctr Dis Control & Prevent, Air Pollut & Resp Hlth Branch, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.	mff7@cdc.gov						Abramson M, 1996, J ASTHMA, V33, P189, DOI 10.3109/02770909609054551; ABRAMSON MJ, 1995, MED J AUSTRALIA, V163, P542, DOI 10.5694/j.1326-5377.1995.tb124724.x; Anderson HR, 1996, BMJ-BRIT MED J, V312, P665; ANDERSON HR, 1989, THORAX, V44, P614, DOI 10.1136/thx.44.8.614; AVOL EL, 1985, AM REV RESPIR DIS, V132, P619; Balagas R, 1996, IMPROVED AIR QUALITY; Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; Becklake MR, 1997, LANCET, V350, P10; BRUNEKREEF B, 1995, ENVIRON HEALTH PERSP, V103, P3, DOI 10.2307/3432443; Buchdahl R, 1996, BRIT MED J, V312, P661; Busse W, 1995, ASTHMA RHINITIS; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P153; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, pSS1; *CDCP, 1993, MMWR-MORBID MORTAL W, V45, P350; *CDCP, 1995, MMWR-MORBID MORTAL W, V43, P952; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P908; CODY RP, 1992, ENVIRON RES, V58, P184, DOI 10.1016/S0013-9351(05)80214-2; Delfino RJ, 1998, ENVIRON HEALTH PERSP, V106, P751, DOI 10.2307/3434265; EDWARDS J, 1994, ARCH ENVIRON HEALTH, V49, P223, DOI 10.1080/00039896.1994.9937471; Goren AI, 1997, J EPIDEMIOL COMMUN H, V51, P227, DOI 10.1136/jech.51.3.227; Hartert TV, 1996, AM J MED, V100, P386, DOI 10.1016/S0002-9343(97)89513-7; HAYES SR, 1991, J AIR WASTE MANAGE, V41, P161, DOI 10.1080/10473289.1991.10466833; Jorres R, 1996, AM J RESP CRIT CARE, V153, P56, DOI 10.1164/ajrccm.153.1.8542163; Livingstone AE, 1996, BRIT MED J, V312, P676; *METR ATL RAP TRAN, 1996, WAY GAM REP MASS TRA; MOLFINO NA, 1991, LANCET, V338, P199, DOI 10.1016/0140-6736(91)90346-Q; MULLALLY DI, 1984, ANN ALLERGY, V53, P15; MURAKAMI M, 1990, Journal of Human Ergology, V19, P101; POPE CA, 1989, AM J PUBLIC HEALTH, V79, P623, DOI 10.2105/AJPH.79.5.623; PORTER C, 1997, 833 NCHRP; ROMIEU I, 1995, AM J EPIDEMIOL, V141, P546, DOI 10.1093/oxfordjournals.aje.a117470; Romieu I, 1996, AM J RESP CRIT CARE, V154, P300, DOI 10.1164/ajrccm.154.2.8756798; Samet J., 1999, AIR POLLUTION HLTH; SCHENKER M, 1993, NEW ENGL J MED, V329, P1807, DOI 10.1056/NEJM199312093292410; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; Tattersfield AE, 1996, THORAX, V51, P13, DOI 10.1136/thx.51.1.13; Thurston GD, 1997, AM J RESP CRIT CARE, V155, P654, DOI 10.1164/ajrccm.155.2.9032209; Tolbert PE, 2000, AM J EPIDEMIOL, V151, P798, DOI 10.1093/oxfordjournals.aje.a010280; *US EPA, 1992, EPA450K92002 US EPA; *US EPA, 1994, EPA451K94001 US EPA; Weiland Stephan K., 1994, Annals of Epidemiology, V4, P243; WHITE MC, 1994, ENVIRON RES, V65, P56, DOI 10.1006/enrs.1994.1021; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; 2001, CLEAN AIR CAMPAIGN	45	378	386	2	101	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2001	285	7					897	905		10.1001/jama.285.7.897	http://dx.doi.org/10.1001/jama.285.7.897			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402BE	11180733	Bronze			2022-12-24	WOS:000166965500027
J	Itoh, T; Koshiba, S; Kigawa, T; Kikuchi, A; Yokoyama, S; Takenawa, T				Itoh, T; Koshiba, S; Kigawa, T; Kikuchi, A; Yokoyama, S; Takenawa, T			Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate binding and endocytosis	SCIENCE			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; CLATHRIN; PHOSPHOINOSITIDES; IDENTIFICATION; VISUALIZATION; COMPLEX; SYSTEM	Endocytic proteins such as epsin, AP180, and Hip1R (SLa2p) share a conserved modular region termed the epsin NH2-terminal homology (ENTH) domain, which plays a crucial role in clathrin-mediated endocytosis through an unknown target. Here, we demonstrate a strong affinity of the ENTH domain for phosphatidylinositol-4,5-bisphosphate [Ptdlns(4,5)P-2]. With nuclear magnetic resonance analysis of the epsin ENTH domain, we determined that a cleft formed with positively charged residues contributed to phosphoinositide binding. Overexpression of a mutant, epsin Lys(76) --> Ala(76), with an ENTH domain defective in phosphoinositide binding, blocked epidermal growth factor internalization in COS-7 cells. Thus, interaction between the ENTH domain and Ptdlns(4,5)P-2 is essential for endocytosis mediated by clathrin-coated pits.	Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1088639, Japan; RIKEN, Genom Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; RIKEN, Harima Inst SPring 8, Cellular Signaling Lab, Sayo, Hyogo 6795148, Japan; Hiroshima Univ, Sch Med, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; RIKEN; RIKEN; Hiroshima University; University of Tokyo	Takenawa, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Kigawa, Takanori/A-7679-2010; Yokoyama, Shigeyuki/N-6911-2015	Kigawa, Takanori/0000-0003-0146-9719; Yokoyama, Shigeyuki/0000-0003-3133-7338				BRUNGER AT, 1993, XPLOR VERSION 3 1 SY; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Engqvist-Goldstein AEY, 1999, J CELL BIOL, V147, P1503, DOI 10.1083/jcb.147.7.1503; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Haffner C, 2000, CURR BIOL, V10, P471, DOI 10.1016/S0960-9822(00)00446-2; Hao WH, 1999, J BIOL CHEM, V274, P22785, DOI 10.1074/jbc.274.32.22785; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Itoh T, 2000, J BIOL CHEM, V275, P19389, DOI 10.1074/jbc.M000426200; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kay BK, 1999, PROTEIN SCI, V8, P435; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; KOSHIBA S, IN PRESS J STRUCT FU; Nagano K, 1999, J BIOL CHEM, V274, P2872, DOI 10.1074/jbc.274.5.2872; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Patki V, 1997, P NATL ACAD SCI USA, V94, P7326, DOI 10.1073/pnas.94.14.7326; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wendland B, 1999, EMBO J, V18, P4383, DOI 10.1093/emboj/18.16.4383; YE WL, 1995, J BIOL CHEM, V270, P10933, DOI 10.1074/jbc.270.18.10933; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	28	376	384	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					1047	1051		10.1126/science.291.5506.1047	http://dx.doi.org/10.1126/science.291.5506.1047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11161217				2022-12-24	WOS:000166860100046
J	Naya, Y; Yoshida, M; Miyashita, Y				Naya, Y; Yoshida, M; Miyashita, Y			Backward spreading of memory-retrieval signal in the primate temporal cortex	SCIENCE			English	Article							STIMULUS ASSOCIATION; PERIRHINAL CORTEX; INFEROTEMPORAL CORTEX; NEURONS; CORTICES; MONKEY; DISSOCIATION; ORGANIZATION; RESPONSES; AREAS	Bidirectional signaling between neocortex and Limbic cortex has been hypothesized to contribute to the retrieval of Long-term memory. We tested this hypothesis by comparing the time courses of perceptual and memory-retrieval signals in two neighboring areas in temporal cortex, area TE (TE) and perirhinal cortex (PRh), while monkeys were performing a visual pair-association task. Perceptual signal reached TE before PRh, confirming its forward propagation. In contrast, memory-retrieval signal appeared earlier in PRh, and TE neurons were then gradually recruited to represent the sought target. A reasonable interpretation of this finding is that the rich backward fiber projections from PRh to TE may underlie the activation of TE neurons that represent a visual object retrieved from Long-term memory.	Natl Inst Physiol Sci, Cognit Neurosci Lab, Aichi 4448585, Japan; Japan Sci & Technol Corp, ICORP, Mind Articulat Project, Tokyo 1130034, Japan; Univ Tokyo, Sch Med, Tokyo 1130033, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); University of Tokyo	Miyashita, Y (corresponding author), Natl Inst Physiol Sci, Cognit Neurosci Lab, Aichi 4448585, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Yoshida, Masatoshi/X-2312-2018; Miyashita, Yasushi/B-7171-2019	Yoshida, Masatoshi/0000-0002-2566-1820; Miyashita, Yasushi/0000-0003-3496-8637				AMIT DJ, 1994, J NEUROSCI, V14, P6435; Buckley MJ, 1997, J NEUROPHYSIOL, V77, P587, DOI 10.1152/jn.1997.77.2.587; Buffalo EA, 1999, LEARN MEMORY, V6, P572, DOI 10.1101/lm.6.6.572; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; DOTY RW, 1994, BEHAV BRAIN RES, V64, P79, DOI 10.1016/0166-4328(94)90120-1; Erickson CA, 1999, J NEUROSCI, V19, P10404; Fuster JM, 1995, MEMORY CEREBRAL CORT; Hasegawa I, 1998, SCIENCE, V281, P814, DOI 10.1126/science.281.5378.814; Higuchi S, 1996, P NATL ACAD SCI USA, V93, P739, DOI 10.1073/pnas.93.2.739; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; Miyashita Y, 2000, CURR OPIN NEUROBIOL, V10, P187, DOI 10.1016/S0959-4388(00)00071-4; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; Movshon JA, 1996, J NEUROSCI, V16, P7733; MURRAY EA, 1993, J NEUROSCI, V13, P4549; Naya Y, 1996, P NATL ACAD SCI USA, V93, P2664, DOI 10.1073/pnas.93.7.2664; NAYA Y, 1999, 29 ANN M SOC NEUR MI; Orlov T, 2000, NATURE, V404, P77, DOI 10.1038/35003571; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Saleem KS, 1996, J NEUROSCI, V16, P4757; Schacter DL, 1998, NEUROBIOL LEARN MEM, V70, P284, DOI 10.1006/nlme.1998.3854; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Tokuyama W, 2000, NAT NEUROSCI, V3, P1134, DOI 10.1038/80655; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; YAKOVIEV V, 1998, NAT NEUROSCI, V4, P310	30	176	177	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2001	291	5504					661	664		10.1126/science.291.5504.661	http://dx.doi.org/10.1126/science.291.5504.661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11158679				2022-12-24	WOS:000166616000046
J	Jankowsky, E; Gross, CH; Shuman, S; Pyle, AM				Jankowsky, E; Gross, CH; Shuman, S; Pyle, AM			Active disruption of an RNA-protein interaction by a DExH/D RNA helicase	SCIENCE			English	Article							U1A PROTEIN; ATP HYDROLYSIS; MESSENGER-RNA; BOX; SPECIFICITY; SPLICEOSOME; BINDING	All aspects of cellular RNA metabolism and the replication of many viruses require DExH/D proteins that manipulate RNA in a manner that requires nucleoside triphosphates. Although DExH/D proteins have been shown to unwind purified RNA duplexes, most RNA molecules in the cellular environment are complexed with proteins. It has therefore been speculated that DExH/D proteins may also affect RNA-protein interactions. We demonstrate that the DExH protein NPH-II from vaccinia virus can displace the protein U1A from RNA in an active adenosine triphosphate-dependent fashion. NPH-II increases the rate of U1A dissociation by more than three orders of magnitude while retaining helicase processivity. This indicates that DExH/D proteins can effectively catalyze protein displacement from RNA and thereby participate in the structural reorganization of ribonucleoprotein assemblies.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Sloan Kettering Inst, New York, NY 10021 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Columbia University; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.			Jankowsky, Eckhard/0000-0001-7677-7412				AUBELE DT, 1997, MOL CELL BIOL, V17, P4842; Avis JM, 1996, J MOL BIOL, V257, P398, DOI 10.1006/jmbi.1996.0171; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Grainger RJ, 1999, J MOL BIOL, V288, P585, DOI 10.1006/jmbi.1999.2717; GROSS CH, 1995, J VIROL, V69, P4727, DOI 10.1128/JVI.69.8.4727-4736.1995; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; JANKOWSKY E, UNPUB; Kadare G, 1997, J VIROL, V71, P2583; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; SCHERLY D, 1990, NATURE, V345, P502, DOI 10.1038/345502a0; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; SHUMAN S, 1993, J BIOL CHEM, V268, P11798; STALEY JP, 1998, CELL, V90, P1041; VANGELDER CWG, 1993, EMBO J, V12, P5191, DOI 10.1002/j.1460-2075.1993.tb06214.x; Varani G, 1998, ANNU REV BIOPH BIOM, V27, P407, DOI 10.1146/annurev.biophys.27.1.407; Varani L, 2000, NAT STRUCT BIOL, V7, P329; Wagner JDO, 1998, EMBO J, V17, P2926, DOI 10.1093/emboj/17.10.2926; WINCOTT F, 1995, NUCLEIC ACIDS RES, V23, P2677, DOI 10.1093/nar/23.14.2677	19	248	258	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2001	291	5501					121	125		10.1126/science.291.5501.121	http://dx.doi.org/10.1126/science.291.5501.121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389VJ	11141562				2022-12-24	WOS:000166259100048
J	Henney, JE				Henney, JE			Nominations for advisory panels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Henney, JE (corresponding author), US FDA, HF-1,14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2001	285	1					34	34		10.1001/jama.285.1.34	http://dx.doi.org/10.1001/jama.285.1.34			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387GH	11150092				2022-12-24	WOS:000166114500006
J	Anderson, J; Baum, M; Bero, LA; Chalmers, I; Chapman, S; Deary, IJ; Ebrahim, S; Martyn, SOOLISS; Evans, M; Farrell, M; Greaves, D; Higginson, I; Hippisley-Cox, J; James, B; McKenzie, H; Macaulay, AC; Rabow, M; Smyth, RL; Stores, G; Wolpert, L				Anderson, J; Baum, M; Bero, LA; Chalmers, I; Chapman, S; Deary, IJ; Ebrahim, S; Martyn, SOOLISS; Evans, M; Farrell, M; Greaves, D; Higginson, I; Hippisley-Cox, J; James, B; McKenzie, H; Macaulay, AC; Rabow, M; Smyth, RL; Stores, G; Wolpert, L			Music to be born to, music to die to	BRITISH MEDICAL JOURNAL			English	Editorial Material									Monash Univ, So Healthcare Network, Ctr Clin Effectiveness, Melbourne, Vic, Australia; UCL, London WC1E 6BT, England; Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; UK Cochrane Ctr, Oxford, England; Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; Univ Bristol, Dept Social Med, Bristol, Avon, England; Natl Addict Ctr, London, England; Kings Coll London, London WC2R 2LS, England; St Christophers Hospice, London, England; Univ Nottingham, Nottingham NG7 2RD, England; Inst Hlth Sector Dev, London, England; McGill Univ, Montreal, PQ H3A 2T5, Canada; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Liverpool, Royal Liverpool Childrens Hosp Alder Hey, Inst Child Hlth, Liverpool, Merseyside, England	Monash University; University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Cochrane Centre; University of Edinburgh; University of Bristol; University of London; King's College London; University of London; King's College London; University of Nottingham; McGill University; University of California System; University of California San Francisco; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool	Anderson, J (corresponding author), Monash Univ, So Healthcare Network, Ctr Clin Effectiveness, Melbourne, Vic, Australia.		Hippisley-Cox, Julia/AAY-2788-2020; Deary, Ian J/C-6297-2009; Higginson, Irene J/C-7309-2012	Hippisley-Cox, Julia/0000-0002-2479-7283; Deary, Ian J/0000-0002-1733-263X; Higginson, Irene J/0000-0002-3687-1313					0	1	1	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 23	2000	321	7276					1577	1579		10.1136/bmj.321.7276.1577	http://dx.doi.org/10.1136/bmj.321.7276.1577			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387RA	11124186	Green Published			2022-12-24	WOS:000166134500023
J	Myers, A; Holmans, P; Marshall, H; Kwon, J; Meyer, D; Ramic, D; Shears, S; Booth, J; DeVrieze, FW; Crook, R; Hamshere, M; Abraham, R; Tunstall, N; Rice, F; Carty, S; Lillystone, S; Kehoe, P; Rudrasingham, V; Jones, L; Lovestone, S; Perez-Tur, J; Williams, J; Owen, MJ; Hardy, J; Goate, AM				Myers, A; Holmans, P; Marshall, H; Kwon, J; Meyer, D; Ramic, D; Shears, S; Booth, J; DeVrieze, FW; Crook, R; Hamshere, M; Abraham, R; Tunstall, N; Rice, F; Carty, S; Lillystone, S; Kehoe, P; Rudrasingham, V; Jones, L; Lovestone, S; Perez-Tur, J; Williams, J; Owen, MJ; Hardy, J; Goate, AM			Susceptibility locus for Alzheimer's disease on chromosome 10	SCIENCE			English	Article							GENOME SCAN; LINKAGE	The apolipoprotein E (APOE) gene is the only genetic risk factor that has so far been Linked to risk for Late-onset Alzheimer's disease (LOAD), However, 50 percent of Alzheimer's disease cases do not carry an APOE4 allele, suggesting that other risk factors must exist. We performed a two-stage genome-wide screen in sibling pairs with LOAD to detect other susceptibility Loci. Here we report evidence for an Alzheimer's disease Locus on chromosome 10. Our stage one multipoint Lod score (Logarithm of the odds ratio for linkage/no Linkage) of 2.48 (266 sibling pairs) increased to 3.83 in stage 2 (429 sibling pairs) close to D10S1225 (79 centimorgans). This Locus modifies risk for Alzheimer's disease independent of APOE genotype.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Mayo Clin Jacksonville, Neurogenet Lab, Jacksonville, FL 32224 USA; Univ Wales Coll Med, Dept Psychol Med, Cardiff CF4 4XN, S Glam, Wales; Inst Psychiat, London SE5 8AF, England; CSIC, Inst Biomed Valencia, Unitat Genet Mol, E-46010 Valencia, Spain	Washington University (WUSTL); Mayo Clinic; Cardiff University; University of London; King's College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Goate, AM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, 660 S Euclid, St Louis, MO 63110 USA.		Lovestone, Simon/E-8725-2010; Myers, Amanda J/B-1796-2010; Holmans, Peter/F-4518-2015; Perez-Tur, Jordi/A-2143-2010; Hardy, John/C-2451-2009; Kehoe, Patrick/P-8760-2018	Myers, Amanda J/0000-0002-3100-9396; Holmans, Peter/0000-0003-0870-9412; Perez-Tur, Jordi/0000-0002-9111-1712; Hardy, John/0000-0002-3122-0423; Lovestone, Simon/0000-0003-0473-4565; Goate, Alison/0000-0002-0576-2472; Kehoe, Patrick/0000-0002-7542-1139; Williams, Julie/0000-0002-4069-0259; Rice, Frances/0000-0002-9484-1729	NIA NIH HHS [AG16208, AG5681, U24 AG021886] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005681, R01AG016208, U24AG021886, Z01AG000950] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729	10	314	325	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2000	290	5500					2304	+		10.1126/science.290.5500.2304	http://dx.doi.org/10.1126/science.290.5500.2304			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125144				2022-12-24	WOS:000165995800044
J	Jankowski, JA; Harrison, RF; Perry, I; Balkwill, F; Tselepis, C				Jankowski, JA; Harrison, RF; Perry, I; Balkwill, F; Tselepis, C			Barrett's metaplasia	LANCET			English	Review							HELICOBACTER-PYLORI INFECTION; GASTROESOPHAGEAL-REFLUX; INTESTINAL METAPLASIA; CATENIN COMPLEXES; TNF-ALPHA; ESOPHAGUS; PREVALENCE; CELLS; ADENOCARCINOMA; ASSOCIATION	The rate of oesophageal adenocarcinoma is increasing In the western world and has a poor prognosis mainly because individuals present at a late stage. Attempts to intervene at an early stage of tumour progression have not proven cost effective, although lesions identified during surveillance programmes have a better prognosis. As a consequence, there has been renewed interest in strategies that might prevent the precursor lesion Barrett's oesophagus. Furthermore, there is an improved understanding of genetic and environmental interactions necessary for the clonal expansion and propagation of metaplastic premalignant lesions. Clearly, three mechanisms promote cancer progression-inheritance of germ-line mutations or polymorphisms, sporadic mutagenesis, and local epigenetic alterations. Locally produced cytokines and bile acids in the refluxate create a microenvironment that sets the scene for metaplastic transformation of the oesophageal epithelium, mainly by directly affecting metaplastic stem cells.	Univ Birmingham, Div Med Sci, Epithelial Lab, Birmingham B15 2TH, W Midlands, England; Imperial Canc Res Fund, Histopathol Lab, London WC2A 3PX, England; Imperial Canc Res Fund, Biol Therapy Lab, London WC2A 3PX, England	University of Birmingham; Cancer Research UK; Cancer Research UK	Jankowski, JA (corresponding author), Univ Birmingham, Div Med Sci, Epithelial Lab, Birmingham B15 2TH, W Midlands, England.	J.jankowski@bham.ac.uk	Jankowski, Janusz/H-2706-2012	Jankowski, Janusz/0000-0003-2130-9181; Balkwill, Frances/0000-0002-5587-9759				Bailey T, 1998, AM J PATHOL, V152, P135; Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Biddleston LR, 1998, AM J SURG PATHOL, V22, P239, DOI 10.1097/00000478-199802000-00013; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; CAMERON AJ, 1992, GASTROENTEROLOGY, V103, P1241, DOI 10.1016/0016-5085(92)91510-B; CAMERON AJ, 1990, GASTROENTEROLOGY, V99, P918, DOI 10.1016/0016-5085(90)90607-3; CHAMPION G, 1994, GASTROENTEROLOGY, V107, P747, DOI 10.1016/0016-5085(94)90123-6; DAHMS BB, 1987, CANCER, V60, P2896, DOI 10.1002/1097-0142(19871215)60:12<2896::AID-CNCR2820601208>3.0.CO;2-P; Di Sebastiano P, 2000, GUT, V47, P423, DOI 10.1136/gut.47.3.423; Dixon MF, 2000, BEST PRACT RES CL GA, V14, P27, DOI 10.1053/bega.1999.0057; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fass R, 2000, ENDOSCOPY, V32, P27, DOI 10.1055/s-2000-82; Galipeau PC, 1999, J NATL CANCER I, V91, P2087, DOI 10.1093/jnci/91.24.2087; Garcia SB, 1999, J PATHOL, V187, P61, DOI 10.1002/(SICI)1096-9896(199901)187:1<61::AID-PATH247>3.0.CO;2-I; Garewal H, 1996, CANCER RES, V56, P1480; GILLEN P, 1988, BRIT J SURG, V75, P540, DOI 10.1002/bjs.1800750612; Goldblum JR, 1998, GASTROENTEROLOGY, V114, P633, DOI 10.1016/S0016-5085(98)70576-1; GRAY MR, 1993, GUT, V34, P727, DOI 10.1136/gut.34.6.727; Harrison RF, 2000, J PATHOL, V192, P1; Higaki S, 1999, J GASTROEN HEPATOL, V14, P709, DOI 10.1046/j.1440-1746.1999.01938.x; Ishikawa N, 1997, GASTROENTEROLOGY, V113, P542, DOI 10.1053/gast.1997.v113.pm9247474; JANKOWSKI J, 1993, AM J GASTROENTEROL, V56, P1480; Jankowski JA, 2000, BRIT MED J, V321, P463, DOI 10.1136/bmj.321.7259.463; Jankowski JA, 1999, AM J PATHOL, V154, P965, DOI 10.1016/S0002-9440(10)65346-1; Jones BE, 2000, AM J PHYSIOL-GASTR L, V278, pG693, DOI 10.1152/ajpgi.2000.278.5.G693; Kaiser GC, 1999, EXP CELL RES, V249, P349, DOI 10.1006/excr.1999.4488; Kim MH, 2000, J IMMUNOL, V164, P5883, DOI 10.4049/jimmunol.164.11.5883; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Lagergren J, 2000, ANN INTERN MED, V133, P165, DOI 10.7326/0003-4819-133-3-200008010-00007; Lee HM, 2000, AM J PHYSIOL-LUNG C, V278, pL185, DOI 10.1152/ajplung.2000.278.1.L185; Lu L, 1997, LAB INVEST, V76, P336; MENKEPLUYMERS MBE, 1993, CANCER, V72, P1155, DOI 10.1002/1097-0142(19930815)72:4<1155::AID-CNCR2820720404>3.0.CO;2-C; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Morales TG, 1999, ARCH INTERN MED, V159, P1411, DOI 10.1001/archinte.159.13.1411; Naya MJ, 1997, GUT, V40, P175, DOI 10.1136/gut.40.2.175; Nomura S, 1998, GUT, V42, P663, DOI 10.1136/gut.42.5.663; Ouatu-Lascar R, 1999, GASTROENTEROLOGY, V117, P327, DOI 10.1053/gast.1999.0029900327; Perry I, 2000, GUT, V46, pA54; POKOWSKI W, 2000, AM J GASTROENTEROL, V95, P617; Powell J, 1992, Eur J Cancer Prev, V1, P265, DOI 10.1097/00008469-199204000-00008; Poynton AR, 1996, AM J GASTROENTEROL, V91, P1855; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Romero Y, 1997, GASTROENTEROLOGY, V113, P1449, DOI 10.1053/gast.1997.v113.pm9352846; SARR MG, 1985, AM J SURG, V149, P187, DOI 10.1016/S0002-9610(85)80031-3; Schmidt PH, 1999, LAB INVEST, V79, P639; Schouten WR, 1998, MEDIAT INFLAMM, V7, P175, DOI 10.1080/09629359891117; Sharma P, 1997, Am J Gastroenterol, V92, P903; Shirvani VN, 2000, GASTROENTEROLOGY, V118, P487, DOI 10.1016/S0016-5085(00)70254-X; SIDRANSKY D, 1992, NEW ENGL J MED, V117, P218; SKINNER DB, 1983, ANN SURG, V198, P554, DOI 10.1097/00000658-198310000-00016; Sodhani P, 1999, CYTOPATHOLOGY, V10, P122, DOI 10.1046/j.1365-2303.1999.00154.x; Spechler SJ, 1999, GASTROENTEROLOGY, V117, P218, DOI 10.1016/S0016-5085(99)70571-8; SPECHLER SJ, 1983, DIGEST DIS SCI, V28, P769, DOI 10.1007/BF01296897; Sung JJY, 2000, GASTROENTEROLOGY, V119, P7, DOI 10.1053/gast.2000.8550; Takeda H, 2000, ENDOSCOPY, V32, P651; THOMAS GA, 1988, J PATHOL, V155, P101, DOI 10.1002/path.1711550205; Tomlinson I, 1999, NAT MED, V5, P11, DOI 10.1038/4687; Triadafilopoulos G, 2000, GUT, V46, P144, DOI 10.1136/gut.46.2.144; TSELEPIS C, 1999, GUT, V45, pA238; Voutilainen M, 1999, GUT, V45, P644, DOI 10.1136/gut.45.5.644; Vujanic GM, 2000, HISTOPATHOLOGY, V36, P41; Wallner B, 2000, SCAND J GASTROENTERO, V35, P17; Weston AP, 2000, AM J GASTROENTEROL, V95, P387, DOI 10.1111/j.1572-0241.2000.01758.x; Weston AP, 1997, AM J GASTROENTEROL, V92, P800; Younes M, 1999, HUM PATHOL, V30, P1309, DOI 10.1016/S0046-8177(99)90061-8	67	273	279	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 16	2000	356	9247					2079	2085		10.1016/S0140-6736(00)03411-5	http://dx.doi.org/10.1016/S0140-6736(00)03411-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385GB	11145505				2022-12-24	WOS:000165994300033
J	Keeling, MJ; Wilson, HB; Pacala, SW				Keeling, MJ; Wilson, HB; Pacala, SW			Reinterpreting space, time lags, and functional responses in ecological models	SCIENCE			English	Article							DELAYED DENSITY-DEPENDENCE; POPULATION-DYNAMICS; PATCHY ENVIRONMENTS; STABILITY; SYSTEMS	Natural enemy-victim interactions are of major applied importance and of fundamental interest to ecologists. A key question is what stabilizes these interactions, allowing the Long-term coexistence of the two species. Three main theoretical explanations have been proposed: behavioral responses, time-dependent factors such as delayed density dependence, and spatial heterogeneity. Here, using the powerful moment-closure technique, we show a fundamental equivalence between these three elements. Limited movement by organisms is a ubiquitous feature of ecological systems, allowing spatial structure to develop; we show that the effects of this can be naturally described in terms of time lags or within-generation functional responses.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Cambridge; Imperial College London; Princeton University	Keeling, MJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	matt@zoo.cam.ac.uk	Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765				Bjornstad ON, 1998, J ANIM ECOL, V67, P110, DOI 10.1046/j.1365-2656.1998.00168.x; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; Crone EE, 1997, THEOR POPUL BIOL, V51, P67, DOI 10.1006/tpbi.1997.1309; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; HANSKI I, 1983, ECOLOGY, V64, P493, DOI 10.2307/1939969; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; HASSELL MP, 1974, J ANIM ECOL, V43, P567, DOI 10.2307/3384; Hassell MP., 1978, DYNAMICS ARTHROPOD P; HASTINGS A, 1977, THEOR POPUL BIOL, V12, P37, DOI 10.1016/0040-5809(77)90034-X; HORNFELDT B, 1994, ECOLOGY, V75, P791, DOI 10.2307/1941735; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; KAREIVA P, 1990, PHILOS T R SOC B, V330, P175, DOI 10.1098/rstb.1990.0191; KEELING M, 1999, ADV ECOLOGICAL THEOR, P64, DOI DOI 10.1002/9781444311501.CH3; Keeling MJ, 2000, J ANIM ECOL, V69, P725, DOI 10.1046/j.1365-2656.2000.00430.x; LOTKA AJ, 1925, ELEMENTS PHYSICAL BI; MAY RM, 1978, J ANIM ECOL, V47, P833, DOI 10.2307/3674; MCCAULEY E, 1993, AM NAT, V142, P412, DOI 10.1086/285547; NICHOLSON AJ, 1935, P ZOOL SOC LOND, V3, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; PACALA SW, 1991, AM NAT, V138, P584, DOI 10.1086/285236; Renshaw E., 1991, MODELLING BIOL POPUL, DOI 10.1017/CBO9780511624094; Rodriguez DJ, 1998, J THEOR BIOL, V191, P95, DOI 10.1006/jtbi.1997.0569; Saitoh T, 1998, RES POPUL ECOL, V40, P61, DOI 10.1007/BF02765222; TURCHIN P, 1990, NATURE, V344, P660, DOI 10.1038/344660a0; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Wilson HB, 1997, P ROY SOC B-BIOL SCI, V264, P625, DOI 10.1098/rspb.1997.0088	27	79	81	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2000	290	5497					1758	1761		10.1126/science.290.5497.1758	http://dx.doi.org/10.1126/science.290.5497.1758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379FY	11099413				2022-12-24	WOS:000165632400041
J	Echtay, KS; Winkler, E; Klingenberg, M				Echtay, KS; Winkler, E; Klingenberg, M			Coenzyme Q is an obligatory cofactor for uncoupling protein function	NATURE			English	Article							FATTY-ACIDS; BACTERIAL EXPRESSION; NUCLEOTIDE-BINDING; H+ TRANSPORT; MITOCHONDRIA; CARRIER; UCP1; RECONSTITUTION; MEMBRANE	Uncoupling proteins (UCPs) are thought to be intricately controlled uncouplers(1-3) that are responsible for the futile dissipation of mitochondrial chemiosmotic gradients, producing heat rather than ATP. They occur in many animal and plant cells(4-9) and forma subfamily of the mitochondrial carrier family(10). Physiological uncoupling of oxidative phosphorylation must be strongly regulated to avoid deterioration of the energy supply and cell death, which is caused by toxic uncouplers. However, an H+ transporting uncoupling function is well established only for UCP1 from brown adipose tissue(2,8,9,11), and the regulation of UCP1 by fatty acids, nucleotides and pH remains controversial(2,12-14). The failure of UCP1 expressed in Escherichia coli inclusion bodies to carry out fatty-acid-dependent H+ transport activity inclusion bodies(15) made us seek a native UCP cofactor. Here we report the identification of coenzyme Q (ubiquinone) as such a cofactor. On addition of CoQ(10) to reconstituted UCP1 from inclusion bodies, fatty-acid-dependent H+ transport reached the same rate as with native UCP1. The H+ transport was highly sensitive to purine nucleotides, and activated only by oxidized but not reduced CoQ. H+ transport of native UCP1 correlated with the endogenous CoQ content.	Univ Munich, Inst Physiol Chem, D-80336 Munich, Germany	University of Munich	Klingenberg, M (corresponding author), Univ Munich, Inst Physiol Chem, Schillerstr 44, D-80336 Munich, Germany.	klingenberg@pbm.med.uni-muenchen.de						AQUILA H, 1987, FEBS LETT, V212, P1, DOI 10.1016/0014-5793(87)81546-6; ARECHAGA I, 1993, BIOCHEM J, V296, P693, DOI 10.1042/bj2960693; BATHGATE B, 1992, MOL MICROBIOL, V6, P363, DOI 10.1111/j.1365-2958.1992.tb01479.x; Boss O, 1998, EUR J ENDOCRINOL, V139, P1, DOI 10.1530/eje.0.1390001; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; BRUSTOVETSKY N, 1994, J BIOL CHEM, V269, P27329; Echtay KS, 1997, BIOCHEMISTRY-US, V36, P8253, DOI 10.1021/bi970513r; Echtay KS, 1999, FEBS LETT, V450, P8, DOI 10.1016/S0014-5793(99)00460-3; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gonzalez-Barroso MM, 1998, J BIOL CHEM, V273, P15528, DOI 10.1074/jbc.273.25.15528; HUANG SG, 1995, BIOCHEMISTRY-US, V34, P349, DOI 10.1021/bi00001a043; Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003; JEZEK P, 1994, J BIOL CHEM, V269, P26184; Kaplan RS, 1996, J BIOENERG BIOMEMBR, V28, P41; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Kowaltowski AJ, 1998, FEBS LETT, V425, P213, DOI 10.1016/S0014-5793(98)00231-2; Laloi M, 1997, NATURE, V389, P135, DOI 10.1038/38156; LIN CS, 1982, BIOCHEMISTRY-US, V21, P2950, DOI 10.1021/bi00541a023; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Matthias A, 1999, J BIOL CHEM, V274, P28150, DOI 10.1074/jbc.274.40.28150; MURDZAINGLIS DL, 1991, J BIOL CHEM, V266, P11871; NEDERGAARD J, 1992, NEW COMPREHENSIVE BI, V23, P385; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Schroers A, 1998, J BIOL CHEM, V273, P14269, DOI 10.1074/jbc.273.23.14269; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; WINKLER E, 1994, J BIOL CHEM, V269, P2508; Winkler E, 1997, BIOCHEMISTRY-US, V36, P148, DOI 10.1021/bi962178x	30	264	276	1	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 30	2000	408	6812					609	613		10.1038/35046114	http://dx.doi.org/10.1038/35046114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117751				2022-12-24	WOS:000165548600124
J	O'Doherty, MJ; Marsden, PK				O'Doherty, MJ; Marsden, PK			Being equipped for clinical PET	LANCET			English	Editorial Material							POSITRON-EMISSION-TOMOGRAPHY; HEAD GAMMA-CAMERA; WHOLE-BODY; FDG-PET; COST-EFFECTIVENESS; LUNG-CANCER; MANAGEMENT; FLUORODEOXYGLUCOSE		St Thomas Hosp, Guys Kings & St Thomas Sch Med, Dept Radiol Sci, London SE1 7EH, England; St Thomas Hosp, Clin PET Ctr, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	O'Doherty, MJ (corresponding author), St Thomas Hosp, Guys Kings & St Thomas Sch Med, Dept Radiol Sci, London SE1 7EH, England.							Ahuja V, 1998, CANCER, V83, P918, DOI 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.0.CO;2-Y; Bakheet SM, 1998, SEMIN NUCL MED, V28, P352; Bangerter M, 1998, ANN ONCOL, V9, P1117, DOI 10.1023/A:1008486928190; Cook GJR, 1999, EUR J NUCL MED, V26, P1363, DOI 10.1007/s002590050597; Delbeke D, 1999, J NUCL MED, V40, P110; Dietlein M, 2000, EUR J NUCL MED, V27, P1441, DOI 10.1007/s002590000324; Gambhir SS, 1996, J NUCL MED, V37, P1428; Gambhir SS, 1998, J CLIN ONCOL, V16, P2113, DOI 10.1200/JCO.1998.16.6.2113; Huebner RH, 2000, J NUCL MED, V41, P1177; Mikhaeel NG, 2000, ANN ONCOL, V11, P147, DOI 10.1023/A:1008381115131; O'Doherty MJ, 2000, NUCL MED COMMUN, V21, P224, DOI 10.1097/00006231-200003000-00004; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Romer W, 1998, BLOOD, V91, P4464; Saunders CAB, 1999, ANN THORAC SURG, V67, P790, DOI 10.1016/S0003-4975(98)01257-0; Warburg O, 1931, METABOLISM TUMORS, P129; Weber WA, 1999, EUR J NUCL MED, V26, P388, DOI 10.1007/s002590050402	16	17	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2000	356	9243					1701	1703		10.1016/S0140-6736(00)03200-1	http://dx.doi.org/10.1016/S0140-6736(00)03200-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	376MX	11095254				2022-12-24	WOS:000165462300005
J	Schwetz, BA				Schwetz, BA			New anticoagulant approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									Off Commissioner Food & Drugs, Rockville, MD 20857 USA		Schwetz, BA (corresponding author), Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2001	285	6					724	724		10.1001/jama.285.6.724-a	http://dx.doi.org/10.1001/jama.285.6.724-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399MP	11176890				2022-12-24	WOS:000166817200006
J	Blumberg, RS; Strober, W				Blumberg, RS; Strober, W			Prospects for research in inflammatory bowel disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CROHNS-DISEASE; ULCERATIVE-COLITIS; MICE; INTERLEUKIN-12; ANTIBODIES; CELLS; ALPHA	Inflammatory bowel disease is a chronic inflammatory condition of the gastrointestinal tract that manifests as ulcerative colitis and Crohn disease. Both these clinical entities result from interrelated genetic and environmental factors that may be channeled through an abnormality in mucosal immune function, possibly due to dysregulated or excessive T helper cell (T-H)1 (Crohn disease) or T(H)2 (ulcerative colitis) responses. This article reviews current knowledge of the role of immune factors in inflammatory bowel disease and the potential therapeutic strategies that target the pathways of T(H)1- or T(H)2-induced inflammation.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol, Boston, MA 02115 USA; NIH, Mucosal Immun Sect, Bethesda, MD USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA	Blumberg, RS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol, 75 Francis St, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000354, Z01AI000354] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andres PG, 1999, GASTROENTEROL CLIN N, V28, P255, DOI 10.1016/S0889-8553(05)70056-X; Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Friedman S, HARRISONS PRINCIPLES, V20; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; HAY JW, 1992, J CLIN GASTROENTEROL, V14, P309, DOI 10.1097/00004836-199206000-00009; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; HOLLANDER GA, 1995, IMMUNITY, V3, P27, DOI 10.1016/1074-7613(95)90156-6; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Ludviksson BR, 1997, J IMMUNOL, V159, P3622; Mizoguchi A, 1996, J EXP MED, V183, P847, DOI 10.1084/jem.183.3.847; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; MORDSSEY PJ, 1993, J EXP MED, V178, P237; Nakajima A, 1996, J IMMUNOL, V157, P5683; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Probert CS, 1996, J IMMUNOL, V157, P3183; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; SHANAHAN F, 1992, GASTROENTEROLOGY, V103, P456, DOI 10.1016/0016-5085(92)90834-L; Soderholm JD, 1999, GASTROENTEROLOGY, V117, P65, DOI 10.1016/S0016-5085(99)70551-2; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; TARGAN SR, IN PRESS INFLAMMATOR	25	109	125	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					643	647		10.1001/jama.285.5.643	http://dx.doi.org/10.1001/jama.285.5.643			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176874	Bronze			2022-12-24	WOS:000166714200027
J	Guo, HW; Mockler, T; Duong, H; Lin, CT				Guo, HW; Mockler, T; Duong, H; Lin, CT			SUB1, an Arabidopsis Ca2+-binding protein involved in cryptochrome and phytochrome coaction	SCIENCE			English	Article							LIGHT RECEPTOR CRYPTOCHROME-2; SIGNAL-TRANSDUCTION PATHWAYS; GENE-EXPRESSION; CA2+ BINDING; UV-B; THALIANA; HYPOCOTYL; INDUCTION; DIVERSITY; ENCODES	Cryptochromes and phytochromes are the major photosensory receptors in plants and often regulate similar photomorphogenic responses. The molecular mechanisms underlying functional interactions of cryptochromes and phytochromes remain Largely unclear. We have identified an Arabidopsis photomorphogenic mutant, sub1, which exhibits hypersensitive responses to blue light and far-red Light. Genetic analyses indicate that SUB1 functions as a component of a cryptochrome signaling pathway and as a modulator of a phytochrome signaling pathway. The SUB1 gene encodes a Ca2+-binding protein that suppresses Light-dependent accumulation of the transcription factor HY5.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Lin, CT (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	clin@mcdb.ucla.edu	Ecker, Joseph R/B-9144-2008; Mockler, Todd C/L-2609-2013	Ecker, Joseph R/0000-0001-5799-5895; Mockler, Todd C/0000-0002-0462-5775	NIGMS NIH HHS [GM 56265] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056265, R29GM056265] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad M, 1997, PLANT J, V11, P421, DOI 10.1046/j.1365-313X.1997.11030421.x; Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Baum G, 1999, P NATL ACAD SCI USA, V96, P13554, DOI 10.1073/pnas.96.23.13554; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Clough RC, 1997, PLANT CELL ENVIRON, V20, P713, DOI 10.1046/j.1365-3040.1997.d01-107.x; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Fuglevand G, 1996, PLANT CELL, V8, P2347, DOI 10.1105/tpc.8.12.2347; GUO H, UNPUB; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Long JC, 1998, PLANT CELL, V10, P2077, DOI 10.1105/tpc.10.12.2077; LUNDBERG S, 1992, BIOCHEMISTRY-US, V31, P5665, DOI 10.1021/bi00139a034; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; Mathur J, 1998, PLANT J, V13, P707, DOI 10.1046/j.1365-313X.1998.00059.x; Mockler TC, 1999, DEVELOPMENT, V126, P2073; MOHR H, 1994, PHOTOMORPHOGENESIS P; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; NEUHAUS G, 1993, CELL, V73, P937, DOI 10.1016/0092-8674(93)90272-R; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	34	108	127	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2001	291	5503					487	490		10.1126/science.291.5503.487	http://dx.doi.org/10.1126/science.291.5503.487			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11161203				2022-12-24	WOS:000166487500042
J	Hu, FB; Stampfer, MJ; Solomon, C; Liu, SM; Colditz, GA; Speizer, FE; Willett, WC; Manson, JE				Hu, FB; Stampfer, MJ; Solomon, C; Liu, SM; Colditz, GA; Speizer, FE; Willett, WC; Manson, JE			Physical activity and risk for cardiovascular events in diabetic women	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; CARDIORESPIRATORY FITNESS; LOGISTIC-REGRESSION; INSULIN SENSITIVITY; LIFE-STYLE; EXERCISE; WALKING; WEIGHT; MORTALITY; MELLITUS	Background: increased physical activity has been associated with reduced risk for cardiovascular disease in the general population, but data are limited on its role among persons with type 2 diabetes mellitus. Objective: To determine whether physical activity decreases risk for cardiovascular disease among diabetic women. Design: Prospective cohort study. Setting: The Nurses' Health Study. Patients: 5125 female nurses with diabetes. Measurements: Physical activity was first assessed in 1980 and was updated in 1982, 1986, 1988, and 1992 through validated questionnaires. Average hours of moderate or vigorous exercise and a metabolic equivalent of task (MET) score were computed. Results: During 14 years of follow-up (31 432 person-years), 323 new cases of cardiovascular disease were documented (225 cases of coronary heart disease and 98 cases of stroke). The age-adjusted relative risks according to average hours of moderate or vigorous activity per week (<1, 1 to 1.9, 2 to 3.9, 4 to 6.9, <greater than or equal to>7) were 1.0, 0.93 (95% CI, 0.69 to 1.26), 0.82 (CI, 0.61 to 1.10), 0.54 (CI, 0.39 to 0.76), and 0.52 (CI, 0.25 to 1.09) (P < 0.001 for trend). These figures did not change materially after adjustment for smoking, body mass index, and other cardiovascular risk factors (1.0, 1.02, 0.87, 0.61, and 0.55, respectively; P = 0.001 for trend). In separate analyses, levels of physical activity were inversely associated with coronary heart disease and ischemic stroke. Among women who did not exercise vigorously, the multivariate relative risks for cardiovascular disease across quartiles of MET score for walking were 1.0, 0.85, 0.63, and 0.56 (P = 0.03 for trend). Faster usual walking pace was independently associated with lower risk. Conclusion: Among diabetic women, increased physical activity, including regular walking, is associated with substantially reduced risk for cardiovascular events.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	Frank.hu@channing.harvard.edu	Liu, Simin/I-3689-2014; Hu, Frank/C-1919-2013; Colditz, Graham/A-3963-2009; Liu, Simin/GSN-4159-2022	Liu, Simin/0000-0003-2098-3844; Colditz, Graham/0000-0002-7307-0291; 	NATIONAL CANCER INSTITUTE [R37CA040356, R01CA040356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036798] Funding Source: NIH RePORTER; NCI NIH HHS [CA40356] Funding Source: Medline; NIDDK NIH HHS [DK 36798] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AINSWORTH BE, 1993, J CLIN EPIDEMIOL, V46, P1403, DOI 10.1016/0895-4356(93)90140-V; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; *AM DIAB ASS, DIAB FACTS FIG; Andersen RE, 1999, JAMA-J AM MED ASSOC, V281, P335, DOI 10.1001/jama.281.4.335; ANNUZZI G, 1991, EUR J CLIN INVEST, V21, P6, DOI 10.1111/j.1365-2362.1991.tb01351.x; [Anonymous], 1996, JAMA, V276, P241; BLAIR SN, 1993, ANN INTERN MED, V119, P702, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00015; Bray GA, 1999, DIABETES CARE, V22, P623; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DEVLIN JT, 1992, DIABETES CARE, V15, P1690, DOI 10.2337/diacare.15.11.1690; Dunn AL, 1999, JAMA-J AM MED ASSOC, V281, P327, DOI 10.1001/jama.281.4.327; Eriksson JG, 1999, SPORTS MED, V27, P381, DOI 10.2165/00007256-199927060-00003; FORD ES, 1991, AM J EPIDEMIOL, V133, P1220, DOI 10.1093/oxfordjournals.aje.a115834; Gavin JR, 1997, DIABETES CARE, V20, P1183; GOODYEAR LJ, 1992, MED SPORT SCI, V37, P201; Halle M, 1999, METABOLISM, V48, P641, DOI 10.1016/S0026-0495(99)90064-1; HARRIS M, 1979, DIABETES, V28, P1039; Henriksson J, 1995, J Cardiovasc Risk, V2, P303, DOI 10.1097/00043798-199508000-00004; Hosmer DW, 1997, STAT MED, V16, P965; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; LEHMANN R, 1995, DIABETOLOGIA, V38, P1313; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; MANSON JE, 1996, PREVENTION MYOCARDIA; Mayer-Davis EJ, 1998, JAMA-J AM MED ASSOC, V279, P669, DOI 10.1001/jama.279.9.669; ROSE GA, 1982, WHO MONOGRAPH, V56; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Walker KZ, 1999, DIABETES CARE, V22, P555, DOI 10.2337/diacare.22.4.555; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002; WING RR, 1988, DIABETOLOGIA, V31, P902; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; YAMANOUCHI K, 1995, DIABETES CARE, V18, P775, DOI 10.2337/diacare.18.6.775; Zinman B, 1997, DIABETES CARE, V20, P1908	34	265	275	1	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2001	134	2					96	105		10.7326/0003-4819-134-2-200101160-00009	http://dx.doi.org/10.7326/0003-4819-134-2-200101160-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391KW	11177312				2022-12-24	WOS:000166356000002
J	Brodersen, DE; Clemons, WM; Carter, AP; Morgan-Warren, RJ; Wimberly, BT; Ramakrishnan, V				Brodersen, DE; Clemons, WM; Carter, AP; Morgan-Warren, RJ; Wimberly, BT; Ramakrishnan, V			The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit	CELL			English	Article							TRANSFER-RIBONUCLEIC-ACID; PROTEIN-SYNTHESIS; TRANSFER-RNA; P-SITE; FUNCTIONAL SITES; A-SITE; BINDING; RESISTANCE; INITIATION; TRANSLOCATION	We have used the recently determined atomic structure of the 30S ribosomal subunit to determine the structures of its complexes with the antibiotics tetracycline, pactamycin, and hygromycin B. The antibiotics bind to discrete sites on the 30S subunit in a manner consistent with much but not all biochemical data. For each of these antibiotics, interactions with the 30S subunit suggest a mechanism for its effects on ribosome function.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA	MRC Laboratory Molecular Biology; Utah System of Higher Education; University of Utah	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-lmb.cam.ac.uk	Clemons, William M/D-1026-2009; Brodersen, Ditlev E./AAQ-5241-2020	Clemons, William M/0000-0002-0021-889X; Brodersen, Ditlev/0000-0002-5413-4667; Ramakrishnan, V/0000-0002-4699-2194; Carter, Andrew/0000-0001-7292-5430				ALLEN PN, 1989, J MOL BIOL, V208, P457, DOI 10.1016/0022-2836(89)90509-3; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BHUYAN BK, 1961, ANTIMICROB AGENTS CH, P184; BROWN CM, 1993, NUCLEIC ACIDS RES, V21, P2109, DOI 10.1093/nar/21.9.2109; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCK MA, 1990, BIOCHEMISTRY-US, V29, P5374, DOI 10.1021/bi00474a024; Burdett V, 1996, J BACTERIOL, V178, P3246, DOI 10.1128/jb.178.11.3246-3251.1996; CABANAS MJ, 1978, BIOCHEM BIOPH RES CO, V83, P991; CABANAS MJ, 1978, EUR J BIOCHEM, V87, P21, DOI 10.1111/j.1432-1033.1978.tb12347.x; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHOPRA I, 1992, J ANTIMICROB CHEMOTH, V29, P245, DOI 10.1093/jac/29.3.245; COHEN LB, 1969, BIOCHEMISTRY-US, V8, P1327, DOI 10.1021/bi00832a005; COHEN LB, 1969, BIOCHEMISTRY-US, V8, P1312, DOI 10.1021/bi00832a004; DAHLBERG AE, 1973, BIOCHEMISTRY-US, V12, P948, DOI 10.1021/bi00729a025; DESTASIO EA, 1990, J MOL BIOL, V212, P127, DOI 10.1016/0022-2836(90)90309-A; EGEBJERG J, 1991, BIOCHIMIE, V73, P1145, DOI 10.1016/0300-9084(91)90158-W; EPE B, 1987, FEBS LETT, V213, P443, DOI 10.1016/0014-5793(87)81539-9; EUSTICE DC, 1984, BIOCHEMISTRY-US, V23, P1462, DOI 10.1021/bi00302a019; EUSTICE DC, 1984, ANTIMICROB AGENTS CH, V26, P53, DOI 10.1128/AAC.26.1.53; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gale E.F., 1981, MOL BASIS ANTIBIOTIC, Vsecond; Garrett R. A., 2000, RIBOSOME STRUCTURE F; GEIGENMULLER U, 1986, EUR J BIOCHEM, V161, P723, DOI 10.1111/j.1432-1033.1986.tb10499.x; GONZALEZ A, 1978, BIOCHIM BIOPHYS ACTA, V521, P459, DOI 10.1016/0005-2787(78)90287-3; GORDON J, 1969, J BIOL CHEM, V244, P5680; GUTELL RR, 1996, RIBOSOMAL RNA STRUCT, P111; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Hlavka J. J., 1985, TETRACYCLINES; KAPPEN LS, 1976, BIOCHEMISTRY-US, V15, P811, DOI 10.1021/bi00649a013; Kolesnikov IV, 1996, BIOCHIMIE, V78, P868, DOI 10.1016/S0300-9084(97)84340-4; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; MANAVATHU EK, 1990, ANTIMICROB AGENTS CH, V34, P71, DOI 10.1128/AAC.34.1.71; Mankin AS, 1997, J MOL BIOL, V274, P8, DOI 10.1006/jmbi.1997.1387; MANN RL, 1958, J AM CHEM SOC, V80, P2714, DOI 10.1021/ja01544a032; MAXWELL IH, 1967, BIOCHIM BIOPHYS ACTA, V138, P337, DOI 10.1016/0005-2787(67)90494-7; MOAZED D, 1995, J MOL BIOL, V248, P207, DOI 10.1016/S0022-2836(95)80042-5; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mueller F, 1997, J MOL BIOL, V271, P524, DOI 10.1006/jmbi.1997.1210; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Noah JW, 1999, J BIOL CHEM, V274, P16576, DOI 10.1074/jbc.274.23.16576; Oehler R, 1997, NUCLEIC ACIDS RES, V25, P1219, DOI 10.1093/nar/25.6.1219; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pestka S, 1974, Methods Enzymol, V30, P261; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Ross JI, 1998, ANTIMICROB AGENTS CH, V42, P1702, DOI 10.1128/AAC.42.7.1702; SALYERS AA, 1990, MOL MICROBIOL, V4, P151, DOI 10.1111/j.1365-2958.1990.tb02025.x; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SEMENKOV YP, 1982, FEBS LETT, V144, P125, DOI 10.1016/0014-5793(82)80584-X; SPANGLER EA, 1985, J BIOL CHEM, V260, P6334; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; STEZOWSKI JJ, 1976, J AM CHEM SOC, V98, P6012, DOI 10.1021/ja00435a039; TAI PC, 1973, BIOCHEMISTRY-US, V12, P616, DOI 10.1021/bi00728a008; Taylor DE, 1996, ANTIMICROB AGENTS CH, V40, P1; VAZQUEZ D, 1974, FEBS LETT, V43, pS63; WHITE JP, 1971, J MOL BIOL, V58, P397, DOI 10.1016/0022-2836(71)90255-5; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WOODCOCK J, 1991, EMBO J, V10, P3099, DOI 10.1002/j.1460-2075.1991.tb07863.x; Yoshizawa S, 1998, EMBO J, V17, P6437, DOI 10.1093/emboj/17.22.6437; ZIERHUT G, 1979, EUR J BIOCHEM, V98, P577, DOI 10.1111/j.1432-1033.1979.tb13219.x	63	636	685	6	132	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2000	103	7					1143	1154		10.1016/S0092-8674(00)00216-6	http://dx.doi.org/10.1016/S0092-8674(00)00216-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163189	Bronze			2022-12-24	WOS:000166040600016
J	Peppard, PE; Young, T; Palta, M; Dempsey, J; Skatrud, J				Peppard, PE; Young, T; Palta, M; Dempsey, J; Skatrud, J			Longitudinal study of moderate weight change and sleep-disordered breathing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR RISK-FACTORS; APNEA-SYNDROME; OBESE PATIENTS; NECK CIRCUMFERENCE; DAYTIME SLEEPINESS; NATURAL EVOLUTION; UNITED-STATES; POPULATION; MEN; HYPERTENSION	Context Excess body weight is positively associated with sleep-disordered breathing (SDB), a prevalent condition in the US general population. No large study has been conducted of the longitudinal association between SDB and change in weight. Objective To measure the independent longitudinal association between weight change and change in SDB severity. Design Population-based, prospective cohort study conducted from July 1989 to January 2000. Setting and Participants Six hundred ninety randomly selected employed Wisconsin residents (mean age at baseline, 46 years; 56% male) who were evaluated twice at 4-year intervals for SDB. Main Outcome Measures Percentage change in the apnea-hypopnea index (AHI; apnea events + hypopnea events per hour of sleep) and odds of developing moderate-to-severe SDB (defined by an AHI greater than or equal to 15 events per hour of sleep), with respect to change in weight. Results Relative to stable weight, a 10% weight gain predicted an approximate 32% (95% confidence interval [CI], 20%-45%) increase in the AHI, A 10% weight loss predicted a 26% (95% CI, 18%-34%) decrease in the AHI. A 10% increase in weight predicted a 6-fold (95% CI, 2.2-17.0) increase in the odds of developing moderate-to-severe SDB. Conclusions Our data indicate that clinical and public health programs that result in even modest weight control are likely to be effective in managing SDB and reducing new occurrence of SDB.	Univ Wisconsin, Sch Med, Dept Prevent Med, Madison, WI 53705 USA; Univ Wisconsin, Sch Med, Dept Med, Madison, WI 53705 USA; Univ Wisconsin, Sch Med, Dept Biostat & Med Informat, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Peppard, PE (corresponding author), Univ Wisconsin, Sch Med, Dept Prevent Med, 502 N Walnut St, Madison, WI 53705 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014124] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03186] Funding Source: Medline; NHLBI NIH HHS [R01HL62252] Funding Source: Medline; NIA NIH HHS [AG14124-05] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEARPARK H, 1995, AM J RESP CRIT CARE, V151, P1459, DOI 10.1164/ajrccm.151.5.7735600; BEARPARK H, 1993, SLEEP, V16, pS3; CHARUZI I, 1985, SURGERY, V97, P535; DAVIES RJO, 1990, EUR RESPIR J, V3, P509; DAVIES RJO, 1992, THORAX, V47, P101, DOI 10.1136/thx.47.2.101; Engleman HM, 1997, THORAX, V52, P114, DOI 10.1136/thx.52.2.114; Enright PL, 1996, SLEEP, V19, P531, DOI 10.1093/sleep/19.7.531; FERINISTRAMBI L, 1994, CHEST, V105, P1759, DOI 10.1378/chest.105.6.1759; Finn L, 1998, SLEEP, V21, P701; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Gottlieb DJ, 1999, AM J RESP CRIT CARE, V159, P502, DOI 10.1164/ajrccm.159.2.9804051; GRUNSTEIN R, 1993, INT J OBESITY, V17, P533; GRUNSTEIN RR, 1995, INT J OBESITY, V19, P410; GUILLEMINAULT C, 1995, ANN INTERN MED, V122, P493, DOI 10.7326/0003-4819-122-7-199504010-00003; HARMAN EM, 1982, CHEST, V82, P291, DOI 10.1378/chest.82.3.291; HOFFSTEIN V, 1992, EUR RESPIR J, V5, P377; Hu FB, 1999, AM J EPIDEMIOL, V150, P806; Hu FB, 2000, J AM COLL CARDIOL, V35, P308, DOI 10.1016/S0735-1097(99)00540-9; JENNUM P, 1992, CHEST, V102, P1371, DOI 10.1378/chest.102.5.1371; JENNUM P, 1993, INT J EPIDEMIOL, V22, P439, DOI 10.1093/ije/22.3.439; JOHNS MW, 1993, CHEST, V103, P30, DOI 10.1378/chest.103.1.30; KATZ I, 1990, AM REV RESPIR DIS, V141, P1228, DOI 10.1164/ajrccm/141.5_Pt_1.1228; Kim HC, 1997, AM J RESP CRIT CARE, V156, P1813, DOI 10.1164/ajrccm.156.6.9610026; KISELAK J, 1993, CHEST, V104, P775, DOI 10.1378/chest.104.3.775; KOSKENVUO M, 1987, BRIT MED J, V294, P16, DOI 10.1136/bmj.294.6563.16; KOSKENVUO M, 1985, LANCET, V1, P893; Kripke DF, 1997, SLEEP, V20, P65, DOI 10.1093/sleep/20.1.65; LEVINSON PD, 1993, CHEST, V103, P1336, DOI 10.1378/chest.103.5.1336; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; Lindberg E, 1998, THORAX, V53, P631, DOI 10.1136/thx.53.8.631; LOHMAN TG, 1988, ANTHROPOMETRIC STAND, P1; MILLMAN RP, 1995, CHEST, V107, P362, DOI 10.1378/chest.107.2.362; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mortimore IL, 1998, AM J RESP CRIT CARE, V157, P280, DOI 10.1164/ajrccm.157.1.9703018; Nahmias J, 1993, N J Med, V90, P48; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Noseda A, 1996, CHEST, V109, P138, DOI 10.1378/chest.109.1.138; OLSON LG, 1995, AM J RESP CRIT CARE, V152, P711, DOI 10.1164/ajrccm.152.2.7633731; PARTINEN M, 1988, CHEST, V94, P1200, DOI 10.1378/chest.94.6.1200; PARTINEN M, 1990, CHEST, V97, P27, DOI 10.1378/chest.97.1.27; PASQUALI R, 1990, INT J OBESITY, V14, P207; PEISER J, 1984, ANN SURG, V199, P125; Pendlebury ST, 1997, THORAX, V52, P872, DOI 10.1136/thx.52.10.872; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; PILLAR G, 1994, CHEST, V106, P1702, DOI 10.1378/chest.106.6.1702; RAJALA R, 1991, J INTERN MED, V230, P125, DOI 10.1111/j.1365-2796.1991.tb00419.x; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Redline S, 1997, SLEEP, V20, P160, DOI 10.1093/sleep/20.2.160; Rothman K., 1998, MODERN EPIDEMIOLOGY; RUBINSTEIN I, 1988, AM REV RESPIR DIS, V138, P1192, DOI 10.1164/ajrccm/138.5.1192; SCHMIDTNOWARA WW, 1990, ARCH INTERN MED, V150, P597, DOI 10.1001/archinte.150.3.597; SCHWARTZ AR, 1991, AM REV RESPIR DIS, V144, P494, DOI 10.1164/ajrccm/144.3_Pt_1.494; SFORZA E, 1994, EUR RESPIR J, V7, P1765, DOI 10.1183/09031936.94.07101765; SHELTON KE, 1993, AM REV RESPIR DIS, V148, P462, DOI 10.1164/ajrccm/148.2.462; Shinohara E, 1997, J INTERN MED, V241, P11, DOI 10.1046/j.1365-2796.1997.63889000.x; SMITH PL, 1985, ANN INTERN MED, V103, P850, DOI 10.7326/0003-4819-103-6-850; STRADLING JR, 1991, THORAX, V46, P85, DOI 10.1136/thx.46.2.85; Strobel RJ, 1996, SLEEP, V19, P104, DOI 10.1093/sleep/19.2.104; SURATT PM, 1987, CHEST, V92, P631, DOI 10.1378/chest.92.4.631; SURATT PM, 1992, AM J CLIN NUTR, V56, P1825; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; WETTER DW, 1994, ARCH INTERN MED, V154, P2219, DOI 10.1001/archinte.154.19.2219; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	65	1003	1065	2	36	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2000	284	23					3015	3021		10.1001/jama.284.23.3015	http://dx.doi.org/10.1001/jama.284.23.3015			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	382VC	11122588	Bronze			2022-12-24	WOS:000165847200026
J	Laub, MT; McAdams, TH; Feldblyum, T; Fraser, CM; Shapiro, L				Laub, MT; McAdams, TH; Feldblyum, T; Fraser, CM; Shapiro, L			Global analysis of the genetic network controlling a bacterial cell cycle	SCIENCE			English	Article							DEPENDENT POLAR LOCALIZATION; CAULOBACTER-CRESCENTUS; DNA-REPLICATION; REGULATOR; PROTEIN	This report presents full-genome evidence that bacterial cells use discrete transcription patterns to control cell cycle progression. Global transcription analysis of synchronized Caulobacter crescentus cells was used to identify 553 genes (19% of the genome) whose messenger RNA Levels varied as a function of the cell cycle. We conclude that in bacteria, as in yeast, (i) genes involved in a given cell function are activated at the time of execution of that function, (ii) genes encoding proteins that function in complexes are coexpressed, and (iii) temporal cascades of gene expression control multiprotein structure biogenesis. A single regulatory factor, the CtrA member of the two-component signal transduction family, is directly or indirectly involved in the control of 26% of the cell cycle-regulated genes.	Stanford Univ, Sch Med, Dept Dev Biol, Beckman Ctr, Stanford, CA 94305 USA; Inst Genom Res, Rockville, MD 20850 USA	Stanford University; J. Craig Venter Institute	Shapiro, L (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Beckman Ctr, Stanford, CA 94305 USA.			Fraser, Claire/0000-0003-1462-2428; Laub, Michael/0000-0002-8288-7607	NIGMS NIH HHS [GM51426, GM32506] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032506, R37GM032506] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; DRAPER GC, 2000, INTERACTIONS GIDA CH; Gober JW, 2000, PROKARYOTIC DEVELOPMENT, P319; Hung D, 2000, PROKARYOTIC DEVELOPMENT, P361; IBA H, 1978, J BACTERIOL, V135, P647, DOI 10.1128/JB.135.2.647-655.1978; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; LAUB MT, UNPUB; Missiakas D, 1998, MOL MICROBIOL, V28, P1059, DOI 10.1046/j.1365-2958.1998.00865.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; NEWTON A, 1972, P NATL ACAD SCI USA, V69, P447, DOI 10.1073/pnas.69.2.447; Ohta N, 2000, PROKARYOTIC DEVELOPMENT, P341; ONEILL EA, 1987, J BACTERIOL, V169, P2618, DOI 10.1128/jb.169.6.2618-2623.1987; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2	19	396	402	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2000	290	5499					2144	2148		10.1126/science.290.5499.2144	http://dx.doi.org/10.1126/science.290.5499.2144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	383ER	11118148				2022-12-24	WOS:000165870600056
J	Blight, KJ; Kolykhalov, AA; Rice, CM				Blight, KJ; Kolykhalov, AA; Rice, CM			Efficient initiation of HCV RNA replication in cell culture	SCIENCE			English	Article							HEPATITIS-C VIRUS; NONSTRUCTURAL PROTEIN 5A; NS5A; INTERFERON; HYPERPHOSPHORYLATION; PHOSPHORYLATION; REGION; LIVER; NS4A; NS3	Hepatitis C virus (HCV) infection is a global health problem affecting an estimated 170 million individuals worldwide. We report the identification of multiple independent adaptive mutations that cluster in the HCV nonstructural protein NS5A and confer increased replicative ability in vitro. Among these adaptive mutations were a single amino acid substitution that allowed HCV RNA replication in 10% of transfected hepatoma cells and a deletion of 47 amino acids encompassing the interferon (IFN) sensitivity determining region (ISDR). Independent of the ISDR, IFN-alpha rapidly inhibited HCV RNA replication in vitro. This work establishes a robust, cell-based system for genetic and functional analyses of HCV replication.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA	Washington University (WUSTL); Rockefeller University	Rice, CM (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	ricec@rockvax.rockefeller.edu			NATIONAL CANCER INSTITUTE [R01CA057973] Funding Source: NIH RePORTER; NCI NIH HHS [CA57973] Funding Source: Medline; NIAID NIH HHS [AI40034] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Chung KM, 2000, J VIROL, V74, P5233, DOI 10.1128/JVI.74.11.5233-5241.2000; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; HAGEDORN CH, 1999, HEPATITIS C VIRUSES; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; Koch JO, 1999, J VIROL, V73, P7138; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Neddermann P, 1999, J VIROL, V73, P9984, DOI 10.1128/JVI.73.12.9984-9991.1999; Noguchi M, 1996, IN VITRO CELL DEV-AN, V32, P135; Reed KE, 1997, J VIROL, V71, P7187, DOI 10.1128/JVI.71.10.7187-7197.1997; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738	18	1191	1346	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 8	2000	290	5498					1972	1974		10.1126/science.290.5498.1972	http://dx.doi.org/10.1126/science.290.5498.1972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382EL	11110665				2022-12-24	WOS:000165810000048
J	Ye, KQ; Hurt, J; Wu, FY; Fang, M; Luo, HBR; Hong, JJ; Blackshaw, S; Ferris, CD; Snyder, SH				Ye, KQ; Hurt, J; Wu, FY; Fang, M; Luo, HBR; Hong, JJ; Blackshaw, S; Ferris, CD; Snyder, SH			PIKE: A nuclear GTPase that enhances PI3Kinase activity and is regulated by protein 4.1N	CELL			English	Article							NERVE GROWTH-FACTOR; PHOSPHATIDYLINOSITOL KINASE-ACTIVITY; GUANINE-NUCLEOTIDE-EXCHANGE; MITOTIC APPARATUS PROTEIN; HUMAN MXB PROTEIN; PC12 CELLS; NEURITE OUTGROWTH; PHOSPHOINOSITIDE 3-KINASE; CYCLIN D1; ACTIVATION	While cytoplasmic PI3Kinase (PI3K) is well characterized, regulation of nuclear PI3K has been obscure. A novel protein, PIKE (PI3Kinase Enhancer), interacts with nuclear PI3K to stimulate its lipid kinase activity. PIKE encodes a 753 amino acid nuclear GTPase. Dominant-negative PIKE prevents the NGF enhancement of PI3K and upregulation of cyclin D1. NGF treatment also leads to PIKE interactions with 4.1N, which has translocated to the nucleus, fitting with the initial identification of PIKE based on its binding 4.1N in a yeast two-hybrid screen. Overexpression of 4.1N abolishes PIKE effects on PI3K. Activation of nuclear PI3K by PIKE is inhibited by the NGF-stimulated 4.1N translocation to the nucleus. Thus, PIKE physiologically modulates the activation by NGF of nuclear PI3K.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Hurt, K. Joseph/J-8266-2019	Hurt, K. Joseph/0000-0001-6906-350X	NCI NIH HHS [CA00266] Funding Source: Medline; NIDA NIH HHS [DA-00074] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; AltunGultekin ZF, 1996, J NEUROSCI RES, V44, P308, DOI 10.1002/(SICI)1097-4547(19960515)44:4<308::AID-JNR2>3.0.CO;2-G; Ashcroft M, 1999, ONCOGENE, V18, P4586, DOI 10.1038/sj.onc.1202814; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BAETGE EE, 1991, NEURON, V6, P21, DOI 10.1016/0896-6273(91)90118-J; Bavelloni A, 1999, J CELL SCI, V112, P631; Blackshaw S, 1997, J NEUROSCI, V17, P8074; Boglari G, 1998, EUR J CELL BIOL, V75, P54, DOI 10.1016/S0171-9335(98)80046-0; BRANDT DR, 1985, J BIOL CHEM, V260, P266; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARTER AN, 1992, J BIOL CHEM, V267, P14563; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; D'Mello SR, 1997, J NEUROSCI, V17, P1548; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; Hallberg B, 1998, ONCOGENE, V17, P691, DOI 10.1038/sj.onc.1201980; Jackson TR, 1996, J CELL SCI, V109, P289; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; Kim SH, 1998, J VIROL, V72, P994, DOI 10.1128/JVI.72.2.994-1004.1998; Kim SJ, 1998, BIOCHEM MOL BIOL INT, V46, P187; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Klinghoffer RA, 1996, MOL CELL BIOL, V16, P5905; Kobayashi M, 1997, J BIOL CHEM, V272, P16089, DOI 10.1074/jbc.272.26.16089; Krugmann S, 1998, CURR BIOL, V8, pR828; Lu PJ, 1998, BIOCHEMISTRY-US, V37, P5738, DOI 10.1021/bi972551g; LYDERSEN BK, 1980, CELL, V22, P489, DOI 10.1016/0092-8674(80)90359-1; MAJERUS PW, 1990, CELL, V63, P459, DOI 10.1016/0092-8674(90)90442-H; Marchisio M, 1998, BIOCHEM BIOPH RES CO, V253, P346, DOI 10.1006/bbrc.1998.9787; Melen K, 1997, J BIOL CHEM, V272, P32353, DOI 10.1074/jbc.272.51.32353; Melen K, 1996, J BIOL CHEM, V271, P23478, DOI 10.1074/jbc.271.38.23478; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; NERI LM, 1994, CELL MOL BIOL, V40, P619; Neri LM, 1999, FASEB J, V13, P2299, DOI 10.1096/fasebj.13.15.2299; OHMICHI M, 1992, NEURON, V9, P769, DOI 10.1016/0896-6273(92)90039-G; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; PRICE CM, 1986, EXP CELL RES, V166, P295, DOI 10.1016/0014-4827(86)90478-7; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Rush MG, 1996, BIOESSAYS, V18, P103, DOI 10.1002/bies.950180206; Salehi A, 1996, NEUROSCIENCE, V75, P373, DOI 10.1016/0306-4522(96)00273-4; SANO M, 1995, BRAIN RES, V688, P213, DOI 10.1016/0006-8993(95)00558-8; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Takuwa N, 1999, MOL CELL BIOL, V19, P1346; Tanaka K, 1999, J BIOL CHEM, V274, P3919, DOI 10.1074/jbc.274.7.3919; UEDA T, 1979, J CELL BIOL, V83, P308, DOI 10.1083/jcb.83.2.308; vanGrunsven LA, 1996, ONCOGENE, V12, P1347; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Walensky LD, 1999, J NEUROSCI, V19, P6457; WARD SG, 1993, EUR J IMMUNOL, V23, P2572, DOI 10.1002/eji.1830231029; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Xiong W, 1997, MOL CELL BIOL, V17, P6585, DOI 10.1128/MCB.17.11.6585; YAN GZ, 1995, J NEUROSCI, V15, P6200; YANG CH, 1992, MOL BIOL CELL, V3, P1259, DOI 10.1091/mbc.3.11.1259; YANKNER BA, 1979, P NATL ACAD SCI USA, V76, P1269, DOI 10.1073/pnas.76.3.1269; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	73	140	146	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 8	2000	103	6					919	930		10.1016/S0092-8674(00)00195-1	http://dx.doi.org/10.1016/S0092-8674(00)00195-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136977	Bronze			2022-12-24	WOS:000165801300011
J	Simpson, AA; Tao, YZ; Leiman, PG; Badasso, MO; He, YN; Jardine, PJ; Olson, NH; Morais, MC; Grimes, S; Anderson, DL; Baker, TS; Rossmann, MG				Simpson, AA; Tao, YZ; Leiman, PG; Badasso, MO; He, YN; Jardine, PJ; Olson, NH; Morais, MC; Grimes, S; Anderson, DL; Baker, TS; Rossmann, MG			Structure of the bacteriophage phi 29 DNA packaging motor	NATURE			English	Article							IN-VITRO; RNA; CONNECTOR; RESOLUTION; SYMMETRY; PROTEIN; PROHEAD; MACHINE; DOMAIN; ATPASE	Motors generating mechanical force, powered by the hydrolysis of ATP, translocate double-stranded DNA into preformed capsids (proheads) of bacterial viruses(1,2) and certain animal viruses(3). Here we describe the motor that packages the double-stranded DNA of the Bacillus subtilis bacteriophage phi 29 into a precursor capsid. We determined the structure of the head-tail connector-the central component of the phi 29 DNA packaging motor-to 3.2 Angstrom resolution by means of X-ray crystallography. We then fitted the connector into the electron densities of the prohead and of the partially packaged prohead as determined using cryo-electron microscopy and image reconstruction analysis. Our results suggest that the prohead plus dodecameric connector, prohead RNA, viral ATPase and DNA comprise a rotary motor with the head-prohead RNA-ATPase complex acting as a stator, the DNA acting as a spindle, and the connector as a ball-race. The helical nature of the DNA converts the rotary action of the connector into translation of the DNA.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Oral Sci, Minneapolis, MN 55455 USA; Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of New Brunswick	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.		Leiman, Petr G/E-5120-2010	Leiman, Petr G/0000-0002-9091-0918; Jardine, Paul/0000-0002-1090-0550; , Timothy/0000-0001-6543-8968	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033050] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM033050] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ANDERSON DL, 1966, J BACTERIOL, V91, P2081, DOI 10.1128/JB.91.5.2081-2089.1966; Badasso MO, 2000, ACTA CRYSTALLOGR D, V56, P1187, DOI 10.1107/S0907444900009239; BAILEY S, 1990, J BIOL CHEM, V265, P22365; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; DONATE LE, 1993, J BIOL CHEM, V268, P20198; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; GRIMES S, 1990, J MOL BIOL, V215, P559, DOI 10.1016/S0022-2836(05)80168-8; Guasch A, 1998, J MOL BIOL, V281, P219, DOI 10.1006/jmbi.1998.1928; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1987, SCIENCE, V236, P690, DOI 10.1126/science.3107124; Guo PX, 1998, MOL CELL, V2, P149, DOI 10.1016/S1097-2765(00)80124-0; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hendrix RW, 1998, CELL, V94, P147, DOI 10.1016/S0092-8674(00)81413-0; Ibarra B, 2000, J MOL BIOL, V298, P807, DOI 10.1006/jmbi.2000.3712; Muller DJ, 1997, EMBO J, V16, P2547, DOI 10.1093/emboj/16.10.2547; REID RJD, 1994, J BIOL CHEM, V269, P9084; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; ROSSMANN MG, IN PRESS INT TABLE C, VF; SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Valle M, 1999, J MOL BIOL, V288, P899, DOI 10.1006/jmbi.1999.2731; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510; Valpuesta JM, 1999, STRUCTURE, V7, P289, DOI 10.1016/S0969-2126(99)80039-2; VLCEK C, 1986, GENE, V46, P215, DOI 10.1016/0378-1119(86)90406-3; Zhang F, 1998, MOL CELL, V2, P141, DOI 10.1016/S1097-2765(00)80123-9; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999	28	428	441	2	47	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2000	408	6813					745	750		10.1038/35047129	http://dx.doi.org/10.1038/35047129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130079	Green Accepted			2022-12-24	WOS:000165815200055
J	[Anonymous]				[Anonymous]			Developing countries and poorest people targeted by UN centre	NATURE			English	Article																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2000	408	6813					754	754		10.1038/35047219	http://dx.doi.org/10.1038/35047219			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130081	Bronze			2022-12-24	WOS:000165815200060
J	Hardy, J				Hardy, J			Sedation in terminally ill patients	LANCET			English	Editorial Material							HOSPICE		Royal Marsden, Dept Palliat Med, Sutton SM2 5PT, Surrey, England	Royal Marsden NHS Foundation Trust	Hardy, J (corresponding author), Royal Marsden, Dept Palliat Med, Sutton SM2 5PT, Surrey, England.		Hardy, Janet/F-2501-2012	Hardy, Janet/0000-0003-1127-9951				Back Ian N., 1992, Palliative Medicine, V6, P293, DOI 10.1177/026921639200600404; Billings JA, 1996, J PALLIAT CARE, V12, P21, DOI 10.1177/082585979601200404; BRUERA E, 1995, J PAIN SYMPTOM MANAG, V10, P287, DOI 10.1016/0885-3924(95)00005-J; Chater S, 1998, PALLIATIVE MED, V12, P255, DOI 10.1191/026921698671831786; Fainsinger RL, 2000, PALLIATIVE MED, V14, P257, DOI 10.1191/026921600666097479; Fainsinger RL, 1998, J PAIN SYMPTOM MANAG, V16, P145, DOI 10.1016/S0885-3924(98)00066-9; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; Stone P, 1997, PALLIATIVE MED, V11, P140, DOI 10.1177/026921639701100208; SYKES N, 2000, PAIN EUROPE, V3, P71	9	21	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 2	2000	356	9245					1866	1867		10.1016/S0140-6736(00)03252-9	http://dx.doi.org/10.1016/S0140-6736(00)03252-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379WD	11130377				2022-12-24	WOS:000165665400004
J	Shorey, L; Piertney, S; Stone, J; Hoglund, J				Shorey, L; Piertney, S; Stone, J; Hoglund, J			Fine-scale genetic structuring on Manacus manacus leks	NATURE			English	Article							KIN SELECTION; RELATEDNESS; MARKERS; SUCCESS; MALES; BIRDS	Leks have traditionally been considered as arenas where males compete to attract females and secure matings. Thus, direct fitness benefits mediated through competition between males to fertilize females have been considered to be the primary force driving the evolution of lekking behaviour(1,2). Inclusive fitness benefits mediated through kin selection(3) may also be involved in lek formation and evolution(4,5), but to date this theory has been largely ignored. According to kin-selection theory, both reproducing and non-reproducing males may gain indirect inclusive fitness benefits. If females are attracted to larger leks, non-reproducing males add attractiveness to a lek, and therefore, in a genetically structured population, boost the reproductive success of kin. Theory predicts that the attractiveness of leks is plastic, and that males establish themselves on a lek in which the top male, in terms of reproductive success, is a close relative(6). Here we show that in white-bearded manakins (Manacus manacus), for which larger leks are more attractive to females(7,8) and so secure the maximum number of matings, there is extraordinary fine-scale genetic structure, with leks being composed of clusters of related kin. We propose that males establish themselves where they rnd relatives to such an extent that they form groups within leks, and that such behaviour is consistent with kin-selection theory to maximize reproductive success of the group.	Uppsala Univ, Populat Biol EBC, SE-75236 Uppsala, Sweden; Univ Aberdeen, Dept Zool, NERC Mol Genet Ecol Initiat, Aberdeen AB24 2TZ, Scotland; Uppsala Univ, Anim Ecol EBC, SE-75236 Uppsala, Sweden	Uppsala University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Aberdeen; Uppsala University	Shorey, L (corresponding author), Uppsala Univ, Populat Biol EBC, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	lisa.shorey@ebc.uu.se	Piertney, Stuart/I-3144-2012	Piertney, Stuart/0000-0001-6654-0569; Hoglund, Jacob/0000-0002-5840-779X				HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hoglund J, 1999, P ROY SOC B-BIOL SCI, V266, P813; Hoglund J, 1995, LEKS, DOI DOI 10.1515/9781400864157; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P919, DOI 10.1098/rspb.1996.0136; Kokko H, 1998, ANIM BEHAV, V56, P755, DOI 10.1006/anbe.1998.0815; LILL A, 1974, Zeitschrift fuer Tierpsychologie, V36, P1; LILL A, 1974, Zeitschrift fuer Tierpsychologie, V36, P513; Lynch M, 1999, GENETICS, V152, P1753; MCDONALD DB, 1994, SCIENCE, V266, P1030, DOI 10.1126/science.7973654; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; Sherman Paul W., 1997, P69; Sherman PW, 1999, NATURE, V401, P119, DOI 10.1038/43574; SNOW D. W., 1962, ZOOLOGICA [NEW YORK], V47, P65; Wiley RH, 1991, ADV STUD BEHAV, V20, P201	14	92	92	0	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 16	2000	408	6810					352	353		10.1038/35042562	http://dx.doi.org/10.1038/35042562			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099040				2022-12-24	WOS:000165296000043
J	Mothes, W; Boerger, AL; Narayan, S; Cunningham, JM; Young, JAT				Mothes, W; Boerger, AL; Narayan, S; Cunningham, JM; Young, JAT			Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein	CELL			English	Article							ROUS-SARCOMA VIRUS; MEMBRANE-FUSION; INFLUENZA HEMAGGLUTININ; AVIAN-LEUKOSIS; CONFORMATIONAL-CHANGES; CELL-FUSION; HIV-1 ENTRY; PROTEIN; INFECTION; CLATHRIN	Avian leukosis virus (ALV) has been used as a model system to understand the mechanism of pH-independent viral entry involving receptor-induced conformational changes in the viral envelope (Env) glycoprotein that lead to membrane fusion. Here, we report the unexpected finding that ALV entry depends on a critical low pH step that was overlooked when this virus was directly compared to the classical pH-dependent influenza A virus. In contrast to influenza A virus, receptor interaction plays an essential role in priming ALV Env for subsequent low pH triggering. Our results reveal a novel principle in viral entry, namely that receptor interaction can convert a pH-insensitive viral glycoprotein to a form that is responsive to low pH.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol & Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison	Young, JAT (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.			Young, John/0000-0003-1824-2561	NATIONAL CANCER INSTITUTE [R01CA070810] Funding Source: NIH RePORTER; NCI NIH HHS [CA70810] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adkins HB, 2000, J VIROL, V74, P3572, DOI 10.1128/JVI.74.8.3572-3578.2000; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; ANDERSEN KB, 1983, VIROLOGY, V125, P85, DOI 10.1016/0042-6822(83)90065-X; Balliet JW, 1999, J VIROL, V73, P3054, DOI 10.1128/JVI.73.4.3054-3061.1999; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; Boerger AL, 1999, P NATL ACAD SCI USA, V96, P9867, DOI 10.1073/pnas.96.17.9867; BOERKOEL CF, 1993, VIROLOGY, V195, P669, DOI 10.1006/viro.1993.1418; Brojatsch J, 1996, CELL, V87, P845, DOI 10.1016/S0092-8674(00)81992-3; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chernomordik LV, 1999, MOL MEMBR BIOL, V16, P33; Damico RL, 1998, P NATL ACAD SCI USA, V95, P2580, DOI 10.1073/pnas.95.5.2580; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; Drose S, 1997, J EXP BIOL, V200, P1; Durrer P, 1996, J BIOL CHEM, V271, P13417, DOI 10.1074/jbc.271.23.13417; DUVE CD, 1974, BIOCHEM PHARMACOL, V23, P2495; FAN H, 1974, J VIROL, V14, P421, DOI 10.1128/JVI.14.3.421-429.1974; GILBERT JM, 1990, J VIROL, V64, P5106, DOI 10.1128/JVI.64.10.5106-5113.1990; GILBERT JM, 1995, J VIROL, V69, P7410, DOI 10.1128/JVI.69.12.7410-7415.1995; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; Hernandez LD, 1997, J CELL BIOL, V139, P1455, DOI 10.1083/jcb.139.6.1455; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Marsh M, 1997, J CELL SCI, V110, P95; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; ORY DS, 1996, P NATL ACAD SCI USA, V93, P1140; PURI A, 1990, J VIROL, V64, P3824, DOI 10.1128/JVI.64.8.3824-3832.1990; REDMOND S, 1984, VIROLOGY, V133, P393, DOI 10.1016/0042-6822(84)90405-7; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Snitkovsky S, 1998, P NATL ACAD SCI USA, V95, P7063, DOI 10.1073/pnas.95.12.7063; Sodroski JG, 1999, CELL, V99, P243, DOI 10.1016/S0092-8674(00)81655-4; STEGMANN T, 1995, BIOCHEM J, V307, P875, DOI 10.1042/bj3070875; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; Telesnitsky A., 1997, P121; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	38	249	259	1	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 10	2000	103	4					679	689		10.1016/S0092-8674(00)00170-7	http://dx.doi.org/10.1016/S0092-8674(00)00170-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	374MB	11106737	Bronze			2022-12-24	WOS:000165348000012
J	Blumberg, H; Conklin, D; Xu, WF; Grossmann, A; Brender, T; Carollo, S; Eagan, M; Foster, D; Haldeman, BA; Hammond, A; Haugen, H; Jelinek, L; Kelly, JD; Madden, K; Maurer, MF; Parrish-Novak, J; Prunkard, D; Sexson, S; Sprecher, C; Waggie, K; West, J; Whitmore, TE; Yao, L; Kuechle, MK; Dale, BA; Chandrasekher, YA				Blumberg, H; Conklin, D; Xu, WF; Grossmann, A; Brender, T; Carollo, S; Eagan, M; Foster, D; Haldeman, BA; Hammond, A; Haugen, H; Jelinek, L; Kelly, JD; Madden, K; Maurer, MF; Parrish-Novak, J; Prunkard, D; Sexson, S; Sprecher, C; Waggie, K; West, J; Whitmore, TE; Yao, L; Kuechle, MK; Dale, BA; Chandrasekher, YA			Interleukin 20: Discovery, receptor identification, and role in epidermal function	CELL			English	Article							DIFFERENTIATION-ASSOCIATED GENE; TRANSGENIC MICE; MELANOMA DIFFERENTIATION; EXPRESSION; PSORIASIS; CYTOKINE; SEQUENCE; PROTEINS; ANTIGEN; GROWTH	A structural, profile-based algorithm was used to identify interleukin 20 (IL-20), a novel IL-10 homolog. Chromosomal localization of IL-20 led to the discovery of an IL-10 family cytokine cluster. Overexpression of IL-20 in transgenic (TG) mice causes neonatal lethality with skin abnormalities including aberrant epidermal differentiation. Recombinant IL-20 protein stimulates a signal transduction pathway through STAT3 in a keratinocyte cell line, demonstrating a direct action of this ligand. An IL-20 receptor was identified as a heterodimer of two orphan class II cytokine receptor subunits. Both receptor subunits are expressed in skin and are dramatically upregulated in psoriatic skin. Taken together, these results demonstrate a role in epidermal function and psoriasis for IL-20, a novel cytokine identified solely by bioinformatics analysis.	Zymogenet Inc, In Vitro Biol, Seattle, WA 98102 USA; Zymogenet Inc, Dept Genet, Seattle, WA 98102 USA; Zymogenet Inc, Biomol Informat, Seattle, WA 98102 USA; Zymogenet Inc, Funct Cloning, Seattle, WA 98102 USA; Univ Washington, Dept Oral Biol & Med Dermatol, Seattle, WA 98195 USA	Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; University of Washington; University of Washington Seattle	Chandrasekher, YA (corresponding author), Zymogenet Inc, In Vitro Biol, 1201 Eastlake Ave E, Seattle, WA 98102 USA.							Asadullah K, 1998, J CLIN INVEST, V101, P783, DOI 10.1172/JCI1476; Asadullah K, 1999, ARCH DERMATOL RES, V291, P628, DOI 10.1007/s004030050467; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Bos JD, 1999, IMMUNOL TODAY, V20, P40, DOI 10.1016/S0167-5699(98)01381-4; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Carroll JM, 1997, J INVEST DERMATOL, V108, P412, DOI 10.1111/1523-1747.ep12289702; Castelijns FACM, 1999, J AM ACAD DERMATOL, V40, P901, DOI 10.1016/S0190-9622(99)70077-0; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DIETRICH DR, 1993, CRIT REV TOXICOL, V23, P77, DOI 10.3109/10408449309104075; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Domanski Paul, 1996, Cytokine and Growth Factor Reviews, V7, P143, DOI 10.1016/1359-6101(96)00017-2; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Eskdale J, 1997, IMMUNOGENETICS, V46, P120, DOI 10.1007/s002510050250; GIJBELS MJJ, 1995, ULTRASTRUCT PATHOL, V19, P107, DOI 10.3109/01913129509014610; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; GRUSSENMEYER T, 1985, P NATL ACAD SCI USA, V82, P7952, DOI 10.1073/pnas.82.23.7952; GUO LF, 1993, EMBO J, V12, P973, DOI 10.1002/j.1460-2075.1993.tb05738.x; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; JAHN H, 1988, APMIS, V96, P723, DOI 10.1111/j.1699-0463.1988.tb00936.x; Jiang HP, 1995, ONCOGENE, V11, P2477; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P9160, DOI 10.1073/pnas.93.17.9160; Karasek MA, 1999, CUTIS, V64, P319; Knappe A, 2000, J VIROL, V74, P3881, DOI 10.1128/JVI.74.8.3881-3887.2000; Koller M R, 1996, J Hematother, V5, P449, DOI 10.1089/scd.1.1996.5.449; Kotenko SV, 2000, ONCOGENE, V19, P2557, DOI 10.1038/sj.onc.1203524; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Michel G, 1997, J IMMUNOL, V159, P6291; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; PALMITER RD, 1993, MOL CELL BIOL, V13, P5266, DOI 10.1128/MCB.13.9.5266; Pestka Sidney, 1997, Cytokine and Growth Factor Reviews, V8, P189, DOI 10.1016/S1359-6101(97)00009-9; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Poulsen LK, 1998, J BIOL CHEM, V273, P6228, DOI 10.1074/jbc.273.11.6228; ROSEN CA, 1999, Patent No. 5985614; SCHERINGPLOUGH CORP, 1999, Patent No. 9946379; SHEEHAN DC, 1980, THEORY PRACTICE HIST, P59; SUN TT, 1985, ANN NY ACAD SCI, V455, P307, DOI 10.1111/j.1749-6632.1985.tb50419.x; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; VIEIRA P, 1991, P NATL ACAD SCI USA, V88, P1172, DOI 10.1073/pnas.88.4.1172; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219; ZYMOGENETICS INC, 2000, Patent No. 0053761	44	438	557	1	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2001	104	1					9	19		10.1016/S0092-8674(01)00187-8	http://dx.doi.org/10.1016/S0092-8674(01)00187-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163236	Bronze			2022-12-24	WOS:000166882300003
J	Gruss, OJ; Carazo-Salas, RE; Schatz, CA; Guarguaglini, G; Kast, J; Wilm, M; Le Bot, N; Vernos, I; Karsenti, E; Mattaj, IW				Gruss, OJ; Carazo-Salas, RE; Schatz, CA; Guarguaglini, G; Kast, J; Wilm, M; Le Bot, N; Vernos, I; Karsenti, E; Mattaj, IW			Ran induces spindle assembly by reversing the inhibitory effect of importin alpha on TPX2 activity	CELL			English	Article							XENOPUS EGG EXTRACTS; NUCLEAR-PROTEIN IMPORT; SMALL GTPASE RAN; SELF-ORGANIZATION; NUCLEOTIDE EXCHANGE; POLYACRYLAMIDE GELS; MICROTUBULE ASTERS; TRANSPORT FACTORS; CELL-CYCLE; BOUND RAN	The small GTPase Ran, bound to GTP, is required for the induction of spindle formation by chromosomes in M phase. High concentrations of Ran.GTP are proposed to surround M phase chromatin. We show that the action of Ran.GTP in spindle formation requires TPX2, a microtubule-associated protein previously known to target a motor protein, Xklp2, to microtubules. TPX2 is normally inactivated by binding to the nuclear import factor, importin alpha, and is displaced from importin alpha by the action of Ran.GTP. TPX2 is required for Ran.GTP and chromatin-induced microtubule assembly in M phase extracts and mediates spontaneous microtubule assembly when present in excess over free importin alpha. Thus, components of the nuclear transport machinery serve to regulate spindle formation in M phase.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Mattaj, IW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Vernos, Isabelle/C-1687-2015	Vernos, Isabelle/0000-0003-1469-9214; Wilm, Matthias/0000-0002-5461-6834; Le Bot, Nathalie/0000-0002-5258-2837; Mattaj, Iain/0000-0002-5537-8284; Carazo-Salas, Rafael E/0000-0002-5943-3981				Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; [Anonymous], 1990, METHOD ENZYMOL, DOI 10.1016/0076-6879(90)82024-v; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boleti H, 1996, CELL, V84, P49, DOI 10.1016/S0092-8674(00)80992-7; Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378; Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; CARAZOSALAS RE, 2001, IN PRESS NAT CELL BI; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; DASSO M, 1993, TRENDS BIOCHEM SCI, V18, P96, DOI 10.1016/0968-0004(93)90161-F; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Heidebrecht HJ, 1997, BLOOD, V90, P226; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hubner S, 1999, J BIOL CHEM, V274, P22610, DOI 10.1074/jbc.274.32.22610; Hyman A, 1998, J CELL SCI, V111, P2077; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; KARSENTI E, 1984, J CELL BIOL, V98, P1730, DOI 10.1083/jcb.98.5.1730; KARSENTI E, 1984, J CELL BIOL, V98, P1763, DOI 10.1083/jcb.98.5.1763; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MURRAY A, 1991, XENOPUS LAEVIS PRACT; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Saitoh H, 1996, MOL BIOL CELL, V7, P1319, DOI 10.1091/mbc.7.9.1319; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 1999, J CELL SCI, V112, P2453	55	477	484	3	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2001	104	1					83	93		10.1016/S0092-8674(01)00193-3	http://dx.doi.org/10.1016/S0092-8674(01)00193-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163242	Bronze			2022-12-24	WOS:000166882300009
J	Zhou, Z; Hartwieg, E; Horvitz, HR				Zhou, Z; Hartwieg, E; Horvitz, HR			CED-1 is a transmembrane receptor that mediates cell corpse engulfment in C-elegans	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; DENSITY-LIPOPROTEIN RECEPTOR; APOPTOTIC CELLS; SCAVENGER RECEPTOR; ENDOTHELIAL-CELLS; KNOCKOUT MICE; GENE-TRANSFER; PROTEIN; PHAGOCYTOSIS; DEATH	We cloned the C. elegans gene ced-1, which is required for the engulfment of cells undergoing programmed cell death, ced-1 encodes a transmembrane protein similar to human SREC (Scavenger Receptor from Endothelial Cells). We showed that ced-1 is expressed in and functions in engulfing cells. The CED-1 protein localizes to cell membranes and clusters around neighboring cell corpses. CED-1 failed to cluster around cell corpses in mutants defective in the engulfment gene ced-7. Motifs in the intracellular domain of CED-1 known to interact with PTB and SH2 domains were necessary for engulfment but not for clustering. Our results indicate that CED-1 is a cell surface phagocytic receptor that recognizes cell corpses. We suggest that the ABC transporter CED-7 promotes cell corpse recognition by CED-1, possibly by exposing a phospholipid ligand on the surfaces of cell corpses.	MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Horvitz, HR (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Bldg 68,Room 425,77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu						Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Conradt B, 1999, CELL, V98, P317, DOI 10.1016/S0092-8674(00)81961-3; ELLIS RE, 1991, GENETICS, V129, P79; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Giles KM, 2000, BRIT J HAEMATOL, V109, P1, DOI 10.1046/j.1365-2141.2000.01805.x; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hall DH, 1999, DEV BIOL, V212, P101, DOI 10.1006/dbio.1999.9356; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Kimble J, 1998, TRENDS BIOCHEM SCI, V23, P353, DOI 10.1016/S0968-0004(98)01263-8; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Kwiatkowska K, 1999, BIOESSAYS, V21, P422, DOI 10.1002/(SICI)1521-1878(199905)21:5<422::AID-BIES9>3.0.CO;2-#; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; Riddle DL, 1997, C ELEGANS; ROBERTSON AMG, 1982, J EMBRYOL EXP MORPH, V67, P89; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Stryer L., 1988, BIOCHEMISTRY-US; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tait JF, 1999, J BIOL CHEM, V274, P3048, DOI 10.1074/jbc.274.5.3048; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Wyllie A H, 1980, Int Rev Cytol, V68, P251; ZHOU SY, 1995, TRENDS BIOCHEM SCI, V20, P470	49	427	440	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2001	104	1					43	56		10.1016/S0092-8674(01)00190-8	http://dx.doi.org/10.1016/S0092-8674(01)00190-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163239	Bronze			2022-12-24	WOS:000166882300006
J	Lane, B; Challen, K; Harris, HJ; Harris, R				Lane, B; Challen, K; Harris, HJ; Harris, R			Existence and quality of written antenatal screening policies in the United Kingdom: postal survey	BRITISH MEDICAL JOURNAL			English	Article									St Marys Hosp, Genet Enquiry Ctr, Manchester M13 0JH, Lancs, England	University of Manchester	Challen, K (corresponding author), St Marys Hosp, Genet Enquiry Ctr, Manchester M13 0JH, Lancs, England.		Challen, Kirsty/AAU-3421-2021	Challen, Kirsty/0000-0003-4032-5531				Harris R, 1999, BRIT J OBSTET GYNAEC, V106, P658, DOI 10.1111/j.1471-0528.1999.tb08364.x; *ROYAL COLL OBST G, 1997, EFF PROC MAT CAR SUI; 2000, CONFIDENTIAL ENQUIRY	3	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	2001	322	7277					22	23		10.1136/bmj.322.7277.22	http://dx.doi.org/10.1136/bmj.322.7277.22			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EP	11141145	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000166341400018
J	Davies, JP; Chen, FW; Ioannou, YA				Davies, JP; Chen, FW; Ioannou, YA			Transmembrane molecular pump activity of Niemann-Pick C1 protein	SCIENCE			English	Article							TOPOLOGICAL ANALYSIS; EFFLUX; GENE; CHOLESTEROL; EXPRESSION; FAMILY; MUTANT	Niemann-Pick C1 (NPC1) disease is characterized by cholesterol accumulation in Lysosomes and aberrant feedback regulation of cellular cholesterol homeostasis, We provide evidence that the NPC1 protein has homology with the resistance-nodulation-division (RND) family of prokaryotic permeases and may normally function as a transmembrane efflux pump, Studies of acriflavine Loading in normal and NPC1 fibroblasts indicated that NPC1 uses a proton motive force to remove accumulated acriflavine from the endosomal/lysosomal system. Expression of NPC1 in Escherichia coli (i) facilitated the transport of acriflavine across the plasma membrane, causing cytosolic accumulation, and (ii) resulted in transport of oleic acid but not cholesterol or cholesterol-oleate across the plasma membrane. These studies establish NPC1 as a eukaryotic member of the RND permease family.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Ioannou, YA (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, Box 1498,1 Gustave L Levy Pl, New York, NY 10029 USA.	Yiannis.Ioannou@mssm.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054736] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK54736] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beja O, 1996, P NATL ACAD SCI USA, V93, P5969, DOI 10.1073/pnas.93.12.5969; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; Gotoh N, 1999, FEBS LETT, V458, P32, DOI 10.1016/S0014-5793(99)01116-3; Li XZ, 1998, J BACTERIOL, V180, P2987, DOI 10.1128/JB.180.11.2987-2991.1998; LISCUM L, 1990, BIOCHIM BIOPHYS ACTA, V1045, P40, DOI 10.1016/0005-2760(90)90201-8; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; NAKAMURA K, 1982, EMBO J, V1, P771, DOI 10.1002/j.1460-2075.1982.tb01244.x; Nikaido H, 1998, J BACTERIOL, V180, P4686, DOI 10.1128/JB.180.17.4686-4692.1998; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Pentchev P. G., 1995, METABOLIC MOL BASES, P2625; PENTCHEV PG, 1994, BBA-MOL BASIS DIS, V1225, P235, DOI 10.1016/0925-4439(94)90001-9; Schuchman EHDR, 1995, METABOLIC MOL BASIS, V7th, P2601; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Ward A, 2000, PRACT APPROACH SER, P141	21	231	241	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2000	290	5500					2295	+		10.1126/science.290.5500.2295	http://dx.doi.org/10.1126/science.290.5500.2295			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125140				2022-12-24	WOS:000165995800040
J	Breitbart, W; Rosenfeld, B; Pessin, H; Kaim, M; Funesti-Esch, J; Galietta, M; Nelson, CJ; Brescia, R				Breitbart, W; Rosenfeld, B; Pessin, H; Kaim, M; Funesti-Esch, J; Galietta, M; Nelson, CJ; Brescia, R			Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN-ASSISTED SUICIDE; ATTITUDES; QUESTIONNAIRE; EUTHANASIA; ONCOLOGY; CARE	Context Understanding why some terminally ill patients desire a hastened death has become an important issue in palliative care and the debate regarding legalization of assisted suicide. Objectives To assess the prevalence of desire for hastened death among terminally ill cancer patients and to identify factors corresponding to desire for hastened death. Design Prospective survey conducted in a 200-bed palliative care hospital in New York, NY. Patients Ninety-two terminally ill cancer patients (60% female; 70% white; mean age, 65.9 years) admitted between June 1998 and January 1999 for end-of-life care who passed a cognitive screening test and provided sufficient data to permit analysis. Main Outcome Measure Scores on the Schedule of Attitudes Toward Hastened Death (SAHD), a self-report measure assessing desire for hastened death among individuals with life-threatening medical illness. Results Sixteen patients (17%) were classified as having a high desire for hastened death based on the SAHD and 15 (16%) of 89 patients met criteria for a current major depressive episode. Desire for hastened death was significantly associated with a clinical diagnosis of depression (P =.001) as well as with measures of depressive symptom severity (P<.001) and hopelessness (P<.001), In multivariate analyses, depression (P=.003) and hopelessness (P<.001) provided independent and unique contributions to the prediction of desire for hastened death, while social support (P=.05) and physical functioning (P=.02) added significant but smaller contributions. Conclusions Desire for hastened death among terminally ill cancer patients is not uncommon. Depression and hopelessness are the strongest predictors of desire for hastened death in this population and provide independent and unique contributions. Interventions addressing depression, hopelessness, and social support appear to be important aspects of adequate palliative care, particularly as it relates to desire for hastened death.	Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, New York, NY 10021 USA; Fordham Univ, Dept Psychol, Bronx, NY USA; Calvary Hosp, Palliat Care Inst, Bronx, NY USA	Memorial Sloan Kettering Cancer Center; Fordham University	Breitbart, W (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, 1242 2nd Ave, New York, NY 10021 USA.							BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Brady MJ, 1999, PSYCHO-ONCOLOGY, V8, P417, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<417::AID-PON398>3.0.CO;2-4; Breitbart W, 1996, AM J PSYCHIAT, V153, P238; BROADHEAD WE, 1988, MED CARE, V26, P709, DOI 10.1097/00005650-198807000-00006; BROWN JH, 1986, AM J PSYCHIAT, V143, P208; Chochinov HM, 1998, PSYCHOSOMATICS, V39, P366, DOI 10.1016/S0033-3182(98)71325-8; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; Cleeland CS, 1989, ADV PAIN RES THER, P391, DOI DOI 10.1093/BRAIN/113.5.1589; COHEN SR, 1995, PALLIATIVE MED, V9, P207, DOI 10.1177/026921639500900306; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Foley KM, 1997, NEW ENGL J MED, V336, P54, DOI 10.1056/NEJM199701023360109; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; GLOCK SD, 2000, ANN INTERN MED, V132, P209; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HENDIN H, 1993, AM J PSYCHIAT, V150, P143; Karnofsky DA, 1949, EVALUATION CHEMOTHER, P191; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Moorey S, 1998, PSYCHO-ONCOL, V7, P218, DOI 10.1002/(SICI)1099-1611(199805/06)7:3<218::AID-PON308>3.3.CO;2-4; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Rosenfeld B, 2000, CANCER, V88, P2868, DOI 10.1002/1097-0142(20000615)88:12<2868::AID-CNCR30>3.0.CO;2-K; Rosenfeld B, 1999, AM J PSYCHIAT, V156, P94, DOI 10.1176/ajp.156.1.94; ROSENFELD B, IN PRESS PSYCHOL PUB; Rousseau P, 2000, J CLIN ONCOL, V18, P2000, DOI 10.1200/JCO.2000.18.9.2000; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; SPIEGEL D, 1995, SUPPORT CARE CANCER, V3, P252; Spitzer R.L., 1996, STRUCTURED CLIN INTE; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822	29	639	650	5	115	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2000	284	22					2907	2911		10.1001/jama.284.22.2907	http://dx.doi.org/10.1001/jama.284.22.2907			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380RJ	11147988	Bronze			2022-12-24	WOS:000165717000031
J	Hayden, MR				Hayden, MR			Predictive testing for Huntington's disease: the calm after the storm	LANCET			English	Editorial Material							WORLDWIDE; DIAGNOSIS		Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada	University of British Columbia	Hayden, MR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.		Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419				ADAM S, 1993, J MED GENET, V30, P549, DOI 10.1136/jmg.30.7.549; Almqvist EW, 1999, AM J HUM GENET, V64, P1293, DOI 10.1086/302374; BENJAMIN CM, 1994, AM J HUM GENET, V55, P606; Benjamin CM, 2000, CLIN GENET, V58, P41, DOI 10.1034/j.1399-0004.2000.580107.x; BRANDT J, 1989, JAMA-J AM MED ASSOC, V261, P3108, DOI 10.1001/jama.261.21.3108; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Harper PS, 2000, J MED GENET, V37, P567, DOI 10.1136/jmg.37.8.567; HAYDEN MR, 1987, LANCET, V1, P1284; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marteau TM, 1997, HEALTH PSYCHOL, V16, P51; Orr HT, 2000, CELL, V101, P1, DOI 10.1016/S0092-8674(00)80617-0; Wellington CL, 2000, CLIN GENET, V57, P1, DOI 10.1034/j.1399-0004.2000.570101.x; WENT L, 1994, J MED GENET, V31, P555	15	33	33	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 9	2000	356	9246					1944	1945		10.1016/S0140-6736(00)03301-8	http://dx.doi.org/10.1016/S0140-6736(00)03301-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383DJ	11130517				2022-12-24	WOS:000165867600003
J	Entchev, EV; Schwabedissen, A; Gonzalez-Gaitan, M				Entchev, EV; Schwabedissen, A; Gonzalez-Gaitan, M			Gradient formation of the TGF-beta homolog Dpp	CELL			English	Article							WING IMAGINAL DISC; DROSOPHILA-MELANOGASTER; MORPHOGEN GRADIENT; CELL-PROLIFERATION; ENDOCYTIC PATHWAY; GENE; PROTEIN; RECEPTOR; PATTERN; DYNAMIN	Secreted morphogens such as the Drosophila TGF-beta homolog Decapentaplegic (Dpp) are thought to spread through target tissues and form long-range concentration gradients providing positional information. Using a GFP-Dpp fusion, we monitored a TGF-beta family member trafficking in situ throughout the target tissue and forming a long-range concentration gradient. Evidence is presented that long-range Dpp movement involves Dpp receptor and Dynamin functions. We also show that the rates of endocytic trafficking and degradation determine Dpp signaling range. We propose a model where the gradient is formed via intracellular trafficking initiated by receptor-mediated endocytosis of the ligand in receiving cells with the gradient slope controlled by endocytic sorting of Dpp toward recycling versus degradation.	Max Planck Inst Mol Zellbiol & Genet, D-01307 Dresden, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Gonzalez-Gaitan, M (corresponding author), Max Planck Inst Mol Zellbiol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.		Entchev, Eugeni V/D-2606-2009	Gonzalez-Gaitan, Marcos/0000-0002-6295-7321; Entchev, Eugeni/0000-0003-0744-5929				BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BAZINET C, 1993, GENETICS, V134, P1119; BEJSOVEC A, 1995, GENETICS, V139, P309; BRAND A, 1996, DROSOPHILA MELANOGAS, P635; Brock P, 1999, CYTOMETRY, V35, P353, DOI 10.1002/(SICI)1097-0320(19990401)35:4<353::AID-CYTO8>3.0.CO;2-M; BRYANT PJ, 1988, DEV BIOL, V128, P386, DOI 10.1016/0012-1606(88)90300-4; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Burke R, 1996, DEVELOPMENT, V122, P2261; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; GARCIABE.A, 1972, MOL GEN GENET, V115, P54, DOI 10.1007/BF00272218; Gonzalez-Gaitan M, 1999, MECH DEVELOP, V87, P143, DOI 10.1016/S0925-4773(99)00156-2; GONZALEZGAITAN M, 1994, MECH DEVELOP, V46, P183, DOI 10.1016/0925-4773(94)90070-1; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; GONZALEZGAITAN MA, 1996, MOL BIOL INSECT DIS, P283; Grant D, 1998, GENETICS, V149, P1019; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; INGHAM PW, 1995, CURR BIOL, V5, P432, DOI 10.1016/S0960-9822(95)00084-4; Jackson SM, 1997, DEVELOPMENT, V124, P4113; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; MASUCCI JD, 1990, GENE DEV, V4, P2011, DOI 10.1101/gad.4.11.2011; MASUR SK, 1990, J NEUROGENET, V6, P191, DOI 10.3109/01677069009107110; McDowell N, 1997, CURR BIOL, V7, P671, DOI 10.1016/S0960-9822(06)00294-6; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; MERESSE S, 1995, J CELL SCI, V108, P3349; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; PANGANIBAN GEF, 1990, MOL CELL BIOL, V10, P2669, DOI 10.1128/MCB.10.6.2669; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Pignoni F, 1997, DEVELOPMENT, V124, P271; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Staples RR, 1999, J NEUROGENET, V13, P119, DOI 10.3109/01677069909083470; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; XU T, 1994, DROSOPHILA MELANOGAS, P655	47	487	502	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 8	2000	103	6					981	991		10.1016/S0092-8674(00)00200-2	http://dx.doi.org/10.1016/S0092-8674(00)00200-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136982	Bronze			2022-12-24	WOS:000165801300016
J	Miki, H; Yamaguchi, H; Suetsugu, S; Takenawa, T				Miki, H; Yamaguchi, H; Suetsugu, S; Takenawa, T			IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling	NATURE			English	Article							ACTIN-BASED MOTILITY; RECEPTOR TYROSINE KINASE; ALDRICH-SYNDROME PROTEIN; WASP-RELATED PROTEIN; ARP2/3 COMPLEX; N-WASP; DEPOLYMERIZING PROTEIN; SHIGELLA-FLEXNERI; NUCLEATION; FILAMENTS	Neural Wiskott-Aldrich syndrome protein (N-WASP)(1) functions in several intracellular events including filopodium formation(2), vesicle transport(3) and movement of Shigella frexneri(4,5) and vaccinia virus(6), by stimulating rapid actin polymerization through the Arp2/3 complex. N-WASP is regulated by the direct binding of Cdc42 (refs 7, 8), which exposes the domain in N-WASP that activates the Arp2/3 complex(2,9). A WASP-related protein, WAVE/ Scar, functions in pac-induced membrane ruffling(10,11); however, pac does not bind directly to WAVE(10), raising the question of how WAVE is regulated by Rac. Here we demonstrate that IRSp53, a substrate for insulin receptor(12) with unknown function, is the 'missing link' between pac and WAVE. Activated Rac binds to the amino terminus of IRSp53, and carboxy-terminal Src-homology-3 domain of IRSp53 binds to WAVE to form a trimolecular complex. From studies of ectopic expression, we found that IRSp53 is essential for Rac to induce membrane ruffling, probably because it recruits WAVE, which stimulates actin polymerization mediated by the Arp2/3 complex.	Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, CREST, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Takenawa, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Yamaguchi, Hideki/AAP-1767-2021; Suetsugu, Shiro/ABB-6033-2020; Suetsugu, Shiro/B-3300-2010; Suetsugu, Shiro/AAF-4427-2019	Yamaguchi, Hideki/0000-0003-2125-9655; Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628				Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bear JE, 1998, J CELL BIOL, V142, P1325, DOI 10.1083/jcb.142.5.1325; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Miki H, 1999, J BIOL CHEM, V274, P27605, DOI 10.1074/jbc.274.39.27605; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Yeh TC, 1996, J BIOL CHEM, V271, P2921, DOI 10.1074/jbc.271.6.2921	23	425	441	1	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2000	408	6813					732	735		10.1038/35047107	http://dx.doi.org/10.1038/35047107			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130076				2022-12-24	WOS:000165815200052
J	Ohshiro, T; Yagami, T; Zhang, C; Matsuzaki, F				Ohshiro, T; Yagami, T; Zhang, C; Matsuzaki, F			Role of cortical tumour-suppressor proteins in asymmetric division of Drosophila neuroblast	NATURE			English	Article							CELL DIVISIONS; LOCALIZATION; GENE; PROSPERO; MYOSIN; POLARITY; PARTNER; MIRANDA; LINEAGE; FATES	Cellular diversity during development arises in part from asymmetric divisions, which generate two distinct cells by transmitting localized determinants from a progenitor cell into one daughter cell. In Drosophila, neuroblasts undergo typical asymmetric divisions to produce another neuroblast and a ganglion mother cell(1,2). At mitosis, neural fate determinants, including Prospero and Numb, localize to the basal cortex(3,4), from which the ganglion mother cell buds off; Inscuteable and Bazooka, which regulate spindle orientation, localize apically(5-8). Here we show that a tumour-suppressor protein, Lethal giant larvae (Lgl)(9), is essential for asymmetric cortical localization of all basal determinants in mitotic neuroblasts, and is therefore indispensable for neural fate decisions. Lgl, which itself is uniformly cortical, interacts with several types of Myosin to localize the determinants. Another tumour-suppressor protein, Lethal discs large (Dlg)(10), participates in this process by regulating the localization of Lgl. The localization of the apical components is unaffected in lgl or dlg mutants. Thus, Lgl and Dlg act in a common process that differentially mediates cortical protein targeting in mitotic neuroblasts, and that creates intrinsic differences between daughter cells.	Japan Sci & Technol Corp, CREST, Sendai, Miyagi, Japan; RIKEN, Ctr Dev Biol, Cell Asymmetry Grp, Sendai, Miyagi, Japan; Tohoku Univ, Inst Dev Aging & Canc, Dept Dev Neurobiol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Japan Science & Technology Agency (JST); RIKEN; Tohoku University	Matsuzaki, F (corresponding author), Japan Sci & Technol Corp, CREST, Sendai, Miyagi, Japan.	fumio@idac.tohoku.ac.jp						Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHOU TB, 1992, GENETICS, V131, P643; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; DAWSON IA, 1993, DEVELOPMENT, V117, P359; De Lorenzo C, 1999, INT J DEV BIOL, V43, P207; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Gho M, 1996, DEVELOPMENT, V122, P1673; Gho M, 1999, DEVELOPMENT, V126, P3573; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; JACOB L, 1987, CELL, V50, P215, DOI 10.1016/0092-8674(87)90217-0; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; Kagami M, 1998, GENETICS, V149, P1717; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Manfruelli P, 1996, DEVELOPMENT, V122, P2283; Matsuzaki F, 2000, CURR OPIN NEUROBIOL, V10, P38, DOI 10.1016/S0959-4388(99)00052-5; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; STRAND D, 1994, J CELL BIOL, V127, P1361, DOI 10.1083/jcb.127.5.1361; Wang SW, 1997, DEVELOPMENT, V124, P4435; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	30	266	276	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 30	2000	408	6812					593	596		10.1038/35046087	http://dx.doi.org/10.1038/35046087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117747				2022-12-24	WOS:000165548600120
J	Csibra, G; Davis, G; Spratling, MW; Johnson, MH				Csibra, G; Davis, G; Spratling, MW; Johnson, MH			Gamma oscillations and object processing in the infant brain	SCIENCE			English	Article							RESPONSES; PERCEPTION; ORGANIZATION	An enduring controversy in neuroscience concerns how the brain "binds" together separately coded stimulus features to form unitary representations of objects. Recent evidence has indicated a close link between this binding process and 40-hertz (gamma-band) oscillations generated by localized neural circuits. In a separate line of research, the ability of young infants to perceive objects as unitary and bounded has become a central focus for debates about the mechanisms of perceptual development. Here we demonstrate that binding-related 40-hertz oscillations are evident in the infant brain around 8 months of age, which is the same age at which behavioral and event-related potential evidence indicates the onset of perceptual binding of spatially separated static visual features.	Univ London Birkbeck Coll, Sch Psychol, Ctr Brain & Cognit Dev, London WC1E 7HX, England	University of London; Birkbeck University London	Csibra, G (corresponding author), Univ London Birkbeck Coll, Sch Psychol, Ctr Brain & Cognit Dev, Malet St, London WC1E 7HX, England.	g.csibra@bbk.ac.uk	Csibra, Gergely/C-4345-2008; Spratling, Michael W/G-7689-2011; Davis, Gregory/G-9954-2012	Csibra, Gergely/0000-0002-7044-3056; Spratling, Michael W/0000-0001-9531-2813; Johnson, Mark/0000-0003-4229-2585				BERTENTHAL BI, 1980, CHILD DEV, V51, P1072, DOI 10.2307/1129546; Csibra G, 1998, INT J PSYCHOPHYSIOL, V29, P201, DOI 10.1016/S0167-8760(98)00016-6; Davis G, 1998, J EXP PSYCHOL HUMAN, V24, P169; Elliott MA, 2000, J EXP PSYCHOL LEARN, V26, P703, DOI 10.1037/0278-7393.26.3.703; Ffytche DH, 1996, NEUROIMAGE, V3, P104, DOI 10.1006/nimg.1996.0012; GHIM HR, 1990, INFANT BEHAV DEV, V13, P221, DOI 10.1016/0163-6383(90)90032-4; Graziano MSA, 1997, SCIENCE, V277, P239, DOI 10.1126/science.277.5323.239; Herrmann CS, 1999, CLIN NEUROPHYSIOL, V110, P636, DOI 10.1016/S1388-2457(99)00002-4; KANIZSA G, 1976, SCI AM, V234, P48, DOI 10.1038/scientificamerican0476-48; KAVSEK MJ, 1999, UNPUB BIENN M SOC RE; Kellman P. J., 1998, HDB CHILD PSYCHOL, V2, P103; Muller MM, 1996, EXP BRAIN RES, V112, P96; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SUGAWARA M, 1991, SCAND J PSYCHOL, V32, P352, DOI 10.1111/j.1467-9450.1991.tb00886.x; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TallonBaudry C, 1997, NEUROREPORT, V8, P1103, DOI 10.1097/00001756-199703240-00008; TREISMAN A, 1982, COGNITIVE PSYCHOL, V14, P459; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B	19	192	193	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2000	290	5496					1582	1585		10.1126/science.290.5496.1582	http://dx.doi.org/10.1126/science.290.5496.1582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	376EX	11090357				2022-12-24	WOS:000165446200052
J	Teotonio, H; Rose, MR				Teotonio, H; Rose, MR			Variation in the reversibility of evolution	NATURE			English	Article							DROSOPHILA-MELANOGASTER; POSTPONED SENESCENCE; LABORATORY EVOLUTION; PEPPERED MOTH; HISTORY; ENVIRONMENT; RESISTANCE; SELECTION	How reversible is adaptive evolution(1-6)? Studies of microbes give mixed answers to this question(6-11). Reverse evolution has been little studied in sexual populations(12-14), even though the population genetics of sexual populations may be quite different. In the present study, 25 diverged replicated populations of Drosophila melanogaster are returned to a common ancestral environment for 50 generations. Here we show that reverse evolution back to the ancestral state occurs, but is not universal, instead depending on previous evolutionary history and the character studied. Hybrid populations showed no greater tendency to undergo successful reverse evolution, suggesting that insufficient genetic variation was not the factor limiting reverse evolution. Adaptive reverse evolution is a contingent process which occurs with only 50 generations of sexual reproduction.	Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92612 USA	University of California System; University of California Irvine	Teotonio, H (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92612 USA.			Teotonio, Henrique/0000-0003-1057-6882				BULL JJ, 1985, EVOLUTION, V39, P1149, DOI 10.1111/j.1558-5646.1985.tb00455.x; Burch CL, 1999, GENETICS, V151, P921; Chippindale AK, 1997, EVOLUTION, V51, P1536, DOI 10.1111/j.1558-5646.1997.tb01477.x; CLARKE CA, 1985, BIOL J LINN SOC, V26, P189, DOI 10.1111/j.1095-8312.1985.tb01555.x; COHAN FM, 1989, AM NAT, V134, P613, DOI 10.1086/285000; Cook LM, 1999, P ROY SOC B-BIOL SCI, V266, P293, DOI 10.1098/rspb.1999.0636; Coyne JA, 1997, EVOLUTION, V51, P643, DOI 10.1111/j.1558-5646.1997.tb03650.x; Crill WD, 2000, GENETICS, V154, P27; FLEMING JE, 1993, GENETICA, V91, P183, DOI 10.1007/BF01435997; GAYON J, 1998, DARWINISMS STRUGGLE; Glantz S., 1990, PRIMER APPL REGRESSI; GRAVES JL, 1992, PHYSIOL ZOOL, V65, P268, DOI 10.1086/physzool.65.2.30158253; LENSKI RE, 1988, EVOLUTION, V42, P433, DOI 10.1111/j.1558-5646.1988.tb04150.x; LEROI AM, 1994, EVOLUTION, V48, P1244, DOI [10.2307/2410382, 10.1111/j.1558-5646.1994.tb05309.x]; Levin BR, 2000, GENETICS, V154, P985; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Moore FBG, 2000, P ROY SOC B-BIOL SCI, V267, P515, DOI 10.1098/rspb.2000.1030; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; ROSE MR, 1992, EXP GERONTOL, V27, P241, DOI 10.1016/0531-5565(92)90048-5; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; SERVICE PM, 1988, EVOLUTION, V42, P708, DOI 10.1111/j.1558-5646.1988.tb02489.x; Simpson GG, 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; *SPSS, 1998, SIGM 5 0 PROGR GUID; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; TYLER RH, 1993, GENETICA, V91, P143, DOI 10.1007/BF01435994; Wright S., 1977, EVOLUTION GENETICS P, V3; Zar JH, 1996, BIOSTATISTICAL ANAL	29	101	101	0	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2000	408	6811					463	466		10.1038/35044070	http://dx.doi.org/10.1038/35044070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100726				2022-12-24	WOS:000165429800046
J	Ngadiman, S; Vallejo, CE; Siegel, B; Axelrod, D				Ngadiman, S; Vallejo, CE; Siegel, B; Axelrod, D			Minimising discomfort with fine-needle aspiration cytology of the breast	LANCET			English	Editorial Material							TRIAL		St Vincents Comprehens Breast Ctr, New York, NY 10012 USA		Ngadiman, S (corresponding author), St Vincents Comprehens Breast Ctr, New York, NY 10012 USA.			Axelrod, Deborah/0000-0002-9929-3389				Cannon CR, 1999, OTOLARYNG HEAD NECK, V120, P458; Daltrey IR, 2000, BRIT J SURG, V87, P777, DOI 10.1046/j.1365-2168.2000.087006777.x; Florentine BD, 1997, DIAGN CYTOPATHOL, V17, P472, DOI 10.1002/(SICI)1097-0339(199712)17:6<472::AID-DC18>3.0.CO;2-J; KOSS LG, 1993, CANCER, V72, P1499, DOI 10.1002/1097-0142(19930901)72:5<1499::AID-CNCR2820720502>3.0.CO;2-#; Walker SR, 1998, J ROY COLL SURG EDIN, V43, P322	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 18	2000	356	9243					1701	1701		10.1016/S0140-6736(00)03199-8	http://dx.doi.org/10.1016/S0140-6736(00)03199-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	376MX	11095253				2022-12-24	WOS:000165462300004
J	Nakagawa, T; Setou, M; Seog, DH; Ogasawara, K; Dohmae, N; Takio, K; Hirokawa, N				Nakagawa, T; Setou, M; Seog, DH; Ogasawara, K; Dohmae, N; Takio, K; Hirokawa, N			A novel motor, KIF13A, transports mannose-6-phosphate receptor to plasma membrane through direct interaction with AP-1 complex	CELL			English	Article							SYNAPTIC VESICLE; MONOMERIC MOTOR; COATED VESICLES; BINDING PROTEIN; GOLGI MEMBRANES; CLATHRIN; ADAPTERS; CHAIN	Intracellular transport mediated by kinesin superfamily proteins (KIFs) is a highly regulated process. The molecular mechanism of KIFs binding to their respective cargoes remains unclear. We report that KIF13A is a novel plus end-directed microtubule-dependent motor protein and associates with beta1-adaptin, a subunit of the AP-1 adaptor complex. The cargo vesicles of KIF13A contained AP-1 and mannnose-6-phosphate receptor (M6PR). Overexpression of KIF13A resulted in mislocalization of the AP-1 and the M6PR. Functional blockade of KIF13A reduced cell surface expression of the M6PR. Thus, KIF13A transports M6PR-containing vesicles and targets the M6PR from TGN to the plasma membrane via direct interaction with the AP-1 adaptor complex.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan	University of Tokyo; University of Tokyo; RIKEN	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, 7-3-1 Hongo, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Dohmae, Naoshi/C-2040-2011; Ogasawara, Kouetsu/G-9892-2011	Dohmae, Naoshi/0000-0002-5242-9410; 				AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Cole NB, 1998, J CELL BIOL, V140, P1, DOI 10.1083/jcb.140.1.1; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; GALLUSSER A, 1993, EMBO J, V12, P5237, DOI 10.1002/j.1460-2075.1993.tb06219.x; Hirokawa N, 1996, TRENDS CELL BIOL, V6, P135, DOI 10.1016/0962-8924(96)10003-9; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; JASMIN BJ, 1989, P NATL ACAD SCI USA, V86, P7218, DOI 10.1073/pnas.86.18.7218; KAWANO JI, 1994, J HISTOCHEM CYTOCHEM, V42, P363, DOI 10.1177/42.3.8308253; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Musacchio A, 1999, MOL CELL, V3, P761, DOI 10.1016/S1097-2765(01)80008-3; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; OEILLY DR, 1992, BACULOVIRUS EXPRESSI; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; OKAYAMA H, 1987, METHOD ENZYMOL, V154, P3; ORCI L, 1993, NATURE, V362, P648, DOI 10.1038/362648a0; PEARSE BMF, 1985, EMBO J, V4, P2457, DOI 10.1002/j.1460-2075.1985.tb03956.x; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P265, DOI 10.1016/S0968-0004(00)89040-4; Presley JF, 1998, MOL BIOL CELL, V9, P1617, DOI 10.1091/mbc.9.7.1617; ROBINSON MS, 1993, J CELL BIOL, V123, P67, DOI 10.1083/jcb.123.1.67; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sambrook JFE, 1989, MOL CLONING LAB MANU; SCHRODER S, 1991, J BIOL CHEM, V266, P7910; SCLAKY N, 1997, J CELL BIOL, V139, P1137; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; ZAREMBA S, 1983, J CELL BIOL, V97, P1339, DOI 10.1083/jcb.97.5.1339	38	209	223	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 10	2000	103	4					569	581		10.1016/S0092-8674(00)00161-6	http://dx.doi.org/10.1016/S0092-8674(00)00161-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	374MB	11106728	Bronze			2022-12-24	WOS:000165348000003
J	Usiello, A; Baik, JH; Rouge-Pont, F; Picetti, R; Dierich, A; LeMeur, M; Piazza, PV; Borrelli, E				Usiello, A; Baik, JH; Rouge-Pont, F; Picetti, R; Dierich, A; LeMeur, M; Piazza, PV; Borrelli, E			Distinct functions of the two isoforms of dopamine D-2 receptors	NATURE			English	Article							DEFICIENT MICE; D2 RECEPTORS; LOCOMOTOR-ACTIVITY; G-PROTEINS; NEURONS; HYPERPLASIA; AGONISTS; RELEASE; GENE	Signalling through dopamine D2 receptors governs physiological functions related to locomotion, hormone production and drug abuse(1-7). D2 receptors are also known targets of antipsychotic drugs that are used to treat neuropsychiatric disorders such as schizophrenia(8). By a mechanism of alternative splicing, the D2 receptor gene encodes two molecularly distinct isoforms(9), D2S and D2L, previously thought to have the same function. Here we show that these receptors have distinct functions in vivo; D2L acts mainly at postsynaptic sites and D2S serves presynaptic autoreceptor functions. The cataleptic effects of the widely used antipsychotic haloperidol(1) are absent in D2L-deficient mice. This suggests that D2L is targeted by haloperidol, with implications for treatment of neuropsychiatric disorders. The absence of D2L reveals that D2S inhibits D1 receptor-mediated functions, uncovering a circuit of signalling interference between dopamine receptors.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; Univ Bordeaux 2, INSERM, U259, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Borrelli, E (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	eb@igbmc.u-strasbg.fr	usiello, alessandro/B-2368-2012; Borrelli, Emiliana/M-8994-2018; Picetti, Roberto/B-9944-2011	Picetti, Roberto/0000-0003-4756-5271; Usiello, Alessandro/0000-0001-9203-853X				Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Boulay D, 2000, EUR J PHARMACOL, V391, P63, DOI 10.1016/S0014-2999(99)00916-4; Boulay D, 1999, NEUROPHARMACOLOGY, V38, P1389, DOI 10.1016/S0028-3908(99)00064-7; Calabresi P, 1997, J NEUROSCI, V17, P4536; CRENSHAW EB, 1987, CELL, V49, P389, DOI 10.1016/0092-8674(87)90291-1; Egan MF, 1997, CURR OPIN NEUROBIOL, V7, P701, DOI 10.1016/S0959-4388(97)80092-X; EILAM D, 1989, EUR J PHARMACOL, V161, P151, DOI 10.1016/0014-2999(89)90837-6; GUIRAMAND J, 1995, J BIOL CHEM, V270, P7354, DOI 10.1074/jbc.270.13.7354; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jung MY, 1999, NEUROSCIENCE, V91, P911, DOI 10.1016/S0306-4522(98)00705-2; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kelly MA, 1998, J NEUROSCI, V18, P3470; Khan ZU, 1998, P NATL ACAD SCI USA, V95, P7731, DOI 10.1073/pnas.95.13.7731; L'hirondel M, 1998, BRAIN RES, V792, P253, DOI 10.1016/S0006-8993(98)00146-2; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; MONTMAYEUR JP, 1993, MOL ENDOCRINOL, V7, P161, DOI 10.1210/me.7.2.161; Nisenbaum ES, 1998, SYNAPSE, V29, P213, DOI 10.1002/(SICI)1098-2396(199807)29:3<213::AID-SYN3>3.3.CO;2-3; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; PROTAIS P, 1983, PSYCHOPHARMACOLOGY, V81, P126, DOI 10.1007/BF00429006; ROUGEPONT F, 1995, J NEUROSCI, V15, P7189; RUBINSTEIN M, 1988, N-S ARCH PHARMACOL, V337, P115; Ruskin DN, 1998, J PHARMACOL EXP THER, V286, P272; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; STARKE K, 1989, PHYSIOL REV, V69, P864, DOI 10.1152/physrev.1989.69.3.864; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; WADDINGTON JL, 1993, DOPAMINE RECEPTOR IN, P52; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839	30	528	549	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2000	408	6809					199	203		10.1038/35041572	http://dx.doi.org/10.1038/35041572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089973				2022-12-24	WOS:000165180400045
J	Fawcett, J; Pawson, T				Fawcett, J; Pawson, T			Signal transduction - N-WASP regulation - the sting in the tail	SCIENCE			English	Editorial Material							ACTIN		Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Fawcett, J (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		Pawson, Tony J/E-4578-2013	Fawcett, Jim/0000-0003-0043-2164				Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Pawson T, 2000, GENE DEV, V14, P1027; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1	7	19	19	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 27	2000	290	5492					725	726		10.1126/science.290.5492.725	http://dx.doi.org/10.1126/science.290.5492.725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ND	11184204				2022-12-24	WOS:000090067600030
J	Cassell, GH; Mekalanos, J				Cassell, GH; Mekalanos, J			Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IDENTIFICATION; EXPRESSION; MULTIDRUG; TRENDS; GENES	During the past 2 decades, new infectious diseases have appeared and old ones previously thought to be controlled have reemerged. New and reemerging infectious agents will continue to pose serious threats well into the 21st century. The prediction that the threat of infectious disease may not diminish is supported by evidence that infectious agents cause many chronic diseases and cancer of previous unknown etiology, Moreover, the utility of existing antimicrobial agents is rapidly eroding, tipping the balance in favor of multidrug-resistant pathogens, and there appear to be few, if any, new classes of drugs currently in clinical development. The need for research directed toward development of new antibiotics has never been greater. Advances in research technologies and microbial genome sequencing in the past decade have led to identification of a large number of new targets. Functional genomics and integrative biology should validate these targets and provide the best opportunity for developing effective new therapies, improved diagnostic techniques, and better tools to understand host-pathogen interactions.	Eli Lilly & Co, Lilly Res Labs, Infect Dis Res & Clin Invest, Indianapolis, IN 46285 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Eli Lilly; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard Medical School	Cassell, GH (corresponding author), Eli Lilly & Co, Lilly Res Labs, Infect Dis Res & Clin Invest, Drop Code 0438,LCC, Indianapolis, IN 46285 USA.	cassell_gail@lilly.com						Akerley BJ, 1998, P NATL ACAD SCI USA, V95, P8927, DOI 10.1073/pnas.95.15.8927; [Anonymous], PREV EM INF DIS STRA; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; BURBAUM JJ, 1995, P NATL ACAD SCI USA, V92, P6027, DOI 10.1073/pnas.92.13.6027; Cassell GH, 1998, EMERG INFECT DIS, V4, P475, DOI 10.3201/eid0403.980339; *CDCP, 1994, ADD EM INF DIS THREA; Center for Disease Control and Prevention (CDC), 1999, MMWR-MORBID MORTAL W, V48, P890; Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206; Enserink M, 2000, SCIENCE, V289, P842, DOI 10.1126/science.289.5481.842; Forum on Emerging Infections Institute of Medicine, 1998, ANT RES ISS OPT; *GOV PRINT OFF, 1997, FOOD SAF FARM TABL N; GREER J, 1994, J MED CHEM, V37, P1035, DOI 10.1021/jm00034a001; Harris AG, 2000, J ANTIMICROB CHEMOTH, V45, P591, DOI 10.1093/jac/45.5.591; HOSHINO K, 1994, ANTIMICROB AGENTS CH, V38, P2623, DOI 10.1128/AAC.38.11.2623; Ichikawa JK, 2000, P NATL ACAD SCI USA, V97, P9659, DOI 10.1073/pnas.160140297; Institute of Medicine, 1992, EM INF MICR THREATS; Judson N, 2000, NAT BIOTECHNOL, V18, P740, DOI 10.1038/77305; Khan AS, 1996, J INFECT DIS, V173, P1297, DOI 10.1093/infdis/173.6.1297; Marwick C, 1998, JAMA-J AM MED ASSOC, V279, P643, DOI 10.1001/jama.279.9.643; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Pisani P, 1997, CANCER EPIDEM BIOMAR, V6, P387; Saier MH, 1998, FASEB J, V12, P265, DOI 10.1096/fasebj.12.3.265; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Tan DS, 1998, J AM CHEM SOC, V120, P8565, DOI 10.1021/ja981746o; Trias J, 1997, CURR OPIN BIOTECH, V8, P757, DOI 10.1016/S0958-1669(97)80131-0; *US NAT INT COUNC, 2000, PUBL NIE D, V9917; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; World Health Organisation (WHO), 1999, WHO REP INF DIS REM	33	114	124	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					601	605		10.1001/jama.285.5.601	http://dx.doi.org/10.1001/jama.285.5.601			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176866				2022-12-24	WOS:000166714200019
J	Cai, HN; Shen, P				Cai, HN; Shen, P			Effects of cis arrangement of chromatin insulators on enhancer-blocking activity	SCIENCE			English	Article							DOMAIN BOUNDARIES; GYPSY INSULATOR; DROSOPHILA; SUPPRESSOR; PROTEIN; GENE; METHYLATION; EXPRESSION; REPRESSION; ELEMENTS	Chromatin boundary elements or insulators are believed to regulate gene activity in complex genetic Loci by organizing specialized chromatin structures. Here, we report that the enhancer-blocking activity of the Drosophila suHw insulator is sensitive to insulator copy number and position. Two tandem copies of suHw were ineffective in blocking various enhancers from a downstream promoter. Moreover, an enhancer was blocked more effectively from a promoter by two flanking suHw insulators than by a single intervening one. Thus, insulators may modulate enhancer-promoter interactions by interacting with each other and facilitating the formation of chromatin Loop domains.	Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Cai, HN (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.			Shen, Ping/0000-0001-5024-3893	NIGMS NIH HHS [R01 GM058458] Funding Source: Medline; PHS HHS [5RO158458-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bell AC, 1999, CURR OPIN GENET DEV, V9, P191, DOI 10.1016/S0959-437X(99)80029-X; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; Cai HN, 1997, EMBO J, V16, P1732, DOI 10.1093/emboj/16.7.1732; Cai HN, 1996, P NATL ACAD SCI USA, V93, P9309, DOI 10.1073/pnas.93.18.9309; CORCES VG, 1995, NATURE, V376, P462, DOI 10.1038/376462a0; GALLONI M, 1993, EMBO J, V12, P1087, DOI 10.1002/j.1460-2075.1993.tb05750.x; Georgiev P, 1996, GENETICS, V142, P425; Gerasimova TI, 1996, CURR OPIN GENET DEV, V6, P185, DOI 10.1016/S0959-437X(96)80049-9; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Geyer PK, 1997, CURR OPIN GENET DEV, V7, P242, DOI 10.1016/S0959-437X(97)80134-7; Hagstrom K, 1996, GENE DEV, V10, P3202, DOI 10.1101/gad.10.24.3202; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kellum R, 1998, CURR BIOL, V8, pR521, DOI 10.1016/S0960-9822(07)00337-5; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kim J, 1996, MOL CELL BIOL, V16, P3381; Mihaly J, 1998, CELL MOL LIFE SCI, V54, P60, DOI 10.1007/s000180050125; Muravyova E, 2001, SCIENCE, V291, P495, DOI 10.1126/science.291.5503.495; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Scott KC, 1999, GENETICS, V153, P787; SHEN B, 1994, MOL CELL BIOL, V14, P5645, DOI 10.1128/MCB.14.9.5645; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; SPANA C, 1990, GENE DEV, V4, P1505, DOI 10.1101/gad.4.9.1505; SU W, 1990, P NATL ACAD SCI USA, V87, P5504, DOI 10.1073/pnas.87.14.5504; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Zhou JM, 1999, DEVELOPMENT, V126, P3057; Zhou JM, 1999, CELL, V99, P567, DOI 10.1016/S0092-8674(00)81546-9	29	156	160	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2001	291	5503					493	495		10.1126/science.291.5503.493	http://dx.doi.org/10.1126/science.291.5503.493			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11161205				2022-12-24	WOS:000166487500044
J	Byrne, ME; Barley, R; Curtis, M; Arroyo, JM; Dunham, M; Hudson, A; Martienssen, RA				Byrne, ME; Barley, R; Curtis, M; Arroyo, JM; Dunham, M; Hudson, A; Martienssen, RA			Asymmetric leaves1 mediates leaf patterning and stem cell function in Arabidopsis	NATURE			English	Article							SHOOT APICAL MERISTEM; ROUGH SHEATH2 GENE; HOMEOBOX GENE; THALIANA; PLANTS; DORSOVENTRALITY; PHANTASTICA; ANTIRRHINUM; EXPRESSION; TRAP	Meristem function in plants requires both the maintenance of stem cells and the specification of founder cells from which lateral organs arise. Lateral organs are patterned along proximodistal, dorsoventral and mediolateral axes(1,2). Here we show that the Arabidopsis mutant asymmetric leaves(1) (as1) disrupts this process. AS1 encodes a myb domain protein, closely related to PHANTASTICA in Antirrhinum and ROUGH SHEATH2 in maize, both of which negatively regulate knotted-class homeobox genes. AS1 negatively regulates the homeobox genes KNAT1 and KNAT2 and is, in turn, negatively regulated by the meristematic homeobox gene SHOOT MERISTEMLESS. This genetic pathway defines a mechanism for differentiating between stem cells and organ founder cells within the shoot apical meristem and demonstrates that genes expressed in organ primordia interact with meristematic genes to regulate shoot morphogenesis.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Cold Spring Harbor Laboratory; University of Edinburgh	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.			Byrne, Mary/0000-0003-4309-3086; Dunham, Maitreya/0000-0001-9944-2666				Aida M, 1999, DEVELOPMENT, V126, P1563; BARTON MK, 1993, DEVELOPMENT, V119, P823; Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; Clark SE, 1996, DEVELOPMENT, V122, P1567; CLARK SE, 1995, DEVELOPMENT, V121, P2057; DOCKX J, 1995, PLANT MOL BIOL, V28, P723, DOI 10.1007/BF00021196; ENDRIZZI K, 1996, PLANT J, V10, P101; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hudson A, 2000, ANNU REV PLANT PHYS, V51, P349, DOI 10.1146/annurev.arplant.51.1.349; JACKSON D, 1994, DEVELOPMENT, V120, P405; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; MARTIENSSEN R, 1998, ARABIDOPSIS ANN PLAN, P262; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; REIDEI GP, 1965, GENETICS, V51, P857; REINHOLZ E, 1965, SERVICE, P24; Reiser L, 2000, PLANT MOL BIOL, V42, P151, DOI 10.1023/A:1006384122567; Schneeberger R, 1998, DEVELOPMENT, V125, P2857; SINHA NR, 1993, GENE DEV, V7, P787, DOI 10.1101/gad.7.5.787; SPRINGER PS, 1995, SCIENCE, V268, P877, DOI 10.1126/science.7754372; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161; WAITES R, 1995, DEVELOPMENT, V121, P2143; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7	30	588	639	7	113	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					967	971		10.1038/35050091	http://dx.doi.org/10.1038/35050091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140682	Green Published			2022-12-24	WOS:000165951100048
J	Nir, E; Kleinermanns, K; de Vries, MS				Nir, E; Kleinermanns, K; de Vries, MS			Pairing of isolated nucleic-acid bases in the absence of the DNA backbone	NATURE			English	Article							VIBRATIONAL-MODES; FREE NUCLEOBASES; SPECTROSCOPY; CYTOSINE; GUANINE; THYMINE; MONONUCLEOSIDES; ULTRAVIOLET; SPECTRA; ADENINE	The two intertwined strands of DNA are held together through base pairing-the formation of hydrogen bonds between bases located opposite each other on the two strands. DNA replication and transcription involve the breaking and re-forming of these hydrogen bonds, but it is difficult to probe these processes directly. For example, conventional DNA spectroscopy(1-3) is dominated by solvent interactions, crystal modes and collective modes of the DNA backbone; gas-phase studies, in contrast, can in principle measure interactions between individual molecules in the absence of external effects, but require the vaporization of the interacting species without thermal degradation(4-9). Here we report the generation of gas-phase complexes comprising paired bases, and the spectroscopic characterization of the hydrogen bonding in isolated guanine-cytosine (G-C) and guanine-guanine (G-G) base pairs. We rnd that the gas-phase G-C base pair adopts a single configuration, which may be Watson-Crick, whereas G-G exists in two different configurations, and we see evidence for proton transfer in the G-C pair, an important step in radiation-induced DNA damage pathways(10). Interactions between different bases and between bases and water molecules can also be characterized by our approach, providing stringent tests for high-level ab initio computations that aim to elucidate the fundamental aspects of nucleotide interactions(11-13).	Hebrew Univ Jerusalem, Dept Chem, IL-91904 Jerusalem, Israel; Univ Dusseldorf, Inst Phys Chem & Elektrochem, D-40225 Dusseldorf, Germany; Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	Hebrew University of Jerusalem; Heinrich Heine University Dusseldorf; University of California System; University of California Santa Barbara	de Vries, MS (corresponding author), Hebrew Univ Jerusalem, Dept Chem, IL-91904 Jerusalem, Israel.	devries@chem.ucsb.edu	NIR, EYAL/F-1621-2012	NIR, EYAL/0000-0002-6656-3282				BRADY BB, 1988, CHEM PHYS LETT, V147, P538, DOI 10.1016/0009-2614(88)80264-1; Cocco S, 2000, J CHEM PHYS, V112, P10017, DOI 10.1063/1.481646; COLSON AO, 1992, J PHYS CHEM-US, V96, P9787, DOI 10.1021/j100203a039; DEY M, 1994, J AM CHEM SOC, V116, P9211, DOI 10.1021/ja00099a042; DEY M, 1994, Z NATURFORSCH A, V49, P776; FLORIAN J, 1995, J MOL STRUCT, V349, P421, DOI 10.1016/0022-2860(95)08799-2; FODOR SPA, 1986, J RAMAN SPECTROSC, V17, P471, DOI 10.1002/jrs.1250170609; Hobza P, 1997, J COMPUT CHEM, V18, P1136, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1136::AID-JCC3>3.0.CO;2-S; Hobza P, 1996, CHEM PHYS LETT, V261, P379, DOI 10.1016/0009-2614(96)00954-2; Hutter M, 1996, J AM CHEM SOC, V118, P7574, DOI 10.1021/ja953370+; Janzen C, 1999, J CHEM PHYS, V110, P9898, DOI 10.1063/1.478863; MEIJER G, 1990, APPL PHYS B-PHOTO, V51, P395, DOI 10.1007/BF00329101; Nir E, 1999, J AM CHEM SOC, V121, P4896, DOI 10.1021/ja984088g; Santamaria R, 1999, J COMPUT CHEM, V20, P511, DOI 10.1002/(SICI)1096-987X(19990415)20:5<511::AID-JCC4>3.0.CO;2-8; Schmitt M, 1998, J CHEM PHYS, V108, P4486, DOI 10.1063/1.475860; SCHUTZ M, 1993, J CHEM PHYS, V98, P3763, DOI 10.1063/1.464055; Shishkin OV, 1999, J MOL STRUCT, V477, P15, DOI 10.1016/S0022-2860(98)00603-6; Sponer J, 1996, J PHYS CHEM-US, V100, P1965, DOI 10.1021/jp952760f; URABE H, 1985, J CHEM PHYS, V82, P531, DOI 10.1063/1.448775; VIANT MR, 1995, J CHEM PHYS, V103, P9502, DOI 10.1063/1.469960; YASON IK, 1997, BIOPOLYMERS, V18, P1149	21	234	236	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2000	408	6815					949	951		10.1038/35050053	http://dx.doi.org/10.1038/35050053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140676				2022-12-24	WOS:000165951100042
J	Strassmann, JE; Zhu, Y; Queller, DC				Strassmann, JE; Zhu, Y; Queller, DC			Altruism and social cheating in the social amoeba Dictyostelium discoideum	NATURE			English	Article							CELLULAR SLIME-MOLDS; EVOLUTION; HETEROCYTOSIS; CHIMERAS; BEHAVIOR	The social amoeba, Dictyostelium discoideum, is widely used as a simple model organism for multicellular development(1,2), but its multicellular fruiting stage is really a society. Most of the time, D. discoideum lives as haploid, free-living, amoeboid cells that divide asexually. When starved, 10(4)-10(5) of these cells aggregate into a slug. The anterior 20% of the slug altruistically differentiates into a non-viable stalk, supporting the remaining cells, most of which become viable spores(3-5). If aggregating cells come from multiple clones, there should be selection for clones to exploit other clones by contributing less than their proportional share to the sterile stalk. Here we use microsatellite markers to show that different clones collected from a field population readily mix to form chimaeras. Half of the chimaeric mixtures show a clear cheater and victim. Thus, unlike the clonal and highly cooperative development of most multicellular organisms, the development of D. discoideum is partly competitive, with conflicts of interests among cells. These conflicts complicate the use of D. discoideum as a model for some aspects of development, but they make it highly attractive as a model system for social evolution.	Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA	Rice University	Strassmann, JE (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, POB 1892, Houston, TX 77251 USA.	strassm@rice.edu		Strassmann, Joan/0000-0003-0638-8440				ARMSTRONG DP, 1984, J THEOR BIOL, V109, P271, DOI 10.1016/S0022-5193(84)80006-5; Atzmony D, 1997, CURR SCI INDIA, V72, P142; BONNER JT, 1967, CELLULAR SLIME MOLDS; BUSS LW, 1982, P NATL ACAD SCI-BIOL, V79, P5337, DOI 10.1073/pnas.79.17.5337; Dawkins R., 1978, P282; ELGAR MA, 1988, ANIM BEHAV, V36, P1511, DOI 10.1016/S0003-3472(88)80221-5; Ennis HL, 2000, P NATL ACAD SCI USA, V97, P3292, DOI 10.1073/pnas.050005097; FILOSA MF, 1962, AM NAT, V96, P79, DOI 10.1086/282209; FRANCIS D, 1993, MOL ECOL, V2, P385, DOI 10.1111/j.1365-294X.1993.tb00031.x; GADAGKAR R, 1994, J BIOSCIENCES, V19, P219, DOI 10.1007/BF02703057; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; GROSBERG RK, 1986, NATURE, V322, P456, DOI 10.1038/322456a0; GROSS JD, 1994, MICROBIOL REV, V58, P330, DOI 10.1128/MMBR.58.3.330-351.1994; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HILSON JA, 1994, ETHOL ECOL EVOL, V6, P529, DOI 10.1080/08927014.1994.9522977; HOLM S, 1979, SCAND J STAT, V6, P65; HOULE J, 1989, P NATL ACAD SCI USA, V86, P3679; HUSS MJ, 1989, MYCOLOGIA, V81, P677, DOI 10.2307/3759871; Kay RR, 1999, TRENDS GENET, V15, P294, DOI 10.1016/S0168-9525(99)01770-9; KESSIN RH, 1997, DICTYOSTELIUM MODEL, P3; KETCHAM RB, 1989, ECOLOGY, V70, P1425, DOI 10.2307/1938201; LOOMIS W F, 1988, 4 BILLION YEARS ESSA; Maeda Y., 1997, DICTYOSTELIUM MODEL; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Raper K. B., 1984, DICTYOSTELIDS; RAPER KENNETH B., 1940, JOUR ELISHA MITCHELL SCI SOC, V56, P241; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; Williams G. C., 1966, P307; WILSON DS, 1989, J THEOR BIOL, V136, P337, DOI 10.1016/S0022-5193(89)80169-9	30	317	325	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2000	408	6815					965	967		10.1038/35050087	http://dx.doi.org/10.1038/35050087			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140681				2022-12-24	WOS:000165951100047
J	Chang, MH; Shau, WY; Chen, CJ; Wu, TC; Kong, MS; Liang, DC; Hsu, HM; Chen, HL; Hsu, HY; Chen, DS				Chang, MH; Shau, WY; Chen, CJ; Wu, TC; Kong, MS; Liang, DC; Hsu, HM; Chen, HL; Hsu, HY; Chen, DS		Taiwan Childhood Hepatoma Study Gr	Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VIRUS-INFECTION; MASS VACCINATION; TAIWAN; CHILDHOOD; CHILDREN	Context Hepatocellular carcinoma (HCC) has a male predominance and is closely related to hepatitis B Virus (HBV) infection. Hepatitis B virus vaccination was launched in 1984 in Taiwan for neonates of mothers carrying hepatitis B e antigen, resulting in a decreased incidence of HCC in children, The effect on boys vs girls is not known. Objective To evaluate the association between a HBV vaccination program with incidence of childhood HCC by sex. Design and Setting Analysis of data collected from Taiwan's National Cancer Registry System and the Taiwan Childhood Hepatoma Study Group between 1981 and 1996. Participants Children aged 6 to 14 years who were diagnosed as having HCC (201 boys and 70 girls). Main Outcome Measure Incidence of HCC in boys and girls before and after implementation of the vaccination program. Results The boy-girl incidence ratio decreased steadily from 4.5 in 1981-1984 (before the program's introduction) to 1.9 in 1990-1996 (6-12 years after the vaccination program was launched). The incidence of HCC in boys born after 1984 was significantly reduced in comparison with those born before 1978 (relative risk [RR], 0.72; P=.002). No significant decrease in HCC incidence was observed in girls born in the same periods (RR, 0.77; P=.20). The incidence of HCC in boys remained stable with increasing age, while an increase of HCC incidence with age in girls was observed. These age and sex effects remained the same regardless of birth before or after the vaccination program. Conclusion Our results suggest that boys may benefit more from HBV Vaccination than girls in the prevention of HCC.	Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan; Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan; Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; Chang Gung Childrens Hosp, Lin Kou, Taiwan; Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; Execut Yuan, Ctr Dis Control, Dept Hlth, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Chang Gung Memorial Hospital; Mackay Memorial Hospital; Centers For Disease Control - Taiwan	Chang, MH (corresponding author), Natl Taiwan Univ Hosp, Dept Pediat, No 7 Chung Shan S Rd, Taipei 10016, Taiwan.		Chen, Chien-Jen/N-4723-2019; Chen, Chien-Jen/C-6976-2008	CHEN, DING-SHINN/0000-0001-7791-6154; Chang, Mei Hwei/0000-0002-3648-9261; Hsu, Hong-Yuan/0000-0002-5720-4835	NHLBI NIH HHS [DOH 88-HR-832, DOH 87-HR-518] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHANG MH, 1989, CANCER-AM CANCER SOC, V64, P2377, DOI 10.1002/1097-0142(19891201)64:11<2377::AID-CNCR2820641130>3.0.CO;2-8; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chen D-S, 1987, NEOPLASMS LIVER, P71; CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; HSU HY, 1984, J MED VIROL, V18, P301; KEMP CJ, 1989, P NATL ACAD SCI USA, V86, P7505, DOI 10.1073/pnas.86.19.7505; KUO C-Y, 1991, Acta Paediatrica Sinica, V32, P79; MUNOZ N, 1987, NEOPLASMS LIVER, P1; NI YH, 1991, CANCER, V68, P1737, DOI 10.1002/1097-0142(19911015)68:8<1737::AID-CNCR2820680815>3.0.CO;2-G; RYDER RW, 1992, AM J EPIDEMIOL, V136, P1122, DOI 10.1093/oxfordjournals.aje.a116578; Selvin S, 1995, PRACTICAL BIOSTATIST, P455; Tang JR, 1998, J PEDIATR-US, V133, P374, DOI 10.1016/S0022-3476(98)70272-0	13	141	147	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2000	284	23					3040	3042		10.1001/jama.284.23.3040	http://dx.doi.org/10.1001/jama.284.23.3040			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	382VC	11122592				2022-12-24	WOS:000165847200030
J	Buckingham, M				Buckingham, M			A cellular cornucopia - Stem cells generate new possibilities for research and therapy.	NATURE			English	Editorial Material									Inst Pasteur, Dept Mol Biol, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Buckingham, M (corresponding author), Inst Pasteur, Dept Mol Biol, 25 Rue Dr Roux, F-75015 Paris, France.								0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2000	408	6814					773	773		10.1038/35048635	http://dx.doi.org/10.1038/35048635			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130698				2022-12-24	WOS:000165831300021
J	White, RH; Gettner, S; Newman, JM; Trauner, KB; Romano, PS				White, RH; Gettner, S; Newman, JM; Trauner, KB; Romano, PS			Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; MOLECULAR-WEIGHT HEPARIN; C-REACTIVE PROTEIN; ELECTIVE HIP; PNEUMATIC COMPRESSION; HOSPITAL DISCHARGE; KNEE ARTHROPLASTY; REPLACEMENT; SURGERY; PROPHYLAXIS	Background: Recent studies have shown that symptomatic venous thromboembolism after total hip arthroplasty most commonly develops after the patient is discharged from the hospital. Risk factors associated with these symptomatic thromboembolic events are not well defined. Methods: Using administrative data from the California Medicare records for 1993 through 1996, we identified 297 patients 65 years of age or older who were rehospitalized for thromboembolism within three months after total hip arthroplasty. We compared demographic, surgical, and medical variables potentially associated with the development of thromboembolism in these patients and 592 unmatched controls. Results: A total of 89.6 percent of patients with thromboembolism and 93.8 percent of control patients were treated with pneumatic compression, warfarin, enoxaparin, or unfractionated heparin, alone or in combination. In addition, 22.2 percent and 29.7 percent, respectively, received warfarin after discharge. A body-mass index (the weight in kilograms divided by the square of the height in meters) of 25 or greater was associated with rehospitalization for thromboembolism, with an odds ratio of 2.5 (95 percent confidence interval, 1.8 to 3.4). In a multivariate model, the only prophylactic regimens associated with a reduced risk of thromboembolism were pneumatic compression in patients with body-mass indexes of less than 25 (odds ratio, 0.3; 95 percent confidence interval, 0.2 to 0.6) and warfarin treatment after discharge (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 1.0). Conclusions: In patients who underwent total hip arthroplasty, a body-mass index of 25 or greater was associated with subsequent hospitalization for thromboembolism. Pneumatic compression in patients with a body-mass index of less than 25 and prophylaxis with warfarin after discharge were independently protective against thromboembolism. (N Engl J Med 2000;343:1758-64.) (C) 2000, Massachusetts Medical Society.	Univ Calif Davis, Dept Med, Div Gen Med, Sacramento, CA 95817 USA; Univ Calif Davis, Dept Orthopaed Surg, Sacramento, CA 95817 USA; Calif Med Review Inc, San Francisco, CA USA	University of California System; University of California Davis; University of California System; University of California Davis	White, RH (corresponding author), Univ Calif Davis, Dept Med, Div Gen Med, Suite 2400,PSSB,4150 V St, Sacramento, CA 95817 USA.		Romano, Patrick S/N-4225-2014	Romano, Patrick S/0000-0001-6749-3979				Anderson FA, 1996, ORTHOPEDICS, V19, P9; Bergqvist D, 1996, NEW ENGL J MED, V335, P696, DOI 10.1056/NEJM199609053351002; BUCHANAN RRC, 1980, J RHEUMATOL, V7, P551; BUCHLER KO, 1999, CLIN ORTHOPAEDICS, V361, P123; Caprini JA, 1999, J VASC SURG, V30, P813, DOI 10.1016/S0741-5214(99)70005-4; CERMAK J, 1993, BLOOD, V82, P513, DOI 10.1182/blood.V82.2.513.513; Clagett GP, 1998, CHEST, V114, p531S, DOI 10.1378/chest.114.5_Supplement.531S; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; Colwell CW, 1999, J BONE JOINT SURG AM, V81A, P932, DOI 10.2106/00004623-199907000-00005; Comerota AJ, 1997, ANN SURG, V226, P306, DOI 10.1097/00000658-199709000-00010; COVENTRY MB, 1974, J BONE JOINT SURG AM, VA 56, P273, DOI 10.2106/00004623-197456020-00005; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; FRANCIS CW, 1992, JAMA-J AM MED ASSOC, V267, P2911, DOI 10.1001/jama.267.21.2911; GRADYBENSON JC, 1994, CLIN ORTHOP RELAT R, P130; Heit JA, 2000, ANN INTERN MED, V132, P853, DOI 10.7326/0003-4819-132-11-200006060-00002; Hirsh J, 1998, Chest, V114, p113S, DOI 10.1378/chest.114.2_Supplement.113S; Hooker JA, 1999, J BONE JOINT SURG AM, V81A, P690, DOI 10.2106/00004623-199905000-00010; HULL R, 1993, NEW ENGL J MED, V329, P1370, DOI 10.1056/NEJM199311043291902; HULL RD, 1990, JAMA-J AM MED ASSOC, V263, P2313, DOI 10.1001/jama.263.17.2313; IMPERIALE TF, 1994, JAMA-J AM MED ASSOC, V271, P1780, DOI 10.1001/jama.271.22.1780; IMPERIALE TF, 1995, JAMA-J AM MED ASSOC, V273, P288; JOHNSON R, 1977, CLIN ORTHOP RELAT R, P123; KAEMPFFE FA, 1991, CLIN ORTHOP RELAT R, P89; LASSEN MR, 1991, LANCET, V337, P618, DOI 10.1016/0140-6736(91)91686-O; LAWRENCE L, 1999, ADV DATA VITAL HLTH, V308, P13; LEVINE MN, 1991, ANN INTERN MED, V114, P545, DOI 10.7326/0003-4819-114-7-545; LIEBERMAN JR, 1994, J BONE JOINT SURG AM, V76A, P341, DOI 10.2106/00004623-199403000-00004; Lowe GDO, 1999, THROMB HAEMOSTASIS, V81, P879; Lundgren CH, 1996, CIRCULATION, V93, P106, DOI 10.1161/01.CIR.93.1.106; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Munin MC, 1998, JAMA-J AM MED ASSOC, V279, P847, DOI 10.1001/jama.279.11.847; National Heart Lung and Blood Institute, 1998, NIH PUBL, V98-4083; O'Brien J, 2000, LANCET, V355, P1295; Paiement G D, 1992, J Arthroplasty, V7, P471, DOI 10.1016/S0883-5403(05)80220-7; Planes A, 1996, LANCET, V348, P224, DOI 10.1016/S0140-6736(96)01453-5; Robinson KS, 1997, ANN INTERN MED, V127, P439, DOI 10.7326/0003-4819-127-6-199709150-00004; Salvati EA, 2000, J BONE JOINT SURG AM, V82A, P252; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; WHITE RH, 1989, ANN INTERN MED, V111, P297, DOI 10.7326/0003-4819-111-4-297; White RH, 1998, ARCH INTERN MED, V158, P1525, DOI 10.1001/archinte.158.14.1525; Woolson ST, 1996, J BONE JOINT SURG AM, V78A, P1735, DOI 10.2106/00004623-199611000-00015; World Health Organization, 1980, INT CLASSIFICATION D	42	196	210	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2000	343	24					1758	1764		10.1056/NEJM200012143432403	http://dx.doi.org/10.1056/NEJM200012143432403			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	382FH	11114314				2022-12-24	WOS:000165812000003
J	Johnston, SC; Gress, DR; Browner, WS; Sidney, S				Johnston, SC; Gress, DR; Browner, WS; Sidney, S			Short-term prognosis after emergency department diagnosis of TIA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRANSIENT-ISCHEMIC-ATTACKS; HEALTH-CARE PROFESSIONALS; AD-HOC-COMMITTEE; STROKE-COUNCIL; INTEROBSERVER AGREEMENT; MANAGEMENT; GUIDELINES; STATEMENT; MINNESOTA; ROCHESTER	Context Management of patients with acute transient ischemic attack (TIA) varies widely, with some institutions admitting all patients and others proceeding with outpatient evaluations. Defining the short-term prognosis and risk factors for stroke after TIA may provide guidance in determining which patients need rapid evaluation. Objective To determine the short-term risk of stroke and other adverse events after emergency department (ED) diagnosis of TIA. Design and Setting Cohort study conducted from March 1997 through February 1998 in 16 hospitals in a health maintenance organization in northern California. Patients A total of 1707 patients (mean age, 72 years) identified by ED physicians as having presented with TIA. Main Outcome Measures Risk of stroke during the 90 days after index TIA; other events, including death, recurrent TIA, and hospitalization for cardiovascular events. Results During the 90 days after index TIA, 180 patients (10.5%) returned to the ED with a stroke, 91 of which occurred in the first 2 days. Five factors were independently associated with stroke: age greater than 60 years (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.1-2.7; P=.01), diabetes mellitus (OR, 2.0; 95% CI, 1.4-2.9; P<.001), symptom duration longer than 10 minutes (OR, 2.3; 95% CI, 1.3-4.2; P=.005), weakness (OR, 1.9, 95% CI, 1.4-2.6; P<.001), and speech impairment (OR, 1.5, 95% CI, 1.1-2.1; P=.01). Stroke or other adverse events occurred in 428 patients (25.1%) in the 90 days after the TIA and included 44 hospitalizations for cardiovascular events (2.6%), 45 deaths (2.6%), and 216 recurrent TIAs (12.7%). Conclusions Our results indicate that the short-term risk of stroke and other adverse events among patients who present to an ED with a TIA is substantial. Characteristics of the patient and the TIA may be useful for identifying patients who may benefit from expeditious evaluation and treatment.	Univ Calif San Francisco, Dept Neurol, Neurovasc Serv, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, Gen Internal Med Sect, San Francisco, CA USA; Kaiser Permanente No Calif, Div Res, Oakland, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Kaiser Permanente	Johnston, SC (corresponding author), Univ Calif San Francisco, Dept Neurol, Neurovasc Serv, 505 Parnassus Ave,M-798, San Francisco, CA 94143 USA.	clayj@itsa.ucsf.edu			NINDS NIH HHS [NS 36016, NS 02042] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036016] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS HP, 1994, STROKE, V25, P1901, DOI 10.1161/01.STR.25.9.1901; Albers GW, 1999, STROKE, V30, P2502, DOI 10.1161/01.STR.30.11.2502; BRAININ M, 1995, STROKE, V26, P1348, DOI 10.1161/01.STR.26.8.1348; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Brown RD, 1996, STROKE, V27, P373; Brown RD, 1998, STROKE, V29, P2109, DOI 10.1161/01.STR.29.10.2109; CALANDRE L, 1990, ACTA NEUROL SCAND, V82, P104; *CAN COOP STUD GRO, 1978, NEW ENGL J MED, V299, P53; DENNIS M, 1990, STROKE, V21, P848, DOI 10.1161/01.STR.21.6.848; DYKEN ML, 1977, JAMA-J AM MED ASSOC, V237, P882, DOI 10.1001/jama.237.9.882; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; FEINBERG WM, 1994, CIRCULATION, V89, P2950, DOI 10.1161/01.CIR.89.6.2950; HANKEY GJ, 1992, J NEUROL NEUROSUR PS, V55, P640, DOI 10.1136/jnnp.55.8.640; HANKEY GJ, 1992, J NEUROL NEUROSUR PS, V55, P171, DOI 10.1136/jnnp.55.3.171; HANKEY GJ, 1982, STROKE, V13, P24; HEYMAN A, 1979, NEUROLOGY, V29, P214, DOI 10.1212/WNL.29.2.214; HEYMAN A, 1984, NEUROLOGY, V34, P626, DOI 10.1212/WNL.34.5.626; *HLTH CAR FIN ADM, 1996, FED REGISTER, V61, P46166; Johnston SC, 1999, EUR NEUROL, V42, P105, DOI 10.1159/000069419; KERNAN WN, 1991, ANN INTERN MED, V114, P552, DOI 10.7326/0003-4819-114-7-552; KOTHARI RU, 1995, STROKE, V26, P2238, DOI 10.1161/01.STR.26.12.2238; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; KOUDSTAAL PJ, 1989, STROKE, V20, P300, DOI 10.1161/01.STR.20.2.300; KRAAIJEVELD CL, 1984, STROKE, V15, P723, DOI 10.1161/01.STR.15.4.723; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; *NAT STROK ASS, 2000, TIA MIN STROK PUBL K; OSTER G, 1994, STROKE, V25, P1149, DOI 10.1161/01.STR.25.6.1149; Selby JV, 1996, NEW ENGL J MED, V334, P635, DOI 10.1056/NEJM199603073341006; Selby JV, 1996, NEW ENGL J MED, V335, P1888, DOI 10.1056/NEJM199612193352506; SORENSEN PS, 1989, ACTA NEUROL SCAND, V79, P204, DOI 10.1111/j.1600-0404.1989.tb03740.x; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WHISNANT JP, 1973, MAYO CLIN PROC, V48, P194; *WHO MONICA PROJ P, 1988, J CLIN EPIDEMIOL, V41, P105, DOI [DOI 10.1016/0895-4356(88)90084-4, 10.1016/0895-4356(88)90084-4]; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Wolf PA, 1999, STROKE, V30, P1991, DOI 10.1161/01.STR.30.9.1991	37	924	986	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2000	284	22					2901	2906		10.1001/jama.284.22.2901	http://dx.doi.org/10.1001/jama.284.22.2901			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380RJ	11147987	Bronze			2022-12-24	WOS:000165717000030
J	Ingman, M; Kaessmann, H; Paabo, S; Gyllensten, U				Ingman, M; Kaessmann, H; Paabo, S; Gyllensten, U			Mitochondrial genome variation and the origin of modern humans	NATURE			English	Article							CONTROL REGION; DNA; POPULATION; EVOLUTION; RECOMBINATION; SEQUENCES; LINKAGE	The analysis of mitochondrial DNA (mtDNA) has been a potent tool in our understanding of human evolution, owing to characteristics such as high copy number, apparent lack of recombination(1), high substitution rate(2) and maternal mode of inheritance(3). However, almost all studies of human evolution based on mtDNA sequencing have been confined to the control region, which constitutes less than 7% of the mitochondrial genome. These studies are complicated by the extreme variation in substitution rate between sites, and the consequence of parallel mutations(4) causing difficulties in the estimation of genetic distance and making phylogenetic inferences questionable(5). Most comprehensive studies of the human mitochondrial molecule have been carried out through restriction-fragment length polymorphism analysis(6), providing data that are ill suited to estimations of mutation rate and therefore the timing of evolutionary events. Here, to improve the information obtained from the mitochondrial molecule for studies of human evolution, We describe the global mtDNA diversity in humans based on analyses of the complete mtDNA sequence of 53 humans of diverse origins. Our mtDNA data, in comparison with those of a parallel study of the Xq13.3 region(7) in the same individuals, provide a concurrent view on human evolution with respect to the age of modern humans.	Uppsala Univ, Rudbeck Lab, Med Genet Sect, Dept Genet & Pathol, S-75185 Uppsala, Sweden; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Uppsala University; Max Planck Society	Gyllensten, U (corresponding author), Uppsala Univ, Rudbeck Lab, Med Genet Sect, Dept Genet & Pathol, S-75185 Uppsala, Sweden.	ulf.gyllensten@genpat.uu.se	Kaessmann, Henrik/B-4989-2013	Kaessmann, Henrik/0000-0001-7563-839X				ANDREWS P, 1992, NATURE, V360, P641, DOI 10.1038/360641a0; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; FU YX, 1993, GENETICS, V133, P693; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Klein RG, 1989, HUMAN CAREER HUMAN B; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LEWONTIN RC, 1964, GENETICS, V49, P49; MADDISON DR, 1992, SYST BIOL, V41, P111, DOI 10.2307/2992510; NEI M, 1992, MOL BIOL EVOL, V9, P1176; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; RUVOLO M, 1993, MOL BIOL EVOL, V10, P1115; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SARICH VM, 1973, SCIENCE, V179, P1144, DOI 10.1126/science.179.4078.1144; Sharma A, 2000, SCIENCE, V288, P977; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WOLPOFF MH, 1989, HUMAN REVOLUTION, P62; Zietkiewicz E, 1998, J MOL EVOL, V47, P146, DOI 10.1007/PL00006371	30	957	1051	9	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2000	408	6813					708	713		10.1038/35047064	http://dx.doi.org/10.1038/35047064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130070				2022-12-24	WOS:000165815200046
J	Xu, X; Zhou, ZH; Wang, XL				Xu, X; Zhou, ZH; Wang, XL			The smallest known non-avian theropod dinosaur	NATURE			English	Article							CHINA	Non-avian dinosaurs are mostly medium to large-sized animals, and to date all known mature specimens are larger than the most primitive bird, Archaeopteryx(1). Here we report on a new dromaeosaurid dinosaur, Microraptor zhaoianus gen. et sp. nov., from the Early Cretaceous Jiufotang Formation of Liaoning, China(2). This is the first mature non-avian dinosaur to be found that is smaller than Archaeopteryx(1), and it eliminates the size disparity between the earliest birds and their closest non-avian theropod relatives. The more bird-like teeth, the Rahonavis-like ischium and the small number of caudal vertebrae of Microraptor are unique among dromaeosaurids and improve our understanding of the morphological transition to birds. The nearly completely articulated foot shows features, such as distally positioned digit I, slender and recurved pedal claws, and elongated penultimate phalanges, that are comparable to those of arboreal birds(3-6). The discovery of these in non-avian theropods provides new insights for studying the palaeoecology of some bird-like theropod dinosaurs.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; China Univ Geosci, Coll Earth Sci & Resources, Beijing 100083, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; China University of Geosciences	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	xxu@midwest.com.cn						Buffetaut E, 1996, NATURE, V381, P689, DOI 10.1038/381689a0; Chatterjee S., 1997, THE RISE OF BIRDS; Chiappe Luis M., 1997, Archaeopteryx, V15, P109; Clark James M., 1994, American Museum Novitates, V3115, P1; Clark JM, 1998, NATURE, V391, P886, DOI 10.1038/36092; Currie P, 1994, CAN J EARTH SCI, V30, P2224, DOI 10.1139/e93-193.; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; Currie PJ, 1995, J VERTEBR PALEONTOL, V15, P576, DOI 10.1080/02724634.1995.10011250; Currie PJ, 1990, DINOSAUR SYSTEMATICS, P108; FEDUCCIA A, 1993, SCIENCE, V259, P790, DOI 10.1126/science.259.5096.790; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Jin F, 1996, VERTEBRATA PALASIATI, V34, P102; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Martin L.D., 1991, P485; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; OSTROM JH, 1986, MEM CALIF ACAD SCI, V8, P73; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Wellnhofer P., 1988, Archaeopteryx, V6, P1; Wellnhofer Peter, 1993, Archaeopteryx, V11, P1; Wellnhofer Peter, 1992, Natural History Museum of Los Angeles County Science Series, V36, P3; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu Xing, 1998, Vertebrata Palasiatica, V36, P147; YADEN DW, 1985, BEGINNINGS BIRDS, P91; Yalden D.W., 1997, Archaeopteryx, V15, P107; Zhou ZH, 1999, SM C PALEOB, P289; Zhou Zhonghe, 1998, Vertebrata Palasiatica, V36, P136	30	224	273	6	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 7	2000	408	6813					705	708		10.1038/35047056	http://dx.doi.org/10.1038/35047056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130069	Green Published			2022-12-24	WOS:000165815200045
J	Sullivan, NJ; Sanchez, A; Rollin, PE; Yang, ZY; Nabel, GJ				Sullivan, NJ; Sanchez, A; Rollin, PE; Yang, ZY; Nabel, GJ			Development of a preventive vaccine for Ebola virus infection in primates	NATURE			English	Article							T-CELL INDUCTION; PROTECTIVE EFFICACY; IMMUNE-RESPONSES; RECOMBINANT; IMMUNIZATION; ADENOVIRUS; PROTEIN; MALARIA; IMMUNOGENICITY; THERAPY	Outbreaks of haemorrhagic fever caused by the Ebola virus are associated with high mortality rates that are a distinguishing feature of this human pathogen. The highest lethality is associated with the Zaire subtype, one of four strains identified to date(1,2). Its rapid progression allows little opportunity to develop natural immunity, and there is currently no effective anti-viral therapy. Therefore, vaccination offers a promising intervention to prevent infection and limit spread. Here we describe a highly effective vaccine strategy for Ebola virus infection in non-human primates. A combination of DNA immunization and boosting with adenoviral vectors that encode viral proteins generated cellular and humoral immunity in cynomolgus macaques. Challenge with a lethal dose of the highly pathogenic, wild-type, 1976 Mayinga strain of Ebola Zaire virus resulted in uniform infection in controls, who progressed to a moribund state and death in less than one week. In contrast, all vaccinated animals were asymptomatic for more than six months, with no detectable virus after the initial challenge. These findings demonstrate that it is possible to develop a preventive vaccine against Ebola virus infection in primates.	NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA 30333 USA	National Institutes of Health (NIH) - USA; Centers for Disease Control & Prevention - USA	Nabel, GJ (corresponding author), NIH, Vaccine Res Ctr, 40 Convent Dr,MSC-3005, Bethesda, MD 20892 USA.			Rollin, Pierre/0000-0002-4608-2641	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005004] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoki K, 1999, MOL MED, V5, P224, DOI 10.1007/BF03402119; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; DAVIS AR, 1985, P NATL ACAD SCI USA, V82, P7560, DOI 10.1073/pnas.82.22.7560; FELDMANN H, 1994, VIROLOGY, V199, P469, DOI 10.1006/viro.1994.1147; FISHERHOCH SP, 1985, J INFECT DIS, V152, P887, DOI 10.1093/infdis/152.5.887; Hanke T, 1998, VACCINE, V16, P439, DOI 10.1016/S0264-410X(97)00226-0; KILEY MP, 1980, J GEN VIROL, V49, P333, DOI 10.1099/0022-1317-49-2-333; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; KSIAZEK TG, 1992, J CLIN MICROBIOL, V30, P947, DOI 10.1128/JCM.30.4.947-950.1992; Letvin NL, 1997, P NATL ACAD SCI USA, V94, P9378, DOI 10.1073/pnas.94.17.9378; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; NATUK RJ, 1992, P NATL ACAD SCI USA, V89, P7777, DOI 10.1073/pnas.89.16.7777; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; Robinson HL, 1999, NAT MED, V5, P526, DOI 10.1038/8406; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sedegah M, 1998, P NATL ACAD SCI USA, V95, P7648, DOI 10.1073/pnas.95.13.7648; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Vanderzanden L, 1998, VIROLOGY, V246, P134, DOI 10.1006/viro.1998.9176; WANG B, 1993, P NATL ACAD SCI USA, V90, P4156, DOI 10.1073/pnas.90.9.4156; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Xiang ZQ, 1999, J IMMUNOL, V162, P6716; Xiang ZQ, 1996, VIROLOGY, V219, P220, DOI 10.1006/viro.1996.0239; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037	29	532	582	0	513	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2000	408	6812					605	609		10.1038/35046108	http://dx.doi.org/10.1038/35046108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117750				2022-12-24	WOS:000165548600123
J	Astrup, A; Marckmann, P; Blundell, J				Astrup, A; Marckmann, P; Blundell, J			Oiling of health messages in marketing of food	LANCET			English	Editorial Material							DIETARY-FAT; METAANALYSIS		Danish Nutr Council, Soborg, Denmark; Royal Vet & Agr Univ, Res Dept Human Nutr, DK-1958 Frederiksberg C, Denmark; Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England	University of Copenhagen; University of Leeds	Astrup, A (corresponding author), Danish Nutr Council, Soborg, Denmark.		Astrup, Arne/B-1407-2015	Astrup, Arne/0000-0001-8968-8996				ASSMANN G, 1997, OLIVE OIL MEDITERRAN; Astrup A, 2000, BRIT J NUTR, V83, pS25; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Doucet E, 1998, EUR J CLIN NUTR, V52, P2, DOI 10.1038/sj.ejcn.1600500; *EUR COMM INT OL O, 2000, 2000 INT C MED DIET; Lawton GL, 2000, BRIT J NUTR, V83, P473; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911, DOI 10.1161/01.ATV.12.8.911; Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632	9	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2000	356	9244					1786	1786		10.1016/S0140-6736(00)03227-X	http://dx.doi.org/10.1016/S0140-6736(00)03227-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377UY	11117907				2022-12-24	WOS:000165545700006
J	Szabowski, A; Maas-Szabowski, N; Andrecht, S; Kolbus, A; Schorpp-Kistner, M; Fusenig, NE; Angel, P				Szabowski, A; Maas-Szabowski, N; Andrecht, S; Kolbus, A; Schorpp-Kistner, M; Fusenig, NE; Angel, P			c-jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin	CELL			English	Article							KERATINOCYTE GROWTH-FACTOR; SUPRABASAL INTEGRIN EXPRESSION; CELL-CYCLE PROGRESSION; TRANSGENIC MICE; GENE-EXPRESSION; GM-CSF; INDUCTION; AP-1; FOS; DIFFERENTIATION	Interactions between mesenchymal and epithelial cells are responsible for organogenesis and tissue homeostasis. This mutual cross-talk involves cell surface proteins and soluble factors, which are mostly the result of regulated transcription. To elucidate dimer-specific functions of the AP-1 family of transcription factors, we reconstituted skin by combining primary human keratinocytes and mouse wild-type, c-jun(-/-) and junB(-/-) fibroblasts. We have discovered an antagonistic function of these AP-1 subunits in the fibroblast-mediated paracrine control of keratinocyte proliferation and differentiation, and traced this effect to the IL-1-dependent regulation of KGF and GM-CSF. These data suggest that the relative activation state of these AP-1 subunits in a non-cell-autonomous, transregulatory fashion directs regeneration of the epidermis and maintenance of tissue homeostasis in skin.	Deutsch Krebsforschungszentrum, Div Signal Transduct & Growth Control, D-69120 Heidelberg, Germany; Deutsch Krebsforschungszentrum, Div Carcinogenesis & Differentiat, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Angel, P (corresponding author), Deutsch Krebsforschungszentrum, Div Signal Transduct & Growth Control, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	p.angel@dkfz-heidelberg.de						ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; BOSSYWETZEL E, 1992, GENE DEV, V6, P2340, DOI 10.1101/gad.6.12a.2340; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; BRAUNSTEIN S, 1994, J INVEST DERMATOL, V103, P601, DOI 10.1111/1523-1747.ep12396936; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CHOI Y, 1990, CELL REGUL, V1, P791, DOI 10.1091/mbc.1.11.791; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; FINCH PW, 1995, J BIOL CHEM, V270, P11230, DOI 10.1074/jbc.270.19.11230; FUSENIG NE, 1994, KERATINOCYTE HDB, P71; FUSENIG NE, 1992, CULTURE EPITHELIAL C, P25; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; GUO LF, 1993, EMBO J, V12, P973, DOI 10.1002/j.1460-2075.1993.tb05738.x; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Huffman JA, 1996, J CLIN INVEST, V97, P649, DOI 10.1172/JCI118461; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; KAUR P, 1992, J CELL SCI, V103, P755; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; KUPPER TS, 1995, J INVEST DERMATOL, V105, P62; LEVER WF, 1984, HISTOPATHOLOGY SKIN; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; LUGER TA, 1995, ALLERGY, V50, P292, DOI 10.1111/j.1398-9995.1995.tb01151.x; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; Maas-Szabowski N, 2000, J INVEST DERMATOL, V114, P1075, DOI 10.1046/j.1523-1747.2000.00987.x; Metcalf D, 1998, IMMUNOL CELL BIOL, V76, P441, DOI 10.1046/j.1440-1711.1998.00761.x; Metcalf D, 1998, LEUKEMIA, V12, P353, DOI 10.1038/sj.leu.2400926; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Ponec M, 1997, ARCH DERMATOL RES, V289, P317, DOI 10.1007/s004030050198; Rikimaru K, 1997, EXP DERMATOL, V6, P214, DOI 10.1111/j.1600-0625.1997.tb00165.x; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; SAIAG P, 1985, SCIENCE, V230, P669, DOI 10.1126/science.2413549; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; SCHRODER JM, 1995, J INVEST DERMATOL, V105, P20; SCHUH AC, 1990, NATURE, V346, P756, DOI 10.1038/346756a0; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; Smola H, 1998, EXP CELL RES, V239, P399, DOI 10.1006/excr.1997.3910; SMOLA H, 1993, J CELL BIOL, V122, P417, DOI 10.1083/jcb.122.2.417; Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x; Stefanidou MP, 1999, BRIT J DERMATOL, V141, P1040, DOI 10.1046/j.1365-2133.1999.03202.x; Takei T, 1998, J CELL BIOCHEM, V69, P95; WANG CY, 1994, MOL CELL BIOL, V14, P1153, DOI 10.1128/MCB.14.2.1153; Welter JF, 1995, ONCOGENE, V11, P2681; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Xing Z, 1997, LAB INVEST, V77, P615; Ye JP, 1996, MOL CELL BIOL, V16, P157; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827	62	331	346	1	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 22	2000	103	5					745	755		10.1016/S0092-8674(00)00178-1	http://dx.doi.org/10.1016/S0092-8674(00)00178-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	375ZJ	11114331	Bronze			2022-12-24	WOS:000165433100007
J	Lanzetti, L; Rybin, V; Malabarba, MG; Christoforidis, S; Scita, G; Zerial, M; Di Fiore, PP				Lanzetti, L; Rybin, V; Malabarba, MG; Christoforidis, S; Scita, G; Zerial, M; Di Fiore, PP			The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5	NATURE			English	Article							GTPASE-ACTIVATING PROTEINS; ENDOCYTIC PATHWAY; BINDING-PROTEIN; SH3 DOMAIN; GROWTH; KINASE; SUBSTRATE; FUSION; E3B1	How epidermal growth factor receptor (EGFR) signalling is linked to EGFR trafficking is largely unknown. Signalling and trafficking involve small GTPases of the Rho and Rab families, respectively. But it remains unknown whether the signalling relying on these two classes of GTPases is integrated, and, if it is, what molecular machinery is involved. Here we report that the protein Eps8 connects these signalling pathways. Eps8 is a substrate of the EGFR(1), which is held in a complex with Sos1 by the adaptor protein E3b1 (ref. 2), thereby mediating activation of Rac(2). Through its src homology-3 domain, Eps8 interacts with RN-tre(3). We show that RN-tre is a Rab5 GTPase-activating protein, whose activity is regulated by the EGFR. By entering in a complex with Eps8, RN-tre acts on Rab5 and inhibits internalization of the EGFR. Furthermore, RN-tre diverts Eps8 from its Rac-activating function, resulting in the attenuation of Rac signalling. Thus, depending on its state of association with E3b1 or RN-tre, Eps8 participates in both EGFR signalling through Rac, and trafficking through Rab5.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; FIRC Inst Mol Oncol, IFOM, I-20134 Milan, Italy	IRCCS European Institute of Oncology (IEO); European Molecular Biology Laboratory (EMBL); Max Planck Society; IFOM - FIRC Institute of Molecular Oncology	Di Fiore, PP (corresponding author), European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy.		Scita, Giorgio/J-9670-2012; Malabarba, Maria Grazia/L-4805-2015; Di Fiore, Pier Paolo/K-2130-2012	Malabarba, Maria Grazia/0000-0002-9457-2047; Di Fiore, Pier Paolo/0000-0002-2252-0950; Scita, Giorgio/0000-0001-7984-1889; Christoforidis, Savvas/0000-0002-0210-0713; LANZETTI, Letizia/0000-0001-7541-5524				Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Carbone R, 1997, CANCER RES, V57, P5498; CASTAGNINO P, 1995, ONCOGENE, V10, P723; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Matoskova B, 1996, ONCOGENE, V12, P2679; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P243, DOI 10.1016/S0968-0004(97)01073-6; Papini E, 1997, EMBO J, V16, P15, DOI 10.1093/emboj/16.1.15; Provenzano C, 1998, EXP CELL RES, V242, P186, DOI 10.1006/excr.1998.4095; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; RUSSELL M, 1995, J BIOL CHEM, V270, P11757, DOI 10.1074/jbc.270.20.11757; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; SORKIN A, 1993, ONCOGENE, V8, P3021	24	227	245	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2000	408	6810					374	377		10.1038/35042605	http://dx.doi.org/10.1038/35042605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099046				2022-12-24	WOS:000165296000049
J	Bartsch, D; Ghirardi, M; Casadio, A; Giustetto, M; Karl, KA; Zhu, HX; Kandel, ER				Bartsch, D; Ghirardi, M; Casadio, A; Giustetto, M; Karl, KA; Zhu, HX; Kandel, ER			Enhancement of memory-related long-term facilitation by ApAF, a novel transcription factor that acts downstream from both CREB1 and CREB2	CELL			English	Article							APLYSIA SENSORY NEURONS; GLUTATHIONE-S-TRANSFERASE; CAMP-RESPONSIVE ELEMENT; STRUCTURAL-CHANGES; BINDING PROTEIN; SYNAPTIC FACILITATION; TRANSMITTER RELEASE; FUSION PROTEINS; SENSITIZATION; HABITUATION	The memory for sensitization of the gill withdrawal reflex in Aplysia is reflected in facilitation of the monosynaptic connection between the sensory and motor neurons of the reflex. The switch from short- to longterm facilitation requires activation of CREB1, derepression of ApCREB2, and induction of ApC/EBP. In search for genes that act downstream from CREB1, we have identified a transcription activator, ApAF, which is stimulated by protein kinase A and can dimerize with both ApC/EBP and ApCREB2. ApAF is necessary for long-term facilitation induced by five pulses of serotonin, by activation of CREB1, or by derepression of ApCREB2. Overexpression of ApAF enhances the long-term facilitation further. Thus, ApAF is a candidate memory enhancer gene downstream from both CREB1 and ApCREB2.	Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Turin, Dipartimento Neurosci, I-10125 Turin, Italy	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; University of Turin	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Howard Hughes Med Inst, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.		giustetto, maurizio/D-6606-2011; ghirardi, mirella/AEQ-0420-2022	giustetto, maurizio/0000-0003-1323-4060; 				Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BAILEY CH, 1988, P NATL ACAD SCI USA, V85, P9356, DOI 10.1073/pnas.85.23.9356; BAILEY CH, 1992, NEURON, V9, P749, DOI 10.1016/0896-6273(92)90037-E; BAILEY CH, 1983, SCIENCE, V220, P91, DOI 10.1126/science.6828885; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Barad M, 1998, P NATL ACAD SCI USA, V95, P15020, DOI 10.1073/pnas.95.25.15020; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRUNELLI M, 1976, SCIENCE, V194, P1178, DOI 10.1126/science.186870; CAREW T J, 1971, International Journal of Neuroscience, V2, P79, DOI 10.3109/00207457109146995; CAREW TJ, 1973, SCIENCE, V182, P1158, DOI 10.1126/science.182.4117.1158; COWELL IG, 1992, MOL CELL BIOL, V12, P3070, DOI 10.1128/MCB.12.7.3070; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DROLET DW, 1991, GENE DEV, V5, P1739, DOI 10.1101/gad.5.10.1739; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FLEXNER JB, 1963, SCIENCE, V141, P57, DOI 10.1126/science.141.3575.57; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; Gass P, 1998, LEARN MEMORY, V5, P274; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GLANZMAN DL, 1990, SCIENCE, V249, P799, DOI 10.1126/science.2389145; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HUNGER SP, 1992, GENE DEV, V6, P1608, DOI 10.1101/gad.6.9.1608; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; IYER SV, 1991, MOL CELL BIOL, V11, P4863, DOI 10.1128/MCB.11.10.4863; KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MECHLER BM, 1985, EMBO J, V4, P1551, DOI 10.1002/j.1460-2075.1985.tb03816.x; Metzstein MM, 1996, NATURE, V382, P545, DOI 10.1038/382545a0; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; MUELLER CR, 1990, CELL, V61, P279, DOI 10.1016/0092-8674(90)90808-R; NORBY PL, 1992, NUCLEIC ACIDS RES, V20, P6317, DOI 10.1093/nar/20.23.6317; Pinsker H, 1970, Adv Biochem Psychopharmacol, V2, P351; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; RAYPORT SG, 1986, J NEUROSCI, V6, P759; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHOLZ KP, 1988, SCIENCE, V240, P1664, DOI 10.1126/science.2837826; SWEATT JD, 1989, NATURE, V339, P51, DOI 10.1038/339051a0; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	47	51	51	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 10	2000	103	4					595	608		10.1016/S0092-8674(00)00163-X	http://dx.doi.org/10.1016/S0092-8674(00)00163-X			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	374MB	11106730	Bronze			2022-12-24	WOS:000165348000005
J	Fischer, KS; Barton, J; Khush, GS; Leung, H; Cantrell, R				Fischer, KS; Barton, J; Khush, GS; Leung, H; Cantrell, R			Genomics and agriculture - Collaborations in rice	SCIENCE			English	Article							YIELD; XA21		Int Rice Res Inst, Makati 1271, Philippines; Stanford Univ, Sch Law, Stanford, CA 94305 USA	CGIAR; International Rice Research Institute (IRRI); Stanford University	Leung, H (corresponding author), Int Rice Res Inst, POB 3127, Makati 1271, Philippines.		Khush, Gurdev Singh/C-5109-2009					Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; DUVICK DN, 1992, MAYDICA, V37, P69; *GEN M ROCK FDN IN, 1999, RIC FUNCT GEN WORKSH; HOSSAIIN M, 1999, IN PRESS AGR BIOTECH; Hossain M., 1998, Sustainability of rice in the global food system., P19; IRRI, 1998, SUST FOOD SEC YEAR 2; KHUSH GS, IN PRESS NEW FRONTIE; Marshall E, 1999, SCIENCE, V284, P406, DOI 10.1126/science.284.5413.406; Normile D, 1999, SCIENCE, V286, P24; PERSLEY G, 1999, P INT C WASH DC 21 2; Reich MR, 2000, SCIENCE, V287, P1979, DOI 10.1126/science.287.5460.1979; RONALD PC, 1992, MOL GEN GENET, V236, P113, DOI 10.1007/BF00279649; Somerville C, 1999, SCIENCE, V285, P380, DOI 10.1126/science.285.5426.380; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; WALBOT V, COMMUNICATION; 2000, INT RIC GEN M 8 9 FE	17	33	35	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 13	2000	290	5490					279	280		10.1126/science.290.5490.279	http://dx.doi.org/10.1126/science.290.5490.279			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363CW	11183373				2022-12-24	WOS:000089818100026
J	Girardi, AM; Pyenson, LR; Morris, J; Brickfield, FX				Girardi, AM; Pyenson, LR; Morris, J; Brickfield, FX			Impact of coronary heart disease on world leaders	ANNALS OF INTERNAL MEDICINE			English	Article								Background: Previous studies have shown that from 1965 to 1996, coronary heart disease was a frequent natural cause of death among world leaders. Objective: To assess incidence of and death from coronary heart disease among world leaders and to determine the effect of this disease on office-holding ability. Design: Archive search of worldwide English-language and translated press and media reports from 1970 to 1999 for reference to coronary events. Setting: U.S. federal government medical analytic unit. Participants: National principal decision makers in countries with populations greater than 250 000. Measurements: Reports of angina, heart attack, myocardial infarction, and arrhythmia attributed to coronary artery disease: use of cardiac procedures; receipt of foreign care; death; and removal from office. Results: 64 leaders had initial coronary heart disease events while holding their nation's highest office. Initial event rates decreased from the 1970s to the 1990s (1.9 events per 100 person-years vs. 1.1 events per 100 person-years). Survival, use of procedures, and receipt of foreign care increased over time. Most leaders who survived an acute event continued to function in office. Conclusions: Incidence of and death from coronary heart disease among office-holding world leaders has decreased over the past 30 years, possibly because of increased use of cardiac procedures. A coronary event in a world leader is unlikely to presage a change in government.	Cent Intelligence Agcy, Washington, DC 20505 USA		Pyenson, LR (corresponding author), Cent Intelligence Agcy, Washington, DC 20505 USA.							Bienen Henry S., 1991, TIME POWER LEADERSHI; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; *CTR INT AG, 1985, WORLD FACT BOOK; *CTR INT AG, 1975, WORLD FACT BOOK; *CTR INT AG, 1995, WORLD FACT BOOK; Pyenson LR, 1998, MIL MED, V163, P797, DOI 10.1093/milmed/163.12.797; THOM TJ, 1998, HEART ARTERIES VEINS, P5; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155	9	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2001	134	4					287	290		10.7326/0003-4819-134-4-200102200-00012	http://dx.doi.org/10.7326/0003-4819-134-4-200102200-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403NW	11182839				2022-12-24	WOS:000167050200005
J	Kirchmaier, AL; Rine, J				Kirchmaier, AL; Rine, J			DNA replication-independent silencing in S-cerevisiae	SCIENCE			English	Article							ORIGIN RECOGNITION COMPLEX; CELL-CYCLE PROGRESSION; ASSEMBLY FACTOR-I; SACCHAROMYCES-CEREVISIAE; YEAST; CHROMATIN; SIR1; INHERITANCE; REGION; LOCI	In Saccharomyces cerevisiae, the silent mating Loci are repressed by their assembly into heterochromatin. The formation of this heterochromatin requires a cell cycle event that occurs between early S phase and G(2)/M phase, which has been widely assumed to be DNA replication. To determine whether DNA replication through a silent mating-type Locus, HMRa, is required for silencing to be established, we monitored heterochromatin formation at HMRa on a chromosome and on a nonreplicating extrachromosomal cassette as cells passed through S phase. Cells that passed through S phase established silencing at both the chromosomal HMRa Locus and the extrachromosomal HMRa Locus with equal efficiency. Thus, in contrast to the prevailing view, the establishment of silencing occurred in the absence of passage of the DNA replication fork through or near the HMR Locus, but retained a cell cycle dependence.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet & Dev, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rine, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet & Dev, 401 Barker Hall, Berkeley, CA 94720 USA.	jrine@uclink4.berkeley.edu		Kirchmaier, Ann/0000-0001-9938-9105	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019392] Funding Source: NIH RePORTER; NHGRI NIH HHS [NIHGM31105] Funding Source: Medline; NIGMS NIH HHS [NIHF32GM19392] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM J, 1984, J MOL BIOL, V176, P307, DOI 10.1016/0022-2836(84)90492-3; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; BROACH JR, 1991, MOL CELLULAR BIOL YE, V1, P297; Cheng TH, 2000, GENE DEV, V14, P452; Dalgaard LZ, 1999, NATURE, V400, P181, DOI 10.1038/22139; Dillin A, 1997, GENETICS, V147, P1053; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; FOX CA, 1995, GENE DEV, V9, P911, DOI 10.1101/gad.9.8.911; Fox CA, 1997, SCIENCE, V276, P1547, DOI 10.1126/science.276.5318.1547; Friedman KL, 1995, J CELL SCI, P51; Gardner KA, 1999, GENETICS, V151, P31; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; KAUFMAN P, COMMUNICATION; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KIRCHMAIER AL, UNPUB; Li YC, 2001, SCIENCE, V291, P650, DOI 10.1126/science.291.5504.650; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; LOO S, 1995, MOL BIOL CELL, V6, P741, DOI 10.1091/mbc.6.6.741; MEYERLEON L, 1987, NUCLEIC ACIDS RES, V15, P6469, DOI 10.1093/nar/15.16.6469; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Rivier DH, 1999, GENETICS, V151, P521; SCHMID A, 1992, CELL, V71, P853, DOI 10.1016/0092-8674(92)90560-Y; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Singer MS, 1998, GENETICS, V150, P613; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	32	109	110	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2001	291	5504					646	650		10.1126/science.291.5504.646	http://dx.doi.org/10.1126/science.291.5504.646			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11158676				2022-12-24	WOS:000166616000042
J	Collins, T				Collins, T			Toward sustainable chemistry	SCIENCE			English	Article									Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Collins, T (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.		Collins, Terrence/A-9807-2017	Collins, Terrence/0000-0003-2611-9184					0	106	108	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2001	291	5501					48	49		10.1126/science.291.5501.48	http://dx.doi.org/10.1126/science.291.5501.48			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389VJ	11141549				2022-12-24	WOS:000166259100023
J	Bhattacharjee, C; Bradley, P; Smith, M; Scally, AJ; Wilson, BJ				Bhattacharjee, C; Bradley, P; Smith, M; Scally, AJ; Wilson, BJ			Do animals bite more during a full moon? Retrospective observational analysis	BRITISH MEDICAL JOURNAL			English	Article							LUNAR	Objective To test the hypothesis that the incidence of animal bites increases at the time of a full moon. Design Retrospective observational analysis. Setting Accident and emergency department at a general hospital in an English city Subjects 1621 consecutive patients, irrespective of age and sex. Main outcome measures Number of patients who attended an accident and emergency department during 1997 to 1999 after being bitten by an animal, The number of bites in each day was compared with the lunar phase in each month. Results The incidence of animal bites rose significantly at the time of a full moon. With the period of the full moon as the reference period, the incidence rate ratio of the bites for all other periods of the lunar cycle was significantly lower(P < 0.001). Conclusions The full moon is associated with a significant increase in animal bites to humans.	Bradford Royal Infirm, Dept Accid & Emergency, Bradford BD9 6RJ, W Yorkshire, England; Clayton Surg, Bradford BD14 6JA, W Yorkshire, England; Univ Bradford, Sch Hlth Studies, Bradford BD5 0BB, W Yorkshire, England	Bradford Royal Infirmary; University of Bradford	Bhattacharjee, C (corresponding author), Bradford Royal Infirm, Dept Accid & Emergency, Bradford BD9 6RJ, W Yorkshire, England.		Callahan, Charles D/L-1641-2013; Scally, Andrew/A-9021-2012	Scally, Andy/0000-0002-6189-2247				DECASTRO JM, 1995, PHYSIOL BEHAV, V57, P439, DOI 10.1016/0031-9384(94)00232-T; Ghiandoni G, 1997, Minerva Ginecol, V49, P91; Laverty WH, 1998, PERCEPT MOTOR SKILL, V86, P299, DOI 10.2466/pms.1998.86.1.299; MIKULECKY M, 1992, EXPERIENTIA, V48, P530, DOI 10.1007/BF01928182; Owen C, 1998, AUST NZ J PSYCHIAT, V32, P496, DOI 10.1046/j.1440-1614.1998.00442.x; Raison CL, 1999, J AFFECT DISORDERS, V53, P99, DOI 10.1016/S0165-0327(99)00016-6; SHARFMAN M, 1980, PERCEPT MOTOR SKILL, V50, P124, DOI 10.2466/pms.1980.50.1.124; Sitar J, 1994, Cas Lek Cesk, V133, P596; Sitar J, 1997, Cas Lek Cesk, V136, P174; SOYMAN P, 1980, J CLIN PSYCHOL, V36, P884; THAKUR CP, 1984, BRIT MED J, V289, P1789, DOI 10.1136/bmj.289.6460.1789; Thompson DA, 1996, AM J EMERG MED, V14, P161, DOI 10.1016/S0735-6757(96)90124-2	12	28	29	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 23	2000	321	7276					1559	1561		10.1136/bmj.321.7276.1559	http://dx.doi.org/10.1136/bmj.321.7276.1559			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	387RA	11124173	Green Published, Bronze			2022-12-24	WOS:000166134500011
J	Mimouni, D; Mimouni, FB; Mimouni, M				Mimouni, D; Mimouni, FB; Mimouni, M			Polydactyly reported by Raphael	BRITISH MEDICAL JOURNAL			English	Article									Rabin Med Ctr, Petah Tiqva, Israel; Tel Aviv Sourasky Med Ctr, Lis Matern Hosp, Tel Aviv, Israel; Schneider Childrens Med Ctr Israel, Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Mimouni, D (corresponding author), Rabin Med Ctr, Petah Tiqva, Israel.			Mimouni, Daniel/0000-0001-7158-2085				Temtamy SA., 1979, BIRTH DEFECTS COMPEN, P873	1	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 23	2000	321	7276					1622	1622		10.1136/bmj.321.7276.1622	http://dx.doi.org/10.1136/bmj.321.7276.1622			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387RA	11124206	Green Published			2022-12-24	WOS:000166134500042
J	Bai, JW; Uehara, Y; Montell, DJ				Bai, JW; Uehara, Y; Montell, DJ			Regulation of invasive cell behavior by taiman, a Drosophila protein related to AlB1, a steroid receptor coactivator amplified in breast cancer	CELL			English	Article							FOCAL ADHESION KINASE; ECDYSONE RECEPTOR; MOSAIC ANALYSIS; DE-CADHERIN; MELANOGASTER; OOGENESIS; MIGRATION; HOMOLOG; REVEALS; GENES	Steroid hormones are key regulators of numerous physiological and developmental processes, including metastasis of breast and ovarian cancer. Here we report the identification of a Drosophila gene, named taiman, which encodes a steroid hormone receptor coactivator related to AIB1. Mutations in tai caused defects in the migration of specific follicle cells, the border cells, in the Drosophila ovary. Mutant cells exhibited abnormal accumulation of E-cadherin, beta -catenin, and focal adhesion kinase. TAI protein colocalized with the ecdysone receptor in vivo and augmented transcriptional activation by the ecdysone receptor in cultured cells. The finding of this type of coactivator required for cell motility suggests a novel role for steroid hormones, in stimulating invasive cell behavior, independent of effects on proliferation.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Montell, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046425] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM46425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREW DJ, 1994, METHOD CELL BIOL, V44, P353, DOI 10.1016/S0091-679X(08)60923-1; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; BEHRENS J, 1993, BREAST CANCER RES TR, V24, P175, DOI 10.1007/BF01833258; Birchmeier W, 1991, CURR OPIN CELL BIOL, V3, P832, DOI 10.1016/0955-0674(91)90057-6; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Carney GE, 2000, GENETICS, V154, P1203; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chou TB, 1996, GENETICS, V144, P1673; CHRISTIANSON AMK, 1992, P NATL ACAD SCI USA, V89, P11503, DOI 10.1073/pnas.89.23.11503; CUZICK J, 1996, IARC SCI PUBL, V139, P99; DePasquale JA, 1999, HISTOCHEM CELL BIOL, V112, P341, DOI 10.1007/s004180050415; Fox GL, 1999, P NATL ACAD SCI USA, V96, P14978, DOI 10.1073/pnas.96.26.14978; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Fujimoto J, 1999, J BIOL CHEM, V274, P29196, DOI 10.1074/jbc.274.41.29196; Green S, 1999, ENDOCR-RELAT CANCER, V6, P349, DOI 10.1677/erc.0.0060349; Guilford P, 1999, MOL MED TODAY, V5, P172, DOI 10.1016/S1357-4310(99)01461-6; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Jordan VC, 1999, TRENDS ENDOCRIN MET, V10, P312, DOI 10.1016/S1043-2760(99)00181-2; King R. C., 1970, OVARIAN DEV DROSOPHI; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; LIU Y, 2001, IN PRESS DEVELOPMENT; Liu YR, 1999, DEVELOPMENT, V126, P1869; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Montell DJ, 1999, DEVELOPMENT, V126, P3035; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; NEUBAUER BL, 1995, PROSTATE, V27, P220, DOI 10.1002/pros.2990270407; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Oda H, 1997, GENES CELLS, V2, P29, DOI 10.1046/j.1365-2443.1997.d01-284.x; Ong A, 2000, INT J CANCER, V85, P430, DOI 10.1002/(SICI)1097-0215(20000201)85:3<430::AID-IJC21>3.0.CO;2-Q; ORO AE, 1992, DEVELOPMENT, V115, P449; Palmer RH, 1999, J BIOL CHEM, V274, P35621, DOI 10.1074/jbc.274.50.35621; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Riddiford Lynn M., 1993, P899; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Schneider H P, 1995, Int J Fertil Menopausal Stud, V40 Suppl 1, P40; SCHWARTZ MB, 1985, J INSECT PHYSIOL, V31, P947, DOI 10.1016/0022-1910(85)90029-0; Shiozaki H, 1996, CANCER, V77, P1605, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.3.CO;2-R; Suen CS, 1998, J BIOL CHEM, V273, P27645, DOI 10.1074/jbc.273.42.27645; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Tinker R, 1998, DEV BIOL, V199, P1, DOI 10.1006/dbio.1998.8941; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tworoger M, 1999, GENETICS, V151, P739; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0	49	222	224	1	31	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 22	2000	103	7					1047	1058		10.1016/S0092-8674(00)00208-7	http://dx.doi.org/10.1016/S0092-8674(00)00208-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163181	Bronze			2022-12-24	WOS:000166040600008
J	Ertekin-Taner, N; Graff-Radford, N; Younkin, LH; Eckman, C; Baker, M; Adamson, J; Ronald, J; Blangero, J; Hutton, M; Younkin, SG				Ertekin-Taner, N; Graff-Radford, N; Younkin, LH; Eckman, C; Baker, M; Adamson, J; Ronald, J; Blangero, J; Hutton, M; Younkin, SG			Linkage of plasma A beta 42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees	SCIENCE			English	Article							AMYLOID-BETA-PROTEIN; TRAIT LOCUS; IN-VIVO; PRESENILIN-1; PRECURSOR	Plasma A beta 42 (amyloid beta 42 peptide) is invariably elevated in early-onset familial Alzheimer's disease (AD), and it is also increased in the first-degree relatives of patients with typical late-onset AD (LOAD), To detect LOAD Loci that increase A beta 42, we used plasma A beta 42 as a surrogate trait and performed Linkage analysis on extended AD pedigrees identified through a LOAD patient with extremely high plasma A beta. Here, we report linkage to chromosome 10 with a maximal Lod score of 3.93 at 81 centimorgans close to D10S1225, Remarkably, Linkage to the same region was obtained independently in a genome-wide screen of LOAD sibling pairs. These results provide strong evidence for a novel LOAD Locus on chromosome 10 that acts to increase A beta.	Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; SW Fdn Biomed Res, San Antonio, TX 78245 USA	Mayo Clinic; Texas Biomedical Research Institute	Hutton, M (corresponding author), Mayo Clin Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.		Blangero, John/ABA-7175-2021		NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG006656, P50AG016574] Funding Source: NIH RePORTER; NIA NIH HHS [P50 AG16574, AG06656] Funding Source: Medline; NIMH NIH HHS [MH59490] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Blangero J, 2000, GENET EPIDEMIOL, V19, pS8, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI2>3.0.CO;2-Y; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Clement K, 1996, DIABETES, V45, P687, DOI 10.2337/diabetes.45.5.687; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; YOUNKIN SG, 2000, NEUROBIOL AGING, V21, pS136	15	311	318	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2000	290	5500					2303	+		10.1126/science.290.5500.2303	http://dx.doi.org/10.1126/science.290.5500.2303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125143				2022-12-24	WOS:000165995800043
J	Roweis, ST; Saul, LK				Roweis, ST; Saul, LK			Nonlinear dimensionality reduction by locally linear embedding	SCIENCE			English	Article								Many areas of science depend on exploratory data analysis and visualization. The need to analyze Large amounts of multivariate data raises the fundamental problem of dimensionality reduction: how to discover compact representations of high-dimensional data. Here, we introduce Locally Linear embedding (LLE), an unsupervised Learning algorithm that computes Low-dimensional, neighborhood-preserving embeddings of high-dimensional inputs. Unlike clustering methods for Local dimensionality reduction, LLE maps its inputs into a single global coordinate system of lower dimensionality, and its optimizations do not involve Local minima. By exploiting the local symmetries of Linear reconstructions, LLE is able to Learn the global structure of nonlinear manifolds, such as those generated by images of faces or documents of text.	UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; AT&T Lab Res, Florham Pk, NJ 07932 USA	University of London; University College London; AT&T	Roweis, ST (corresponding author), UCL, Gatsby Computat Neurosci Unit, 17 Queen Sq, London WC1N 3AR, England.	roweis@gatsby.ucl.ac.uk; lsaul@research.att.com	cai, chao/C-4840-2009					Bai Z., 2000, TEMPLATES SOLUTION A; Beymer D, 1996, SCIENCE, V272, P1905, DOI 10.1126/science.272.5270.1905; Bishop CM, 1998, NEURAL COMPUT, V10, P215, DOI 10.1162/089976698300017953; Cox T. F, 1994, MULTIDIMENSIONAL SCA; DeMers D., 1993, ADV NEURAL INFORM PR, P580; DONNELL DJ, 1994, ANN STAT, V22, P1635, DOI 10.1214/aos/1176325746; HASTIE T, 1989, J AM STAT ASSOC, V84, P502, DOI 10.2307/2289936; Horn R.A., 2013, MATRIX ANAL, P321; Jolliffe I., 1989, APPL OPTICS; Kambhatla N, 1997, NEURAL COMPUT, V9, P1493, DOI 10.1162/neco.1997.9.7.1493; Klock H, 2000, PATTERN RECOGN, V33, P651, DOI 10.1016/S0031-3203(99)00078-3; Kohonen T., 1988, SELF ORG ASS MEMORY; KRAMER MA, 1991, AICHE J, V37, P233, DOI 10.1002/aic.690370209; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LITTMAN M, 1992, COMPUTING SCIENCE AND STATISTICS : VOL 24, P208; MARTINETZ T, 1994, NEURAL NETWORKS, V7, P507, DOI 10.1016/0893-6080(94)90109-0; TAKANE Y, 1977, PSYCHOMETRIKA, V42, P7, DOI 10.1007/BF02293745; Tarjan R., 1983, CBMS, V44; Tenenbaum JB, 1998, ADV NEUR IN, V10, P682	19	9348	10548	56	1162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2000	290	5500					2323	+		10.1126/science.290.5500.2323	http://dx.doi.org/10.1126/science.290.5500.2323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125150				2022-12-24	WOS:000165995800050
J	Fichtenberg, CM; Glantz, SA				Fichtenberg, CM; Glantz, SA			Association of the california tobacco control program with declines in cigarette consumption and mortality from heart disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CAMPAIGNS; SMOKING	Background: The California Tobacco Control Program, a large, aggressive antitobacco program implemented in 1989 and funded by a voter-enacted cigarette surtax, accelerated the decline in cigarette consumption and in the prevalence of smoking in California. Since the excess risk of heart disease falls rapidly after the cessation of smoking, we tested the hypothesis that this program was associated with lower rates of death from heart disease. Methods: Data on per capita cigarette consumption and age-adjusted rates of death from heart disease in California and the United States from 1980 to 1997 were fitted in multiple regression analyses. The regression analyses included the rates in the rest of the United States and variables that allowed for changes in the rates after 1988, when the tobacco-control program was approved, and after 1992, when the program was cut back. Results: Between 1989 and 1992, the rates of decline in per capita cigarette consumption and mortality from heart disease in California, relative to the rest of the United States, were significantly greater than the pre-1989 rates, by 2.72 packs per year per year (P=0.001) and by 2.93 deaths per year per 100,000 population per year (P<0.001). These rates of decline were reduced (by 2.05 packs per year per year [P=0.04], and by 1.71 deaths per year per 100,000 population per year [P=0.03]) when the program was cut back, beginning in 1992. Despite these problems, the program was associated with 33,300 fewer deaths from heart disease between 1989 and 1997 than the number that would have been expected if the earlier trend in mortality from heart disease in California relative to the rest of the United States had continued. The diminished effectiveness of the program after 1992 was associated with 8300 more deaths than would have been expected had its initial effectiveness been maintained. Conclusions: A large and aggressive tobacco-control program is associated with a reduction in deaths from heart disease in the short run. (N Engl J Med 2000;343:1772-7.) (C) 2000, Massachusetts Medical Society.	Univ Calif San Francisco, Cardiovasc Res Inst, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Glantz, SA (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, Inst Hlth Policy Studies, Box 0130, San Francisco, CA 94143 USA.				NCI NIH HHS [CA-61021] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061021] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAL DG, 1990, JAMA-J AM MED ASSOC, V264, P1570, DOI 10.1001/jama.264.12.1570; Balbach ED, 1998, TOB CONTROL, V7, P397, DOI 10.1136/tc.7.4.397; BAUER U, 2000, 1 FLOR DEP HLTH SURV; Biener L, 2000, BRIT MED J, V321, P351, DOI 10.1136/bmj.321.7257.351; BURNS DM, 1997, NIH PUBL; *CA DEP HLTH SERV, MOD CHANG CAL EXP TO; *CIG SMOK EXC TAX, 1990, MMWR-MORBID MORTAL W, V45, P966; *CTR H**CTR HLTH S, 1998, HEART DIS DEATHS CAL; *DECL CIG CONS FOL, 1999, MMWR MORTAL WKLY REP, V7, P140; *DEP HLTH HUM SERV, 1990, DHHS PUBL; *DEP HLTH HUM SERV, 1983, DHHS PUBL; Glantz S., 1993, TOB CONTROL, V2, P311, DOI DOI 10.1136/TC.2.4.311; Glantz SA, 2000, TOBACCO WAR INSIDE C; Goldman LK, 1998, JAMA-J AM MED ASSOC, V279, P772, DOI 10.1001/jama.279.10.772; KIEGEL M, 1978, AM J PUBLIC HEALTH, V90, P372; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; *NAT CANC POL BOAR, 2000, STAT PROGR RED TOB U; *NAT CTR HLTH STAT, 1995, HLTH US 1995; *NAT CTR HLTH STAT, 1999, HLTH US 199 HLTH AG; National Center for Health Statistics, 1999, HLTH US 1999 HLTH AG; ORZECHOWSKI W, 1999, TAX BURDEN TOBACCO; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Pierce JP, 1999, JAMA-J AM MED ASSOC, V281, P37; Pierce JP, 1998, JAMA-J AM MED ASSOC, V280, P893, DOI 10.1001/jama.280.10.893; Pierce JP., 1998, TOBACCO CONTROL CALI; *TOB ED RES OV COM, 1997, TOB FREE CAL REN COM	26	215	217	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2000	343	24					1772	1777		10.1056/NEJM200012143432406	http://dx.doi.org/10.1056/NEJM200012143432406			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	382FH	11114317				2022-12-24	WOS:000165812000006
J	Cifu, B; Levinson, W				Cifu, B; Levinson, W			Influenza	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NEURAMINIDASE INHIBITOR OSELTAMIVIR; COST-EFFECTIVENESS; ELDERLY PERSONS; HEALTHY-ADULTS; WORKING ADULTS; VACCINATION; EFFICACY; VIRUS; LIVE; INTRANASAL		Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Levinson, W (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	wendy@medicine.bsd.uchicago.edu						[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; *BLA SUBM, 1999, MOUNT VIEW; *BLA SUBM TIM, 2000, MOUNT VIEW; Boivin G, 2000, J INFECT DIS, V181, P1471, DOI 10.1086/315392; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; CHANCE JF, 1990, NEW ENGL J MED, V322, P1753; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; DOUGLAS RG, 1990, NEW ENGL J MED, V322, P443, DOI 10.1056/NEJM199002153220706; *FDA FLUM, 1998, MOUNT VIEW; FEDSON DS, 1993, JAMA-J AM MED ASSOC, V270, P1956, DOI 10.1001/jama.270.16.1956; GLEZEN WP, 1991, AM J EPIDEMIOL, V133, P296, DOI 10.1093/oxfordjournals.aje.a115874; GLEZEN WP, 1982, EPIDEMIOL REV, V4, P25, DOI 10.1093/oxfordjournals.epirev.a036250; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; HAYDEN FG, 1989, NEW ENGL J MED, V321, P1696, DOI 10.1056/NEJM198912213212502; LAFORCE FM, 1994, AM J PREV MED, V10, P31, DOI 10.1016/S0749-3797(18)30513-0; Longini IM, 2000, VACCINE, V18, P1902, DOI 10.1016/S0264-410X(99)00419-3; LUI KJ, 1987, AM J PUBLIC HEALTH, V77, P712, DOI 10.2105/AJPH.77.6.712; Marwick C, 2000, JAMA-J AM MED ASSOC, V283, P1814, DOI 10.1001/jama.283.14.1814; Monto AS, 2000, JAMA-J AM MED ASSOC, V284, P1699, DOI 10.1001/jama.284.13.1699; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; Monto AS, 1999, J INFECT DIS, V180, P254, DOI 10.1086/314904; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; Muszkat M, 2000, J MED VIROL, V61, P100, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;100::AID-JMV16&gt;3.0.CO;2-5; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Treanor JJ, 1998, VACCINE, V16, P1756, DOI 10.1016/S0264-410X(98)00136-4; VANVORIS LP, 1981, JAMA-J AM MED ASSOC, V245, P1128, DOI 10.1001/jama.245.11.1128; 1999, MED LETT, V41, P121	33	13	13	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2000	284	22					2847	2849		10.1001/jama.284.22.2847	http://dx.doi.org/10.1001/jama.284.22.2847			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380RJ	11147973				2022-12-24	WOS:000165717000002
J	Baulcombe, DC				Baulcombe, DC			Molecular biology - Unwinding RNA silencing	SCIENCE			English	Editorial Material							GENE		John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baulcombe, DC (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.			Baulcombe, David/0000-0003-0780-6878				Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gura T, 2000, NATURE, V404, P804, DOI 10.1038/35009245; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90338-A; Marx J, 2000, SCIENCE, V288, P1370, DOI 10.1126/science.288.5470.1370; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	14	39	50	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 10	2000	290	5494					1108	1109		10.1126/science.290.5494.1108	http://dx.doi.org/10.1126/science.290.5494.1108			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	372HL	11185008				2022-12-24	WOS:000165228200033
J	Suzuki, M; Youle, RJ; Tjandra, N				Suzuki, M; Youle, RJ; Tjandra, N			Structure of Bax: Coregulation of dimer formation and intracellular localization	CELL			English	Article							PROGRAMMED CELL-DEATH; CYTOCHROME-C RELEASE; ORIENTED MACROMOLECULES; BACKBONE DYNAMICS; DIPOLAR COUPLINGS; CHEMICAL-SHIFT; BCL-2 FAMILY; BH3 DOMAIN; APOPTOSIS; MITOCHONDRIA	Apoptosis is stimulated by the insertion of Bax from the cytosol into mitochondrial membranes. The solution structure of Bax, including the putative transmembrane domain at the C terminus, was determined in order to understand the regulation of its subcellular location. Bax consists of 9 alpha helices where the assembly of helices alpha1 through alpha8 resembles that of the apoptosis inhibitor, Bcl-x(L). The C-terminal alpha9 helix occupies the hydrophobic pocket proposed previously to mediate heterodimer formation and bioactivity of opposing members of the Bcl-2 family. The Bax structure shows that the orientation of helix alpha9 provides simultaneous control over its mitochondrial targeting and dimer formation.	NHLBI, Biophys Chem Lab, NIH, Bethesda, MD 20892 USA; NINCDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tjandra, N (corresponding author), NHLBI, Biophys Chem Lab, NIH, Bethesda, MD 20892 USA.			Suzuki, Motoshi/0000-0002-4346-7677	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002674, ZIANS002859, ZIANS002674, Z01NS002859] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BRUNGER AT, 1992, XPLOR VERSION 3 1; Calera MR, 2000, J BIOL CHEM, V275, P6308, DOI 10.1074/jbc.275.9.6308; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUSZEWSKI J, 1992, J BIOMOL NMR, V2, P33, DOI 10.1007/BF02192799; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LI JF, 1995, J BIOL CHEM, V270, P3203, DOI 10.1074/jbc.270.7.3203; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546; Ottiger M, 1999, J BIOMOL NMR, V13, P187, DOI 10.1023/A:1008395916985; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281	41	867	920	0	29	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 10	2000	103	4					645	654		10.1016/S0092-8674(00)00167-7	http://dx.doi.org/10.1016/S0092-8674(00)00167-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	374MB	11106734	Bronze			2022-12-24	WOS:000165348000009
J	Sigmund, K; Nowak, MA				Sigmund, K; Nowak, MA			Evolution and social science - A tale of two selves	SCIENCE			English	Editorial Material							COOPERATION		Univ Vienna, Inst Math, Laxenburg, Austria; Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; Inst Adv Study, Princeton, NJ 08540 USA	University of Vienna; International Institute for Applied Systems Analysis (IIASA); Institute for Advanced Study - USA	Sigmund, K (corresponding author), Univ Vienna, Inst Math, Laxenburg, Austria.	karl.sigmund@univie.ac.at; nowak@ias.edu	Nowak, Martin A/A-6977-2008					BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Colman AM., 1995, GAME THEORY ITS APPL; de Waal FBM, 2000, NATURE, V404, P563, DOI 10.1038/35007138; FEHR E, 1998, EUR ECON REV, V42, P232; HAIG D, IN PRESS ANN REV ECO; Hofbauer J., 1998, EVOLUTIONARY GAMES P; HOPFIELD JJ, 1999, CRITICAL PROBLEMS PH, P29; Jackendoff R., 1997, ARCHITECTURE LANGUAG; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Maynard Smith J., 1982, pi; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Nowak MA, 2000, NATURE, V404, P495, DOI 10.1038/35006635; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Pinker S., 1994, LANGUAGE INSTINCT MI; Smith J. M., 1999, ORIGINS LIFE; STRINGER C, 1999, HUMAN INHERITANCE, P33; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; 2000, EUROPEAN SCI DAYS EV	20	5	5	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2000	290	5493					949	950		10.1126/science.290.5493.949	http://dx.doi.org/10.1126/science.290.5493.949			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11184736				2022-12-24	WOS:000165103200037
J	Caron, H; van Schaik, B; van der Mee, M; Baas, F; Riggins, G; van Sluis, P; Hermus, MC; van Asperen, R; Boon, K; Voute, PA; Heisterkamp, S; van Kampen, A; Versteeg, R				Caron, H; van Schaik, B; van der Mee, M; Baas, F; Riggins, G; van Sluis, P; Hermus, MC; van Asperen, R; Boon, K; Voute, PA; Heisterkamp, S; van Kampen, A; Versteeg, R			The human transcriptome map: Clustering of highly expressed genes in chromosomal domains	SCIENCE			English	Article								The chromosomal position of human genes is rapidly being established. We integrated these mapping data with genome-wide messenger RNA expression profiles as provided by SAGE (serial analysis of gene expression). Over 2.45 million SAGE transcript tags, including 160,000 tags of neuroblastomas, are presently known for 12 tissue types. We developed algorithms to assign these tags to UniGene clusters and their chromosomal position. The resulting Human Transcriptome Map generates gene expression profiles for ant chromosomal region in 12 normal and pathologic tissue types. The map reveals a clustering of highly expressed genes to specific chromosomal regions. It provides a tool to search for genes that are overexpressed or silenced in cancer.	Emma Childrens Hosp, Acad Med Ctr, Dept Human Genet, NL-1100 DE Amsterdam, Netherlands; Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Neurozintuigen Lab, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; Duke Univ, Med Ctr, Dept Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Duke University; Duke University	Caron, H (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Dept Human Genet, POB 22700, NL-1100 DE Amsterdam, Netherlands.		van Kampen, Antoine HC/C-1925-2008; Baas, Frank/F-9574-2010; Versteeg, Rogier/AAQ-1765-2020	Baas, Frank/0000-0003-3912-5428; Versteeg, Rogier/0000-0001-7172-0388; van Schaik, Barbera/0000-0002-5568-8127				Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; CRAIG JM, 1994, NAT GENET, V7, P376, DOI 10.1038/ng0794-376; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; Lal A, 1999, CANCER RES, V59, P5403; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SPIEKER N, IN PRESS GENOMICS; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Wei XY, 1999, J CELL BIOL, V146, P543, DOI 10.1083/jcb.146.3.543	14	573	616	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1289	+		10.1126/science.1056794	http://dx.doi.org/10.1126/science.1056794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11181992				2022-12-24	WOS:000166993400038
J	Newman, AB; Arnold, AM; Burke, GL; O'Leary, DH; Manolio, TA				Newman, AB; Arnold, AM; Burke, GL; O'Leary, DH; Manolio, TA			Cardiovascular disease and mortality in older adults with small abdominal aortic aneurysms detected by ultrasonography: The cardiovascular health study	ANNALS OF INTERNAL MEDICINE			English	Article							RISK-FACTORS; PREVALENCE; ATHEROSCLEROSIS; RUPTURE; FATE	Background: Persons with abdominal aortic aneurysm are more likely to have a higher prevalence of risk factors for and clinical manifestations of cardiovascular disease. It is unknown whether these factors explain the high mortality rate associated with abdominal aortic aneurysm. Objective: To describe the risk for mortality, cardiovascular mortality, and cardiovascular morbidity in persons screened for abdominal aortic aneurysm. Design: Longitudinal cohort study. Setting: Four communities in the United States. Participants: 4734 men and women older than 65 years of age recruited from Medicare eligibility lists. Measurements: Abdominal ultrasonography was used to measure the aortic diameter and the ratio of infrarenal to suprarenal measurement of aortic diameter in 1992-1993. Abdominal aortic aneurysm was defined as aortic diameter of 3 cm or greater or infrarenal-to-suprarenal ratio of 1.2 or greater. Mortality, cardiovascular disease mortality, incident cardiovascular disease, and repair or rupture were assessed after 4.5 years. Results: The prevalence of aneurysm was 8.8%, and 87.7% of aneurysms were 3.5 cm or less in diameter, Rates of total mortality (65.1 vs. 32.8 per 1000 person-years), cardiovascular mortality (34.3 vs. 13.8 per 1000 person-years), and incident cardiovascular disease (47.3 vs. 31.0 per 1000 person-years) were higher in participants with aneurysm than in those without aneurysm; after adjustment for age, risk factors, and presence of other cardiovascular disease, the respective relative risks were 1.32, 1.36, and 1.57. Rates of repair and rupture were low. Conclusions: Rates of total mortality, cardiovascular disease mortality, and incident cardiovascular disease were higher in participants with abdominal aortic aneurysm than in those without aneurysm, independent of age, sex, other clinical cardiovascular disease, and extent of atherosclerosis detected by noninvasive testing. Persons with smaller aneurysms detected by ultrasonography should be advised to modify risk factors for cardiovascular disease while under surveillance for increase in the size of the aneurysm.	Univ Pittsburgh, Sch Med, Div Geriatr Med, Pittsburgh, PA 15213 USA; Univ Washington, Seattle, WA 98195 USA; Wake Forest Univ, Winston Salem, NC 27109 USA; Tufts Univ New England Med Ctr, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; Wake Forest University; Tufts Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Newman, AB (corresponding author), Univ Pittsburgh, Sch Med, Div Geriatr Med, 3520 5th Ave,Suite 300, Pittsburgh, PA 15213 USA.	anewman+@pitt.edu	Newman, Anne B./C-6408-2013	Newman, Anne B./0000-0002-0106-1150				Alcorn HG, 1996, ARTERIOSCL THROM VAS, V16, P963, DOI 10.1161/01.ATV.16.8.963; Blanchard JF, 2000, AM J EPIDEMIOL, V151, P575; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Choksy SA, 1999, ANN ROY COLL SURG, V81, P27; Collet D, 1994, MODELING SURVIVAL DA; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FURBERG CD, 1992, AM J CARDIOL, V69, P1329, DOI 10.1016/0002-9149(92)91231-R; Galland RB, 1998, EUR J VASC ENDOVASC, V16, P104, DOI 10.1016/S1078-5884(98)80150-0; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Kanagasabay R, 1996, J Med Screen, V3, P208; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; MITTELMARK MB, 1993, AM J EPIDEMIOL, V137, P311, DOI 10.1093/oxfordjournals.aje.a116678; Moore WS, 1999, ANN SURG, V230, P298, DOI 10.1097/00000658-199909000-00003; Naydeck BL, 1999, AM J CARDIOL, V83, P759, DOI 10.1016/S0002-9149(98)00985-0; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Pleumeekers HJCM, 1995, AM J EPIDEMIOL, V142, P1291, DOI 10.1093/oxfordjournals.aje.a117596; Powell JT, 1998, LANCET, V352, P1649; SCOTT RAP, 1991, BRIT J SURG, V78, P1122, DOI 10.1002/bjs.1800780929; SZILAGYI DE, 1972, ARCH SURG-CHICAGO, V104, P600; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; Vardulaki KA, 1998, BRIT J SURG, V85, P1674; Veith FJ, 1999, ANN SURG, V230, P306	24	118	124	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2001	134	3					182	190		10.7326/0003-4819-134-3-200102060-00008	http://dx.doi.org/10.7326/0003-4819-134-3-200102060-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397KR	11177330				2022-12-24	WOS:000166695300002
J	Duchek, P; Rorth, P				Duchek, P; Rorth, P			Guidance of cell migration by EGF receptor signaling during Drosophila oogenesis	SCIENCE			English	Article							GROWTH; ACTIVATION; PATHWAY; KINASE; CHEMOTAXIS; COMPONENT; MEMBRANE; ENCODES; GURKEN; C/EBP	Directed cell migration is important for many aspects of normal animal development, but Little is known about how cell migrations are guided or the mechanisms by which guidance cues are translated into directed cell movement. Here we present evidence that signaling mediated by the epidermal growth factor receptor (EGFR) guides dorsal migration of border cells during Drosophila oogenesis. The transforming growth factor-alpha (TGF-alpha)-like ligand Gurken appears to serve as the guidance cue. To mediate this guidance function, EGFR signals via a pathway that is independent of Raf-MAP kinase and receptor-specific.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Rorth, P (corresponding author), European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany.		Rørth, Pernille/H-3020-2011					CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Han DD, 2000, DEVELOPMENT, V127, P573; King R. C., 1970, OVARIAN DEV DROSOPHI; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Lee T, 1996, DEVELOPMENT, V122, P409; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Michelson AM, 1998, DEVELOPMENT, V125, P4379; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; MURPHY AM, 1995, DEVELOPMENT, V121, P2255; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; O'Keefe L, 1997, DEVELOPMENT, V124, P4837; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Queenan AM, 1999, MECH DEVELOP, V89, P35, DOI 10.1016/S0925-4773(99)00196-3; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Rorth P, 2000, MOL CELL, V6, P23; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Thackeray JR, 1998, DEVELOPMENT, V125, P5033; Van Buskirk C, 1999, TRENDS CELL BIOL, V9, P1, DOI 10.1016/S0962-8924(98)01413-5; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; WENNSTROM S, 1994, ONCOGENE, V9, P651	26	197	202	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2001	291	5501					131	133		10.1126/science.291.5501.131	http://dx.doi.org/10.1126/science.291.5501.131			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389VJ	11141565				2022-12-24	WOS:000166259100051
J	Mota, MM; Pradel, G; Vanderberg, JP; Hafalla, JCR; Frevert, U; Nussenzweig, RS; Nussenzweig, V; Rodriguez, A				Mota, MM; Pradel, G; Vanderberg, JP; Hafalla, JCR; Frevert, U; Nussenzweig, RS; Nussenzweig, V; Rodriguez, A			Migration of Plasmodium sporozoites through cells before infection	SCIENCE			English	Article							CIRCUMSPOROZOITE PROTEIN; EXOERYTHROCYTIC STAGE; MALARIA PARASITES; FINE-STRUCTURE; MIDGUT CELLS; IN-VITRO; INVASION; BERGHEI; ULTRASTRUCTURE; MICROSCOPY	Intracellular bacteria and parasites typically invade host cells through the formation of an internalization vacuole around the invading pathogen. Plasmodium sporozoites, the infective stage of the malaria parasite transmitted by mosquitoes, have an alternative mechanism to enter cells. We observed breaching of the plasma membrane of the host cell followed by rapid repair. This mode of entry did not result in the formation of a vacuole around the sporozoite, and was followed by exit of the parasite from the host cell. Sporozoites traversed the cytosol of several cells before invading a hepatocyte by formation of a parasitophorous vacuole, in which they developed into the next infective stage. Sporozoite migration through several cells in the mammalian host appears to be essential for the completion of the life cycle.	NYU, Sch Med, Dept Med & Mol Parasitol, 341 E 25 St, New York, NY 10010 USA; NYU, Sch Med, Dept Pathol, New York, NY 10010 USA	New York University; New York University	Rodriguez, A (corresponding author), NYU, Sch Med, Dept Med & Mol Parasitol, 341 E 25 St, New York, NY 10010 USA.	rodria02@popmail.med.nyu.edu	Mota, Maria/AAF-2048-2019	Mota, Maria Manuel/0000-0002-2858-1041; Rodriguez, Ana/0000-0002-0060-3405				AIKAWA M, 1984, AM J TROP MED HYG, V33, P792, DOI 10.4269/ajtmh.1984.33.792; BOYD MARK F., 1939, AMER JOUR TROP MED, V19, P27; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; CHAROENVIT Y, 1987, INFECT IMMUN, V55, P604, DOI 10.1128/IAI.55.3.604-608.1987; CHOBOTAR B, 1993, PARASITOL RES, V79, P15, DOI 10.1007/BF00931212; DANFORTH HD, 1992, PARASITOL RES, V78, P570, DOI 10.1007/BF00936454; Entzeroth R, 1998, INT J PARASITOL, V28, P1015, DOI 10.1016/S0020-7519(98)00079-4; GARNHAM PCC, 1969, T ROY SOC TROP MED H, V63, P328, DOI 10.1016/0035-9203(69)90005-4; GRIFFITHS RB, 1952, ANN TROP MED PARASIT, V46, P311, DOI 10.1080/00034983.1952.11685536; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hugel FU, 1996, MOL BIOCHEM PARASIT, V81, P151, DOI 10.1016/0166-6851(96)02701-6; Jiang ST, 1999, KIDNEY INT, V56, P92, DOI 10.1046/j.1523-1755.1999.00520.x; MCNEIL PL, 1999, CURRENT PROTOCOLS CE; MEIS JFGM, 1983, NATURE, V302, P424, DOI 10.1038/302424a0; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; MOTA MM, IN PRESS EXP PARASIT; MUTHUKRISHNAN L, 1991, J CELL PHYSIOL, V148, P1, DOI 10.1002/jcp.1041480102; SHIN SCJ, 1982, J PROTOZOOL, V29, P448, DOI 10.1111/j.1550-7408.1982.tb05431.x; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; SODEMAN T, 1970, SCIENCE, V170, P340, DOI 10.1126/science.170.3955.340; Speer CA, 1997, J PARASITOL, V83, P565, DOI 10.2307/3284226; SPITALNY GL, 1972, P HELM SOC WASH, V39, P506; STEWART MJ, 1986, INFECT IMMUN, V51, P859, DOI 10.1128/IAI.51.3.859-864.1986; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; STEWART MJ, 1991, J PROTOZOOL, V38, P411, DOI 10.1111/j.1550-7408.1991.tb01379.x; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; VANDERBERG JP, 1990, J PROTOZOOL, V37, P528, DOI 10.1111/j.1550-7408.1990.tb01260.x; Zieler H, 2000, P NATL ACAD SCI USA, V97, P11516, DOI 10.1073/pnas.97.21.11516	28	371	385	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2001	291	5501					141	144		10.1126/science.291.5501.141	http://dx.doi.org/10.1126/science.291.5501.141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389VJ	11141568				2022-12-24	WOS:000166259100054
J	Petersen, M; Brodersen, P; Naested, H; Andreasson, E; Lindhart, U; Johansen, B; Nielsen, HB; Lacy, M; Austin, MJ; Parker, JE; Sharma, SB; Klessig, DF; Martienssen, R; Mattsson, O; Jensen, AB; Mundy, J				Petersen, M; Brodersen, P; Naested, H; Andreasson, E; Lindhart, U; Johansen, B; Nielsen, HB; Lacy, M; Austin, MJ; Parker, JE; Sharma, SB; Klessig, DF; Martienssen, R; Mattsson, O; Jensen, AB; Mundy, J			Arabidopsis MAP kinase 4 negatively regulates systemic acquired resistance	CELL			English	Article							ACTIVATED PROTEIN-KINASE; SALICYLIC-ACID INDUCTION; PROGRAMMED CELL-DEATH; DEFENSE RESPONSES; GENE-EXPRESSION; FUNCTIONAL-ANALYSIS; DISEASE-RESISTANCE; TOBACCO; SIGNAL; TRANSDUCTION	Transposon inactivation of Arabidopsis MAP kinase 4 produced the mpk4 mutant exhibiting constitutive systemic acquired resistance (SAR) including elevated salicylic acid (SA) revels, increased resistance to virulent pathogens, and constitutive pathogenesis-related gene expression shown by Northern and microarray hybridizations. MPK4 kinase activity is required to repress SAR, as an inactive MPK4 form failed to complement mpk4. Analysis of mpk4 expressing the SA hydroxylase NahG and of mpk4/npr1 double mutants indicated that SAR expression in mpk4 is dependent upon elevated SA levels but is independent of NPR1. PDF1.2 and THI2.1 gene induction by jasmonate was blocked in mpk4 expressing NahG, suggesting that MPK4 is required for jasmonic acid-responsive gene expression.	Univ Copenhagen, Inst Mol Biol, DK-1353 Copenhagen K, Denmark; Univ Copenhagen, Inst Bot, DK-1353 Copenhagen K, Denmark; Danish Tech Univ, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; Monsanto Co, St Louis, MO 63167 USA; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7U11, Norfolk, England; Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Copenhagen; University of Copenhagen; Technical University of Denmark; Monsanto; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Rutgers State University New Brunswick; Cold Spring Harbor Laboratory	Mundy, J (corresponding author), Univ Copenhagen, Inst Mol Biol, Oster Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	mundy@biobase.dk	Nielsen, Henrik/B-8961-2019; mundy, john/A-2361-2013; Petersen, Morten/J-5023-2014	Nielsen, Henrik/0000-0003-2281-5713; mundy, john/0000-0001-7490-4588; Petersen, Morten/0000-0002-3035-5991; Andreasson, Erik/0000-0003-0666-7204; Austin, Mark/0000-0003-4943-7265				Blatt MR, 1999, PLANT J, V19, P453, DOI 10.1046/j.1365-313x.1999.00534.x; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Felton GW, 1999, CURR BIOL, V9, P317, DOI 10.1016/S0960-9822(99)80140-7; Forsburg SL, 1997, GENE, V191, P191, DOI 10.1016/S0378-1119(97)00058-9; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Glazebrook J, 1997, ANNU REV GENET, V31, P547, DOI 10.1146/annurev.genet.31.1.547; Glazebrook J, 1999, CURR OPIN PLANT BIOL, V2, P280, DOI 10.1016/S1369-5266(99)80050-8; GRANTZ A, 1995, PLANT PHYSIOL, V108, P411, DOI 10.1104/pp.108.1.411; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; Gupta V, 2000, MOL PLANT MICROBE IN, V13, P503, DOI 10.1094/MPMI.2000.13.5.503; HAMMONDKOSACK KE, 1994, P NATL ACAD SCI USA, V91, P10445, DOI 10.1073/pnas.91.22.10445; Hoyos ME, 2000, PLANT PHYSIOL, V122, P1355, DOI 10.1104/pp.122.4.1355; Ichimura K, 1998, BIOCHEM BIOPH RES CO, V253, P532, DOI 10.1006/bbrc.1998.9796; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; Johansen B, 1997, ANN BOT-LONDON, V80, P697, DOI 10.1006/anbo.1997.0502; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kumar D, 2000, MOL PLANT MICROBE IN, V13, P347, DOI 10.1094/MPMI.2000.13.3.347; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lebel E, 1998, PLANT J, V16, P223, DOI 10.1046/j.1365-313x.1998.00288.x; Li X, 1999, CELL, V98, P329, DOI 10.1016/S0092-8674(00)81962-5; Ligterink W, 1997, SCIENCE, V276, P2054, DOI 10.1126/science.276.5321.2054; Liu YH, 2000, MOL PLANT MICROBE IN, V13, P118, DOI 10.1094/MPMI.2000.13.1.118; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Merkouropoulos G, 1999, PLANTA, V208, P212, DOI 10.1007/s004250050552; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; MITTLER R, 1995, PLANT CELL, V7, P29, DOI 10.1105/tpc.7.1.29; Mizoguchi T, 1997, TRENDS BIOTECHNOL, V15, P15, DOI 10.1016/S0167-7799(96)10074-3; Mizoguchi T, 1996, P NATL ACAD SCI USA, V93, P765, DOI 10.1073/pnas.93.2.765; Molina A, 1999, PLANT J, V17, P667, DOI 10.1046/j.1365-313X.1999.00420.x; Molina A, 1997, PLANT J, V12, P669, DOI 10.1046/j.1365-313X.1997.00669.x; Morris PC, 1997, PLANT MOL BIOL, V35, P1057, DOI 10.1023/A:1005963222768; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Rate DN, 1999, PLANT CELL, V11, P1695, DOI 10.1105/tpc.11.9.1695; Romeis T, 1999, PLANT CELL, V11, P273, DOI 10.1105/tpc.11.2.273; Ruan Y, 1998, PLANT J, V15, P821, DOI 10.1046/j.1365-313X.1998.00254.x; Seo S, 1999, PLANT CELL, V11, P289, DOI 10.1105/tpc.11.2.289; SEO S, 1995, SCIENCE, V270, P1988, DOI 10.1126/science.270.5244.1988; Shah J, 1999, PLANT CELL, V11, P191, DOI 10.1105/tpc.11.2.191; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Taipalensuu J, 1997, EUR J BIOCHEM, V247, P963, DOI 10.1111/j.1432-1033.1997.00963.x; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Weymann K, 1995, PLANT CELL, V7, P2013, DOI 10.1105/tpc.7.12.2013; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7433, DOI 10.1073/pnas.95.13.7433; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; ZHANG ZG, 1995, PLANT J, V8, P139, DOI 10.1046/j.1365-313X.1995.08010139.x; Zhou N, 1998, PLANT CELL, V10, P1021, DOI 10.1105/tpc.10.6.1021	65	710	784	5	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2000	103	7					1111	1120		10.1016/S0092-8674(00)00213-0	http://dx.doi.org/10.1016/S0092-8674(00)00213-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163186	Bronze			2022-12-24	WOS:000166040600013
J	Deliens, L; Mortier, F; Bilsen, J; Cosyns, M; Vander Stichele, R; Vanoverloop, J; Ingels, K				Deliens, L; Mortier, F; Bilsen, J; Cosyns, M; Vander Stichele, R; Vanoverloop, J; Ingels, K			End-of-life decisions in medical practice in Flanders, Belgium: a nationwide survey	LANCET			English	Article							PHYSICIAN-ASSISTED SUICIDE; MAIL SURVEYS; EUTHANASIA; NETHERLANDS	Background Our study is a repeat of the Dutch death-certificate study on end-of-life decisions (ELDs). The main objective was to estimate the frequency of euthanasia (the administration of lethal drugs with the explicit intention of shortening the patient's life at the patient's explicit request), physician-assisted suicide (PAS), and other ELDs in medical practice in Flanders, Belgium. Methods A 20% random sample of 3999 deaths was selected from all deaths recorded between Jan 1 and April 30, 1998. The physicians who signed the corresponding death certificates received one questionnaire by post per death. Findings The physicians' response rate was 1355 (52%). 1925 deaths were described. The results were corrected for non-response bias, and extrapolated to estimated annual rates after seasonal adjustment for death causes, and we estimate that 705 (1.3%, 95% CI 1.0-1.6) deaths resulted from euthanasia or PAS. In 1796 (3.2%, 2.7-3.8) cases, lethal drugs were given without the explicit request of the patient. Alleviation of pain and symptoms with opioids in doses with a potential life-shortening effect preceded death in 10 416 (18.5%, 17.3-19.7) cases and non-treatment decisions in 9218 (16.4%, 15.3-17.5) cases, of which 3261 (5.8%, 5.1-6.5) with the explicit intention of ending the patient's life. Interpretation ELDs are prominent in medical practice in Flanders. The frequency of deaths preceded by an ELD is similar to that in the Netherlands, but lower than that in Australia. However, in Flanders the rate of administration of lethal drugs to patients without their explicit request is similar to Australia, and significantly higher than that in the Netherlands.	Free Univ Brussels, Dept Med Sociol & Hlth Sci, B-1090 Brussels, Belgium; State Univ Ghent, Ctr Environm Philosophy & Bioeth, B-9000 Ghent, Belgium; State Univ Ghent, Dept Gen Practice, B-9000 Ghent, Belgium; Flemish Inst Gen Practice, Antwerp, Belgium; Minist Flanders, Prevent & Social Hlth Care Div, Brussels, Belgium; Catholic Univ Nijmegen, Acad Hosp, Nijmegen, Netherlands	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University; Ghent University; Radboud University Nijmegen	Deliens, L (corresponding author), Free Univ Brussels, Dept Med Sociol & Hlth Sci, Laarbeeklaan 103, B-1090 Brussels, Belgium.		Stichele, Robert Vander/K-7203-2015; Ingels, K.J.A.O./L-4404-2015	Stichele, Robert Vander/0000-0001-9118-9651; Mortier, Freddy/0000-0002-5390-3508; Deliens, Luc/0000-0002-8158-2422				Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; BERNARD HR, 1984, ANNU REV ANTHROPOL, V13, P495, DOI 10.1146/annurev.an.13.100184.002431; DELIENS L, 1991, NUISARTS NU, V20, P113; DILLMAN DA, 1991, ANNU REV SOCIOL, V17, P225, DOI 10.1146/annurev.so.17.080191.001301; Hendin H, 1997, JAMA-J AM MED ASSOC, V277, P1720, DOI 10.1001/jama.277.21.1720; Jochemsen H, 1999, J MED ETHICS, V25, P16, DOI 10.1136/jme.25.1.16; Kaner EF, 1998, BRIT J GEN PRACT, V48, P1067; KEOWN J, 1995, EUTHANASIA EXAMINED, P261; Kuhse H, 1997, MED J AUSTRALIA, V166, P191, DOI 10.5694/j.1326-5377.1997.tb140074.x; LEMESHOW S, 1992, ADEQUACY SAMPLE SIZE, P1; MCCULLAGH P, 1994, GEN LINEAR MODELS, P72; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Mortier F, 2000, BIOETHICS, V14, P254, DOI 10.1111/1467-8519.00195; *NAT RAAD ORD GEN, 1997, TIJDSCHR NAT RAAD OR, V7, P27; *RAADG COM BIOETH, 1998, BIOETHIC BELG    MAY, P2; SIBBALD B, 1998, BR J GE PRACT, V48, P1067; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; [No title captured]	19	225	227	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2000	356	9244					1806	1811		10.1016/S0140-6736(00)03233-5	http://dx.doi.org/10.1016/S0140-6736(00)03233-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	377UY	11117913				2022-12-24	WOS:000165545700012
J	Imai, K; Matsuyama, S; Miyake, S; Suga, K; Nakachi, K				Imai, K; Matsuyama, S; Miyake, S; Suga, K; Nakachi, K			Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population	LANCET			English	Article							KILLER-CELL-ACTIVITY; DRINKING GREEN TEA; NK CELLS; JAPANESE POPULATION; GROWTH; MICE	Background One of the most critical questions in immunosurveillance is whether differences between individuals with regards to natural immunological host defence can predict future development of cancer. Although this question has so far remained open, there are clear indications of significant roles of several naturally cytotoxic lymphocytes in preventing the development of cancer. We began a prospective cohort study among a Japanese general population in 1986, using various immunological and biochemical markers. Methods Natural cytotoxic activity of peripheral-blood mononuclear cells was assessed by isotope-release assay in 3625 residents of a Japanese population mostly older than 40 years of age, between 1986 and 1990. Immunological and biochemical markers were also measured, and participants were given a questionnaire on lifestyle. We did an Ii-year follow-up survey of the cohort members looking at cancer incidence and death from all causes, and analysed the association between cytotoxic activity of peripheral-blood lymphocytes assessed at baseline and cancer incidence found in the subsequent follow-up. Findings 154 cancer cases were used in the analysis. When we categorised the cytotoxic activity of peripheral-blood lymphocytes by tertiles, age-adjusted relative risk of cancer incidence (all sites) was 0.72 (95% CI 0.45-1.16) for men with high cytotoxic activity, and 0.62 (0.38-1.03) for men with medium cytotoxic activity, taking the risk of those with low cytotoxic activity as reference. For women with high cytotoxic activity relative risk was 0.52 (0.28-0.95), and for those with medium cytotoxic activity 0.56 (0.31-1.01). For both sexes with high and medium cytotoxic activity risk was 0.63 (0.43-0.92) and 0.59 (0.40-0.87), respectively. Interpretation Our results indicate that medium and high cytotoxic activity of peripheral-blood lymphocytes is associated with reduced cancer risk, whereas low activity is associated with increased cancer risk suggesting a role for natural immunological host defence mechanisms against cancer.	Saitama Canc Ctr, Res Inst, Ina, Saitama 3620806, Japan		Nakachi, K (corresponding author), Saitama Canc Ctr, Res Inst, 818 Komuro, Ina, Saitama 3620806, Japan.		wang, edwin/G-5372-2010					Brittenden J, 1996, CANCER-AM CANCER SOC, V77, P1226, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1226::AID-CNCR2>3.0.CO;2-G; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; GORELIK E, 1982, INT J CANCER, V30, P107, DOI 10.1002/ijc.2910300118; HERBERMAN RB, 1981, SCIENCE, V214, P24, DOI 10.1126/science.7025208; HERBERMAN RB, 1983, PROGR IMMUNOLOGY, V5, P1157; HERSEY P, 1979, BRIT J CANCER, V40, P113, DOI 10.1038/bjc.1979.147; IMAI K, 1995, BRIT MED J, V310, P693, DOI 10.1136/bmj.310.6981.693; Imai K, 1997, PREV MED, V26, P769, DOI 10.1006/pmed.1997.0242; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Moretta A, 1997, CELL, V90, P13, DOI 10.1016/S0092-8674(00)80309-8; Moretta A, 2000, IMMUNOL TODAY, V21, P228, DOI 10.1016/S0167-5699(00)01596-6; NAKACHI K, 1992, JPN J CANCER RES, V83, P798, DOI 10.1111/j.1349-7006.1992.tb01983.x; NAKACHI K, 1993, CANCER RES, V53, P2994; NAKAJIMA T, 1987, JPN J CLIN ONCOL, V17, P327; PENN I, 1977, TRANSPLANT P, V9, P1121; PROSS HF, 1982, INT J CANCER, V29, P383, DOI 10.1002/ijc.2910290404; PROSS HF, 1993, NAT IMMUN, V12, P279; RODER JC, 1980, NATURE, V284, P553, DOI 10.1038/284553a0; SCHANTZ SP, 1986, JNCI-J NATL CANCER I, V77, P869; STRAYER DR, 1984, CANCER RES, V44, P370; SULLIVAN JL, 1980, SCIENCE, V210, P543, DOI 10.1126/science.6158759; TALMADGE JE, 1980, NATURE, V284, P622, DOI 10.1038/284622a0	22	752	780	2	27	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2000	356	9244					1795	1799		10.1016/S0140-6736(00)03231-1	http://dx.doi.org/10.1016/S0140-6736(00)03231-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377UY	11117911				2022-12-24	WOS:000165545700010
J	Soong, RK; Bachand, GD; Neves, HP; Olkhovets, AG; Craighead, HG; Montemagno, CD				Soong, RK; Bachand, GD; Neves, HP; Olkhovets, AG; Craighead, HG; Montemagno, CD			Powering an inorganic nanodevice with a biomolecular motor	SCIENCE			English	Article							GAMMA-SUBUNIT; WILD-TYPE; F-1-ATPASE; ROTATION; FORCE; NM	Biomolecular motors such as F-1-adenosine triphosphate synthase (F-1-ATPase) and myosin are similar in size, and they generate forces compatible with currently producible nanoengineered structures. We have engineered individual biomolecular motors and nanoscale inorganic systems, and we describe their integration in a hybrid nanomechanical device powered by a biomolecular motor. The device consisted of three components: an engineered substrate, an F-1-ATPase biomolecular motor; and fabricated nanopropellers. Rotation of the nanopropeller was initiated with 2 mM adenosine triphosphate and inhibited by sodium azide.	Cornell Univ, Nanobiotechnol Ctr, Ithaca, NY 14853 USA; Cornell Univ, Dept Agr & Biol Engn, Ithaca, NY 14853 USA; Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Montemagno, CD (corresponding author), Cornell Univ, Nanobiotechnol Ctr, Ithaca, NY 14853 USA.	cdm11@cornell.edu	Neves, Herc/K-6873-2019	Bachand, George/0000-0002-3169-9980; Neves, Hercules/0000-0003-2211-356X				Bachand GD, 2000, BIOMED MICRODEVICES, V2, P179, DOI 10.1023/A:1009924327649; Block SM, 1998, CELL, V93, P5, DOI 10.1016/S0092-8674(00)81138-1; Carr DW, 1999, APPL PHYS LETT, V75, P920, DOI 10.1063/1.124554; Carr DW, 1998, J VAC SCI TECHNOL B, V16, P3821, DOI 10.1116/1.590416; Hisabori T, 1999, FEBS LETT, V463, P35, DOI 10.1016/S0014-5793(99)01602-6; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; JEFFREY DJ, 1981, Q J MECH APPL MATH, V34, P129, DOI 10.1093/qjmam/34.2.129; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; MARCUS RB, 1990, APPL PHYS LETT, V56, P236, DOI 10.1063/1.102841; MATSUI T, 1995, BBA-BIOENERGETICS, V1231, P139, DOI 10.1016/0005-2728(95)00070-Y; Montemagno C, 1999, NANOTECHNOLOGY, V10, P225, DOI 10.1088/0957-4484/10/3/301; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Sone J, 1999, NANOTECHNOLOGY, V10, P135, DOI 10.1088/0957-4484/10/2/306; Soong RK, 1999, 1999 INTERNATIONAL CONFERENCE ON MODELING AND SIMULATION OF MICROSYSTEMS, P95; STRYER L, 1999, BIOCHEMISTRY-US, P445; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	20	494	519	3	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2000	290	5496					1555	1558		10.1126/science.290.5496.1555	http://dx.doi.org/10.1126/science.290.5496.1555			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376EX	11090349				2022-12-24	WOS:000165446200044
J	Willard, HF				Willard, HF			Genomics and gene therapy - Artificial chromosomes coming to life	SCIENCE			English	Editorial Material							ALPHA-SATELLITE; DNA-SEQUENCES; CENTROMERE; CONSTRUCTION; GENERATION; YEAST; MINICHROMOSOMES; RECOMBINATION; VECTORS; CELLS		Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Willard, HF (corresponding author), Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA.	hfw@po.CWRU.edu						Brown WRA, 2000, TRENDS BIOTECHNOL, V18, P218, DOI 10.1016/S0167-7799(00)01438-4; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Calos MP, 1996, TRENDS GENET, V12, P463, DOI 10.1016/0168-9525(96)40049-X; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Choo KHA, 1997, AM J HUM GENET, V61, P1225, DOI 10.1086/301657; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Csink AK, 1998, TRENDS GENET, V14, P200, DOI 10.1016/S0168-9525(98)01444-9; Ebersole TA, 2000, HUM MOL GENET, V9, P1623, DOI 10.1093/hmg/9.11.1623; GRIMES B, UNPUB; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Heller R, 1996, P NATL ACAD SCI USA, V93, P7125, DOI 10.1073/pnas.93.14.7125; Henning KA, 1999, P NATL ACAD SCI USA, V96, P592, DOI 10.1073/pnas.96.2.592; Higgins AW, 1999, CHROMOSOMA, V108, P256, DOI 10.1007/s004120050376; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Kuroiwa Y, 1998, NUCLEIC ACIDS RES, V26, P3447, DOI 10.1093/nar/26.14.3447; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; MAYS RW, UNPUB; Mills W, 1999, HUM MOL GENET, V8, P751, DOI 10.1093/hmg/8.5.751; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; Rosenberg LE, 2000, SCIENCE, V287, P1751, DOI 10.1126/science.287.5459.1751; Shen MH, 2000, CURR BIOL, V10, P31, DOI 10.1016/S0960-9822(99)00261-4; Shen MH, 1997, HUM MOL GENET, V6, P1375, DOI 10.1093/hmg/6.8.1375; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Tomizuka K, 2000, P NATL ACAD SCI USA, V97, P722, DOI 10.1073/pnas.97.2.722; Tyler-Smith C, 2000, CELL, V102, P5, DOI 10.1016/S0092-8674(00)00004-0; TYLERSMITH C, 1993, NAT GENET, V5, P368, DOI 10.1038/ng1293-368; Verma IM, 2000, MOL THER, V1, P493, DOI 10.1006/mthe.2000.0084; Vos JMH, 1998, CURR OPIN GENET DEV, V8, P351, DOI 10.1016/S0959-437X(98)80093-2; WEVRICK R, 1990, MOL CELL BIOL, V10, P6374, DOI 10.1128/MCB.10.12.6374; Willard HF, 1998, CURR OPIN GENET DEV, V8, P219, DOI 10.1016/S0959-437X(98)80144-5; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086, DOI 10.1038/80287	34	48	52	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 17	2000	290	5495					1308	1309		10.1126/science.290.5495.1308	http://dx.doi.org/10.1126/science.290.5495.1308			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375BN	11185406				2022-12-24	WOS:000165379800030
J	Attwood, TK				Attwood, TK			Genomics - The babel of bioinformatics	SCIENCE			English	Article							EVOLUTION; PROTEINS		Univ Manchester, Sch Biol Sci, Manchester, Lancs, England	University of Manchester	Attwood, TK (corresponding author), Univ Manchester, Sch Biol Sci, Manchester, Lancs, England.	attwood@bioinf.man.ac.uk		Attwood, Teresa/0000-0003-2409-4235				APWEILER R, IN PRESS BIOINFORMAT; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attwood TK, 2000, NUCLEIC ACIDS RES, V28, P225, DOI 10.1093/nar/28.1.225; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Gold L, 1997, CURR OPIN GENET DEV, V7, P848, DOI 10.1016/S0959-437X(97)80050-0; Henikoff JG, 2000, NUCLEIC ACIDS RES, V28, P228, DOI 10.1093/nar/28.1.228; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Olszewski KA, 2000, COMPUT CHEM, V24, P499, DOI 10.1016/S0097-8485(99)00078-9; Panchenko AR, 2000, J MOL BIOL, V296, P1319, DOI 10.1006/jmbi.2000.3541; REECK GR, 1987, CELL, V50, P667, DOI 10.1016/0092-8674(87)90322-9; Reese MG, 2000, GENOME RES, V10, P483, DOI 10.1101/gr.10.4.483; Rost B, 1997, COMPUT APPL BIOSCI, V13, P345; Sternberg MJE, 1999, CURR OPIN STRUC BIOL, V9, P368, DOI 10.1016/S0959-440X(99)80050-5; Zarembinski TI, 1998, P NATL ACAD SCI USA, V95, P15189, DOI 10.1073/pnas.95.26.15189	16	44	514	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 20	2000	290	5491					471	473		10.1126/science.290.5491.471	http://dx.doi.org/10.1126/science.290.5491.471			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	365HN	11183771				2022-12-24	WOS:000089946000037
J	Burke, BP; White, JC				Burke, BP; White, JC			Wellbeing of gay, lesbian and bisexual doctors (Reprinted from Western Journal of Medicine, vol 174, pg 59-62, 2001)	BRITISH MEDICAL JOURNAL			English	Reprint							PHYSICIANS; HOMOSEXUALITY; ATTITUDES; STUDENTS		Legacy Clin NW, Portland, OR 97210 USA; Oregon Hlth Sci Univ, Columbia Univ, Joseph Mailman Sch Publ Hlth, Legacy Portland Hosp, Portland, OR 97210 USA	Columbia University; Oregon Health & Science University	Burke, BP (corresponding author), Legacy Clin NW, 1130 NW 22nd Ave,Suite 220, Portland, OR 97210 USA.							Brogan DJ, 1999, JAMA-J AM MED ASSOC, V282, P1290, DOI 10.1001/jama.282.13.1290; Burke BP, 2001, WESTERN J MED, V174, P59, DOI 10.1136/ewjm.174.1.59; FLETCHER JL, 1984, SOUTHERN MED J, V77, P149, DOI 10.1097/00007611-198402000-00001; GOLDFARB A, 1997, J GAY LESBIAN ASS, V1, P245; HAYWARD RA, 1993, J GEN INTERN MED, V8, P10, DOI 10.1007/BF02600286; KATSUFRAKIS PJ, 1997, J GAY LESBIAN MED AS, V1, P181; MAKADON HJ, 1998, J GAYLESBIAN MED ASS, V2, P153; MATHEWS WC, 1986, WESTERN J MED, V144, P106; MULLER MJ, 1997, J GAY LESBIAN MED AS, V1, P155; Olsen C., 1997, J GAY LESBIAN MED AS, V1, P149; Oriel K A, 1996, Fam Med, V28, P720; PRICHARD JG, 1988, J FAM PRACTICE, V27, P637; Ramos MM, 1998, ACAD MED, V73, P436, DOI 10.1097/00001888-199804000-00020; Schatz B, 1994, ANTIGAY DISCRIMINATI; Townsend MH, 1996, ACAD MED, V71, P1012, DOI 10.1097/00001888-199609000-00018; WALLICK MM, 1992, ACAD MED, V67, P601, DOI 10.1097/00001888-199209000-00013	16	22	22	3	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 17	2001	322	7283					422	424		10.1136/bmj.322.7283.422	http://dx.doi.org/10.1136/bmj.322.7283.422			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404JH	11179168	Green Published			2022-12-24	WOS:000167093600033
J	Vaccarino, V; Krumholz, HM; Yarzebski, J; Gore, JM; Goldberg, RJ				Vaccarino, V; Krumholz, HM; Yarzebski, J; Gore, JM; Goldberg, RJ			Sex differences in 2-year mortality after hospital discharge for myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; COMMUNITY-WIDE PERSPECTIVE; WORCESTER HEART-ATTACK; CASE-FATALITY RATES; RISK-FACTORS; PREMENOPAUSAL WOMEN; GENDER-DIFFERENCES; SURVIVAL RATES; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS	Background: An interaction between sex and age is thought to affect hospital mortality after myocardial infarction; younger, but not older, women have been shown to have higher mortality rates than men. It is currently unknown whether findings are similar after hospital discharge. Objective: To determine whether an interaction between sex and age affects a-year mortality after myocardial infarction. Design: Community-based prospective cohort study. Setting: 16 community hospitals serving the Worcester, Massachusetts, metropolitan area. Patients: 6826 patients who survived hospitalization for acute myocardial infarction during ten 1-year periods between 1975 and 1995. Measurements: Mortality 2 years after hospital discharge. Results: The overall 2-year mortality rate was higher in women (28.9%) than in men (19.6%). When patients were examined by age group, however, only women younger than 60 years of age had a higher mortality rate than men of similar age. The sex difference decreased with increasing age; among the oldest patients, women had a lower mortality rate than men (P = 0.009 for the interaction between sex and age). This relationship was not affected by adjustment for demographic characteristics and medical history, clinical characteristics, and hospital and discharge treatments; the hazard of 2-year death for women compared with men increased 15.4% (95% Cl, 4.3% to 27.6%) for every 10-year decrease in age. In absolute terms, after adjustment for demographic characteristics and medical history, among patients younger than 60 years of age women were at greater risk than men (risk difference, 1.8 percentage points). At older ages, however, women were at lower risk than men. Conclusions: Younger, but not older, women who survive hospitalization for myocardial infarction have a higher long-term mortality rate than men. This provides additional evidence that younger women with myocardial infarction are at greater risk for death than men.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA; Univ Massachusetts, Sch Med, Worcester, MA USA; Emory Univ, Sch Med, Dept Med Cardiol, Atlanta, GA 30306 USA	Yale University; Yale University; University of Massachusetts System; University of Massachusetts Worcester; Emory University	Vaccarino, V (corresponding author), Emory Univ, Sch Med, Dept Med Cardiol, Emory W,1256 Briarcliff Rd,Suite 1 N, Atlanta, GA 30306 USA.		, Harlan/AAI-2875-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035434] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL35434] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; Albert CM, 1996, CIRCULATION, V93, P1170, DOI 10.1161/01.CIR.93.6.1170; Behar S, 1997, AM HEART J, V133, P290, DOI 10.1016/S0002-8703(97)70222-9; BERKMAN LF, 1992, ANN INTERN MED, V117, P1003, DOI 10.7326/0003-4819-117-12-1003; Burke AP, 1998, CIRCULATION, V97, P2110, DOI 10.1161/01.CIR.97.21.2110; CARNEY RM, 1988, PSYCHOSOM MED, V50, P627, DOI 10.1097/00006842-198811000-00009; CASE RB, 1992, JAMA-J AM MED ASSOC, V267, P515, DOI 10.1001/jama.267.4.515; CHIRIBOGA DE, 1993, AM J CARDIOL, V71, P268, DOI 10.1016/0002-9149(93)90789-F; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; Coronado BE, 1997, J AM COLL CARDIOL, V29, P1490, DOI 10.1016/S0735-1097(97)00077-6; COX DR, 1972, J R STAT SOC B, V34, P187; CUNNINGHAM MA, 1989, J GEN INTERN MED, V4, P392, DOI 10.1007/BF02599688; DONAHUE RP, 1993, J CLIN EPIDEMIOL, V46, P245, DOI 10.1016/0895-4356(93)90072-9; FIEBACH NH, 1990, JAMA-J AM MED ASSOC, V263, P1092, DOI 10.1001/jama.263.8.1092; FLANDERS WD, 1987, J CHRON DIS, V40, P697, DOI 10.1016/0021-9681(87)90106-8; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Gabbay FH, 1996, J AM COLL CARDIOL, V27, P585, DOI 10.1016/0735-1097(95)00510-2; GOLDBERG RJ, 1988, AM HEART J, V115, P761, DOI 10.1016/0002-8703(88)90876-9; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; GOLDBERG RJ, 1986, JAMA-J AM MED ASSOC, V255, P2774, DOI 10.1001/jama.255.20.2774; GOLDBERG RJ, 1993, CIRCULATION, V87, P1947, DOI 10.1161/01.CIR.87.6.1947; Hanke H, 1997, CORONARY ARTERY DIS, V8, P511; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; JOHANSSON S, 1984, AM J EPIDEMIOL, V119, P610, DOI 10.1093/oxfordjournals.aje.a113778; Kober L, 1996, AM J CARDIOL, V77, P1052, DOI 10.1016/S0002-9149(96)00129-4; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; LAVECCHIA C, 1987, AM J OBSTET GYNECOL, V157, P1108, DOI 10.1016/S0002-9378(87)80271-5; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; LIAO YL, 1992, JAMA-J AM MED ASSOC, V268, P1867, DOI 10.1001/jama.268.14.1867; LOSORDO DW, 1994, CIRCULATION, V89, P1501, DOI 10.1161/01.CIR.89.4.1501; Malacrida R, 1998, NEW ENGL J MED, V338, P8, DOI 10.1056/NEJM199801013380102; Marrugat J, 1998, JAMA-J AM MED ASSOC, V280, P1405, DOI 10.1001/jama.280.16.1405; Maynard C, 1997, ARCH INTERN MED, V157, P1379, DOI 10.1001/archinte.157.12.1379; MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972; Miettinen H, 1998, DIABETES CARE, V21, P69, DOI 10.2337/diacare.21.1.69; Nohria Anju, 1998, Cardiology Clinics, V16, P45, DOI 10.1016/S0733-8651(05)70383-0; OLIVER MF, 1974, BMJ-BRIT MED J, V4, P253, DOI 10.1136/bmj.4.5939.253; ORENCIA A, 1993, JAMA-J AM MED ASSOC, V269, P2392, DOI 10.1001/jama.269.18.2392; PAGLEY PR, 1993, ARCH INTERN MED, V153, P625, DOI 10.1001/archinte.153.5.625; PETER T, 1978, MED J AUSTRALIA, V1, P189, DOI 10.5694/j.1326-5377.1978.tb107829.x; POHJOLA S, 1980, BRIT HEART J, V43, P176, DOI 10.1136/hrt.43.2.176; Punnonen R, 1997, MATURITAS, V27, P231, DOI 10.1016/S0378-5122(97)00040-6; RAHE RH, 1974, ARCH INTERN MED, V133, P221, DOI 10.1001/archinte.133.2.221; ROBINSON K, 1988, J AM COLL CARDIOL, V11, P932, DOI 10.1016/S0735-1097(98)90048-1; ROBINSON K, 1992, EUR HEART J, V13, P67, DOI 10.1093/oxfordjournals.eurheartj.a060050; Rosen M, 1999, NEW ENGL J MED, V341, P1931; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; ROZANSKI A, 1988, NEW ENGL J MED, V318, P1005, DOI 10.1056/NEJM198804213181601; RUBERMAN W, 1984, NEW ENGL J MED, V311, P552, DOI 10.1056/NEJM198408303110902; UDVARHELYI IS, 1992, JAMA-J AM MED ASSOC, V268, P2530, DOI 10.1001/jama.268.18.2530; Vaccarino V, 1996, J AM GERIATR SOC, V44, P1174, DOI 10.1111/j.1532-5415.1996.tb01366.x; Vaccarino V, 1998, ARCH INTERN MED, V158, P2054, DOI 10.1001/archinte.158.18.2054; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2000, AM J CARDIOL, V85, P1486, DOI 10.1016/S0002-9149(00)00800-6; WEINBLATT E, 1973, AM J PUBLIC HEALTH, V63, P577, DOI 10.2105/AJPH.63.7.577; WEINBLATT E, 1978, NEW ENGL J MED, V299, P60, DOI 10.1056/NEJM197807132990202; Wexler LF, 1999, NEW ENGL J MED, V341, P275, DOI 10.1056/NEJM199907223410409; WHITE HD, 1993, CIRCULATION, V88, P2097, DOI 10.1161/01.CIR.88.5.2097; WILLIAMS RB, 1992, JAMA-J AM MED ASSOC, V267, P520, DOI 10.1001/jama.267.4.520; WONG ND, 1989, AM J EPIDEMIOL, V130, P469, DOI 10.1093/oxfordjournals.aje.a115360	64	262	270	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2001	134	3					173	181		10.7326/0003-4819-134-3-200102060-00007	http://dx.doi.org/10.7326/0003-4819-134-3-200102060-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397KR	11177329				2022-12-24	WOS:000166695300001
J	Bertram, L; Blacker, D; Mullin, K; Keeney, D; Jones, J; Basu, S; Yhu, S; McInnis, MG; Go, RCP; Vekrellis, K; Selkoe, DJ; Saunders, AJ; Tanzi, RE				Bertram, L; Blacker, D; Mullin, K; Keeney, D; Jones, J; Basu, S; Yhu, S; McInnis, MG; Go, RCP; Vekrellis, K; Selkoe, DJ; Saunders, AJ; Tanzi, RE			Evidence for genetic linkage of Alzheimer's disease to chromosome 10q	SCIENCE			English	Article							ONSET	Recent studies suggest that insulin-degrading enzyme (IDE) in neurons and microglia degrades A beta, the principal component of beta -amyloid and one of the neuropathological hallmarks of Alzheimer's disease (AD). We performed parametric and nonparametric linkage analyses of seven genetic markers on chromosome 10q, six of which map near the IDE gene, in 435 multiplex AD families. These analyses revealed significant evidence of linkage for adjacent markers (D10S1671, D10S583, D10S1710, and D10S566), which was most pronounced in late-onset families. Furthermore, we found evidence for allele-specific association between the putative disease locus and marker D10S583, which has recently been located within 195 kilobases of the IDE gene.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,Genet & Aging Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat,Gerontol Res Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Johns Hopkins Univ, Inst Med, Dept Psychiat, Baltimore, MD 21287 USA; Univ Alabama, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Tanzi, RE (corresponding author), Massachusetts Gen Hosp E, Genet & Aging Unit, 149 13th St, Charlestown, MA 02129 USA.		Bertram, Lars/K-3889-2015; Tanzi, Rudolph/AAE-9622-2019; McInnis, Melvin G/F-6963-2012	Bertram, Lars/0000-0002-0108-124X; Tanzi, Rudolph/0000-0002-7032-1454; McInnis, Melvin G/0000-0002-0375-6247; Saunders, Aleister/0000-0002-7298-7823				Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; *GENB, AL356128 GENB; Hauser ER, 1997, AM J HUM GENET, V61, pA278; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; MYERS AJ, 2000, NEUROBIOL AGING S, V21, pS103; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Vekrellis K, 2000, J NEUROSCI, V20, P1657	13	424	457	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2000	290	5500					2302	+		10.1126/science.290.5500.2302	http://dx.doi.org/10.1126/science.290.5500.2302			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125142				2022-12-24	WOS:000165995800042
J	Wohlschlegel, JA; Dwyer, BT; Dhar, SK; Cvetic, C; Walter, JC; Dutta, A				Wohlschlegel, JA; Dwyer, BT; Dhar, SK; Cvetic, C; Walter, JC; Dutta, A			Inhibition of eukaryotic DNA replication by geminin binding to Cdt1	SCIENCE			English	Article							S-PHASE; MITOSIS; PHOSPHORYLATION; YEAST; COMPLEX; NUCLEUS; CDC6; CDK	In all eukaryotic organisms, inappropriate firing of replication origins during the G(2) phase of the cell cycle is suppressed by cyclin-dependent kinases. Multicellular eukaryotes contain a second putative inhibitor of re-replication called geminin, Geminin is believed to block binding of the mini-chromosome maintenance (MCM) complex to origins of replication, but the mechanism of this inhibition is unclear. Here we show that geminin interacts tightly with Cdt1, a recently identified replication initiation factor necessary for MCM Loading. The inhibition of DNA replication by geminin that is observed in cell-free DNA replication extracts is reversed by the addition of excess Cdt1. In the normal cell cycle, Cdt1 is present only in G(1) and S, whereas geminin is present in S and G(2) phases of the cell cycle. Together, these results suggest that geminin inhibits inappropriate origin firing by targeting Cdt1.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Dutta, A (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.		Dutta, Anindya/P-3203-2016	Dutta, Anindya/0000-0002-4319-0073; Walter, Johannes/0000-0002-4186-7570	NATIONAL CANCER INSTITUTE [R01CA060499] Funding Source: NIH RePORTER; NCI NIH HHS [CA60499] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; Costanzo V, 2000, MOL CELL, V6, P649, DOI 10.1016/S1097-2765(00)00063-0; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; HAYLES J, 1994, CELL, V78, P813, DOI 10.1016/S0092-8674(94)90542-8; Jiang W, 1999, P NATL ACAD SCI USA, V96, P6193, DOI 10.1073/pnas.96.11.6193; Lin YL, 1996, J BIOL CHEM, V271, P17190, DOI 10.1074/jbc.271.29.17190; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Natale DA, 2000, EMBO J, V19, P2728, DOI 10.1093/emboj/19.11.2728; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Saha P, 1998, MOL CELL BIOL, V18, P2758, DOI 10.1128/MCB.18.5.2758; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; TADA S, IN PRESS NATURE CELL; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Whittaker AJ, 2000, GENE DEV, V14, P1765; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	20	575	590	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2000	290	5500					2309	+		10.1126/science.290.5500.2309	http://dx.doi.org/10.1126/science.290.5500.2309			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125146				2022-12-24	WOS:000165995800046
J	Schrag, D; Cramer, LD; Bach, PB; Cohen, AM; Warren, JL; Begg, CB				Schrag, D; Cramer, LD; Bach, PB; Cohen, AM; Warren, JL; Begg, CB			Influence of hospital procedure volume on outcomes following surgery for colon cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEW-YORK-STATE; COLORECTAL-CANCER; PATIENT OUTCOMES; ADMINISTRATIVE DATA; MEDICARE PATIENTS; BREAST-CANCER; RECTAL-CANCER; HEALTH-CARE; MORTALITY; QUALITY	Context Survival following high-risk cancer surgery, such as pancreatectomy and esophagectomy, is superior at hospitals where high volumes of these procedures are per formed. Conflicting evidence exists as to whether the association between hospital experience and favorable health outcomes also applies to more frequently performed operations, such as those for colon cancer. Objective To determine whether hospital procedure volume predicts survival following colon cancer surgery. Design, Setting, and Participants Retrospective cohort study of data from the Surveillance, Epidemiology and End Results-Medicare linked database on 27986 colon cancer patients aged 65 years and older who had surgical resection for primary adenocarcinoma diagnosed between 1991 and 1996. Main Outcome Measures Thirty-day postoperative mortality and overall and cancer-specific long-term survival, by hospital procedure volume. Results We found small differences in 30-day postoperative mortality for patients treated at low- vs high-volume hospitals (3.5% at hospitals in the top-volume quartile vs 5.5% at hospitals in the bottom-volume quartile). However, the correlation was statistically significant and persisted after adjusting for age at diagnosis, sex, race, cancer stage, comorbid illness, socioeconomic status, and acuity of hospitalization (P<.001). The association was evident for subgroups with stage I, II, and III disease. Hospital Volume directly correlated with survival beyond 30 days and also was not attributable to differences in case mix (P<.001). The association between hospital volume and long-term survival was concentrated among patients with stage II and III disease (P<.001 for both). Among stage III patients. Variation in use of adjuvant chemotherapy did not explain this finding. Conclusion Our data suggest that hospital procedure volume predicts clinical outcomes following surgery for colon cancer, although the absolute magnitudes of these differences are modest in comparison with the variation observed for higher-risk cancer surgeries.	Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, Hlth Outcomes Res Grp, New York, NY 10021 USA; NCI, Appl Res Branch, Bethesda, MD 20892 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schrag, D (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, 1275 York Ave, New York, NY 10021 USA.			Schrag, Deborah/0000-0002-4334-5717				Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Begg MD, 1999, BIOMETRICS, V55, P302, DOI 10.1111/j.0006-341X.1999.00302.x; Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1067/msy.1999.98741; Birkmeyer JD, 2000, JAMA-J AM MED ASSOC, V283, P1191, DOI 10.1001/jama.283.9.1191; BURNS LR, 1991, MED CARE, V29, P251, DOI 10.1097/00005650-199103000-00007; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chassin MR, 1996, NEW ENGL J MED, V334, P394, DOI 10.1056/NEJM199602083340611; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; FLOOD AB, 1984, MED CARE, V22, P115, DOI 10.1097/00005650-198402000-00003; FLOOD AB, 1984, MED CARE, V22, P98, DOI 10.1097/00005650-198402000-00002; Gordon TA, 1998, ANN SURG, V228, P71, DOI 10.1097/00000658-199807000-00011; Hannan EL, 1998, STROKE, V29, P2292, DOI 10.1161/01.STR.29.11.2292; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; Hannan EL, 1999, NEW ENGL J MED, V340, P1677, DOI 10.1056/NEJM199905273402112; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; Harmon JW, 1999, ANN SURG, V230, P404, DOI 10.1097/00000658-199909000-00013; Hermanek P, 1996, EUR J SURG ONCOL, V22, P213, DOI 10.1016/S0748-7983(96)80004-7; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Hillner BE, 1998, JAMA-J AM MED ASSOC, V280, P1783, DOI 10.1001/jama.280.20.1783; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; HUGHES RG, 1987, MED CARE, V25, P489, DOI 10.1097/00005650-198706000-00004; HUGHES RG, 1988, MED CARE, V26, P1057, DOI 10.1097/00005650-198811000-00004; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; LLOYD SS, 1985, JAMA-J AM MED ASSOC, V254, P1330, DOI 10.1001/jama.254.10.1330; Merrill RM, 1999, MED CARE RES REV, V56, P177, DOI 10.1177/107755879905600204; NATTINGER AB, 1992, NEW ENGL J MED, V326, P1102, DOI 10.1056/NEJM199204233261702; Parry JM, 1999, BRIT J SURG, V86, P475, DOI 10.1046/j.1365-2168.1999.01064.x; Percy C., 1990, INT CLASSIFICATION D; Porter GA, 1998, ANN SURG, V227, P157, DOI 10.1097/00000658-199802000-00001; POTOSKY AL, 1993, MED CARE, V31, P732; Riley G, 1985, Health Care Financ Rev, V7, P37; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Simons AJ, 1997, DIS COLON RECTUM, V40, P641, DOI 10.1007/BF02140891; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; Yao SL, 1999, J NATL CANCER I, V91, P1950, DOI 10.1093/jnci/91.22.1950	38	405	412	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2000	284	23					3028	3035		10.1001/jama.284.23.3028	http://dx.doi.org/10.1001/jama.284.23.3028			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	382VC	11122590				2022-12-24	WOS:000165847200028
J	Barolo, S; Walker, RG; Polyanovsky, AD; Freschi, G; Keil, T; Posakony, JW				Barolo, S; Walker, RG; Polyanovsky, AD; Freschi, G; Keil, T; Posakony, JW			A notch-independent activity of suppressor of hairless is required for normal mechanoreceptor physiology	CELL			English	Article							SENSORY ORGAN DEVELOPMENT; ALTERNATIVE CELL FATES; SPLIT COMPLEX GENES; DROSOPHILA-MELANOGASTER; BRISTLE DEVELOPMENT; PAX2 HOMOLOG; PROTEIN; PATHWAY; EXPRESSION; VIRUS	Suppressor of Hairless [Su(H)]/Lag-1/RBP-J kappa /CBF1 is the only known transducing transcription factor for Notch receptor signaling. Here, we show that Su(H) has three distinct functions in the development of external mechanosensory organs in Drosophila: Notch-dependent transcriptional activation and a novel autorepression function, both of which direct cell fate decisions, and a novel auto-activation function required for normal socket cell differentiation. This third phase of activity, the first known Notch-independent activation function for Su(H) in development, depends on a cell type-specific autoregulatory enhancer that is active throughout adult life and is required for proper mechanoreception. These results establish a direct link between a broadly deployed cell signaling pathway and an essential physiological function of the nervous system.	Univ Calif San Diego, CDB, Div Biol, La Jolla, CA 92093 USA; Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia; Max Planck Inst Verhaltensphysiol, D-82305 Seewiesen, Germany	University of California System; University of California San Diego; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Max Planck Society	Posakony, JW (corresponding author), Univ Calif San Diego, CDB, Div Biol, La Jolla, CA 92093 USA.	jposakony@ucsd.edu		Polyanovsky, Andrey/0000-0002-8116-022X	NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020123] Funding Source: NIH RePORTER; NCI NIH HHS [5POCA23100-16] Funding Source: Medline; NIGMS NIH HHS [GM20123, GM46993] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; BAILEY AM, 1996, THESIS U CALIFORNIA; BANG AG, 1991, DEVELOPMENT, V111, P89; BANG AG, 1992, GENE DEV, V6, P1752, DOI 10.1101/gad.6.9.1752; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BEVERLEY SM, 1984, J MOL EVOL, V21, P1, DOI 10.1007/BF02100622; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; BROU C, 1994, GENE DEV, V8, P2491, DOI 10.1101/gad.8.20.2491; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; Gho M, 1996, DEVELOPMENT, V122, P1673; Gho M, 1999, DEVELOPMENT, V126, P3573; Go MJ, 1998, DEVELOPMENT, V125, P2031; GRIMWADE BG, 1985, DEV BIOL, V107, P503, DOI 10.1016/0012-1606(85)90331-8; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; HAMAGUCHI Y, 1989, NUCLEIC ACIDS RES, V17, P9015, DOI 10.1093/nar/17.22.9015; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kavaler J, 1999, DEVELOPMENT, V126, P2261; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Lees AD, 1942, PROC R SOC SER B-BIO, V131, P87, DOI 10.1098/rspb.1942.0019; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; Matsuno K, 1997, DEVELOPMENT, V124, P4265; Morel V, 2000, GENE DEV, V14, P377; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; Parks AL, 1997, MECH DEVELOP, V63, P61, DOI 10.1016/S0925-4773(97)00675-8; PARODY TR, 1993, GENETICS, V135, P527; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; SCHWEISGUTH F, 1994, DEVELOPMENT, V120, P1433; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Shawber C, 1996, DEVELOPMENT, V122, P3765; SHELLENBARGER DL, 1978, DEV BIOL, V62, P432, DOI 10.1016/0012-1606(78)90226-9; Thurm U., 1980, P735; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Van De Bor V, 2000, DEVELOPMENT, V127, P3735; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Wang SW, 1997, DEVELOPMENT, V124, P4435	50	113	114	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 8	2000	103	6					957	969		10.1016/S0092-8674(00)00198-7	http://dx.doi.org/10.1016/S0092-8674(00)00198-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136980	Bronze			2022-12-24	WOS:000165801300014
J	The, AM; Hak, T; Koeter, G; van der Wal, G				The, AM; Hak, T; Koeter, G; van der Wal, G			Collusion in doctor-patient communication about imminent death: an ethnographic study	BRITISH MEDICAL JOURNAL			English	Article								Objective To discover and explore the factors that result in "false optimism about recovery" observed in patients with small cell lung cancer. Design A qualitative observational (ethnographic) study in two stages over four years. Setting Lung diseases ward and outpatient clinic in university hospital in the Netherlands. Participants 35 patients with small cell lung cancer. Results "False optimism about recovery" usually developed during the (first) course of chemotherapy and was most prevalent when the cancer could no longer be seen in the x ray pictures. This optimism tended to vanish when the tumour recurred, but it could develop again, though to a lesser extent, during further courses of chemotherapy. Patients gradually found out the facts about their poor prognosis, partly because of physical deterioration and partly through contact with fellow patients who were in a more advanced stage of the illness and were dying. "False optimism about recovery" was the result an association between doctors' activism and patients' adherence to the treatment calendar and to the "recovery plot," which allowed them not to acknowledge explicitly what they should and could know. The doctor did and did net want to pronounce a "death sentence" and the patient did and did not want to hear it. Conclusion Solutions to the problem of collusion between doctor and patient require an active, patient oriented approach from the doctor. Perhaps solutions have to be found outside the doctor-patient relationship itself-for example, by involving "treatment brokers."	Univ Groningen Hosp, Dept Lung Dis, NL-9700 RB Groningen, Netherlands; Vrije Univ Amsterdam, Dept Social Med, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands	University of Groningen; Vrije Universiteit Amsterdam	The, AM (corresponding author), Vrije Univ Amsterdam, Dept Social Med, Inst Res Extramural Med, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.		The, Anne-Mei/AAE-3468-2020; Hak, Tony/A-2227-2009	Hak, Tony/0000-0002-7208-3795				Christakis Nicholas, 1999, DEATH FORETOLD PROPH; Frank AW., 2013, WOUNDED STORYTELLER; Geertz C., 1973, INTERPRETATION CULTU; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; MAYS N, 1995, BRIT MED J, V311, P182, DOI 10.1136/bmj.311.6998.182; Meredith C, 1996, BMJ-BRIT MED J, V313, P724; Nuland S.B., 1994, WE DIE REFLECTIONS L; SCHOU KC, 1999, EXPERIENCING CANC; Smith TJ, 1998, JAMA-J AM MED ASSOC, V279, P1746, DOI 10.1001/jama.279.21.1746; TEH AM, 1997, NURSING DILEMMAS EUT; THE AM, 1999, PALLIATIVE CARE COMM; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709	12	310	310	0	20	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 2	2000	321	7273					1376	1381		10.1136/bmj.321.7273.1376	http://dx.doi.org/10.1136/bmj.321.7273.1376			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380TT	11099281	Green Published, Bronze			2022-12-24	WOS:000165720100024
J	Brazelton, TR; Rossi, FMV; Keshet, GI; Blau, HM				Brazelton, TR; Rossi, FMV; Keshet, GI; Blau, HM			From marrow to brain: Expression of neuronal phenotypes in adult mice	SCIENCE			English	Article							DIFFERENTIATION ANTIGENS; PROGENITOR CELLS; OLFACTORY-BULB; BONE-MARROW; IN-VIVO; HETEROKARYONS; ACTIVATION; PLASTICITY; ANTIBODIES; MICROGLIA	After intravascular delivery of genetically marked adult mouse bone marrow into Lethally irradiated normal adult hosts, donor-derived cells expressing neuronal proteins (neuronal phenotypes) developed in the central nervous system. Flow cytometry revealed a population of donor-derived cells in the brain with characteristics distinct from bone marrow. Confocal microscopy of individual cells showed that hundreds of marrow-derived cells in brain sections expressed gene products typical of neurons (NeuN, 200-kilodalton neurofilament, and class III beta -tubulin) and were able to activate the transcription factor CAMP response element-binding protein (CREB). The generation of neuronal phenotypes in the adult brain 1 to 6 months after an adult bone marrow transplant demonstrates a remarkable plasticity of adult tissues with potential clinical applications.	Stanford Univ, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Dept Mol Pharmacol, CCSR 4215,269 Campus Dr, Stanford, CA 94305 USA.		Rossi, Fabio MV/B-5587-2013	Rossi, Fabio MV/0000-0002-0368-2620; Keshet, Gilmor/0000-0002-1907-3029	NCI NIH HHS [CA59717] Funding Source: Medline; NIA NIH HHS [AG09521] Funding Source: Medline; NICHD NIH HHS [HD18179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA059717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009521, R37AG009521] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; Liu N, 1999, J BIOL CHEM, V274, P3042, DOI 10.1074/jbc.274.5.3042; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; SPEAR BT, 1990, MOL CELL BIOL, V10, P5047, DOI 10.1128/MCB.10.10.5047; SPRINGER T, 1978, EUR J IMMUNOL, V8, P539, DOI 10.1002/eji.1830080802; Vescovi AL, 1999, BRAIN PATHOL, V9, P569, DOI 10.1111/j.1750-3639.1999.tb00542.x; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; WRIGHT WE, 1984, EXP CELL RES, V151, P55, DOI 10.1016/0014-4827(84)90355-0	28	1372	1651	1	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2000	290	5497					1775	1779		10.1126/science.290.5497.1775	http://dx.doi.org/10.1126/science.290.5497.1775			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379FY	11099418				2022-12-24	WOS:000165632400046
J	Lyko, F; Ramsahoye, BH; Jaenisch, R				Lyko, F; Ramsahoye, BH; Jaenisch, R			Development - DNA methylation in Drosophila melanogaster	NATURE			English	Article							METHYLTRANSFERASES; 5-METHYLCYTOSINE; ABSENCE; CELLS; RDNA		Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Edinburgh, Western Gen Hosp, Dept Oncol, John Hughes Bennett Lab, Edinburgh EH4 2XU, Midlothian, Scotland; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Edinburgh; Massachusetts Institute of Technology (MIT)	Lyko, F (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Hu, Ruogu/B-2203-2008					ACHWAL CW, 1984, EMBO J, V3, P263, DOI 10.1002/j.1460-2075.1984.tb01795.x; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1485, DOI 10.1093/nar/8.7.1485; Hung MS, 1999, P NATL ACAD SCI USA, V96, P11940, DOI 10.1073/pnas.96.21.11940; Lyko F, 2000, MECH DEVELOP, V95, P215, DOI 10.1016/S0925-4773(00)00325-7; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; PATEL CV, 1987, ANAL BIOCHEM, V164, P164, DOI 10.1016/0003-2697(87)90381-2; RAE PMM, 1979, NUCLEIC ACIDS RES, V6, P2987, DOI 10.1093/nar/6.9.2987; Ramsahoye BH, 1996, BLOOD, V87, P2065, DOI 10.1182/blood.V87.5.2065.bloodjournal8752065; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Tweedie S, 1999, NAT GENET, V23, P389, DOI 10.1038/70490; URIELISHOVAL S, 1982, FEBS LETT, V146, P148, DOI 10.1016/0014-5793(82)80723-0; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279	15	338	360	3	39	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 30	2000	408	6812					538	540		10.1038/35046205	http://dx.doi.org/10.1038/35046205			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	377WE	11117732				2022-12-24	WOS:000165548600104
J	Jiang, YJ; Aerne, BL; Smithers, L; Haddon, C; Ish-Horowicz, D; Lewis, J				Jiang, YJ; Aerne, BL; Smithers, L; Haddon, C; Ish-Horowicz, D; Lewis, J			Notch signalling and the synchronization of the somite segmentation clock	NATURE			English	Article							LUNATIC-FRINGE; VERTEBRATE SEGMENTATION; DANIO-RERIO; ZEBRAFISH; EXPRESSION; GENE; MESODERM; MOUSE; HOMOLOG; DIFFERENTIATION	In vertebrates with mutations in the Notch cell-cell communication pathway, segmentation fails: the boundaries demarcating somites, the segments of the embryonic body axis, are absent or irregular(1-8). This phenotype has prompted many investigations, but the role of Notch signalling in somitogenesis remains mysterious(1,9-12). Somite patterning is thought to be governed by a "clock-and-wavefront" mechanism(13) : a biochemical oscillator (the segmentation clock) operates in the cells of the presomitic mesoderm, the immature tissue from which the somites are sequentially produced, and a wavefront of maturation sweeps back through this tissue, arresting oscillation and initiating somite differentiation(14,15). Cells arrested in different phases of their cycle express different genes, defining the spatially periodic pattern of somites and controlling the physical process of segmentation(1,16-19). Notch signalling, one might think, must be necessary for oscillation, or to organize subsequent events that create the somite boundaries. Here we analyse a set of zebrafish mutants and arrive at a different interpretation: the essential function of Notch signalling in somite segmentation is to keep the oscillations of neighbouring presomitic mesoderm cells synchronized.	Imperial Canc Res Fund, Vertebrate Dev Lab, London WC2A 3PX, England; Imperial Canc Res Fund, Dev Genet Lab, London WC2A 3PX, England	Cancer Research UK; Cancer Research UK	Lewis, J (corresponding author), Imperial Canc Res Fund, Vertebrate Dev Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	j.lewis@icrf.icnet.uk	Lewis, Julian H/E-8733-2010; Jiang, Yun-Jin/E-3995-2010	Jiang, Yun-Jin/0000-0003-0499-7306; Ish-Horowicz, David/0000-0001-5684-7129				Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; CONLON RA, 1995, DEVELOPMENT, V121, P1533; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Haddon C, 1998, DEVELOPMENT, V125, P4637; Haddon C, 1998, DEVELOPMENT, V125, P359; Holley SA, 2000, GENE DEV, V14, P1678; Jen WC, 1999, GENE DEV, V13, P1486, DOI 10.1101/gad.13.11.1486; Jiang YJ, 1998, CURR BIOL, V8, pR868, DOI 10.1016/S0960-9822(07)00547-7; Jiang YJ, 1996, DEVELOPMENT, V123, P205; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Muller M, 1996, DEVELOPMENT, V122, P2071; OKA C, 1995, DEVELOPMENT, V121, P3291; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 1999, CURR OPIN GENET DEV, V9, P559, DOI 10.1016/S0959-437X(99)00011-8; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Sawada A, 2000, DEVELOPMENT, V127, P1691; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Takke C, 1999, DEVELOPMENT, V126, P3005; Van Eeden FJM, 1998, DEV GENET, V23, P65; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Yamamoto A, 1998, DEVELOPMENT, V125, P3389; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	30	416	423	0	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2000	408	6811					475	479		10.1038/35044091	http://dx.doi.org/10.1038/35044091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100729				2022-12-24	WOS:000165429800049
J	Luo, JY; Su, F; Chen, DL; Shiloh, A; Gu, W				Luo, JY; Su, F; Chen, DL; Shiloh, A; Gu, W			Deacetylation of p53 modulates its effect on cell growth and apoptosis	NATURE			English	Article							METASTASIS-ASSOCIATED GENE; HISTONE DEACETYLASE; TRANSCRIPTIONAL ACTIVATION; TERMINAL DOMAIN; DNA METHYLATION; COMPLEX; MTA1; OVEREXPRESSION; ACETYLATION; REPRESSION	The p53 tumour suppressor is a transcriptional factor whose activity is modulated by protein stability and post-translational modifications including acetylation(1-4). The mechanism by which acetylated p53 is maintained in vivo remains unclear. Here we show that the deacetylation of p53 is mediated by an histone deacetylase-1 (HDAC1)-containing complex. We have also purified a p53 target protein in the deacetylase complexes (designated PID; but identical to metastasis-associated protein 2 (MTA2)), which has been identified as a component of the NuRD complex(5-7). PID specifically interacts with p53 both in vitro and in vivo, and its expression reduces significantly the steady-state levels of acetylated p53. PID expression strongly represses p53-dependent transcriptional activation, and, notably, it modulates p53-mediated cell growth arrest and apoptosis. These results show that deacetylation and functional interactions by the PID/MTA2-associated NuRD complex may represent an important pathway to regulate p53 function.	Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, 1150 St Nicholas Ave, New York, NY 10032 USA.		Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914				Amundson SA, 1998, ONCOGENE, V17, P3287, DOI 10.1038/sj.onc.1202576; Attardi LD, 1996, EMBO J, V15, P3693, DOI 10.1002/j.1460-2075.1996.tb00739.x; Futamura M, 1999, J HUM GENET, V44, P52, DOI 10.1007/s100380050107; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Liu L, 1999, MOL CELL BIOL, V19, P1202; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Prives C, 1999, J PATHOL, V187, P112; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.3.CO;2-H; Toh Y, 1999, BRIT J CANCER, V79, P1723, DOI 10.1038/sj.bjc.6690274; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	30	656	684	0	47	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2000	408	6810					377	381		10.1038/35042612	http://dx.doi.org/10.1038/35042612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099047				2022-12-24	WOS:000165296000050
J	Wessberg, J; Stambaugh, CR; Kralik, JD; Beck, PD; Laubach, M; Chapin, JK; Kim, J; Biggs, J; Srinivasan, MA; Nicolelis, MAL				Wessberg, J; Stambaugh, CR; Kralik, JD; Beck, PD; Laubach, M; Chapin, JK; Kim, J; Biggs, J; Srinivasan, MA; Nicolelis, MAL			Real-time prediction of hand trajectory by ensembles of cortical neurons in primates	NATURE			English	Article							PREMOTOR CORTEX; CORTICOMOTONEURONAL CELLS; MOTOR CORTEX; OWL MONKEYS; REPRESENTATION; DIRECTION; MOVEMENTS; DORSAL; AREAS	Signals derived from the rat motor cortex can be used for controlling one-dimensional movements of a robot arm(1). It remains unknown, however, whether real-time processing of cortical signals can be employed to reproduce, in a robotic device, the kind of complex arm movements used by primates to reach objects in space. Here we recorded the simultaneous activity of large populations of neurons, distributed in the premotor, primary motor and posterior parietal cortical areas, as non-human primates performed two distinct motor tasks. Accurate real-time predictions of one- and three-dimensional arm movement trajectories were obtained by applying both linear and nonlinear algorithms to cortical neuronal ensemble activity recorded from each animal. In addition, cortically derived signals were successfully used for real-time control of robotic devices, both locally and through the Internet. These results suggest that long-term control of complex prosthetic robot arm movements can be achieved by simple real-time transformations of neuronal population signals derived from multiple cortical areas in primates.	Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Dept Biomed Engn, Durham, NC 27710 USA; Duke Univ, Dept Expt Psychol, Durham, NC 27710 USA; SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; MIT, Dept Mech Engn, Lab Human & Machine Hapt, Cambridge, MA 02139 USA; MIT, Elect Res Lab, Cambridge, MA 02139 USA	Duke University; Duke University; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Nicolelis, MAL (corresponding author), Duke Univ, Dept Neurobiol, Durham, NC 27710 USA.		Kim, Jung/C-1636-2011	Laubach, Mark/0000-0002-2403-4497				Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Bendat J.S., 1986, RANDOM DATA ANAL MEA; Brillinger D.R., 1981, TIME SERIES DATA ANA; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; Ferraina S, 1997, J NEUROPHYSIOL, V77, P1034, DOI 10.1152/jn.1997.77.2.1034; FETZ EE, 1978, J PHYSIOL-PARIS, V74, P239; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; MITZ AR, 1991, J NEUROSCI, V11, P1855; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; NICOLELIS MAL, IN PRESS NATURE; POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790; Preuss TM, 1996, J COMP NEUROL, V371, P649, DOI 10.1002/(SICI)1096-9861(19960805)371:4<649::AID-CNE12>3.0.CO;2-E; Salisbury JK, 1997, IEEE COMPUT GRAPH, V17, P6, DOI 10.1109/MCG.1997.1626171; SCHMIDT EM, 1980, ANN BIOMED ENG, V8, P339, DOI 10.1007/BF02363437; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Scott SH, 1997, J NEUROPHYSIOL, V78, P2413, DOI 10.1152/jn.1997.78.5.2413; STEPNIEWSKA I, 1993, J COMP NEUROL, V330, P238, DOI 10.1002/cne.903300207; WEINRICH M, 1982, J NEUROSCI, V2, P1329; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	30	961	1028	11	201	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2000	408	6810					361	365		10.1038/35042582	http://dx.doi.org/10.1038/35042582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099043				2022-12-24	WOS:000165296000046
J	Mas, P; Devlin, PF; Panda, S; Kay, SA				Mas, P; Devlin, PF; Panda, S; Kay, SA			Functional interaction of phytochrome B and cryptochrome 2	NATURE			English	Article							LIGHT RECEPTOR CRYPTOCHROME-2; SIGNAL-TRANSDUCTION; ARABIDOPSIS; PROTEIN; PHOTORECEPTORS; TRANSLOCATION; NUCLEUS	Light is a crucial environmental signal that controls many photomorphogenic and circadian responses in plants(1). Perception and transduction of light is achieved by at least two principal groups of photoreceptors, phytochromes and cryptochromes(2,3). Phytochromes are red/far-red light-absorbing receptors encoded by a gene family of five members (phyA to phyE)(2,4) in Arabidopsis. Cryptochrome 1 (cry1), cryptochrome 2 (cry2) and phototropin are the blue/ultraviolet-A light receptors that have been characterized in Arabidopsis(5). Previous studies showed that modulation of many physiological responses in plants is achieved by genetic interactions between different photoreceptors(6); however, little is known about the nature of these interactions and their roles in the signal transduction pathway. Here we show the genetic interaction that occurs between the Arabidopsis photoreceptors phyB and cry2 in the control of flowering time, hypocotyl elongation and circadian period by the clock. PhyB interacts directly with cry2 as observed in co-immunoprecipitation experiments with transgenic Arabidopsis plants overexpressing cry2. Using fluorescent resonance energy transfer microscopy, we show that phyB and cry2 interact in nuclear speckles that are formed in a light-dependent fashion.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Natl Sci Fdn, Ctr Biol Timing, La Jolla, CA 92037 USA	Scripps Research Institute; National Science Foundation (NSF); NSF - Center for Biological Timing; Scripps Research Institute	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevek@scripps.edu	Mas, Paloma/B-8215-2016; Kay, Steve A/F-6025-2011; Panda, Satchidananda/J-6891-2012	Mas, Paloma/0000-0002-3780-8041; Kay, Steve A/0000-0002-0402-2878; Devlin, Paul/0000-0002-0168-3793				Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Bastiaens PIH, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P136; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; CARRINGTON JC, 1991, PLANT CELL, V3, P953, DOI 10.1105/tpc.3.9.953; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Choi G, 1999, NATURE, V401, P610, DOI 10.1038/44176; Chory J, 1997, PLANT CELL, V9, P1225, DOI 10.1105/tpc.9.7.1225; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Gadella TWJ, 1999, TRENDS PLANT SCI, V4, P287, DOI 10.1016/S1360-1385(99)01426-0; Guo HW, 1999, PLANT J, V19, P279, DOI 10.1046/j.1365-313X.1999.00525.x; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Kendric RE, 1994, PHOTOMORPHOGENESIS P; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Kleiner O, 1999, PLANT J, V19, P289, DOI 10.1046/j.1365-313X.1999.00535.x; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Mas P, 1999, J CELL BIOL, V147, P945, DOI 10.1083/jcb.147.5.945; MILLAR AJ, 1995, SCIENCE, V267, P1163, DOI 10.1126/science.7855596; Mockler TC, 1999, DEVELOPMENT, V126, P2073; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; WHETLAM GC, 1998, PLANT CELL ENVIRON, V20, P752; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	30	311	333	6	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2000	408	6809					207	211		10.1038/35041583	http://dx.doi.org/10.1038/35041583			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089975				2022-12-24	WOS:000165180400047
J	Mast, ST; Jollis, JG; Ryan, T; Anstrom, KJ; Crary, JL				Mast, ST; Jollis, JG; Ryan, T; Anstrom, KJ; Crary, JL			The progression of fenfluramine-associated valvular heart disease assessed by echocardiography	ANNALS OF INTERNAL MEDICINE			English	Article							APPETITE-SUPPRESSANT DRUGS; AORTIC REGURGITATION; VALVE ABNORMALITIES; OBESE-PATIENTS; DEXFENFLURAMINE; PHENTERMINE; PREVALENCE; RISK	Background: An association between the dietary suppressants fenfluramine and dexfenfluramine and valvular heart disease was first described in patients from North Dakota and Minnesota in 1997. Limited data are available on the natural history of this valvulopathy after discontinuation of drug therapy. Objective: To follow the progression of fenfluramine-associated valvular heart disease after discontinuation of therapy by using serial echocardiography. Design: Retrospective cohort study. Setting: Regional medical center in Fargo, North Dakota. Patients: 50 patients with previous exposure to fenfluramines who had at least mild mitral regurgitation or aortic regurgitation after exposure to fenfluramines on serial echocardiography between December 1994 and February 1999 (96% were female, mean body mass index was 36.6 kg/m(2), and mean duration of drug exposure was 447 days). Measurements: serial echocardiograms were reviewed by two echocardiographers who were blinded to the order of image acquisition. The severity of valvular regurgitation and presence or absence of valve leaflet restriction were assessed. Results: As described in the initial report, significant valvular disease on initial postexposure echocardiography was common in this cohort; 38 patients (76%) had at least mild mitral regurgitation and 43 patients (86%) had at least mild aortic regurgitation. On serial echocardiograms obtained an average of 356 days apart, mitral regurgitation improved by at least one grade in 17 patients (P = 0.001) and aortic regurgitation improved by at least one grade in 19 patients (P = 0.004). Nineteen and 22 patients, respectively, experienced no change in severity of mitral and aortic regurgitation. Two patients in each group experienced worsening of regurgitation by at least one grade. Results were similar for tricuspid (P = 0.002) and pulmonic (P = 0.012) regurgitation. Conclusion: On serial echocardiography, fenfluramine-associated valvular regurgitation improved or remained stable in most patients after therapy ended. Worsening of valvular regurgitation was uncommon. The potential for stabilization or regression of valvular regurgitation should be taken into account when counseling patients and considering the need for and timing of valve surgery.	Duke Univ, Med Ctr, Durham, NC USA; MeritCare Med Ctr, Fargo, ND USA	Duke University	Jollis, JG (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.				NHLBI NIH HHS [HL03995-01] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Burger AJ, 1999, J AM COLL CARDIOL, V34, P1153, DOI 10.1016/S0735-1097(99)00321-6; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Gardin JM, 2000, JAMA-J AM MED ASSOC, V283, P1703, DOI 10.1001/jama.283.13.1703; HENRY WL, 1980, CIRCULATION, V62, P212, DOI 10.1161/01.CIR.62.2.212; Hensrud DD, 1999, MAYO CLIN PROC, V74, P1191, DOI 10.4065/74.12.1191; Jick H, 1998, NEW ENGL J MED, V339, P719, DOI 10.1056/NEJM199809103391102; Jollis JG, 2000, CIRCULATION, V101, P2071, DOI 10.1161/01.CIR.101.17.2071; Khan MA, 1998, NEW ENGL J MED, V339, P713, DOI 10.1056/NEJM199809103391101; LIN M, 1994, J AM COLL CARDIOL, V24, P1046, DOI 10.1016/0735-1097(94)90868-0; Schiller NB, 1999, J AM COLL CARDIOL, V34, P1159; SCOGNAMIGLIO R, 1994, NEW ENGL J MED, V331, P689, DOI 10.1056/NEJM199409153311101; Wee CC, 1998, ANN INTERN MED, V129, P870, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00005; Weissman NJ, 1999, J AM COLL CARDIOL, V34, P2088, DOI 10.1016/S0735-1097(99)00445-3; Weissman NJ, 1998, NEW ENGL J MED, V339, P725, DOI 10.1056/NEJM199809103391103; 1997, MMWR MORB WKLY REP, V46, P1061	15	42	44	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2001	134	4					261	266		10.7326/0003-4819-134-4-200102200-00008	http://dx.doi.org/10.7326/0003-4819-134-4-200102200-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403NW	11182835				2022-12-24	WOS:000167050200001
J	Gilbert, PB; DeGruttola, V; Hammer, SM; Kuritzkes, DR				Gilbert, PB; DeGruttola, V; Hammer, SM; Kuritzkes, DR			Virologic and regimen termination surrogate end points in AIDS clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIV-1 RNA LEVELS; IMMUNODEFICIENCY-VIRUS-INFECTION; COMBINATION ANTIRETROVIRAL THERAPY; CD4 CELL COUNT; REPORTING OUTCOMES; VIRAL LOAD; PROGRESSION; ZIDOVUDINE; INDINAVIR; LYMPHOCYTES	Suppression of plasma human immunodeficiency virus (HIV) RNA levels has been widely accepted as an appropriate surrogate end point for HIV disease progression, and it is currently used as the primary end point to determine efficacy in many antiretroviral trials. However, this end point does not always measure other important effects of treatment, such as inducement of multidrug resistance, which depletes future therapy options, and toxic effects. An alternative that directly factors in these treatment costs is a composite regimen termination end point, defined as a protocol-determined change in regimen due to either virologic failure or treatment-related toxic effects. Pros and cons for using purely virologic vs various composite primary end points are discussed. Conclusions include (1) a trial's clinical objective guides the choice of primary end point, (2) a purely virologic end point is often preferable, (3) it may be important to analyze both end point types in interpreting study results, and (4) long-term clinical outcome studies are needed for identifying the most predictive surrogate end points.	Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Columbia Presbyterian Ctr, Div Infect Dis, New York, NY USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA	Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gilbert, PB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 655 Huntington Ave, Boston, MA 02115 USA.	pgilbert@hsph.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI028076, U01AI038855, R01AI028076] Funding Source: NIH RePORTER; NIAID NIH HHS [5-U01-AI38855, 5-U01-AI28076] Funding Source: Medline; PHS HHS [A1-32770] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBRECHT M, 2000, 7 C RETR OPP INF JAN; ANDERSON JR, 1988, J CLIN ONCOL, V6, P559, DOI 10.1200/JCO.1988.6.3.559; [Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], 1998, MMWR Recomm Rep, V47, P43; Babiker A, 2000, AIDS RES HUM RETROV, V16, P1123; *CARD ARRH PIL STU, 1988, AM J CARDIOL, V61, P501; CHOI SS, 1993, ANN INTERN MED, V118, P674, DOI 10.7326/0003-4819-118-9-199305010-00003; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; Coombs RW, 1996, J INFECT DIS, V174, P704, DOI 10.1093/infdis/174.4.704; DEGRUTTOLA V, 1993, J ACQ IMMUN DEF SYND, V6, P359; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; DIXON DO, 1987, J CLIN ONCOL, V5, P1670, DOI 10.1200/JCO.1987.5.10.1670; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; Fisher L.D., 1990, STAT ISSUES DRUG RES, P331, DOI DOI 10.1201/9780203738610; Fleming T. R., 1992, STAT SCI, V7, P428; FLEMING TR, 1990, J ACQ IMMUN DEF SYND, V3, pS82; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; FLEMING TR, 1994, STAT MED, V13, P1423, DOI 10.1002/sim.4780131318; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; Gilbert PB, 2000, AIDS RES HUM RETROV, V16, P1325, DOI 10.1089/08892220050140874; Gilbert PB, 2000, AIDS, V14, P1961, DOI 10.1097/00002030-200009080-00012; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gulick RM, 2000, J INFECT DIS, V182, P1375, DOI 10.1086/315867; HAMMER S, 1999, 6 C RETR OPP INF JAN; HAMMER S, 2000, 7 C RETR OPP INF JAN; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Hoyert D L, 1999, Natl Vital Stat Rep, V47, P1; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Hughes MD, 1997, ANN INTERN MED, V126, P929, DOI 10.7326/0003-4819-126-12-199706150-00001; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI; Katzenstein D A, 1997, J Assoc Nurses AIDS Care, V8 Suppl, P10, DOI 10.1016/S1055-3290(97)80003-9; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Kaufmann D, 1998, LANCET, V351, P723, DOI 10.1016/S0140-6736(98)24010-4; Kuritzkes DR, 2000, AIDS, V14, P1553, DOI 10.1097/00002030-200007280-00011; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; LEE TH, 1994, J ACQ IMMUN DEF SYND, V7, P381; LIN DY, 1993, STAT MED, V12, P835, DOI 10.1002/sim.4780120904; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Murphy RL, 1999, J INFECT DIS, V179, P808, DOI 10.1086/314668; Murray JS, 1999, AIDS, V13, P797, DOI 10.1097/00002030-199905070-00008; *NAT I ALL INF DIS, 1998, 25 AIDS CLIN TRIALS; OBrien TR, 1996, JAMA-J AM MED ASSOC, V276, P105, DOI 10.1001/jama.276.2.105; OBrien WA, 1996, NEW ENGL J MED, V334, P426, DOI 10.1056/NEJM199602153340703; Painter George R., 1996, Drugs of the Future, V21, P347; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PARTALEDIS JA, 1995, J VIROL, V69, P5228, DOI 10.1128/JVI.69.9.5228-5235.1995; Phillips AN, 1996, AIDS, V10, P859, DOI 10.1097/00002030-199607000-00009; Piketty C, 1998, AIDS, V12, P745, DOI 10.1097/00002030-199807000-00011; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; SADLER BM, 1995, 5 EUR C CLIN ASP TRE; Scharfstein DO, 1999, J AM STAT ASSOC, V94, P1096, DOI 10.2307/2669923; SHCOOLEY RT, 1996, 36 INT C ANT AG CHEM; SMEATON L, IN PRESS CONTROL CLI; SQUIRES K, 2000, 7 C RETR OPP INF JAN; Staszewski S, 1998, AIDS, V12, P1991, DOI 10.1097/00002030-199815000-00010; StClair MH, 1996, ANTIVIR RES, V29, P53, DOI 10.1016/0166-3542(95)00916-7; Stone VE, 1998, J GEN INTERN MED, V13, P586, DOI 10.1046/j.1525-1497.1998.00180.x; TISDALE M, 1995, ANTIMICROB AGENTS CH, V39, P1704, DOI 10.1128/AAC.39.8.1704; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Welles SL, 1996, J INFECT DIS, V174, P696, DOI 10.1093/infdis/174.4.696; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yeh KC, 1998, ANTIMICROB AGENTS CH, V42, P332	67	34	35	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2001	285	6					777	784		10.1001/jama.285.6.777	http://dx.doi.org/10.1001/jama.285.6.777			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399MP	11176916				2022-12-24	WOS:000166817200035
J	Runnels, LW; Yue, LX; Capham, DE				Runnels, LW; Yue, LX; Capham, DE			TRP-PLIK, a bifunctional protein with kinase and ion channel activities	SCIENCE			English	Article							CATALYTIC DOMAIN; PHOTOTRANSDUCTION; DROSOPHILA	We cloned and characterized a protein kinase and ion channel, TRP-PLIK. As part of the Long transient receptor potential channel subfamily implicated in control of cell division, it is a protein that is both an ion channel and a protein kinase. TRP-PLIK phosphorylated itself, displayed a wide tissue distribution, and, when expressed in CHO-K1 cells, constituted a nonselective, calcium-permeant, 105-picosiemen, steeply outwardly rectifying conductance. The zinc finger containing alpha -kinase domain was functional, Inactivation of the kinase activity by site-directed mutagenesis and the channel's dependence on intracellular adenosine triphosphate (ATP) demonstrated that the channel's kinase activity is essential for channel function.	Harvard Univ, Childresn Hosp,Sch Med, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; Harvard Univ, Childrens Hosp,Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Capham, DE (corresponding author), Harvard Univ, Childresn Hosp,Sch Med, Howard Hughes Med Inst, Dept Cardiol, 1309 Enders Bldg,320 Longwood Ave, Boston, MA 02115 USA.		Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428; Runnels, Loren/0000-0002-2537-7360				BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Diggle TA, 1999, FEBS LETT, V457, P189, DOI 10.1016/S0014-5793(99)01034-0; FUTEY LM, 1995, J BIOL CHEM, V270, P523, DOI 10.1074/jbc.270.2.523; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Levitan IB, 1999, ADV SEC MESS PHOSPH, V33, P3; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448	12	577	599	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					1043	1047		10.1126/science.1058519	http://dx.doi.org/10.1126/science.1058519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11161216				2022-12-24	WOS:000166860100045
J	Kawaguchi, K; Ishiwata, S				Kawaguchi, K; Ishiwata, S			Nucleotide-dependent single- to double-headed binding of kinesin	SCIENCE			English	Article							DIMERIC KINESIN; OPTICAL TWEEZERS; ATP HYDROLYSIS; MICROTUBULES; MOLECULES; MECHANISM; MOVEMENT; MOTILITY; FORCE; SITE	The motility of kinesin motors is explained by a "hand-over-hand" model in which two heads of kinesin alternately repeat single-headed and double-headed binding with a microtubule. To investigate the binding mode of kinesin at the key nucleotide states during adenosine 5'-triphosphate (ATP) hydrolysis, we measured the mechanical properties of a single kinesin-microtubule complex by applying an external Load with optical tweezers. Both the unbinding force and the elastic modulus in solutions containing AMP-PNP tan ATP analog) were twice the value of those in nucleotide-free solution or in the presence of both AMP-PNP and adenosine 5'-diphosphate, Thus, kinesin binds through two heads in the former and one head in the latter two states, which supports a major prediction of the hand-over-hand model.	Waseda Univ, Sch Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698585, Japan; Waseda Univ, Adv Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698585, Japan; Waseda Univ, Mat Res Lab Biosci & Photon, Shinjuku Ku, Tokyo 1698585, Japan; CREST, Genet Programming Team 13, Miyamae Ku, Kawasaki, Kanagawa 2160001, Japan	Waseda University; Waseda University; Waseda University; Japan Science & Technology Agency (JST)	Ishiwata, S (corresponding author), Waseda Univ, Sch Sci & Engn, Dept Phys, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698585, Japan.	ishiwata@mn.waseda.ac.jp		Kawaguchi, Kenji/0000-0002-0791-0870				Arnal I, 1998, STRUCTURE, V6, P33, DOI 10.1016/S0969-2126(98)00005-7; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirose K, 1999, MOL BIOL CELL, V10, P2063, DOI 10.1091/mbc.10.6.2063; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; HYMAN AA, 1991, J CELL SCI, P125; Kawaguchi K, 2000, BIOCHEM BIOPH RES CO, V272, P895, DOI 10.1006/bbrc.2000.2856; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; LOCKHART A, 1995, J MOL BIOL, V249, P763, DOI 10.1006/jmbi.1995.0335; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Mandelkow E, 1998, TRENDS BIOCHEM SCI, V23, P429, DOI 10.1016/S0968-0004(98)01278-X; NISHIZAKA T, 1995, NATURE, V377, P251, DOI 10.1038/377251a0; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; SCHNAPP BJ, 1990, P NATL ACAD SCI USA, V87, P10053, DOI 10.1073/pnas.87.24.10053; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Thormahlen' M, 1998, J MOL BIOL, V275, P795, DOI 10.1006/jmbi.1997.1503; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; VALE RD, 1999, GUIDEBOOK CYTOSKELET, P398; Vugmeyster Y, 1998, BIOCHEMISTRY-US, V37, P747, DOI 10.1021/bi971534o	26	106	109	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2001	291	5504					667	669		10.1126/science.291.5504.667	http://dx.doi.org/10.1126/science.291.5504.667			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11158681				2022-12-24	WOS:000166616000048
J	Ullian, EM; Sapperstein, SK; Christopherson, KS; Barres, BA				Ullian, EM; Sapperstein, SK; Christopherson, KS; Barres, BA			Control of synapse number by glia	SCIENCE			English	Article							TRANSMITTER RELEASE; SUPERIOR COLLICULUS; RAT; SYNAPTOGENESIS; HIPPOCAMPUS; EXOCYTOSIS	Although astrocytes constitute nearly half of the cells in our brain, their function is a Long-standing neurobiological mystery. Here we show by quantal analyses, FM1-43 imaging, immunostaining, and electron microscopy that few synapses form in the absence of glial cells and that the few synapses that do form are functionally immature. Astrocytes increase the number of mature, functional synapses on central nervous system (CNS) neurons by sevenfold and are required for synaptic maintenance in vitro, We also show that most synapses are generated concurrently with the development of glia in vivo. These data demonstrate a previously unknown function for glia in inducing and stabilizing CNS synapses, show that CNS synapse number can be profoundly regulated by nonneuronal signals, and raise the possibility that glia may actively participate in synaptic plasticity.	Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA	Stanford University	Ullian, EM (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Fairchild Sci Bldg, Stanford, CA 94305 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NINDS NIH HHS [NS10784] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bergles DE, 1998, J NEUROSCI, V18, P7709; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Capogna M, 1996, J NEUROPHYSIOL, V76, P3149, DOI 10.1152/jn.1996.76.5.3149; CHRISTOPHERSON K, UNPUB; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HAYDON PG, 1995, TRENDS NEUROSCI, V18, P196, DOI 10.1016/0166-2236(95)93901-9; KATZ B, 1979, PROC R SOC SER B-BIO, V205, P369, DOI 10.1098/rspb.1979.0070; Lonart G, 1998, NEURON, V21, P1141, DOI 10.1016/S0896-6273(00)80631-5; LUND RD, 1972, BRAIN RES, V42, P1, DOI 10.1016/0006-8993(72)90038-8; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schikorski T, 1997, J NEUROSCI, V17, P5858; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; ULLIAN E, UNPUB; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; WARTON SS, 1989, SYNAPSE, V3, P136, DOI 10.1002/syn.890030205; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	24	973	1056	5	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2001	291	5504					657	661		10.1126/science.291.5504.657	http://dx.doi.org/10.1126/science.291.5504.657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11158678				2022-12-24	WOS:000166616000045
J	Lindsay, R; Silverman, SL; Cooper, C; Hanley, DA; Barton, I; Broy, SB; Licata, A; Benhamou, L; Geusens, P; Flowers, K; Stracke, H; Seeman, E				Lindsay, R; Silverman, SL; Cooper, C; Hanley, DA; Barton, I; Broy, SB; Licata, A; Benhamou, L; Geusens, P; Flowers, K; Stracke, H; Seeman, E			Risk of new vertebral fracture in the year following a fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WOMEN; OSTEOPOROSIS	Context Vertebral fractures significantly increase lifetime risk of future fractures, but risk of further vertebral fractures in the period immediately following a vertebral fracture has not been evaluated. Objective To determine the incidence of further vertebral fracture in the year following a vertebral fracture. Design and setting Analysis of data from 4 large 3-year osteoporosis treatment trials conducted at 373 study centers in North America, Europe, Australia, and New Zealand from November 1993 to April 1998. Subjects Postmenopausal women who had been randomized to a placebo group and for whom vertebral fracture status was known at entry (n=2725). Main Outcome Measure Occurrence of radiographically identified vertebral fracture during the year following an incident vertebral fracture. Results Subjects were a mean age of 74 years and had a mean of 28 years since menopause. The cumulative incidence of new vertebral fractures in the first year was 6.6%. Presence of 1 or more vertebral fractures at baseline increased risk of sustaining a vertebral fracture by 5-fold during the initial year of the study compared with the incidence in subjects without prevalent vertebral fractures at baseline (relative risk [RR], 5.1;95% confidence interval [CI], 3.1-8.4; P<.001). Among the 381 participants who developed an incident vertebral fracture, the incidence of a new vertebral fracture in the subsequent year was 19.2% (95% CI, 13.6%-24.8%). This risk was also increased in the presence of prevalent vertebral fractures (RR, 9.3; 95% CI, 1.2-71.6; P=.03). Conclusion Our data indicate that women who develop a vertebral fracture are at substantial risk for additional fracture within the next year.	Helen Hayes Hosp, Reg Bone Ctr, W Haverstraw, NY 10993 USA; Cedars Sinai Med Ctr, Osteoporosis Med Ctr, Los Angeles, CA 90048 USA; Greater Los Angeles VA Hlth Syst, Los Angeles, CA USA; Univ Southampton, MRC, Environm Epidemiol Unit, Southampton, Hants, England; Univ Calgary, Hlth Sci Ctr, Calgary, AB, Canada; Procter & Gamble Pharmaceut, Staines, Middx, England; Illinois Bone & Joint Inst, Ctr Arthrit & Osteoporosis, Des Plaines, IL USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Ctr Hosp Orleans, Orleans, France; Limburgs Univ Ctr, Diepenbeek, Belgium; Univ Maastricht, Maastricht, Netherlands; Procter & Gamble Co, Cincinnati, OH USA; Univ Giessen, Giessen, Germany; Univ Melbourne, Melbourne, Vic, Australia	Cedars Sinai Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Southampton; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; Procter & Gamble; Cleveland Clinic Foundation; Centre Hospitalier Regional d'Orleans; Hasselt University; Maastricht University; Procter & Gamble; Justus Liebig University Giessen; University of Melbourne	Lindsay, R (corresponding author), Helen Hayes Hosp, Reg Bone Ctr, Route 9W, W Haverstraw, NY 10993 USA.		Seeman, Ego/AAC-3656-2019	Seeman, Ego/0000-0002-9692-048X; Cooper, Cyrus/0000-0003-3510-0709				Black DM, 1999, J BONE MINER RES, V14, P821, DOI 10.1359/jbmr.1999.14.5.821; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; KANIS JA, 1984, LANCET, V1, P27; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; LAURITZEN JB, 1993, ACTA ORTHOP SCAND, V64, P297, DOI 10.3109/17453679308993629; Melton LJ, 1999, OSTEOPOROSIS INT, V10, P214, DOI 10.1007/s001980050218; Miller P, 1999, ARTHRITIS RHEUM, V42, pS287; Nevitt MC, 2000, ARCH INTERN MED, V160, P77, DOI 10.1001/archinte.160.1.77; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; ROSS PD, 1991, ANN INTERN MED, V114, P919, DOI 10.7326/0003-4819-114-11-919; ROSS PD, 1993, OSTEOPOROSIS INT, V3, P120, DOI 10.1007/BF01623272; Ross Philip D., 1997, American Journal of Medicine, V103, p30S, DOI 10.1016/S0002-9343(97)90025-5	14	1193	1285	0	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 17	2001	285	3					320	323		10.1001/jama.285.3.320	http://dx.doi.org/10.1001/jama.285.3.320			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390XD	11176842	Green Published, Bronze			2022-12-24	WOS:000166324300023
J	Khaw, KT; Wareham, N; Luben, R; Bingham, S; Oakes, S; Welch, A; Day, N				Khaw, KT; Wareham, N; Luben, R; Bingham, S; Oakes, S; Welch, A; Day, N			Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; IMPAIRED GLUCOSE-TOLERANCE; RISK-FACTOR; CARDIOVASCULAR-DISEASE; GLYCOSYLATED HEMOGLOBIN; PLASMA-GLUCOSE; BLOOD-GLUCOSE; EPIC-NORFOLK; ALL-CAUSE; MELLITUS	Objective To examine the value of glycated haemoglobin (HbA(1c)) concentration, a marker of blood glucose concentration, as a predictor of death from cardiovascular and all causes in men. Design Prospective population study. Setting Norfolk cohort of European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk). Subjects 4662 men aged 45-79 years who had had glycated haemoglobin measured at the baseline survey in-1995-7 who were followed up to December 1999. Main outcome measures Mortality from all causes, cardiovascular disease, ischaemic heart disease, and other causes. Results Men with known diabetes had increased mortality: from all causes, cardiovascular disease, and ischaemic disease (relative risks 2.2, 3.3, and 4.2, respectively, P < 0.001 independent of age and other risk factors) compared with men without known diabetes. The increased risk of death among men with diabetes was largely explained by HbA(1c) concentration. HbA(1c) was continuously related to subsequent all cause, cardiovascular, and ischaemic heart disease mortality through the whole population distribution, with lowest rates in those with HbA(1c) concentrations below 5%. An increase of 1% in HbA(1c) was associated with a 28% (P < 0.002) increase in risk of death independent of age, blood pressure, serum cholesterol, body mass index, and cigarette smoking habit; this effect remained (relative risk 1.46, P = 0.05 adjusted for age and risk factors) after men with known diabetes, a HbA(1c) concentration greater than or equal to 7%, or history of myocardial infarction or stroke were excluded. 18% of the population excess mortality risk associated with a HbA(1c) concentration greater than or equal to5% occurred in men with diabetes, but 82% occurred in men with concentrations of 5%-6.9% (the majority of the population). Conclusions Glycated haemoglobin concentration seems to explain most of the excess mortality risk of diabetes in men and to be a continuous risk factor through the whole population distribution. Preventive efforts need to consider not just chose with established diabetes but whether it is possible to reduce the population distribution of HbA(1c) through behavioural means.	Univ Cambridge, Sch Clin Med, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Khaw, KT (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Box 251, Cambridge CB2 2QQ, England.	kk101@medschl.cam.ac.uk	Luben, Robert N/H-5519-2015; Welch, Ailsa Ann/A-4850-2008; Khaw, Kay-Tee/AAZ-3209-2021	Luben, Robert N/0000-0002-5088-6343; Welch, Ailsa Ann/0000-0002-6702-3704; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I; [Anonymous], 1996, DIABETES, V45, P1289; [Anonymous], 1995, DIABETES, V44, P968; [Anonymous], 2000, DIABETES CARE S1, V23, pS20; Barzilay JI, 1999, LANCET, V354, P622, DOI 10.1016/S0140-6736(98)12030-5; Borch-Johnsen K, 1999, LANCET, V354, P617; *BRIT CARD SOC, 1998, HEART, V2, pS1; BROWNLEE M, 1994, DIABETES, V43, P836, DOI 10.2337/diab.43.6.836; BUTLER WJ, 1985, AM J EPIDEMIOL, V121, P541; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; COX DR, 1972, J R STAT SOC B, V34, P187; Day N, 1999, BRIT J CANCER, V80, P95; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; DONAHUE RP, 1987, DIABETES, V36, P689, DOI 10.2337/diabetes.36.6.689; ESCHWEGE E, 1985, HORM METAB RES, V15, P41; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FULLER JH, 1980, LANCET, V1, P1373; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gerstein HC, 1997, DIABETIC MED, V14, pS25, DOI 10.1002/(SICI)1096-9136(199708)14:3+<S25::AID-DIA441>3.3.CO;2-T; Gregory J., 1990, DIETARY NUTR SURVEY; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HAMMAN RF, 1992, DIABETES METAB REV, V8, P287, DOI 10.1002/dmr.5610080402; HARRIS M, 1979, DIABETES, V28, P1039; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marshall SM, 2000, DIABETIC MED, V17, P5, DOI 10.1046/j.1464-5491.2000.00228.x; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; MOSS SE, 1994, ARCH INTERN MED, V154, P2473; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; OHLSON LO, 1986, DIABETIC MED, V3, P33, DOI 10.1111/j.1464-5491.1986.tb00702.x; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450; PYORALA K, 1985, ACTA MED SCAND, P38; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Sargeant LA, 2000, DIABETES CARE, V23, P726, DOI 10.2337/diacare.23.6.726; SCHEIDTNAVE C, 1991, AM J EPIDEMIOL, V133, P565, DOI 10.1093/oxfordjournals.aje.a115928; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shaw JE, 1999, DIABETOLOGIA, V42, P1050, DOI 10.1007/s001250051269; SINGER DE, 1992, DIABETES, V41, P202, DOI 10.2337/diabetes.41.2.202; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vitelli LL, 1997, DIABETES CARE, V20, P1454, DOI 10.2337/diacare.20.9.1454; Wareham NJ, 2000, AM J EPIDEMIOL, V152, P132, DOI 10.1093/aje/152.2.132; *WHO STUD GROUP, 1985, WHO TECH REP SER, V727, P9; Williams DEM, 1999, J CLIN EPIDEMIOL, V52, P329, DOI 10.1016/S0895-4356(99)00006-2; Wingard DL., 1995, DIABETES AM, P429; Wood D, 1998, EUR HEART J, V19, P1434	51	671	705	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2001	322	7277					15	18B		10.1136/bmj.322.7277.15	http://dx.doi.org/10.1136/bmj.322.7277.15			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EP	11141143	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000166341400016
J	Majeti, R; Xu, Z; Parslow, TG; Olson, JL; Daikh, DI; Killeen, N; Weiss, A				Majeti, R; Xu, Z; Parslow, TG; Olson, JL; Daikh, DI; Killeen, N; Weiss, A			An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SYSTEMIC LUPUS-ERYTHEMATOSUS; CELL ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; LYMPHOCYTE-ACTIVATION; THYMOCYTE DEVELOPMENT; CRYSTAL-STRUCTURE; STEM-CELLS; EXPRESSION; DIMERIZATION	A model has been proposed for the regulation of CD45, and by homology other RPTPs, in which dimerization inhibits phosphatase activity through symmetrical interactions between an inhibitory structural wedge and the catalytic site. Here, we report the phenotype of mice with a single point mutation, glutamate 613 to arginine, that inactivates the inhibitory wedge of CD45. The CD45 E613R mutation causes polyclonal lymphocyte activation leading to lymphoproliferation and severe autoimmune nephritis with autoantibody production, resulting in death. Both homozygotes and heterozygotes develop pathology, indicating genetic dominance of CD45 E613R. The dramatic phenotype of CD45 E613R mice demonstrates the in vivo importance of negative regulation of CD45 by dimerization, supporting the model for regulation of CD45, and RPTPs in general.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Weiss, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	aweiss@medicine.ucsf.edu			NIGMS NIH HHS [R01-GM39553] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039553] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKBAR AN, 1988, J IMMUNOL, V140, P2171; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; BIRKELAND ML, 1989, P NATL ACAD SCI USA, V86, P6734, DOI 10.1073/pnas.86.17.6734; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Cale CM, 1997, ARCH DIS CHILD, V76, P163, DOI 10.1136/adc.76.2.163; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; DESAI DM, 1993, CELL, V73, P541, DOI 10.1016/0092-8674(93)90141-C; Felberg J, 1998, J BIOL CHEM, V273, P17839, DOI 10.1074/jbc.273.28.17839; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Harley JB, 1998, CURR OPIN IMMUNOL, V10, P690, DOI 10.1016/S0952-7915(98)80090-3; Hoffmann KMV, 1997, J BIOL CHEM, V272, P27505, DOI 10.1074/jbc.272.44.27505; Hogan B, 1994, MANIPULATING MOUSE E; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; JUSTEMENT LB, 1991, SCIENCE, V252, P1839, DOI 10.1126/science.1648262; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; Kung C, 2000, NAT MED, V6, P343; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCCALL MN, 1992, IMMUNOLOGY, V76, P310; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Neel BG, 1997, CURR OPIN IMMUNOL, V9, P405, DOI 10.1016/S0952-7915(97)80088-X; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; ROTHGEB CL, 1984, BEHAV SOC SCI LIBR, V3, P1, DOI 10.1300/J103v03n04_01; Schaapveld R, 1997, MOL BIOL REP, V24, P247, DOI 10.1023/A:1006870016238; Seavitt JR, 1999, MOL CELL BIOL, V19, P4200; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; SOROKIN A, 1994, J BIOL CHEM, V269, P9752; STEINBERG AD, 1984, ANN INTERN MED, V100, P714, DOI 10.7326/0003-4819-100-5-714; TAKEDA A, 1992, J BIOL CHEM, V267, P16651; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; WEAVER CT, 1991, MOL CELL BIOL, V11, P4415, DOI 10.1128/MCB.11.9.4415; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; WOFSY D, 1985, J EXP MED, V161, P378, DOI 10.1084/jem.161.2.378	49	202	208	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2000	103	7					1059	1070		10.1016/S0092-8674(00)00209-9	http://dx.doi.org/10.1016/S0092-8674(00)00209-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163182	Bronze			2022-12-24	WOS:000166040600009
J	Ren, B; Robert, F; Wyrick, JJ; Aparicio, O; Jennings, EG; Simon, I; Zeitlinger, J; Schreiber, J; Hannett, N; Kanin, E; Volkert, TL; Wilson, CJ; Bell, SP; Young, RA				Ren, B; Robert, F; Wyrick, JJ; Aparicio, O; Jennings, EG; Simon, I; Zeitlinger, J; Schreiber, J; Hannett, N; Kanin, E; Volkert, TL; Wilson, CJ; Bell, SP; Young, RA			Genome-wide location and function of DNA binding proteins	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; REGULATED GENES; IDENTIFICATION; GROWTH; FUSION; GIC1	Understanding how DNA binding proteins control global gene expression and chromosomal maintenance requires knowledge of the chromosomal Locations at which these proteins function in vivo. We developed a microarray method that reveals the genome-wide Location of DNA-bound proteins and used this method to monitor binding of gene-specific transcription activators in yeast. A combination of location and expression profiles was used to identify genes whose expression is directly controlled by Gal4 and Ste12 as cells respond to changes in carbon source and mating pheromone, respectively. The results identify pathways that are coordinately regulated by each of the two activators and reveal previously unknown functions for Gal4 and Ste12. Genome-wide Location analysis will facilitate investigation of gene regulatory networks, gene function, and genome maintenance.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ So Calif, Program Mol Biol, Los Angeles, CA 90089 USA; Corning Inc, Corning, NY 14834 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Southern California; Corning Inc; State University of New York (SUNY) System; SUNY Community College	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Robert, Francois/D-2316-2012; Rosa, Bruce/F-6393-2010; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Wilson, Christopher/0000-0002-9146-522X; Bell, Stephen/0000-0002-2876-610X; Simon, Itamar/0000-0002-8517-1903; Aparicio, Oscar/0000-0002-5591-0277				Brown JL, 1997, GENE DEV, V11, P2972, DOI 10.1101/gad.11.22.2972; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; CHASMAN DI, 1990, GENE DEV, V4, P503, DOI 10.1101/gad.4.4.503; Chen GC, 1997, GENE DEV, V11, P2958, DOI 10.1101/gad.11.22.2958; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Erdman S, 1998, J CELL BIOL, V140, P461, DOI 10.1083/jcb.140.3.461; FUJIMURA H, 1990, CURR GENET, V18, P395, DOI 10.1007/BF00309907; Huang DQ, 1998, MOL CELL BIOL, V18, P3289, DOI 10.1128/MCB.18.6.3289; JOHNSTON M, 1992, MOL CELLULAR BIOL YE, V2, P193; JUND R, 1988, EUR J BIOCHEM, V171, P417, DOI 10.1111/j.1432-1033.1988.tb13806.x; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; KONOPKA JB, 1993, MOL CELL BIOL, V13, P6876, DOI 10.1128/MCB.13.11.6876; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; MARSH L, 1997, MOL CELLULAR BIOL YE, V3, P827; MCCAFFREY G, 1987, MOL CELL BIOL, V7, P2680, DOI 10.1128/MCB.7.8.2680; Olson KA, 2000, MOL CELL BIOL, V20, P4199, DOI 10.1128/MCB.20.12.4199-4209.2000; ORLANDO, 2000, TRENDS BIOCH SCI, V25, P99; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; ROY A, 1991, MOL CELL BIOL, V11, P4196, DOI 10.1128/MCB.11.8.4196; Schmidt MC, 1999, MOL CELL BIOL, V19, P4561; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SPRAGUE GF, 1992, MOL CELLULAR BIOL YE, V2, P657; TRUEHEART J, 1987, MOL CELL BIOL, V7, P2316, DOI 10.1128/MCB.7.7.2316	27	1487	1599	6	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2000	290	5500					2306	+		10.1126/science.290.5500.2306	http://dx.doi.org/10.1126/science.290.5500.2306			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125145				2022-12-24	WOS:000165995800045
J	Ebell, MH; Smith, MA; Barry, HC; Ives, K; Carey, M				Ebell, MH; Smith, MA; Barry, HC; Ives, K; Carey, M			Does this patient have strep throat?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STREPTOCOCCAL PHARYNGITIS; SORE THROAT; SCORING SYSTEM; RHEUMATIC-FEVER; DIAGNOSIS; ADULTS; MANAGEMENT; PREVENTION; PREVALENCE; PREDICTION	Context Sore throat is a common complaint, and identifying patients with group A P-hemolytic streptococcal pharyngitis (strep throat) is an important task for clinicians. Previous reviews have not systematically reviewed and synthesized the evidence. Objective To review the precision and accuracy of the clinical examination in diagnosing strep throat. Data Source MEDLINE search for articles about diagnosis of strep throat using history-taking and physical examination. Study Selection Large blinded, prospective studies (having greater than or equal to 300 patients with sore throat) reporting history and physical examination data and using throat culture as the reference standard were included. Of 917 articles identified by the search, 9 met ail inclusion criteria. Data Extraction Pairs of authors independently reviewed each article and used consensus to resolve discrepancies. Data Synthesis The most useful findings for evaluating the likelihood of strep throat are presence of tonsillar exudate, pharyngeal exudate, or exposure to strep throat infection in the previous 2 weeks (positive likelihood ratios, 3.4, 2.1, and 1.9, respectively) and the absence of tender anterior cervical nodes, tonsillar enlargement, or exudate (negative likelihood ratios, 0.60, 0.63, and 0.74, respectively). No individual element of history-taking or physical examination is accurate enough by itself to rule in or rule out strep throat. Three validated clinical prediction rules are described for adult and pediatric populations. Conclusions While no single element of history-taking or physical examination is sufficiently accurate to exclude or diagnose strep throat, a well-validated clinical prediction rule can be useful and can help physicians make more informed use of rapid antigen tests and throat cultures.	Michigan State Univ, Dept Family Practice, Clin Ctr B101, E Lansing, MI 48824 USA; First Consulting Grp, Okemos, MI USA	Michigan State University	Ebell, MH (corresponding author), Michigan State Univ, Dept Family Practice, Clin Ctr B101, E Lansing, MI 48824 USA.		Barry, Henry C/A-9057-2009	Barry, Henry C/0000-0001-6135-9349				BISNO AL, 1995, PRINCIPLES PRACTICE; BREESE BB, 1977, AM J DIS CHILD, V131, P514, DOI 10.1001/archpedi.1977.02120180028003; BREESE BB, 1961, J PEDIATR, P670; *CDCP, 1998, MMWR-MORBID MORTAL W, V46, P1; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; CENTOR RM, 1986, ANN INTERN MED, V105, P892, DOI 10.7326/0003-4819-105-6-892; CLANCY CM, 1988, J GEN INTERN MED, V3, P213, DOI 10.1007/BF02596334; CRAWFORD G, 1979, ANN INTERN MED, V90, P293, DOI 10.7326/0003-4819-90-3-293; DAJANI A, 1995, PEDIATRICS, V96, P758; DENNY FW, 1985, PEDIATR INFECT DIS J, V4, P352, DOI 10.1097/00006454-198507000-00003; Dobbs F, 1996, BRIT J GEN PRACT, V46, P461; FOONG BB, 1992, SINGAPORE MED J, V33, P597; FUNAMURA JL, 1983, CLIN PEDIATR, V22, P622, DOI 10.1177/000992288302200906; Gunnarsson RK, 1997, SCAND J PRIM HEALTH, V15, P149, DOI 10.3109/02813439709018506; Hoffmann Steen, 1992, Scandinavian Journal of Primary Health Care, V10, P295, DOI 10.3109/02813439209014077; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; KAHAN E, 1995, PUBLIC HEALTH, V109, P347, DOI 10.1016/S0033-3506(95)80006-9; KAPLAN EL, 1971, J INFECT DIS, V123, P490, DOI 10.1093/infdis/123.5.490; KARDAUN JWPF, 1990, METHOD INFORM MED, V29, P12; KLJAKOVIC M, 1993, NEW ZEAL MED J, V106, P381; KOMAROFF AL, 1986, J GEN INTERN MED, V1, P1, DOI 10.1007/BF02596317; KOMAROFF AL, 1983, SCIENCE, V222, P927, DOI 10.1126/science.6415813; Kreher NE, 1998, J FAM PRACTICE, V46, P159; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McIsaac WJ, 1998, MED DECIS MAKING, V18, P220, DOI 10.1177/0272989X9801800211; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; MELAND E, 1993, SCAND J INFECT DIS, V25, P177, DOI 10.3109/00365549309008482; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121403; *NAT CTR HLTH STAT, 1995, CEDROM SER, V13; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Pichichero M, 1999, ARCH PEDIAT ADOL MED, V153, P672, DOI 10.1001/archpedi.153.7.672; PICHICHERO ME, 1992, PEDIATR ANN, V21, P789; POSES RM, 1986, ANN INTERN MED, V105, P586, DOI 10.7326/0003-4819-105-4-586; REED BD, 1990, ARCH INTERN MED, V150, P1727, DOI 10.1001/archinte.150.8.1727; SEPPALA H, 1993, ARCH OTOLARYNGOL, V119, P288; SNELLMAN L, 1993, PEDIATRICS, V96, P758; Steinhoff MC, 1997, LANCET, V350, P918, DOI 10.1016/S0140-6736(97)03317-5; STILLERMAN M, 1961, AM J DIS CHILD, V101, P476, DOI 10.1001/archpedi.1961.04020050066011; TOMPKINS RK, 1977, ANN INTERN MED, V86, P481, DOI 10.7326/0003-4819-86-4-481; WALSH BT, 1975, ARCH INTERN MED, V135, P1493, DOI 10.1001/archinte.135.11.1493; Webb KH, 2000, J FAM PRACTICE, V49, P34; WIGTON RS, 1986, ARCH INTERN MED, V146, P81, DOI 10.1001/archinte.146.1.81	42	201	221	1	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2000	284	22					2912	2918		10.1001/jama.284.22.2912	http://dx.doi.org/10.1001/jama.284.22.2912			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380RJ	11147989				2022-12-24	WOS:000165717000032
J	Talbot, EA; Moore, M; McCray, E; Binkin, NJ				Talbot, EA; Moore, M; McCray, E; Binkin, NJ			Tuberculosis among foreign-born persons in the United States, 1993-1998	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMIGRANTS; EPIDEMIOLOGY; REFUGEES; CHILDREN; COUNTY	Context Immigration is a major force sustaining the incidence of tuberculosis (TB) in the United States. Objective To describe trends and characteristics of foreign-born persons with TB and the implications for TB program planning and policy development. Design, setting, and subjects Descriptive analysis of US TB surveillance data from case reports submitted from 1993 to 1998. Main Outcome Measure Demographic and clinical characteristics of foreign-born persons with TB, Results The number of TB cases among foreign-born persons increased 2.6%, from 7402 in 1993 to 7591 in 1998, and the proportion of US cases that were foreign-born increased from 29.8% to 41.6%. During 1993-1998, the TB case rate was 32.9 per 100 000 population in foreign-born persons compared with 5.8 per 100 000 in US-born persons. Six states reported 73.4% of foreign-born cases (California, New York, Texas, Florida, New Jersey, and illinois). Approximately two thirds of these cases were originally from Mexico, the Philippines, Vietnam, India, China, Haiti, and South Korea. Among those for whom date of US entry was known, 51.5% arrived 5 years or less prior to the diagnosis of TB. Most were male and aged 25 to 44 years. During 1993-1996, the proportion receiving some portion of treatment under directly observed therapy increased from 27.3% to 59.1% and approximately 70% completed therapy in 12 months. The rate of primary resistance to isoniazid was 11.6% and to both isoniazid and rifampin was 1.7%. Conclusions As the United States moves toward the goal of TB elimination, success will depend increasingly on reducing the impact of TB in foreign-born persons. Continued efforts to tailor local TB control strategies to the foreign-born community and commitment to the global TB battle are essential.	Ctr Dis Control & Prevent, Surveillance & Epidemiol Branch, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Moore, M (corresponding author), Ctr Dis Control & Prevent, Surveillance & Epidemiol Branch, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Mail Stop E-10, Atlanta, GA 30333 USA.	MMoore@cdc.gov						[Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779; Binkin NJ, 1996, CLIN INFECT DIS, V23, P1226, DOI 10.1093/clinids/23.6.1226; CDC, 1999, MMWR-MORBID MORTAL W, V48, P1; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P40; *CDCP, 2000, REP TUB US 1998; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P656; *CDCP, 1993, MMWR-MORBID MORTAL W, V42, P628; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P732; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P1032; Childs James E., 1993, Morbidity and Mortality Weekly Report, V42, P1; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; *DIV TB EL CDCP, 1998, TUB INF MAN SYST TIM; DRIVER CR, 1995, PEDIATR INFECT DIS J, V14, P112, DOI 10.1097/00006454-199502000-00006; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; HALL CB, 1994, PEDIATRICS, V93, P131; Jasmer RM, 1997, INT J TUBERC LUNG D, V1, P536; KENYON TA, 1995, TUBERC LUNG DIS S, V76, P52; MCKENNA MT, 1995, NEW ENGL J MED, V332, P1071, DOI 10.1056/NEJM199504203321606; McKenna MT, 1998, AM J PUBLIC HEALTH, V88, P1059, DOI 10.2105/AJPH.88.7.1059; Moore M, 1997, JAMA-J AM MED ASSOC, V278, P833, DOI 10.1001/jama.278.10.833; ORR PH, 1990, CAN MED ASSOC J, V142, P453; PICKERING LK, 2000, 2000 RED BOOK REPORT, P593; Sciortino S, 1999, INT J TUBERC LUNG D, V3, P778; STEHRGREEN JK, 1992, NEW ZEAL MED J, V105, P301; TOMIEPORTH NG, 1997, INT J TUBERC LUNG D, V1, P528; *US BUR CENS, 2000, NAT POP EST NAT; Ussery XT, 1996, PEDIATR INFECT DIS J, V15, P697, DOI 10.1097/00006454-199608000-00013; Wells CD, 1997, AM J RESP CRIT CARE, V156, P573, DOI 10.1164/ajrccm.156.2.9611101; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304; Zuber PLF, 1996, TUBERCLE LUNG DIS, V77, P524, DOI 10.1016/S0962-8479(96)90050-7; Zuber PLF, 1996, AM J RESP CRIT CARE, V154, P151, DOI 10.1164/ajrccm.154.1.8680671	33	125	129	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2000	284	22					2894	2900		10.1001/jama.284.22.2894	http://dx.doi.org/10.1001/jama.284.22.2894			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380RJ	11147986	Bronze			2022-12-24	WOS:000165717000029
J	Bonneux, L				Bonneux, L			Cholesterol-lowering therapy for smokers and non-smokers: a life-table analysis	LANCET			English	Editorial Material							CORONARY HEART-DISEASE; PRIMARY PREVENTION; TASK-FORCE; RISK; MORTALITY; SMOKING; MEN; WOMEN		Erasmus Univ, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam	Bonneux, L (corresponding author), Erasmus Univ, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.							ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Califf RM, 1996, J AM COLL CARDIOL, V27, P1007, DOI 10.1016/0735-1097(96)87733-3; *CENTR GOV BOD INT, 1998, TREATM PREV COR HEAR; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; HAQ IU, 1995, LANCET, V346, P1467, DOI 10.1016/S0140-6736(95)92477-9; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; PETO R, 1994, BRIT MED J, V309, P937, DOI 10.1136/bmj.309.6959.937; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pharoah PDP, 1996, BMJ-BRIT MED J, V312, P1443, DOI 10.1136/bmj.312.7044.1443; Prescott E, 1998, INT J EPIDEMIOL, V27, P27, DOI 10.1093/ije/27.1.27; PYORALA K, 1994, EUR HEART J, V15, P1300; Ramsay LE, 1996, LANCET, V348, P387, DOI 10.1016/S0140-6736(96)05516-X; ROGERS RG, 1991, SOC SCI MED, V32, P1151, DOI 10.1016/0277-9536(91)90092-Q; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Smith R, 1999, BRIT MED J, V319, P936, DOI 10.1136/bmj.319.7215.936; *STAND MED ADV COM, 1997, US STAT; TSEVAT J, 1991, CIRCULATION, V83, P1194, DOI 10.1161/01.CIR.83.4.1194	18	7	7	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 9	2000	356	9246					2004	2006		10.1016/S0140-6736(00)03319-5	http://dx.doi.org/10.1016/S0140-6736(00)03319-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383DJ	11130539				2022-12-24	WOS:000165867600041
J	Ranganathan, R; Cannon, SC; Horvitz, HR				Ranganathan, R; Cannon, SC; Horvitz, HR			MOD-1 is a serotonin-gated chloride channel that modulates locomotory behaviour in C. elegans	NATURE			English	Article							XENOPUS-LAEVIS OOCYTES; NICOTINIC ACETYLCHOLINE-RECEPTOR; CAENORHABDITIS-ELEGANS; MEDICINAL LEECH; ION CURRENTS; NEURONS; EXPRESSION; MUTATIONS; GENETICS; SUBUNIT	The neurotransmitter and neuromodulator serotonin (5-HT) functions by binding either to metabotropic G-protein-coupled receptors (for example, 5-HT1, 5-HT2, 5-HT4 to 5-HT7), which mediate 'slow' modulatory responses through numerous second messenger pathways(1), or to the ionotropic 5-HT3 receptor, a non-selective cation channel that mediates 'fast' membrane depolarizations(2). Here we report that the gene mod-1 (for modulation of locomotion defective) from the nematode Caenorhabditis elegans encodes a new type of ionotropic 5-HT receptor, a 5-HT-gated chloride channel. The predicted MOD-1 protein is similar to members of the nicotinic acetylcholine receptor family of ligand-gated ion channels, in particular to GABA (gamma -aminobutyric acid)- and glycine-gated chloride channels. The MOD-1 channel has distinctive ion selectivity and pharmacological properties. The reversal potential of the MOD-1 channel is dependent on the concentration of chloride ions but not of cations. The MOD-1 channel is not blocked by calcium ions or 5-HT3a-specific antagonists but is inhibited by the metabotropic 5-HT receptor antagonists mianserin and methiothepin. mod-1 mutant animals are defective in a 5-HT-mediated experience-dependent behaviour(3) and are resistant to exogenous 5-HT, confirming that MOD-1 functions as a 5-HT receptor in vivo.	MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Horvitz, HR (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Room 68-425,77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu	Cannon, Stephen/V-5343-2019	Cannon, Stephen/0000-0001-8428-3690				Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; Aizenberg D, 1997, CLIN NEUROPHARMACOL, V20, P210, DOI 10.1097/00002826-199706000-00004; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Cooper J.R., 1996, BIOCH BASIS NEUROPHA, Vseventh; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; DOWNIE DL, 1994, NEUROPHARMACOLOGY, V33, P473, DOI 10.1016/0028-3908(94)90078-7; Granas C, 1999, EUR J PHARMACOL, V380, P171, DOI 10.1016/S0014-2999(99)00520-8; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; Hayward LJ, 1996, J GEN PHYSIOL, V107, P559, DOI 10.1085/jgp.107.5.559; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; LESSMANN V, 1991, J NEUROSCI, V11, P800; LESSMANN V, 1995, J NEUROSCI, V15, P1496; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Martin GR, 1998, TRENDS PHARMACOL SCI, V19, P2, DOI 10.1016/S0165-6147(97)01143-7; MCCLINTOCK TS, 1989, P NATL ACAD SCI USA, V86, P8137, DOI 10.1073/pnas.86.20.8137; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morrill JA, 1999, J PHYSIOL-LONDON, V520, P321, DOI 10.1111/j.1469-7793.1999.00321.x; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; SUMIKAWA K, 1992, J BIOL CHEM, V267, P6286; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2	30	169	181	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 23	2000	408	6811					470	475		10.1038/35044083	http://dx.doi.org/10.1038/35044083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100728				2022-12-24	WOS:000165429800048
J	Scully, R; Livingston, DM				Scully, R; Livingston, DM			In search of the tumour-suppressor functions of BRCA1 and BRCA2	NATURE			English	Article							TRANSCRIPTIONAL ACTIVATION; DNA-DAMAGE; MEIOTIC CELLS; GENE BRCA1; STRAND; REPAIR; BREAST; ATM; PHOSPHORYLATION; PRODUCT	Hereditary breast and ovarian cancer syndromes can be caused by loss-of-function germline mutations in one of two tumour-suppressor genes, BRCA1 and BRCA2 (ref. 1). Each gene product interacts with recombination/DNA repair proteins in pathways that participate in preserving intact chromosome structure. However, it is unclear to what extent such functions specifically suppress breast and ovarian cancer. Here we analyse what is known of BRCA gene function and highlight some unanswered questions in the field.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Livingston, DM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Scully, Ralph/F-5008-2013		NATIONAL CANCER INSTITUTE [K01CA079576] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA079576-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Brown EJ, 2000, GENE DEV, V14, P397; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Cordeiro-Stone M, 1999, J MOL BIOL, V289, P1207, DOI 10.1006/jmbi.1999.2847; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Deng CX, 2000, ONCOGENE, V19, P1059, DOI 10.1038/sj.onc.1203269; Fishman J, 1995, ANN NY ACAD SCI, V768, P91, DOI 10.1111/j.1749-6632.1995.tb12113.x; FORNACE AJ, 1983, NATURE, V304, P552, DOI 10.1038/304552a0; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Henikoff S, 1997, CURR OPIN CELL BIOL, V9, P388, DOI 10.1016/S0955-0674(97)80012-9; Irminger-Finger I, 1999, BIOL CHEM, V380, P117, DOI 10.1515/BC.1999.019; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Le Page F, 2000, CANCER RES, V60, P5548; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; SCULLY R, IN PRESS ONCOGENE; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Snouwaert JN, 1999, ONCOGENE, V18, P7900, DOI 10.1038/sj.onc.1203334; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; TIBBETTS RS, IN PRESS GENES DEV; TOKUNAGA M, 1979, J NATL CANCER I, V62, P1347; Wang Y, 2000, GENE DEV, V14, P927; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; Wolden SL, 1998, J CLIN ONCOL, V16, P536, DOI 10.1200/JCO.1998.16.2.536; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430	42	518	550	1	77	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2000	408	6811					429	432		10.1038/35044000	http://dx.doi.org/10.1038/35044000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100717	Green Accepted			2022-12-24	WOS:000165429800037
J	Hendrie, HC; Ogunniyi, A; Hall, KS; Baiyewu, O; Unverzagt, FW; Gureje, O; Gao, SJ; Evans, RM; Ogunseyinde, AO; Adeyinka, AO; Musick, B; Hui, SL				Hendrie, HC; Ogunniyi, A; Hall, KS; Baiyewu, O; Unverzagt, FW; Gureje, O; Gao, SJ; Evans, RM; Ogunseyinde, AO; Adeyinka, AO; Musick, B; Hui, SL			Incidence of dementia and Alzheimer disease in 2 communities - Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COGNITIVE DECLINE; RISK-FACTORS; OLD-OLD; POPULATION; AGE; PREVALENCE; DIAGNOSIS; SAMPLE; METAANALYSIS; PERFORMANCE	Context Alzheimer disease (AD) represents a major and increasing public health problem. If populations were identified with significantly lower or higher incidence rates of AD, the search for risk factors in the genesis of AD could be greatly enhanced. Objective To compare incidence rates of dementia and AD in 2 diverse, elderly community-dwelling populations. Design The Indianapolis-Ibadan Dementia Project, a longitudinal, prospective population-based study consisting of a baseline survey (1992-1993) and 2 subsequent follow-up waves after 2 years (1994-1995) and 5 years (1997-1998). Each wave followed a 2-stage design, with an in-home screening interview followed by a full diagnostic workup of a subsample of participants based on screening performance. Setting and Participants A total of 2459 community-dwelling Yoruba residents of Ibadan, Nigeria, without dementia, and 2147 community-dwelling African American residents of Indianapolis, Ind, without dementia (all aged 65 years or older). The cohorts were followed up for a mean of 5.1 years and 4.7 years, respectively. Main Outcome Measures Incident cases of dementia and AD in each of the 2 populations. Results The age-standardized annual incidence rates were significantly lower among Yoruba than among African Americans for dementia (Yoruba, 1.35% [95% confidence interval {Cl}, 1.13%-1.56%]; African Americans, 3.24% [95% CI, 2.11%-4.38%]) and for AD (Yoruba, 1.15% [95% CI, 0.96%-1.35%]; African Americans, 2.52% [95% CI, 1.40%-3.64%]). Conclusion This is the first report of incidence rate differences for dementia and AD in studies of 2 populations from nonindustrialized and industrialized countries using identical methods and the same group of investigators in both sites. Further explorations of these population differences may identify potentially modifiable environmental or genetic factors to account for site differences in dementia and AD.	Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; Indiana Univ, Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Regenstrief Inst, Indianapolis, IN USA; Univ Ibadan, Dept Med, Ibadan, Nigeria; Univ Ibadan, Dept Radiol, Ibadan, Nigeria	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; University of Ibadan; University of Ibadan	Hendrie, HC (corresponding author), Indiana Univ, Sch Med, Dept Psychiat, 541 Clin Dr,Room 394A, Indianapolis, IN 46202 USA.		Gureje, Oye/J-1183-2014	Gureje, Oye/0000-0003-0094-5947	NIA NIH HHS [R01 AGO9956] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG009956] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aevarsson O, 1996, J AM GERIATR SOC, V44, P1455, DOI 10.1111/j.1532-5415.1996.tb04070.x; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; ARONSON MK, 1991, ARCH INTERN MED, V151, P989, DOI 10.1001/archinte.1991.00400050129024; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; BOOTHBY H, 1994, PSYCHOL MED, V24, P89, DOI 10.1017/S0033291700026866; BRAYNE C, 1995, BRIT J PSYCHIAT, V167, P255, DOI 10.1192/bjp.167.2.255; Brayne C, 1999, J AM GERIATR SOC, V47, P1283, DOI 10.1111/j.1532-5415.1999.tb07426.x; Breslow NE, 1989, STAT METHODS CANC RE; BRETELER MMB, 1999, EPIDEMIOLOGY ALZHEIM, P79; CORRADA M, 1995, INT J EPIDEMIOL, V24, P1000, DOI 10.1093/ije/24.5.1000; Di Bari M, 1999, J AM GERIATR SOC, V47, P1380; ERNST RL, 1994, AM J PUBLIC HEALTH, V84, P1261, DOI 10.2105/AJPH.84.8.1261; Fichter MM, 1996, EUR ARCH PSY CLIN N, V246, P320, DOI 10.1007/BF02189026; Fillenbaum GG, 1998, J CLIN EPIDEMIOL, V51, P587, DOI 10.1016/S0895-4356(98)00024-9; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Gureje O, 1995, W AFR J MED, V14, P29; HAGNELL O, 1992, NEUROEPIDEMIOLOGY, V11, P61, DOI 10.1159/000110981; Hall KS, 2000, INT J GERIATR PSYCH, V15, P521, DOI 10.1002/1099-1166(200006)15:6<521::AID-GPS182>3.0.CO;2-F; Hall KS, 1996, INT J METHOD PSYCH, V6, P129, DOI 10.1002/(SICI)1234-988X(199610)6:3<129::AID-MPR164>3.3.CO;2-A; HEBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354, DOI 10.1001/jama.273.17.1354; HENDRIE HC, 1995, AM J PSYCHIAT, V152, P1485; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; LETENNEUR L, 1994, INT J EPIDEMIOL, V23, P1256, DOI 10.1093/ije/23.6.1256; Levy R, 1994, Int Psychogeriatr, V6, P63, DOI 10.1017/S1041610294001626; LI G, 1991, ACTA PSYCHIAT SCAND, V83, P99, DOI 10.1111/j.1600-0447.1991.tb07373.x; MAESTRE G, 1995, ANN NEUROL, V37, P154; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORGAN K, 1993, BRIT J PSYCHIAT, V163, P467, DOI 10.1192/bjp.163.4.467; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Ogunniyi A, 2000, EUR J NEUROL, V7, P485, DOI 10.1046/j.1468-1331.2000.00124.x; Ogunniyi A, 1993, West Afr J Med, V12, P189; OSUNTOKUN BO, 1995, ANN NEUROL, V38, P463, DOI 10.1002/ana.410380319; PAYKEL ES, 1994, ARCH GEN PSYCHIAT, V51, P325; Prince M, 1997, TROP MED INT HEALTH, V2, P993, DOI 10.1046/j.1365-3156.1997.d01-156.x; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Sahota A, 1997, ANN NEUROL, V42, P659, DOI 10.1002/ana.410420418; SKOOG I, 1999, ALZHEIMERS DIS RELAT, V58, P523; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Unverzagt FW, 1996, CLIN NEUROPSYCHOL, V10, P180, DOI 10.1080/13854049608406679; *WHO, 1992, INT CLASS DIS 10TH R; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161	45	278	292	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2001	285	6					739	747		10.1001/jama.285.6.739	http://dx.doi.org/10.1001/jama.285.6.739			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	399MP	11176911	Bronze			2022-12-24	WOS:000166817200030
J	Li, YC; Cheng, TH; Gartenberg, MR				Li, YC; Cheng, TH; Gartenberg, MR			Establishment of transcriptional silencing in the absence of DNA replication	SCIENCE			English	Article							ORIGIN RECOGNITION COMPLEX; HETEROCHROMATIN; SIR1; LOCI; MAINTENANCE; REPRESSION; TELOMERES; PROTEINS; DYNAMICS; REQUIRES	Transcriptional repression of the silent mating-type Loci in Saccharomyces cerevisiae requires a cell cycle-dependent establishment step that is commonly assumed to involve DNA replication. Using site-specific recombination, we created a nonreplicating DNA ring in vivo to test directly the role of replication in establishment of silencing. Sir1 was tethered to the ring following excision from the chromosome to activate a dormant silencer. We show here that silencing can be established in DNA that does not replicate. The silenced ring adopted structural features characteristic of bona fide silent chromatin, including an altered Level of DNA supercoiling and reduced histone acetylation. In addition, the process required silencing factors Sir2, Sir3, and Sir4 and progression between early S and M phases of the cell cycle. The results indicate that passage of a replication fork is not the cell-cycle event required for establishment of silencing in yeast.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Gartenberg, MR (corresponding author), Canc Inst New Jersey, New Brunswick, NJ 08901 USA.	gartenbe@umdnj.edu		Gartenberg, Marc/0000-0003-0713-7993	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM051402, R01GM051402] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM51402] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ansari A, 1997, MOL CELL BIOL, V17, P7061, DOI 10.1128/MCB.17.12.7061; APARICIO OM, 1994, GENE DEV, V8, P1133, DOI 10.1101/gad.8.10.1133; AXELROD A, 1991, MOL CELL BIOL, V11, P1080, DOI 10.1128/MCB.11.2.1080; Bi X, 1997, MOL CELL BIOL, V17, P7077, DOI 10.1128/MCB.17.12.7077; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Cheng TH, 2000, GENE DEV, V14, P452; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; Dillin A, 1997, GENETICS, V147, P1053; DUBEY DD, 1991, MOL CELL BIOL, V11, P5346, DOI 10.1128/MCB.11.10.5346; Ehrenhofer-Murray AE, 1999, GENETICS, V153, P1171; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; Fox CA, 1997, SCIENCE, V276, P1547, DOI 10.1126/science.276.5318.1547; Guarente L, 2000, GENE DEV, V14, P1021; HARTWELL LH, 1976, J MOL BIOL, V104, P803, DOI 10.1016/0022-2836(76)90183-2; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; Laroche T, 2000, J STRUCT BIOL, V129, P159, DOI 10.1006/jsbi.2000.4240; LI Y, UNPUB; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; Marheineke K, 1998, J BIOL CHEM, V273, P15279, DOI 10.1074/jbc.273.24.15279; Meluh PB, 1999, METHOD ENZYMOL, V304, P414; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0	28	114	115	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2001	291	5504					650	653		10.1126/science.291.5504.650	http://dx.doi.org/10.1126/science.291.5504.650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11158677				2022-12-24	WOS:000166616000043
J	Wagner, EH; Sandhu, N; Newton, KM; McCulloch, DK; Ramsey, SD; Grothaus, LC				Wagner, EH; Sandhu, N; Newton, KM; McCulloch, DK; Ramsey, SD; Grothaus, LC			Effect of improved glycemic control on health care costs and utilization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLICATIONS; BENEFITS; OUTCOMES; NIDDM; MODEL	Context Because of the additional costs associated with improving diabetes management, there is interest in whether improved glycemic control leads to reductions in health care costs, and, if so, when such cost savings occur, Objective To determine whether sustained improvements in hemoglobin A(1c) (HbA(1c)) levels among diabetic patients are followed by reductions in health care utilization and costs. Design and Setting Historical cohort study conducted in 1992-1997 in a staff-model health maintenance organization (HMO) in western Washington State. Participants All diabetic patients aged 18 years or older who were continuously enrolled between January 1992 and March 1996 and had HbA(1c) measured at least once per year in 1992-1994 (n = 4744). Patients whose HbA(1c) decreased 1% or more between 1992 and 1993 and sustained the decline through 1994 were considered to be improved (n=732), All others were classified as unimproved (n=4012). Main Outcome Measures Total health care costs, percentage hospitalized, and number of primary care and specialty visits among the improved vs unimproved cohorts in 1992-1997. Results Diabetic patients whose HbA(1c) measurements improved were similar demographically to those whose levels did not improve but had higher baseline HbA(1c) measurements (10.0% vs 7.7%; P<.001). Mean total health care costs were $685 to $950 less each year in the improved cohort for 1994 (P=.09), 1995 (P=.003), 1996 (P=.002), and 1997 (P=.01). Cost savings in the improved cohort were statistically significant only among those with the highest baseline HbA(1c) levels (<greater than or equal to>10%) for these years but appeared to be unaffected by presence of complications at baseline. Beginning in the year following improvement (1994), utilization was consistently lower in the improved cohort, reaching statistical significance for primary care visits in 1994 (P=.001), 1995 (P<.001), 1996 (P=.005), and 1997 (P=.004) and for specialty visits in 1997 (P=.02). Differences in hospitalization rates were not statistically significant in any year. Conclusion Our data suggest that a sustained reduction in HbA(1c) level among adult diabetic patients is associated with significant cost savings within 1 to 2 years of improvement.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, MacColl Inst Healthcare Innovat, Seattle, WA 98101 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Hlth Serv, Seattle, WA 98195 USA	Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Wagner, EH (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, MacColl Inst Healthcare Innovat, 1730 Minor Ave,Suite 1290, Seattle, WA 98101 USA.	wagner.e@ghc.org	Oliveira, Claudia DL/G-8618-2011					Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Clark CM, 2000, JAMA-J AM MED ASSOC, V284, P363, DOI 10.1001/jama.284.3.363; DIABET CONTROL COMPLICATIONS TRIAL RES GRP, 1995, DIABETES CARE, V18, P1468; DUAN N, 1983, J AM STAT ASSOC, V78, P605, DOI 10.2307/2288126; Eastman RC, 1997, DIABETES CARE, V20, P735, DOI 10.2337/diacare.20.5.735; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; Fishman P, 1997, HEALTH AFFAIR, V16, P239, DOI 10.1377/hlthaff.16.3.239; Gilmer TP, 1997, DIABETES CARE, V20, P1847, DOI 10.2337/diacare.20.12.1847; Hayward RA, 1997, JAMA-J AM MED ASSOC, V278, P1663, DOI 10.1001/jama.278.20.1663; McCulloch D K, 1998, Eff Clin Pract, V1, P12; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; Newton KM, 1999, J CLIN EPIDEMIOL, V52, P199, DOI 10.1016/S0895-4356(98)00161-9; O'Connor P J, 1992, J Am Board Fam Pract, V5, P381; Peters A L, 1995, HMO Pract, V9, P8; Ramsey SD, 1999, PHARMACOECONOMICS, V16, P285, DOI 10.2165/00019053-199916030-00005; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; RUTTENVANMOLKEN MPMH, 1994, HEALTH ECON, V3, P333, DOI 10.1002/hec.4730030507; Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490; WAGNER EH, 1995, ARCH INTERN MED, V155, P1789, DOI 10.1001/archinte.155.16.1789; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wanger EH, 1998, ANN INTERN MED, V129, P654, DOI 10.7326/0003-4819-129-8-199810150-00015	21	371	380	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 10	2001	285	2					182	189		10.1001/jama.285.2.182	http://dx.doi.org/10.1001/jama.285.2.182			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	389FB	11176811	Bronze			2022-12-24	WOS:000166227000026
J	Dumitru, CD; Ceci, JD; Tsatsanis, C; Kontoyiannis, D; Stamatakis, K; Lin, JH; Patriotis, C; Jenkins, NA; Copeland, NG; Kollias, G; Tsichlis, PN				Dumitru, CD; Ceci, JD; Tsatsanis, C; Kontoyiannis, D; Stamatakis, K; Lin, JH; Patriotis, C; Jenkins, NA; Copeland, NG; Kollias, G; Tsichlis, PN			TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway	CELL			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; T-CELL LINES; TRANSLATION INITIATION; SIGNALS ACTIVATION; ENDOTOXIC-SHOCK; INNATE IMMUNITY; MICE DEFICIENT; TPL-2	Tpl2 knockout mice produce tow levels of TNF-alpha when exposed to lipopolysaccharide (LPS) and they are resistant to LPS/D-Galactosamine-induced pathology. LPS stimulation of peritoneal macrophages from these mice did not activate MEK1, ERK1, and ERK2 but did activate JNK, p38 MAPK, and NF-kappaB. The block in ERK1 and ERK2 activation was causally linked to the defect in TNF-alpha induction by experiments showing that normal murine macrophages treated with the MEK inhibitor PD98059 exhibit a similar defect. Deletion of the AU-rich motif in the TNF-alpha mRNA minimized the effect of Tpl2 inactivation on the induction of TNF-alpha. Subcellular fractionation of LPS-stimulated macrophages revealed that LPS signals transduced by Tpl2 specifically promote the transport of TNF-alpha mRNA from the nucleus to the cytoplasm.	Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; NCI, Mouse Canc Genet Program, FCRDC, Frederick, MD 21702 USA; Hellenic Pasteur Inst, Genet Mol Lab, Athens 11521, Greece	Jefferson University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Tsichlis, PN (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, 233 S 10th St, Philadelphia, PA 19107 USA.	p_tsichlis@lac.jci.tju.edu	Tsatsanis, Christos/AAM-9362-2020; Kollias, George/A-7079-2012; Stamatakis, Konstantinos/A-6596-2017	Tsatsanis, Christos/0000-0003-1214-4151; Kollias, George/0000-0003-1867-3150; Stamatakis, Konstantinos/0000-0001-9934-3502; Kontoyiannis, Dimitris/0000-0003-4682-9490	NATIONAL CANCER INSTITUTE [R01CA038047] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA38047] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; Ballester A, 1998, J BIOL CHEM, V273, P14099, DOI 10.1074/jbc.273.23.14099; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; DINARELLO CA, 1993, JAMA-J AM MED ASSOC, V269, P1829, DOI 10.1001/jama.269.14.1829; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Erny KM, 1996, ONCOGENE, V13, P2015; FINK MP, 1990, J SURG RES, V49, P186, DOI 10.1016/0022-4804(90)90260-9; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; GEPPERT TD, 1994, MOL MED, V1, P93; KABOORD B, 2000, PREVEIWS PIERCE CHEM, V3, P4; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; LEIST M, 1994, J IMMUNOL, V153, P1778; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PATRIOTIS C, 1994, P NATL ACAD SCI USA, V91, P9755, DOI 10.1073/pnas.91.21.9755; PATRIOTIS C, 1993, P NATL ACAD SCI USA, V90, P2251, DOI 10.1073/pnas.90.6.2251; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Tsatsanis C, 1998, ONCOGENE, V17, P2609, DOI 10.1038/sj.onc.1202460; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827; UCHIDA N, 1980, J BIOL CHEM, V255, P8638; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; van der Bruggen T, 1999, INFECT IMMUN, V67, P3824, DOI 10.1128/IAI.67.8.3824-3829.1999; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; WARREN MK, 1985, J IMMUNOL, V134, P982	45	675	715	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2000	103	7					1071	1083		10.1016/S0092-8674(00)00210-5	http://dx.doi.org/10.1016/S0092-8674(00)00210-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163183	Bronze			2022-12-24	WOS:000166040600010
J	Traver, D; Akashi, K; Manz, M; Merad, M; Miyamoto, T; Engleman, EG; Weissman, IL				Traver, D; Akashi, K; Manz, M; Merad, M; Miyamoto, T; Engleman, EG; Weissman, IL			Development of CD8 alpha-positive dendritic cells from a common myeloid progenitor	SCIENCE			English	Article							MOUSE BONE-MARROW; T-CELLS; IN-VIVO; LYMPHOID ORGANS; B-CELLS; EXPRESSION; MARKERS; SPLEEN	Dendritic cells (DCs) are critical in both initiating adaptive immune responses and maintaining tolerance to self antigens. These apparently contradictory roles have been suggested to depend on different subsets of DCs that arise from either myeloid or Lymphoid hematopoietic origins, respectively, Although DC expression of CD8 alpha is attributed to a lymphoid origin, here we show that both CD8 alpha (+) and CD8 alpha (-) DCs can arise from clonogenic common myeloid progenitors in both thymus and spleen. Thus, expression of CD8 alpha is not indicative of a lymphoid origin, and phenotypic and functional differences among DC subsets are likely to reflect maturation status rather than ontogeny.	Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Stanford University; Stanford University; Harvard University; Dana-Farber Cancer Institute	Manz, M (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.		Manz, Markus G/C-7588-2011	Manz, Markus/0000-0002-4676-7931	NATIONAL CANCER INSTITUTE [R35CA042551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NCI NIH HHS [CA42551] Funding Source: Medline; NIAID NIH HHS [5T32 AI-07290] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Ardavin C, 1997, IMMUNOL TODAY, V18, P350, DOI 10.1016/S0167-5699(97)01090-6; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; INABA K, 1993, P NATL ACAD SCI USA, V90, P3038, DOI 10.1073/pnas.90.7.3038; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Merad M, 2000, BLOOD, V96, P1865, DOI 10.1182/blood.V96.5.1865.h8001865_1865_1872; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Rodewald HR, 1999, P NATL ACAD SCI USA, V96, P15068, DOI 10.1073/pnas.96.26.15068; Shortman K, 1997, STEM CELLS, V15, P409, DOI 10.1002/stem.150409; Shreedhar V, 1999, IMMUNITY, V11, P625, DOI 10.1016/S1074-7613(00)80137-5; Steinman RM, 1999, J LEUKOCYTE BIOL, V66, P205, DOI 10.1002/jlb.66.2.205; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Vremec D, 1997, J IMMUNOL, V159, P565; WEISSMAN IL, 1994, IMMUNITY, V1, P529, DOI 10.1016/1074-7613(94)90042-6; Wu L, 1998, IMMUNITY, V9, P839, DOI 10.1016/S1074-7613(00)80649-4	24	303	312	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2000	290	5499					2152	2154		10.1126/science.290.5499.2152	http://dx.doi.org/10.1126/science.290.5499.2152			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	383ER	11118150				2022-12-24	WOS:000165870600058
J	Yean, SL; Wuenschell, G; Termini, J; Lin, RJ				Yean, SL; Wuenschell, G; Termini, J; Lin, RJ			Metal-ion coordination by U6 small nuclear RNA contributes to catalysis in the spliceosome	NATURE			English	Article							PRE-MESSENGER-RNA; TERTIARY INTERACTION; PHOSPHOROTHIOATE INTERFERENCE; HAMMERHEAD RIBOZYME; SITE; SNRNA; STEREOCHEMISTRY; POLYMERASE; LINKS	Introns are removed from nuclear messenger RNA precursors through two sequential phospho-transesterification reactions in a dynamic RNA-protein complex called the spliceosome(1,2). But whether splicing is catalysed by small nuclear RNAs3,4 in the spliceosome is unresolved. As the spliceosome is a metalloenzyme(5-7), it is important to determine whether snRNAs coordinate catalytic metals. Here we show that yeast U6 snRNA coordinates a metal ion that is required for the catalytic activity of the spliceosome. With Mg2+, U6 snRNA with a sulphur substitution for the pro-R-P or pro-S-P non-bridging phosphoryl oxygen of nucleotide U-80 reconstitutes a fully assembled yet catalytically inactive spliceosome. Adding a thiophilic ion such as Mn2+ allows the first transesterification reaction to occur in the U6/sU(80)(S-P)- but not the U6/sU80 (R-P)-reconstituted spliceosome. Mg2+ competitively inhibits the Mn2+-rescued reaction, indicating that the metal-binding site at U6/U-80 exists in the wild-type spliceosome and that the site changes its metal requirement for activity in the S-P spliceosome. Thus, U6 snRNA contributes to pre-messenger RNA splicing through metal-ion coordination, which is consistent with RNA catalysis by the spliceosome.	City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Lin, RJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Biol, Duarte, CA 91010 USA.	rlin@coh.org	Lin, Ren-Jang/G-2052-2014	Lin, Ren-Jang/0000-0002-2738-2438	NIGMS NIH HHS [R01 GM040639, R01 GM040639-10] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040639] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basu S, 1999, RNA, V5, P1399, DOI 10.1017/S135583829999115X; Boudvillain M, 2000, NATURE, V406, P315, DOI 10.1038/35018589; Brautigam CA, 1998, J MOL BIOL, V277, P363, DOI 10.1006/jmbi.1997.1586; BURGERS PMJ, 1978, P NATL ACAD SCI USA, V75, P4798, DOI 10.1073/pnas.75.10.4798; CHANFREAU G, 1994, SCIENCE, V266, P1383, DOI 10.1126/science.7973729; Christian EL, 2000, RNA, V6, P511, DOI 10.1017/S1355838200000042; CHRISTIAN EL, 1993, BIOCHEMISTRY-US, V32, P4475, DOI 10.1021/bi00068a001; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; FABRIZIO P, 1992, NUCLEIC ACIDS RES, V20, P3659, DOI 10.1093/nar/20.14.3659; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Guthrie C, 1994, Harvey Lect, V90, P59; Kim CH, 1996, RNA, V2, P995; Kim SH, 1996, MOL CELL BIOL, V16, P6810; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; MOORE MJ, 1993, NATURE, V365, P364, DOI 10.1038/365364a0; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Murray JB, 2000, J MOL BIOL, V296, P33, DOI 10.1006/jmbi.1999.3428; Nilsen TW, 1998, COLD SPRING HARBOR M, P279; Peracchi A, 1997, J BIOL CHEM, V272, P26822, DOI 10.1074/jbc.272.43.26822; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; PYLE AM, 1993, SCIENCE, V261, P709, DOI 10.1126/science.7688142; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; Sigel RKO, 1997, J AM CHEM SOC, V119, P744, DOI 10.1021/ja962970l; Smith JS, 2000, BIOCHEMISTRY-US, V39, P5642, DOI 10.1021/bi992712b; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Valadkhan S, 2000, RNA, V6, P206, DOI 10.1017/S1355838200992197; Weinstein LB, 1997, NATURE, V388, P805, DOI 10.1038/42076; YU YT, 1995, RNA, V1, P46	30	194	199	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2000	408	6814					881	884		10.1038/35048617	http://dx.doi.org/10.1038/35048617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130730	Green Accepted			2022-12-24	WOS:000165831300056
J	Dalva, MB; Takasu, MA; Lin, MZ; Shamah, SM; Hu, L; Gale, NW; Greenberg, ME				Dalva, MB; Takasu, MA; Lin, MZ; Shamah, SM; Hu, L; Gale, NW; Greenberg, ME			EphB receptors interact with NMDA receptors and regulate excitatory synapse formation	CELL			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; AGRIN-DEFICIENT MICE; D-ASPARTATE RECEPTOR; HIPPOCAMPAL-NEURONS; TYROSINE KINASES; NEUROMUSCULAR-JUNCTION; TRANSMEMBRANE LIGANDS; GLUTAMATE RECEPTORS	EphB receptor tyrosine kinases are enriched at synapses, suggesting that these receptors play a role in synapse formation or function. We find that EphrinB binding to EphB induces a direct interaction of EphB with NMDA-type glutamate receptors. This interaction occurs at the cell surface and is mediated by the extracellular regions of the two receptors, but does not require the kinase activity of EphB. The kinase activity of EphB may be important for subsequent steps in synapse formation, as perturbation of EphB tyrosine kinase activity affects the number of synaptic specializations that form in cultured neurons. These findings indicate that EphrinB activation of EphB promotes an association of EphB with NMDA receptors that may be critical for synapse development or function.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Regeneron	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.			Lin, Michael/0000-0002-0492-1961; Dalva, Matthew/0000-0002-7737-8787	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER; NCI NIH HHS [CA43855] Funding Source: Medline; NICHD NIH HHS [HD18655] Funding Source: Medline; NINDS NIH HHS [R01 NS045500] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Birgbauer E, 2000, DEVELOPMENT, V127, P1231; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1998, CURR OPIN NEUROBIOL, V8, P117, DOI 10.1016/S0959-4388(98)80015-9; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Li Z, 1999, J NEUROBIOL, V39, P547, DOI 10.1002/(SICI)1097-4695(19990615)39:4<547::AID-NEU8>3.0.CO;2-C; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; OBrien RJ, 1997, J NEUROSCI, V17, P7339; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Rao A, 1998, J NEUROSCI, V18, P1217; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Stein E, 1996, J BIOL CHEM, V271, P23588, DOI 10.1074/jbc.271.38.23588; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yu XM, 1999, P NATL ACAD SCI USA, V96, P7697, DOI 10.1073/pnas.96.14.7697	45	529	554	1	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 8	2000	103	6					945	956		10.1016/S0092-8674(00)00197-5	http://dx.doi.org/10.1016/S0092-8674(00)00197-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136979	Bronze			2022-12-24	WOS:000165801300013
J	McWatters, HG; Bastow, RM; Hall, A; Millar, AJ				McWatters, HG; Bastow, RM; Hall, A; Millar, AJ			The ELF3 zeitnehmer regulates light signalling to the circadian clock	NATURE			English	Article							ARABIDOPSIS-THALIANA; DYSFUNCTION; EXPRESSION; MUTANTS	The circadian system regulates 24-hour biological rhythms' and seasonal rhythms, such as flowering(2). Long-day flowering plants like Arabidopsis thaliana, measure day length with a rhythm that is not reset at lights-off(3), whereas short-day plants measure night length on the basis of circadian rhythm of light sensitivity that is set from dusk(2). early flowering 3 (elf3) mutants of Arabinopsis are aphotoperiodic(4) and exhibit light-conditional arrhythmia(5,6). Here we show that the elf3-7 mutant retains oscillator function in the light but blunts circadian gating of CAB gene activation, indicating that deregulated phototransduction may mask rhythmicity. Furthermore, elf3 mutations confer the resetting pattern of short-day photoperiodism, indicating that gating of phototransduction may control resetting. Temperature entrainment can bypass the requirement for normal ELF3 function for the oscillator and partially restore rhythmic CAB expression. Therefore, ELF3 specifically affects light input to the oscillator, similar to its function in gating CAB activation, allowing oscillator progression past a light-sensitive phase in the subjective evening. ELF3 provides experimental demonstration of the zeitnehmer ('time-taker') Concept(7,8).	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Millar, AJ (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.		Hall, Anthony/D-2844-2009; Millar, Andrew J/G-2423-2012	Hall, Anthony/0000-0002-1806-020X; Millar, Andrew J/0000-0003-1756-3654				Bognar LK, 1999, P NATL ACAD SCI USA, V96, P14652, DOI 10.1073/pnas.96.25.14652; Carre IA, 1995, PLANT CELL, V7, P2039, DOI 10.2307/3870149; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Lakin-Thomas PL, 2000, TRENDS GENET, V16, P135, DOI 10.1016/S0168-9525(99)01945-9; LUMSDEN PJ, 1998, BIOL RHYTHMS PHOTOPE, P167; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Reed JW, 2000, PLANT PHYSIOL, V122, P1149, DOI 10.1104/pp.122.4.1149; Roenneberg T, 1999, J BIOL RHYTHM, V14, P449, DOI 10.1177/074873099129001019; Roenneberg T, 1998, J BIOL RHYTHM, V13, P167, DOI 10.1177/074873098129000011; Samach A, 2000, BIOESSAYS, V22, P38, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;38::AID-BIES8&gt;3.0.CO;2-L; SOMERS DE, 1995, PLANT PHYSIOL, V107, P523, DOI 10.1104/pp.107.2.523; ZAGOTTA MT, 1992, AUST J PLANT PHYSIOL, V19, P411, DOI 10.1071/PP9920411	17	262	278	1	35	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2000	408	6813					716	720		10.1038/35047079	http://dx.doi.org/10.1038/35047079			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130072				2022-12-24	WOS:000165815200048
J	Henney, JE				Henney, JE			Microwave therapy warning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	22	25	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2000	284	21					2711	2711		10.1001/jama.284.21.2711-c	http://dx.doi.org/10.1001/jama.284.21.2711-c			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377JB	11105160				2022-12-24	WOS:000165509500004
J	McDonald, PH; Chow, CW; Miller, WE; Laporte, SA; Field, ME; Lin, FT; Davis, RJ; Lefkowitz, RJ				McDonald, PH; Chow, CW; Miller, WE; Laporte, SA; Field, ME; Lin, FT; Davis, RJ; Lefkowitz, RJ			beta-Arrestin 2: A receptor-regulated MAPK scaffold for the activation of JNK3	SCIENCE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; PROTEIN-KINASE; CLATHRIN ADAPTER; COMPLEX; ENDOCYTOSIS; CELLS; YEAST	beta -Arrestins, originally discovered in the context of heterotrimeric guanine nucleotide binding protein-coupled receptor (GPCR) desensitization, also function in internalization and signaling of these receptors. We identified c-Jun amino-terminal kinase 3 (JNK3) as a binding partner of beta -arrestin 2 using a yeast two-hybrid screen and by coimmunoprecipitation from mouse brain extracts or cotransfected COS-7 cells. The upstream JNK activators apoptosis signal-regulating kinase 1 (ASK1) and mitogen-activated protein kinase (MAPK) kinase 4 were also found in complex with beta -arrestin 2. cellular transfection of beta -arrestin 2 caused cytosolic retention of JNK3 and enhanced JNK3 phosphorylation stimulated by ASK1. Moreover, stimulation of the angiotensin II type 1A receptor activated JNK3 and triggered the colocalization of beta -arrestin 2 and active JNK3 to intracellular vesicles. Thus, beta -arrestin 2 acts as a scaffold protein, which brings the spatial distribution and activity of this MAPK module under the control of a GPCR.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Program Mol Med, Worcester, MA 01605 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3821, Durham, NC 27710 USA.		Lefkowitz, Robert/AAW-2649-2021; Chow, Chung-Wai/AAP-5533-2020; Laporte, Stephane A/F-3282-2012; Laporte, Stephane/ABC-4228-2021	Chow, Chung-Wai/0000-0001-9344-8522; Laporte, Stephane/0000-0002-0633-543X	NCI NIH HHS [CA65861, CA85422] Funding Source: Medline; NHLBI NIH HHS [HL16037] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085422, R01CA065861] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; MCDONALD PJ, UNPUB; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; MITCHELL FM, 1995, BIOCHEM J, V309, P381, DOI 10.1042/bj3090381; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tournier C, 1999, MOL CELL BIOL, V19, P1569; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; ZOHN IE, 1995, MOL CELL BIOL, V15, P6160	25	600	626	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2000	290	5496					1574	1577		10.1126/science.290.5496.1574	http://dx.doi.org/10.1126/science.290.5496.1574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376EX	11090355				2022-12-24	WOS:000165446200050
J	Orth, K; Xu, ZH; Mudgett, MB; Bao, ZQ; Palmer, LE; Bliska, JB; Mangel, WF; Staskawicz, B; Dixon, JE				Orth, K; Xu, ZH; Mudgett, MB; Bao, ZQ; Palmer, LE; Bliska, JB; Mangel, WF; Staskawicz, B; Dixon, JE			Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease	SCIENCE			English	Article							CAMPESTRIS PV VESICATORIA; AVIRULENCE GENE AVRRXV; NF-KAPPA-B; ALPHA PRODUCTION; DOWN-REGULATION; ACTIVATION; INHIBITION; SUPPRESSION; EXPRESSION; RESISTANCE	Homologs of the Yersinia virulence effector YopJ are found in both plant and animal bacterial pathogens, as well as plant symbionts. These YopJ family members were shown to act as cysteine proteases. The catalytic triad of the protease was required for inhibition of the mitogen-activated protein kinase (MAPK) and nuclear factor kappaB (NF-kappaB) signaling in animal cells and for induction of Localized cell death in plants. The substrates for YopJ were shown to be highly conserved ubiquitin-like molecules, which are covalently added to numerous regulatory proteins. YopJ family members exert their pathogenic effect on cells by disrupting this posttranslational modification.	Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of Michigan System; University of Michigan; University of California System; University of California Berkeley; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory	Dixon, JE (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.		Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620	NIAID NIH HHS [AI41599] Funding Source: Medline; PHS HHS [18024] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI041599, R01AI041599] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998; Ciesiolka LD, 1999, MOL PLANT MICROBE IN, V12, P35, DOI 10.1094/MPMI.1999.12.1.35; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; MINSAVAGE GV, 1990, MOL PLANT MICROBE IN, V3, P41, DOI 10.1094/MPMI-3-041; MUDGETT MB, UNPUB; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; ORTH K, UNPUB; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Palmer LE, 1999, INFECT IMMUN, V67, P708, DOI 10.1128/IAI.67.2.708-716.1999; Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; WEBSTER A, 1993, CELL, V72, P97, DOI 10.1016/0092-8674(93)90053-S; WHALEN MC, 1993, MOL PLANT MICROBE IN, V6, P616, DOI 10.1094/MPMI-6-616; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; ZHENG CF, 1994, J BIOL CHEM, V269, P19947	25	423	447	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 24	2000	290	5496					1594	1597		10.1126/science.290.5496.1594	http://dx.doi.org/10.1126/science.290.5496.1594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376EX	11090361				2022-12-24	WOS:000165446200056
J	Hastings, PJ; Bull, HJ; Klump, JR; Rosenberg, SM				Hastings, PJ; Bull, HJ; Klump, JR; Rosenberg, SM			Adaptive amplification: An inducible chromosomal instability mechanism	CELL			English	Article							STATIONARY-PHASE MUTATION; ESCHERICHIA-COLI; GENE AMPLIFICATION; MISMATCH REPAIR; FRAMESHIFT MUTATION; LAC OPERON; EVOLUTION; TRANSIENT; MUTATORS; HYPERMUTATION	Adaptive mutation is an induced response to environmental stress in which mutation rates rise, producing permanent genetic changes that can adapt cells to stress. This contrasts with neo-Darwinian views of genetic change rates blind to environmental conditions. DNA amplification is a flexible, reversible genomic change that has long been postulated to be adaptive. We report the discovery of adaptive amplification at the lac operon in Escherichia coli. Additionally, we find that adaptive amplification is separate from, and does not lead to, adaptive point mutation. This contradicts a prevailing alternative hypothesis whereby adaptive mutation is normal mutability in amplified DNA. Instead, adaptive mutation and amplification are parallel routes of inducible genetic instability allowing rapid evolution under stress, and escape from growth inhibition.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Hastings, PJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	hastings@bcm.tmc.edu		Rosenberg, Susan M./0000-0003-1444-473X	NIAID NIH HHS [R01-AI43917] Funding Source: Medline; NIGMS NIH HHS [R01-GM53158] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053158] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson DI, 1998, SCIENCE, V282, P1133, DOI 10.1126/science.282.5391.1133; BRODEUR GM, 1998, GENETIC BASIS HUMAN, P161; Bull HJ, 2000, GENETICS, V154, P1427; CAIMS J, 1991, GENETICS, V128, P695; CAIMS J, 1988, NATURE, V335, P142; Darwin C., 1859, ORIGIN SPECIES FACSI; DELBRUCK M, 1946, COLD SPRING HARB SYM, V11, P33; Dickinson WJ, 1999, NATURE, V399, P30, DOI 10.1038/19894; ECHOLS H, 1981, CELL, V25, P1, DOI 10.1016/0092-8674(81)90223-3; Foster PL, 1999, ANNU REV GENET, V33, P57, DOI 10.1146/annurev.genet.33.1.57; FOSTER PL, 1995, P NATL ACAD SCI USA, V92, P5487, DOI 10.1073/pnas.92.12.5487; Foster PL, 1996, GENETICS, V142, P25; FOSTER PL, 1994, SCIENCE, V265, P407, DOI 10.1126/science.8023164; FOSTER PL, 1994, GENETICS, V138, P253; GALITSKI T, 1995, SCIENCE, V268, P421, DOI 10.1126/science.7716546; Godoy VG, 2000, GENETICS, V154, P49; HALL BG, 1990, GENETICS, V126, P5; Harris RS, 1999, MUTAT RES-REV MUTAT, V437, P51; Harris RS, 1996, GENETICS, V142, P681; Harris RS, 1997, GENE DEV, V11, P2426, DOI 10.1101/gad.11.18.2426; HORIUCHI T, 1963, GENETICS, V48, P151; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; LOEB LA, 1991, CANCER RES, V51, P3075; Lombardo MJ, 1999, J GENET, V78, P13, DOI 10.1007/BF02994698; Longerich S, 1995, P NATL ACAD SCI USA, V92, P12017, DOI 10.1073/pnas.92.26.12017; Luria SE, 1943, GENETICS, V28, P491; Mao EF, 1997, J BACTERIOL, V179, P417, DOI 10.1128/jb.179.2.417-422.1997; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833; Mayr E., 1982, GROWTH BIOL THOUGHT; MCCLINTOCK B, 1978, STADLER GENET S, V10, P25; McKenzie GJ, 1998, GENETICS, V149, P1163; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; MODRICH P, 1994, SCIENCE, V266, P1959, DOI 10.1126/science.7801122; NINIO J, 1991, GENETICS, V129, P957; ONO S, 1970, EVOLUTION GENE DUPLI; Prival MJ, 1996, GENETICS, V144, P1337; Radman M, 1975, Basic Life Sci, V5A, P355; Reynolds TY, 1996, CANCER RES, V56, P5754; Rosche WA, 1999, P NATL ACAD SCI USA, V96, P6862, DOI 10.1073/pnas.96.12.6862; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Rosenberg SM, 1998, GENETICS, V148, P1559; ROTH JR, 1996, ESCHERICHIA COLI SAL, P2256; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; TIsty T.D., 1989, P NATL ACAD SCI USA, V86, P9441; TLSTY TD, 1984, CELL, V37, P217, DOI 10.1016/0092-8674(84)90317-9; Torkelson J, 1997, EMBO J, V16, P3303, DOI 10.1093/emboj/16.11.3303; Von Borstel R C, 1978, Methods Cell Biol, V20, P1, DOI 10.1016/S0091-679X(08)62005-1; WHORISKEY SK, 1987, GENE DEV, V1, P227, DOI 10.1101/gad.1.3.227; WINDLE BE, 1992, MUTAT RES, V276, P199, DOI 10.1016/0165-1110(92)90009-X	51	120	125	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 22	2000	103	5					723	731		10.1016/S0092-8674(00)00176-8	http://dx.doi.org/10.1016/S0092-8674(00)00176-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	375ZJ	11114329	Bronze			2022-12-24	WOS:000165433100005
J	Olivier, M; Aggarwal, A; Allen, J; Almendras, AA; Bajorek, ES; Beasley, EM; Brady, SD; Bushard, JM; Bustos, VI; Chu, A; Chung, TR; De Witte, A; Denys, ME; Dominguez, R; Fang, NY; Foster, BD; Freudenberg, RW; Hadley, D; Hamilton, LR; Jeffrey, TJ; Kelly, L; Lazzeroni, L; Levy, MR; Lewis, SC; Liu, X; Lopez, FJ; Louie, B; Marquis, JP; Martinez, RA; Matsuura, MK; Misherghi, NS; Norton, JA; Olshen, A; Perkins, SM; Perou, AJ; Piercy, C; Piercy, M; Qin, F; Reif, T; Sheppard, K; Shokoohi, V; Smick, GA; Sun, WL; Stewart, EA; Tejeda, JF; Tran, NM; Trejo, T; Vo, NT; Yan, SCM; Zierten, DL; Zhao, SY; Sachidanandam, R; Trask, BJ; Myers, RM; Cox, DR				Olivier, M; Aggarwal, A; Allen, J; Almendras, AA; Bajorek, ES; Beasley, EM; Brady, SD; Bushard, JM; Bustos, VI; Chu, A; Chung, TR; De Witte, A; Denys, ME; Dominguez, R; Fang, NY; Foster, BD; Freudenberg, RW; Hadley, D; Hamilton, LR; Jeffrey, TJ; Kelly, L; Lazzeroni, L; Levy, MR; Lewis, SC; Liu, X; Lopez, FJ; Louie, B; Marquis, JP; Martinez, RA; Matsuura, MK; Misherghi, NS; Norton, JA; Olshen, A; Perkins, SM; Perou, AJ; Piercy, C; Piercy, M; Qin, F; Reif, T; Sheppard, K; Shokoohi, V; Smick, GA; Sun, WL; Stewart, EA; Tejeda, JF; Tran, NM; Trejo, T; Vo, NT; Yan, SCM; Zierten, DL; Zhao, SY; Sachidanandam, R; Trask, BJ; Myers, RM; Cox, DR			A high-resolution radiation hybrid map of the human genome draft sequence	SCIENCE			English	Article							PHYSICAL MAP; CHROMOSOMES; PANEL-2; PCR	We have constructed a physical map of the human genome by using a panel of 90 whole-genome radiation hybrids (the TNG panel) in conjunction with 40,322 sequence-tagged sites (STSs) derived from random genomic sequences as well as expressed sequences. Of 36,678 STSs on the TNC radiation hybrid map, only 3604 (9.8%) were absent from the unassembled draft sequence of the human genome. Of 20,030 STSs ordered on the TNG map as well as the assembled human genome draft sequence and the Celera assembled human genome sequence, 36% of the STSs had a discrepant order between the working draft sequence and the Celera sequence. The TNG map order was identical to one of the two sequence orders in 60% of these discrepant cases.	Stanford Univ, Stanford Human Genome Ctr, Sch Med, Palo Alto, CA 94304 USA; Inst Genome Res, Rockville, MD 20850 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Stanford University; J. Craig Venter Institute; Cold Spring Harbor Laboratory; Fred Hutchinson Cancer Center	Cox, DR (corresponding author), Stanford Univ, Stanford Human Genome Ctr, Sch Med, 975 Calif Ave, Palo Alto, CA 94304 USA.	cox@shgc.stanford.edu	sachidanandam, ravi/Q-6916-2019; Lazzeroni, Laura/F-2903-2010	sachidanandam, ravi/0000-0001-9844-4459; Lazzeroni, Laura/0000-0002-1846-6920	NIGMS NIH HHS [R01 GM062628] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062628] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTCHUL SF, 1990, J MOL BIOL, V215, P403; BEASLEY EM, 1999, PCR APPL PROTOCOLS F, P55; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRWINGA HL, 1993, GENOMICS, V16, P311, DOI 10.1006/geno.1993.1190; DUBOIS BL, 1993, GENOMICS, V16, P315, DOI 10.1006/geno.1993.1191; GREEN ED, 1990, SCIENCE, V250, P94, DOI 10.1126/science.2218515; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LUNETTA KL, 1994, GENOMICS, V21, P92, DOI 10.1006/geno.1994.1229; Lunetta KL, 1996, AM J HUM GENET, V59, P717; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; Schuler GD, 1998, TRENDS BIOTECHNOL, V16, P456, DOI 10.1016/S0167-7799(98)01232-3; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	23	89	92	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2001	291	5507					1298	+		10.1126/science.1057437	http://dx.doi.org/10.1126/science.1057437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	402MX	11181994				2022-12-24	WOS:000166993400040
J	Bundred, P; Kitchiner, D; Buchan, I				Bundred, P; Kitchiner, D; Buchan, I			Prevalence of overweight and obese children between 1989 and 1998: population based series of cross sectional studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; REFERENCE CURVES; CHILDHOOD; UK	Objective To determine trends in weight, height, and body mass index in children between 1989 and 1998. Design Retrospective series of cross sectional studies of routinely collected data. Setting Primary care in the Wirral Health Authority Participants 35 662 infants aged 1-3 months (representing 88% of live births) and 28 768 children aged 2.9-4.0 years. 21 582 infants and children (25.1%) were excluded because of missing or inaccurate data. Main outcome measures Weight, height sex, and age routinely recorded by health visitors, Height, weight, and body mass index standardised for age and sex, SD score > 1.04 for body mass index (>85th centile) was defined as overweight and > 1.64 (> 95th centile) as obese, Body mass index was not calculated in infants as it is difficult to interpret. Results From 1989 to 1998 there was a highly significant increasing trend in die proportion of overweight children (14.7% to 23.6%; P < 0.001) and obese children (5.4% to 9.2%; P < 0.001). There was also a highly significant increasing trend in the mean SD score for weight (0.05 to 0.29; P< 0.001) and body mass index (- 0.15 to 0.31 ; P < 0.001) but not height Infants showed a small but significantly increasing trend in mean SD score for weight (- 0.17 to - 0.05; P = 0.005). Conclusions From 1989 to 1998 there was a highly significant increase in weight and body mass index in children under 4 years of age, Routinely collected data are valuable in identifying anthropometric trends in populations.	Univ Liverpool, Liverpool L69 3GB, Merseyside, England; Royal Liverpool Childrens NHS Trust, Liverpool L12 2AP, Merseyside, England; W Hertfordshire Hlth Author, St Albans AL1 3ER, Herts, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust	Bundred, P (corresponding author), Univ Liverpool, Liverpool L69 3GB, Merseyside, England.	peterb@liv.ac.uk	Buchan, Iain E/H-5767-2013	Buchan, Iain E/0000-0003-3392-1650				Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Bellizzi MC, 1999, AM J CLIN NUTR, V70, p173S; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; *CHILD GROWTH F, 1996, UK CROSS SECT REF DA; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dietz WH, 1998, J NUTR, V128, p411S, DOI 10.1093/jn/128.2.411S; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Fruhbeck G, 2000, BRIT MED J, V320, P328, DOI 10.1136/bmj.320.7231.328; Kotani K, 1997, INT J OBESITY, V21, P912, DOI 10.1038/sj.ijo.0800492; Luepker RV, 1996, JAMA-J AM MED ASSOC, V275, P768, DOI 10.1001/jama.275.10.768; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; NHS Executive, 2000, NAT SERV FRAM COR HE; Pietrobelli A, 1998, J PEDIATR-US, V132, P204, DOI 10.1016/S0022-3476(98)70433-0; Power C, 1997, AM J CLIN NUTR, V66, P1094, DOI 10.1093/ajcn/66.5.1094; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; Prentice AM, 1998, BRIT MED J, V317, P1401, DOI 10.1136/bmj.317.7170.1401; Reilly JJ, 1999, BRIT MED J, V319, P1039, DOI 10.1136/bmj.319.7216.1039	20	204	213	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2001	322	7282					326	328		10.1136/bmj.322.7282.326	http://dx.doi.org/10.1136/bmj.322.7282.326			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	403NU	11159654	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000167050000025
J	Boskey, AL				Boskey, AL			Musculoskeletal disorders and orthopedic conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMORPHOUS CALCIUM-PHOSPHATE; RECEPTOR ANTAGONIST; BINDING-PROTEIN; GENE-THERAPY; BONE; MICE; ARTHROPLASTY; OSTEOPOROSIS; BIOSYNTHESIS; DEGRADATION	Ongoing advances in orthopedics include discoveries of functions of matrix proteins, development of new implant materials that are more durable and more compatible with magnetic resonance imaging, and identification of genes causing musculoskeletal disorders and disease. The Human Genome Project will further clarify the genetic basis of specific musculoskeletal disorders, enhancing risk factor identification, diagnosis, and therapy. Engineered, cell-based materials will replace metals and plastics in implants, and new composite materials will promote bone in-growth.	Hosp Special Surg, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, New York, NY USA; Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA	Cornell University; Cornell University	Boskey, AL (corresponding author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.	BoskeyA@HSS.edu		Boskey, Adele/0000-0002-6181-2219	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041325, R01AR037661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE004141, R01DE004141] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR041325, AR037661] Funding Source: Medline; NIDCR NIH HHS [DE04141] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler RS, 1999, RADIOL CLIN N AM, V37, P623, DOI 10.1016/S0033-8389(05)70119-6; Ahrendt SA, 1999, P NATL ACAD SCI USA, V96, P7382, DOI 10.1073/pnas.96.13.7382; Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; ASHTON BA, 1980, CLIN ORTHOP RELAT R, P294; Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267; Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552; Bergstrom JD, 2000, ARCH BIOCHEM BIOPHYS, V373, P231, DOI 10.1006/abbi.1999.1502; BETTS F, 1975, P NATL ACAD SCI USA, V72, P2088, DOI 10.1073/pnas.72.6.2088; BODEN SD, 1999, CLIN ORTHOP S, V367, pS84; Boskey AL, 1997, J DENT RES, V76, P1433, DOI 10.1177/00220345970760080501; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403; CHOI YC, 1980, CONNECT TISSUE RES, V7, P105, DOI 10.3109/03008208009152295; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Cook SD, 1998, J ORTHOP TRAUMA, V12, P407, DOI 10.1097/00005131-199808000-00007; Cummings SR, 1996, BONE, V18, pS165, DOI 10.1016/8756-3282(95)00505-6; Davies B, 2000, P I MECH ENG H, V214, P129, DOI 10.1243/0954411001535309; Delmas PD, 2000, OSTEOPOROSIS INT, V11, P95, DOI 10.1007/PL00004181; DRAKE JM, 1991, NEUROSURGERY, V29, P27, DOI 10.1227/00006123-199107000-00005; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Engh GA, 2000, J BONE JOINT SURG AM, V82A, P516, DOI 10.2106/00004623-200004000-00007; Espehaug B, 1999, ACTA ORTHOP SCAND, V70, P12, DOI 10.3109/17453679909000949; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Evans CH, 1999, INTERNAL MED, V38, P233, DOI 10.2169/internalmedicine.38.233; Ezzell C, 2000, SCI AM, V283, P64, DOI 10.1038/scientificamerican0700-64; Ferguson CM, 1998, ANN NY ACAD SCI, V857, P33, DOI 10.1111/j.1749-6632.1998.tb10105.x; Fitzgerald R, 2000, PHYS TODAY, V53, P23, DOI 10.1063/1.1292471; Furukawa T, 2000, J BIOMED MATER RES, V50, P410, DOI 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y; Granchi D, 1998, J BONE JOINT SURG BR, V80B, P912, DOI 10.1302/0301-620X.80B5.8513; Grande DA, 1999, CLIN ORTHOP RELAT R, pS176; Guetens G, 2000, J CHROMATOGR B, V739, P139, DOI 10.1016/S0378-4347(99)00553-8; Hutchinson CR, 1998, CURR OPIN MICROBIOL, V1, P319, DOI 10.1016/S1369-5274(98)80036-2; Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219; Itonaga I, 2000, ANN RHEUM DIS, V59, P26, DOI 10.1136/ard.59.1.26; JACENKO O, 1994, AM J HUM GENET, V54, P163; Johnson EE, 2000, CLIN ORTHOP RELAT R, P61, DOI 10.1097/00003086-200002000-00008; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; KANG R, 2000, CLIN ORTHOP RELAT R, V375, P324; Kardos T B, 1982, Prog Clin Biol Res, V101, P45; KITAZAWA R, 1994, J CLIN INVEST, V94, P2397, DOI 10.1172/JCI117606; Ko SC, 1996, CANCER RES, V56, P4614; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lark MW, 1999, J PHARMACOL EXP THER, V291, P612; Lee MS, 1999, J CELL BIOCHEM, V75, P566, DOI 10.1002/(SICI)1097-4644(19991215)75:4<566::AID-JCB3>3.0.CO;2-0; LIAN JB, 1978, FED PROC, V37, P2615; Mendelsohn R, 1999, J BIOMED OPT, V4, P14, DOI 10.1117/1.429916; Menetrey J, 1999, TISSUE ENG, V5, P435, DOI 10.1089/ten.1999.5.435; Montgomery KD, 1997, J ORTHOP TRAUMA, V11, P330, DOI 10.1097/00005131-199707000-00006; Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60; Mosley JR, 2000, J REHABIL RES DEV, V37, P189; Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6; Ohlstein EH, 2000, ANNU REV PHARMACOL, V40, P177, DOI 10.1146/annurev.pharmtox.40.1.177; OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5; Persson U, 1999, ACTA ORTHOP SCAND, V70, P163, DOI 10.3109/17453679909011256; Peterson L, 2000, CLIN ORTHOP RELAT R, P212, DOI 10.1097/00003086-200005000-00020; Potter HG, 2000, CLIN ORTHOP RELAT R, P9; Praemer A., 1992, MUSCULOSKELETAL COND, P143; Reginster J Y, 1999, Drugs R D, V1, P195, DOI 10.2165/00126839-199901030-00001; Richards M, 1999, J ORTHOP RES, V17, P900, DOI 10.1002/jor.1100170615; Rickard DJ, 1999, J CELL BIOCHEM, P123; Robey Pamela Gehron, 1996, P95; Robey PG, 2000, J CLIN INVEST, V105, P1489, DOI 10.1172/JCI10256; ROUGHLEY PJ, 1977, BIOCHEM J, V167, P639, DOI 10.1042/bj1670639; SANDHU HS, 2000, CLIN ORTHOP RELAT R, V371, P56; Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#; Shapiro I M, 1999, Clin Orthod Res, V2, P42; Shi XM, 2000, J CELL BIOCHEM, V76, P518, DOI 10.1002/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M; STACEY A, 1988, NATURE, V332, P131, DOI 10.1038/332131a0; Steinke B, 1999, SPINE, V24, P1, DOI 10.1097/00007632-199901010-00002; Takacs I, 2000, BONE, V27, P169, DOI 10.1016/S8756-3282(00)00296-9; TERMINE JD, 1981, J BIOL CHEM, V256, P403; Trayhurn P, 1999, INT J OBESITY, V23, P22, DOI 10.1038/sj.ijo.0800791; URIST MR, 1975, CALC TISS RES, V19, P73, DOI 10.1007/BF02563992; Veber DF, 1997, CURR OPIN CHEM BIOL, V1, P151, DOI 10.1016/S1367-5931(97)80003-8; WOO SL, 1999, CLIN ORTHOP S, V367, pS312; Wu YT, 1999, P NATL ACAD SCI USA, V96, P1574, DOI 10.1073/pnas.96.4.1574; Yamashita DS, 2000, CURR PHARM DESIGN, V6, P1, DOI 10.2174/1381612003401569; Yingling CD, 1999, PEDIATR SURG INT, V15, P535, DOI 10.1007/s003830050664; ZAMAN G, 1992, CALCIFIED TISSUE INT, V51, P132, DOI 10.1007/BF00298501	82	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					619	623		10.1001/jama.285.5.619	http://dx.doi.org/10.1001/jama.285.5.619			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176869	Bronze			2022-12-24	WOS:000166714200022
J	Fisher, RJ; Pevsner, J; Burgoyne, RD				Fisher, RJ; Pevsner, J; Burgoyne, RD			Control of fusion pore dynamics during exocytosis by Munc18	SCIENCE			English	Article							ADRENAL-MEDULLARY CELLS; PROTEIN-KINASE-C; KISS-AND-RUN; VESICLE FUSION; SECRETORY PRODUCTS; NSEC-1 MUNC-18; PC12 CELLS; SYNTAXIN; COMPLEX; CHROMAFFIN	Intracellular membrane fusion is mediated by the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins. All vesicle transport steps also have an essential requirement for a member of the Sec1 protein family, including the neuronal Munc18-1 (also known as nSec1) in regulated exocytosis. Here, in adrenal chromaffin cells, we expressed a Munc18 mutant with reduced affinity for syntaxin, which specifically modified the kinetics of single-granule exocytotic release events, consistent with an acceleration of fusion pore expansion, Thus, Munc18 functions in a late stage in the fusion process, where its dissociation from syntaxin determines the kinetics of postfusion events.	Univ Liverpool, Physiol Lab, Liverpool L69 3BX, Merseyside, England; Kennedy Krieger Inst, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of Liverpool; Kennedy Krieger Institute; Johns Hopkins University	Burgoyne, RD (corresponding author), Univ Liverpool, Physiol Lab, Crown St, Liverpool L69 3BX, Merseyside, England.		Burgoyne, Robert D/P-6641-2019; Burgoyne, Robert/C-6706-2008	Burgoyne, Robert D/0000-0002-9219-0387; Burgoyne, Robert/0000-0002-9219-0387	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036670] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS36670-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; CORCORAN JJ, 1984, J BIOL CHEM, V259, P6208; Cousin MA, 2000, J NEUROCHEM, V75, P1645, DOI 10.1046/j.1471-4159.2000.0751645.x; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; FERNANDEZCHACON R, 1995, FEBS LETT, V363, P221, DOI 10.1016/0014-5793(95)00319-5; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Graham ME, 2000, J NEUROSCI, V20, P1281; Graham ME, 2000, BIOCHIMIE, V82, P469, DOI 10.1016/S0300-9084(00)00196-6; Graham ME, 1997, J NEUROCHEM, V69, P2369; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; HARTMANN J, 1995, FEBS LETT, V363, P217, DOI 10.1016/0014-5793(95)00318-4; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Haynes LP, 1999, BIOCHEM J, V342, P707, DOI 10.1042/0264-6021:3420707; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Schroeder TJ, 1996, BIOPHYS J, V70, P1061, DOI 10.1016/S0006-3495(96)79652-2; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; WICK PF, 1993, J BIOL CHEM, V268, P10983; WIGHTMAN RM, 1995, BIOPHYS J, V68, P383, DOI 10.1016/S0006-3495(95)80199-2; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247	30	166	171	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2001	291	5505					875	878		10.1126/science.291.5505.875	http://dx.doi.org/10.1126/science.291.5505.875			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11157167				2022-12-24	WOS:000166771700045
J	Duncan, B; Hart, G; Scoular, A; Bigrigg, A				Duncan, B; Hart, G; Scoular, A; Bigrigg, A			Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening	BRITISH MEDICAL JOURNAL			English	Article							INFECTION	Objectives To investigate the psychosocial impact for women of a diagnosis of Chlamydia trachomatis and discuss the implications for the proposed UK chlamydia screening programme. Design Qualitative study with semistructured intel views. Interview transcripts analysed to identify recurrent themes. Participants Seventeen women with a current or recent diagnosis of chlamydia Setting A family planning clinic and a genitourinary medicine clinic in Glasgow. Results Three themes were identified: perceptions of stigma associated with sexually transmitted infection, uncertainty about reproductive health after diagnosis, and anxieties regarding partner's reaction to diagnosis, Most women had not previously perceived sexually transmitted infections as personally relevant; this was a function of stereotypical beliefs about who was "at risk" of sexually transmitted infection. These beliefs were pervasive ans negatively affected reactions to diagnosis and produced anxiety about disclosure of the condition to others (particularly) sexual partners) and future reproductive morbidity. This anxiety, given the uncertain natural history of chlamydia, may prove difficult to dispel. Conclusions There are three primary areas of concern for women after a diagnosis of chlamydia which need to be examined in the proposed screening programme. Information provided should normalise and destigmatise chlamydial infection and positively promote genitourinary medicine services. Support services should be available because notification of partner can cause anxiety. Uncertainty about future reproductive morbidity may be inevitable; staff providing screening will require guidance in providing advice under such conditions.	Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Sandyford Initiat, Dept Genitourinary Med, Glasgow G3 7NB, Lanark, Scotland; Sandyford Initiat, Family Planning & Reprod Hlth Directorate, Glasgow G3 7NB, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Duncan, B (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.		Hart, Graham J/C-1591-2008	Hart, Graham/0000-0001-9676-6577				Ainslie DC, 1999, HASTINGS CENT REP, V29, P26, DOI 10.2307/3527734; BLACK N, 1994, J EPIDEMIOL COMMUN H, V48, P425, DOI 10.1136/jech.48.5.425-a; Buston K, 1998, BRIT J PSYCHIAT, V172, P197, DOI 10.1192/bjp.172.3.197; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; *CDC, 1997, JAMA-J AM MED ASSOC, V277, P952; Chief Medical Officer's Expert Advisory Group, 1998, MAIN REP CMOS EXP AD; Flowers P, 1997, BRIT J HEALTH PSYCH, V2, P73, DOI 10.1111/j.2044-8287.1997.tb00524.x; Holgate HS, 1998, J ROY SOC HEALTH, V118, P94, DOI 10.1177/146642409811800210; Kellock DJ, 1999, SEX TRANSM INFECT, V75, P36, DOI 10.1136/sti.75.1.36; Redfern N, 1994, Health Care Women Int, V15, P423; SANTER M, 2000, SCREENING WOMEN CHLA; SCHOLES D, 1996, NEW ENGL J MED, V334, P1352; *SIGN, 2000, MAN GEN CHLAM TRACH; Smith JA, 1996, PSYCHOL HEALTH, V11, P261, DOI 10.1080/08870449608400256	14	148	148	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	2001	322	7280					195	199		10.1136/bmj.322.7280.195	http://dx.doi.org/10.1136/bmj.322.7280.195			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	398BF	11159612	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000166733700023
J	Ruland, J; Duncan, GS; Elia, A; Barrantes, ID; Nguyen, L; Plyte, S; Millar, DG; Bouchard, D; Wakeham, A; Ohashi, PS; Mak, TW				Ruland, J; Duncan, GS; Elia, A; Barrantes, ID; Nguyen, L; Plyte, S; Millar, DG; Bouchard, D; Wakeham, A; Ohashi, PS; Mak, TW			Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappa B and neural tube closure	CELL			English	Article							CASPASE RECRUITMENT DOMAIN; T-CELL; LYMPHOCYTE-PROLIFERATION; DEFICIENT LYMPHOCYTES; TRANSCRIPTION FACTOR; CONTAINING PROTEIN; DEATH RECEPTORS; MICE LACKING; IN-VIVO; APOPTOSIS	Bcl10, a CARD-containing protein identified from the t(1;14)(p22;q32) breakpoint in MALT lymphomas, has been shown to induce apoptosis and activate NF-kappaB in vitro. We show that one-third of bcl10(-/-) embryos developed exencephaly, leading to embryonic lethality. Surprisingly, bcl10(-/-) cells retained susceptibility to various apoptotic stimuli in vivo and in vitro. However, surviving bcl10(-/-) mice were severely immunodeficient and bcl10(-/-) lymphocytes are defective in antigen receptor or PMA/lonomycin-induced activation. Early tyrosine phosphorylation, MAPK and AP-1 activation, and Ca2+ signaling were normal in mutant lymphocytes, but antigen receptor-induced NF-kappaB activation was absent. Thus, Bcl10 functions as a positive regulator of lymphocyte proliferation that specifically connects antigen receptor signaling in B and T cells to NF-kappaB activation.	Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Mak, TW (corresponding author), Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.		Duncan, Gordon/AIE-7011-2022; Ruland, Jurgen/Q-6680-2018	Ruland, Jurgen/0000-0002-8381-3597; Millar, Douglas/0000-0002-8640-7148; Ohashi, Pamela S./0000-0003-2915-9317				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BACHMANN MF, 1994, CURR OPIN IMMUNOL, V6, P320, DOI 10.1016/0952-7915(94)90108-2; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Costanzo A, 1999, J BIOL CHEM, V274, P20127, DOI 10.1074/jbc.274.29.20127; Dienz O, 2000, J BIOL CHEM, V275, P24547, DOI 10.1074/jbc.C000177200; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Du MQ, 2000, BLOOD, V95, P3885; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; GRATZNER HG, 1981, CYTOMETRY, V1, P385, DOI 10.1002/cyto.990010606; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Juriloff DM, 2000, HUM MOL GENET, V9, P993, DOI 10.1093/hmg/9.6.993; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kayagaki N, 1997, P NATL ACAD SCI USA, V94, P3914, DOI 10.1073/pnas.94.8.3914; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Li QT, 2000, GENE DEV, V14, P1729; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Oxenius A, 1998, IMMUNITY, V9, P449, DOI 10.1016/S1074-7613(00)80628-7; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; ROOST HP, 1990, EUR J IMMUNOL, V20, P2547, DOI 10.1002/eji.1830201204; Rudolph D, 2000, GENE DEV, V14, P854; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; SMITH BH, 1989, J INSECT BEHAV, V2, P397, DOI 10.1007/BF01068064; Spencer J, 1999, GUT, V44, P778, DOI 10.1136/gut.44.6.778; Srinivasula SM, 1999, J BIOL CHEM, V274, P17946, DOI 10.1074/jbc.274.25.17946; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thome M, 1999, J BIOL CHEM, V274, P9962, DOI 10.1074/jbc.274.15.9962; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zucca E, 2000, BLOOD, V96, P410	39	453	474	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2001	104	1					33	42		10.1016/S0092-8674(01)00189-1	http://dx.doi.org/10.1016/S0092-8674(01)00189-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163238	Bronze			2022-12-24	WOS:000166882300005
J	Tetley, M				Tetley, M			Instinctive sleeping and resting postures: an anthropological and zoological approach to treatment of low back and joint pain	BRITISH MEDICAL JOURNAL			English	Article											Tetley, M (corresponding author), 27 Cunningham Hill Rd, St Albans AL1 5B, England.							ROSEN SI, 1974, INTRO PRIMATES LIVIN, P20	1	9	9	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 23	2000	321	7276					1616	1618		10.1136/bmj.321.7276.1616	http://dx.doi.org/10.1136/bmj.321.7276.1616			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387RA	11124203	Green Published			2022-12-24	WOS:000166134500039
J	Pugh, J; Clarke, L; Gray, J; Haveman, J; Lawler, P; Bonner, S				Pugh, J; Clarke, L; Gray, J; Haveman, J; Lawler, P; Bonner, S			Presence of relatives during testing for brain stem death: questionnaire study	BRITISH MEDICAL JOURNAL			English	Article									S Cleveland Hosp, Intens Care Unit, Middlesbrough TS4 3BW, Cleveland, England; Univ Teesside, Ctr Hlth & Med Res, Middlesbrough TS1 3BA, Cleveland, England	University of Teesside	Bonner, S (corresponding author), S Cleveland Hosp, Intens Care Unit, Middlesbrough TS4 3BW, Cleveland, England.			gray, joanne/0000-0001-6157-230X				Black D, 1997, J ROY COLL PHYS LOND, V31, P260; COLLICAN MB, 1994, CRIT CARE NURS CLIN, V6, P607; Pallis C., 1996, ABC BRAINSTEM DEATH; Robinson SM, 1998, LANCET, V352, P614, DOI 10.1016/S0140-6736(97)12179-1; Swinburn JMA, 1999, BMJ-BRIT MED J, V318, P1753	5	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 16	2000	321	7275					1505	+		10.1136/bmj.321.7275.1505	http://dx.doi.org/10.1136/bmj.321.7275.1505			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385GF	11118177	Bronze, Green Published			2022-12-24	WOS:000165994700026
J	Rogina, B; Reenan, RA; Nilsen, SP; Helfand, SL				Rogina, B; Reenan, RA; Nilsen, SP; Helfand, SL			Extended life-span conferred by cotransporter gene mutations in Drosophila	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; LONGEVITY; DIAPAUSE; STRESS; MUTANT	Aging is genetically determined and environmentally modulated. In a study of Longevity in the adult fruit fly, Drosophila melanogaster, we found that five independent P-element insertional mutations in a single gene resulted in a near doubling of the average adult Life-span without a decline in fertility or physical activity. Sequence analysis revealed that the product of this gene, named Indy (for I'm not dead yet), is most closely related to a mammalian sodium dicarboxylate cotransporter-a membrane protein that transports Krebs cycle intermediates. Indy was most abundantly expressed in the fat body, midgut, and oenocytes: the principal sites of intermediary metabolism in the fly. Excision of the P element resulted in a reversion to normal Life-span. These mutations may create a metabolic state that mimics caloric restriction, which has been shown to extend Life-span.	Univ Connecticut, Ctr Hlth, Sch Med, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Connecticut	Helfand, SL (corresponding author), Univ Connecticut, Ctr Hlth, Sch Med, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	shelfand@neuron.uchc.edu		Rogina, Blanka/0000-0003-1195-905X	NIA NIH HHS [R37 AG016667, AG14532, AG16667] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R03AG014532, R37AG016667, R01AG016667] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bartke A, 2000, RES PRO CEL, V29, P181; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; BOYNTON S, 1992, GENETICS, V131, P655; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Chen XZ, 1998, J BIOL CHEM, V273, P20972, DOI 10.1074/jbc.273.33.20972; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Hekimi S, 2000, RES PRO CEL, V29, P81; HELFAND SL, 1995, GENETICS, V140, P549; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pajor AM, 1996, AM J PHYSIOL-RENAL, V270, pF642, DOI 10.1152/ajprenal.1996.270.4.F642; Pajor AM, 1999, ANNU REV PHYSIOL, V61, P663, DOI 10.1146/annurev.physiol.61.1.663; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; PARTRIDGE L, 1987, J INSECT PHYSIOL, V33, P745, DOI 10.1016/0022-1910(87)90060-6; Rose M.R., 1991, EVOLUTIONARY BIOL AG; SOHAL RS, 1981, EXP GERONTOL, V16, P157, DOI 10.1016/0531-5565(81)90040-1; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; SONDERGAARD L, 1993, TRENDS GENET, V9, P193, DOI 10.1016/0168-9525(93)90113-V; Wigglesworth VB, 1972, PRINCIPLES INSECT PH	26	356	389	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 15	2000	290	5499					2137	2140		10.1126/science.290.5499.2137	http://dx.doi.org/10.1126/science.290.5499.2137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	383ER	11118146				2022-12-24	WOS:000165870600054
J	Koster, R; Vieluf, D; Kiehn, M; Sommerauer, M; Kahler, J; Baldus, S; Meinertz, T; Hamm, CW				Koster, R; Vieluf, D; Kiehn, M; Sommerauer, M; Kahler, J; Baldus, S; Meinertz, T; Hamm, CW			Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis	LANCET			English	Article							METALS	Background Coronary in-stent restenosis might be triggered by contact allergy to nickel, chromate, or molybdenum ions released from stainless-steel stents. We investigated the association between allergic reactions to stent components and the occurrence of in-stent restenosis. Methods Patients with coronary stainless-steel stents who underwent angiography for suspected restenosis were consecutively included in this study. Quantitative coronary angiography for analysis of percentage diameter stenosis was done on 131 patients (mean age 62 years [SD 9]) with 171 stents 6.1 months (2.7) after stent implantation. All patients underwent epicutaneous patch tests (Finn chamber method) for nickel, chromate, molybdenum, manganese, and small 316L stainless-steel plates. Patch tests were assessed by independent dermatologists after 48 h, 72 h, and when necessary 96 h of contact with the potential allergen. Findings In-stent restenosis (greater than or equal to 50% diameter stenosis) occurred in 89 patients. All ten patients with positive patch-test results had restenoses (p=0.03). Four male patients had positive reactions to molybdenum, and seven patients (four male, three female) had reactions to nickel. No patient with an allergic reaction to the standard test substances had a positive reaction to the stainless-steel plates. All patients with positive results had recurrent angina pectoris and needed target-vessel revascularisation. Interpretation Patients with allergic patch-test reactions to nickel and molybdenum had a higher frequency of in-stent restenoses than patients without hypersensitivity. Allergic reactions to nickel and molybdenum released from stents may be one of the triggering mechanisms for in-stent restenosis.	Univ Hamburg, Hosp Eppendorf, Med Clin, Dept Cardiol, D-20249 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Med Clin, Dept Dermatol, D-20249 Hamburg, Germany	University of Hamburg; University of Hamburg	Koster, R (corresponding author), Univ Hamburg, Hosp Eppendorf, Med Clin, Dept Cardiol, Martinistr 52, D-20249 Hamburg, Germany.		Hamm, Christian W./I-3155-2017	Hamm, Christian W./0000-0001-6763-4161				Beythien C., 1998, EUR HEART J SUPPL, V19, P1947; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; Fregert S., 1981, MANUAL CONTACT DERMA, V2nd ed.; Gotman I, 1997, J ENDOUROL, V11, P383, DOI 10.1089/end.1997.11.383; KANERVA L, 1994, CONTACT DERMATITIS, V31, P299, DOI 10.1111/j.1600-0536.1994.tb02023.x; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Koster R, 1997, AM J CARDIOL, V80, P1424, DOI 10.1016/S0002-9149(97)00703-0; LYELL A, 1978, LANCET, V2, P657; Mintz GS, 1998, AM J CARDIOL, V81, p7E, DOI 10.1016/S0002-9149(98)00190-8; PELTONEN L, 1979, CONTACT DERMATITIS, V5, P27, DOI 10.1111/j.1600-0536.1979.tb05531.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; San Martin M., 1997, Allergy (Copenhagen), V52, P690, DOI 10.1111/j.1398-9995.1997.tb01064.x; SCHUBERT H, 1988, CONTACT DERMATITIS, V18, P237, DOI 10.1111/j.1600-0536.1988.tb02811.x; WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439; WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, V1, P127	15	374	399	2	43	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 2	2000	356	9245					1895	1897		10.1016/S0140-6736(00)03262-1	http://dx.doi.org/10.1016/S0140-6736(00)03262-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379WD	11130387				2022-12-24	WOS:000165665400014
J	Reisz, RR; Sues, HD				Reisz, RR; Sues, HD			Palaeontology the 'feathers' of Longisquama	NATURE			English	Article									Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; Royal Ontario Museum, Dept Palaeobiol, Toronto, ON M5S 2C6, Canada	University of Toronto; University Toronto Mississauga; Royal Ontario Museum	Reisz, RR (corresponding author), Univ Toronto, Dept Biol, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.							Feduccia A., 1996, ORIGIN EVOLUTION BIR; Jones TD, 2000, SCIENCE, V288, P2202, DOI 10.1126/science.288.5474.2202; SHAROV AG, 1970, PALEONTOL ZH, P127	3	17	18	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2000	408	6811					428	428		10.1038/35044204	http://dx.doi.org/10.1038/35044204			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100716	Bronze			2022-12-24	WOS:000165429800035
J	Fukai, S; Nureki, O; Sekine, S; Shimada, A; Tao, JS; Vassylyev, DG; Yokoyama, S				Fukai, S; Nureki, O; Sekine, S; Shimada, A; Tao, JS; Vassylyev, DG; Yokoyama, S			Structural basis for double-sieve discrimination of L-valine from L-isoleucine and L-threonine by the complex of tRNA(Val) and valyl-tRNA synthetase	CELL			English	Article							ANGSTROM CRYSTAL-STRUCTURE; AMINO-ACID DISCRIMINATION; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; BAKERS-YEAST; ZINC ION; AMINOACYLATION; ADENYLATE; MECHANISM; DETERMINANTS	Valyl-tRNA synthetase (ValRS) strictly discriminates the cognate L-valine from the larger L-isoleucine and the isosteric L-threonine by the tRNA-dependent "double sieve" mechanism. In this study, we determined the 2.9 Angstrom crystal structure of a complex of Thermus thermophilus ValRS, tRNA(Val), and an analog of the Val-adenylate intermediate. The analog is bound in a pocket, where Pro(41) allows accommodation of the Val and Thr moieties but precludes the lie moiety (the first sieve), on the aminoacylation domain, The editing domain, which hydrolyzes incorrectly synthesized Thr-tRNA(Val), is bound to the 3' adenosine of tRNA(Val). A contiguous pocket was found to accommodate the Thr moiety, but not the Val moiety (the second sieve). Furthermore, another Thr binding pocket for Thr-adenylate hydrolysis was suggested on the editing domain.	Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130033, Japan; SPring 8, Riken Harima Inst, Cellular Signaling Lab, Sayo, Hyogo 6795148, Japan; Cubist Pharmaceut Inc, Cambridge, MA 02139 USA	University of Tokyo; Japan Synchrotron Radiation Research Institute; RIKEN	Yokoyama, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Sekine, Shun-ichi/N-5450-2015; Fukai, Shuya/X-4838-2018; Vassylyev, Dmitry/A-9005-2008; Yokoyama, Shigeyuki/N-6911-2015	Sekine, Shun-ichi/0000-0001-8174-8704; Fukai, Shuya/0000-0002-1241-1443; Yokoyama, Shigeyuki/0000-0003-3133-7338; Shimada, Atsushi/0000-0002-4108-770X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Farrow MA, 1999, BIOCHEMISTRY-US, V38, P16898, DOI 10.1021/bi9920782; FERSHT A, 1985, ENZYME STRUCTURE MEC, P1; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P1238, DOI 10.1021/bi00574a019; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P818, DOI 10.1021/bi00649a014; FREIST W, 1985, BIOCHEMISTRY-US, V24, P7014, DOI 10.1021/bi00345a040; FREIST W, 1994, EUR J BIOCHEM, V220, P745, DOI 10.1111/j.1432-1033.1994.tb18675.x; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Hale SP, 1997, SCIENCE, V276, P1250, DOI 10.1126/science.276.5316.1250; Hale SP, 1996, P NATL ACAD SCI USA, V93, P2755, DOI 10.1073/pnas.93.7.2755; IGLOI GL, 1977, BIOCHEMISTRY-US, V16, P1696, DOI 10.1021/bi00627a027; JAKUBOWSKI H, 1980, BIOCHEMISTRY-US, V19, P5071, DOI 10.1021/bi00563a021; JAKUBOWSKI H, 1981, NUCLEIC ACIDS RES, V9, P3105, DOI 10.1093/nar/9.13.3105; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOHDA D, 1984, FEBS LETT, V174, P20, DOI 10.1016/0014-5793(84)81069-8; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin L, 1996, BIOCHEMISTRY-US, V35, P5596, DOI 10.1021/bi960011y; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Mechulam Y, 1999, J MOL BIOL, V294, P1287, DOI 10.1006/jmbi.1999.3339; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nomanbhoy TK, 2000, P NATL ACAD SCI USA, V97, P5119, DOI 10.1073/pnas.090102197; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rath VL, 1998, STRUCT FOLD DES, V6, P439, DOI 10.1016/S0969-2126(98)00046-X; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Sugiura I, 2000, STRUCTURE, V8, P197, DOI 10.1016/S0969-2126(00)00095-2; SUSSMAN JL, 1976, SCIENCE, V192, P853, DOI 10.1126/science.775636; TAMURA K, 1994, J BIOL CHEM, V269, P22173; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627	44	233	240	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 22	2000	103	5					793	803		10.1016/S0092-8674(00)00182-3	http://dx.doi.org/10.1016/S0092-8674(00)00182-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	375ZJ	11114335	Bronze			2022-12-24	WOS:000165433100011
J	Autran, B; Carcelain, G				Autran, B; Carcelain, G			AIDS - Boosting immunity to HIV - Can the virus help?	SCIENCE			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; RESPONSES; DISCONTINUATION; INFECTION; VIREMIA; TYPE-1		Hop La Pitie Salpetriere, Lab Immunol Cellulaire & Tissulaire, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Autran, B (corresponding author), Hop La Pitie Salpetriere, Lab Immunol Cellulaire & Tissulaire, F-75013 Paris, France.	brigitte.autran@psl.ap-hop-paris.fr						CARCELAIN G, IN PRESS J VIROL; Dalod M, 1998, J INFECT DIS, V178, P61, DOI 10.1086/515587; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Mollet L, 2000, J IMMUNOL, V165, P1692, DOI 10.4049/jimmunol.165.3.1692; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Neumann AU, 1999, AIDS, V13, P677, DOI 10.1097/00002030-199904160-00008; Ortiz GM, 1999, J CLIN INVEST, V104, pR13, DOI 10.1172/JCI7371; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Ruiz L, 2000, AIDS, V14, P397, DOI 10.1097/00002030-200003100-00013	12	43	44	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 3	2000	290	5493					946	+		10.1126/science.290.5493.946	http://dx.doi.org/10.1126/science.290.5493.946			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370BV	11184735				2022-12-24	WOS:000165103200036
J	Kourtis, AP; Bulterys, M; Nesheim, SR; Lee, FK				Kourtis, AP; Bulterys, M; Nesheim, SR; Lee, FK			Understanding the timing of HIV transmission from mother to infant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; POLYMERASE-CHAIN-REACTION; CHILD TRANSMISSION; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION; ZIDOVUDINE PROPHYLAXIS; ORAL ZIDOVUDINE; COTE-DIVOIRE; PREVENTION; INFECTION		Emory Univ, Sch Med, Div Infect Dis Epidemiol & Immunol, Dept Pediat, Atlanta, GA 30303 USA; Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Atlanta, GA USA	Emory University; Centers for Disease Control & Prevention - USA	Kourtis, AP (corresponding author), Emory Univ, Sch Med, Div Infect Dis Epidemiol & Immunol, Dept Pediat, 69 Butler St SE, Atlanta, GA 30303 USA.	akourti@pol.net		Kourtis, Athena/0000-0003-1585-1310				Andiman W, 1999, NEW ENGL J MED, V340, P977, DOI 10.1056/NEJM199904013401301; BROSSARD Y, 1995, AIDS, V9, P359, DOI 10.1097/00002030-199509040-00007; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; Bulterys M, 2000, PEDIATR CLIN N AM, V47, P241, DOI 10.1016/S0031-3955(05)70203-0; BULTERYS M, 1999, 2 C GLOB STRAT PREV; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; DEROSSI A, 1993, AIDS, V7, P1528, DOI 10.1097/00002030-199311000-00020; Fiscus SA, 1999, J INFECT DIS, V180, P99, DOI 10.1086/314840; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Kalish LA, 1997, J INFECT DIS, V175, P712, DOI 10.1093/infdis/175.3.712; KANEDA T, 1997, J PEDIAT, V111, P877; Kind C, 1998, AIDS, V12, P205, DOI 10.1097/00002030-199802000-00011; Kourtis AP, 2000, AIDS, V14, P2429, DOI 10.1097/00002030-200011100-00003; Kuhn L, 1997, AIDS, V11, P429, DOI 10.1097/00002030-199704000-00005; Kuhn L, 1996, AIDS, V10, P1181, DOI 10.1097/00002030-199609000-00026; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Landesman SH, 1996, NEW ENGL J MED, V334, P1617, DOI 10.1056/NEJM199606203342501; Lin HH, 1996, OBSTET GYNECOL, V87, P244, DOI 10.1016/0029-7844(95)00385-1; Lin HH, 1996, LANCET, V347, P1116, DOI 10.1016/S0140-6736(96)90314-1; LIN HH, 1987, J PEDIATR-US, V111, P877, DOI 10.1016/S0022-3476(87)80210-X; Mandelbrot L, 1998, JAMA-J AM MED ASSOC, V280, P55, DOI 10.1001/jama.280.1.55; MINKOFF H, 1995, AM J OBSTET GYNECOL, V173, P585, DOI 10.1016/0002-9378(95)90286-4; Mofenson L, 1998, IMMUNOL ALLERGY CLIN, V18, P441, DOI 10.1016/S0889-8561(05)70013-8; MOODLEY D, 2000, 13 INT AIDS C DURB S; MSELLATI P, 1995, J ACQ IMMUN DEF SYND, V8, P506; NEWELL ML, 1994, LANCET, V343, P1464; Newell ML, 1998, AIDS, V12, P831, DOI 10.1097/00002030-199808000-00004; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2; Pascual A, 2000, AM J OBSTET GYNECOL, V183, P638, DOI 10.1067/mob.2000.106591; Rogers AB, 1998, J INFECT DIS, V178, P960, DOI 10.1086/515692; SABA J, 1999, 6 C RETR OPP INF JAN; Shaffer N, 1999, NEW ENGL J MED, V340, P1042; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Steketee RW, 1997, J INFECT DIS, V175, P707, DOI 10.1093/infdis/175.3.707; THOMPSON LF, 1984, J IMMUNOL, V133, P2513; *US PHS TASK FORC, 2001, MMWR-MORBID MORTAL W, V47, P1; Van Rompay KKA, 2000, J VIROL, V74, P1767, DOI 10.1128/JVI.74.4.1767-1774.2000; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; ZACK JA, 1992, J VIROL, V66, P1717, DOI 10.1128/JVI.66.3.1717-1725.1992; [No title captured]	44	111	119	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2001	285	6					709	712		10.1001/jama.285.6.709	http://dx.doi.org/10.1001/jama.285.6.709			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399MP	11176886				2022-12-24	WOS:000166817200002
J	Schwetz, BA				Schwetz, BA			First drug for cervical dystonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									Off Commissioner Food & Drugs, Rockville, MD 20857 USA		Schwetz, BA (corresponding author), Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2001	285	6					724	724		10.1001/jama.285.6.724-a	http://dx.doi.org/10.1001/jama.285.6.724-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399MP	11176890				2022-12-24	WOS:000166817200007
J	Hammel, P; Couvelard, A; O'Toole, D; Ratouis, A; Sauvanet, A; Flejou, JF; Degott, C; Belghiti, J; Bernades, P; Valla, D; Ruszniewski, P; Levy, P				Hammel, P; Couvelard, A; O'Toole, D; Ratouis, A; Sauvanet, A; Flejou, JF; Degott, C; Belghiti, J; Bernades, P; Valla, D; Ruszniewski, P; Levy, P			Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC-ALCOHOLIC PANCREATITIS; MEDICAL-SURGICAL SERIES; CIRRHOSIS; RAT; PROGRESSION; MODEL	Background: Chronic obstruction of the common bile duct may cause hepatic fibrosis and secondary biliary cirrhosis. Methods: We studied liver-biopsy specimens from 11 patients with chronic stenosis of the common bile duct due to chronic pancreatitis; all the patients had undergone liver biopsy before or at the time of surgical biliary decompression and underwent a subsequent liver biopsy for various clinical reasons. The patients were followed as part of a prospective study of 501 patients who had been treated for chronic pancreatitis. Two pathologists, who were unaware of the sequence of specimens, graded fibrosis on a scale of 0 (none) to 3 (cirrhosis). Results: The 11 patients were all men. Chronic pancreatitis was due to alcohol abuse in 10 of the men; 1 had idiopathic disease. The median age at diagnosis was 38 years. The median interval between the first and second liver biopsies was 2.5 years (range, 0.3 to 9.0). The two patients who had restenosis of the biliary anastomosis were excluded from the analysis of fibrosis. In the group of nine patients without restenosis, the second specimen showed significant improvement in fibrosis (P = 0.01). The fibrosis improved by two grades in two patients and by one grade in four patients; in three patients, the grade did not change. The pathologists agreed on the grading of specimens from 10 of the 11 patients. Conclusions: In patients with chronic pancreatitis and stenosis of the common bile duct, liver fibrosis may regress after biliary drainage. (N Engl J Med 2001;344:418-23.) Copyright (C) 2001 Massachusetts Medical Society.	Hop Beaujon, AP HP, Serv Gastroenterol, F-92118 Clichy, France; Hop Beaujon, Serv Anat Pathol, F-92118 Clichy, France; Hop Beaujon, Serv Chirurg Digest, F-92118 Clichy, France; Hop Beaujon, Serv Hepatol, F-92118 Clichy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Ruszniewski, P (corresponding author), Hop Beaujon, AP HP, Serv Gastroenterol, F-92118 Clichy, France.			Anne, Couvelard/0000-0002-6316-1210; Valla, Dominique/0000-0002-4460-7643; SAUVANET, alain/0000-0002-7436-5999; Hammel, Pascal/0000-0002-4630-4996; O'Toole, Dermot/0000-0001-6404-991X				ADSON MA, 1968, ARCH SURG-CHICAGO, V96, P604; AFROUDAKIS A, 1981, HEPATOLOGY, V1, P65, DOI 10.1002/hep.1840010111; AXON ATR, 1984, GUT, V25, P1107, DOI 10.1136/gut.25.10.1107; BARTHET M, 1994, ENDOSCOPY, V26, P569, DOI 10.1055/s-2007-1009041; BERNADES P, 1983, GASTROEN CLIN BIOL, V7, P8; BUNTON GL, 1963, ANN NY ACAD SCI, V111, P412, DOI 10.1111/j.1749-6632.1963.tb36981.x; Degott C, 1999, HEPATOLOGY, V29, P1007, DOI 10.1002/hep.510290444; DEVIERE J, 1994, GUT, V35, P122, DOI 10.1136/gut.35.1.122; FRANCO D, 1979, ARCH SURG-CHICAGO, V114, P1064; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; GROSS JB, 1987, HEPATOLOGY, V7, P457, DOI 10.1002/hep.1840070308; Hollander M., 1973, NONPARAMETRIC STAT M; Kaplan MM, 1997, ANN INTERN MED, V126, P682, DOI 10.7326/0003-4819-126-9-199705010-00002; KONTOURAS J, 1984, BR J EXP PATHOL, V65, P305; LESUR G, 1993, HEPATOLOGY, V18, P1078; LEVY P, 1989, GASTROENTEROLOGY, V96, P1165, DOI 10.1016/0016-5085(89)91637-5; LEVY P, 1993, PANCREAS, V8, P563, DOI 10.1097/00006676-199309000-00006; Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P944, DOI 10.1111/j.1530-0277.1999.tb04209.x; POSNER MC, 1990, J SURG RES, V48, P204, DOI 10.1016/0022-4804(90)90214-M; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; SCOBIE BA, 1965, AM J DIG DIS, V10, P135, DOI 10.1007/BF02236664; Sobesky R, 1999, GASTROENTEROLOGY, V116, P378, DOI 10.1016/S0016-5085(99)70135-6; WAY LW, 1981, SURG CLIN N AM, V61, P963; ZIMMERMANN H, 1992, GASTROENTEROLOGY, V103, P579, DOI 10.1016/0016-5085(92)90850-X	24	308	321	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2001	344	6					418	423		10.1056/NEJM200102083440604	http://dx.doi.org/10.1056/NEJM200102083440604			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	399FH	11172178	Bronze			2022-12-24	WOS:000166800600004
J	Crystal, RG				Crystal, RG			Research opportunities and advances in lung disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOWER RESPIRATORY-TRACT; CYSTIC-FIBROSIS GENE; ALPHA-1-ANTITRYPSIN DEFICIENCY; ELASTASE DEFENSES; MEDICAL PROGRESS; THERAPY; IDENTIFICATION; ADENOVIRUS; AEROSOL; INVIVO	Lung diseases cause morbidity, mortality, and economic burden. Susceptibility to pathogenesis of most lung diseases result from a complex interaction of a relevant challenge from the environment, genetic background, and the nature of the host responses. Cutting-edge research in lung disease now centers on understanding the lung as a genetically determined biological organ that functions to mediate gas exchange and defend against a hostile environment. A major challenge is to determine the hierarchy of gene expression that integrates the function of multiple cell types in this complex anatomy. Emerging therapies that will play a major role in the future treatment of lung disease include the use of recombinant proteins. including monoclonal antibodies, cell therapy (including stem cells), and gene therapy. Future advances will include the cure of the major hereditary lung disorders by gene therapy, new treatment for asthma, chronic obstructive pulmonary disease, and interstitial lung disease; development of vaccines to protect the lung from major lung pathogens; and pathogen-specific "designer" therapies to eradicate chronic lung infections.	Cornell Univ, Weill Med Coll, Inst Med Genet, New York, NY 10021 USA	Cornell University	Crystal, RG (corresponding author), Cornell Univ, Weill Med Coll, Inst Med Genet, 520 E 70th St,Suite 505, New York, NY 10021 USA.							Anderson WF, 1998, NATURE, V392, P25; ANTO JM, 1989, NEW ENGL J MED, V320, P1097, DOI 10.1056/NEJM198904273201701; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Barnes PJ, 1999, NEW ENGL J MED, V341, P2006, DOI 10.1056/NEJM199912233412610; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; BARNES PJ, 1997, ASTHMA; BECKLAKE MR, 2000, TXB RESP MED, P1811; BEWIG B, 1997, LUNG SCI FDN, P395; BITTERMAN PB, 1986, NEW ENGL J MED, V314, P1343, DOI 10.1056/NEJM198605223142103; Cannizzo SJ, 1997, NAT BIOTECHNOL, V15, P570, DOI 10.1038/nbt0697-570; Crystal R. G., 1997, LUNG SCI FDN; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; CRYSTAL RG, 1994, NAT GENET, V8, P42, DOI 10.1038/ng0994-42; CRYSTAL RG, 1995, SCIENCE, V270, P404, DOI 10.1126/science.270.5235.404; CRYSTAL RG, 1984, MED HLTH ANN, P271; CRYSTAL RG, 1988, CECIL TXB MED, P421; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Finkbeiner WE., 1997, LUNG SCI FDN, P415; FRIZZELL RA, 1999, PHYSIOL REV, V79, P1; GADEK JE, 1979, SCIENCE, V206, P1315, DOI 10.1126/science.316188; GALLIN J, 1992, INFLAMMATION, P983; GARVER RI, 1987, SCIENCE, V237, P762, DOI 10.1126/science.3497452; Goldhaber SZ, 1998, NEW ENGL J MED, V339, P93, DOI 10.1056/NEJM199807093390207; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Harvey BG, 1999, J CLIN INVEST, V104, P1245, DOI 10.1172/JCI7935; HARVEY BG, 1997, LUNG SCI FDN, P2339; HUBBARD RC, 1990, LUNG, V168, P565, DOI 10.1007/BF02718179; HUBBARD RC, 1989, ANN INTERN MED, V111, P206, DOI 10.7326/0003-4819-111-3-206; HUBBARD RC, 1989, J CLIN INVEST, V84, P1349, DOI 10.1172/JCI114305; JOBE AH, 1993, NEW ENGL J MED, V328, P861; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kikuchi T, 2000, NAT MED, V6, P1154, DOI 10.1038/80498; MASTRANGELI A, 1997, LUNG SCI FDN, P2795; MCELVANEY NG, 1997, LUNG SCI FDN, P2537; MCELVANEY NG, 1997, LUNG SCI FDN, P2219; McElvaney NG, 1997, LUNG SCI FDN, P2205; Milgrom H, 1999, NEW ENGL J MED, V341, P1966, DOI 10.1056/NEJM199912233412603; Murin S, 1998, AM J RESP CRIT CARE, V158, P1369, DOI 10.1164/ajrccm.158.5.9712022; NAIDICH DP, 1998, COMPUTER TOMOGRAPHY; *NAT ASTHM ED PREV, 2000, NAT HEART LUNG BLOOD; *NAT HEART LUNG BL, 2000, NAT HEART LUNG BLOOD; NUKIWA T, 1986, J BIOL CHEM, V261, P5989; PARKES WR, 1994, OCCUPATIONAL LUNG DI; Perl AKT, 1999, CLIN GENET, V56, P14, DOI 10.1034/j.1399-0004.1999.560103.x; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; Remy-Jardin M, 1999, RADIOLOGY, V212, P615, DOI 10.1148/radiology.212.3.r99se02615; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rose CS, 2000, TXB RESP MED, P1867; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Russi TJ, 1997, LUNG SCI FDN, V1, P371; SANFORD AJ, 2000, AM J RESP CRIT CARE, V161, pS202; Shields TLJ, 2000, GEN THORACIC SURG; Song S, 1998, P NATL ACAD SCI USA, V95, P14384, DOI 10.1073/pnas.95.24.14384; Strollo PJ, 1996, NEW ENGL J MED, V334, P99, DOI 10.1056/NEJM199601113340207; TOBIN MJ, 1998, PRINCIPLES PRACTICES; WALDRON HA, 1994, OCCUPATIONAL LUNG DI, P593; WANG KP, 1995, FLEXIBLE BRONCHOSCOP; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; WEWERS MD, 1987, NEW ENGL J MED, V316, P1055, DOI 10.1056/NEJM198704233161704; Whitsett J, 1998, NAT GENET, V20, P7, DOI 10.1038/1654; WHITSETT JA, 1997, LUNG SCI FDN, P383; WHITSETT JA, 1997, LUNG SCI FDN, P2167; Wolff G., 1997, LUNG SCI FDN, P2509; WORSLEY D, 2000, TXB RESP MED, P697; 2000, NAT GENET S, V21, P1	69	10	11	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					612	618		10.1001/jama.285.5.612	http://dx.doi.org/10.1001/jama.285.5.612			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176868	Bronze			2022-12-24	WOS:000166714200021
J	Prigozy, TI; Naidenko, O; Qasba, P; Elewaut, D; Brossay, L; Khurana, A; Natori, T; Koezuka, Y; Kulkarni, A; Kronenberg, M				Prigozy, TI; Naidenko, O; Qasba, P; Elewaut, D; Brossay, L; Khurana, A; Natori, T; Koezuka, Y; Kulkarni, A; Kronenberg, M			Glycolipid antigen processing for presentation by CD1d molecules	SCIENCE			English	Article							ALPHA-GALACTOSIDASE; T-CELLS; MOUSE; GLYCOSIDASES; RECOGNITION; SPECIFICITY; DEGRADATION; REACTIVITY	The requirement for processing glycolipid antigens in T cell recognition was examined with mouse CD1d-mediated responses to glycosphingolipids (GSLs). Although some disaccharide GSL antigens can be recognized without processing, the responses to three other antigens, including the disaccharide GSL Gal(alpha1-->2)GalCer (Gal, galactose; GalCer, galactosylceramide), required removal of the terminal sugars to permit interaction with the T cell receptor. A Lysosomal enzyme, alpha -galactosidase A, was responsible for the processing of Gal(alpha1-->2)GalCer to generate the antigenic monosaccharide epitope. These data demonstrate a carbohydrate antigen processing system analogous to that used for peptides and an ability of T cells to recognize processed fragments of complex glycolipids.	La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA; NINCDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA; Kirin Brewery Co Ltd, Pharmaceut Res Lab, Gunma 37012, Japan; Natl Inst Dent & Craniofacial Res, Funct Genom Unit, Bethesda, MD 20892 USA	La Jolla Institute for Immunology; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Kirin Brewery Company Limited; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, 10355 Sci Ctr Dr, San Diego, CA 92121 USA.	mitch@liai.org	Elewaut, Dirk/K-6831-2014	Brossay, Laurent/0000-0002-7497-8488	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040617] Funding Source: NIH RePORTER; NCI NIH HHS [CA52511] Funding Source: Medline; NIAID NIH HHS [AI40617] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASANO N, 1994, J MED CHEM, V37, P3701, DOI 10.1021/jm00048a006; Asano N, 1997, EUR J BIOCHEM, V248, P296, DOI 10.1111/j.1432-1033.1997.00296.x; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Brossay L, 1998, J IMMUNOL, V160, P3681; Burdin N, 1998, J IMMUNOL, V161, P3271; Glithero A, 1999, IMMUNITY, V10, P63, DOI 10.1016/S1074-7613(00)80007-2; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Harada M, 1997, LIVER, V17, P244; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; LUSIS AJ, 1976, BIOCHIM BIOPHYS ACTA, V437, P487, DOI 10.1016/0304-4165(76)90017-9; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; NATORI T, 1994, TETRAHEDRON, V50, P2771, DOI 10.1016/S0040-4020(01)86991-X; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Sandhoff K, 1996, TRENDS CELL BIOL, V6, P98, DOI 10.1016/0962-8924(96)80999-8; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; YAGI F, 1990, ARCH BIOCHEM BIOPHYS, V280, P61, DOI 10.1016/0003-9861(90)90518-4	23	253	266	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2001	291	5504					664	667		10.1126/science.291.5504.664	http://dx.doi.org/10.1126/science.291.5504.664			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396BG	11158680				2022-12-24	WOS:000166616000047
J	de Bock, GH; van Asperen, CJ; de Vries, JM; Hageman, GCHA; Springer, MP; Kievit, J				de Bock, GH; van Asperen, CJ; de Vries, JM; Hageman, GCHA; Springer, MP; Kievit, J			How women with a family history of breast cancer and their general practitioners act on genetic advice in general practice: prospective longitudinal study	BRITISH MEDICAL JOURNAL			English	Article									Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Gen Practice, NL-2300 RC Leiden, Netherlands; Wantveld Hlth Care Ctr, Noordwijk, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Bock, GH (corresponding author), Leiden Univ, Med Ctr, Dept Med Decis Making, POB 9600, NL-2300 RC Leiden, Netherlands.		Kievit, Job/A-3924-2008; de Bock, Geertruida Hendrika/F-6529-2014	de Bock, Geertruida Hendrika/0000-0003-3104-4471				deBock GH, 1997, FAM PRACT, V14, P40, DOI 10.1093/fampra/14.1.40; Duijm LEM, 1997, FAM PRACT, V14, P450, DOI 10.1093/fampra/14.6.450; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; Kinmonth AL, 1998, BMJ-BRIT MED J, V316, P767, DOI 10.1136/bmj.316.7133.767; Moss SM, 1999, LANCET, V353, P1909, DOI 10.1016/S0140-6736(98)07412-1	5	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JAN 6	2001	322	7277					26	27		10.1136/bmj.322.7277.26	http://dx.doi.org/10.1136/bmj.322.7277.26			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391EP	11141149	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000166341400021
J	Mayle, FE; Burbridge, R; Killeen, TJ				Mayle, FE; Burbridge, R; Killeen, TJ			Millennial-scale dynamics of southern Amazonian rain forests	SCIENCE			English	Article							REGION; BOLIVIA; RECORD; CLIMATE; BP	Amazonian rain forest-savanna boundaries are highly sensitive to climatic change and may also play an important role in rain forest speciation. However, their dynamics over millennial time scales are poorly understood. Here, we present late Quaternary pollen records from the southern margin of Amazonia, which show that the humid evergreen rain forests of eastern Bolivia have been expanding southward over the past 3000 years and that their present-day Limit represents the southernmost extent of Amazonian rain forest over at Least the past 50,000 years. This rain forest expansion is attributed to increased seasonal Latitudinal migration of the Intertropical Convergence Zone, which can in turn be explained by Milankovitch astronomic forcing.	Univ Leicester, Dept Geog, Leicester LE1 7RH, Leics, England; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20037 USA; Museo Hist Nat Noel Kempff Mercado, Santa Cruz De La Sierra, Santa Cruz, Bolivia	University of Leicester; Conservation International	Mayle, FE (corresponding author), Univ Leicester, Dept Geog, Leicester LE1 7RH, Leics, England.			Mayle, Francis/0000-0001-9208-0519				Abbott MB, 1997, QUATERNARY RES, V47, P169, DOI 10.1006/qres.1997.1881; ABSY M L, 1976, Acta Amazonica, V6, P293; ABSY ML, 1991, CR ACAD SCI II, V312, P673; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BURBRIDGE R, UNPUB; COLINVAUX P, 1999, AMAZON PLLEN MANUAL; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Cross SL, 2000, HOLOCENE, V10, P21, DOI 10.1191/095968300671452546; DEFREITAS HA, IN PRESS QUAT RES; Faegri K., 1975, TXB MODERN POLLEN AN; KILLEEN T, 1998, HUANCHACA PLATEAU NO; KILLEEN TJ, 1992, J TROP ECOL, V8, P389, DOI 10.1017/S0266467400006714; Killeen TJ, 1998, J TROP ECOL, V14, P803, DOI 10.1017/S0266467498000583; KILLEEN TJ, UNPUB; Latrubesse E., 1994, QUATERN INT, V21, P163; Litherland M., 1989, J S AM EARTH SCI, V2, P1, DOI [DOI 10.1016/0895-9811(89)90023-0, 10.1016/0895-9811(89)90023-0]; Martin L, 1997, QUATERNARY RES, V47, P117, DOI 10.1006/qres.1996.1866; MAYLE FE, UNPUB; Pessenda LCR, 1998, HOLOCENE, V8, P599, DOI 10.1191/095968398673187182; Pessenda LCR, 1998, RADIOCARBON, V40, P1013, DOI 10.1017/S0033822200018981; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Soubies F., 1979, CAH ORSTOM G, V1, P133; SOUBIES F, 1991, B IG USP PUBL ESP, V8, P233; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; Turcq B, 1998, AMBIO, V27, P139; VANDERHAMMEN T, 1994, PALAEOGEOGR PALAEOCL, V109, P247, DOI 10.1016/0031-0182(94)90178-3; WIRRMANN D, 1995, QUATERNARY RES, V43, P344, DOI 10.1006/qres.1995.1040; WRIGHT HE, 1967, J SEDIMENT PETROL, V27, P957	29	351	366	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 22	2000	290	5500					2291	+		10.1126/science.290.5500.2291	http://dx.doi.org/10.1126/science.290.5500.2291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125139	Green Published			2022-12-24	WOS:000165995800039
J	Toth, A; Rabitsch, KP; Galova, M; Schleiffer, A; Buonomo, SBC; Nasmyth, K				Toth, A; Rabitsch, KP; Galova, M; Schleiffer, A; Buonomo, SBC; Nasmyth, K			Functional genomics identifies Monopolin: A kinetochore protein required for segregation of homologs during meiosis I	CELL			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; DNA-REPLICATION; MEIOTIC DIVISION; CELL-CYCLE; YEAST; SEPARATION; RECOMBINATION; TRANSITION	The orderly reduction in chromosome number that occurs during meiosis depends on two aspects of chromosome behavior specific to the first meiotic division. These are the retention of cohesion between sister centromeres and their attachment to microtubules that extend to the same pole (monopolar attachment). By deleting genes that are upregulated during meiosis, we identified in Saccharomyces cerevisiae a kinetochore associated protein, Mam1 (Monopolin), which is essential for monopolar attachment. We also show that the meiosis-specific cohesin, Rec8, is essential for maintaining cohesion between sister centromeres but not for monopolar attachment. We conclude that monopolar attachment during meiosis I requires at least one meiosis-specific protein and is independent of the process that protects sister centromere cohesion.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Nasmyth, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Toth, Attila/C-9624-2013	Toth, Attila/0000-0001-5744-3847; Buonomo, Sara/0000-0002-0177-2884; Schleiffer, Alexander/0000-0001-6251-2747; Nasmyth, Kim/0000-0001-7030-4403				Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Kamieniecki RJ, 2000, CURR BIOL, V10, P1182, DOI 10.1016/S0960-9822(00)00723-5; KLAPHOLZ S, 1980, GENETICS, V96, P567; KLAPHOLZ S, 1980, GENETICS, V96, P589; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; LOIDL J, 1988, NUCL STRUCTURE FUNCT; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Mendel JG., 1865, VERHANDLUNGEN NATURF, V4, P3, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A106151; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MIYAZAKI WY, 1994, ANNU REV GENET, V28, P167, DOI 10.1146/annurev.ge.28.120194.001123; Moore DP, 1998, CURR TOP DEV BIOL, V37, P263; Moore DP, 1998, J CELL BIOL, V140, P1003, DOI 10.1083/jcb.140.5.1003; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; OSTERGREN G, 1951, HEREDITAS, V37, P85; Paliulis LV, 2000, J CELL BIOL, V150, P1223, DOI 10.1083/jcb.150.6.1223; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Sambrook J, 1989, MOL CLONING, V3; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SUJA JA, 1991, GENOME, V34, P19, DOI 10.1139/g91-004; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tang TTL, 1998, GENE DEV, V12, P3843, DOI 10.1101/gad.12.24.3843; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Zeng XM, 2000, GENETICS, V155, P577; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	44	231	238	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 22	2000	103	7					1155	1168		10.1016/S0092-8674(00)00217-8	http://dx.doi.org/10.1016/S0092-8674(00)00217-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163190	Bronze			2022-12-24	WOS:000166040600017
J	Huh, GS; Boulanger, LM; Du, HP; Riquelme, PA; Brotz, TM; Shatz, CJ				Huh, GS; Boulanger, LM; Du, HP; Riquelme, PA; Brotz, TM; Shatz, CJ			Functional requirement for class I MHC in CNS development and plasticity	SCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; LONG-TERM POTENTIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; CENTRAL-NERVOUS-SYSTEM; SYNAPTIC PLASTICITY; GENE-EXPRESSION; MICE; RETINOGENICULATE; SEGREGATION; SYNAPSES	Class I major histocompatibility complex (class I MHC) molecules, known to be important for immune responses to antigen, are expressed also by neurons that undergo activity-dependent, Long-term structural and synaptic modifications. Here, we show that in mice genetically deficient for cell surface class I MHC or for a class I MHC receptor component, CD3 zeta, refinement of connections between retina and central targets during development is incomplete. In the hippocampus of adult mutants, N-methyl-D-aspartate receptor-dependent Long-term potentiation (LTP) is enhanced, and Long-term depression (LTD) is absent. Specific class I MHC messenger RNAs are expressed by distinct mosaics of neurons, reflecting a potential for diverse neuronal functions. These results demonstrate an important role for these molecules in the activity-dependent remodeling and plasticity of connections in the developing and mature mammalian central nervous system (CNS).	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Huh, GS (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Brotz, Tilmann M/R-6599-2016	Brotz, Tilmann M/0000-0001-8212-459X; Boulanger, Lisa/0000-0002-6578-7890	NATIONAL EYE INSTITUTE [F32EY007016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NEI NIH HHS [F32 EY007016-02, EY06912, 1F32EY07016, F32 EY007016-03, F32 EY007016] Funding Source: Medline; NIMH NIH HHS [MH48108] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGGELOPOULOS N, 1989, ANAT EMBRYOL, V180, P243, DOI 10.1007/BF00315883; Amadou C, 1999, IMMUNOL REV, V167, P211, DOI 10.1111/j.1600-065X.1999.tb01394.x; Amsen D, 1998, IMMUNOL REV, V165, P209, DOI 10.1111/j.1600-065X.1998.tb01241.x; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Deisseroth K, 1995, CURR BIOL, V5, P1334, DOI 10.1016/S0960-9822(95)00262-4; Dorfman JR, 1997, J IMMUNOL, V159, P5219; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; JACKSON MR, 1993, ANNU REV CELL BIOL, V9, P207, DOI 10.1146/annurev.cb.09.110193.001231; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LIEBERMAN AR, 1974, J NEUROCYTOL, V3, P677, DOI 10.1007/BF01097191; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; SO KF, 1990, J EXP BIOL, V153, P85; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; TESSIERLAVIGNE M, 1995, CELL, V82, P345, DOI 10.1016/0092-8674(95)90421-2; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	37	617	634	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2000	290	5499					2155	2159		10.1126/science.290.5499.2155	http://dx.doi.org/10.1126/science.290.5499.2155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	383ER	11118151	Green Accepted			2022-12-24	WOS:000165870600059
J	Morisset, S; Rouleau, A; Ligneau, X; Gbahou, F; Tardivel-Lacombe, J; Stark, H; Schunack, W; Ganellin, CR; Schwartz, JC; Arrang, JM				Morisset, S; Rouleau, A; Ligneau, X; Gbahou, F; Tardivel-Lacombe, J; Stark, H; Schunack, W; Ganellin, CR; Schwartz, JC; Arrang, JM			High constitutive activity of native H(3) receptors regulates histamine neurons in brain	NATURE			English	Article							INVERSE AGONISTS; CEREBRAL-CORTEX; EXPRESSION; LIGANDS; BINDING; POTENT; H-3-RECEPTORS; ANTAGONISTS; ISOFORMS; RELEASE	Some G-protein-coupled receptors display 'constitutive activity', that is, spontaneous activity in the absence of agonist(1-4). This means that a proportion of the receptor population spontaneously undergoes an allosteric transition, leading to a conformation that can bind G proteins(3). The process has been shown to occur with recombinant receptors expressed at high density, and/or mutated, but also non-mutated recombinant receptors expressed at physiological concentrations(5-7). Transgenic mice that express a constitutively active mutant of the beta (2)-adrenergic receptor display cardiac anomalies(8); and spontaneous receptor mutations leading to constitutive activity are at the origin of some human diseases(9,10). Nevertheless, this process has not previously been found to occur in animals expressing normal levels of receptor(3,4). Here we show that two isoforms of the recombinant rat H(3) receptor(11,12) display high constitutive activity. Using drugs that abrogate this activity ('inverse agonists') and a drug that opposes both agonists and inverse agonists ('neutral antagonist'), we show that constitutive activity of native H(3) receptors is present in rodent brain and that it controls histaminergic neuron activity in vivo. Inverse agonists may therefore rnd therapeutic applications, even in the case of diseases involving non-mutated receptors expressed at normal levels.	Ctr Paul Broca, INSERM, U109, Unite Neurobiol & Pharmacol Mol, F-75014 Paris, France; Lab Bioprojet, F-75002 Paris, France; Free Univ Berlin, Inst Pharm, D-14195 Berlin, Germany; UCL, Christopher Ingold Labs, Dept Chem, London WC1H 0AJ, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Free University of Berlin; University of London; University College London	Arrang, JM (corresponding author), Ctr Paul Broca, INSERM, U109, Unite Neurobiol & Pharmacol Mol, 2ter Rue Alesia, F-75014 Paris, France.	arrang@broca.inserm.fr	QUEMENER, Agnès/R-9489-2019; Gbahou, Florence/L-4664-2017; Stark, Holger/A-4235-2009; MORISSET, Séverine/S-7450-2017	QUEMENER, Agnès/0000-0002-4026-8496; Stark, Holger/0000-0003-3336-1710; MORISSET, Séverine/0000-0002-9930-7824; Ligneau, Xavier/0000-0003-3097-4482				ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; ARRANG JM, 1985, NEUROSCIENCE, V15, P553, DOI 10.1016/0306-4522(85)90233-7; ARRANG JM, 1987, NATURE, V327, P117, DOI 10.1038/327117a0; Berg KA, 1999, MOL PHARMACOL, V55, P863; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Claeysen S, 1999, MOL PHARMACOL, V55, P910; Clark EA, 1996, EUR J PHARMACOL, V296, P223, DOI 10.1016/0014-2999(95)00800-4; CLARK EA, 1995, BRIT J PHARMACOL, V114, P357, DOI 10.1111/j.1476-5381.1995.tb13234.x; COSTA T, 1992, MOL PHARMACOL, V41, P549; GARBARG M, 1992, J PHARMACOL EXP THER, V263, P304; GARBARG M, 1989, EUR J PHARMACOL, V164, P1, DOI 10.1016/0014-2999(89)90225-2; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; Harper EA, 1999, BRIT J PHARMACOL, V128, P751, DOI 10.1038/sj.bjp.0702861; Hill SJ, 1997, PHARMACOL REV, V49, P253; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; LIGNEAU X, 1994, J PHARMACOL EXP THER, V271, P452; Ligneau X, 1998, J PHARMACOL EXP THER, V287, P658; Lovenberg TW, 1999, MOL PHARMACOL, V55, P1101, DOI 10.1124/mol.55.6.1101; MILLIGAN G, 1995, TRENDS PHARMACOL SCI, V16, P10, DOI 10.1016/S0165-6147(00)88963-4; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sasse A, 1999, J MED CHEM, V42, P4269, DOI 10.1021/jm991068w; SCHUTZ W, 1992, TRENDS PHARMACOL SCI, V13, P376, DOI 10.1016/0165-6147(92)90116-N; Smith GP, 1996, MOL DIVERS, V2, P2, DOI 10.1007/BF01718693; Spiegel AM, 1996, ANNU REV PHYSIOL, V58, P143, DOI 10.1146/annurev.ph.58.030196.001043; Tardivel-Lacombe J, 2000, NEUROREPORT, V11, P755, DOI 10.1097/00001756-200003200-00020; WEST RE, 1990, MOL PHARMACOL, V38, P610; Yates SL, 1999, BIOCHEM PHARMACOL, V57, P1059, DOI 10.1016/S0006-2952(98)00378-5	30	392	434	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2000	408	6814					860	864		10.1038/35048583	http://dx.doi.org/10.1038/35048583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130725				2022-12-24	WOS:000165831300051
J	McNamee, D				McNamee, D			Pies flying low in a blue sky	LANCET			English	Editorial Material									Lancet, London WC1X 8RR, England		McNamee, D (corresponding author), Lancet, London WC1X 8RR, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 9	2000	356	9246					1948	1948		10.1016/S0140-6736(00)03305-5	http://dx.doi.org/10.1016/S0140-6736(00)03305-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383DJ	11130521				2022-12-24	WOS:000165867600007
J	Chang, HY; Ready, DF				Chang, HY; Ready, DF			Rescue of photoreceptor degeneration in rhodopsin-null Drosophila mutants by activated Rac1	SCIENCE			English	Article							SMALL GTPASES; ACTIN CYTOSKELETON; CYTOCHALASIN-D; RHO GTPASES; G-PROTEINS; MORPHOGENESIS; GENE; DISRUPTION; MICE; ROD	Rhodopsin is essential for photoreceptor morphogenesis; photoreceptors lacking rhodopsin degenerate in humans, mice, and Drosophila. Here we report that transgenic expression of a dominant-active Drosophila Rho guanosine triphosphatase, Drac1, rescued photoreceptor morphogenesis in rhodopsin-null mutants; expression of dominant-negative Drac1 resulted in a phenotype similar to that seen in rhodopsin-null mutants. Drac1 was localized in a specialization of the photoreceptor cortical actin cytoskeleton, which was lost in rhodopsin-null mutants. Thus, rhodopsin appears to organize the actin cytoskeleton through Drac1, contributing a structural support-essential for photoreceptor morphogenesis.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ready, DF (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.				NEI NIH HHS [EY10306] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010306] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Fan SS, 1997, DEVELOPMENT, V124, P1497; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harden N, 1999, J CELL SCI, V112, P273; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Kumar JP, 1997, DEV BIOL, V188, P43, DOI 10.1006/dbio.1997.8636; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; LEONARD DS, 1992, J NEUROBIOL, V23, P605, DOI 10.1002/neu.480230602; LONGLEY R, UNPUB; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Magie CR, 1999, DEVELOPMENT, V126, P5353; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; PAULSEN R, 1979, BIOCHIM BIOPHYS ACTA, V557, P385, DOI 10.1016/0005-2736(79)90336-5; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; VAUGHAN DK, 1989, INVEST OPHTH VIS SCI, V30, P339; WILLIAMS DS, 1991, BIOESSAYS, V13, P171, DOI 10.1002/bies.950130405; WILLIAMS DS, 1992, J CELL SCI, V103, P183; WILLIAMS DS, 1988, J COMP NEUROL, V272, P161, DOI 10.1002/cne.902720202	23	101	101	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2000	290	5498					1978	1980		10.1126/science.290.5498.1978	http://dx.doi.org/10.1126/science.290.5498.1978			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382EL	11110667				2022-12-24	WOS:000165810000050
J	Malin, MC; Edgett, KS				Malin, MC; Edgett, KS			Sedimentary rocks of early Mars	SCIENCE			English	Article							LAYERED DEPOSITS; VALLES-MARINERIS; GLOBAL SURVEYOR; ASTRONOMICAL THEORY; MARTIAN HIGHLANDS; RECENT VOLCANISM; EVOLUTION; SURFACE; CHANNELS; ORIGIN	Layered and massive outcrops on Mars, some as thick as 4 kilometers, display the geomorphic attributes and stratigraphic relations of sedimentary rock. Repeated beds in some locations imply a dynamic depositional environment during early martian history. Subaerial (such as eolian, impact, and volcaniclastic) and subaqueous processes may have contributed to the formation of the layers. Affinity for impact craters suggests dominance of lacustrine deposition; alternatively, the materials were deposited in a dry, subaerial setting in which atmospheric density, and variations thereof mimic a subaqueous depositional environment. The source regions and transport paths for the materials are not preserved.	Malin Space Sci Syst, San Diego, CA 92191 USA		Malin, MC (corresponding author), Malin Space Sci Syst, POB 910148, San Diego, CA 92191 USA.			Edgett, Kenneth/0000-0001-7197-5751				BLANEY DL, 1989, J GEOPHYS RES-SOLID, V94, P10159, DOI 10.1029/JB094iB08p10159; Blasius K. R., 1977, Journal of Geophysical Research, V82, P4067, DOI 10.1029/JS082i028p04067; Cabrol NA, 1999, ICARUS, V142, P160, DOI 10.1006/icar.1999.6191; Carr MH, 2000, ICARUS, V146, P366, DOI 10.1006/icar.2000.6428; CHAPMAN CR, 1974, ICARUS, V22, P272, DOI 10.1016/0019-1035(74)90177-8; CHAPMAN CR, 1968, ASTRON J, V74, P1039; CHRISTENSEN PR, 1988, J GEOPHYS RES-SOLID, V93, P7611, DOI 10.1029/JB093iB07p07611; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 1998, SCIENCE, V279, P1692, DOI 10.1126/science.279.5357.1692; CHRISTENSEN PR, 1986, J GEOPHYS RES, V91, P496; CRADDOCK RA, 1990, J GEOPHYS RES-SOLID, V95, P14265, DOI 10.1029/JB095iB09p14265; CRADDOCK RA, 1993, J GEOPHYS RES-PLANET, V98, P3453, DOI 10.1029/92JE02508; CUTTS JA, 1973, J GEOPHYS RES, V78, P4231, DOI 10.1029/JB078i020p04231; Edgett KS, 1997, GEOPHYS RES LETT, V24, P2897, DOI 10.1029/97GL02840; FANALE FP, 1976, ICARUS, V28, P179, DOI 10.1016/0019-1035(76)90032-4; Farmer JD, 1999, J GEOPHYS RES-PLANET, V104, P26977, DOI 10.1029/1998JE000540; Fisher R.V., 1984, PYROCLASTIC ROCKS, P186, DOI [10.1007/978-3-642-74864-6_8, DOI 10.1007/978-3-642-74864-6_8, DOI 10.1007/978-3-642-74864-6_10]; Hartmann WK, 1999, METEORIT PLANET SCI, V34, P167, DOI 10.1111/j.1945-5100.1999.tb01743.x; Hartmann WK, 2000, J GEOPHYS RES-PLANET, V105, P15011, DOI 10.1029/1999JE001189; Hartmann WK, 1999, NATURE, V397, P586, DOI 10.1038/17545; HARTMANN WK, 1966, ICARUS, V5, P565, DOI 10.1016/0019-1035(66)90071-6; HARTMANN WK, 1971, ICARUS, V15, P410, DOI 10.1016/0019-1035(71)90119-9; HARTMANN WK, 1973, J GEOPHYS RES, V78, P4096, DOI 10.1029/JB078i020p04096; HARTMANN WK, 1981, BASALTIC VOLCANISM T, P1050; JONES KL, 1974, J GEOPHYS RES, V79, P3917, DOI 10.1029/JB079i026p03917; KERRIDGE JF, 1995, NASA SPEC PUBL NASA; Keszthelyi L, 2000, J GEOPHYS RES-PLANET, V105, P15027, DOI 10.1029/1999JE001191; KOMATSU G, 1993, J GEOPHYS RES-PLANET, V98, P11105, DOI 10.1029/93JE00537; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; LEIGHTON RB, 1965, SCIENCE, V149, P627, DOI 10.1126/science.149.3684.627; Lucchitta B. K., 1992, MARS, P453; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; Malin MC, 1998, SCIENCE, V279, P1681, DOI 10.1126/science.279.5357.1681; Malin MC, 1999, NATURE, V397, P589, DOI 10.1038/17551; MALIN MC, 1999, 5 INT C MARS LUN PLA; MALIN MC, 1976, THESIS CALTECH PASAD, pCH3; McCauley J. F., 1977, US GEOL SURV INTERAG, V81; MCCAULEY JF, 1978, US GEOL SURV MISC I, V897; McEwen AS, 1999, NATURE, V397, P584, DOI 10.1038/17539; MCKAY CP, 1989, REV GEOPHYS, V27, P189, DOI 10.1029/RG027i002p00189; MELLON MT, IN PRESS ICARUS; NEDELL SS, 1987, ICARUS, V70, P409, DOI 10.1016/0019-1035(87)90086-8; NEUKUM G, 1981, J GEOPHYS RES, V86, P3097, DOI 10.1029/JB086iB04p03097; NEUKUM G, 1976, SCIENCE, V194, P1381, DOI 10.1126/science.194.4272.1381; OPIK EJ, 1965, IR ASTRON J, V7, P473; PIERI D, 1976, ICARUS, V27, P25, DOI 10.1016/0019-1035(76)90182-2; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; SCOTT DH, 1986, US GEOL SURV MISC IN; SELIVANOV AS, 1989, NATURE, V341, P593, DOI 10.1038/341593a0; SHARP RP, 1975, GEOL SOC AM BULL, V86, P593, DOI 10.1130/0016-7606(1975)86<593:COM>2.0.CO;2; SHARP RP, 1963, J GEOL, V71, P617, DOI 10.1086/626936; SHARP RP, 1973, J GEOPHYS RES, V78, P4073, DOI 10.1029/JB078i020p04073; SHOEMAKER EM, 1962, MOON S, V14, P289; SODERBLOM LA, 1974, ICARUS, V22, P239, DOI 10.1016/0019-1035(74)90175-4; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; SQUYRES SW, 1989, ICARUS, V79, P229, DOI 10.1016/0019-1035(89)90078-X; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; TANAKA KL, 1992, P LUNAR PLANET SCI, V22, P73; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; WARD WR, 1974, J GEOPHYS RES, V79, P3387, DOI 10.1029/JC079i024p03387; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Wilhelms D.E., 1990, PLANETARY MAPPING, P208; Zimbelman J.R., 1990, LUNAR PLANET SCI, V21, P1375; [No title captured]	65	572	582	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2000	290	5498					1927	1937		10.1126/science.290.5498.1927	http://dx.doi.org/10.1126/science.290.5498.1927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382EL	11110654				2022-12-24	WOS:000165810000037
J	Teleman, AA; Cohen, SM				Teleman, AA; Cohen, SM			Dpp gradient formation in the Drosophila wing imaginal disc	CELL			English	Article							LONG-RANGE ACTION; MORPHOGEN GRADIENT; PHOSPHOINOSITIDE 3-KINASE; CELL-SIZE; EXPRESSION; GROWTH; RECEPTOR; BRINKER; AXIS; LEG	The secreted signaling protein Dpp acts as a morphogen to pattern the anterior-posterior axis of the Drosophila wing. Dpp activity is required in all cells of the developing wing imaginal disc, but the ligand gradient that supports this activity has not been characterized. Here we make use of a biologically active form of Dpp tagged with GFP to examine the ligand gradient. Dpp-GFP forms an unstable extracellular gradient that spreads rapidly in the wing disc. The activity gradient visualized by MAD phosphorylation differs in shape from the ligand gradient. The pMAD gradient adjusted to compartment size when this was experimentally altered. These observations suggest that the Dpp activity gradient may be shaped at the level of receptor activation.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Cohen, SM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Cohen, Stephen M/G-9930-2011; Teleman, Aurelio A/E-6864-2013; Teleman, Aurelio/V-8470-2019	Cohen, Stephen M/0000-0003-2858-9163; Teleman, Aurelio A/0000-0002-4237-9368; Teleman, Aurelio/0000-0002-4237-9368				Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bretscher MS, 1996, J CELL SCI, V109, P3113; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gonzalez-Gaitan M, 1999, MECH DEVELOP, V87, P143, DOI 10.1016/S0925-4773(99)00156-2; GONZALEZGAITAN M, 1994, MECH DEVELOP, V46, P183, DOI 10.1016/0925-4773(94)90070-1; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Massague J, 2000, GENE DEV, V14, P627; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neumann CJ, 1997, DEVELOPMENT, V124, P871; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Strigini M, 1997, DEVELOPMENT, V124, P4697; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weigmann K, 1999, DEVELOPMENT, V126, P3823; Weinkove D, 2000, CURR OPIN GENET DEV, V10, P75, DOI 10.1016/S0959-437X(99)00042-8; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Wu J, 1999, DEVELOPMENT, V126, P109; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	37	356	368	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 8	2000	103	6					971	980		10.1016/S0092-8674(00)00199-9	http://dx.doi.org/10.1016/S0092-8674(00)00199-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136981	Bronze			2022-12-24	WOS:000165801300015
J	Gray, JE; Holroyd, GH; van der Lee, FM; Bahrami, AR; Sijmons, PC; Woodward, FI; Schuch, W; Heterington, AM				Gray, JE; Holroyd, GH; van der Lee, FM; Bahrami, AR; Sijmons, PC; Woodward, FI; Schuch, W; Heterington, AM			The HIC signalling pathway links CO2 perception to stomatal development	NATURE			English	Article							ARABIDOPSIS-THALIANA; FEEDING STRUCTURES; TRANSGENIC PLANTS; GENE-EXPRESSION; FOSSIL PLANTS; DENSITY; FIDDLEHEAD; GENOME; MUTANT; INDEX	Stomatal pores on the leaf surface control both the uptake of CO2 for photosynthesis and the loss of water during transpiration. Since the industrial revolution, decreases in stomatal numbers in parallel with increases in atmospheric CO2 concentration have provided evidence of plant responses to changes in CO2 levels caused by human activity(1,2). This inverse correlation between stomatal density and CO2 concentration also holds for fossil material from the past 400 million years(3) and has provided dues to the causes of global extinction events(4). Here we report the identification of the Arabidopsis gene HIC (for high carbon dioxide), which encodes a negative regulator of stomatal development that responds to CO2 concentration. This gene encodes a putative 3-keto acyl coenzyme A synthase-an enzyme involved in the synthesis of very-long-chain fatty acids(5). Mutant hic plants exhibit up to a 42% increase in stomatal density in response to a doubling of CO2. Our results identify a gene involved in the signal transduction pathway responsible for controlling stomatal numbers at elevated CO2.	Univ Lancaster, Dept Biol Sci, Lancaster LA1 4YQ, England; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Zeneca Mogen, NL-2300 AP Leiden, Netherlands; Cellscreen, NL-6700 AC Wageningen, Netherlands; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Zeneca Wheat Improvement Ctr, Norwich NR4 7UH, Norfolk, England	Lancaster University; University of Sheffield; University of Sheffield	Heterington, AM (corresponding author), Univ Lancaster, Dept Biol Sci, Lancaster LA1 4YQ, England.		Gray, Julie E/B-4271-2014; Woodward, Ian F/B-7762-2008; Bahrami, Ahmad Reza/AAA-4090-2020; Woodward, Frank Ian/P-4530-2019	Gray, Julie E/0000-0001-9972-5156; Bahrami, Ahmad Reza/0000-0001-9122-7216; Hetherington, Alistair/0000-0001-6060-9203				Barthels N, 1997, PLANT CELL, V9, P2119, DOI 10.1105/tpc.9.12.2119; BECKMAN AA, 1994, PLANT MOL BIOL REP, V12, P37; Berger D, 2000, GENE DEV, V14, P1119; BUNNING E, 1948, Z NATURFORSCH B, V3, P203; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GODDIJN OJM, 1993, PLANT J, V4, P863, DOI 10.1046/j.1365-313X.1993.04050863.x; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; JENKS MA, 1995, PLANT PHYSIOL, V108, P369, DOI 10.1104/pp.108.1.369; KORN RW, 1993, INT J PLANT SCI, V154, P367, DOI 10.1086/297118; Larkin JC, 1997, PLANT CELL, V9, P1109, DOI 10.1105/tpc.9.7.1109; Lassner MW, 1996, PLANT CELL, V8, P281, DOI 10.1105/tpc.8.2.281; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LOLLE SJ, 1992, DEV BIOL, V152, P383, DOI 10.1016/0012-1606(92)90145-7; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; MCELWAIN JC, 1995, ANN BOT-LONDON, V76, P389, DOI 10.1006/anbo.1995.1112; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; NEIGHBOUR EA, 1990, ENVIRON POLLUT, V64, P155, DOI 10.1016/0269-7491(90)90112-P; Poole I, 1996, PLANT CELL ENVIRON, V19, P705, DOI 10.1111/j.1365-3040.1996.tb00405.x; Post-Beittenmiller D, 1998, PLANT PHYSIOL BIOCH, V36, P157, DOI 10.1016/S0981-9428(98)80100-9; PostBeittenmiller D, 1996, ANNU REV PLANT PHYS, V47, P405, DOI 10.1146/annurev.arplant.47.1.405; SALISBURY EJ, 1927, PHIL T R SOC       B, V216, P1, DOI DOI 10.1098/RSTB.1928.0001; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; TOPPING JF, 1991, DEVELOPMENT, V112, P1009; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; WEYERS JDB, 1985, NEW PHYTOL, V101, P109, DOI 10.1111/j.1469-8137.1985.tb02820.x; WOODWARD FI, 1995, NEW PHYTOL, V131, P311, DOI 10.1111/j.1469-8137.1995.tb03067.x; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227; Yephremov A, 1999, PLANT CELL, V11, P2187, DOI 10.1105/tpc.11.11.2187; ZEIGER E, 1972, AM J BOT, V59, P143, DOI 10.2307/2441393	30	287	326	2	122	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2000	408	6813					713	716		10.1038/35047071	http://dx.doi.org/10.1038/35047071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130071				2022-12-24	WOS:000165815200047
J	Veizer, J; Godderis, Y; Francois, LM				Veizer, J; Godderis, Y; Francois, LM			Evidence for decoupling of atmospheric CO2 and global climate during the Phanerozoic eon	NATURE			English	Article							LAST GLACIAL MAXIMUM; SURFACE-TEMPERATURE; CARBON-CYCLE; SEAWATER; RECORDS; TIME	Atmospheric carbon dioxide concentrations are believed to drive climate changes from glacial to interglacial modes', although geological(1-3) and astronomical(4-6) mechanisms have been invoked as ultimate causes. Additionally, it is unclear(7,8) whether the changes between cold and warm modes should be regarded as a global phenomenon, affecting tropical and high-latitude temperatures alike(9-13), or if they are better described as an expansion and contraction of the latitudinal climate zones, keeping equatorial temperatures approximately constant(14-16). Here we present a reconstruction of tropical sea surface temperatures throughout the phanerozoic eon (the past similar to 550 Myr) from our database(17) of oxygen isotopes in calcite and aragonite shells. The data indicate large oscillations of tropical sea surface temperatures in phase with the cold-warm cycles, thus favouring the idea of climate variability as a global phenomenon. But our data conflict with a temperature reconstruction using an energy balance model that is forced by reconstructed atmospheric carbon dioxide concentrations(18). The results can be reconciled if atmospheric carbon dioxide concentrations were not the principal driver of climate variability on geological timescales for at least one-third of the Phanerozoic eon, or if the reconstructed carbon dioxide concentrations are not reliable.	Ruhr Univ Bochum, Inst Geol Mineral & Geophys, D-44780 Bochum, Germany; Univ Ottawa, Ottawa Carleton Geosci Ctr, Ottawa, ON K1N 6N5, Canada; Univ Liege, Lab Phys Atmospher & Planetaire, B-4000 Liege, Belgium	Ruhr University Bochum; University of Ottawa; University of Liege	Veizer, J (corresponding author), Ruhr Univ Bochum, Inst Geol Mineral & Geophys, D-44780 Bochum, Germany.		Veizer, Jan/ABG-3321-2020; François, Louis/K-9172-2019	François, Louis/0000-0001-8292-8360				[Anonymous], 1962, AAPG B; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; Beck JW, 1997, NATURE, V385, P705, DOI 10.1038/385705a0; Berner RA, 1998, PHILOS T ROY SOC B, V353, P75, DOI 10.1098/rstb.1998.0192; BERNER RA, 1994, AM J SCI, V294, P56, DOI 10.2475/ajs.294.1.56; Broecker W, 1996, SCIENCE, V272, P1902, DOI 10.1126/science.272.5270.1902; Bush ABG, 1998, SCIENCE, V279, P1341, DOI 10.1126/science.279.5355.1341; CROWLEY TJ, 1994, NATURE, V371, P664, DOI 10.1038/371664a0; Crowley TJ, 2000, CLIM DYNAM, V16, P241, DOI 10.1007/s003820050325; ENDAL AS, 1981, ASTROPHYS J, V243, P625, DOI 10.1086/158628; Fischer A.G., 1982, CLIMATE EARTH HIST, P97, DOI DOI 10.17226/11798; Frakes L. A, 1992, CLIMATE MODES PHANER; FRAKES LA, 1988, NATURE, V333, P547, DOI 10.1038/333547a0; FRANCOIS LM, 1992, AM J SCI, V292, P81, DOI 10.2475/ajs.292.2.81; Gibbs M.T., 2000, WARM CLIMATES EARTH, P386; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; HARLAND WB, 1990, GEOLOGIC TIMESCALE; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; HAYS PD, 1991, GEOLOGY, V19, P441, DOI 10.1130/0091-7613(1991)019<0441:OIIMCC>2.3.CO;2; KNAUTH LP, 1976, GEOCHIM COSMOCHIM AC, V40, P1095, DOI 10.1016/0016-7037(76)90051-X; RAILSBACK LB, 1990, GEOCHIM COSMOCHIM AC, V54, P1501, DOI 10.1016/0016-7037(90)90175-K; RIND D, 1985, QUATERNARY RES, V24, P1, DOI 10.1016/0033-5894(85)90080-8; SAVIN SM, 1977, ANNU REV EARTH PL SC, V5, P319, DOI 10.1146/annurev.ea.05.050177.001535; STEINER J, 1973, GEOL SOC AM BULL, V84, P1003, DOI 10.1130/0016-7606(1973)84<1003:PGCFPA>2.0.CO;2; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9; WILLIAMS GE, 1975, EARTH PLANET SC LETT, V26, P361, DOI 10.1016/0012-821X(75)90012-6; Worsley TR, 1986, PALEOCEANOGRAPHY, V1, P233, DOI 10.1029/PA001i003p00233	29	289	308	3	95	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 7	2000	408	6813					698	701		10.1038/35047044	http://dx.doi.org/10.1038/35047044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382GU	11130067				2022-12-24	WOS:000165815200043
J	Phillips, KA; Shlipak, MG; Coxson, P; Heidenreich, PA; Hunink, MGM; Goldman, PA; Williams, LW; Weinstein, MC; Goldman, L				Phillips, KA; Shlipak, MG; Coxson, P; Heidenreich, PA; Hunink, MGM; Goldman, PA; Williams, LW; Weinstein, MC; Goldman, L			Health and economic benefits of increased beta-blocker use following myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; QUALITY-OF-LIFE; COOPERATIVE CARDIOVASCULAR PROJECT; RANDOMIZED CLINICAL-TRIALS; COST-EFFECTIVENESS; UNITED-STATES; PRACTICE GUIDELINES; ELDERLY PATIENTS; DRUG-TREATMENT; POLICY MODEL	Context beta -Blockers are underused in patients who have myocardial infarction (MI), despite the proven efficacy of these agents. New evidence indicates that beta -blockers can have benefit in patients with conditions that have been considered relative contraindications, Understanding the consequences of underuse of beta -blockers is important because of the implications for current policy debates over quality-of-care measures and Medicare prescription drug coverage, Objective To examine the potential health and economic impact of increased use of beta -blockers in patients who have had MI. Design and Setting We used the Coronary Heart Disease (CHD) Policy Model, a computer-simulation Markov model of CHD in the US population, to estimate the epidemiological impact and cost-effectiveness of increased beta -blocker use from current to target levels among survivors of MI aged 35 to 84 years. Simulations included 1 cohort of MI survivors in 2000 followed up for 20 years and 20 successive annual cohorts of all first-MI survivors in 2000-2020. Mortality and morbidity from CHD were derived from published meta-analyses and recent studies. This analysis used a societal perspective. Main Outcome Measures Prevented Mis, CHD mortality, life-years gained, and cost per quality-adjusted life-year (QALY) gained in 2000-2020, Results Initiating beta -blocker use for all MI survivors except those with absolute contraindications in 2000 and continuing treatment for 20 years would result in 4300 fewer CHD deaths, 3500 Mis prevented, and 45000 life-years gained compared with current use. The incremental cost per QALY gained would be $4500, If this increase in beta -blocker use were implemented in all first-MI survivors annually over 20 years, beta -blockers would save $18 million and result in 72000 fewer CHD deaths, 62000 Mis prevented, and 447000 life-years gained. Sensitivity analyses demonstrated that the cost-effectiveness of beta -blocker therapy would always be less than $11000 per QALY gained, even under unfavorable assumptions, and may even be cost saving, Restricting beta -blockers only to ideal patients (those without absolute or relative contraindications) would reduce the epidemiological impact of beta -blocker therapy by about 60%, Conclusions Our simulation indicates that increased use of beta -blockers after MI would lead to impressive gains in health and would be potentially cost saving.	Univ Calif San Francisco, Sch Pharm, Inst Hlth Policy Studies, Dept Clin Pharm, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Excellence Hlth Care Markets & Managed Care, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; San Francisco Vet Affairs Med Ctr, San Francisco, CA USA; Stanford Univ, Palo Alto VA Hlth Care Syst, Palo Alto, CA 94304 USA; Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Erasmus Univ, Med Ctr, Rotterdam, Netherlands	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Stanford University; Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC	Phillips, KA (corresponding author), Univ Calif San Francisco, Sch Pharm, Inst Hlth Policy Studies, Dept Clin Pharm, 3333 Calif St,Room 420,Box 0613, San Francisco, CA 94143 USA.		Heidenreich, Paul/AAU-6864-2021	Heidenreich, Paul/0000-0001-7730-8490				AYANIAN JZ, 1994, NEW ENGL J MED, V331, P1136, DOI 10.1056/NEJM199410273311707; Bradford WD, 1999, PHARMACOECONOMICS, V15, P257, DOI 10.2165/00019053-199915030-00005; BRAND DA, 1995, J AM COLL CARDIOL, V26, P1432, DOI 10.1016/0735-1097(95)00362-2; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Cleophas TJM, 1996, INT J CLIN PHARM TH, V34, P312; EDELSON JT, 1990, JAMA-J AM MED ASSOC, V263, P408; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Gattis WA, 1999, ARCH INTERN MED, V159, P1939, DOI 10.1001/archinte.159.16.1939; GOLDMAN L, 1992, CIRCULATION, V85, P1960, DOI 10.1161/01.CIR.85.5.1960; GOLDMAN L, 1988, NEW ENGL J MED, V319, P152, DOI 10.1056/NEJM198807213190306; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; GOLDMAN L, 1989, CIRCULATION, V80, P254, DOI 10.1161/01.CIR.80.2.254; GOLDMAN L, 1993, AM J CARDIOL, V72, pD75, DOI 10.1016/0002-9149(93)90015-5; Goldman L, 1999, J AM COLL CARDIOL, V34, P768, DOI 10.1016/S0735-1097(99)00260-0; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Grimm RH, 1997, ARCH INTERN MED, V157, P638, DOI 10.1001/archinte.157.6.638; Heidenreich PA, 1997, J AM COLL CARDIOL, V30, P27, DOI 10.1016/S0735-1097(97)00104-6; HJALMARSON A, 1981, LANCET, V2, P823; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Jackson G, 1999, INT J CLIN PRACT, V53, P363; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McLaughlin TJ, 1996, ARCH INTERN MED, V156, P799, DOI 10.1001/archinte.156.7.799; *MED EC CO, 1998, DRUG TOP RED BOOK; *NAT COMM QUAL ASS, 1999, STAT MAN CAR QUAL RE; *NAT COMM QUAL ASS, 1997, WID QUAL CIRC 1996 A; PASHOS CL, 1994, J AM COLL CARDIOL, V23, P1023, DOI 10.1016/0735-1097(94)90585-1; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; Phillips BG, 1996, AM HEART J, V131, P872, DOI 10.1016/S0002-8703(96)90167-2; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; Siegel D, 1997, JAMA-J AM MED ASSOC, V278, P1745, DOI 10.1001/jama.278.21.1745; SIEGEL J, 1996, COST EFFECTIVENESS H, pCH9; SIM I, 1999, SOC MED DEC MAK C OC; Soumerai SB, 1999, ARCH INTERN MED, V159, P2013, DOI 10.1001/archinte.159.17.2013; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; Stinett AA, 1996, COST EFFECTIVENESS H, P349; Tosteson ANA, 1997, CIRCULATION, V95, P24, DOI 10.1161/01.CIR.95.1.24; TOSTESON ANA, 1990, AM J PUBLIC HEALTH, V80, P1481, DOI 10.2105/AJPH.80.12.1481; TSEVAT J, 1995, J AM COLL CARDIOL, V26, P914, DOI 10.1016/0735-1097(95)00284-1; TSEVAT J, 1991, CIRCULATION, V83, P1194, DOI 10.1161/01.CIR.83.4.1194; TSEVAT J, 1992, AM J MED, V93, pS43, DOI 10.1016/0002-9343(92)90627-N; Wang TJ, 1998, ARCH INTERN MED, V158, P1901, DOI 10.1001/archinte.158.17.1901; Wassertheilsmoller S, 1991, ANN INTERN MED, V114, P613, DOI 10.7326/0003-4819-114-8-613; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	51	80	82	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2000	284	21					2748	2754		10.1001/jama.284.21.2748	http://dx.doi.org/10.1001/jama.284.21.2748			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377JB	11105180	Bronze			2022-12-24	WOS:000165509500029
J	Greenberg, JE; Lynn, M; Kirsner, RS; Hanly, AJ				Greenberg, JE; Lynn, M; Kirsner, RS; Hanly, AJ			Mucocutaneous pigmentation due to zinc deposition	LANCET			English	Article									Univ Miami, Dept Pathol, Miami, FL 33136 USA; Univ Miami, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; Univ Miami, Ctr Adv Microscopy, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Greenberg, JE (corresponding author), Univ Miami, Dept Pathol, Miami, FL 33136 USA.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2000	356	9244					1817	1817		10.1016/S0140-6736(00)03235-9	http://dx.doi.org/10.1016/S0140-6736(00)03235-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377UY	11117915				2022-12-24	WOS:000165545700014
J	Karels, TJ; Boonstra, R				Karels, TJ; Boonstra, R			Concurrent density dependence and independence in populations of arctic ground squirrels	NATURE			English	Article							SNOWSHOE HARE CYCLE; BOREAL FOREST; PREDATION; FOOD; SIZE	No population increases without limit. The processes that prevent this can operate in either a density-dependent way (acting with increasing severity to increase mortality rates or decrease reproductive rates as density increases), a density-independent way, or in both ways simultaneously(1-3). However, ecologists disagree for two main reasons about the relative roles and influences that density-dependent and density-independent processes have in determining population size(4,5). First, empirical studies showing both processes operating simultaneously are rare(6). Second, time-series analyses of long-term census data sometimes overestimate dependence(7,8). By using a density-perturbation experiment(9-12) on arctic ground squirrels, we show concurrent density-dependent and density-independent declines in weaning rates, followed by density-dependent declines in overwinter survival during hibernation. These two processes result in strong, density-dependent convergence of experimentally increased populations to those of control populations that had been at low, stable levels.	Univ Toronto, Div Life Sci, Scarborough, ON M1C 1A4, Canada	University of Toronto; University Toronto Scarborough	Boonstra, R (corresponding author), Univ Toronto, Div Life Sci, 1265 Mil Trail, Scarborough, ON M1C 1A4, Canada.							ANUFRIEV AI, 1990, SOV J ECOL+, V21, P279; BATZLI GO, 1980, ARCTIC ALPINE RES, V12, P501, DOI 10.2307/1550497; BOUTIN S, 1995, OIKOS, V74, P69, DOI 10.2307/3545676; Buck CL, 1999, J MAMMAL, V80, P1264, DOI 10.2307/1383177; Byrom AE, 1999, CAN J ZOOL, V77, P1048, DOI 10.1139/cjz-77-7-1048; Cappuccino N, 1996, FRONTIERS OF POPULATION ECOLOGY, P53; CARL EA, 1971, ECOLOGY, V52, P395, DOI 10.2307/1937623; Florant GL, 1998, AM ZOOL, V38, P331; Green J. E., 1977, THESIS U BRIT COLUMB; Harrison Susan, 1995, P131, DOI 10.1016/B978-012159270-7/50008-7; Hubbs AH, 1997, J ANIM ECOL, V66, P527, DOI 10.2307/5947; Karels TJ, 2000, J ANIM ECOL, V69, P235, DOI 10.1046/j.1365-2656.2000.00387.x; KARELS TJ, 2000, THESIS U TORONTO; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; LACEY EA, 1997, ANIM BEHAV, V53, P565; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Lewellen RH, 1998, ECOL MONOGR, V68, P571, DOI 10.1890/0012-9615(1998)068[0571:TEODDA]2.0.CO;2; MAY RM, 1973, AM NAT, V107, P621, DOI 10.1086/282863; MURDOCH WW, 1970, ECOLOGY, V51, P497, DOI 10.2307/1935385; Murray BG, 1999, OIKOS, V84, P148, DOI 10.2307/3546875; OSTFELD RS, 1993, NATURE, V366, P259, DOI 10.1038/366259a0; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; RISCH TS, 1995, ECOLOGY, V76, P1643, DOI 10.2307/1938165; Shenk TM, 1998, ECOL MONOGR, V68, P445, DOI 10.1890/0012-9615(1998)068[0445:SVEODD]2.0.CO;2; Sinclair A.R.E., 1989, P197; Sinclair ARE, 1996, OIKOS, V75, P164, DOI 10.2307/3546240; Strong D.R., 1984, P313; Turchin Peter, 1995, P19, DOI 10.1016/B978-012159270-7/50003-8	28	53	60	0	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2000	408	6811					460	463		10.1038/35044064	http://dx.doi.org/10.1038/35044064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100725	Green Published			2022-12-24	WOS:000165429800045
J	Robbiani, DF; Finch, RA; Jager, D; Muller, WA; Sartorelli, AC; Randolph, GJ				Robbiani, DF; Finch, RA; Jager, D; Muller, WA; Sartorelli, AC; Randolph, GJ			The leukotriene C-4 transporter MRP1 regulates CCL19 (MIP-3 beta, ELC)-dependent mobilization of dendritic cells to lymph nodes	CELL			English	Article							RESISTANCE PROTEIN MRP; MOUSE BONE-MARROW; P-GLYCOPROTEIN; T-LYMPHOCYTES; MICE LACKING; EXPORT PUMP; IN-VIVO; CHEMOKINE; GLUTATHIONE; EXPRESSION	Adaptive immune responses begin after antigen-bearing dendritic cells (DCs) traffic from peripheral tissues to lymph nodes. Here, we show that DC migration from skin to lymph nodes utilizes the leukotriene C-4 (LTC4) transporter multidrug resistance-associated protein 1 (MRP1). DC mobilization from the epidermis and trafficking into lymphatic vessels was greatly reduced in MRP1(-/-) mice, but migration was restored by exogenous cysteinyl leukotrienes LTC4 or LTD,. In vitro, these cysteinyl leukotrienes promoted optimal chemotaxis to the chemokine CCL19, but not to other related chemokines. Antagonism of CCL19 in vivo prevented DC migration out of the epidermis. Thus, MRP-1 regulates DC migration to lymph nodes, apparently by transporting LTC4, which in turn promotes chemotaxis to CCL19 and mobilization of DCs from the epidermis.	Cornell Univ, Program Immunol, New York, NY USA; Cornell Univ, Weill Med Coll, New York, NY USA; Cornell Univ, Weill Med Coll, New York, NY USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; Krankenhaus Nordwest, Med Klin Hamatol Onkol, Frankfurt, Germany; Cornell Univ, Dept Pathol, New York, NY USA	Cornell University; Cornell University; Cornell University; Yale University; Krankenhaus Nordwest; Cornell University	Randolph, GJ (corresponding author), CUNY Mt Sinai Sch Med, Inst Gene Therapy & Mol Med, 1425 Madison Ave,Box 1496, New York, NY 10029 USA.	gwendalyn.randolph@mssm.edu	Robbiani, Davide F./AAF-7662-2019	Robbiani, Davide F./0000-0001-7379-3484				CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; CROCKER PR, 1986, J EXP MED, V164, P1862, DOI 10.1084/jem.164.6.1862; Cyster JG, 1999, J EXP MED, V189, P447, DOI 10.1084/jem.189.3.447; Drach J, 1996, BLOOD, V88, P1747, DOI 10.1182/blood.V88.5.1747.bloodjournal8851747; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Gosling J, 2000, J IMMUNOL, V164, P2851, DOI 10.4049/jimmunol.164.6.2851; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; INABA K, 1992, J EXP MED, V175, P1157, DOI 10.1084/jem.175.5.1157; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; ISHIKAWA T, 1990, J BIOL CHEM, V265, P19279; JOHNSTON MG, 1983, PROSTAG OTH LIPID M, V25, P85, DOI 10.1016/0090-6980(83)90138-7; JORIS I, 1987, AM J PATHOL, V126, P19; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; LABAT C, 1992, J PHARMACOL EXP THER, V263, P800; LEACH L, 1993, J CELL SCI, V104, P1073; LEIER I, 1994, J BIOL CHEM, V269, P27807; LEVEILLEWEBSTER CR, 1995, J MEMBRANE BIOL, V143, P89; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Loe DW, 1998, CANCER RES, V58, P5130; Lohoff M, 1998, J CLIN INVEST, V101, P703, DOI 10.1172/JCI824; Lorico A, 1997, CANCER RES, V57, P5238; Lukas M, 1996, J INVEST DERMATOL, V106, P1293, DOI 10.1111/1523-1747.ep12349010; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lynch KR, 1999, NATURE, V399, P789; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; Nuessler V, 1997, Eur J Med Res, V2, P159; Ortner U, 1996, J IMMUNOL METHODS, V193, P71, DOI 10.1016/0022-1759(96)00058-0; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; Randolph GJ, 1998, P NATL ACAD SCI USA, V95, P6924, DOI 10.1073/pnas.95.12.6924; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rappa G, 1997, CANCER RES, V57, P5232; Saeki H, 1999, J IMMUNOL, V162, P2472; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sato K, 1998, J IMMUNOL, V161, P6835; Spanbroek R, 1998, P NATL ACAD SCI USA, V95, P663, DOI 10.1073/pnas.95.2.663; SPANBROEK R, 2000, IN PRESS BLOOD; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Vellenga E, 1999, BRIT J PHARMACOL, V127, P441, DOI 10.1038/sj.bjp.0702577; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	48	379	403	2	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 22	2000	103	5					757	768		10.1016/S0092-8674(00)00179-3	http://dx.doi.org/10.1016/S0092-8674(00)00179-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	375ZJ	11114332	Bronze			2022-12-24	WOS:000165433100008
J	Naqvi, SWA; Jayakumar, DA; Narvekar, PV; Naik, H; Sarma, VVSS; D'Souza, W; Joseph, S; George, MD				Naqvi, SWA; Jayakumar, DA; Narvekar, PV; Naik, H; Sarma, VVSS; D'Souza, W; Joseph, S; George, MD			Increased marine production of N2O due to intensifying anoxia on the Indian continental shelf	NATURE			English	Article							GULF-OF-MEXICO; NITROUS-OXIDE; ARABIAN SEA; DENITRIFICATION; OXYGEN; HYPOXIA; MONSOON; WATER; CO2	Eutrophication of surface waters and hypoxia in bottom waters has been increasing in many coastal areas(1-4), leading to very large depletions of marine life in the affected regions(4). These areas of high surface productivity and low bottom-water oxygen concentration are caused by increasing runoff of nutrients from land. Although the local ecological and socio-economic effects have received much attention(2-4), the potential contribution of increasing hypoxia to global-change phenomena is unknown. Here we report the intensification of one of the largest low-oxygen zones in the ocean, which develops naturally over the western Indian continental shelf during late summer and autumn. We also report the highest accumulations yet observed of hydrogen sulphide (H2S) and nitrous oxide (N2O) in open coastal waters. Increased N2O production is probably caused by the addition of anthropogenic nitrate and its subsequent denitrification, which is favoured by hypoxic conditions. We suggest that a global expansion of hypoxic zones may lead to an increase in marine production and emission of N2O, which, as a potent greenhouse gas, could contribute significantly to the accumulation of radiatively active trace gases in the atmosphere(5).	Natl Inst Oceanog, Dona Paula 403004, Goa, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Naqvi, SWA (corresponding author), Natl Inst Oceanog, Dona Paula 403004, Goa, India.		Sarma, VVSS/B-5087-2008; Joseph, Sudheer/N-8662-2016	Joseph, Sudheer/0000-0002-9163-3027				Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; BANGE HW, IN PRESS GLOBAL BIOG; BANSE K, 1968, DEEP-SEA RES, V15, P45, DOI 10.1016/0011-7471(68)90028-4; Banse K., 1959, J MAR BIOL ASSOC IND, V1, P33; CALVERT SE, 1971, DEEP-SEA RES, V18, P505, DOI 10.1016/0011-7471(71)90074-X; CARRUTHERS JN, 1959, NATURE, V183, P1084, DOI 10.1038/1831084a0; Codispoti L.A., 1992, OCEANOGRAPHY INDIAN, P271; CODISPOTI LA, 1980, J MAR RES, V38, P453; CODISPOTI LA, 1986, SCIENCE, V233, P1200, DOI 10.1126/science.233.4769.1200; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; FIRESTONE MK, 1979, APPL ENVIRON MICROB, V38, P673, DOI 10.1128/AEM.38.4.673-679.1979; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; Grasshoff K., 1999, METHODS SEAWATER ANA; JAYAKUMAR DA, IN PRESS MAR CHEM; Justic D, 1996, LIMNOL OCEANOGR, V41, P992, DOI 10.4319/lo.1996.41.5.0992; Kitoh A, 1997, J METEOROL SOC JPN, V75, P1019, DOI 10.2151/jmsj1965.75.6_1019; LAW CS, 1990, NATURE, V346, P826, DOI 10.1038/346826a0; Liss P.S., 1986, ROLE AIR SEA EXCHANG, P113, DOI [10.1007/978-94-009-4738-2_5, DOI 10.1007/978-94-009-4738-2_5]; Malakoff D, 1998, SCIENCE, V281, P190, DOI 10.1126/science.281.5374.190; NAQVI SWA, 1987, J MAR RES, V45, P1049, DOI 10.1357/002224087788327118; Naqvi SWA, 1998, NATURE, V394, P462, DOI 10.1038/28828; NAQVI SWA, 1991, DEEP-SEA RES, V38, P871, DOI 10.1016/0198-0149(91)90023-9; Rabalais N.N., 2000, OXYGEN DEPLETION COA; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; SHETYE SR, 1990, J MAR RES, V48, P359, DOI 10.1357/002224090784988809; TURNER RE, 1994, NATURE, V368, P619, DOI 10.1038/368619a0; *UNDP FAO PEL FISH, 1973, 3 UNDPFAO PEL FISH P, P1; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; YOH M, 1983, NATURE, V301, P327, DOI 10.1038/301327a0	30	445	462	5	123	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2000	408	6810					346	349		10.1038/35042551	http://dx.doi.org/10.1038/35042551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099038				2022-12-24	WOS:000165296000041
J	Sousa, MC; Trame, CB; Tsuruta, H; Wilbanks, SM; Reddy, VS; McKay, DB				Sousa, MC; Trame, CB; Tsuruta, H; Wilbanks, SM; Reddy, VS; McKay, DB			Crystal and solution structures of an HsIUV protease-chaperone complex	CELL			English	Article							ATP-DEPENDENT PROTEASE; ESCHERICHIA-COLI HOMOLOG; CELL-DIVISION INHIBITOR; 20S PROTEASOME; PROTEOLYTIC ACTIVITY; HSLVU PROTEASE; BETA-SUBUNITS; PROTEINS; DEGRADATION; SCATTERING	HslUV is a "prokaryotic proteasome" composed of the HslV protease and the HslU ATPase, a chaperone of the Clp/Hsp100 family. The 3.4 a crystal structure of an HslUV complex is presented here. Two hexameric ATP binding rings of HslU bind intimately to opposite sides of the HslV protease; the HslU "intermediate domains" extend outward from the complex. The solution structure of HslUV, derived from small angle X-ray scattering data under conditions where the complex is assembled and active, agrees with this crystallographic structure. When the complex forms, the carboxy-terminal helices of HslU distend and bind between subunits of HslV, and the apical helices of HsIV shift substantially, transmitting a conformational change to the active site region of the protease.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Scripps Research Institute	McKay, DB (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	dave.mckay@stanford.edu		Wilbanks, Sigurd/0000-0001-7565-8913	NCRR NIH HHS [RR12255] Funding Source: Medline; NIGMS NIH HHS [GM-39928] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039928] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Bogyo M, 1997, P NATL ACAD SCI USA, V94, P6629, DOI 10.1073/pnas.94.13.6629; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHUANG SE, 1993, GENE, V134, P1, DOI 10.1016/0378-1119(93)90167-2; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Huang HC, 1997, J BIOL CHEM, V272, P21364, DOI 10.1074/jbc.272.34.21364; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kanemori M, 1999, J BACTERIOL, V181, P3674, DOI 10.1128/JB.181.12.3674-3680.1999; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kessel M, 1996, FEBS LETT, V398, P274, DOI 10.1016/S0014-5793(96)01261-6; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Missiakas D, 1996, EMBO J, V15, P6899, DOI 10.1002/j.1460-2075.1996.tb01082.x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neuwald AF, 1999, GENOME RES, V9, P27; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Seol JH, 1997, EUR J BIOCHEM, V247, P1143, DOI 10.1111/j.1432-1033.1997.01143.x; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; WILBANKS SM, 1995, BIOCHEMISTRY-US, V34, P12095, DOI 10.1021/bi00038a002; Yoo SJ, 1997, BIOCHEM BIOPH RES CO, V238, P581, DOI 10.1006/bbrc.1997.7341; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843	45	253	257	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 10	2000	103	4					633	643		10.1016/S0092-8674(00)00166-5	http://dx.doi.org/10.1016/S0092-8674(00)00166-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	374MB	11106733	Bronze			2022-12-24	WOS:000165348000008
J	Betts, RA				Betts, RA			Offset of the potential carbon sink from boreal forestation by decreases in surface albedo	NATURE			English	Article							CLIMATE-CHANGE; VEGETATION FEEDBACKS; GLOBAL CLIMATE; SNOW COVER; MODEL; SEQUESTRATION; WATER; GCM	Carbon uptake by forestation is one method proposed(1) to reduce net carbon dioxide emissions to the atmosphere and so limit the radiative forcing of climate change(2). But the overall impact of forestation on climate will also depend on other effects associated with the creation of new forests. In particular, the albedo of a forested landscape is generally lower than that of cultivated land, especially when snow is lying(3-9), and decreasing albedo exerts a positive radiative forcing on climate. Here I simulate the radiative forcings associated with changes in surface albedo as a result of forestation in temperate and boreal forest areas, and translate these forcings into equivalent changes in local carbon stock for comparison with estimated carbon sequestration potentials(10-12). I suggest that in many boreal forest areas, the positive forcing induced by decreases in albedo can offset the negative forcing that is expected from carbon sequestration. Some high-latitude forestation activities may therefore increase climate change, rather than mitigating it as intended.	Hadley Ctr Climate Predict & Res, Met Off, Bracknell RG12 2SY, Berks, England	Met Office - UK; Hadley Centre	Betts, RA (corresponding author), Hadley Ctr Climate Predict & Res, Met Off, Bracknell RG12 2SY, Berks, England.		Betts, Richard A/P-8976-2015	Betts, Richard A/0000-0002-4929-0307				Betts RA, 1997, NATURE, V387, P796, DOI 10.1038/42924; BONAN GB, 1995, CLIMATIC CHANGE, V29, P145, DOI 10.1007/BF01094014; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cox PM, 1999, CLIM DYNAM, V15, P183, DOI 10.1007/s003820050276; DOUVILLE H, 1997, CLIM DYNAM, V13, P57; Edwards JM, 1996, Q J ROY METEOR SOC, V122, P689, DOI 10.1002/qj.49712253107; Essery R, 1997, ANN GLACIOL, V25, P362, DOI 10.3189/S0260305500014282; Gedney N, 2000, GEOPHYS RES LETT, V27, P3053, DOI 10.1029/2000GL011794; HANSEN J, 1983, MON WEATHER REV, V111, P609, DOI 10.1175/1520-0493(1983)111<0609:ETDGMF>2.0.CO;2; Harding RJ, 1996, J CLIMATE, V9, P2778, DOI 10.1175/1520-0442(1996)009<2778:TEBOTW>2.0.CO;2; KEELING CD, 1998, NDP001 CARB DIOX INF; Kondratyev K. Ya., 1982, Land Surface Processes in Atmospheric General Circulation Models. World Climate Research Programme Study Conference, P463; Levis S, 1999, GEOPHYS RES LETT, V26, P747, DOI 10.1029/1999GL900107; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; NABUURS GJ, 1995, CAN J FOREST RES, V25, P1157, DOI 10.1139/x95-128; NILSSON S, 1995, CLIMATIC CHANGE, V30, P267, DOI 10.1007/BF01091928; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; POSEY JW, 1964, GEOFIS INT, V4, P333; ROBINSON DA, 1984, J CLIM APPL METEOROL, V23, P1626, DOI 10.1175/1520-0450(1984)023<1626:AOADSC>2.0.CO;2; SCHIMEL D, 1995, CLIMATE CHANGE 1995, P65; Sharratt BS, 1998, AGR FOREST METEOROL, V89, P269, DOI 10.1016/S0168-1923(97)00071-3; THOMAS G, 1992, Q J ROY METEOR SOC, V118, P469, DOI 10.1002/qj.49711850505; *UNFCCC, 1999, UNEPIUC992 UNFCCC; *UNFCCC, 1998, UNEPINC982 UNFCCC; Watson RT, 2000, LAND USE LAND USE CH; WILLMOTT CJ, 1985, J CLIMATOL, V5, P589, DOI 10.1002/joc.3370050602; WILSON MF, 1985, J CLIMATOL, V5, P119, DOI 10.1002/joc.3370050202; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432	30	683	713	10	247	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 9	2000	408	6809					187	190		10.1038/35041545	http://dx.doi.org/10.1038/35041545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089969				2022-12-24	WOS:000165180400041
J	Fishbein, EA				Fishbein, EA			What price mice?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Univ, Off Vice President & Gen Counsel, Baltimore, MD 21218 USA	Johns Hopkins University	Fishbein, EA (corresponding author), Johns Hopkins Univ, Off Vice President & Gen Counsel, 3400 N Charles St,113 Garland Hall, Baltimore, MD 21218 USA.							Loder N, 2000, NATURE, V404, P529, DOI 10.1038/35007202; *NIH, 2000, NIH PUBL, V8023; PILLING DP, 2000, FINANCIAL TIMES 0406; *RDS, 2000, RDS RES DEF SOC NEWS; Trull FL, 1999, SCIENCE, V284, P1463, DOI 10.1126/science.284.5419.1463; *US DHEW, 1963, GUID LAB AN FAC CAR	6	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2001	285	7					939	941		10.1001/jama.285.7.939	http://dx.doi.org/10.1001/jama.285.7.939			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	402BE	11180739				2022-12-24	WOS:000166965500033
J	Samuelsson, A; Towers, TL; Ravetch, JV				Samuelsson, A; Towers, TL; Ravetch, JV			Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor	SCIENCE			English	Article							IMMUNE THROMBOCYTOPENIC PURPURA; INTRAVENOUS GAMMA-GLOBULIN; RANDOMIZED TRIAL; IMMUNOGLOBULIN; AUTOIMMUNE; MICE; AUTOANTIBODIES; CHILDHOOD; RESPONSES; THERAPY	The molecular basis for the anti-inflammatory property of intravenous gamma globulin (IVIG) was investigated in a murine model of immune thrombocytopenia. Administration of clinically protective doses of intact antibody or monomeric Fe fragments to wild-type or Fc gamma receptor-humanized mice prevented platelet consumption triggered by a pathogenic autoantibody. The inhibitory Pc receptor, Fc gamma RIIB, was required for protection, because disruption either by genetic deletion or with a blocking monoclonal antibody reversed the therapeutic effect of IVIG. Protection was associated with the ability of IVIG administration to induce surface expression of Fc gamma RIIB on splenic macrophages. Modulation of inhibitory signaling is thus a potent therapeutic strategy for attenuating autoantibody-triggered inflammatory diseases.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.		Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041				Ballow M, 1997, J ALLERGY CLIN IMMUN, V100, P151, DOI 10.1016/S0091-6749(97)70217-3; BLANCHETTE V, 1994, LANCET, V344, P703, DOI 10.1016/S0140-6736(94)92205-5; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; CLARKSON SB, 1986, NEW ENGL J MED, V314, P1236, DOI 10.1056/NEJM198605083141907; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; CLYNES R, 1995, IMMUNITY, V3, P21, DOI 10.1016/1074-7613(95)90155-8; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; DALAKAS MC, 1993, NEW ENGL J MED, V329, P1993, DOI 10.1056/NEJM199312303292704; DEBRE M, 1993, LANCET, V342, P945, DOI 10.1016/0140-6736(93)92000-J; DWYER JM, 1992, NEW ENGL J MED, V326, P107; GAJDOS P, 1984, LANCET, V1, P406; IMBACH P, 1981, LANCET, V1, P1228; JAYNE DRW, 1991, LANCET, V337, P1137, DOI 10.1016/0140-6736(91)92797-6; LeHoang P, 2000, OCUL IMMUNOL INFLAMM, V8, P49, DOI 10.1076/0927-3948(200003)8:1;1-S;FT049; Li M, 1996, J EXP MED, V183, P1259, DOI 10.1084/jem.183.3.1259; MIZUTANI H, 1993, BLOOD, V82, P837; Nakamura A, 2000, J EXP MED, V191, P899, DOI 10.1084/jem.191.5.899; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; SALAMA A, 1984, BLUT, V49, P29, DOI 10.1007/BF00320381; Schiller C, 2000, EUR J IMMUNOL, V30, P481; SOUBRANE C, 1993, BLOOD, V81, P15; SULTAN Y, 1984, LANCET, V2, P765; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; Viard I, 1998, SCIENCE, V282, P490, DOI 10.1126/science.282.5388.490	26	798	884	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2001	291	5503					484	486		10.1126/science.291.5503.484	http://dx.doi.org/10.1126/science.291.5503.484			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11161202				2022-12-24	WOS:000166487500041
J	Nowak, MA; Komarova, NL; Niyogi, P				Nowak, MA; Komarova, NL; Niyogi, P			Evolution of universal grammar	SCIENCE			English	Article							LANGUAGE	Universal grammar specifies the mechanism of Language acquisition. It determines the range of grammatical hypothesis that children entertain during language Learning and the procedure they use for evaluating input sentences. How universal grammar arose is a major challenge for evolutionary biology. We present a mathematical framework for the evolutionary dynamics of grammar learning. The central result is a coherence threshold, which specifies the condition for a universal grammar to induce coherent communication within a population. We study selection of grammars within the same universal grammar and competition between different universal grammars. We calculate the condition under which natural selection favors the emergence of rule-based generative grammars that underlie complex Language.	Inst Adv Study, Princeton, NJ 08540 USA; Univ Leeds, Dept Math, Leeds LS2 9JT, W Yorkshire, England; Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA	Institute for Advanced Study - USA; University of Leeds; University of Chicago	Nowak, MA (corresponding author), Inst Adv Study, Einstein Dr, Princeton, NJ 08540 USA.		Nowak, Martin A/A-6977-2008					Batali J., 1998, APPROACHES EVOLUTION; BRANDON R N, 1986, Biology and Philosophy, V1, P169; Chomsky N, 1980, RULES REPRESENTATION; Chomsky Noam, 1993, VIEW BUILDING, P1; Eigen M, 1979, THE HYPERCYCLE, P60; GIBSON E, 1994, LINGUIST INQ, V25, P407; GOLD EM, 1967, INFORM CONTROL, V10, P447, DOI 10.1016/S0019-9958(67)91165-5; Gopnik M, 1999, LANGUAGE, LOGIC, AND CONCEPTS, P263; Hashimoto T, 1996, BIOSYSTEMS, V38, P1, DOI 10.1016/0303-2647(95)01563-9; Hauser, 1996, EVOL COMMUN; Hornstein N., 1981, EXPLANATION LINGUIST; Hyams N., 1986, LANG ACQUIS; Jackendoff R., 1997, ARCHITECTURE LANGUAG; LIGHTFOOT DW, 1999, DEV LANGUAGE ACQUIST; MANZINI MR, 1987, LINGUIST INQ, V18, P413; Miller G.A., 1996, SCI WORDS; NIYOGI P, 1998, INFORMATIONAL COMPLE; Nowak MA, 2000, NATURE, V404, P495, DOI 10.1038/35006635; Nowak MA, 1999, P NATL ACAD SCI USA, V96, P8028, DOI 10.1073/pnas.96.14.8028; OSHERSON DN, 1986, SYSTEMS LEARN; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; Pinker S., 1999, WORDS RULES; Pinker S., 1994, LANGUAGE INSTINCT MI; PRINCE A, 1993, TR2 RUCCS, P234; Radford A., 1990, SYNTACTIC THEORY ACQ; Smith J. M., 1995, MAJOR TRANSITIONS EV; Tesar BB, 1998, LINGUA, V106, P161, DOI 10.1016/S0024-3841(98)00033-3; VALIANT LG, 1984, COMMUN ACM, V27, P436; Vapnik V., 2013, TECHNOMETRICS; VONHUMBOLDT W, 1972, UNGUISTIC VARIABILIT; WEXLER K, 1980, FORMAL PRINCIPLES LA	31	240	244	7	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 5	2001	291	5501					114	118		10.1126/science.291.5501.114	http://dx.doi.org/10.1126/science.291.5501.114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	389VJ	11141560				2022-12-24	WOS:000166259100046
J	Chapman, S; Morrell, S				Chapman, S; Morrell, S			Barking mad? Another lunatic hypothesis bites the dust	BRITISH MEDICAL JOURNAL			English	Article							FULL MOON; CYCLE	Objective To assess whether dog bites requiring hospital admission occur more at the full moon. Design Review of dates of admission for dog bites to accident and emergency departments,June 1997 to June 1998, compared with dates of the full moon. Setting All public hospitals in Australia. Main outcome measures Admissions for dog bites. Results 12 peak clusters of admissions were unrelated to the time of the full moon. Conclusion Dog bites are no more frequent on full moons than at any other time of the month. Sceptics rejoice.	Univ Sydney, Dept Publ Hlth & Community Med, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Dept Publ Hlth & Community Med, Sydney, NSW 2006, Australia.							BUCKLEY NA, 1993, MED J AUSTRALIA, V159, P786, DOI 10.5694/j.1326-5377.1993.tb141350.x; Chapman S, 2000, BRIT MED J, V320, P1512, DOI 10.1136/bmj.320.7248.1512; COATES W, 1989, ANN EMERG MED, V18, P763, DOI 10.1016/S0196-0644(89)80014-9; COHENMANSFIELD J, 1989, J CLIN PSYCHOL, V45, P611, DOI 10.1002/1097-4679(198907)45:4<611::AID-JCLP2270450417>3.0.CO;2-F; DECASTRO JM, 1995, PHYSIOL BEHAV, V57, P439, DOI 10.1016/0031-9384(94)00232-T; Ghiandoni G, 1998, EUR J OBSTET GYN R B, V77, P47, DOI 10.1016/S0301-2115(97)00226-1; Laverty WH, 1998, PERCEPT MOTOR SKILL, V86, P299, DOI 10.2466/pms.1998.86.1.299; LAW SP, 1986, ACTA OBSTET GYN SCAN, V65, P45, DOI 10.3109/00016348609158228; LIEBER AL, 1978, J CLIN PSYCHIAT, V39, P385; MATHEW VM, 1991, PSYCHOL REP, V68, P927, DOI 10.2466/PR0.68.3.927-930; Myers Daniel E., 1995, Journal of Emergency Medicine, V13, P529; ODERDA GM, 1983, J TOXICOL-CLIN TOXIC, V20, P487, DOI 10.3109/15563658308990614; Owen C, 1998, AUST NZ J PSYCHIAT, V32, P496, DOI 10.1046/j.1440-1614.1998.00442.x; Raison CL, 1999, J AFFECT DISORDERS, V53, P99, DOI 10.1016/S0165-0327(99)00016-6; SANDS JM, 1991, PSYCHOL REP, V69, P959, DOI 10.2466/PR0.69.7.959-962; THAKUR CP, 1984, BRIT MED J, V289, P1789, DOI 10.1136/bmj.289.6460.1789; Thompson DA, 1996, AM J EMERG MED, V14, P161, DOI 10.1016/S0735-6757(96)90124-2; Wilkinson G, 1997, INT J SOC PSYCHIATR, V43, P29, DOI 10.1177/002076409704300103	18	25	25	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 23	2000	321	7276					1561	1563		10.1136/bmj.321.7276.1561	http://dx.doi.org/10.1136/bmj.321.7276.1561			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	387RA	11124174	Bronze, Green Published			2022-12-24	WOS:000166134500012
J	Ness, G; Macaskill, N				Ness, G; Macaskill, N			Near drowning: self therapy in situ	BRITISH MEDICAL JOURNAL			English	Article							POSTTRAUMATIC-STRESS-DISORDER		Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England; Leeds Community Mental Hlth Trust, Leeds LS6 4QB, W Yorkshire, England	University of Sheffield	Ness, G (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield S1 4DA, S Yorkshire, England.							BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Marks I, 1998, ARCH GEN PSYCHIAT, V55, P317, DOI 10.1001/archpsyc.55.4.317; Mayou RA, 2000, BRIT J PSYCHIAT, V176, P589, DOI 10.1192/bjp.176.6.589; Meichenbaum D, 1975, HELPING PEOPLE CHANG, P357	6	1	1	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 23	2000	321	7276					1604	1606		10.1136/bmj.321.7276.1604	http://dx.doi.org/10.1136/bmj.321.7276.1604			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387RA	11124197	Green Published			2022-12-24	WOS:000166134500033
J	Marlow, JR; Lange, CB; Wefer, G; Rosell-Mele, A				Marlow, JR; Lange, CB; Wefer, G; Rosell-Mele, A			Upwelling intensification as part of the Pliocene-Pleistocene climate transition	SCIENCE			English	Article							WALVIS RIDGE; ATLANTIC; ALKENONES; DEGRADATION; CIRCULATION; EVOLUTION; MARINE; DIATOM	A deep-sea sediment core underlying the Benguela upwelling system off southwest Africa provides a continuous time series of sea surface temperature (SST) for the past 4.5 million years. Our results indicate that temperatures in the region have declined by about 10 degreesC since 3.2 million years ago, Records of paleoproductivity suggest that this cooling was associated with an increase in wind-driven upwelling tied to a shift from relatively stable global warmth during the mid-Pliocene to the high-amplitude glacial-interglacial cycles of the Late Quaternary, These observations imply that Atlantic Ocean surface water circulation was radically different during the mid-Pliocene.	Newcastle Univ, Dept Fossil Fuels & Environm Geochem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA; Univ Bremen, Dept Earth Sci FB5, D-28334 Bremen, Germany; Univ Durham, Dept Geog, Durham DH1 3LE, England	Newcastle University - UK; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Bremen; Durham University	Marlow, JR (corresponding author), Newcastle Univ, Dept Fossil Fuels & Environm Geochem, Drummond Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	J.R.Marlow@ncl.ac.uk	Gerold, Wefer/S-2291-2016; Rosell-Melé, Antoni/B-3433-2013; Lange, Carina/AHC-2015-2022	Gerold, Wefer/0000-0002-6803-2020; Rosell-Melé, Antoni/0000-0002-5513-2647; Lange, Carina/0000-0002-2916-4207				ABELMANN A, 1990, NATO ADV SCI I C-MAT, V308, P729; BARRON JA, 1989, LIFE SCI R, V44, P341; Berger W.H., 1998, P ODP INIT REP, V175, P505, DOI [10.2973/odp.proc.ir. 175.117.1998, DOI 10.2973/ODP.PROC.IR.175.117.1998]; Berger WH, 1996, SOUTH ATLANTIC, P363; Billups K, 1998, PALEOCEANOGRAPHY, V13, P84, DOI 10.1029/97PA02995; BRASSELL SC, 1986, NATURE, V320, P129, DOI 10.1038/320129a0; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Diester-Haass L., 1992, GEOLOGICAL SOC LONDO, V63, P331; Dowsett H, 1996, MAR MICROPALEONTOL, V27, P13, DOI 10.1016/0377-8398(95)00050-X; Dowsett H, 1996, MAR MICROPALEONTOL, V27, P181, DOI 10.1016/0377-8398(95)00059-3; DOWSETT HJ, 1990, MAR MICROPALEONTOL, V16, P1, DOI 10.1016/0377-8398(90)90026-I; Emeis K.-C., 1995, P OCEAN DRILL PROGRA, V138, P605; FranceLanord C, 1997, NATURE, V390, P65, DOI 10.1038/36324; Gong C, 1999, GEOCHIM COSMOCHIM AC, V63, P405, DOI 10.1016/S0016-7037(98)00283-X; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Haug GH, 1999, NATURE, V401, P779, DOI 10.1038/44550; Hay W.W., 1992, GEOL SOC SPEC PUBL L, P463, DOI DOI 10.1144/GSL.SP.1992.064.01.31; Herbert T.D., 1998, P OCEAN DRILLING PRO, V159T, P17, DOI [10.2973/odp.proc.sr.159T.063.1998, DOI 10.2973/ODP.PROC.SR.159T.063.1998]; Herbert TD, 1998, PALEOCEANOGRAPHY, V13, P263, DOI 10.1029/98PA00069; Hodell David A., 1992, Antarctic Research Series, V56, P265; Hoefs MJL, 1998, PALEOCEANOGRAPHY, V13, P42, DOI 10.1029/97PA02893; HOVAN SA, 1991, P OC DRILL PROGR SCI, V0121; Lange CB, 1999, MAR GEOL, V161, P93, DOI 10.1016/S0025-3227(99)00081-X; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; LUTJEHARMS JRE, 1987, S AFR J MARINE SCI, V5, P35, DOI 10.2989/025776187784522612; MARLOWE IT, 1990, CHEM GEOL, V88, P349, DOI 10.1016/0009-2541(90)90098-R; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Muller PJ, 1997, PALAEOGEOGR PALAEOCL, V135, P71, DOI 10.1016/S0031-0182(97)00018-7; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Pflaumann U., 1998, P OCEAN DRILLING PRO, V159T, P3; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Rind D, 1998, J GEOPHYS RES-ATMOS, V103, P5943, DOI 10.1029/97JD03649; ROSELLMELE A, 1994, THESIS U BRISTOL UK; Ruddiman WF, 1989, PALEOCEANOGRAPHY, V4, P353, DOI 10.1029/PA004i004p00353; RUDDIMAN WF, 1989, P OCEAN DRILLING PRO, V0108; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; *SHIPB SCI PART, 1998, P ODP IN REP, V175, P339; Sloan LC, 1996, MAR MICROPALEONTOL, V27, P51, DOI 10.1016/0377-8398(95)00063-1; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; Treppke UF, 1996, J MAR RES, V54, P991, DOI 10.1357/0022240963213655; Watson AJ, 1995, DAHL WS ENV, V18, P321	42	266	279	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 22	2000	290	5500					2288	+						5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	385GQ	11125138				2022-12-24	WOS:000165995800038
J	Simpson, JH; Bland, KS; Fetter, RD; Goodman, CS				Simpson, JH; Bland, KS; Fetter, RD; Goodman, CS			Short-range and long-range guidance by slit and its Robo receptors: A combinatorial code of Robo receptors controls lateral position	CELL			English	Article							NEURONAL GROWTH CONES; CELL-ADHESION MOLECULE; GRASSHOPPER EMBRYOS; AXON GUIDANCE; FASCICLIN-II; CNS MIDLINE; RETINOTECTAL PROJECTION; SELECTIVE FASCICULATION; GENETIC-ANALYSIS; DROSOPHILA	Slit is secreted by midline glia in Drosophila and functions as a short-range repellent to control midline crossing. Although most Slit stays near the midline, some diffuses laterally, functioning as a long-range chemorepellent. Here we show that a combinatorial code of Robe receptors controls lateral position in the CNS by responding to this presumptive Slit gradient. Medial axons express only Robe, intermediate axons express Robo3 and Robe, while lateral axons express Robo2, Robo3, and Robe. Removal of robo2 or robo3 causes lateral axons to extend medially; ectopic expression of Robo2 or Robo3 on medial axons drives them laterally. Precise topography of longitudinal pathways appears to be controlled by a combination of long-range guidance (the Robe code determining region) and short-range guidance (discrete local cues determining specific location within a region).	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Div Neurobiol, 519 LSA, Berkeley, CA 94720 USA.	goodman@uclink4.berkeley.edu		Bland, Kimberly/0000-0003-4863-6772; Simpson, Julie/0000-0002-6793-7100	NINDS NIH HHS [NS18366] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BASTIANI MJ, 1984, J NEUROSCI, V4, P2311; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; GIERER A, 1987, DEVELOPMENT, V101, P479; Gierer Alfred, 1995, Current Opinion in Neurobiology, V5, P91, DOI 10.1016/0959-4388(95)80092-1; Goodman C.S., 1985, P295; Goodman C. S., 1993, DEV DROSOPHILA MELAN; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; RAPER JA, 1983, J NEUROSCI, V3, P20; RAPER JA, 1983, COLD SPRING HARB SYM, V48, P587, DOI 10.1101/SQB.1983.048.01.063; RAPER JA, 1984, J NEUROSCI, V4, P2329; RAPER JA, 1983, J NEUROSCI, V3, P31; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; SNOW PM, 1989, CELL, V59, P313, DOI 10.1016/0092-8674(89)90293-6; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Wong JTW, 1997, DEVELOPMENT, V124, P3597; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	45	224	225	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2000	103	7					1019	1032		10.1016/S0092-8674(00)00206-3	http://dx.doi.org/10.1016/S0092-8674(00)00206-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163179	Bronze			2022-12-24	WOS:000166040600006
J	Chen, L; Chetkovich, DM; Petralia, RS; Sweeney, NT; Kawasaki, Y; Wenthold, RJ; Bredt, DS; Nicoll, RA				Chen, L; Chetkovich, DM; Petralia, RS; Sweeney, NT; Kawasaki, Y; Wenthold, RJ; Bredt, DS; Nicoll, RA			Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms	NATURE			English	Article							MUTANT MOUSE; GLUTAMATE RECEPTORS; SYNAPSES; FAMILY; ORGANIZATION; EXPRESSION; PROTEINS; SUBUNITS; REVEALS; WAGGLER	Stargazer, an ataxic and epileptic mutant mouse, lacks functional AMPA (alpha -amino-3-hydroxyl-5-methyl-4-isoxazolepropionate) receptors on cerebellar granule cells. Stargazin, the mutated protein, interacts with both AMPA receptor subunits and synaptic PDZ proteins, such as PSD-95. The interaction of stargazin with AMPA receptor subunits is essential for delivering functional receptors to the surface membrane of granule cells, whereas its binding with PSD-95 and related PDZ proteins through a carboxy-terminal PDZ-binding domain is required for targeting the AMPA receptor to synapses. Expression of a mutant stargazin lacking the PDZ-binding domain in hippocampal pyramidal cells disrupts synaptic AMPA receptors, indicating that stargazin-like mechanisms for targeting AMPA receptors may be widespread in the central nervous system.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; NIDCD, Neurochem Lab, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	nicoll@phy.ucsf.edu	Chetkovich, Dane/AAV-5457-2021	Chen, Lu/0000-0002-8097-2699				Bao SW, 1998, LEARN MEMORY, V5, P355; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Burgess DL, 1999, GENOME RES, V9, P1204, DOI 10.1101/gr.9.12.1204; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsubara A, 1996, J NEUROSCI, V16, P4457; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Palay S. L., 1974, CEREBELLAR CORTEX CY; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Petralia RS, 1998, NEUROPHARMACOLOGY, V37, P1321, DOI 10.1016/S0028-3908(98)00118-X; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; PETRALIA RS, 1994, J NEUROSCI, V14, P667; RANDALL A, 1995, J NEUROSCI, V15, P2995; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wang YX, 1998, J NEUROSCI, V18, P1148; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; Zhao HM, 1998, J NEUROSCI, V18, P5517, DOI 10.1523/JNEUROSCI.18-14-05517.1998	37	840	864	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2000	408	6815					936	943		10.1038/35050030	http://dx.doi.org/10.1038/35050030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140673				2022-12-24	WOS:000165951100039
J	Cheung, AT; Dayanandan, B; Lewis, JT; Korbutt, GS; Rajotte, RV; Bryer-Ash, M; Boylan, MO; Wolfe, MM; Kieffer, TJ				Cheung, AT; Dayanandan, B; Lewis, JT; Korbutt, GS; Rajotte, RV; Bryer-Ash, M; Boylan, MO; Wolfe, MM; Kieffer, TJ			Glucose-dependent insulin release from genetically engineered K cells	SCIENCE			English	Article							GASTROINTESTINAL-TRACT; POLYPEPTIDE GIP; GENE-EXPRESSION; REVERSAL; HORMONE; MICE	Genetic engineering of non-beta cells to release insulin upon feeding could be a therapeutic modality for patients with diabetes. A tumor-derived K-cell line was induced to produce human insulin by providing the cells with the human insulin gene linked tb the 5'-regulatory region of the gene encoding glucose-dependent insulinotropic polypeptide (GIP). Mice expressing this transgene produced human insulin specifically in gut K cells. This insulin protected the mice from developing diabetes and maintained glucose tolerance after destruction of the native insulin-producing beta cells.	Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Surg, Edmonton, AB T6G 2S2, Canada; enGene Inc, Edmonton, AB T6G 2T5, Canada; Univ Tennessee, Dept Med, Memphis, TN 38103 USA; Boston Med Ctr, Gastroenterol Sect, Boston, MA 02118 USA	University of Alberta; University of Alberta; University of Alberta; University of Tennessee System; University of Tennessee Health Science Center; Boston Medical Center	Kieffer, TJ (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada.	tim.kieffer@ualberta.ca						Bartlett RJ, 1997, TRANSPLANT P, V29, P2199, DOI 10.1016/S0041-1345(97)00294-7; Bochan MR, 1999, TRANSPLANT P, V31, P690, DOI 10.1016/S0041-1345(98)01611-X; Boylan MO, 1997, J BIOL CHEM, V272, P17438, DOI 10.1074/jbc.272.28.17438; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CATALAND S, 1974, J CLIN ENDOCR METAB, V39, P223, DOI 10.1210/jcem-39-2-223; CHEUNG ASC, UNPUB; Croyle MA, 1998, GENE THER, V5, P645, DOI 10.1038/sj.gt.3300645; Falqui L, 1999, HUM GENE THER, V10, P1753, DOI 10.1089/10430349950017437; FERRI GL, 1983, GASTROENTEROLOGY, V84, P777; Goldfine ID, 1997, NAT BIOTECHNOL, V15, P1378, DOI 10.1038/nbt1297-1378; HENNING SJ, 1997, ADV DRUG DELIV REV, V17, P341; KIEFFER TJ, 1994, AM J PHYSIOL-ENDOC M, V267, pE489, DOI 10.1152/ajpendo.1994.267.4.E489; KOLODKA TM, 1995, P NATL ACAD SCI USA, V92, P3293, DOI 10.1073/pnas.92.8.3293; Lipes MA, 1996, P NATL ACAD SCI USA, V93, P8595, DOI 10.1073/pnas.93.16.8595; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; RINDI G, 1990, AM J PATHOL, V136, P1349; Sandstrom O, 1999, MECH AGEING DEV, V108, P39, DOI 10.1016/S0047-6374(98)00154-7; SIMON PB, 2000, CARCINOGENESIS, V21, P469; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Thule PM, 2000, GENE THER, V7, P205, DOI 10.1038/sj.gt.3301076; TSENG CC, 1994, AM J PHYSIOL, V266, pG887, DOI 10.1152/ajpgi.1994.266.5.G887; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wolfe MM, 1999, CONT ENDOCRINOL, V8, P439; Yeung CM, 1999, MOL CELL ENDOCRINOL, V154, P161, DOI 10.1016/S0303-7207(99)00106-9	24	216	241	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2000	290	5498					1959	1962		10.1126/science.290.5498.1959	http://dx.doi.org/10.1126/science.290.5498.1959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382EL	11110661				2022-12-24	WOS:000165810000044
J	Denke, MA; Adams-Huet, B; Nguyen, AT				Denke, MA; Adams-Huet, B; Nguyen, AT			Individual cholesterol variation in response to a margarine- or butter-based diet - A study in families	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; FATTY-ACID-COMPOSITION; SERUM-CHOLESTEROL; LOWERING DIET; PLASMA-CHOLESTEROL; APOLIPOPROTEIN-E; RESPONSIVENESS; WEIGHT; ESTERS; MEN	Context The effectiveness of dietary modification in reducing low-density lipoprotein cholesterol (LDL-C) levels can be reliably predicted for populations, but not for individuals. Objective To determine whether individual variation in cholesterol response to dietary modification is a familial trait. Design Two-period, outpatient crossover trial conducted from September 1997 to September 1999, Setting and Participants Fifty-six families from the Dallas-Ft Worth, Tex, area with 2 biological parents and at least 2 children aged 5 years or older volunteered; 46 families (n=92 adults and n=134 children) completed the study. Intervention All families followed two 5-week dietary regimens that included individualized daily dietary prescriptions and emphasized a low-saturated fat diet supplemented with specially manufactured baked goods and spreadable fat. One regimen used butter only and the other used margarine only. Main Outcome Measure Mean LDL-C levels during the last 2 weeks of each dietary period. Results Margarine intake compared with butter intake lowered LDL-C levels 11% in adults (95% confidence interval [CI], -13% to -9%) and 9% in children (95% CI, -12% to -6%) (P<.001 for both adults and children). The distribution of individual responses were peaked around the mean response. For adults and children together, family membership accounted for 19% of variability in response (P=.007). In children, family membership accounted for 40% of variability in response of percent change in LDL-C levels (P=.002). Body mass index and change in cholesterol ester (CE) 18, 2/18:1 ratio accounted for 26% of variation, leaving 26% still attributable to family membership. In all participants, BMI predicted response-heavier individuals had higher LDL-C levels, less excursion in CE fatty acids, and less LDL-C response to dietary change. Conclusions Our results suggest that individual variation in response to a cholesterol-lowering diet is a familial trait. Body weight is an important modifiable factor that influences response.	Univ Texas, SW Med Ctr, Ctr Human Nutr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Denke, MA (corresponding author), Univ Texas, SW Med Ctr, Ctr Human Nutr, Dept Internal Med, 5323 Harry Hines Blvd,Room Y3-234, Dallas, TX 75390 USA.	mdenke@mednet.swmed.edu			NCRR NIH HHS [MO1-RR00633] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ascherio A, 1997, AM J CLIN NUTR, V66, P1006, DOI 10.1093/ajcn/66.4.1006S; BAKER BM, 1968, CIRCULATION, V37, P1; BEYNEN AC, 1987, ADV LIPID RES, V22, P115; CARLETON RA, 1991, CIRCULATION, V83, P2154, DOI 10.1161/01.CIR.83.6.2154; COLE TG, 1992, AM J CLIN NUTR, V55, P385, DOI 10.1093/ajcn/55.2.385; DENKE MA, 1994, ARCH INTERN MED, V154, P1977, DOI 10.1001/archinte.154.17.1977; DENKE MA, 1993, AM J MED, V94, P626, DOI 10.1016/0002-9343(93)90215-B; DENKE MA, 1993, ARCH INTERN MED, V153, P1093, DOI 10.1001/archinte.153.9.1093; DENKE MA, 1994, ARCH INTERN MED, V154, P401, DOI 10.1001/archinte.154.4.401; DENKE MA, 1994, ARCH INTERN MED, V154, P317, DOI 10.1001/archinte.154.3.317; DOLE VP, 1960, J BIOL CHEM, V235, P2595; Hannah JS, 1997, INT J OBESITY, V21, P445, DOI 10.1038/sj.ijo.0800427; HEGSTED DM, 1965, AM J CLIN NUTR, V17, P281; HIXSON JE, 1990, J LIPID RES, V31, P545; HUDGINS LC, 1991, AM J CLIN NUTR, V53, P1372, DOI 10.1093/ajcn/53.6.1372; JACOBS DR, 1983, ARTERIOSCLEROSIS, V3, P349, DOI 10.1161/01.ATV.3.4.349; Jansen S, 1998, J NUTR, V128, P1144, DOI 10.1093/jn/128.7.1144; Judd JT, 1998, AM J CLIN NUTR, V68, P768, DOI 10.1093/ajcn/68.4.768; KANG KW, 1976, LIPIDS, V11, P722, DOI 10.1007/BF02533045; KATAN MB, 1988, J LIPID RES, V29, P883; KEYS A, 1957, LANCET, V2, P959; KNUIMAN JT, 1980, ATHEROSCLEROSIS, V37, P617, DOI 10.1016/0021-9150(80)90068-4; Krauss RM, 1996, CIRCULATION, V94, P1795, DOI 10.1161/01.CIR.94.7.1795; LEHTIMAKI T, 1990, J LIPID RES, V31, P487; LEPAGE G, 1986, J LIPID RES, V27, P114; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lichtenstein AH, 1999, NEW ENGL J MED, V340, P1933, DOI 10.1056/NEJM199906243402501; LITTELL RC, 1986, SAS SYSTEM MIXED MOD; MA J, 1995, AM J CLIN NUTR, V62, P564, DOI 10.1093/ajcn/62.3.564; MCCOMBS RJ, 1994, NEW ENGL J MED, V331, P706, DOI 10.1056/NEJM199409153311104; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911, DOI 10.1161/01.ATV.12.8.911; MOILANEN T, 1983, ATHEROSCLEROSIS, V48, P49, DOI 10.1016/0021-9150(83)90016-3; Ordovas JM, 1999, P NUTR SOC, V58, P171, DOI 10.1079/PNS19990023; QUIVERS ES, 1992, PEDIATRICS, V89, P925; ROTTERDAM EP, 1987, CLIN CHEM, V33, P1913; SARKKINEN ES, 1994, AM J CLIN NUTR, V59, P364, DOI 10.1093/ajcn/59.2.364; SHENBERGER DM, 1992, J AM DIET ASSOC, V92, P441; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Tall A, 1997, ARTERIOSCL THROM VAS, V17, P3326, DOI 10.1161/01.ATV.17.11.3326; TIKKANEN MJ, 1990, ARTERIOSCLEROSIS, V10, P285, DOI 10.1161/01.ATV.10.2.285; TONSTAD S, 1995, ARTERIOSCL THROM VAS, V15, P1009, DOI 10.1161/01.ATV.15.8.1009; WALD ER, 1995, CLIN UPDATES PEDIAT, V1, P1; Wang JP, 1998, J CLIN INVEST, V101, P1283, DOI 10.1172/JCI1343; XU CF, 1987, GENET EPIDEMIOL, V126, P202; YU SM, 1995, AM J CLIN NUTR, V61, P1129, DOI 10.1093/ajcn/61.5.1129; Zock PL, 1997, ATHEROSCLEROSIS, V131, P7, DOI 10.1016/S0021-9150(96)06063-7; Zock PL, 1997, AM J EPIDEMIOL, V145, P1114, DOI 10.1093/oxfordjournals.aje.a009074	48	53	53	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2000	284	21					2740	2747		10.1001/jama.284.21.2740	http://dx.doi.org/10.1001/jama.284.21.2740			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377JB	11105179	Bronze			2022-12-24	WOS:000165509500028
J	Graham, CS; Koziel, MJ				Graham, CS; Koziel, MJ			Why should hepatitis C affect immune reconstitution in HIV-1-infected patients?	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; PROGRESSION; INFECTIONS; CELLS; AIDS		Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Koziel, MJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA.							Alter MJ, 1998, INFECT DIS CLIN N AM, V12, P13, DOI 10.1016/S0891-5520(05)70405-0; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Donahoe RM, 1998, J NEUROIMMUNOL, V83, P77, DOI 10.1016/S0165-5728(97)00224-5; Gougeon ML, 1999, ANN NY ACAD SCI, V887, P199, DOI 10.1111/j.1749-6632.1999.tb07934.x; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; Jenny-Avital ER, 2000, CLIN INFECT DIS, V30, P409, DOI 10.1086/313676; Lai MMC, 2000, HEPATOLOGY, V32, P427, DOI 10.1053/jhep.2000.9856; Laskus T, 2000, J INFECT DIS, V181, P442, DOI 10.1086/315283; Lerat H, 1996, J CLIN INVEST, V97, P845, DOI 10.1172/JCI118485; Pezzotti P, 1999, J ACQ IMMUN DEF SYND, V20, P275, DOI 10.1097/00042560-199903010-00010; Staples CT, 1999, CLIN INFECT DIS, V29, P150, DOI 10.1086/520144; Taya N, 2000, BRIT J HAEMATOL, V110, P89, DOI 10.1046/j.1365-2141.2000.01945.x; VOGT MW, 1987, SCIENCE, V235, P1376, DOI 10.1126/science.2435003; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Zylberberg H, 1996, CLIN INFECT DIS, V23, P1117, DOI 10.1093/clinids/23.5.1117	16	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 2	2000	356	9245					1865	1866		10.1016/S0140-6736(00)03251-7	http://dx.doi.org/10.1016/S0140-6736(00)03251-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379WD	11130376				2022-12-24	WOS:000165665400003
J	Morice, AH				Morice, AH			Helium/oxygen and severe COPD	LANCET			English	Editorial Material							PRESSURE		Castle Hill Hosp, Acad Dept Med, Cottingham HU16 5JQ, East Yorkshire, England	University of Hull	Morice, AH (corresponding author), Castle Hill Hosp, Acad Dept Med, Cottingham HU16 5JQ, East Yorkshire, England.							PEPE PE, 1982, AM REV RESPIR DIS, V126, P166; SASSOON CSH, 1991, AM REV RESPIR DIS, V143, P469, DOI 10.1164/ajrccm/143.3.469; Tassaux D, 2000, CRIT CARE MED, V28, P2721, DOI 10.1097/00003246-200008000-00006	3	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 25	2000	356	9244					1785	1786		10.1016/S0140-6736(00)03226-8	http://dx.doi.org/10.1016/S0140-6736(00)03226-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377UY	11117906				2022-12-24	WOS:000165545700005
J	Hoshi, E; Tanji, J				Hoshi, E; Tanji, J			Integration of target and body-part information in the premotor cortex when planning action	NATURE			English	Article							SUPERIOR PARIETAL LOBULE; NEURONAL-ACTIVITY; PRIMATE PREMOTOR; PREFRONTAL CORTEX; MACAQUE MONKEY; MOTOR; MOVEMENT; AREA; ORGANIZATION; DIRECTION	To plan an action, we must first select an object to act on and the body part (or parts) to use to accomplish our intention. To plan the motor task of reaching, we specify both the target to reach for and the arm to use. In the process of planning and preparing a motor task, information about the motor target and the arm to use must be integrated before a motor program can be formulated to generate the appropriate limb movement. One of the structures in the brain that is probably involved in integrating these two sets of information is the premotor area in the cerebral cortex of primates(1-5). The lateral sector of the dorsal premotor cortex is known to receive both visual and somatosensory input(6-8), and we show here that neurons in this area gather information about both the target and the body part, while subsequent activity specifies the planned action.	Tohoku Univ, Sch Med, Dept Physiol, Aoba Ku, Sendai, Miyagi 9808575, Japan; Core Res Evolut Sci & Technol Program, Kawaguchi 3320012, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Tanji, J (corresponding author), Tohoku Univ, Sch Med, Dept Physiol, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	tanjij@mail.cc.tohoku.ac.jp						BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P15, DOI 10.1007/BF00229650; Caminiti R, 1996, CEREB CORTEX, V6, P319, DOI 10.1093/cercor/6.3.319; DIPELLEGRINO G, 1993, J NEUROSCI, V13, P1227; DUM RP, 1991, LIFE SCI R, V50, P383; Fogassi L, 1999, EXP BRAIN RES, V128, P194, DOI 10.1007/s002210050835; HALSBAND V, 1982, BRAIN RES, V240, P368; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; KURATA K, 1985, EXP BRAIN RES, V60, P188; KURATA K, 1994, BEHAV BRAIN RES, V61, P135, DOI 10.1016/0166-4328(94)90154-6; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; KURATA K, 1988, EXP BRAIN RES, V69, P327; Matelli M, 1998, J COMP NEUROL, V402, P327; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; PASSINGHAM RE, 1988, EXP BRAIN RES, V70, P590; Passingham RE., 1993, FRONTAL LOBES VOLUNT; PETRIDES M, 1985, BEHAV BRAIN RES, V16, P95, DOI 10.1016/0166-4328(85)90085-3; RIEHLE A, 1989, J NEUROPHYSIOL, V61, P534, DOI 10.1152/jn.1989.61.3.534; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Tokuno H, 2000, NEUROSCI RES, V36, P335, DOI 10.1016/S0168-0102(99)00133-9; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; WISE SP, 1985, ANNU REV NEUROSCI, V8, P1, DOI 10.1146/annurev.ne.08.030185.000245	23	191	192	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2000	408	6811					466	470		10.1038/35044075	http://dx.doi.org/10.1038/35044075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100727				2022-12-24	WOS:000165429800047
J	Modvig, J; Pagaduan-Lopez, J; Rodenburg, J; Salud, CMD; Cabigon, RV; Panelo, CIA				Modvig, J; Pagaduan-Lopez, J; Rodenburg, J; Salud, CMD; Cabigon, RV; Panelo, CIA			Torture and trauma in post-conflict East Timor	LANCET			English	Editorial Material									Int Rehabil Council Torture Victims, Copenhagen K, Denmark		Modvig, J (corresponding author), Int Rehabil Council Torture Victims, Copenhagen K, Denmark.								0	46	46	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 18	2000	356	9243					1763	1763		10.1016/S0140-6736(00)03218-9	http://dx.doi.org/10.1016/S0140-6736(00)03218-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	376MX	11095275				2022-12-24	WOS:000165462300041
J	Smith, J				Smith, J			Nice work - but is it science?	NATURE			English	Editorial Material									Winfrith Technol Ctr, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, Dorset, England	UK Centre for Ecology & Hydrology (UKCEH)	Smith, J (corresponding author), Winfrith Technol Ctr, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, Dorset, England.		Smith, Jim/G-7716-2011	Smith, Jim/0000-0002-0808-2739				Peters R.H., 1991, CRITIQUE ECOLOGY; Popper K., 1963, CONJECTURES REFUTAT	2	8	9	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2000	408	6810					293	293		10.1038/35042642	http://dx.doi.org/10.1038/35042642			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099020	Bronze			2022-12-24	WOS:000165296000021
J	Gogos, JA; Osborne, J; Nemes, A; Mendelsohn, M; Axel, R				Gogos, JA; Osborne, J; Nemes, A; Mendelsohn, M; Axel, R			Genetic ablation and restoration of the olfactory topographic map	CELL			English	Article							BROMIDE-INDUCED LESION; ADULT MAMMALIAN BRAIN; NEURAL STEM-CELL; TOXIN-A-CHAIN; TRANSGENIC MICE; SUBVENTRICULAR ZONE; MARKER PROTEIN; SENSORY MAP; EXPRESSION; BULB	In the olfactory sensory system, neurons expressing a given odorant receptor project with precision to two of 1800 spatially invariant glomeruli creating a topographic map within the olfactory bulb. Olfactory sensory neurons have a half-life of about 90 days and are continually renewing. This poses the problem of how this precise spatial map is maintained throughout the life of the organism. We have developed a genetic approach to effect the synchronous ablation of subpopulations of neurons expressing a given receptor. The axons of newly generated neurons can then be followed as they enter the brain and converge on glomerular targets during adult life. The observation that following neuronal cell killing, the spatial map is faithfully restored, demonstrates that the information necessary for the establishment of the sensory map persists throughout the life of the organism.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.			Axel, Richard/0000-0002-3141-4076				ATTARDI DG, 1963, EXP NEUROL, V7, P46, DOI 10.1016/0014-4886(63)90093-1; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; BREITMAN ML, 1990, MOL CELL BIOL, V10, P474, DOI 10.1128/MCB.10.2.474; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; BURD GD, 1993, MICROSC RES TECHNIQ, V24, P195, DOI 10.1002/jemt.1070240302; CAGGIANO M, 1994, NEURON, V13, P339, DOI 10.1016/0896-6273(94)90351-4; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Costanzo RM, 2000, CHEM SENSES, V25, P199, DOI 10.1093/chemse/25.2.199; Cummings DM, 2000, J COMP NEUROL, V421, P362; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065; GRAZIADEI PPC, 1978, DEV SENSORY SYSTEMS, P55; HINDS JW, 1984, ANAT REC, V210, P375, DOI 10.1002/ar.1092100213; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Koster NL, 1996, BRAIN RES, V724, P117, DOI 10.1016/0006-8993(96)00281-8; Lee P, 1998, P NATL ACAD SCI USA, V95, P11371, DOI 10.1073/pnas.95.19.11371; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; MACKAYSIM A, 1991, EUR J NEUROSCI, V3, P209, DOI 10.1111/j.1460-9568.1991.tb00081.x; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MAXWELL F, 1987, MOL CELL BIOL, V7, P1576, DOI 10.1128/MCB.7.4.1576; MAXWELL IH, 1986, CANCER RES, V46, P4660; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Royal SJ, 1999, J NEUROSCI, V19, P9856; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schwob JE, 1999, J COMP NEUROL, V412, P439, DOI 10.1002/(SICI)1096-9861(19990927)412:3<439::AID-CNE5>3.0.CO;2-H; SCHWOB JE, 1995, J COMP NEUROL, V359, P15, DOI 10.1002/cne.903590103; STROTMANN J, 1994, CELL TISSUE RES, V276, P429; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; VERHAAGEN J, 1990, J NEUROSCI RES, V26, P31, DOI 10.1002/jnr.490260105; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WANG F, 1998, THESIS COLUMBIA U NE; Whitlock KE, 1998, J NEUROSCI, V18, P8919; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Yee KK, 1998, CHEM SENSES, V23, P513, DOI 10.1093/chemse/23.5.513; YEE KK, 1995, PHYSIOL BEHAV, V58, P959, DOI 10.1016/0031-9384(95)00159-G; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	50	109	112	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 10	2000	103	4					609	620		10.1016/S0092-8674(00)00164-1	http://dx.doi.org/10.1016/S0092-8674(00)00164-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	374MB	11106731	Bronze			2022-12-24	WOS:000165348000006
J	Rickman, J				Rickman, J			A patient's perspective	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	2001	322	7281					293	294		10.1136/bmj.322.7281.293	http://dx.doi.org/10.1136/bmj.322.7281.293			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401FM	11157537	Green Published			2022-12-24	WOS:000166917600039
J	Tung, BY; Emond, MJ; Haggitt, RC; Bronner, MP; Kimmey, MB; Kowdley, KV; Brentnall, TA				Tung, BY; Emond, MJ; Haggitt, RC; Bronner, MP; Kimmey, MB; Kowdley, KV; Brentnall, TA			Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis	ANNALS OF INTERNAL MEDICINE			English	Article							PROTEIN-KINASE-C; FECAL BILE-ACIDS; INFLAMMATORY BOWEL-DISEASE; II PHOSPHOLIPASE A(2); COLORECTAL-CANCER; URSODEOXYCHOLIC ACID; REDUCED RISK; ASPIRIN USE; F344 RATS; CARCINOGENESIS	Background: Patients with ulcerative colitis and primary sclerosing cholangitis are at high risk for colonic dysplasia and cancer. This risk approaches 50% after 25 years of colitis. Ursodiol has been shown to protect against development of colorectal neoplasia in animal models. Objective: To assess the relationship between ursodiol use and colonic dysplasia, the precursor to colon cancer, in patients with ulcerative colitis and primary sclerosing cholangitis. Design: Cross-sectional study. Setting: University medical center. Patients: 59 patients with ulcerative colitis and primary sclerosing cholangitis who were undergoing colonoscopic surveillance for colonic dysplasia. Measurements: Use of ursodiol was assessed in all patients. The presence or absence of colonic dysplasia was evaluated by colonoscopic surveillance. Other variables assessed were age at onset and duration of ulcerative colitis; duration of primary sclerosing cholangitis; Child-Pugh classification; and use of sulfasalazine, other 5-aminosalicylic acid preparations, prednisone, cyclosporine, azathioprine, and methotrexate. Results: Ursodiol use was strongly associated with decreased prevalence of colonic dysplasia (odds ratio, 0.18 [95% CI, 0.05 to 0.61]; P = 0.005). The association between dysplasia and ursodiol use remained after adjustment for sex, age at onset of colitis, duration of colitis, duration of sclerosing cholangitis, severity of liver disease, and sulfasalazine use (adjusted odds ratio, 0.14 [Cl, 0.03 to 0.64]; P = 0.01). Younger age at onset of colitis was associated with an increased risk for dysplasia. Conclusions: Ursodiol use appears to be associated with a lower frequency of colonic dysplasia in patients with ulcerative colitis and primary sclerosing cholangitis. A randomized trial investigating the chemoprotective effect of ursodiol in patients with ulcerative colitis may be warranted.	Univ Washington, Div Gastroenterol, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Brentnall, TA (corresponding author), Univ Washington, Div Gastroenterol, Sch Med, 1959 NE Pacific St,Box 356424, Seattle, WA 98195 USA.	teribr@u.washingon.edu	Kowdley, Kris/AAF-5202-2019		NATIONAL CANCER INSTITUTE [P01CA074184, R01CA068124] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA68124, P01CA74184] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Batta AK, 1998, CANCER RES, V58, P1684; BAYERDORFFER E, 1993, GASTROENTEROLOGY, V104, P145, DOI 10.1016/0016-5085(93)90846-5; Brentnall TA, 1996, GASTROENTEROLOGY, V110, P331, DOI 10.1053/gast.1996.v110.pm8566577; BROOME U, 1994, GUT, V35, P84, DOI 10.1136/gut.35.1.84; BROOME U, 1995, HEPATOLOGY, V22, P1404, DOI 10.1016/0270-9139(95)90144-2; COHEN BI, 1980, J NATL CANCER I, V64, P573; EARNEST DL, 1994, CANCER RES, V54, P5071; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; FAUSA O, 1991, SEMIN LIVER DIS, V11, P31, DOI 10.1055/s-2008-1040420; GALLOWAY DJ, 1986, BRIT J SURG, V73, P233, DOI 10.1002/bjs.1800730327; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GUILLEM JG, 1987, ARCH SURG-CHICAGO, V122, P1475; GURBUZ AK, 1995, DIS COLON RECTUM, V38, P37, DOI 10.1007/BF02053855; HENDRICKSE CW, 1995, BRIT J SURG, V82, P475, DOI 10.1002/bjs.1800820415; HILL MJ, 1987, LANCET, V2, P185; Ikegami T, 1998, CANCER LETT, V134, P129, DOI 10.1016/S0304-3835(98)00248-1; KOPP R, 1991, CANCER RES, V51, P205; Kornfeld K, 1997, GUT, V41, P522, DOI 10.1136/gut.41.4.522; KUSUNOKI M, 1992, CANCER, V69, P24, DOI 10.1002/1097-0142(19920101)69:1<24::AID-CNCR2820690107>3.0.CO;2-1; Lindor KD, 1997, NEW ENGL J MED, V336, P691, DOI 10.1056/NEJM199703063361003; Loftus EV, 1996, GASTROENTEROLOGY, V110, P432, DOI 10.1053/gast.1996.v110.pm8566590; Martinez JD, 1998, NUTR CANCER, V31, P111, DOI 10.1080/01635589809514689; MCSHERRY CK, 1989, CANCER RES, V49, P6039; MINAMI T, 1994, GUT, V35, P1593, DOI 10.1136/gut.35.11.1593; Mitsuyoshi H, 1999, BIOCHEM BIOPH RES CO, V263, P537, DOI 10.1006/bbrc.1999.1403; Moody GA, 1996, EUR J GASTROEN HEPAT, V8, P1179, DOI 10.1097/00042737-199612000-00009; Narisawa T, 1998, JPN J CANCER RES, V89, P1009, DOI 10.1111/j.1349-7006.1998.tb00489.x; Ochsenkuhn T, 1999, CANCER, V85, P1664, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1664::AID-CNCR4>3.0.CO;2-O; OLSSON R, 1991, GASTROENTEROLOGY, V100, P1319; PINCZOWSKI D, 1994, GASTROENTEROLOGY, V107, P117, DOI 10.1016/0016-5085(94)90068-X; PONGRACZ J, 1995, INT J CANCER, V61, P35, DOI 10.1002/ijc.2910610107; REDDY BS, 1977, CANCER-AM CANCER SOC, V39, P2533, DOI 10.1002/1097-0142(197706)39:6<2533::AID-CNCR2820390634>3.0.CO;2-X; REDDY BS, 1981, CANCER RES, V41, P3700; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; RODRIGUES CMP, 1995, GASTROENTEROLOGY, V109, P1835, DOI 10.1016/0016-5085(95)90750-5; Rosenberg L, 1998, CANCER-AM CANCER SOC, V82, P2326, DOI 10.1002/(SICI)1097-0142(19980615)82:12<2326::AID-CNCR5>3.0.CO;2-Q; SAKANOUE Y, 1992, SCAND J GASTROENTERO, V27, P275, DOI 10.3109/00365529209000074; Seraj MJ, 1997, CANCER LETT, V115, P97, DOI 10.1016/S0304-3835(97)04719-8; Shetty K, 1999, AM J GASTROENTEROL, V94, P1643; STADLER J, 1988, CANCER LETT, V38, P315, DOI 10.1016/0304-3835(88)90023-7; SUGITA A, 1991, GUT, V32, P167, DOI 10.1136/gut.32.2.167; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; WALI RK, 1995, CANCER RES, V55, P5257; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404	44	326	333	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2001	134	2					89	95		10.7326/0003-4819-134-2-200101160-00008	http://dx.doi.org/10.7326/0003-4819-134-2-200101160-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391KW	11177311				2022-12-24	WOS:000166356000001
J	Wilcox, ER; Burton, QL; Naz, S; Riazuddin, S; Smith, TN; Ploplis, B; Belyantseva, I; Ben-Yosef, T; Liburd, NA; Morell, RJ; Kachar, B; Wu, DK; Griffith, AJ; Riazuddin, S; Friedman, TB				Wilcox, ER; Burton, QL; Naz, S; Riazuddin, S; Smith, TN; Ploplis, B; Belyantseva, I; Ben-Yosef, T; Liburd, NA; Morell, RJ; Kachar, B; Wu, DK; Griffith, AJ; Riazuddin, S; Friedman, TB			Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29	CELL			English	Article							STRIA VASCULARIS; INNER-EAR; INTERCELLULAR-JUNCTIONS; STRANDS; PROTEINS; SEQUENCE; ORGAN; OCCLUDIN; LOCALIZATION; MATURATION	Tight junctions in the cochlear duct are thought to compartmentalize endolymph and provide structural support for the auditory neuroepithelium. The claudin family of genes is known to express protein components of tight junctions in other tissues. The essential function of one of these claudins in the inner ear was established by identifying mutations in CLDN14 that cause nonsyndromic recessive deafness DFNB29 in two large consanguineous Pakistani families. In situ hybridization and immunofluorescence studies demonstrated mouse claudin-14 expression in the sensory epithelium of the organ of Corti.	NIDCD, Mol Genet Lab, NIH, Rockville, MD 20850 USA; Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan; NIDCD, Sect Sensory Cell Regenerat & Dev, NIH, Rockville, MD 20850 USA; NIDCD, Sect Struct Cell biol, NIH, Rockville, MD 20850 USA; NIDCD, Neurootol Branch, NIH, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Punjab; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Wilcox, ER (corresponding author), NIDCD, Mol Genet Lab, NIH, 5 Res Court, Rockville, MD 20850 USA.	wilcoxe@nidcd.nih.gov	Naz, Sadaf/C-3911-2019; Morell, Robert James/Q-2042-2019	Naz, Sadaf/0000-0002-1912-0235; Morell, Robert/0000-0003-1537-7356	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000021, ZIADC000002, ZIADC000060, Z01DC000002, Z01DC000060, ZIADC000064, Z01DC000048, Z01DC000021, ZIADC000048, ZIADC000039, Z01DC000039, Z01DC000064] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANNIKO M, 1984, SCAN ELECTRON MICROS, P2067; ANNIKO M, 1982, AM J OTOLARYNG, V3, P242, DOI 10.1016/S0196-0709(82)80062-8; BAGGERSJOBACK D, 1988, ACTA OTO-LARYNGOL, V106, P19, DOI 10.3109/00016488809107366; Balda MS, 2000, SEMIN CELL DEV BIOL, V11, P281, DOI 10.1006/scdb.2000.0177; Berry A, 2000, GENOMICS, V68, P22, DOI 10.1006/geno.2000.6253; BonneTamir B, 1996, AM J HUM GENET, V58, P1254; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BUCHANAN LH, 1990, SCAND AUDIOL, V19, P103, DOI 10.3109/01050399009070760; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ferrary E, 1998, KIDNEY INT, pS98; Friedman T, 2000, CURR OPIN NEUROBIOL, V10, P487, DOI 10.1016/S0959-4388(00)00120-3; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Gratton MA, 1997, HEARING RES, V108, P9, DOI 10.1016/S0378-5955(97)00034-8; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; GULLEY RL, 1976, J NEUROCYTOL, V5, P479, DOI 10.1007/BF01181652; Harris NL, 1997, GENOME RES, V7, P754, DOI 10.1101/gr.7.7.754; Hassmann E, 1998, INT J PEDIATR OTORHI, V45, P199, DOI 10.1016/S0165-5876(98)00106-2; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Jahnke K, 1975, Acta Otolaryngol Suppl, V336, P1; JOHNSTONE BM, 1972, Q REV BIOPHYS, V5, P1, DOI 10.1017/S0033583500000032; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liu XZ, 2000, HUM MOL GENET, V9, P63, DOI 10.1093/hmg/9.1.63; LUCIANO L, 1995, HEARING RES, V85, P199, DOI 10.1016/0378-5955(95)00047-8; Marcus DC, 1999, HEARING RES, V134, P48, DOI 10.1016/S0378-5955(99)00074-X; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Milhaud PG, 1999, PFLUG ARCH EUR J PHY, V437, P823, DOI 10.1007/s004240050851; Mitic LL, 2000, AM J PHYSIOL-GASTR L, V279, pG250, DOI 10.1152/ajpgi.2000.279.2.G250; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Morsli H, 1998, J NEUROSCI, V18, P3327; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; NADOL JB, 1978, ANN OTO RHINOL LARYN, V87, P70, DOI 10.1177/000348947808700113; Riazuddin S, 2000, NAT GENET, V26, P431, DOI 10.1038/82558; RYAN AF, 1979, OTOLARYNG HEAD NECK, V87, P659, DOI 10.1177/019459987908700522; RYAN AF, 1983, SCAN ELECTRON MICROS, P201; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHNAPP B, 1978, PHYSL PATHOBIOLOGY A, P83; SCOTT HS, 2001, IN PRESS NAT GENET; Shapiro BL, 1997, HUM GENET, V99, P421, DOI 10.1007/s004390050383; Shapiro BL, 1999, J NEURAL TRANSM-SUPP, P41; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Slepecky N. B., 1996, COCHLEA, V8, P44; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Souter M, 1998, HEARING RES, V119, P81, DOI 10.1016/S0378-5955(98)00042-2; Stankovic KM, 1997, HEARING RES, V114, P21, DOI 10.1016/S0378-5955(97)00072-5; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Ulfendahl M, 2000, NEUROIMAGE, V12, P307, DOI 10.1006/nimg.2000.0617; Wong V, 1999, SCIENCE, V285, P62, DOI 10.1126/science.285.5424.62; Xia JH, 1998, NAT GENET, V20, P370, DOI 10.1038/3845; Yu ASL, 2000, CURR OPIN NEPHROL HY, V9, P513, DOI 10.1097/00041552-200009000-00009	65	333	353	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 12	2001	104	1					165	172		10.1016/S0092-8674(01)00200-8	http://dx.doi.org/10.1016/S0092-8674(01)00200-8			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163249	Bronze			2022-12-24	WOS:000166882300016
J	Feikin, DR; Lezotte, DC; Hamman, RF; Salmon, DA; Chen, RT; Hoffman, RE				Feikin, DR; Lezotte, DC; Hamman, RF; Salmon, DA; Chen, RT; Hoffman, RE			Individual and community risks of measles and pertussis associated with personal exemptions to immunization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDREN; VACCINATION; OUTBREAK; HEALTH; LAWS	Context The risk of vaccine-preventable diseases among children who have philosophical and religious exemptions from immunization has been understudied, Objectives To evaluate whether personal exemption from immunization is associated with risk of measles and pertussis at individual and community levels. Design, Setting, and Participants Population-based, retrospective cohort study using data collected on standardized forms regarding all reported measles and pertussis cases among children aged 3 to 18 years in Colorado during 1987-1998, Main Outcome Measures Relative risk of measles and pertussis among exemptors and vaccinated children; association between incidence rates among vaccinated children and frequency of exemptors in Colorado counties; association between school outbreaks and frequency of exemptors in schools; and risk associated with exposure to an exemptor in measles outbreaks. Results Exemptors were 22.2 times (95% confidence interval [CI], 15.9-31.1) more likely to acquire measles and 5.9 times (95% CI, 4.2-8.2) more likely to acquire pertussis than Vaccinated children. After adjusting for confounders, the frequency of exemptors in a county was associated with the incidence rate of measles (relative risk [RR], 1.6, 95% CI, 1.0-2.4) and pertussis (RR, 1.9; 95 % CI, 1.7-2.1) in vaccinated children. Schools with pertussis outbreaks had more exemptors (mean, 4.3% of students) than schools without outbreaks (1.5% of students; P=.001), At least 11% of vaccinated children in measles outbreaks acquired infection through contact with an exemptor, Conclusions The risk of measles and pertussis is elevated in personal exemptors. Public health personnel should recognize the potential effect of exemptors in outbreaks in their communities, and parents should be made aware of the risks involved in not vaccinating their children.	Ctr Dis Control & Prevent, Resp Dis Branch, Epidemiol Program Off, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA; Colorado Dept Publ Hlth & Environm, Denver, CO USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado Department of Public Health & Environment; Johns Hopkins University	Feikin, DR (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Epidemiol Program Off, 1600 Clifton Rd,MS-C23, Atlanta, GA 30333 USA.		Chen, Robert T/AIA-8164-2022	Chen, Robert T/0000-0002-3094-8367; salmon, daniel/0000-0002-1035-4422				Advisory Committee on Immunization Practices, 1997, MMWR-MORBID MORTAL W, V46, P1; Alm JS, 1999, LANCET, V353, P1485, DOI 10.1016/S0140-6736(98)09344-1; [Anonymous], 1990, MMWR Recomm Rep, V39, P1; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; Centers for Disease Control and Prevention (CDC, 1994, MMWR-MORBID MORTAL W, V43, P463; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Chen RT, 1998, LANCET, V351, P611, DOI 10.1016/S0140-6736(05)78423-3; *COL DIV LOC GOVT, 1987, POP PROJ AG; Deeks S, 1999, CLIN INFECT DIS, V28, P840, DOI 10.1086/515203; EDWARDS KM, 1999, VACCINES, P293; ETKIND P, 1992, AM J DIS CHILD, V146, P173, DOI 10.1001/archpedi.1992.02160140039017; FINE PEM, 1986, AM J EPIDEMIOL, V124, P1012, DOI 10.1093/oxfordjournals.aje.a114471; Freed GL, 1996, JAMA-J AM MED ASSOC, V276, P1869, DOI 10.1001/jama.276.23.1869; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Howson CP, 1991, ADVERSE EFFECTS PERT; KITCH EW, 1999, VACCINES, P1165; Meszaros JR, 1996, J CLIN EPIDEMIOL, V49, P697, DOI 10.1016/0895-4356(96)00007-8; National Toxicology Program, 1998, M NTP BOARD SCI COUN, P1; ORENSTEIN WA, 1978, J INFECT DIS, V137, P847, DOI 10.1093/infdis/137.6.847; Paunio M, 2000, JAMA-J AM MED ASSOC, V283, P343, DOI 10.1001/jama.283.3.343; Redd SC, 1999, VACCINES-BASEL, V3rd, P222; ROBBINS KB, 1981, AM J PUBLIC HEALTH, V71, P270, DOI 10.2105/AJPH.71.3.270; RODGERS DV, 1993, PEDIATR INFECT DIS J, V12, P288, DOI 10.1097/00006454-199304000-00006; Salmon DA, 1999, JAMA-J AM MED ASSOC, V282, P47, DOI 10.1001/jama.282.1.47; Vitek CR, 1999, PEDIATR INFECT DIS J, V18, P620, DOI 10.1097/00006454-199907000-00010	26	283	286	0	43	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2000	284	24					3145	3150		10.1001/jama.284.24.3145	http://dx.doi.org/10.1001/jama.284.24.3145			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	385FZ	11135778	Bronze			2022-12-24	WOS:000165994100032
J	Wu, G; Chai, JJ; Suber, TL; Wu, JW; Du, CY; Wang, XD; Shi, YG				Wu, G; Chai, JJ; Suber, TL; Wu, JW; Du, CY; Wang, XD; Shi, YG			Structural basis of IAP recognition by Smac/DIABLO	NATURE			English	Article							PROGRAMMED CELL-DEATH; SURVIVIN REVEALS; NMR STRUCTURE; BIR DOMAIN; PROTEIN; APOPTOSIS; INHIBITOR; MUTAGENESIS; ACTIVATION; REAPER	Apoptosis is an essential process in the development and homeostasis of all metazoans(1-4). The inhibitor-of-apoptosis (IAP) proteins suppress cell death by inhibiting the activity of caspases; this inhibition is performed by the zinc-binding BIR domains(5,6) of the IAP proteins. The mitochondrial protein Smac/DIABLO promotes apoptosis by eliminating the inhibitory effect of IAPs through physical interactions(7-9). Amino-terminal sequences in Smac/DIABLO are required for this function, as mutation of the very first amino acid leads to loss of interaction with IAPs and concomitant loss of Smac/DIABLO function(9). Here we report the high-resolution crystal structure of Smac/DIABLO complexed with the third BIR domain (BIR3) of XIAP. Our results show that the N-terminal four residues (Ala-Val-Pro-Ile) in Smac/DIABLO recognize a surface groove on BIR3, with the first residue Ala binding a hydrophobic pocket and making five hydrogen bonds to neighbouring residues on BIR3. These observations provide a structural explanation for the roles of the Smac N terminus as well as the conserved N-terminal sequences in the Drosophila proteins Hid/Grim/Reaper. In conjunction with other observations, our results reveal how Smac may relieve IAP inhibition of caspase-9 activity. In addition to explaining a number of biological observations, our structural analysis identifies potential targets for drug screening.	Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA; Univ N Carolina, Chapel Hill, NC 27514 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA	Princeton University; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Shi, YG (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Washington Rd, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu		Chai, Jijie/0000-0001-7591-3873; Wang, Xiaodong/0000-0001-9885-356X; Shi, Yigong/0000-0003-2030-168X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL137248] Funding Source: NIH RePORTER; NHLBI NIH HHS [F32 HL137248] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1991, XPLOR SYSTEM CRYSTAL; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Hengartner MO, 1996, CURR OPIN GENET DEV, V6, P34, DOI 10.1016/S0959-437X(96)90007-6; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Horvitz HR, 1999, CANCER RES, V59, p1701S; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946; Lisi S, 2000, GENETICS, V154, P669; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Shi YG, 2000, NAT STRUCT BIOL, V7, P620, DOI 10.1038/77904; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1	27	674	751	4	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 21	2000	408	6815					1008	1012		10.1038/35050012	http://dx.doi.org/10.1038/35050012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140638				2022-12-24	WOS:000165951100059
J	Vision, TJ; Brown, DG; Tanksley, SD				Vision, TJ; Brown, DG; Tanksley, SD			The origins of genomic duplications in Arabidopsis	SCIENCE			English	Article							MONOCOT-DICOT DIVERGENCE; NUCLEOTIDE SUBSTITUTION; HIGHER-PLANTS; THALIANA; SEQUENCE; DNA; CHROMOSOME-4; GENERATION; PREDICTION; BRASSICA	Large segmental duplications cover much of the Arabidopsis thaliana genome. Little is known about their origins. We show that they are primarily due to at Least four different Large-scale duplication events that occurred 100 to 200 million years ago. a formative period in the diversification of the angiosperms. A better understanding of the complex structural history of angiosperm genomes is necessary to make full use of Arabidopsis as a genetic model for other plant species.	USDA ARS, Ctr Agr Bioinformat, Ithaca, NY 14853 USA; Whitehead Inst MIT Ctr Genome Res, Cambridge, MA 02141 USA; Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA; Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA	United States Department of Agriculture (USDA); Massachusetts Institute of Technology (MIT); Whitehead Institute; Cornell University; Cornell University	Vision, TJ (corresponding author), USDA ARS, Ctr Agr Bioinformat, 604 Rhodes Hall, Ithaca, NY 14853 USA.		Vision, Todd J/B-4867-2010	Vision, Todd J/0000-0002-6133-2581; Brown, Dan/0000-0002-5205-5762				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Bancroft I, 2000, YEAST, V17, P1, DOI 10.1002/(SICI)1097-0061(200004)17:1<1::AID-YEA3>3.0.CO;2-V; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Copenhaver GP, 1998, P NATL ACAD SCI USA, V95, P247, DOI 10.1073/pnas.95.1.247; CORMEN TH, 1990, INTRO ALGORITHMS, P536; Devos KM, 1999, GENOME RES, V9, P825, DOI 10.1101/gr.9.9.825; FELLER W, 1957, INTRO PROBABILITY TH, P238; Gaut BS, 1998, EVOL BIOL, V30, P93; Grant D, 2000, P NATL ACAD SCI USA, V97, P4168, DOI 10.1073/pnas.070430597; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Koch M, 1999, PLANT BIOLOGY, V1, P529, DOI 10.1055/s-2007-978548; KOWALSKI SP, 1994, GENETICS, V138, P499; Ku HM, 2000, P NATL ACAD SCI USA, V97, P9121, DOI 10.1073/pnas.160271297; Lan TH, 2000, GENOME RES, V10, P776, DOI 10.1101/gr.10.6.776; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LYNCH M, 1997, GENETICS ANAL QUANTI, P359; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; MCGRATH JM, 1993, THEOR APPL GENET, V86, P880, DOI 10.1007/BF00212616; McLysaght A, 2000, COMP GENOMICS, P47; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Muse SV, 2000, PLANT MOL BIOL, V42, P25, DOI 10.1023/A:1006319803002; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Paterson AH, 1996, NAT GENET, V14, P380, DOI 10.1038/ng1296-380; Semple C, 1999, J MOL EVOL, V48, P555, DOI 10.1007/PL00006498; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; SOMERVILLE CC, COMMUNICATION; Terryn N, 1999, FEBS LETT, V445, P237, DOI 10.1016/S0014-5793(99)00097-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Dodeweerd AM, 1999, GENOME, V42, P887, DOI 10.1139/gen-42-5-887; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Yang Z., 2000, PHYLOGENETIC ANAL MA	37	759	793	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 15	2000	290	5499					2114	2117		10.1126/science.290.5499.2114	http://dx.doi.org/10.1126/science.290.5499.2114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	383ER	11118139				2022-12-24	WOS:000165870600047
J	Sparano, JA; Wolff, AC; Brown, D				Sparano, JA; Wolff, AC; Brown, D			Troponins for predicting cardiotoxicity from cancer therapy	LANCET			English	Editorial Material							CARDIOMYOPATHY; DOXORUBICIN		Montefiore Med Ctr, Albert Einstein Comprehens Canc Ctr, Bronx, NY 10461 USA; Albert Einstein Coll Med, Bronx, NY 10467 USA; Johns Hopkins Oncol Ctr, Baltimore, MD USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University; Johns Hopkins Medicine	Sparano, JA (corresponding author), Montefiore Med Ctr, Albert Einstein Comprehens Canc Ctr, Bronx, NY 10461 USA.		Wolff, Antonio C./T-8796-2019	Wolff, Antonio C./0000-0003-3734-1063				BILLINGHAM ME, 1978, CANCER TREAT REP, V62, P865; Cardinale D, 2000, J AM COLL CARDIOL, V36, P517, DOI 10.1016/S0735-1097(00)00748-8; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Herman EH, 1999, J CLIN ONCOL, V17, P2237, DOI 10.1200/JCO.1999.17.7.2237; HUDIS C, 1998, BREAST CANC RES TREA; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; LIPSHULZ S, 1999, P AM SOC CLIN ONCOL, V8, pA568; Myers C, 1998, SEMIN ONCOL, V25, P10; Norton L, 1999, P AN M AM SOC CLIN, V18, p127a; Sparano JA, 1998, SEMIN ONCOL, V25, P66	10	14	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 9	2000	356	9246					1947	1948		10.1016/S0140-6736(00)03304-3	http://dx.doi.org/10.1016/S0140-6736(00)03304-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	383DJ	11130520				2022-12-24	WOS:000165867600006
J	Dock-Bregeon, AC; Sankaranarayanan, R; Romby, P; Caillet, J; Springer, M; Rees, B; Francklyn, CS; Ehresmann, C; Moras, D				Dock-Bregeon, AC; Sankaranarayanan, R; Romby, P; Caillet, J; Springer, M; Rees, B; Francklyn, CS; Ehresmann, C; Moras, D			Transfer RNA-mediated editing in threonyl-tRNA synthetase: The class II solution to the double discrimination problem	CELL			English	Article							RIBONUCLEIC-ACID SYNTHETASE; ESCHERICHIA-COLI; AMINO-ACIDS; ZINC ION; ERRORS; AMINOACYLATION; SELECTION; SIEVE; DEACYLATION; ISOLEUCINE	Threonyl-tRNA synthetase, a class II synthetase, uses a unique zinc ion to discriminate against the isosteric valine at the activation step. The crystal structure of the enzyme with an analog of seryl adenylate shows that the noncognate serine cannot be fully discriminated at that step. We show that hydrolysis of the incorrectly formed ser-tRNA(Thr) is performed at a specific site in the N-terminal domain of the enzyme. The present study suggests that both classes of synthetases use effectively the ability of the CCA end of tRNA to switch between a hairpin and a helical conformation for aminoacylation and editing. As a consequence, the editing mechanism of both classes of synthetases can be described as mirror images, as already seen for tRNA binding and amino acid activation.	ULP, INSERM, CNRS, IGBMC,UPR Biol Struct 9004, F-67404 Illkirch Graffenstaden, France; Inst Biol Mol & Cellulaire, CNRS, UPR 9002, F-67084 Strasbourg, France; Inst Biol Phys Chim, CNRS, UPR 9073, F-75005 Paris, France; Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); University of Vermont	Moras, D (corresponding author), ULP, INSERM, CNRS, IGBMC,UPR Biol Struct 9004, BP163, F-67404 Illkirch Graffenstaden, France.	moras@igbmc.u-strasbg.fr	ROMBY, Pascale/AGP-3328-2022; Sankaranarayanan, Rajan/AAI-9295-2020	Dock-Bregeon, Anne-Catherine/0000-0002-6913-4061; Rajan, Sankaranarayanan/0000-0003-4524-9953	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054899] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM054899] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; BRUNEL C, 1993, BIOCHIMIE, V75, P1167, DOI 10.1016/0300-9084(93)90016-L; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Fersht A., 1985, ENZYME STRUCTURE MEC; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; GIEGE R, 1971, FEBS LETT, V15, P281, DOI 10.1016/0014-5793(71)80638-5; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JAKUBOWSKI H, 1981, NUCLEIC ACIDS RES, V9, P3105, DOI 10.1093/nar/9.13.3105; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Musier-Forsyth K, 2000, NAT STRUCT BIOL, V7, P435, DOI 10.1038/75816; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauling L., 1957, FESTSCHRIFT ARTHUR S, P597; RAUNIO R, 1970, ACTA CHEM SCAND, V24, P2737, DOI 10.3891/acta.chem.scand.24-2737; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SCHMIDT E, 1995, BIOCHEMISTRY-US, V34, P11204, DOI 10.1021/bi00035a028; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627	36	153	160	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 8	2000	103	6					877	884		10.1016/S0092-8674(00)00191-4	http://dx.doi.org/10.1016/S0092-8674(00)00191-4			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	382CR	11136973	Bronze			2022-12-24	WOS:000165801300007
J	Danovaro-Holliday, MC; LeBaron, CW; Allensworth, C; Raymond, R; Borden, TG; Murray, AB; Ieenogle, JP; Reef, SE				Danovaro-Holliday, MC; LeBaron, CW; Allensworth, C; Raymond, R; Borden, TG; Murray, AB; Ieenogle, JP; Reef, SE			A large rubella outbreak with spread from the workplace to the community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VACCINATION LEVELS; UNITED-STATES; SYNDROME CRS; CHILDREN; PRESCHOOL; PROGRAM	Context Childhood vaccination has reduced rubella disease to low levels in the United States, but outbreaks continue to occur. The largest outbreak in the past 5 years occurred in Nebraska in 1999. Objectives To examine risk factors for disease, susceptibility of the risk population, role of vaccine failure, and the need for new vaccination strategies in response to the Nebraska rubella outbreak. Design, Setting, and Patients Investigation of 83 confirmed rubella cases occurring in Douglas County, Nebraska, between March 23 and August. 24, 1999; serosurvey of 413 pregnant women in the outbreak locale between October 1998 and March 1999 (prior to outbreak) and April and November 1999 (during and after outbreak). Main Outcome Measures Case characteristics, compared with that of the general county population; area childhood rubella vaccination rates; and susceptibility among pregnant women before vs during and after the outbreak. Results All 83 rubella cases were unvaccinated or had unknown vaccination status and fell into 3 groups: (1) 52 (63%) were young adults (median age, 26 years), 83% of whom were born in Latin American countries where rubella vaccination was not routine. They were either employed in meatpacking plants or were their household contacts. Attack rates in the plants were high (14.4 per 1000 vs 0.19 per 1000 for general county population); (2) 16 (19%), including 14 children (9 of whom were aged <12 months) and 2 parents, were US-born and non-Hispanic, who acquired the disease through contacts at 2 day care facilities (attack rate, 88.1 per 1000); and (3) 15 (18%) were young adults (median age, 22 years) whose major disease risk was residence in population-dense census tracts where meatpacking-related cases resided (R-2=0.343; P<.001); 87% of these persons were born in Latin America. Among pregnant women, susceptibility rates were 13% before the outbreak and 11% during and after the outbreak. Six (25%) of 24 susceptible women tested were seropositive for rubella IgM. Rubella vaccination rates were 90.2% for preschool children and 99.8% for school-aged children. Conclusions A large rubella outbreak occurred among unvaccinated persons in a community with high immunity levels. Crowded working and living conditions facilitated transmission, but vaccine failure did not. Workplace vaccination could be considered to prevent similar outbreaks.	Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Douglas Cty Hlth Dept, Omaha, NE USA; Nebraska Hlth & Human Serv Syst, Lincoln, NE USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Danovaro-Holliday, MC (corresponding author), Ctr Dis Control & Prevent, Natl Immunizat Program, 1600 Clifton Rd NE,Mail Stop E-61, Atlanta, GA 30333 USA.	mmd9@cdc.gov						ANDERSON RM, 1986, J HYG-CAMBRIDGE, V96, P305, DOI 10.1017/S0022172400066079; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; CHERRY JD, 1992, TXB PEDIATRIC INFECT, P1792; Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176; DYKEWICZ CA, 1997, 37 INT C ANT AG CHEM; HESELTINE PNR, 1985, INFECT CONT HOSP EP, V6, P371, DOI 10.1017/S0195941700063347; Hethcote HW, 1989, APPL MATH ECOLOGY, P119, DOI DOI 10.1007/978-3-642-61317-3{\_}5; Hoekstra EJ, 1998, JAMA-J AM MED ASSOC, V280, P1143, DOI 10.1001/jama.280.13.1143; Johnson CE, 1996, PEDIATR INFECT DIS J, V15, P687, DOI 10.1097/00006454-199608000-00010; Lamphere L., 1994, NEWCOMERS WORKPLACE; Langmuir A D, 1980, Ann N Y Acad Sci, V353, P35; LeBaron CW, 1996, AM J PUBLIC HEALTH, V86, P1551, DOI 10.2105/AJPH.86.11.1551; LEBARON CW, 1997, 37 INT C ANT AG CHEM; LEHANE DE, 1970, J AMER MED ASSOC, V213, P2236, DOI 10.1001/jama.213.13.2236; LINDEGREN ML, 1991, EPIDEMIOL REV, V13, P341, DOI 10.1093/oxfordjournals.epirev.a036077; *NATL CTR HLTH STA, 1999, HLTH PEOPL 2000 REV, P204; ORENSTEIN WA, 1984, JAMA-J AM MED ASSOC, V251, P1988, DOI 10.1001/jama.251.15.1988; PLOTKIN SA, 1998, VACCINES, P409; Rangel Maria C., 1999, Ethnicity and Disease, V9, P230; REEF S, 1999, MANUAL SURVEILLANCE; Robertson SE, 1997, B WORLD HEALTH ORGAN, V75, P69; SCHLENKER TL, 1992, JAMA-J AM MED ASSOC, V267, P823, DOI 10.1001/jama.267.6.823; Schluter WW, 1998, J INFECT DIS, V178, P636, DOI 10.1086/515384; *SECR HLTH MEX, 2000, B EP 1994 1998; *US BUR CENS, 1998, POP EST DOUGL COUNT; *US NAT IMM SURV, 1998, EST VACC COV IND VAC; ZELL ER, 1994, JAMA-J AM MED ASSOC, V271, P833, DOI 10.1001/jama.271.11.833; 1999, MMWR MORB MORTAL WKL, V48, P1	28	44	44	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 6	2000	284	21					2733	2739		10.1001/jama.284.21.2733	http://dx.doi.org/10.1001/jama.284.21.2733			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	377JB	11105178	Bronze			2022-12-24	WOS:000165509500027
J	Wang, Q; Khillan, J; Gadue, P; Nishikura, K				Wang, Q; Khillan, J; Gadue, P; Nishikura, K			Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis	SCIENCE			English	Article							DSRNA-ADENOSINE-DEAMINASE; SUBUNIT GLUR-B; 2 FORMS; ENZYME; CELLS; MICE	The members of the ADAR (adenosine deaminase acting on RNA) gene family are involved in site-selective RNA editing that changes adenosine residues of target substrate RNAs to inosine, Analysis of staged chimeric mouse embryos with a high contribution from embryonic stem cells with a functional null allele for ADAR1 revealed a heterozygous embryonic-lethal phenotype. Most ADAR1(+/-) chimeric embryos died before embryonic day 14 with defects in the hematopoietic system. Our results suggest the importance of regulated Levels of ADAR1 expression, which is critical for embryonic erythropoiesis in the liver.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Nishikura, K (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	kazuko@wistar.upenn.edu						Bass BL, 1997, RNA, V3, P947; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Dabiri GA, 1996, EMBO J, V15, P34, DOI 10.1002/j.1460-2075.1996.tb00331.x; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gerber A, 1997, RNA, V3, P453; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hu NP, 1997, CANCER RES, V57, P4123; Joyner AL, 1993, GENE TARGETING PRACT; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Lai F, 1997, J NEUROCHEM, V69, P43; Lai F, 1997, MOL CELL BIOL, V17, P2413, DOI 10.1128/MCB.17.5.2413; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Polson AG, 1996, NATURE, V380, P454; RAILSKIN O, UNPUB; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Wang QD, 2000, J NEUROCHEM, V74, P1290; WANG Y, 1995, J MOL BIOL, V254, P184, DOI 10.1006/jmbi.1995.0610	28	336	358	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 1	2000	290	5497					1765	1768		10.1126/science.290.5497.1765	http://dx.doi.org/10.1126/science.290.5497.1765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379FY	11099415				2022-12-24	WOS:000165632400043
J	Zha, JP; Weiler, S; Oh, KJ; Wei, MC; Korsmeyer, SJ				Zha, JP; Weiler, S; Oh, KJ; Wei, MC; Korsmeyer, SJ			Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis	SCIENCE			English	Article							CYTOCHROME-C RELEASE; PROTEIN; DEATH; MEMBRANES; SURVIVAL; PATHWAY; BCL-2; DNA	Many apoptotic molecules relocate subcellularly in cells undergoing apoptosis. The pro-apoptotic protein BID underwent posttranslational (rather than classic cotranslational) N-myristoylation when cleavage by caspase 8 caused exposure of a glycine residue. N-myristoylation enabled the targeting of a complex of p7 and myristoylated p15 fragments of BID to artificial membranes bearing the Lipid composition of mitochondria, as well as to intact mitochondria. This post-proteolytic N-myristoylation serves as an activating switch, enhancing BID-induced release of cytochrome c and cell death.	Harvard Univ, Sch Med, Dept Pathol, Dana Farber Canc Inst,Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Dana Farber Canc Inst,Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Dana Farber Canc Inst,Howard Hughes Med Inst, Boston, MA 02115 USA.			OH, KYOUNG JOON/0000-0002-4729-9674	NATIONAL CANCER INSTITUTE [R37CA050239, K01CA082231, T32CA072320, R01CA050239] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA82231, CA50239-13, T32 CA72320-01A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Blobel G, 1995, COLD SPRING HARB SYM, V60, P1; Borgese N, 1996, J CELL BIOL, V135, P1501, DOI 10.1083/jcb.135.6.1501; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Wei MC, 2000, GENE DEV, V14, P2060; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	24	458	488	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2000	290	5497					1761	1765		10.1126/science.290.5497.1761	http://dx.doi.org/10.1126/science.290.5497.1761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379FY	11099414				2022-12-24	WOS:000165632400042
J	Ichimura, Y; Kirisako, T; Takao, T; Satomi, Y; Shimonishi, Y; Ishihara, N; Mizushima, N; Tanida, I; Kominami, E; Ohsumi, M; Noda, T; Ohsumi, Y				Ichimura, Y; Kirisako, T; Takao, T; Satomi, Y; Shimonishi, Y; Ishihara, N; Mizushima, N; Tanida, I; Kominami, E; Ohsumi, M; Noda, T; Ohsumi, Y			A ubiquitin-like system mediates protein lipidation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; AUTOPHAGY; YEAST; DEGRADATION; APG7P/CVT2P; PEPTIDES; VACUOLE	Autophagy is a dynamic membrane phenomenon for bulk protein degradation in the lysosome/vacuole(1,2). Apg8/Aut7 is an essential factor for autophagy in yeast(3-5). We previously found that the carboxy-terminal arginine of nascent Apg8 is removed by Apg4/Aut2 protease, leaving a glycine residue at the C terminus(6). Apg8 is then converted to a form (Apg8-X) that is tightly bound to the membrane(6). Here we report a new mode of protein lipidation. Apg8 is covalently conjugated to phosphatidylethanolamine through an amide bond between the C-terminal glycine and the amino group of phosphatidylethanolamine. This lipidation is mediated by a ubiquitination-like system. Apg8 is a ubiquitin-like protein that is activated by an E1 protein, Apg7 (refs 7, 8), and is transferred subsequently to the E2 enzymes Apg3/Aut1 (ref. 9). Apg7 activates two different ubiquitin-like proteins, Apg12 (ref. 10) and Apg8, and assigns them to specific E2 enzymes, Apg10 (ref. 11) and Apg3, respectively. These reactions are necessary for the formation of Apg8-phosphatidylethanolamine. This lipidation has an essential role in membrane dynamics during autophagy(6).	Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Sch Life Sci, Dept Mol Biomech, Okazaki, Aichi 4448585, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; JST, PRESTO, Kawaguchi 3320012, Japan; Teikyo Univ Sci & Technol, High Tech Res Ctr, Dept Biosci, Yamanashi 4090193, Japan; Juntendo Univ, Sch Med, Dept Biochem, Tokyo 1138421, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Osaka University; Japan Science & Technology Agency (JST); Juntendo University	Ohsumi, Y (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.		Ohsumi, Yoshinori/C-6449-2009; Tanida, Isei/C-8277-2009; Kominami, Eiki/D-3802-2009; Noda, Takeshi/B-7240-2008; Mizushima, Noboru/C-3635-2009	Ohsumi, Yoshinori/0000-0003-2384-2166; Noda, Takeshi/0000-0003-3581-7961; Mizushima, Noboru/0000-0002-6258-6444; Ishihara, Naotada/0000-0002-6305-7149; Tanida, Isei/0000-0001-8999-3990; Satomi, Yoshinori/0000-0002-8991-1040				BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Fernandez-de-Cossio J, 1998, RAPID COMMUN MASS SP, V12, P1867, DOI 10.1002/(SICI)1097-0231(19981215)12:23<1867::AID-RCM407>3.0.CO;2-S; GUARINO LA, 1995, CELL, V80, P301, DOI 10.1016/0092-8674(95)90413-1; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; JOHNSON RS, 1987, ANAL CHEM, V59, P2621, DOI 10.1021/ac00148a019; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kametaka S, 1996, GENE, V178, P139, DOI 10.1016/0378-1119(96)00354-X; Kim J, 1999, MOL BIOL CELL, V10, P1337, DOI 10.1091/mbc.10.5.1337; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Legesse-Miller A, 2000, J BIOL CHEM, V275, P32966, DOI 10.1074/jbc.M000917200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; Rose MD., 1990, METHODS YEAST GENETI; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schlumpberger M, 1997, J BACTERIOL, V179, P1068, DOI 10.1128/jb.179.4.1068-1076.1997; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264	28	1456	1522	2	208	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 23	2000	408	6811					488	492		10.1038/35044114	http://dx.doi.org/10.1038/35044114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	375YD	11100732				2022-12-24	WOS:000165429800052
J	Roll-Mecak, A; Cao, C; Dever, TE; Burley, SK				Roll-Mecak, A; Cao, C; Dever, TE; Burley, SK			X-ray structures of the universal translation initiation factor IF2/elF5B: Conformational changes on GDP and GTP binding	CELL			English	Article							ELONGATION-FACTOR TU; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; FACTOR IF2; FACTOR-II; EF-TU; RNA; DIFFRACTION; RESOLUTION; HYDROLYSIS	X-ray structures of the universal translation initiation factor IF2/eIF5B have been determined in three stales: free enzyme, inactive IF2/eIF5B.GDP, and active IF2/eIF5B.GTP. The "chalice-shaped" enzyme is a GTPase that facilitates ribosomal subunit joining and Met-tRNA(i) binding to ribosomes in all three kingdoms of life. The conserved core of IF2/eIF5B consists of an N-terminal G domain (I) plus an EF-Tu-type beta barrel (II), followed by a novel alpha/beta/alpha -sandwich (III) connected via an alpha helix to a second EF-Tu-type beta barrel (IV). Structural comparisons reveal a molecular lever, which amplifies a modest conformational change in the Switch 2 region of the G domain induced by Mg2+/GTP binding over a distance of 90 Angstrom from the G domain active center to domain IV. Mechanisms of GTPase function and ribosome binding are discussed.	Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; NICHHD, Lab Eukaryot Gene Regulat, NIH, Bethesda, MD 20892 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Burley, SK (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.	burley@rockvax.rockefeller.edu	Dever, Thomas/GSE-0966-2022	Dever, Thomas/0000-0001-7120-9678; Roll-Mecak, Antonina/0000-0003-2621-7307; Burley, Stephen K./0000-0002-2487-9713	NIGMS NIH HHS [GM61262] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061262] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEVARSSON A, 1994, EMBO J, V13, P1669; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BOILEAU G, 1983, BIOCHEMISTRY-US, V22, P3162, DOI 10.1021/bi00282a020; Brock S, 1998, MOL MICROBIOL, V29, P409, DOI 10.1046/j.1365-2958.1998.00893.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrera P, 2000, MOL CELL, V5, P181, DOI 10.1016/S1097-2765(00)80414-1; Choi SK, 1998, SCIENCE, V280, P1757, DOI 10.1126/science.280.5370.1757; Choi SK, 2000, MOL CELL BIOL, V20, P7183, DOI 10.1128/MCB.20.19.7183-7191.2000; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; KOLAKOFSKY D, 1968, NATURE, V220, P244, DOI 10.1038/220244a0; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P3726, DOI 10.1073/pnas.95.7.3726; LAALAMI S, 1991, J MOL BIOL, V220, P335, DOI 10.1016/0022-2836(91)90017-Z; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JH, 1999, P NATL ACAD SCI USA, V96, P4342, DOI 10.1073/pnas.96.8.4342; Luchin S, 1999, J BIOL CHEM, V274, P6074, DOI 10.1074/jbc.274.10.6074; Meunier S, 2000, EMBO J, V19, P1918, DOI 10.1093/emboj/19.8.1918; MOAZED D, 1995, J MOL BIOL, V248, P207, DOI 10.1016/S0022-2836(95)80042-5; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sette M, 1997, EMBO J, V16, P1436, DOI 10.1093/emboj/16.6.1436; Spurio R, 2000, J BIOL CHEM, V275, P2447, DOI 10.1074/jbc.275.4.2447; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wilson SA, 1999, BIOCHEM J, V342, P97, DOI 10.1042/0264-6021:3420097; Wu XQ, 1996, EMBO J, V15, P4734, DOI 10.1002/j.1460-2075.1996.tb00850.x	39	189	191	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 22	2000	103	5					781	792		10.1016/S0092-8674(00)00181-1	http://dx.doi.org/10.1016/S0092-8674(00)00181-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	375ZJ	11114334	Bronze			2022-12-24	WOS:000165433100010
J	Gonczy, P; Echeverri, C; Oegema, K; Coulson, A; Jones, SJM; Copley, RR; Duperon, J; Oegema, J; Brehm, M; Cassin, E; Hannak, E; Kirkham, M; Pichler, S; Flohrs, K; Goessen, A; Leidel, S; Alleaume, AM; Martin, C; Ozlu, N; Bork, P; Hyman, AA				Gonczy, P; Echeverri, C; Oegema, K; Coulson, A; Jones, SJM; Copley, RR; Duperon, J; Oegema, J; Brehm, M; Cassin, E; Hannak, E; Kirkham, M; Pichler, S; Flohrs, K; Goessen, A; Leidel, S; Alleaume, AM; Martin, C; Ozlu, N; Bork, P; Hyman, AA			Functional genomic analysis of cell division in C-elegans using RNAi of genes on chromosome III	NATURE			English	Article							CAENORHABDITIS-ELEGANS; MICROTUBULE ORGANIZATION; CYTOPLASMIC DYNEIN; SPINDLE FORMATION; GERM-LINE; PROTEIN; EMBRYOS; POLARITY; RAN; CYTOKINESIS	Genome sequencing projects generate a wealth of information; however, the ultimate goal of such projects is to accelerate the identification of the biological function of genes. This creates a need for comprehensive studies to fill the gap between sequence and function. Here we report the results of a functional genomic screen to identify genes required for cell division in Caenorhabditis elegans. We inhibited the expression of similar to 96% of the similar to2,300 predicted open reading frames on chromosome III using RNA-mediated interference (RNAi). By using an in vivo time-lapse differential interference contrast microscopy assay, we identified 133 genes (similar to6%) necessary for distinct cellular processes in early embryos. Our results indicate that these genes represent most of the genes on chromosome III that are required for proper cell division in C. elegans embryos. The complete data set, including sample time-lapse recordings, has been deposited in an open access database. We found that similar to 47% of the genes associated with a differential interference contrast phenotype have clear orthologues in other eukaryotes, indicating that this screen provides putative gene functions for other species as well.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Sanger Ctr, Cambridge CB10 1SA, England; British Columbia Canc Res Ctr, Genome Sequence Ctr, Vancouver, BC V5Z 4E6, Canada; Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany	European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; British Columbia Cancer Agency; Max Planck Society	Gonczy, P (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.	Pierre.Gonczy@isrec.unil.ch; hyman@EMBL-Heidelberg.de	Hyman, Anthony A/B-3917-2017; Kirkham, Matthew/I-5458-2012; Bork, Peer/F-1813-2013; Jones, Steven J/C-3621-2009; Leidel, Sebastian/K-9507-2019; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Bork, Peer/0000-0002-2627-833X; Jones, Steven J/0000-0003-3394-2208; Leidel, Sebastian/0000-0002-0523-6325; Kirkham, Matthew/0000-0003-0920-5355; Gonczy, Pierre/0000-0002-6305-6883; Ozlu, Nurhan/0000-0002-5157-8780; Alleaume, Anne-Marie/0000-0001-7881-1880				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Boxem M, 1999, DEVELOPMENT, V126, P2227; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; CARTER PW, 1990, MOL GEN GENET, V221, P72, DOI 10.1007/BF00280370; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furuta T, 2000, MOL BIOL CELL, V11, P1401, DOI 10.1091/mbc.11.4.1401; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hung TJ, 1999, DEVELOPMENT, V126, P127; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; LEVITAN DJ, 1994, P NATL ACAD SCI USA, V91, P6108, DOI 10.1073/pnas.91.13.6108; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nicolas FJ, 1997, J CELL SCI, V110, P3019; Pichler S, 2000, DEVELOPMENT, V127, P2063; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Rose LS, 1998, DEVELOPMENT, V125, P1337; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Swan KA, 1998, J CELL SCI, V111, P2017; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Willins DA, 1997, MOL GEN GENET, V255, P194, DOI 10.1007/s004380050489; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429	44	683	771	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 16	2000	408	6810					331	336		10.1038/35042526	http://dx.doi.org/10.1038/35042526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099034				2022-12-24	WOS:000165296000037
J	Kreiman, G; Koch, C; Fried, I				Kreiman, G; Koch, C; Fried, I			Imagery neurons in the human brain	NATURE			English	Article							INFERIOR TEMPORAL CORTEX; VISUAL-IMAGERY; OBJECT RECOGNITION; PREFRONTAL CORTEX; MENTAL-IMAGERY; MEMORY; PERCEPTION; REPRESENTATION; DISSOCIATION; ORGANIZATION	Vivid visual images can be voluntarily generated in our minds in the absence of simultaneous visual input. While trying to count the number of flowers in Van Gogh's Sunflowers, understanding a description or recalling a path, subjects report forming an image in their "mind's eye''(1). Whether this process is accomplished by the same neuronal mechanisms as visual perception has long been a matter of debate(1-3). Evidence from functional imaging(1.4-8), psychophysics(1.9), neurological studies(2) and monkey electrophysiology(10-12) suggests a common process, yet there are patients with deficits in one but not the other(3,13). Here we directly investigated the neuronal substrates of visual recall by recording from single neurons in the human medial temporal lobe(14,15) while the subjects were asked to imagine previously viewed images. We found single neurons in the hippocampus, amygdala, entorhinal cortex and parahippocampal gyrus that selectively altered their firing rates depending on the stimulus the subjects were imagining. Of the neurons that fired selectively during both vision and imagery, the majority (88%) had identical selectivity. Our study reveals single neuron correlates of volitional visual imagery in humans and suggests a common substrate for the processing of incoming visual information and visual recall.	Univ Calif Los Angeles, Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Biobehav Sci, Los Angeles, CA 90095 USA; CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology	Fried, I (corresponding author), Univ Calif Los Angeles, Sch Med, Div Neurosurg, 740 Westwood Plaza, Los Angeles, CA 90095 USA.			Kreiman, Gabriel/0000-0003-3505-8475; Koch, Christof/0000-0001-6482-8067				Bartolomeo P, 1998, NEUROPSYCHOLOGIA, V36, P239, DOI 10.1016/S0028-3932(97)00103-6; BEHRMANN M, 1992, NATURE, V359, P636, DOI 10.1038/359636a0; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; DEsposito M, 1997, NEUROPSYCHOLOGIA, V35, P725, DOI 10.1016/S0028-3932(96)00121-2; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FARAH MJ, 1988, PSYCHOL REV, V95, P307, DOI 10.1037/0033-295X.95.3.307; FRIED I, 1982, BRAIN, V105, P349, DOI 10.1093/brain/105.2.349; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Frith C, 1997, PHILOS T R SOC B, V352, P1221, DOI 10.1098/rstb.1997.0104; GREEN DM, 1966, SIGNAL DETECTION THE; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; Kanwisher N, 2000, COGN NEUROPSYCHOL, V17, P1, DOI 10.1080/026432900380454; Kosslyn S. M., 1994, IMAGE BRAIN; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Meunier M, 1996, J NEUROPHYSIOL, V75, P1190, DOI 10.1152/jn.1996.75.3.1190; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; OCRAVEN K, IN PRESS J COG NEURO; OJEMANN G, 1979, SCIENCE, V205, P1401, DOI 10.1126/science.472757; Penfield W, 1954, EPILEPSY FUNCTIONAL; Rainer G, 1999, J NEUROSCI, V19, P5493; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P281, DOI 10.1016/0166-2236(94)90057-4; Rolls E T, 1991, Curr Opin Neurobiol, V1, P274, DOI 10.1016/0959-4388(91)90090-T; Suzuki WA, 1996, SEMIN NEUROSCI, V8, P3, DOI 10.1006/smns.1996.0002; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; [No title captured]	30	227	231	2	39	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2000	408	6810					357	361		10.1038/35042575	http://dx.doi.org/10.1038/35042575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099042				2022-12-24	WOS:000165296000045
J	Sherwood, P; Lyburn, I; Brown, S; Ryder, S				Sherwood, P; Lyburn, I; Brown, S; Ryder, S			How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact	BRITISH MEDICAL JOURNAL			English	Article							HEPATITIS-C; ALCOHOL-CONSUMPTION; ANTIBODIES; DISEASE; ENZYMES	Objective To determine whether abnormal results for liver function tests are investigated in primary care and findings on full investigation. Design Retrospective audit and prospective clinical investigation. Setting University hospital and surrounding general practices serving a round 330 000 people. Subjects Adults with abnormal results for liver function based on tests requested by their doctor between 1 January and 30 June 1995. Interventions All patients with gamma -glutamyltransferase, alanine aminotransferase, or alkaline phosphatase concentrations at least twice the upper limit of the reference range were studied. A median of 15 months later (range 12-21) records of hospital attendances and further investigations were examined. Where investigations were incomplete the records from the general practiced were examined, and suitable patients were invited to attend the liver clinic. Main outcome measures Investigations requested by the doctor and final diagnoses reached. Results 933 patients with abnormal liver function tests were identified follow up data were obtained in 873 (94%). 531 patients were already under hospital review. Of the remaining 342 patients, 157 were suitable for investigation; the others had died, moved away, were elderly, or had repeat liver function tests with normal results. No further tests were requested for 91 (58%) of these patients. 66 had been partially investigated by their doctor, and in seven patients results suggesting a treatable chronic liver disease had not been followed up. On investigation, 97 (62%) had an identifiable diagnosis requiring hospital intervention for follow up, or both. Conclusions Abnormal results for liver function are often not adequately investigated, missing an important change of identifying treatable chronic liver disease.	Queens Med Ctr, Div Gastroenterol, Nottingham NG7 2UH, England; Queens Med Ctr, Dept Clin Chem, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Ryder, S (corresponding author), Queens Med Ctr, Div Gastroenterol, Nottingham NG7 2UH, England.							Guterman S J, 1998, J Emerg Med, V16, P215, DOI 10.1016/S0736-4679(97)00288-6; HULTCRANTZ R, 1986, SCAND J GASTROENTERO, V21, P109, DOI 10.3109/00365528609034632; Johnston DE, 1999, AM FAM PHYSICIAN, V59, P2223; LEVIN DM, 1979, AM J MED, V66, P429, DOI 10.1016/0002-9343(79)91064-7; MENDENHALL CL, 1993, AM J GASTROENTEROL, V88, P1022; MENDENHALL CL, 1991, HEPATOLOGY, V14, P581; NALPAS B, 1992, J HEPATOL, V14, P381, DOI 10.1016/0168-8278(92)90187-T; ROSALKI SB, 1999, OXFORD TXB HEPATOLOG, P506; Steffensen FH, 1997, INT J EPIDEMIOL, V26, P92, DOI 10.1093/ije/26.1.92; Sucov A, 1999, J EMERG MED, V17, P391, DOI 10.1016/S0736-4679(99)00017-7; VANNESS MM, 1989, ANN INTERN MED, V111, P473, DOI 10.7326/0003-4819-111-6-473; Wisdom K, 1997, DIABETES CARE, V20, P971, DOI 10.2337/diacare.20.6.971	12	60	63	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	2001	322	7281					276	278		10.1136/bmj.322.7281.276	http://dx.doi.org/10.1136/bmj.322.7281.276			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	401FM	11157530	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000166917600029
J	Crawley, MJ; Harral, JE				Crawley, MJ; Harral, JE			Scale dependence in plant biodiversity	SCIENCE			English	Article							SPECIES-AREA; ABUNDANCE; DIVERSITY	The relationship between the number of species and the area sampled is one of the oldest and best-documented patterns in community ecology. Several theoretical models and field data from a wide range of plant and animal taxa suggest that the slope, z, of a graph of the Logarithm of species richness against the Logarithm of area is roughly constant, with z approximate to 0.25. We collected replicated and randomized plant data at 11 spatial scales from 0.01 to 10(8) square meters in Great Britain which show that the slope of the Log-Log plot is not constant, but varies systematically with spatial scale, and from habitat to habitat at the same spatial scale. Values of z were Low (0.1 to 0.2) at small scales (<100 square meters), high (0.4 to 0.5) at intermediate scales (1 hectare to 10 square kilometers), and Low again (0.1 to 0.2) for the Largest scale transitions (e.g,, East Perks to all of Berkshire). Instead of one process determining changes in species richness across a wide range of scales, different processes might determine plant biodiversity at different spatial scales.	Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Dept Biol, Ascot SL5 7PY, Berks, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Crawley, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Dept Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.	m.crawley@ic.ac.uk						Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Bolker BM, 1999, AM NAT, V153, P575, DOI 10.1086/303199; Condit R, 1996, J ECOL, V84, P549, DOI 10.2307/2261477; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Crawley Michael J., 1997, P595; DRUCE GC, 1897, FLORA BERKSHIRE; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; GOODALL DW, 1952, BIOL REV, V27, P194, DOI 10.1111/j.1469-185X.1952.tb01393.x; Hanski I, 1997, SCIENCE, V275, P397, DOI 10.1126/science.275.5298.397; Harte J, 1999, OIKOS, V86, P45, DOI 10.2307/3546568; Harte J, 1999, SCIENCE, V284, P334, DOI 10.1126/science.284.5412.334; HOPKINS B, 1955, J ECOL, V43, P409, DOI 10.2307/2257004; KILBURN PD, 1966, ECOLOGY, V47, P831, DOI 10.2307/1934269; Kunin WE, 1998, SCIENCE, V281, P1513, DOI 10.1126/science.281.5382.1513; May R.M., 1975, P81; Pacala Stephen W., 1997, P532; PALMER MW, 1994, AM NAT, V144, P717, DOI 10.1086/285704; PIELOU E C, 1969, P286; Plotkin JB, 2000, P NATL ACAD SCI USA, V97, P10850, DOI 10.1073/pnas.97.20.10850; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Rodwell J.S., 1991, BRIT PLANT COMMUNITI, V4; Rodwell J.S., 1991, BRIT PLANT COMMUNITI, V5; Rodwell J.S., 1991, BRIT PLANT COMMUNITI, V2; Rodwell JS, 1991, WOODLANDS SCRUB, V1-5; RODWELL JS, 1991, BRIT PLANT COMMUNITI, V3; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SHMIDA A, 1984, ISRAEL J BOT, V33, P41; SKELLAM JG, 1952, BIOMETRIKA, V39, P346, DOI 10.2307/2334030; Stace C., 1997, NEW FLORA BRIT ISLES; SUGIHARA G, 1981, AM NAT, V117, P790, DOI 10.1086/283762; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; [No title captured]	33	350	392	3	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2001	291	5505					864	868		10.1126/science.291.5505.864	http://dx.doi.org/10.1126/science.291.5505.864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	398TD	11157164				2022-12-24	WOS:000166771700042
J	Norton, SA				Norton, SA			Tokelau on Naboo	BRITISH MEDICAL JOURNAL			English	Article											Norton, SA (corresponding author), 7506 Tarrytown Rd, Chevy Chase, MD 20815 USA.							BRADBURY R, 1986, MARTIAN CHRONICLES, P50; DAFONSECA O, 1972, ESSAYS TROPICAL DERM, P339; Fox T., 1874, LANCET, V2, P304; Hay R J, 1988, Curr Top Med Mycol, V2, P55; Heyerdahl Thor, 1950, KON TIKI PACIFIC RAF; Hildebrand M., 1985, P38; MACGREGOR G, 1937, ETHNOLOGY TOKELAU IS, P72; MANSON P, 1892, BRIT J DERMATOL, V4, P5; Manson P, 1878, MED REPORTS, V16, P1; REYNOLDS D, 1999, STAR WARS EPISODE 1, P36; VONDANIKEN E, 1973, GOLD GODS, P166; WELLS HG, 1960, WAR WORLDS, P188; WILKES C, 1845, NARRATIVE US EXPLORI, V5, P104	13	2	2	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 23	2000	321	7276					1619	1620		10.1136/bmj.321.7276.1619	http://dx.doi.org/10.1136/bmj.321.7276.1619			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387RA	11124204	Green Published			2022-12-24	WOS:000166134500040
J	Lykke-Andersen, J; Shu, MD; Steitz, JA				Lykke-Andersen, J; Shu, MD; Steitz, JA			Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon	CELL			English	Article							HUMAN TRIOSEPHOSPHATE ISOMERASE; BETA-GLOBIN GENE; SACCHAROMYCES-CEREVISIAE; TRANSLATION TERMINATION; CAENORHABDITIS-ELEGANS; REGULATORY MECHANISM; CIS EFFECTORS; HUMAN HOMOLOG; IN-VIVO; SURVEILLANCE	Nonsense-mediated decay (NMD) rids eukaryotic cells of aberrant mRNAs containing premature termination codons. These are discriminated from true termination codons by downstream cis-elements, such as exon-exon junctions. We describe three novel human proteins involved in NMD, hUpf2, hUpf3a, and hUpf3b. While in HeLa cell extracts these proteins are complexed with hUpf1, in intact cells hUpf3a and hUpf3b are nucleocytoplasmic shuttling proteins, hUpf2 is perinuclear, and hUpf1 cytoplasmic. hUpf3a and hUpf3b associate selectively with spliced beta -globin mRNA in vivo, and tethering of any hUpf protein to the 3'UTR of beta -globin mRNA elicits NMD. These data suggest that assembly of a dynamic hUpf complex initiates in the nucleus at mRNA exon-exon junctions and triggers NMD in the cytoplasm when recognized downstream of a translation termination site.	Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu		Lykke-Andersen, Jens/0000-0003-1821-0754	NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Applequist SE, 1997, NUCLEIC ACIDS RES, V25, P814, DOI 10.1093/nar/25.4.814; Atkin AL, 1997, J BIOL CHEM, V272, P22163, DOI 10.1074/jbc.272.35.22163; ATKIN AL, 1995, MOL BIOL CELL, V6, P611; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Cali BM, 1999, GENETICS, V151, P605; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; CHENG J, 1994, MOL CELL BIOL, V14, P6317, DOI 10.1128/MCB.14.9.6317; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; CZAPLINSKI K, 1995, RNA, V1, P610; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; ENSSLE J, 1993, P NATL ACAD SCI USA, V90, P10091, DOI 10.1073/pnas.90.21.10091; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; GRACEFFA P, 1992, ARCH BIOCHEM BIOPHYS, V297, P46, DOI 10.1016/0003-9861(92)90639-E; HAGAN KW, 1995, MOL CELL BIOL, V15, P809; HALL GW, 1994, BLOOD, V83, P2031; He F, 1996, RNA, V2, P153; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; HE F, 1995, GENE DEV, V9, P437, DOI 10.1101/gad.9.4.437; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Hilleren P, 1999, RNA, V5, P711, DOI 10.1017/S1355838299990519; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Jensen TH, 1997, FEBS LETT, V414, P50, DOI 10.1016/S0014-5793(97)00988-5; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kessler O, 1996, MOL CELL BIOL, V16, P4426; Le Hir H, 2000, GENE DEV, V14, P1098; LECUYER KA, 1995, BIOCHEMISTRY-US, V34, P10600, DOI 10.1021/bi00033a035; LEE BS, 1995, P NATL ACAD SCI USA, V92, P10354, DOI 10.1073/pnas.92.22.10354; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; MAQUAT LE, 1995, RNA, V1, P453; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Page MF, 1999, MOL CELL BIOL, V19, P5943; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P423, DOI 10.1016/S0968-0004(00)01628-5; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Shirley RL, 1998, J CELL SCI, V111, P3129; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; THEIN SL, 1990, P NATL ACAD SCI USA, V87, P3924, DOI 10.1073/pnas.87.10.3924; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Weng YM, 1998, RNA, V4, P205; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang J, 1996, RNA, V2, P235; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849; ZHANG SA, 1995, MOL CELL BIOL, V15, P2231	67	438	453	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 22	2000	103	7					1121	1131		10.1016/S0092-8674(00)00214-2	http://dx.doi.org/10.1016/S0092-8674(00)00214-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	386BQ	11163187	Bronze			2022-12-24	WOS:000166040600014
J	Chen, GQ; Chen, KS; Knox, J; Inglis, J; Bernard, A; Martin, SJ; Justice, A; McConlogue, L; Games, D; Freedman, SB; Morris, RGM				Chen, GQ; Chen, KS; Knox, J; Inglis, J; Bernard, A; Martin, SJ; Justice, A; McConlogue, L; Games, D; Freedman, SB; Morris, RGM			A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease	NATURE			English	Article							PRECURSOR PROTEIN; TRANSGENIC MICE; MEMORY; PATHOLOGY; RATS	;Mice that overexpress the human mutant amyloid precursor protein (hAPP) show learning deficits, but the apparent lack of a relationship between these deficits and the progressive beta -amyloid plaque formation that the hAPP mice display is puzzling. In the water maze(1), hAPP mice are impaired before and after amyloid plaque deposition(2-7). Here we show, using a new water-maze training protocol, that PDAPP mice(8) also exhibit a separate age-related deficit in learning a series of spatial locations. This impairment correlates with b-amyloid plaque burden and is shown in both cross-sectional and longitudinal experimental designs. Cued navigation and object-recognition memory are normal. These findings indicate that Ab overexpression and/or Ab plaques are associated with disturbed cognitive function and, importantly, suggest that some but not all forms of learning and memory are suitable behavioural assays of the progressive cognitive deficits associated with Alzheimer's-disease-type pathologies.	Univ Edinburgh, Dept Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Elan Pharmaceut, S San Francisco, CA 94080 USA	University of Edinburgh	Morris, RGM (corresponding author), Univ Edinburgh, Dept Neurosci, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.		Morris, Richard G M/C-9982-2013	Martin, Stephen/0000-0003-0805-8541				Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chen KS, 1998, PROG BRAIN RES, V117, P327; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; DHooge R, 1996, NEUROREPORT, V7, P2807, DOI 10.1097/00001756-199611040-00080; Dodart JC, 2000, NEUROBIOL DIS, V7, P71, DOI 10.1006/nbdi.1999.0278; Dodart JC, 1999, BEHAV NEUROSCI, V113, P982, DOI 10.1037/0735-7044.113.5.982; Dodart JC, 1999, NEUROSCI LETT, V277, P49, DOI 10.1016/S0304-3940(99)00847-2; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Johnson D, 1997, EDN, V42, P94; Justice A., 1997, Society for Neuroscience Abstracts, V23, P1637; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Masliah E, 1996, J NEUROSCI, V16, P5795; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Raber J, 2000, NATURE, V404, P352, DOI 10.1038/35006165; RAWLINS JNP, 1985, BEHAV BRAIN SCI, V8, P479, DOI 10.1017/S0140525X00001291; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Whishaw IQ, 1997, HIPPOCAMPUS, V7, P361, DOI 10.1002/(SICI)1098-1063(1997)7:4<361::AID-HIPO2>3.0.CO;2-M; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; YAMAGUCHI F, 1991, NEUROREPORT, V2, P781, DOI 10.1097/00001756-199112000-00013	28	616	656	1	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					975	979		10.1038/35050103	http://dx.doi.org/10.1038/35050103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140684				2022-12-24	WOS:000165951100050
J	Dennis, C; Surridge, C				Dennis, C; Surridge, C			A. thaliana genome	NATURE			English	Editorial Material														Surridge, Christopher/0000-0003-4264-5176					0	32	33	3	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 14	2000	408	6814					791	791						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130708				2022-12-24	WOS:000165831300034
J	Salanoubat, M; Lemcke, K; Rieger, M; Ansorge, W; Unseld, M; Fartmann, B; Valle, G; Blocker, H; Perez-Alonso, M; Obermaier, B; Delseny, M; Boutry, M; Grivell, LA; Mache, R; Puigdomenech, P; De Simone, V; Choisne, N; Artiguenave, F; Robert, C; Brottier, P; Wincker, P; Cattolico, L; Weissenbach, J; Saurin, W; Quetier, F; Schafer, M; Muller-Auer, S; Gabel, C; Fuchs, M; Benes, V; Wurmbach, E; Drzonek, H; Erfle, H; Jordan, N; Bangert, S; Wiedelmann, R; Kranz, H; Voss, H; Holland, R; Brandt, P; Nyakatura, G; Vezzi, A; D'Angelo, M; Pallavicini, A; Toppo, S; Simionati, B; Conrad, A; Hornischer, K; Kauer, G; Lohnert, TH; Nordsiek, G; Reichelt, J; Scharfe, M; Schon, O; Bargues, M; Terol, J; Climent, J; Navarro, P; Collado, C; Perez-Perez, A; Ottenwalder, B; Duchemin, D; Cooke, R; Laudie, M; Berger-Llauro, C; Purnelle, B; Masuy, D; de Haan, M; Maarse, AC; Alcaraz, JP; Cottet, A; Casacuberta, E; Monfort, A; Argiriou, A; Flores, M; Liguori, R; Vitale, D; Mannhaupt, G; Haase, D; Schoof, H; Rudd, S; Zaccaria, P; Mewes, HW; Mayer, KFX; Kaul, S; Town, CD; Koo, HL; Tallon, LJ; Jenkins, J; Rooney, T; Rizzo, M; Walts, A; Utterback, T; Fujii, CY; Shea, TP; Creasy, TH; Haas, B; Maiti, R; Wu, DY; Peterson, J; Van Aken, S; Pai, G; Militscher, J; Sellers, P; Gill, JE; Feldblyum, TV; Preuss, D; Lin, XY; Nierman, WC; Salzberg, SL; White, O; Venter, JC; Fraser, CM; Kaneko, T; Nakamura, Y; Sato, S; Kato, T; Asamizu, E; Sasamoto, S; Kimura, T; Idesawa, K; Kawashima, K; Kishida, Y; Kiyokawa, C; Kohara, M; Matsumoto, M; Matsuno, A; Muraki, A; Nakayama, S; Nakazaki, N; Shinpo, S; Takeuchi, C; Wada, T; Watanabe, A; Yamada, M; Yasuda, M; Tabata, S				Salanoubat, M; Lemcke, K; Rieger, M; Ansorge, W; Unseld, M; Fartmann, B; Valle, G; Blocker, H; Perez-Alonso, M; Obermaier, B; Delseny, M; Boutry, M; Grivell, LA; Mache, R; Puigdomenech, P; De Simone, V; Choisne, N; Artiguenave, F; Robert, C; Brottier, P; Wincker, P; Cattolico, L; Weissenbach, J; Saurin, W; Quetier, F; Schafer, M; Muller-Auer, S; Gabel, C; Fuchs, M; Benes, V; Wurmbach, E; Drzonek, H; Erfle, H; Jordan, N; Bangert, S; Wiedelmann, R; Kranz, H; Voss, H; Holland, R; Brandt, P; Nyakatura, G; Vezzi, A; D'Angelo, M; Pallavicini, A; Toppo, S; Simionati, B; Conrad, A; Hornischer, K; Kauer, G; Lohnert, TH; Nordsiek, G; Reichelt, J; Scharfe, M; Schon, O; Bargues, M; Terol, J; Climent, J; Navarro, P; Collado, C; Perez-Perez, A; Ottenwalder, B; Duchemin, D; Cooke, R; Laudie, M; Berger-Llauro, C; Purnelle, B; Masuy, D; de Haan, M; Maarse, AC; Alcaraz, JP; Cottet, A; Casacuberta, E; Monfort, A; Argiriou, A; Flores, M; Liguori, R; Vitale, D; Mannhaupt, G; Haase, D; Schoof, H; Rudd, S; Zaccaria, P; Mewes, HW; Mayer, KFX; Kaul, S; Town, CD; Koo, HL; Tallon, LJ; Jenkins, J; Rooney, T; Rizzo, M; Walts, A; Utterback, T; Fujii, CY; Shea, TP; Creasy, TH; Haas, B; Maiti, R; Wu, DY; Peterson, J; Van Aken, S; Pai, G; Militscher, J; Sellers, P; Gill, JE; Feldblyum, TV; Preuss, D; Lin, XY; Nierman, WC; Salzberg, SL; White, O; Venter, JC; Fraser, CM; Kaneko, T; Nakamura, Y; Sato, S; Kato, T; Asamizu, E; Sasamoto, S; Kimura, T; Idesawa, K; Kawashima, K; Kishida, Y; Kiyokawa, C; Kohara, M; Matsumoto, M; Matsuno, A; Muraki, A; Nakayama, S; Nakazaki, N; Shinpo, S; Takeuchi, C; Wada, T; Watanabe, A; Yamada, M; Yasuda, M; Tabata, S		European Union Chromosome 3 Arabid; Inst Genomic Res; Kazusa DNA Res Inst	Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana	NATURE			English	Article							LIBRARY; GENOME; CONSTRUCTION; REGIONS; GENES; MAP; P1	Arabidopsis thaliana is an important model system for plant biologists(1). In 1996 an international collaboration (the Arabidopsis Genome Initiative) was formed to sequence the whole genome of Arabidopsis(2) and in 1999 the sequence of the first two chromosomes was reported(3,4). The sequence of the last three chromosomes and an analysis of the whole genome are reported in this issue(5-7). Here we present the sequence of chromosome 3, organized into four sequence segments (contigs). The two largest (13.5 and 9.2 Mb) correspond to the top (long) and the bottom (short) arms of chromosome 3, and the two small contigs are located in the genetically defined centromere(8). This chromosome encodes 5,220 of the roughly 25,500 predicted protein-coding genes in the genome. About 20% of the predicted proteins have significant homology to proteins in eukaryotic genomes for which the complete sequence is available, pointing to important conserved cellular functions among eukaryotes.	Genoscope, F-91057 Evry, France; CNRS, F-91057 Evry, France; GSF, Natl Res Ctr Environm & Hlth, Munich Informat Ctr Prot Sequences, Max Planck Inst Biochem, D-82152 Martinsried, Germany; Genotype GmbH, D-69259 Wilhelmshaven, Germany; European Mol Biol Lab, Biochem Instrumentat Program, D-69117 Heidelberg, Germany; LION Biosci AG, D-69120 Heidelberg, Germany; MWG Biotech AG, D-85560 Ebersberg, Germany; Univ Padua, CRIBI, I-35131 Padua, Italy; GBF, German Res Ctr Biotechnol, Dept Genome Anal, D-38124 Braunschweig, Germany; Univ Valencia, Dept Genet, E-46100 Burjassot, Spain; Sistemas Genom SL, Paterna 46980, Spain; MediGenomix GmbH, D-82152 Planegg Martinsried, Germany; Univ Perpignan, CNRS, UMR 5096, Lab Genome & Dev Plantes, F-66860 Perpignan 13, France; Univ Louvain, Unite Biochim Physiol, B-1348 Louvain, Belgium; Univ Amsterdam, Swammerdam Inst Life Sci, Mol Biol Sect, NL-1098 SM Amsterdam, Netherlands; Univ Grenoble 1, CNRS, Lab Plastes & Differenciat Cellulaire, F-38041 Grenoble 9, France; CSIC, Cid, Inst Biol Mol Barcelona, ES-08034 Barcelona, Spain; Univ Naples Federico II, CEINGE, I-80131 Naples, Italy; Univ Naples Federico II, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy; Inst Genom Res, Rockville, MD 20850 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Celera Genom Corp, Rockville, MD 20850 USA; Kazusa DNA Res Inst, Chiba 2920812, Japan	Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; European Molecular Biology Laboratory (EMBL); University of Padua; Helmholtz Association; Helmholtz-Center for Infection Research; University of Valencia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; University of Amsterdam; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II; J. Craig Venter Institute; University of Chicago; Kazusa DNA Research Institute	Salanoubat, M (corresponding author), Genoscope, 2 Rue G Cremieux, F-91057 Evry, France.	salanou@genoscope.cns.fr	Nakamura, Yasukazu/T-9038-2019; Pérez-Alonso, Manuel/M-3333-2014; Schoof, Heiko/Y-7073-2018; D'Angelo, Maria Grazia/K-4685-2016; Toppo, Stefano/Z-5479-2019; Pallavicini, Alberto/J-4158-2012; Sato, Shusei/A-3616-2015; Rudd, Stephen A/A-6434-2013; Monfort, Amparo/K-1356-2015; Salzberg, Steven/Q-6514-2019; Pallavicini, Alberto/H-9281-2019; Terol, Javier/H-6401-2013; Ansorge, Wilhelm/AAN-8780-2020; Mayer, Klaus FX/M-7941-2015; Salzberg, Steven L/F-6162-2011; Climent, Joan/O-5877-2017; ALCARAZ, jean-pierre/M-6821-2014; Mewes, Hans-Werner/A-8204-2019; Quetier, Francis/J-7923-2017	Pérez-Alonso, Manuel/0000-0002-3266-0340; Schoof, Heiko/0000-0002-1527-3752; D'Angelo, Maria Grazia/0000-0003-1241-4350; Toppo, Stefano/0000-0002-0246-3119; Pallavicini, Alberto/0000-0001-7174-4603; Sato, Shusei/0000-0002-0293-5366; Rudd, Stephen A/0000-0002-0344-7487; Monfort, Amparo/0000-0001-7106-7745; Salzberg, Steven/0000-0002-8859-7432; Pallavicini, Alberto/0000-0001-7174-4603; Terol, Javier/0000-0003-3345-0078; Mayer, Klaus FX/0000-0001-6484-1077; Salzberg, Steven L/0000-0002-8859-7432; Climent, Joan/0000-0002-8927-6614; ALCARAZ, jean-pierre/0000-0002-5924-9519; Mewes, Hans-Werner/0000-0002-9713-6398; VALLE, GIORGIO/0000-0003-4377-5685; Nakamura, Yasukazu/0000-0002-6782-5715; Boutry, Marc/0000-0002-2315-6900; Argiriou, Anagnostis/0000-0002-9164-632X; Benes, Vladimir/0000-0002-0352-2547; Quetier, Francis/0000-0003-4388-9287; Fraser, Claire/0000-0003-1462-2428; Cooke, Richard/0000-0001-6335-1092; simionati, barbara/0000-0002-0522-0737; Casacuberta, Elena/0000-0002-8203-8357				Alexiadis V, 2000, GENE DEV, V14, P1308; Asamizu E, 2000, DNA RES, V7, P175, DOI 10.1093/dnares/7.3.175; Bevan M, 1997, PLANT CELL, V9, P476, DOI 10.1105/tpc.9.4.476; Camilleri C, 1998, PLANT J, V14, P633, DOI 10.1046/j.1365-313X.1998.00159.x; CHOI S, 1995, PLANT MOL BIOL REP, V13, P124, DOI 10.1007/BF02668782; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; DANGEL AW, 1995, NUCLEIC ACIDS RES, V23, P2120, DOI 10.1093/nar/23.12.2120; Fransz P, 1998, PLANT J, V13, P867, DOI 10.1046/j.1365-313X.1998.00086.x; Glemet E, 1997, COMPUT APPL BIOSCI, V13, P137; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lazar G, 2000, PLANT MOL BIOL, V42, P571, DOI 10.1023/A:1006394207479; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LIU YG, 1995, PLANT J, V7, P351, DOI 10.1046/j.1365-313X.1995.7020351.x; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Lopato S, 1999, GENE DEV, V13, P987, DOI 10.1101/gad.13.8.987; MARTINEZZAPATER JM, 1986, MOL GEN GENET, V204, P417, DOI 10.1007/BF00331018; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Mozo T, 1998, MOL GEN GENET, V258, P562, DOI 10.1007/s004380050769; RICHARDS EJ, 1988, CELL, V53, P127, DOI 10.1016/0092-8674(88)90494-1; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; Sablowski RWM, 1998, PLANT CELL, V10, P1453, DOI 10.1105/tpc.10.9.1453; Sato S, 2000, DNA RES, V7, P131, DOI 10.1093/dnares/7.2.131; Sato S, 1998, DNA Res, V5, P163, DOI 10.1093/dnares/5.3.163; Schouten J, 2000, MOL GEN GENET, V263, P309, DOI 10.1007/PL00008682; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tabata S, 2000, NATURE, V408, P823, DOI 10.1038/35048507; Theologis A, 2000, NATURE, V408, P816, DOI 10.1038/35048500	29	130	2155	7	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 14	2000	408	6814					820	822						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382PK	11130713				2022-12-24	WOS:000165831300039
J	Anderson, JS; Lampl, I; Gillespie, DC; Ferster, D				Anderson, JS; Lampl, I; Gillespie, DC; Ferster, D			The contribution of noise to contrast invariance of orientation tuning in cat visual cortex	SCIENCE			English	Article							STOCHASTIC RESONANCE; SIMPLE CELLS; SELECTIVITY; NEURONS; PSYCHOPHYSICS; MODEL; INPUT	Feedforward models of visual cortex appear to be inconsistent with a well-known property of cortical cells: contrast invariance of orientation tuning. The models' fixed threshold broadens orientation tuning as contrast increases, whereas in real cells tuning width is invariant with contrast. We have compared the orientation tuning of spike and membrane potential responses in single cells. Both are contrast invariant, yet a threshold-linear relation applied to the membrane potential accurately predicts the orientation tuning of spike responses. The key to this apparent paradox lies in the noisiness of the membrane potential. Responses that are subthreshold on average are still capable of generating spikes on individual trials. Unlike the iceberg effect, contrast invariance remains intact even as threshold narrows orientation selectivity. Noise may, by extension, smooth the average relation between membrane potential and spike rate throughout the brain.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Ferster, D (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 N Campus Dr, Evanston, IL 60208 USA.			Lampl, Ilan/0000-0002-9380-0730; Anderson, Jeffrey/0000-0002-9669-3846	NATIONAL EYE INSTITUTE [R01EY004726] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY04726] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BULSARA A, 1991, J THEOR BIOL, V152, P531, DOI 10.1016/S0022-5193(05)80396-0; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; LI CY, 1984, PFLUG ARCH EUR J PHY, V401, P304; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Troyer TW, 1998, J NEUROSCI, V18, P5908; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0	23	305	310	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2000	290	5498					1968	1972		10.1126/science.290.5498.1968	http://dx.doi.org/10.1126/science.290.5498.1968			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382EL	11110664				2022-12-24	WOS:000165810000047
J	Kamisago, M; Sharma, SD; DePalma, SR; Solomon, S; Sharma, P; McDonough, B; Smoot, L; Mullen, MP; Woolf, PK; Wigle, ED; Seidman, JG; Seidman, CE				Kamisago, M; Sharma, SD; DePalma, SR; Solomon, S; Sharma, P; McDonough, B; Smoot, L; Mullen, MP; Woolf, PK; Wigle, ED; Seidman, JG; Seidman, CE			Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							X-LINKED GENE; HYPERTROPHIC CARDIOMYOPATHY; HEART-FAILURE; TROPONIN-C; MYOSIN; LOCUS; FREQUENCY; LINKAGE; DOMAIN; SYSTEM	Background: The molecular basis of idiopathic dilated cardiomyopathy, a primary myocardial disorder that results in reduced contractile function, is largely unknown. Some cases of familial dilated cardiomyopathy are caused by mutations in cardiac cytoskeletal proteins; this finding implicates defects in contractile-force transmission as one mechanism underlying this disorder. To elucidate this important cause of heart failure, we investigated other genetic causes of dilated cardiomyopathy. Methods: Clinical evaluations were performed in 21 kindreds with familial dilated cardiomyopathy. A genome-wide linkage study prompted a search of the genes encoding beta -myosin heavy chain, troponin T, troponin I, and alpha -tropomyosin for disease-causing mutations. Results: A genetic locus for mutations associated with dilated cardiomyopathy was identified at chromosome 14q11.2-13 (maximal lod score, 5.11; theta =0), where the gene for cardiac beta -myosin heavy chain is encoded. Analyses of this and other genes for sarcomere proteins identified disease-causing dominant mutations in four kindreds. Cardiac beta -myosin heavy-chain missense mutations (Ser532Pro and Phe764Leu) and a deletion in cardiac troponin T (Delta Lys210) caused early-onset ventricular dilatation (average age at diagnosis, 24 years) and diminished contractile function and frequently resulted in heart failure. Affected persons had neither antecedent cardiac hypertrophy (average maximal left-ventricular-wall thickness, 8.5 mm) nor histopathological findings characteristic of hypertrophy. Conclusions: Mutations in sarcomere protein genes account for approximately 10 percent of cases of familial dilated cardiomyopathy and are particularly prevalent in families with early-onset ventricular dilatation and dysfunction. Because distinct mutations in sarcomere proteins cause either dilated or hypertrophic cardiomyopathy, the effects of mutant sarcomere proteins on muscle mechanics must trigger two different series of events that remodel the heart. (N Engl J Med 2000;343:1688-96.) (C) 2000, Massachusetts Medical Society.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Div Cardiovasc, Boston, MA 02114 USA; New York Med Coll, Westchester Cty Med Ctr, Dept Pediat, Valhalla, NY 10595 USA; Univ Toronto, Toronto Gen Hosp, Dept Med, Toronto, ON M5G 1L7, Canada	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; New York Medical College; Westchester Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Alpert Bldg,Rm 533,200 Longwood Ave, Boston, MA 02115 USA.			DePalma, Steven/0000-0002-0381-5016				Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Cohn JN, 1997, CIRCULATION, V95, P766; Cope MJTV, 1996, STRUCTURE, V4, P969, DOI 10.1016/S0969-2126(96)00103-7; DAdamo P, 1997, AM J HUM GENET, V61, P862, DOI 10.1086/514886; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; DURAND JB, 1995, CIRCULATION, V92, P3387, DOI 10.1161/01.CIR.92.12.3387; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; HINA K, 1993, CLIN CARDIOL, V16, P403, DOI 10.1002/clc.4960160507; Houdusse A, 1997, STRUCTURE, V5, P1695, DOI 10.1016/S0969-2126(97)00315-8; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Jha PK, 1996, BIOCHEMISTRY-US, V35, P16573, DOI 10.1021/bi9622433; Jung M, 1998, CIRCULATION, V98, P246; Kobayashi T, 1999, BIOCHEMISTRY-US, V38, P5386, DOI 10.1021/bi981320m; KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846; LESZYK J, 1988, BIOCHEMISTRY-US, V27, P6983, DOI 10.1021/bi00418a047; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Rayment I, 1996, ANNU REV PHYSIOL, V58, P671; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; RUSS AP, 1993, HUM MOL GENET, V2, P609, DOI 10.1093/hmg/2.5.609; SEIDMAN CE, 1999, MOL BASIS CARDIOVASC, P251; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; SPIRITO P, 1987, AM J CARDIOL, V60, P123, DOI 10.1016/0002-9149(87)90998-2; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Towbin JA, 1999, NAT MED, V5, P266, DOI 10.1038/6474; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; TOWNSEND PJ, 1994, GENOMICS, V21, P311, DOI 10.1006/geno.1994.1271; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; WIGLE ED, 1995, CIRCULATION, V92, P1680, DOI 10.1161/01.CIR.92.7.1680	37	497	521	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 7	2000	343	23					1688	1696		10.1056/NEJM200012073432304	http://dx.doi.org/10.1056/NEJM200012073432304			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	380PX	11106718				2022-12-24	WOS:000165711900004
J	Paulson, S; Helser, A; Nardelli, MB; Taylor, RM; Falvo, M; Superfine, R; Washburn, S				Paulson, S; Helser, A; Nardelli, MB; Taylor, RM; Falvo, M; Superfine, R; Washburn, S			Tunable resistance of a carbon nanotube-graphite interface	SCIENCE			English	Article							CONTACT RESISTANCE	The transfer of electrons from one material to another is usually described in terms of energy conservation, with no attention being paid to momentum conservation. Here we present results on the junction resistance between a carbon nanotube and a graphite substrate and show that details of momentum conservation also can change the contact resistance. By changing the angular alignment of the atomic lattices, we found that contact resistance varied by more than an order of magnitude in a controlled and reproducible fashion, indicating that momentum conservation, in addition to energy conservation, can dictate the junction resistance in graphene systems such as carbon nanotube junctions and devices.	Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Falvo, M (corresponding author), Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA.		Nardelli, Marco Buongiorno/AAO-8938-2020; Superfine, Richard/A-1968-2012; Nardelli, Marco Buongiorno/C-9089-2009	Nardelli, Marco Buongiorno/0000-0003-0793-5055; Superfine, Richard/0000-0002-2569-071X; 				Bachtold A, 1999, NATURE, V397, P673, DOI 10.1038/17755; Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; BUONGIORNO M, 1999, PHYS REV B, V60; Collins PG, 2000, SCIENCE, V287, P1801, DOI 10.1126/science.287.5459.1801; Crespi VH, 1997, PHYS REV LETT, V79, P2093, DOI 10.1103/PhysRevLett.79.2093; Dai HJ, 1996, SCIENCE, V272, P523, DOI 10.1126/science.272.5261.523; Delaney P, 1999, APPL PHYS LETT, V75, P4028, DOI 10.1063/1.125527; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Falvo MR, 2000, PHYS REV B, V62, P10665, DOI 10.1103/PhysRevB.62.R10665; Falvo MR, 1999, NATURE, V397, P236, DOI 10.1038/16662; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; Fuhrer MS, 2000, SCIENCE, V288, P494, DOI 10.1126/science.288.5465.494; Maarouf AA, 2000, PHYS REV B, V61, P11156, DOI 10.1103/PhysRevB.61.11156; MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631; Schonenberger C, 1999, APPL PHYS A-MATER, V69, P283, DOI 10.1007/s003390051003; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954; Tersoff J, 1999, APPL PHYS LETT, V75, P4030, DOI 10.1063/1.125529; Tersoff J, 1999, APPL PHYS LETT, V74, P2122, DOI 10.1063/1.123776; WALLACE PR, 1947, PHYS REV, V71, P622, DOI 10.1103/PhysRev.71.622; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241	21	103	125	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 1	2000	290	5497					1742	1744		10.1126/science.290.5497.1742	http://dx.doi.org/10.1126/science.290.5497.1742			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	379FY	11099407				2022-12-24	WOS:000165632400035
J	Catchpole, MA; McGarrigle, CA; Rogers, PA; Jordan, LF; Mercey, D; Gill, ON				Catchpole, MA; McGarrigle, CA; Rogers, PA; Jordan, LF; Mercey, D; Gill, ON			Serosurveillance of prevalence of undiagnosed HIV-1 infection in homosexual men with acute sexually transmitted infection	BRITISH MEDICAL JOURNAL			English	Article							GENITOURINARY MEDICINE CLINICS; ATTENDERS; ENGLAND		Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, HIV STI Sect, London NW9 5EQ, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Stat Unit, London NW9 5EQ, England; UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AU, England	Public Health England; Public Health England; University of London; University College London; UCL Medical School	Catchpole, MA (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, HIV STI Sect, London NW9 5EQ, England.	mcatchpole@phls.nhs.uk	McGarrigle, Christine/J-8331-2017	McGarrigle, Christine/0000-0001-5814-5673				Catchpole M, 1997, GENITOURIN MED, V73, P457; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; *HIV SURV STEER GR, 1999, PREV HIV UK DAT END; NARDONE A, 1995, AIDS RES WORKSH ABST, P5; Simms I, 1999, SEX TRANSM INFECT, V75, P332, DOI 10.1136/sti.75.5.332	5	10	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 25	2000	321	7272					1319	1320		10.1136/bmj.321.7272.1319	http://dx.doi.org/10.1136/bmj.321.7272.1319			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	378BK	11090514	Green Published, Bronze			2022-12-24	WOS:000165561600025
J	Johnson, AP; Warner, M; Broughton, K; James, D; Efsratiou, A; George, RC; Livermore, DM				Johnson, AP; Warner, M; Broughton, K; James, D; Efsratiou, A; George, RC; Livermore, DM			Antibiotic susceptibility of streptococci and related genera causing endocarditis: analysis of UK reference laboratory referrals, January 1996 to March 2000	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFECTIVE ENDOCARDITIS; ENTEROCOCCI		Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England; Cent Publ Hlth Lab, Streptococcus & Diphtheria Reference Unit, Resp & Systemat Infect Lab, London NW9 5HT, England	Public Health England; Public Health England	Johnson, AP (corresponding author), Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England.	Ajohnson@phls.nhs.uk	Johnson, Alan P/F-4420-2014					COX RA, 1991, J ANTIMICROB CHEMOTH, V27, P1, DOI 10.1093/jac/27.1.1; Dyson C, 1999, J INFECTION, V38, P87, DOI 10.1016/S0163-4453(99)90074-9; Johnson AP, 1998, BMJ-BRIT MED J, V317, P629, DOI 10.1136/bmj.317.7159.629; Simmons NA, 1998, HEART, V79, P207; WILSON WR, 1995, JAMA-J AM MED ASSOC, V274, P1706, DOI 10.1001/jama.274.21.1706	5	14	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2001	322	7283					395	396		10.1136/bmj.322.7283.395	http://dx.doi.org/10.1136/bmj.322.7283.395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404JH	11179156	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000167093600024
J	Ford, MGJ; Pearse, BMF; Higgins, MK; Vallis, Y; Owen, DJ; Gibson, A; Hopkins, CR; Evans, PR; McMahon, HT				Ford, MGJ; Pearse, BMF; Higgins, MK; Vallis, Y; Owen, DJ; Gibson, A; Hopkins, CR; Evans, PR; McMahon, HT			Simultaneous binding of PtdIns(4,5)P-2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes	SCIENCE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; ASSEMBLY PROTEIN; COATED PITS; DOMAIN; ALPHA; AP-3; LOCALIZATION; INHIBITION; APPENDAGE; VESICLES	Adaptor protein 180 (AP180) and its homolog, clathrin assembly Lymphoid myeloid Leukemia protein (CALM), are closely related proteins that play important roles in clathrin-mediated endocytosis. Here, we present the structure of the NH2-terminal domain of CALM bound to phosphatidylinositol-4,5-bisphosphate [Ptdlns(4,5)P-2] via a lysine-rich motif. This motif is found in other proteins predicted to have domains of similar structure (for example, Huntingtin interacting protein 1). The structure is in part similar to the epsin NH2-terminal (ENTH) domain, but epsin Lacks the Ptdlns(4,5) P-2-binding site. Because AP180 could bind to Ptdins(4,5)P-2 and clathrin simultaneously, it may serve to tether clathrin to the membrane. This was shown by using purified components and a budding assay on preformed Lipid monolayers. In the presence of AP180, clathrin lattices formed on the monolayer. When AP2 was also present, coated pits were formed.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Evans, PR (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Higgins, Matthew/0000-0002-2870-1955				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kornberg RD, 1991, CURR OPIN STRUC BIOL, V1, P642, DOI 10.1016/S0959-440X(05)80090-9; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Levy D, 1999, J STRUCT BIOL, V127, P44, DOI 10.1006/jsbi.1999.4155; LINDNER R, 1992, J BIOL CHEM, V267, P16567; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; McMahon HT, 1999, CURR BIOL, V9, pR332, DOI 10.1016/S0960-9822(99)80206-1; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; NORRIS FA, 1995, J BIOL CHEM, V270, P214, DOI 10.1074/jbc.270.1.214; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Smith CJ, 1998, EMBO J, V17, P4943, DOI 10.1093/emboj/17.17.4943; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhao XH, 2001, J CELL SCI, V114, P353	36	583	594	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2001	291	5506					1051	1055		10.1126/science.291.5506.1051	http://dx.doi.org/10.1126/science.291.5506.1051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	400EW	11161218	Green Submitted			2022-12-24	WOS:000166860100047
J	Lefkowitz, RJ; Willerson, JT				Lefkowitz, RJ; Willerson, JT			Prospects for cardiovascular research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY DISEASE; ADRENERGIC-RECEPTOR KINASE; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; TRANSGENIC MICE; HEART-FAILURE; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; BETA(2)-ADRENERGIC RECEPTOR; ATHEROSCLEROTIC PLAQUES	Cardiovascular disease is the greatest threat to human life and health. The past decade has seen remarkable progress in clinical and basic cardiovascular research, and many areas of opportunity are promising. The pace of current progress in clinical and basic research is such that remarkable improvement in the quality and length of life for those at risk for cardiovascular disease is likely.	Univ Texas, Sch Med, Dept Internal Med, Houston, TX 77030 USA; Howard Hughes Med Inst, Chevy Chase, MD USA; Duke Univ, Dept Med, Durham, NC USA; Duke Univ, Dept Biochem, Durham, NC USA; Texas Heart Inst, Houston, TX 77025 USA	University of Texas System; Howard Hughes Medical Institute; Duke University; Duke University; Texas Heart Institute	Willerson, JT (corresponding author), Univ Texas, Sch Med, Dept Internal Med, 6431 Fannin,Suite 1-150, Houston, TX 77030 USA.		Lefkowitz, Robert/AAW-2649-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL50179, HL16037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akhter SA, 1999, CIRCULATION, V100, P648, DOI 10.1161/01.CIR.100.6.648; Antman EM, 1999, CIRCULATION, V99, P2720, DOI 10.1161/01.CIR.99.21.2720; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; BERK BC, 1990, AM J CARDIOL, V65, P168, DOI 10.1016/0002-9149(90)90079-G; Biasucci LM, 1999, CIRCULATION, V99, P2079, DOI 10.1161/01.CIR.99.16.2079; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Bray MS, 2000, CIRCULATION, V101, P2877, DOI 10.1161/01.CIR.101.25.2877; BUJA LM, 1981, AM J CARDIOL, V47, P343, DOI 10.1016/0002-9149(81)90407-0; Carter AM, 1997, CIRCULATION, V96, P1424, DOI 10.1161/01.CIR.96.5.1424; Casscells W, 1996, LANCET, V347, P1447, DOI 10.1016/S0140-6736(96)91684-0; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Cho MC, 1999, J BIOL CHEM, V274, P22251, DOI 10.1074/jbc.274.32.22251; CONSTANT.P, 1966, J ATHEROSCLER RES, V6, P1, DOI 10.1016/S0368-1319(66)80056-X; Cooke JP, 1997, ANNU REV MED, V48, P489, DOI 10.1146/annurev.med.48.1.489; DAVIES MJ, 1985, BRIT HEART J, V53, P363; Deswal A, 1999, CIRCULATION, V99, P3224, DOI 10.1161/01.CIR.99.25.3224; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; FALK E, 1983, BRIT HEART J, V50, P127; Fayad ZA, 2000, CIRCULATION, V102, P506; FOWLER MB, 1986, CIRCULATION, V74, P1290, DOI 10.1161/01.CIR.74.6.1290; Gao MH, 1999, CIRCULATION, V99, P1618, DOI 10.1161/01.CIR.99.12.1618; Gibbons GH, 1997, AM J CARDIOL, V79, P3, DOI 10.1016/S0002-9149(97)00122-7; Gimbrone MA, 1999, THROMB HAEMOSTASIS, V82, P722; Hendel RC, 2000, CIRCULATION, V101, P118, DOI 10.1161/01.CIR.101.2.118; Kersten JR, 1999, CARDIOVASC RES, V43, P44, DOI 10.1016/S0008-6363(99)00077-2; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; KRUSKAL JB, 1987, NEW ENGL J MED, V317, P1361, DOI 10.1056/NEJM198711263172201; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Liggett SB, 2000, CIRCULATION, V101, P1707; Liggett SB, 1998, J CLIN INVEST, V102, P1534, DOI 10.1172/JCI4059; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Seta Y, 1996, J Card Fail, V2, P243, DOI 10.1016/S1071-9164(96)80047-9; Stefanadis C, 1999, CIRCULATION, V99, P1965, DOI 10.1161/01.CIR.99.15.1965; Sullivan GW, 2000, J LEUKOCYTE BIOL, V67, P591, DOI 10.1002/jlb.67.5.591; TREASURE CB, 1995, NEW ENGL J MED, V332, P481, DOI 10.1056/NEJM199502233320801; Vatner SF, 2000, CIRC RES, V86, P502, DOI 10.1161/01.RES.86.5.502; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; WILLERSON JT, 1989, CIRCULATION, V80, P198, DOI 10.1161/01.CIR.80.1.198; WILLERSON JT, 1986, J AM COLL CARDIOL, V8, P245, DOI 10.1016/S0735-1097(86)80121-8	50	79	85	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					581	587		10.1001/jama.285.5.581	http://dx.doi.org/10.1001/jama.285.5.581			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176863	Bronze			2022-12-24	WOS:000166714200016
J	Mentzer, WC; Kan, YW				Mentzer, WC; Kan, YW			Prospects for research in hematologic disorders - Sickle cell disease and thalassemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BETA-THALASSEMIA; DIAGNOSIS; ANEMIA; BLOOD; TRANSPLANTATION; OLIGONUCLEOTIDE; MANAGEMENT	Sickle cell anemia and thalassemia constitute the most common genetic diseases in the world. Affected patients carry a heavy burden of morbidity and early mortality. With improved understanding of the pathophysiology and molecular basis of these diseases, treatment is evolving from management of symptoms to more effective strategies that aim to modify diseased red blood cells or replace them with normal cells. Available treatment options include red blood cell transfusions, pharmacologic interventions to increase fetal hemoglobin levels, and stem cell transplantation. Improvements in these approaches or the development of means to replace defective genes with normal ones using techniques of gene transfer offer hope for the future.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Cardiovasc Res Inst, Dept Lab Med, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mentzer, WC (corresponding author), San Francisco Gen Hosp, Room 331,Bldg 100,1001 Potrero Ave, San Francisco, CA 94110 USA.							Arcasoy MO, 1999, SEMIN HEMATOL, V36, P328; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Cao A, 1996, SEMIN HEMATOL, V33, P66; Cheung MC, 1996, NAT GENET, V14, P264, DOI 10.1038/ng1196-264; Corash L, 1999, TRANSFUS MED REV, V13, P18, DOI 10.1016/S0887-7963(99)80085-6; EHLERS KH, 1991, J PEDIATR-US, V118, P540, DOI 10.1016/S0022-3476(05)83374-8; Flake AW, 1999, BLOOD, V94, P2179, DOI 10.1182/blood.V94.7.2179.419k43_2179_2191; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hebbel RP, 2000, NEW ENGL J MED, V342, P1910, DOI 10.1056/NEJM200006223422512; Kren BT, 1999, P NATL ACAD SCI USA, V96, P10349, DOI 10.1073/pnas.96.18.10349; Loukopoulos D, 1996, SEMIN HEMATOL, V33, P76; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Mentzer WC, 2000, CURR OPIN HEMATOL, V7, P95, DOI 10.1097/00062752-200003000-00004; Olivieri NF, 1999, NEW ENGL J MED, V341, P99, DOI 10.1056/NEJM199907083410207; Olivieri NF, 1996, SEMIN HEMATOL, V33, P24; Osarogiagbon UR, 2000, BLOOD, V96, P314, DOI 10.1182/blood.V96.1.314.013k39_314_320; Paszty C, 1997, Curr Opin Hematol, V4, P88; Persons DA, 2000, P NATL ACAD SCI USA, V97, P5022, DOI 10.1073/pnas.97.10.5022; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Steinberg MH, 1999, NEW ENGL J MED, V340, P1021, DOI 10.1056/NEJM199904013401307; Xu KP, 1999, JAMA-J AM MED ASSOC, V281, P1701, DOI 10.1001/jama.281.18.1701; Yoon K, 1996, P NATL ACAD SCI USA, V93, P2071, DOI 10.1073/pnas.93.5.2071	24	14	15	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2001	285	5					640	642		10.1001/jama.285.5.640	http://dx.doi.org/10.1001/jama.285.5.640			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	397TV	11176873	Bronze			2022-12-24	WOS:000166714200026
J	Slanger, TG; Cosby, PC; Huestis, DL; Bida, TA				Slanger, TG; Cosby, PC; Huestis, DL; Bida, TA			Discovery of the atomic oxygen green line in the Venus night airglow	SCIENCE			English	Article							MOLECULAR-OXYGEN; SPECTROSCOPY; EXCITATION; EMISSIONS; ATMOSPHERES; SYSTEM; BANDS; MARS	Green line emission at 557.7 nanometers arising from the O(S-1 - D-1) transition of atomic oxygen has been observed on the nightside of Venus with HIRES, the echelle spectrograph on the W. M. Keck I 10-meter telescope. We also observe optical emissions of molecular oxygen, consistent with the spectra from the Venera orbiters, but our green Line intensity is so high that we cannot explain how it could be inconspicuous in the Venera spectra. An upper Limit for the intensity of the O(D-1 - P-3) oxygen red Line at 630 nanometers has also been obtained. The Large green/red ratio indicates that the source is not associated with the Venus ionosphere. An important conclusion is that observation of the green line in a planetary atmosphere is not an indicator of an atmosphere rich in molecular oxygen.	SRI Int, Mol Phys Lab, Aeron Grp, Menlo Park, CA 94025 USA; Lowell Observ, Flagstaff, AZ 86001 USA	SRI International	Slanger, TG (corresponding author), SRI Int, Mol Phys Lab, Aeron Grp, 333 Ravenswood Ave, Menlo Park, CA 94025 USA.			Cosby, Philip/0000-0002-5139-018X				AKASOFU S, 1999, EOS T AGU, V80, P397; BARTH CA, 1961, SCIENCE, V134, P1426; BATES DR, 1989, PLANET SPACE SCI, V37, P881, DOI 10.1016/0032-0633(89)90139-6; BATES DR, 1988, PLANET SPACE SCI, V36, P883, DOI 10.1016/0032-0633(88)90094-3; BOUGHER SW, 1994, J GEOPHYS RES-PLANET, V99, P3759, DOI 10.1029/93JE03431; Chapman S, 1931, P R SOC LOND A-CONTA, V132, P353, DOI 10.1098/rspa.1931.0105; CONNES P, 1979, ASTROPHYS J, V233, pL29, DOI 10.1086/183070; Crisp D, 1996, J GEOPHYS RES-PLANET, V101, P4577, DOI 10.1029/95JE03136; FELDMAN PD, 1979, NATURE, V279, P221, DOI 10.1038/279221a0; FOX JL, 1986, CAN J PHYS, V64, P1631, DOI 10.1139/p86-288; FOX JL, 1990, ADV SPACE RES-SERIES, V10, P31, DOI 10.1016/0273-1177(90)90162-S; FOX JL, GEOPHYS MONOGR AM GE, V66; HUESTIS DL, 1993, J GEOPHYS RES-PLANET, V98, P10839, DOI 10.1029/93JE00997; KRASNOPOLSKY VA, 1981, PLANET SPACE SCI, V29, P925, DOI 10.1016/0032-0633(81)90053-2; KRASNOPOLSKY VA, 1986, PLANET SPACE SCI, V34, P511, DOI 10.1016/0032-0633(86)90089-9; KRASNOPOLSKY VA, 1976, KOSM ISSLED, V14, P789; LAWRENCE GM, 1977, SCIENCE, V195, P573, DOI 10.1126/science.195.4278.573; LUHMANN JG, 1992, GEOPHYS MONOGR, V66, P191; LUHMANN JG, 1996, ATOMIC MOL OPTICAL P, P940; RAMSAY DA, 1986, CAN J PHYS, V64, P717, DOI 10.1139/p86-130; Rowland GA, 2000, GEOPHYS RES LETT, V27, P3301, DOI 10.1029/2000GL011793; SLANGER TG, 1981, J GEOPHYS RES-SPACE, V86, P3551, DOI 10.1029/JA086iA05p03551; SLANGER TG, 1988, J PHYS CHEM-US, V92, P267, DOI 10.1021/j100313a008; SLANGER TG, 1978, GEOPHYS RES LETT, V5, P947, DOI 10.1029/GL005i011p00947; STEGMAN J, 1991, PLANET SPACE SCI, V39, P595, DOI 10.1016/0032-0633(91)90054-E; STEWART AI, 1979, SCIENCE, V203, P777, DOI 10.1126/science.203.4382.777; STEWART AI, 1979, SCIENCE, V205, P59, DOI 10.1126/science.205.4401.59; TRAUGER JT, 1983, ICARUS, V55, P272, DOI 10.1016/0019-1035(83)90082-9; Zhang SPP, 1999, GEOPHYS RES LETT, V26, P529, DOI 10.1029/1999GL900033	29	60	60	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 19	2001	291	5503					463	465		10.1126/science.291.5503.463	http://dx.doi.org/10.1126/science.291.5503.463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11161195				2022-12-24	WOS:000166487500034
J	Stokkan, KA; Yamazaki, S; Tei, H; Sakaki, Y; Menaker, M				Stokkan, KA; Yamazaki, S; Tei, H; Sakaki, Y; Menaker, M			Entrainment of the circadian clock in the liver by feeding	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; ANTICIPATORY ACTIVITY; PERIPHERAL-TISSUES; FOOD; RHYTHMS; CORTICOSTERONE; OSCILLATORS; TEMPERATURE; PERSISTENCE; PACEMAKER	Circadian rhythms of behavior are driven by oscillators in the brain that are coupled to the environmental light cycle. Circadian rhythms of gene expression occur widely in peripheral organs, It is unclear how these multiple rhythms are coupled together to form a coherent system. To study such coupling, we investigated the effects of cycles of food availability (which exert powerful entraining effects on behavior) on the rhythms of gene expression in the Liver, Lung, and suprachiasmatic nucleus (SCN). We used a transgenic rat model whose tissues express Luciferase in vitro. Although rhythmicity in the SCN remained phase-locked to the light-dark cycle, restricted feeding rapidly entrained the Liver, shifting its rhythm by 10 hours within 2 days. Our results demonstrate that feeding cycles can entrain the Liver independently of the SCN and the light cycle, and they suggest the need to reexamine the mammalian circadian hierarchy. They also raise the possibility that peripheral circadian oscillators Like those in the liver may be coupled to the SCN primarily through rhythmic behavior, such as feeding.	Univ Virginia, Natl Sci Fdn Ctr Biol Timing, Charlottesville, VA 22904 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ Tromso, Dept Arctic Biol, N-9037 Tromso, Norway; Univ Tromso, Inst Med Biol, N-9037 Tromso, Norway; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo 108639, Japan	National Science Foundation (NSF); NSF - Center for Biological Timing; University of Virginia; University of Virginia; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University of Tokyo	Menaker, M (corresponding author), Univ Virginia, Natl Sci Fdn Ctr Biol Timing, POB 400328, Charlottesville, VA 22904 USA.	mm7e@virginia.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Yamazaki, Shin/0000-0002-6691-1531	NIMH NIH HHS [MH 56647] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; COMPERATORE C A, 1987, Journal of Biological Rhythms, V2, P227, DOI 10.1177/074873048700200306; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; HONMA KI, 1983, AM J PHYSIOL, V245, pR339, DOI 10.1152/ajpregu.1983.245.3.R339; Honma S, 1996, AM J PHYSIOL-REG I, V271, pR1514, DOI 10.1152/ajpregu.1996.271.6.R1514; INOUYE SIT, 1982, BRAIN RES, V232, P194, DOI 10.1016/0006-8993(82)90625-4; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KRIEGER DT, 1974, ENDOCRINOLOGY, V95, P1195, DOI 10.1210/endo-95-5-1195; Meerlo P, 1997, J BIOL RHYTHM, V12, P80, DOI 10.1177/074873049701200109; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; MOORE RY, 1974, BRAIN RES, V71, P17, DOI 10.1016/0006-8993(74)90188-7; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Richter C.P., 1922, PSYCHOL MONOGR, V1, P1; SAITO M, 1976, BIOCHIM BIOPHYS ACTA, V421, P177, DOI 10.1016/0304-4165(76)90181-1; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P731, DOI 10.1016/0031-9384(89)90359-4; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; STOKKAN KA, UNPUB; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yamazaki S, 1998, J NEUROSCI, V18, P10709	23	1241	1278	2	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2001	291	5503					490	493		10.1126/science.291.5503.490	http://dx.doi.org/10.1126/science.291.5503.490			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	393UF	11161204				2022-12-24	WOS:000166487500043
J	Adams, RH; Diella, F; Hennig, S; Helmbacher, F; Deutsch, U; Klein, R				Adams, RH; Diella, F; Hennig, S; Helmbacher, F; Deutsch, U; Klein, R			The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration	CELL			English	Article							RECEPTOR TYROSINE KINASES; EPH RECEPTORS; CARDIOVASCULAR DEVELOPMENT; SPROUTING ANGIOGENESIS; COMMISSURAL AXONS; HINDBRAIN; GENE; ANGIOPOIETIN-1; SEGMENTATION; EXPRESSION	The transmembrane ligand ephrinB2 and its cognate Eph receptor tyrosine kinases are important regulators of vascular morphogenesis. EphrinB2 may have an active signaling role, resulting in bi-directional signal transduction downstream of both ephrinB2 and Eph receptors. To separate the ligand and receptorlike functions of ephrinB2 in mice, we replaced the endogenous gene by cDNAs encoding either carboxyterminally truncated (ephrinB2(DeltaC)) or, as a control, full-length ligand (ephrinB2(WT)). While homozygous ephrinB2(WT/WT) animals were viable and fertile, loss of the ephrinB2 cytoplasmic domain resulted in midgestation lethality similar to ephrinB2 null mutants (ephrinB2(KO)). The truncated ligand was sufficient to restore guidance of migrating cranial neural crest cells, but ephrinB2(DeltaC/DeltaC) embryos showed defects in vasculogenesis and angiogenesis very similar to those observed in ephrinB2(KO/KO) animals. Our results indicate distinct requirements of functions mediated by the ephrinB carboxyterminus for developmental processes in the vertebrate embryo.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Max Planck Inst Physiol & Clin Res, WG Kerckhoff Inst, D-6350 Bad Nauheim, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Klein, R (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Helmbacher, Francoise/AAM-2318-2021; Klein, Ruediger/C-6147-2008; Adams, Ralf H/AAE-9274-2019	Helmbacher, Francoise/0000-0001-6822-1246; Klein, Ruediger/0000-0002-3109-0163; Deutsch, Urban/0000-0003-4265-6262				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Helbling PM, 2000, DEVELOPMENT, V127, P269; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holder N, 1999, DEVELOPMENT, V126, P2033; Kanzler B, 2000, DEVELOPMENT, V127, P1095; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; Kontges G, 1996, DEVELOPMENT, V122, P3229; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; KULLANDER K, 2001, IN PRESS NEURON; MADEN M, 1992, MECH DEVELOP, V37, P13, DOI 10.1016/0925-4773(92)90011-8; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; SHAM MH, 1993, CELL, V72, P183, DOI 10.1016/0092-8674(93)90659-E; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; Studer M, 1998, DEVELOPMENT, V125, P1025; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wang YJ, 1998, WORLD J GASTROENTERO, V4, P74; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452	30	219	224	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 12	2001	104	1					57	69		10.1016/S0092-8674(01)00191-X	http://dx.doi.org/10.1016/S0092-8674(01)00191-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	400QD	11163240	Bronze			2022-12-24	WOS:000166882300007
J	Nurminsky, D; De Aguiar, D; Bustamante, CD; Hartl, DL				Nurminsky, D; De Aguiar, D; Bustamante, CD; Hartl, DL			Chromosomal effects of rapid gene evolution in Drosophila melanogaster	SCIENCE			English	Article							BACKGROUND SELECTION; SEGREGATING SITES; DNA; POLYMORPHISM; PATTERNS; NUMBER; RATES	Rapid adaptive fixation of a new favorable mutation is expected to affect neighboring genes along the chromosome. Evolutionary theory predicts that the chromosomal region would show a reduced level of genetic variation and an excess of rare alleles, We have confirmed these predictions in a region of the X chromosome of Drosophila melanogaster that contains a newly evolved gene far a component of the sperm axoneme. In D, simulans, where the novel gene does not exist, the pattern of genetic variation is consistent with selection against recurrent deleterious mutations. These findings imply that the pattern of genetic variation along a chromosome may be useful for inferring its evolutionary history and for revealing regions in which recent adaptive fixations have taken place.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02137 USA; ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32604 USA; Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA	Harvard University; United States Department of Agriculture (USDA); Tufts University	Hartl, DL (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02137 USA.	dhartl@oeb.harvard.edu		Bustamante, Carlos D./0000-0002-4187-7920	NIGMS NIH HHS [GM 60035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060035] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aquadro CF, 1997, CURR OPIN GENET DEV, V7, P835, DOI 10.1016/S0959-437X(97)80048-2; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; CACCONE A, 1988, GENETICS, V118, P671; Charlesworth B, 1999, NATURE, V400, P519, DOI 10.1038/22922; CHARLESWORTH B, 1993, GENETICS, V134, P1289; CHARLESWORTH D, 1995, GENETICS, V141, P1619; HUDSON RR, 1995, GENETICS, V141, P1605; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; Perlitz M, 1997, J MATH BIOL, V36, P1, DOI 10.1007/s002850050087; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; TAJIMA F, 1989, GENETICS, V123, P585; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9	15	31	32	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	2001	291	5501					128	130		10.1126/science.291.5501.128	http://dx.doi.org/10.1126/science.291.5501.128			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	389VJ	11141564				2022-12-24	WOS:000166259100050
J	Henney, JE				Henney, JE			New combination drug for HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Henney, JE (corresponding author), US FDA, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 3	2001	285	1					34	34		10.1001/jama.285.1.34	http://dx.doi.org/10.1001/jama.285.1.34			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	387GH	11150092				2022-12-24	WOS:000166114500005
J	Whitney, CG; Farley, MM; Hadler, J; Harrison, LH; Lexau, C; Reingold, A; Lefkowitz, L; Cieslak, PR; Cetron, M; Zell, ER; Jorgensen, JH; Schuchat, A				Whitney, CG; Farley, MM; Hadler, J; Harrison, LH; Lexau, C; Reingold, A; Lefkowitz, L; Cieslak, PR; Cetron, M; Zell, ER; Jorgensen, JH; Schuchat, A		Active Bacterial Core Surveillance	Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE OTITIS-MEDIA; COMMUNITY-ACQUIRED PNEUMONIA; PENICILLIN-RESISTANT; NASOPHARYNGEAL CARRIAGE; PNEUMOCOCCAL BACTEREMIA; MENINGITIS; SUSCEPTIBILITY; SURVEILLANCE; MANAGEMENT; INFECTIONS	Background: The emergence of drug-resistant strains of bacteria has complicated treatment decisions and may lead to treatment failures. Methods: We examined data on invasive pneumococcal disease in patients identified from 1995 to 1998 in the Active Bacterial Core Surveillance program of the Centers for Disease Control and Prevention. Pneumococci that had a high level of resistance or had intermediate resistance according to the definitions of the National Committee for Clinical Laboratory Standards were defined as "resistant'' for this analysis. Results: During 1998, 4013 cases of invasive Streptococcus pneumoniae disease were reported (23 cases per 100,000 population); isolates were available for 3475 (87 percent). Overall, 24 percent of isolates from 1998 were resistant to penicillin. The proportion of isolates that were resistant to penicillin was highest in Georgia (33 percent) and Tennessee (35 percent), in children under five years of age (32 percent, vs. 21 percent for persons five or more years of age), and in whites (26 percent, vs. 22 percent for blacks). Penicillin-resistant isolates were more likely than susceptible isolates to have a high level of resistance to other antimicrobial agents. Serotypes included in the 7-valent conjugate and 23-valent pneumococcal polysaccharide vaccines accounted for 78 percent and 88 percent of penicillin-resistant strains, respectively. Between 1995 and 1998 (during which period 12,045 isolates were collected), the proportion of isolates that were resistant to three or more classes of drugs increased from 9 percent to 14 percent; there also were increases in the proportions of isolates that were resistant to penicillin (from 21 percent to 25 percent), cefotaxime (from 10 percent to 14 percent), meropenem (from 10 percent to 16 percent), erythromycin (from 11 percent to 15 percent), and trimethoprim-sulfamethoxazole (from 25 percent to 29 percent). The increases in the frequency of resistance to other antimicrobial agents occurred exclusively among penicillin-resistant isolates. Conclusions: Multidrug-resistant pneumococci are common and are increasing. Because a limited number of serotypes account for most infections with drug-resistant strains, the new conjugate vaccines offer protection against most drug-resistant strains of S. pneumoniae. (N Engl J Med 2000;343:1917-24.) (C) 2000, Massachusetts Medical Society.	Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Emory Univ, Sch Med, Atlanta, GA USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Connecticut Dept Publ Hlth, Hartford, CT USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA; Minnesota Dept Hlth, Minneapolis, MN USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Vanderbilt Univ Sch Med, Dept Prevent Med, Nashville, TN USA; Oregon Dept Human Serv, Hlth Div, Portland, OR USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Centers for Disease Control & Prevention - USA; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Johns Hopkins University; Minnesota Department of Health (MHD); University of California System; University of California Berkeley; Vanderbilt University; University of Texas System; University of Texas Health San Antonio	Whitney, CG (corresponding author), Ctr Dis Control & Prevent, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Mailstop C-23,1600 Clifton Rd NE, Atlanta, GA 30333 USA.							[Anonymous], 1997, MMWR MORB MORT WKLY, V46, P1; [Anonymous], 1997, M7A4 NCCLS; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; BARNETT ED, 1995, PEDIATR CLIN N AM, V42, P509; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; BREIMAN RF, 1994, JAMA-J AM MED ASSOC, V271, P1831, DOI 10.1001/jama.271.23.1831; Buckingham SC, 1998, J PEDIATR-US, V132, P174, DOI 10.1016/S0022-3476(98)70510-4; CATALAN MJ, 1994, CLIN INFECT DIS, V18, P766, DOI 10.1093/clinids/18.5.766; Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403; Chen FM, 1998, AM J EPIDEMIOL, V148, P1212, DOI 10.1093/oxfordjournals.aje.a009611; Choi EH, 1998, CLIN INFECT DIS, V26, P1346, DOI 10.1086/516340; Dagan R, 1997, J INFECT DIS, V176, P1253, DOI 10.1086/514120; Dagan R, 1997, PEDIATR INFECT DIS J, V16, P1060, DOI 10.1097/00006454-199711000-00011; Dagan R, 1996, J INFECT DIS, V174, P1271, DOI 10.1093/infdis/174.6.1271; DEAN A, 1995, EPI INFO VERSION 6 W; Deeks SL, 1999, PEDIATRICS, V103, P409, DOI 10.1542/peds.103.2.409; del Castillo F, 1998, PEDIATR INFECT DIS J, V17, P94, DOI 10.1097/00006454-199802000-00003; Doern GV, 1999, EMERG INFECT DIS, V5, P757, DOI 10.3201/eid0506.990603; Dowell SF, 1999, CLIN INFECT DIS, V29, P462, DOI 10.1086/588389; Dowell SF, 1999, PEDIATR INFECT DIS J, V18, P1, DOI 10.1097/00006454-199901000-00002; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Heffelfinger JD, 2000, ARCH INTERN MED, V160, P1399, DOI 10.1001/archinte.160.10.1399; HOFMANN J, 1995, NEW ENGL J MED, V333, P481, DOI 10.1056/NEJM199508243330803; Jacobs MR, 1996, PEDIATR INFECT DIS J, V15, P940, DOI 10.1097/00006454-199610000-00031; Jones RN, 1998, DIAGN MICR INFEC DIS, V32, P119, DOI 10.1016/S0732-8893(98)00072-8; Jorgensen JH, 1996, J CLIN MICROBIOL, V34, P2679, DOI 10.1128/JCM.34.11.2679-2684.1996; Jorgensen JH, 1999, ANTIMICROB AGENTS CH, V43, P329, DOI 10.1128/AAC.43.2.329; KRAMER MR, 1987, ISRAEL J MED SCI, V23, P174; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; MCCAIG LF, 1998, JAMA-J AM MED ASSOC, V279, P434; MELNICK SL, 1992, ANN PHARMACOTHER, V26, P1292, DOI 10.1177/106002809202601020; National Committee for Clinical Laboratory Standars, 1999, M100S9 NCCLS; Pan XS, 1996, ANTIMICROB AGENTS CH, V40, P2321, DOI 10.1128/AAC.40.10.2321; Poole Michael D., 1995, Pediatric Infectious Disease Journal, V14, pS23, DOI 10.1097/00006454-199504001-00005; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; SLOAS MM, 1992, PEDIATR INFECT DIS J, V11, P662; Thornsberry C, 1998, CLIN THER, V20, P1179, DOI 10.1016/S0149-2918(98)80113-6; Turett GS, 1999, CLIN INFECT DIS, V29, P321, DOI 10.1086/520209; 1999, MMWR MORB MORTAL WKL, V48, P656	41	685	732	0	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 28	2000	343	26					1917	1924		10.1056/NEJM200012283432603	http://dx.doi.org/10.1056/NEJM200012283432603			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	386VR	11136262	Bronze			2022-12-24	WOS:000166082700003
J	Janus, C; Pearson, J; McLaurin, J; Mathews, PM; Jiang, Y; Schmidt, SD; Chishti, MA; Horne, P; Heslin, D; French, J; Mount, HTJ; Nixon, RA; Mercken, M; Bergeron, C; Fraser, PE; St George-Hyslop, P; Westaway, D				Janus, C; Pearson, J; McLaurin, J; Mathews, PM; Jiang, Y; Schmidt, SD; Chishti, MA; Horne, P; Heslin, D; French, J; Mount, HTJ; Nixon, RA; Mercken, M; Bergeron, C; Fraser, PE; St George-Hyslop, P; Westaway, D			A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease	NATURE			English	Article							WATER-MAZE; TRANSGENIC MICE; PROTEIN; MEMORY; NEUROTOXICITY; DEFICITS; TASKS; MOUSE; TRIAL	Much evidence indicates that abnormal processing and extracellular deposition of amyloid-beta peptide (A beta), a proteolytic derivative of the beta -amyloid precursor protein (beta APP), is central to the pathogenesis of Alzheimer's disease (reviewed in ref. 1). In the PDAPP transgenic mouse model of Alzheimer's disease, immunization with Ab causes a marked reduction in burden of the brain amyloid(2,3). Evidence that A beta immunization also reduces cognitive dysfunction in murine models of Alzheimer's disease would support the hypothesis that abnormal A beta processing is essential to the pathogenesis of Alzheimer's disease, and would encourage the development of other strategies directed at the 'amyloid cascade'. Here we show that A beta immunization reduces both deposition of cerebral fibrillar A beta and cognitive dysfunction in the TgCRND8 murine model of Alzheimer's disease without, however, altering total levels of A beta in the brain. This implies that either a similar to 50% reduction in dense-cored A beta plaques is sufficient to affect cognition, or that vaccination may modulate the activity/abundance of a small subpopulation of especially toxic A beta species.	Univ Toronto, Dept Med, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Med Biophys, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Nathan S Kline Inst Ctr Dementia Res, Orangeburg, NY 10962 USA; NYU, Sch Med, Orangeburg, NY 10962 USA; Univ Hlth Network, Toronto Western Hosp, Dept Med, Div Neurol, Toronto, ON M5S 1A8, Canada; Janssen Res Fdn, B-2340 Beerse, Belgium	University of Toronto; University of Toronto; University of Toronto; Nathan Kline Institute for Psychiatric Research; New York University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Johnson & Johnson	St George-Hyslop, P (corresponding author), Univ Toronto, Dept Med, Ctr Res Neurodegenerat Dis, Tanz Neurosci Bldg,6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.		Mount, Howard/B-4097-2013; Schmidt, Stephen/B-5398-2012; Schmidt, Stephen/AAC-6967-2019	Mathews, Paul/0000-0003-1742-7687				Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Cain DP, 1997, PSYCHOBIOLOGY, V25, P286; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Dudchenko PA, 1997, J EXP PSYCHOL-ANIM B, V23, P194, DOI 10.1037/0097-7403.23.2.194; Gass P, 1998, LEARN MEMORY, V5, P274; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Janus C, 2000, NEUROBIOL AGING, V21, P541, DOI 10.1016/S0197-4580(00)00107-X; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; MARKOWSKA AL, 1993, BEHAV NEUROSCI, V107, P627; Martin P, 1996, MEASURING BEHAV; McLaurin J, 1998, J MOL BIOL, V278, P183, DOI 10.1006/jmbi.1998.1677; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Solomon B, 1996, P NATL ACAD SCI USA, V93, P452, DOI 10.1073/pnas.93.1.452; St George-Hyslop PH, 1999, NATURE, V400, P116; Steiner H, 1999, EUR ARCH PSY CLIN N, V249, P266, DOI 10.1007/s004060050098; SUSUKI N, 1994, SCIENCE, V264, P1336; TERRY R, 1999, ALZHEIMER DIS; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; WEHNER JM, 1990, BRAIN RES, V523, P181, DOI 10.1016/0006-8993(90)91485-Y; Whitehouse PJ, 1998, ALZ DIS ASSOC DIS, V12, P281, DOI 10.1097/00002093-199812000-00007; WISNIEWSKI HM, 1989, ACTA NEUROPATHOL, V78, P22, DOI 10.1007/BF00687398	30	1241	1387	4	109	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 21	2000	408	6815					979	982		10.1038/35050110	http://dx.doi.org/10.1038/35050110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	384NE	11140685				2022-12-24	WOS:000165951100051
J	Katz, SJ; Kabeto, M; Langa, KM				Katz, SJ; Kabeto, M; Langa, KM			Gender disparities in the receipt of home care for elderly people with disability in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the Society-for-General-Internal-Medicine	MAY 05-06, 2000	BOSTON, MASSACHUSETTS	Soc Gen Internal Med			INFORMAL CARE; PREDICTORS; PATTERNS; PARENTS; HELP	Context Projected demographic shifts in the US population over the next 50 years will cause families, health care practitioners, and policymakers to confront a marked increase in the number of people with disabilities living in the community. Concerns about the adequacy of community support are particularly salient to women, who make up a disproportionate number of disabled elderly people and who may be particularly vulnerable because they are more likely to live alone with limited financial resources. Objective To address gender differences in receipt of informal and formal home care. Design, Setting, and Participants Nationally representative survey conducted in 1993 among 7443 noninstitutionalized people (4538 women and 2905 men) aged 70 years or older. Main Outcome Measure Number of hours per week of informal (generally unpaid) and formal (generally paid) home care received by survey participants who reported any activity of daily living (ADL) or instrumental activity of daily living (IADL) impairment (n = 3109) com pared by gender and living arrangement and controlling for other factors. Results Compared with disabled men, disabled women were much more likely to be living alone (45.4% vs 16.8%, P<.001) and much less likely to be living with a spouse (27.8% vs 73.6%, P<.001). Overall, women received fewer hours of informal care per week than men (15.7 hours; 95% confidence interval [CI], 14.5-16.9 vs 21.2 hours; 95% CI, 19.7-22.8). Married disabled women received many fewer hours per week of informal home care than married disabled men (14.8 hours; 95% CI, 13.7-15.8 vs 26.2 hours; 95% CI, 24.6-27.9). Children (>80% women) were the dominant caregivers for disabled women while wives were the dominant caregivers of disabled men. Gender differences in formal home care were small (2.8 hours for women; 95% CI, 2.5-3.1 vs 2.1 hours for men; 95% CI, 1.7-2.4). Conclusion Large gender disparities appear to exist in the receipt of informal home care for disabled elderly people in the United States, even within married households, Programs providing home care support for disabled elderly people need to consider these large gender disparities and the burden they impose on families when developing intervention strategies in the community.	Univ Michigan, Dept Med, Div Gen Med, Ann Arbor, MI 48109 USA; Univ Michigan, Vet Affairs Ctr Practice Management & Outcomes Re, Ann Arbor, MI 48109 USA; Univ Michigan, CHOICES, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Hlth Policy & Management, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Social Res, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Katz, SJ (corresponding author), Univ Michigan, Dept Med, Div Gen Med, 300 N Ingalls,Suite 7E12,Box 0429, Ann Arbor, MI 48109 USA.		KATZ, STEVEN/ABH-8886-2020	Langa, Kenneth/0000-0002-2798-1836	NIA NIH HHS [U01 AG009740] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [U01AG009740] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson GF, 2000, HEALTH AFFAIR, V19, P191, DOI 10.1377/hlthaff.19.3.191; BARER BM, 1994, INT J AGING HUM DEV, V38, P29, DOI 10.2190/MCH0-VTER-DL6G-LECR; Boaz RF, 1997, J GERONTOL B-PSYCHOL, V52, pS317, DOI 10.1093/geronb/52B.6.S317; BURTON L, 1995, GERONTOLOGIST, V35, P744, DOI 10.1093/geront/35.6.744; *COLL STAT, 1999, STATA REF MAN; DUAN N, 1983, J EC BUSINESS STATIS, V1, P115, DOI DOI 10.2307/1391852; *HLTH CAR FIN ADM, 1998, NAT HLTH CAR EXP PRO; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; Hopp FP, 1999, GERONTOLOGIST, V39, P167, DOI 10.1093/geront/39.2.167; IngersollDayton B, 1996, GERONTOLOGIST, V36, P483, DOI 10.1093/geront/36.4.483; KEMPEN GIJM, 1990, GERONTOLOGIST, V30, P497, DOI 10.1093/geront/30.4.497; KEMPER P, 1992, HEALTH SERV RES, V27, P421; Langa KM, 2000, J GEN INTERN MED, V15, P79; LANGA KM, IN PRESS MED CARE; LEE GR, 1993, J GERONTOL, V48, pS9, DOI 10.1093/geronj/48.1.S9; Merlis M, 2000, HEALTH AFFAIR, V19, P141, DOI 10.1377/hlthaff.19.3.141; MILLER B, 1992, GERONTOLOGIST, V32, P498, DOI 10.1093/geront/32.4.498; Norgard TM, 1997, J GERONTOL B-PSYCHOL, V52, P93, DOI 10.1093/geronb/52B.Special_Issue.93; PENNING MJ, 1994, J GERONTOL, V49, P5202; Soldo BJ, 1997, J GERONTOL B-PSYCHOL, V52, P1, DOI 10.1093/geronb/52B.Special_Issue.1; SPECTOR WD, 1987, J CHRON DIS, V40, P481, DOI 10.1016/0021-9681(87)90004-X; STOLLER EP, 1993, GERONTOLOGIST, V33, P31, DOI 10.1093/geront/33.1.31; Stump TE, 1997, J GERONTOL B-PSYCHOL, V52, P49, DOI 10.1093/geronb/52B.Special_Issue.49; Wolf DA, 1997, J GERONTOL B-PSYCHOL, V52, P102, DOI 10.1093/geronb/52B.Special_Issue.102	24	126	127	1	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2000	284	23					3022	3027		10.1001/jama.284.23.3022	http://dx.doi.org/10.1001/jama.284.23.3022			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	382VC	11122589	Bronze			2022-12-24	WOS:000165847200027
J	Muscat, JE; Malkin, MC; Thompson, S; Shore, RE; Stellman, SD; McRee, D; Neugut, AI; Wynder, EL				Muscat, JE; Malkin, MC; Thompson, S; Shore, RE; Stellman, SD; McRee, D; Neugut, AI; Wynder, EL			Handheld cellular telephone use and risk of brain cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	International Workshop on Mobil Phone and Tumors of Brain, Head and Neck	NOV 13, 1999	BEIDELBERY, GERMANY				CENTRAL-NERVOUS-SYSTEM; FIELD EXPOSURE; TUMORS; HEAD; EPIDEMIOLOGY; MORTALITY; RADIATION; PHONES; NECK	Context A relative paucity of data exist on the possible health effects of using cellular telephones. Objective To test the hypothesis that using handheld cellular telephones is related to the risk of primary brain cancer. Design and Setting Case-control study conducted in 5 US academic medical centers between 1994 and 1998 using a structured questionnaire. Patients A total of 469 men and women aged 18 to 80 years with primary brain cancer and 422 matched controls without brain cancer. Main Outcome Measure Risk of brain cancer compared by use of handheld cellular telephones, in hours per month and years of use. Results The median monthly hours of use were 2.5 for cases and 2.2 for controls. Compared with patients who never used handheld cellular telephones, the multivariate odds ratio (OR) associated with regular past or current use was 0.85 (95% confidence interval [CI], 0.6-1.2). The OR for infrequent users (<0.72 h/mo) was 1.0 (95% CI, 0.5-2.0) and for frequent users (>10.1 h/mo) was 0.7 (95% CI, 0.3-1.4). The mean duration of use was 2.8 years for cases and 2.7 years for controls; no association with brain cancer was observed according to duration of use (P=.54), In cases, cerebral tumors occurred more frequently on the same side of the head where cellular telephones had been used (26 vs 15 cases; P=.06), but in the cases with temporal lobe cancer a greater proportion of tumors occurred in the contralateral than ipsilateral side (9 vs 5 cases; P=.33). The OR was less than 1.0 for all histologic categories of brain cancer except for uncommon neuroepitheliomatous cancers (OR, 2.1; 95% CI, 0.9-4.7). Conclusions Our data suggest that use of handheld cellular telephones is not associated with risk of brain cancer, but further studies are needed to account for longer induction periods, especially for slow-growing tumors with neuronal features.	Amer Hlth Fdn, Div Epidemiol, Valhalla, NY 10595 USA; Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; NYU, Dept Environm Med, New York, NY 10016 USA; Wireless Technol Res Inc, Raleigh, NC USA; Columbia Univ, Sch Publ Hlth, New York, NY USA	American Health Foundation; Memorial Sloan Kettering Cancer Center; New York University; Columbia University	Muscat, JE (corresponding author), Amer Hlth Fdn, Div Epidemiol, 1 Dana Rd, Valhalla, NY 10595 USA.	jmuscat2@earthlink.net		Shore, Roy/0000-0002-6842-2248	NCPDCID CDC HHS [NCI68384, NCI17613, NCI32617] Funding Source: Medline	NCPDCID CDC HHS		Adey WR, 1999, RADIAT RES, V152, P293, DOI 10.2307/3580329; Adey WR, 2000, CANCER RES, V60, P1857; BALZANO Q, 1995, IEEE T VEH TECHNOL, V44, P390, DOI 10.1109/25.406605; Brusick D, 1998, ENVIRON MOL MUTAGEN, V32, P1; Cardis E, 1999, RADIAT PROT DOSIM, V83, P179, DOI 10.1093/oxfordjournals.rpd.a032657; Davidson JA, 1998, MED J AUSTRALIA, V168, P48, DOI 10.5694/j.1326-5377.1998.tb123359.x; Dimbylow PJ, 1999, RADIAT PROT DOSIM, V83, P139, DOI 10.1093/oxfordjournals.rpd.a032648; Dreyer NA, 1999, JAMA-J AM MED ASSOC, V282, P1814, DOI 10.1001/jama.282.19.1814-a; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Elwood JM, 1999, ENVIRON HEALTH PERSP, V107, P155, DOI 10.2307/3434480; Funch DP, 1996, EPIDEMIOLOGY, V7, P299, DOI 10.1097/00001648-199605000-00014; Gandhi OP, 1996, IEEE T MICROW THEORY, V44, P1884, DOI 10.1109/22.539947; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Guy AW, 1997, HUM ECOL RISK ASSESS, V3, P25, DOI 10.1080/10807039709383666; Hardell L, 1999, INT J ONCOL, V15, P113; HARDELL L, 2000, CASE CONTROL STUDY R; Hocking B, 1998, MED J AUSTRALIA, V168, P48, DOI 10.5694/j.1326-5377.1998.tb123360.x; Inskip PD, 1999, RADIAT PROT DOSIM, V86, P45, DOI 10.1093/oxfordjournals.rpd.a032924; Inskip PD, 1995, EPIDEMIOL REV, V17, P382; Jauchem JR, 1998, J MICROWAVE POWER EE, V33, P263; Johansen C, 1999, RADIAT PROT DOSIM, V83, P155, DOI 10.1093/oxfordjournals.rpd.a032652; Juutilainen J, 1998, SCAND J WORK ENV HEA, V24, P245, DOI 10.5271/sjweh.317; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; KELLER JJ, 1993, WALL STREET J   0125, pB; KLEIHUES P, 1997, TUMORS NERVOUS SYSTE, P1; KUSTER N, 1992, IEEE T VEH TECHNOL, V41, P17, DOI 10.1109/25.120141; LAI H, 1995, BIOELECTROMAGNETICS, V16, P207, DOI 10.1002/bem.2250160309; Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382; Malyapa RS, 1998, RADIAT RES, V149, P637, DOI 10.2307/3579911; MCKINLAY A, 1999, RADIOL PROTECTION B, V187, P9; Morris HH, 1998, EPILEPSIA, V39, P307, DOI 10.1111/j.1528-1157.1998.tb01378.x; Moulder JE, 1999, RADIAT RES, V151, P513, DOI 10.2307/3580028; PrestonMartin S, 1996, NEUROL CLIN, V14, P273, DOI 10.1016/S0733-8619(05)70256-5; Quinn B, 1998, AM J SURG PATHOL, V22, P550, DOI 10.1097/00000478-199805000-00005; Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701; Repacholi MH, 1997, ENVIRON HEALTH PERSP, V105, P1565, DOI 10.2307/3433671; Rothman KJ, 1996, EPIDEMIOLOGY, V7, P291, DOI 10.1097/00001648-199605000-00013; Rothman KJ, 1996, EPIDEMIOLOGY, V7, P303, DOI 10.1097/00001648-199605000-00015; Royal Society of Canada, 1999, REV POT HLTH RISKS R; *SAS I INC, 1985, SAS IML US GUID VERS; Smirniotopoulos JG, 1999, NEUROIMAG CLIN N AM, V9, P595; Stewart W., 2000, REPORT INDEPENDENT E, P1; Stuchly MA, 1998, CRIT REV BIOMED ENG, V26, P117, DOI 10.1615/CritRevBiomedEng.v26.i1-2.20; Valberg PA, 1997, CANCER CAUSE CONTROL, V8, P323, DOI 10.1023/A:1018449003394; Verschaeve L, 1998, MUTAT RES-REV MUTAT, V410, P141, DOI 10.1016/S1383-5742(97)00037-9; Violanti JM, 1998, ACCIDENT ANAL PREV, V30, P519, DOI 10.1016/S0001-4575(97)00094-8	46	184	202	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2000	284	23					3001	3007		10.1001/jama.284.23.3001	http://dx.doi.org/10.1001/jama.284.23.3001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	382VC	11122586	Green Published			2022-12-24	WOS:000165847200024
J	Ladher, RK; Anakwe, KU; Gurney, AL; Schoenwolf, GC; Francis-West, PH				Ladher, RK; Anakwe, KU; Gurney, AL; Schoenwolf, GC; Francis-West, PH			Identification of synergistic signals initiating inner ear development	SCIENCE			English	Article							DEVELOPING CHICK LIMB; PRIMITIVE STREAK; EXPRESSION; HINDBRAIN; INDUCTION; XENOPUS; PATTERN; GENE; PROTOONCOGENE; ORGANIZATION	Tissue manipulation experiments in amphibians more than 50 years ago showed that induction of the inner ear requires two signals: a mesodermal signal followed by a neural signal. However, the molecules mediating this process have remained elusive. We present evidence for mesodermal initiation of otic development in higher Vertebrates and show that the mesoderm can direct terminal differentiation of the inner ear in rostral ectoderm. Furthermore, we demonstrate the synergistic interactions of the extracellular polypeptide ligands FGF-19 and Wnt-8c as mediators of mesodermal and neural signals, respectively, initiating inner ear development.	Kings Coll, Dept Craniofacial Dev, London SE1 9RT, England; Genentech Inc, Dept Mol Biol, San Francisco, CA USA; Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	University of London; King's College London; Roche Holding; Genentech; Utah System of Higher Education; University of Utah	Francis-West, PH (corresponding author), Kings Coll, Dept Craniofacial Dev, London SE1 9RT, England.		Ladher, Raj/B-3001-2008	Ladher, Raj/0000-0002-3613-9456				BARTOLAMI S, 1991, J COMP NEUROL, V314, P777, DOI 10.1002/cne.903140410; CHRISTIAN JL, 1992, EMBO J, V11, P33, DOI 10.1002/j.1460-2075.1992.tb05024.x; DEITCHER DL, 1994, J NEUROSCI, V14, P486; FERRARI D, 1995, MECH DEVELOP, V52, P257, DOI 10.1016/0925-4773(95)98113-O; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; Groves AK, 2000, DEVELOPMENT, V127, P3489; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Herbrand H, 1998, DEVELOPMENT, V125, P645; HUME CR, 1993, DEVELOPMENT, V119, P1147; JACOBSON AG, 1966, SCIENCE, V152, P25, DOI 10.1126/science.152.3718.25; KURATANI SC, 1993, DEVELOPMENT, V117, P105; LaBonne C, 1998, DEVELOPMENT, V125, P2403; MAHMOOD R, 1995, DEVELOPMENT, V121, P1399; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; REPRESA J, 1991, NATURE, V353, P561, DOI 10.1038/353561a0; SECHRIST J, 1994, DEVELOPMENT, V120, P1777; Torres M, 1998, MECH DEVELOP, V71, P5, DOI 10.1016/S0925-4773(97)00155-X; Uusitalo M, 1999, EXP CELL RES, V253, P336, DOI 10.1006/excr.1999.4710; Vendrell V, 2000, DEVELOPMENT, V127, P2011; Yuan SP, 1998, DEVELOPMENT, V125, P201	23	202	207	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 8	2000	290	5498					1965	1967		10.1126/science.290.5498.1965	http://dx.doi.org/10.1126/science.290.5498.1965			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382EL	11110663				2022-12-24	WOS:000165810000046
J	Burgio, GR; Locatelli, F				Burgio, GR; Locatelli, F			Ethics of creating programmed stem-cell donors	LANCET			English	Editorial Material									Univ Pavia, IRCCS, Policlin San Matteo, Dipartimento Sci Pediat, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia	Burgio, GR (corresponding author), Univ Pavia, IRCCS, Policlin San Matteo, Dipartimento Sci Pediat, I-27100 Pavia, Italy.							BURGIO GR, 1988, LANCET, V1, P945; BURGIO GR, 1987, LANCET, V1, P1484; BURGIO GR, 1997, BONE MARROW TRANSPL, V19, P163; BURGIO GR, 1997, LANCET, V379, P1482; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Jecker N S, 1990, J Clin Ethics, V1, P99; WEISS R, 2000, WASHINGTON POST 1003	7	12	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 2	2000	356	9245					1868	1869		10.1016/S0140-6736(00)03254-2	http://dx.doi.org/10.1016/S0140-6736(00)03254-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379WD	11130379				2022-12-24	WOS:000165665400006
J	Terskikh, A; Fradkov, A; Ermakova, G; Zaraisky, A; Tan, P; Kajava, AV; Zhao, XN; Lukyanov, S; Matz, M; Kim, S; Weissman, I; Siebert, P				Terskikh, A; Fradkov, A; Ermakova, G; Zaraisky, A; Tan, P; Kajava, AV; Zhao, XN; Lukyanov, S; Matz, M; Kim, S; Weissman, I; Siebert, P			"Fluorescent timer": Protein that changes color with time	SCIENCE			English	Article							GENE; MUTANTS; XANF-1	We generated a mutant of the red fluorescent protein drFP583. The mutant (E5) changes its fluorescence from green to red over time. The rate of color conversion is independent of protein concentration and therefore can be used to trace time-dependent expression. We used in vivo labeling with E5 to measure expression from the heat shock-dependent promoter in Caenorhabditis elegans and from the Otx-2 promoter in developing Xenopus embryos. Thus, E5 is a "fluorescent timer" that can be used to monitor both activation and downregulation of target promoters on the whole-organism scale.	Stanford Univ, Sch Med, Stanford, CA 94305 USA; Russian Acad Sci, Inst Bioorgan Chem, Moscow 117871, Russia; NIH, Ctr Mol Modeling, Ctr Informat Technol, Bethesda, MD 20892 USA; Clontech Labs, Palo Alto, CA 94303 USA	Stanford University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Terskikh, A (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	Alexey.Terskikh@Stanford.edu	Zaraisky, Andrey G/Q-2323-2016; Lukyanov, Sergey/F-9140-2014; Kajava, Andrey V/E-1107-2014; Terskikh, Alexey/U-8407-2019; Matz, Mikhail V/K-4392-2017	Zaraisky, Andrey G/0000-0003-4681-8169; Kajava, Andrey V/0000-0002-2342-6886; Matz, Mikhail V/0000-0001-5453-9819	CENTER FOR INFORMATION TECHNOLOGY [Z01CT000259] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R03TW001362] Funding Source: NIH RePORTER; FIC NIH HHS [1 RO3 TW01362-01] Funding Source: Medline	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; DELAGRAVE S, 1995, BIO-TECHNOL, V13, P151, DOI 10.1038/nbt0295-151; EHRIG T, 1995, FEBS LETT, V367, P163, DOI 10.1016/0014-5793(95)00557-P; Ermakova GV, 1999, DEVELOPMENT, V126, P4513; ETKIN LD, 1987, DEVELOPMENT, V99, P15; Galliot B, 2000, TRENDS GENET, V16, P1, DOI 10.1016/S0168-9525(99)01888-0; HELM R, 1994, P NATL ACAD SCI USA, V91, P12501; HELM R, 1995, NATURE, V373, P663; JONES D, 1989, DNA-J MOLEC CELL BIO, V8, P481, DOI 10.1089/dna.1.1989.8.481; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; OKKEMA PG, 1993, GENETICS, V135, P385; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; ZARAISKY AG, 1995, DEVELOPMENT, V121, P3839	16	306	342	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 24	2000	290	5496					1585	1588		10.1126/science.290.5496.1585	http://dx.doi.org/10.1126/science.290.5496.1585			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376EX	11090358				2022-12-24	WOS:000165446200053
J	Guo, S; Yamaguchi, Y; Schilbach, S; Wada, T; Lee, J; Goddard, A; French, D; Handa, H; Rosenthal, A				Guo, S; Yamaguchi, Y; Schilbach, S; Wada, T; Lee, J; Goddard, A; French, D; Handa, H; Rosenthal, A			A regulator of transcriptional elongation controls vertebrate neuronal development	NATURE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; SPT5; DSIF; PROTEIN; GENES; EXPRESSION; ZEBRAFISH; CELLS	The development of distinct vertebrate neurons is defined by the unique profiles of genes that neurons express. It is accepted that neural genes are regulated at the point of transcription initiation, but the role of messenger RNA elongation in neural gene regulation has not been examined(1-3). Here we describe the mutant foggy, identified in a genetic screen for mutations that affect neuronal development in zebrafish(4), that displayed a reduction of dopamine-containing neurons and a corresponding surplus of serotonin-containing neurons in the hypothalamus. Positional cloning disclosed that Foggy is a brain-enriched nuclear protein that is structurally related to the transcription elongation factor Spt5 (refs 5-12). Foggy is not part of the basic transcription apparatus but a phosphorylation-dependent, dual regulator of transcription elongation. The mutation disrupts its repressive but not its stimulatory activity. Our results provide molecular, genetic and biochemical evidence that negative regulators of transcription elongation control key aspects of neuronal development.	Genentech Inc, Dept Mol Biol, S San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, S San Francisco, CA 94080 USA; Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 2268501, Japan; Tokyo Inst Technol, Frontier Collaborat Res Ctr, Yokohama, Kanagawa 2268501, Japan	Roche Holding; Genentech; Roche Holding; Genentech; Tokyo Institute of Technology; Tokyo Institute of Technology	Rosenthal, A (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, S San Francisco, CA 94080 USA.		Yamaguchi, Yuki/B-9390-2015	Yamaguchi, Yuki/0000-0002-0197-614X				Anderson D, 1997, MOL CELLULAR APPROAC, P26; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Greenblatt J, 1997, CURR OPIN CELL BIOL, V9, P310, DOI 10.1016/S0955-0674(97)80002-6; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Hubbard EJA, 1996, SCIENCE, V273, P112, DOI 10.1126/science.273.5271.112; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shilatifard A, 1997, CURR OPIN GENET DEV, V7, P199, DOI 10.1016/S0959-437X(97)80129-3; SULLIVAN SL, 1992, J BACTERIOL, V174, P1339, DOI 10.1128/jb.174.4.1339-1344.1992; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; SWANSON MS, 1991, MOL CELL BIOL, V11, P3009, DOI 10.1128/MCB.11.6.3009; SWANSON MS, 1992, GENETICS, V132, P325; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Yamaguchi Y, 1998, GENES CELLS, V3, P9, DOI 10.1046/j.1365-2443.1998.00162.x; Zorick TS, 1999, DEVELOPMENT, V126, P1397	25	130	131	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2000	408	6810					366	369		10.1038/35042590	http://dx.doi.org/10.1038/35042590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11099044				2022-12-24	WOS:000165296000047
J	Lincoln, T				Lincoln, T			Medicine - Cardiac arrest can be less of a gamble	NATURE			English	Editorial Material																		Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 16	2000	408	6810					302	302		10.1038/35042660	http://dx.doi.org/10.1038/35042660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	373NR	11185494				2022-12-24	WOS:000165296000028
J	Holmberg, J; Clarke, DL; Frisen, J				Holmberg, J; Clarke, DL; Frisen, J			Regulation of repulsion versus adhesion by different splice forms of an Eph receptor	NATURE			English	Article							NEURAL-TUBE DEFECTS; RETINAL AXON GUIDANCE; TYROSINE KINASE; IN-VITRO; EPHRINS; IDENTIFICATION; MORPHOGENESIS; EXPRESSION; LIGANDS; GROWTH	Eph tyrosine kinase receptors and their membrane-bound ephrin ligands mediate cell interactions and participate in several developmental processes(1-4). Ligand binding to an Eph receptor results in tyrosine phosphorylation of the kinase domain, and repulsion of axonal growth cones and migrating cells. Here we report that a subpopulation of ephrin-A5 null mice display neural tube defects resembling anencephaly in man. This is caused by the failure of the neural folds to fuse in the dorsal midline, suggesting that ephrin-A5, in addition to its involvement in cell repulsion(5,6), can participate in cell adhesion. During neurulation, ephrin-A5 is coexpressed with its cognate receptor EphA7 in cells at the edges of the dorsal neural folds. Three different EphA7 splice variants(7,8), a full-length form and two truncated versions lacking kinase domains, are expressed in the neural folds. Co-expression of an endogenously expressed truncated form of EphA7 suppresses tyrosine phosphorylation of the full-length EphA7 receptor and shifts the cellular response from repulsion to adhesion in vitro. We conclude that alternative usage of different splice forms of a tyrosine kinase receptor can mediate cellular adhesion or repulsion during embryonic development.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Frisen, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@cmb.ki.se						Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Castellani V, 1998, J NEUROSCI, V18, P4663; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; CIOSSEK T, 1995, ONCOGENE, V10, P97; Ciossek T, 1999, MOL BRAIN RES, V74, P231, DOI 10.1016/S0169-328X(99)00285-5; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Fleming A, 1998, SCIENCE, V280, P2107, DOI 10.1126/science.280.5372.2107; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gao PP, 2000, J NEUROSCI RES, V60, P427, DOI 10.1002/(SICI)1097-4547(20000515)60:4<427::AID-JNR1>3.3.CO;2-4; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Holder N, 1999, DEVELOPMENT, V126, P2033; Holland SJ, 1998, CURR OPIN NEUROBIOL, V8, P117, DOI 10.1016/S0959-4388(98)80015-9; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; KALLEN B, 1994, TERATOLOGY, V50, P322, DOI 10.1002/tera.1420500503; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; VALENZUELA DM, 1995, ONCOGENE, V10, P1573; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wikstrom K, 1996, EXP CELL RES, V227, P360, DOI 10.1006/excr.1996.0285; Xu QL, 1996, NATURE, V381, P319, DOI 10.1038/381319a0; Xu QL, 1995, DEVELOPMENT, V121, P4005; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	30	279	290	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 9	2000	408	6809					203	206		10.1038/35041577	http://dx.doi.org/10.1038/35041577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371LL	11089974				2022-12-24	WOS:000165180400046
